data_2kxx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kxx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.639 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 5.5 tp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.881 0.372 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.499 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 28.2 p -127.7 -174.38 3.17 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.486 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.69 -34.87 78.8 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.939 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -56.2 -46.43 79.45 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.509 0.671 . . . . 0.0 110.353 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.596 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.3 m-20 -74.13 -28.44 61.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.308 -176.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.913 HG21 HD23 ' A' ' 91' ' ' LEU . 84.0 t -62.94 -40.56 89.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.406 0.622 . . . . 0.0 109.82 172.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.2 t -64.93 -22.88 67.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.564 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.596 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 42.9 mtpt -70.41 -46.35 64.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.35 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.601 HG23 ' HE1' ' A' ' 50' ' ' MET . 22.8 pt -75.77 173.04 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-O 122.01 0.909 . . . . 0.0 112.728 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.69 148.24 10.59 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.469 -176.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -71.1 143.03 14.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.65 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.96 -32.69 4.5 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.31 -0.947 . . . . 0.0 112.608 -176.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.601 ' HE1' HG23 ' A' ' 46' ' ' ILE . 16.3 ptt? -85.65 177.91 7.54 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 117.371 0.586 . . . . 0.0 111.126 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.76 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 38.9 p -91.9 -171.38 2.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.979 -172.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.462 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 97.1 mt-30 -68.74 -46.26 69.32 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.094 172.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.482 ' HA ' ' HE1' ' A' ' 68' ' ' PHE . 9.9 pt20 -63.4 -35.03 79.05 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.448 0.642 . . . . 0.0 110.171 -175.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.76 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.5 mm-40 -61.43 -56.97 14.28 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.246 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.614 HG13 ' CD2' ' A' ' 93' ' ' LEU . 80.2 t -61.91 -41.78 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.813 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.524 ' HB2' HG21 ' A' ' 61' ' ' THR . . . -56.4 -36.93 69.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.147 0.499 . . . . 0.0 110.228 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -82.26 -34.18 28.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.15 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.66 -41.67 71.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.527 0.679 . . . . 0.0 111.006 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.639 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -92.31 -44.26 8.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.425 -1.262 . . . . 0.0 111.428 -173.343 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.18 122.94 4.16 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -170.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.536 HG21 ' HG3' ' A' ' 67' ' ' PRO . 58.5 p -58.86 135.92 87.11 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 120.963 0.411 . . . . 0.0 111.235 -175.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 23.0 Cg_exo -63.27 172.91 4.64 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.71 2.94 . . . . 0.0 113.585 -172.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.471 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 11.5 mt -47.66 -48.64 28.85 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.024 -174.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.522 ' HE1' HG22 ' A' ' 70' ' ' THR . 10.7 ptt? -53.67 -19.57 4.21 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.364 178.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.6 t 73.13 -4.82 2.08 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.749 0.82 . . . . 0.0 111.75 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -124.12 90.97 50.18 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-O 121.998 0.904 . . . . 0.0 110.044 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.56 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 57.4 Cg_endo -70.62 -32.92 14.18 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.462 2.108 . . . . 0.0 112.075 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.482 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 10.5 m-85 -78.09 9.46 3.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.848 -175.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.33 -23.32 19.74 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.841 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.522 HG22 ' HE1' ' A' ' 64' ' ' MET . 10.7 t -124.83 174.37 7.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.818 0.342 . . . . 0.0 110.816 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -119.73 5.38 11.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.357 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.4 m -133.95 110.89 10.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.162 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.56 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 48.6 m0 -104.18 138.84 40.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -175.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -116.45 120.97 40.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.868 0.366 . . . . 0.0 110.632 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.574 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 68.1 m-85 -132.15 174.79 9.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.214 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.482 HG11 ' H ' ' A' ' 77' ' ' PHE . 2.7 t -122.23 169.09 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -172.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.482 ' H ' HG11 ' A' ' 76' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.913 HD23 HG21 ' A' ' 43' ' ' VAL . 13.7 tp -99.64 117.47 34.06 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 173.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.58 ' OG1' ' HE2' ' A' ' 107' ' ' LYS . 78.9 m -111.59 107.2 16.27 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.865 ' HG ' HD22 ' A' ' 101' ' ' LEU . 7.2 tp -88.54 125.41 34.77 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.613 -174.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.7 m -106.91 124.34 49.48 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.886 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -114.69 141.54 47.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.96 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.576 ' HB3' HG22 ' A' ' 102' ' ' THR . 30.2 p30 -75.69 -175.31 2.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.354 176.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.5 m -57.65 -35.19 70.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.636 ' HB3' HG23 ' A' ' 100' ' ' VAL . 30.2 t -76.8 -19.84 57.11 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.995 0.426 . . . . 0.0 110.904 -175.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.79 26.86 9.4 Favored Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.636 HG23 ' HB3' ' A' ' 98' ' ' SER . 4.4 t -106.83 142.06 20.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.944 -0.628 . . . . 0.0 109.672 -177.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.865 HD22 ' HG ' ' A' ' 93' ' ' LEU . 5.8 mt -60.86 123.95 19.05 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.21 0.529 . . . . 0.0 111.837 178.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.576 HG22 ' HB3' ' A' ' 96' ' ' ASN . 19.2 p -109.69 -41.72 4.47 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.327 176.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -148.95 145.85 27.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.249 0.547 . . . . 0.0 112.016 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.748 HG22 HD11 ' A' ' 91' ' ' LEU . 3.9 mm -106.27 94.73 3.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 174.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.579 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 9.3 t70 -86.74 98.81 11.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.897 0.38 . . . . 0.0 110.916 -171.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -106.88 106.36 16.85 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.925 0.869 . . . . 0.0 110.29 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.58 ' HE2' ' OG1' ' A' ' 92' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.799 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.054 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.688 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 3.2 tp . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.853 0.359 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 43.1 p -127.0 -173.49 2.9 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.107 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.65 -37.86 88.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.354 0.597 . . . . 0.0 111.379 -178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -62.05 -42.45 99.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.795 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.505 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 16.7 m-20 -70.25 -32.68 70.63 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.842 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.853 HG21 HD23 ' A' ' 91' ' ' LEU . 58.6 t -58.58 -36.03 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.089 0.471 . . . . 0.0 111.128 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.8 t -62.22 -16.29 52.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.552 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 46.1 mtpt -74.07 -24.02 59.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.643 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.714 HG22 HD11 ' A' ' 59' ' ' LEU . 37.8 pt -100.73 175.83 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.619 0.723 . . . . 0.0 112.244 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -164.13 150.8 11.45 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.079 -177.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -73.12 143.06 14.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.655 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.76 -21.97 8.85 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.352 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.661 ' HE1' HG23 ' A' ' 46' ' ' ILE . 16.0 ptt? -96.46 178.24 5.42 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.164 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.795 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 41.5 p -92.78 -175.49 3.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.96 -171.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.471 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 77.3 mt-30 -63.05 -46.81 85.75 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.528 171.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.512 ' HA ' ' HE1' ' A' ' 68' ' ' PHE . 9.7 pt20 -65.25 -35.34 80.73 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.334 0.588 . . . . 0.0 109.84 -173.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.795 ' HG3' ' H ' ' A' ' 51' ' ' THR . 7.7 mm-40 -60.25 -51.87 67.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.177 176.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.644 HG13 HD21 ' A' ' 93' ' ' LEU . 69.5 t -66.94 -45.0 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.9 -175.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.71 ' HB3' HG21 ' A' ' 61' ' ' THR . . . -64.08 -25.11 67.96 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.436 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -80.9 -42.35 21.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.029 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.78 76.95 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.653 0.74 . . . . 0.0 111.342 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.714 HD11 HG22 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -90.12 -36.4 14.86 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.563 -172.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.6 127.76 5.76 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -170.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.71 HG21 ' HB3' ' A' ' 56' ' ' ALA . 56.9 p -59.15 136.21 88.12 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-O 120.93 0.395 . . . . 0.0 110.659 -177.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.512 ' CD ' ' HB3' ' A' ' 67' ' ' PRO . 22.2 Cg_exo -62.07 171.96 4.51 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.478 2.785 . . . . 0.0 113.309 -172.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.5 mt -51.08 -43.68 61.07 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.038 0.535 . . . . 0.0 111.606 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.1 ptt? -58.66 -12.23 3.94 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.423 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.2 t 68.98 -0.59 2.37 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.513 0.725 . . . . 0.0 111.827 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -134.72 91.52 20.86 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.605 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 90.6 Cg_endo -77.85 -29.07 4.63 Favored 'Trans proline' 0 C--N 1.327 -0.554 0 C-N-CA 123.268 2.645 . . . . 0.0 113.15 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.512 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 13.0 m-85 -80.59 21.62 0.63 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.038 -172.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.7 -17.41 8.02 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.989 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 t -124.81 172.27 9.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.732 0.301 . . . . 0.0 110.385 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -125.01 15.57 8.51 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.282 0.563 . . . . 0.0 109.975 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.6 m -138.88 109.24 6.49 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.495 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.605 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 50.3 m0 -104.48 143.23 33.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.707 -175.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -118.06 115.03 24.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.156 0.503 . . . . 0.0 111.241 -176.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.578 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 57.2 m-85 -129.93 176.46 8.03 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.2 p -128.87 153.57 38.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.598 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.419 ' CE1' HG22 ' A' ' 43' ' ' VAL . 1.5 m-30 . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.301 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.438 -1.064 0 CA-C-O 121.22 0.533 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.853 HD23 HG21 ' A' ' 43' ' ' VAL . 14.1 tp -93.0 112.55 24.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.875 174.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.686 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 10.6 m -107.09 105.98 16.25 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.884 ' HG ' HD22 ' A' ' 101' ' ' LEU . 7.0 tp -87.37 118.21 26.66 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.515 -175.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 38.6 m -101.64 122.68 44.32 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.127 -174.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -116.13 140.88 48.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.241 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.514 HD22 ' HB ' ' A' ' 100' ' ' VAL . 30.1 p30 -76.43 -177.19 4.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.16 175.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.0 t -54.42 -38.31 66.1 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.475 ' HB2' HG23 ' A' ' 100' ' ' VAL . 49.8 m -80.2 -3.8 50.51 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -174.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.33 28.0 34.68 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.824 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.514 ' HB ' HD22 ' A' ' 96' ' ' ASN . 6.6 t -106.41 140.86 23.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.884 HD22 ' HG ' ' A' ' 93' ' ' LEU . 7.3 mt -59.91 126.2 26.62 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.328 0.585 . . . . 0.0 112.195 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.507 HG22 ' HB3' ' A' ' 96' ' ' ASN . 18.0 p -111.18 -36.7 5.53 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.365 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -152.95 152.98 32.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.325 0.583 . . . . 0.0 111.673 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.811 HG22 HD11 ' A' ' 91' ' ' LEU . 3.3 mm -108.41 92.6 2.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 171.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.686 ' HB2' ' HB ' ' A' ' 92' ' ' THR . 2.3 m-20 -78.4 96.33 5.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.574 0.226 . . . . 0.0 110.989 -174.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -112.07 107.42 16.36 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.829 0.824 . . . . 0.0 110.49 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.875 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.445 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.624 HD12 HD12 ' A' ' 59' ' ' LEU . 2.5 tp . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.743 0.306 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 43.6 p -127.14 -174.66 3.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.171 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.82 -38.19 85.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.332 0.586 . . . . 0.0 110.606 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -54.31 -40.7 68.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.44 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.565 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 12.9 m-20 -73.92 -33.35 63.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.783 -1.098 . . . . 0.0 111.209 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.789 HG21 HD23 ' A' ' 91' ' ' LEU . 74.0 t -60.71 -37.73 76.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.314 0.578 . . . . 0.0 110.211 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.7 t -58.54 -22.39 55.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.126 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.443 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 45.2 mtpt -71.61 -40.59 69.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.78 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.602 HG22 HD11 ' A' ' 59' ' ' LEU . 41.6 pt -85.58 179.2 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-O 121.938 0.875 . . . . 0.0 112.925 -175.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.445 ' N ' ' HD3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -168.26 147.2 4.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.464 -175.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.431 HG21 ' CG1' ' A' ' 104' ' ' ILE . 0.8 OUTLIER -72.61 144.22 13.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.742 -179.353 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.98 -31.75 5.03 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.861 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.533 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 21.7 ptt? -86.39 175.14 8.56 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.976 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.876 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 26.0 p -93.29 -170.77 2.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.974 -171.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -66.69 -46.04 76.89 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.616 172.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.491 ' OE1' ' HG2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -66.73 -29.31 69.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.469 0.652 . . . . 0.0 110.47 -175.242 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.876 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.0 mm-40 -63.19 -56.59 15.43 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.397 174.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.613 HG13 ' CD2' ' A' ' 93' ' ' LEU . 82.9 t -67.51 -38.82 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.455 -177.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.655 ' HB2' HG21 ' A' ' 61' ' ' THR . . . -58.7 -32.17 68.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.182 0.515 . . . . 0.0 110.109 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -82.26 -39.17 23.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.589 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.79 -44.94 63.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.167 0.508 . . . . 0.0 111.881 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.624 HD12 HD12 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -95.73 -12.63 25.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.411 -174.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.77 129.33 2.28 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.255 -0.974 . . . . 0.0 110.876 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.655 HG21 ' HB2' ' A' ' 56' ' ' ALA . 22.1 p -55.3 133.4 69.64 Favored Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-O 121.466 0.65 . . . . 0.0 111.284 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 34.8 Cg_exo -63.49 166.93 14.14 Favored 'Trans proline' 0 C--O 1.23 0.092 0 C-N-CA 123.753 2.969 . . . . 0.0 113.377 -171.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.448 ' C ' ' H ' ' A' ' 65' ' ' SER . 1.5 mt -54.08 -33.16 56.84 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.104 -170.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.628 ' HE1' HG22 ' A' ' 70' ' ' THR . 0.0 OUTLIER -63.68 3.33 0.36 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.39 176.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.448 ' H ' ' C ' ' A' ' 63' ' ' LEU . 27.7 p 53.94 24.81 4.87 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.8 0.84 . . . . 0.0 111.593 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -169.9 105.11 0.45 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.41 -178.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.577 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 83.6 Cg_endo -80.07 -23.03 6.85 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 122.833 2.355 . . . . 0.0 113.201 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -82.8 -6.75 59.57 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -171.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.28 -20.68 51.66 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.328 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.628 HG22 ' HE1' ' A' ' 64' ' ' MET . 14.6 t -125.16 174.74 7.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.993 0.425 . . . . 0.0 110.228 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -129.24 14.01 6.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.366 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.7 m -131.2 110.32 11.05 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.84 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.595 ' O ' ' HA ' ' A' ' 92' ' ' THR . 46.3 m0 -108.66 149.08 29.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.885 -175.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -125.13 123.22 39.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.544 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.575 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 86.6 m-85 -133.01 173.75 11.08 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.9 t -113.24 164.82 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -175.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.218 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.252 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.438 -1.033 0 CA-C-O 121.28 0.562 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.789 HD23 HG21 ' A' ' 43' ' ' VAL . 14.4 tp -90.02 110.95 21.91 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.95 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 24.4 m -103.68 105.01 15.12 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.83 ' HG ' HD22 ' A' ' 101' ' ' LEU . 8.2 tp -88.36 124.27 33.76 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.37 -173.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 42.1 m -104.16 120.98 42.29 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.978 -176.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -114.5 137.73 51.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.744 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.554 ' HB3' HG22 ' A' ' 102' ' ' THR . 33.3 p30 -75.26 -171.96 1.58 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.45 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.1 m -55.61 -37.99 68.86 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.52 ' HB3' HG23 ' A' ' 100' ' ' VAL . 22.8 t -84.2 -3.61 58.28 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.985 0.422 . . . . 0.0 110.869 -173.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.59 31.85 35.59 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.621 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.52 HG23 ' HB3' ' A' ' 98' ' ' SER . 11.2 t -107.02 141.47 22.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.83 HD22 ' HG ' ' A' ' 93' ' ' LEU . 7.0 mt -62.68 122.88 16.97 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.559 0.695 . . . . 0.0 112.254 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.554 HG22 ' HB3' ' A' ' 96' ' ' ASN . 21.1 p -109.62 -42.09 4.39 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.711 175.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.527 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 5.3 m-20 -137.06 154.83 50.25 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.271 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.76 HG22 HD11 ' A' ' 91' ' ' LEU . 5.0 mm -116.7 91.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 167.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 92' ' ' THR . 5.6 m-20 -83.55 94.91 8.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.039 0.447 . . . . 0.0 110.752 -172.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -100.78 102.85 14.03 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.755 0.788 . . . . 0.0 109.414 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.1 mttt . . . . . 0 C--N 1.314 -0.963 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.482 -177.386 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.69 HD12 HD12 ' A' ' 59' ' ' LEU . 11.4 tp . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 121.129 0.49 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.486 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 33.5 p -127.71 177.19 6.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.156 170.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.43 -30.61 66.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.009 0.433 . . . . 0.0 110.495 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -55.69 -45.04 77.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.714 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.66 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 22.7 m-20 -67.2 -26.35 66.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.231 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 1.028 HG21 HD23 ' A' ' 91' ' ' LEU . 79.3 t -64.32 -37.28 79.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.172 0.511 . . . . 0.0 110.026 176.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.3 t -66.54 -20.84 66.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.452 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.66 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 36.4 mtpt -71.34 -32.28 68.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.92 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.602 HG23 ' HE1' ' A' ' 50' ' ' MET . 30.9 pt -94.76 177.6 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-O 121.895 0.855 . . . . 0.0 112.032 177.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.414 ' HE ' ' HB3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -172.3 154.31 3.24 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.417 -174.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.442 HG21 HD12 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -71.95 144.99 12.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.048 -178.378 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.38 -36.81 3.16 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.163 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.602 ' HE1' HG23 ' A' ' 46' ' ' ILE . 5.6 ptt? -85.25 171.61 11.8 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.191 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.798 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 44.0 p -86.07 -172.49 4.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.007 -172.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.492 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 39.5 mt-30 -68.31 -42.59 79.19 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.216 173.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.532 ' HA ' ' HE1' ' A' ' 68' ' ' PHE . 9.0 pt20 -66.36 -36.03 81.85 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.264 -175.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.798 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.8 mm-40 -58.26 -54.21 49.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.889 176.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.597 HG13 ' CD2' ' A' ' 93' ' ' LEU . 85.6 t -65.58 -41.3 90.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.793 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.429 ' HB2' HG22 ' A' ' 61' ' ' THR . . . -57.67 -33.12 67.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.385 0.612 . . . . 0.0 110.096 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -81.3 -36.78 29.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.825 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.35 -42.07 55.12 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.249 0.547 . . . . 0.0 111.764 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.69 HD12 HD12 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -95.24 -16.94 22.12 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.83 -173.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.95 130.46 5.43 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.305 -0.95 . . . . 0.0 110.756 -174.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.452 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 4.5 p -65.11 134.95 96.09 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 121.343 0.592 . . . . 0.0 111.304 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 22.0 Cg_exo -67.59 171.41 12.0 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.998 3.132 . . . . 0.0 113.14 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.439 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 7.7 mt -49.09 -48.23 44.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.518 -178.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.759 ' HE1' HG22 ' A' ' 70' ' ' THR . 12.5 ptt? -59.59 144.73 46.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.757 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.3 p -73.02 1.72 8.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -154.44 108.59 2.4 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-O 121.345 0.593 . . . . 0.0 110.528 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.644 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 59.2 Cg_endo -73.29 -25.39 15.67 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.078 2.519 . . . . 0.0 113.048 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.532 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 8.3 m-85 -81.57 -5.44 58.02 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -170.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.21 -8.17 63.2 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.71 -174.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.759 HG22 ' HE1' ' A' ' 64' ' ' MET . 9.2 t -123.58 171.96 9.14 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -119.38 1.25 11.23 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 m -126.64 115.2 19.1 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.555 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.644 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 44.6 m0 -109.36 141.68 41.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.708 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -119.12 120.71 37.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.477 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.618 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 90.3 m-85 -128.03 175.56 8.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.228 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.9 t -124.26 152.66 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -172.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.433 ' CE1' HG22 ' A' ' 43' ' ' VAL . 7.3 m-30 . . . . . 0 C--N 1.323 -0.567 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 171.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.44 -0.956 0 CA-C-O 121.216 0.531 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.028 HD23 HG21 ' A' ' 43' ' ' VAL . 38.7 tp -91.11 110.76 22.03 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 28.7 m -105.27 102.69 12.15 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.786 ' HG ' HD22 ' A' ' 101' ' ' LEU . 8.9 tp -88.39 126.78 35.38 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.547 -171.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.5 m -103.8 121.24 42.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.008 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.486 ' CZ ' ' HA ' ' A' ' 52' ' ' GLN . 25.8 m-85 -111.92 148.52 33.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.914 0.864 . . . . 0.0 112.503 -175.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -73.8 173.1 10.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.874 -1.512 . . . . 0.0 110.451 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.8 m -62.34 -30.07 70.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.17 0.509 . . . . 0.0 110.862 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.472 ' HB3' HG23 ' A' ' 100' ' ' VAL . 30.8 t -87.55 4.43 43.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.793 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.11 34.53 55.17 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.954 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' A' ' 98' ' ' SER . 15.4 t -107.37 139.31 29.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.786 HD22 ' HG ' ' A' ' 93' ' ' LEU . 6.3 mt -60.73 127.5 31.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.393 0.616 . . . . 0.0 111.673 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 66.5 p -116.38 -39.94 3.3 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.136 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -144.7 149.56 35.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.854 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.812 HG22 HD11 ' A' ' 91' ' ' LEU . 3.8 mm -112.6 94.06 2.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 173.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.594 ' HB2' ' O ' ' A' ' 92' ' ' THR . 4.5 m-20 -80.48 95.49 6.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.024 0.44 . . . . 0.0 110.523 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -106.57 102.78 12.14 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.72 0.771 . . . . 0.0 110.269 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.959 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.62 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.649 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 3.1 tp . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.925 0.393 . . . . 0.0 110.459 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.3 p -127.41 -178.36 4.43 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.079 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.15 -35.54 79.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.383 0.611 . . . . 0.0 110.552 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -59.32 -46.46 88.52 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.985 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.565 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 14.9 m-20 -69.31 -32.14 71.06 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.798 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.779 HG21 HD23 ' A' ' 91' ' ' LEU . 68.0 t -57.92 -38.18 64.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.109 0.481 . . . . 0.0 110.525 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -59.24 -21.59 59.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.154 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 45.9 mtpt -70.85 -29.3 65.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.982 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.718 HG22 HD11 ' A' ' 59' ' ' LEU . 38.9 pt -95.48 176.11 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.787 0.803 . . . . 0.0 112.257 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.441 ' HE ' ' HB3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -164.71 148.42 8.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.775 -177.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -70.79 140.14 18.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.332 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.43 -17.57 8.94 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.488 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.549 ' HE1' HG23 ' A' ' 46' ' ' ILE . 17.6 ptt? -102.43 173.09 6.51 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.109 174.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.654 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 12.7 p -88.08 -173.35 4.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.007 -172.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.517 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 13.2 mt-30 -69.44 -41.93 75.62 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.562 175.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.549 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -65.5 -33.19 75.35 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.609 0.719 . . . . 0.0 109.591 -175.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.654 ' HG3' ' H ' ' A' ' 51' ' ' THR . 11.2 mm-40 -61.61 -55.93 25.38 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.598 175.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.6 HG13 ' CD2' ' A' ' 93' ' ' LEU . 82.5 t -66.03 -40.4 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.387 -176.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.628 ' HB2' HG21 ' A' ' 61' ' ' THR . . . -58.74 -34.2 71.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.278 0.561 . . . . 0.0 110.012 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -81.16 -39.97 24.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.769 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.27 -49.68 53.86 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.782 0.801 . . . . 0.0 111.402 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.718 HD11 HG22 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -86.07 -45.07 11.75 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.189 -173.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.02 126.8 3.46 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -174.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.628 HG21 ' HB2' ' A' ' 56' ' ' ALA . 47.6 p -59.84 132.09 89.15 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-O 121.15 0.5 . . . . 0.0 110.934 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.476 ' CD ' ' HB3' ' A' ' 67' ' ' PRO . 28.0 Cg_exo -63.59 164.18 21.84 Favored 'Trans proline' 0 CA--C 1.52 -0.208 0 C-N-CA 123.745 2.963 . . . . 0.0 112.554 -172.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 mt -52.72 -32.96 45.63 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.47 -168.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.569 ' HE1' HG22 ' A' ' 70' ' ' THR . 10.8 ptt? -62.48 -9.87 9.92 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.685 0.616 . . . . 0.0 111.926 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 t 72.27 -2.3 2.63 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.669 0.788 . . . . 0.0 112.466 173.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -138.12 91.97 12.66 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-O 121.159 0.504 . . . . 0.0 109.999 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.556 ' HG3' HG21 ' A' ' 61' ' ' THR . 74.0 Cg_endo -74.0 -30.25 9.22 Favored 'Trans proline' 0 CA--C 1.529 0.247 0 C-N-CA 123.193 2.595 . . . . 0.0 112.964 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.49 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 12.7 m-85 -76.78 3.6 11.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.105 -172.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.49 -25.7 25.07 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.881 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.569 HG22 ' HE1' ' A' ' 64' ' ' MET . 8.4 t -123.78 174.21 7.65 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -175.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -122.33 2.58 9.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.107 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.4 m -123.07 108.66 13.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.813 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.578 ' O ' ' HA ' ' A' ' 92' ' ' THR . 47.0 m0 -105.58 148.68 27.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.875 -174.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -124.48 118.2 26.1 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.976 0.417 . . . . 0.0 111.249 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.601 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 80.3 m-85 -128.9 175.5 8.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.274 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.8 t -122.85 165.74 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 120.65 0.262 . . . . 0.0 110.632 176.386 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.439 -1.021 0 CA-C-O 120.876 0.369 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.779 HD23 HG21 ' A' ' 43' ' ' VAL . 13.8 tp -89.66 103.39 16.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 18.2 m -98.21 100.62 11.93 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.903 ' HG ' HD22 ' A' ' 101' ' ' LEU . 8.4 tp -86.01 121.58 28.83 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.256 -172.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.4 m -101.54 119.6 39.02 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.018 -175.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.435 ' CE1' ' HG ' ' A' ' 101' ' ' LEU . 72.2 m-85 -113.22 142.36 45.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.492 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.54 ' HB3' HG22 ' A' ' 102' ' ' THR . 30.1 p30 -75.85 -177.72 3.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.96 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.2 m -56.61 -30.55 63.36 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.492 ' HB3' HG23 ' A' ' 100' ' ' VAL . 34.2 t -85.91 -3.86 59.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.701 0.286 . . . . 0.0 111.257 -173.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.48 32.72 27.17 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.424 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.492 HG23 ' HB3' ' A' ' 98' ' ' SER . 5.0 t -113.7 139.21 40.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.794 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.903 HD22 ' HG ' ' A' ' 93' ' ' LEU . 6.7 mt -61.14 123.14 16.84 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.276 0.56 . . . . 0.0 112.307 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.54 HG22 ' HB3' ' A' ' 96' ' ' ASN . 12.4 p -110.29 -39.14 5.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.025 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -148.92 150.63 33.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.481 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.622 ' CG2' HD11 ' A' ' 91' ' ' LEU . 5.6 mm -105.35 92.76 2.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 171.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 92' ' ' THR . 7.2 m-20 -83.94 94.88 8.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.284 0.564 . . . . 0.0 110.259 -177.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -95.25 102.08 13.86 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.881 0.848 . . . . 0.0 108.978 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm . . . . . 0 C--N 1.316 -0.885 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.873 -172.218 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.759 HD12 ' HG ' ' A' ' 59' ' ' LEU . 3.6 mm? . . . . . 0 CA--C 1.511 -0.545 0 CA-C-O 121.727 0.775 . . . . 0.0 112.4 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 43' ' ' VAL . 30.7 p -128.92 -177.9 4.4 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.516 170.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.04 -44.33 89.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.861 0.362 . . . . 0.0 111.624 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.457 ' N ' HD21 ' A' ' 41' ' ' ASN . 0.9 OUTLIER -61.16 -40.58 94.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.569 -177.533 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -68.74 -33.44 73.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.572 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.587 HG21 HD23 ' A' ' 91' ' ' LEU . 54.9 t -57.32 -37.7 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.811 0.339 . . . . 0.0 111.475 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.7 p -64.09 -12.42 39.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.149 0.499 . . . . 0.0 111.627 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 43.8 mtpt -77.2 -14.19 59.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.246 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.731 HG22 HD11 ' A' ' 59' ' ' LEU . 35.3 pt -104.21 -176.9 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 121.894 0.854 . . . . 0.0 112.808 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.557 ' HD2' ' HE3' ' A' ' 50' ' ' MET . 0.0 OUTLIER -172.64 150.47 2.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.009 -1.45 . . . . 0.0 109.055 -177.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.491 HG21 HD12 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -71.09 144.48 13.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.15 -178.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.15 -32.31 4.78 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.473 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.671 ' HE1' HG23 ' A' ' 46' ' ' ILE . 14.4 ptt? -88.3 178.39 6.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 111.415 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.822 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 34.9 p -90.77 -177.04 4.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.793 -171.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.476 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 36.7 mt-30 -66.18 -42.63 88.63 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.506 171.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -37.34 77.48 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.147 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.822 ' HG3' ' H ' ' A' ' 51' ' ' THR . 5.4 mm-40 -67.83 -52.03 41.63 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.318 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.681 HG11 HG21 ' A' ' 46' ' ' ILE . 78.6 t -64.94 -40.84 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.741 -177.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.512 ' HB2' HG21 ' A' ' 61' ' ' THR . . . -58.41 -33.33 69.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 110.181 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -81.87 -40.28 22.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.098 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.44 -42.4 75.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.686 0.755 . . . . 0.0 111.11 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.759 ' HG ' HD12 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -92.63 -54.94 3.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.992 -174.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.2 134.94 3.61 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -171.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.512 HG21 ' HB2' ' A' ' 56' ' ' ALA . 28.7 p -66.92 135.92 94.28 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-O 121.224 0.535 . . . . 0.0 111.308 -177.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 17.0 Cg_exo -65.79 174.72 5.24 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 C-N-CA 124.19 3.26 . . . . 0.0 113.411 -174.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.448 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 8.2 mt -46.3 -48.47 18.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.353 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.707 ' HE1' HG22 ' A' ' 70' ' ' THR . 0.0 OUTLIER -66.22 126.88 30.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.572 170.226 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 t -68.78 -7.25 32.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 0.0 111.726 -173.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.434 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 11.1 p-10 -122.14 92.49 48.87 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-O 121.714 0.768 . . . . 0.0 110.199 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.525 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 18.7 Cg_endo -60.05 -36.11 90.53 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.864 2.376 . . . . 0.0 112.186 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -83.48 8.89 12.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.803 -177.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.1 -17.33 57.85 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.707 HG22 ' HE1' ' A' ' 64' ' ' MET . 11.8 t -124.45 175.14 7.32 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -125.1 8.04 7.95 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.818 0.342 . . . . 0.0 110.127 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.7 m -131.36 111.82 12.19 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.313 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.676 ' O ' ' HA ' ' A' ' 92' ' ' THR . 48.8 m0 -106.0 142.95 34.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.582 -176.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -123.44 116.32 23.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.75 0.31 . . . . 0.0 110.543 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.553 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 31.1 m-85 -124.72 170.25 11.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.523 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 77' ' ' PHE . 41.3 t -120.69 158.63 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -175.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.441 ' N ' HG13 ' A' ' 76' ' ' VAL . 1.3 m-30 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.338 . . . . 0.0 110.788 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 19.2 p . . . . . 0 N--CA 1.442 -0.845 0 CA-C-O 121.226 0.536 . . . . 0.0 111.65 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.915 HD13 HG22 ' A' ' 104' ' ' ILE . 14.7 tp -93.6 111.69 23.41 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.862 174.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.692 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 40.2 m -106.9 103.45 12.88 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.889 ' HG ' HD22 ' A' ' 101' ' ' LEU . 7.2 tp -90.21 122.82 33.49 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.254 -173.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -109.72 124.22 50.86 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.394 -176.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.5 ' CE1' ' HG ' ' A' ' 101' ' ' LEU . 92.0 m-85 -112.27 144.97 40.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.296 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.519 ' HB3' HG22 ' A' ' 102' ' ' THR . 29.7 p30 -74.88 -173.96 2.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.172 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.1 p -54.59 -32.17 58.22 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.555 ' HB3' HG23 ' A' ' 100' ' ' VAL . 9.7 t -89.45 -3.03 58.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.054 0.454 . . . . 0.0 111.245 -173.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.62 32.98 32.14 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.597 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.555 HG23 ' HB3' ' A' ' 98' ' ' SER . 7.3 t -108.82 138.86 33.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.889 HD22 ' HG ' ' A' ' 93' ' ' LEU . 5.7 mt -60.07 124.91 21.68 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.648 0.737 . . . . 0.0 112.102 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 96' ' ' ASN . 34.0 p -112.85 -45.0 3.23 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.348 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -136.52 152.75 50.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.247 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.915 HG22 HD13 ' A' ' 91' ' ' LEU . 3.7 mm -116.08 93.36 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 171.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.692 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 8.0 t70 -89.53 97.34 11.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.04 0.447 . . . . 0.0 111.052 -169.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 90' ' ' THR . 29.0 t-20 -117.64 119.52 35.22 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.36 0.6 . . . . 0.0 110.693 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.526 ' HE2' ' N ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.858 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.144 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.767 HD13 ' HG ' ' A' ' 59' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.508 -0.647 0 CA-C-O 121.881 0.848 . . . . 0.0 110.892 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.4 p -130.81 177.93 7.04 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.21 172.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 77' ' ' PHE . . . -70.88 -28.97 64.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.453 0.644 . . . . 0.0 109.904 176.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -59.08 -44.44 91.89 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.525 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.582 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 27.0 m-20 -70.41 -32.85 70.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.697 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.968 HG21 HD23 ' A' ' 91' ' ' LEU . 56.3 t -62.54 -36.24 74.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.859 0.361 . . . . 0.0 110.81 177.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.3 p -68.19 -15.32 63.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.074 0.464 . . . . 0.0 110.525 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.582 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 40.8 mtpt -78.78 -19.53 51.99 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.078 177.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.622 ' HA ' ' HE3' ' A' ' 50' ' ' MET . 44.5 pt -103.38 169.0 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-O 121.735 0.779 . . . . 0.0 112.099 176.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.94 148.76 8.75 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.493 -173.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -72.19 143.17 14.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.074 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.9 -33.8 4.28 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.703 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.622 ' HE3' ' HA ' ' A' ' 46' ' ' ILE . 21.8 ptt? -86.48 175.72 8.22 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.148 0.499 . . . . 0.0 111.189 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.789 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 44.0 p -91.16 -173.38 3.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.081 -170.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.473 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 13.8 mt-30 -65.38 -46.93 78.17 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.385 172.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -64.08 -37.4 87.31 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.98 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.789 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.0 mm-40 -58.34 -49.43 77.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.584 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.602 HG13 ' CD2' ' A' ' 93' ' ' LEU . 61.8 t -69.7 -45.11 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.466 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.587 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -63.45 -25.03 68.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.002 0.43 . . . . 0.0 110.684 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -80.44 -35.77 34.56 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.291 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.81 -39.87 61.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.742 0.782 . . . . 0.0 111.07 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.767 ' HG ' HD13 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -93.24 -32.55 14.31 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.339 -172.461 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.3 119.93 4.45 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -171.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.587 HG22 ' HB3' ' A' ' 56' ' ' ALA . 46.9 p -53.52 134.54 53.7 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 120.968 0.413 . . . . 0.0 111.426 -173.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 32.3 Cg_exo -63.0 164.43 19.37 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.614 2.876 . . . . 0.0 113.278 -172.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.7 mt -53.31 -36.73 61.57 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.164 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.709 ' HE1' HG22 ' A' ' 70' ' ' THR . 8.6 ptt? -62.26 -3.26 1.25 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.164 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.4 t 70.39 2.89 4.22 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.445 0.698 . . . . 0.0 112.259 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 23.5 t70 -152.09 100.52 2.85 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.664 0.745 . . . . 0.0 110.34 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.622 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 38.0 Cg_endo -67.1 -49.71 1.27 Allowed 'Trans proline' 0 C--N 1.332 -0.314 0 C-N-CA 123.63 2.887 . . . . 0.0 113.648 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -80.61 19.1 0.84 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -172.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.36 -19.88 47.6 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 171.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.709 HG22 ' HE1' ' A' ' 64' ' ' MET . 13.4 t -124.25 171.15 10.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.982 -0.609 . . . . 0.0 109.53 177.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -122.72 13.99 10.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.41 0.624 . . . . 0.0 109.681 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 m -139.11 110.53 7.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.022 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.622 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 48.4 m0 -106.94 141.36 38.28 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.941 -175.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -120.04 125.46 48.38 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.18 0.3 . . . . 0.0 110.515 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.55 ' CE2' HD23 ' A' ' 59' ' ' LEU . 60.1 m-85 -135.66 174.69 10.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.53 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 77' ' ' PHE . 1.6 p -122.5 150.63 26.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.639 -176.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.483 ' O ' HG21 ' A' ' 76' ' ' VAL . 10.0 m-30 . . . . . 0 C--N 1.322 -0.598 0 CA-C-O 121.126 0.489 . . . . 0.0 110.571 177.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.447 -0.604 0 CA-C-O 121.153 0.501 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.968 HD23 HG21 ' A' ' 43' ' ' VAL . 21.3 tp -89.72 114.14 25.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.478 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.626 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 35.9 m -108.25 102.7 11.81 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.923 ' HG ' HD22 ' A' ' 101' ' ' LEU . 7.4 tp -85.59 121.94 29.0 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.5 -173.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.4 m -100.34 119.86 39.07 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.956 -176.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -113.77 136.8 52.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.817 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.482 ' HB3' HG22 ' A' ' 102' ' ' THR . 32.3 p30 -75.27 -177.6 3.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.933 175.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.0 m -52.84 -33.94 51.82 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.648 ' HB3' HG23 ' A' ' 100' ' ' VAL . 8.7 t -83.83 -9.6 58.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.018 0.437 . . . . 0.0 110.849 -173.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.57 29.66 20.92 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.648 HG23 ' HB3' ' A' ' 98' ' ' SER . 21.5 t -107.62 140.19 26.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.742 -0.729 . . . . 0.0 109.323 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.923 HD22 ' HG ' ' A' ' 93' ' ' LEU . 6.5 mt -62.3 125.29 23.4 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.286 0.565 . . . . 0.0 111.885 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.482 HG22 ' HB3' ' A' ' 96' ' ' ASN . 11.1 p -109.6 -45.49 3.67 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.418 174.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -138.33 155.02 48.96 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.63 0.728 . . . . 0.0 111.556 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.71 HG22 HD11 ' A' ' 91' ' ' LEU . 5.3 mm -113.16 93.11 2.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.626 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 30.4 t70 -85.49 96.36 9.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.125 0.488 . . . . 0.0 111.0 -171.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -105.42 102.76 12.21 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.976 0.893 . . . . 0.0 110.106 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.6 pttm . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.275 -175.491 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.699 ' HB3' ' HB3' ' A' ' 75' ' ' TYR . 6.0 tp . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.2 p -127.9 -173.93 3.06 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.106 174.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.551 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -67.82 -47.33 69.35 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.21 0.528 . . . . 0.0 112.007 -173.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.67 -31.68 69.78 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.101 177.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.521 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 63.4 m-20 -72.29 -35.11 68.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.313 176.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.902 HG21 HD23 ' A' ' 91' ' ' LEU . 53.3 t -57.48 -36.61 54.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.206 0.527 . . . . 0.0 110.506 174.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.1 t -61.61 -17.73 56.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.533 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 48.4 mtpt -74.75 -28.73 60.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.849 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.715 HG22 HD11 ' A' ' 59' ' ' LEU . 43.3 pt -97.56 176.32 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 122.108 0.956 . . . . 0.0 113.163 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.54 150.59 6.09 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.516 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.414 HG21 ' CG1' ' A' ' 104' ' ' ILE . 0.7 OUTLIER -70.54 145.6 12.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.125 -178.077 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.93 -35.15 3.92 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.16 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.61 ' HE1' HG23 ' A' ' 46' ' ' ILE . 6.8 ptt? -85.3 165.8 17.0 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.285 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.675 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 12.4 p -83.1 -172.3 4.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.409 -173.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 99' ' ' GLY . 92.2 mt-30 -68.24 -41.84 80.61 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.737 176.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.53 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -66.58 -32.12 73.25 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -175.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.675 ' HG3' ' H ' ' A' ' 51' ' ' THR . 15.8 mm-40 -61.93 -56.58 17.69 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.44 176.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.614 HG13 ' CD2' ' A' ' 93' ' ' LEU . 82.0 t -65.4 -40.45 88.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.57 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.571 ' HB2' HG21 ' A' ' 61' ' ' THR . . . -58.69 -35.55 72.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.163 0.506 . . . . 0.0 110.297 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -81.65 -35.37 30.03 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.088 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.04 -45.15 43.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.554 0.692 . . . . 0.0 111.393 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.715 HD11 HG22 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -90.95 -54.42 3.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.316 -174.231 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.68 130.1 2.91 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.571 HG21 ' HB2' ' A' ' 56' ' ' ALA . 40.5 p -65.34 128.82 94.13 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-O 121.533 0.682 . . . . 0.0 110.687 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 14.6 Cg_exo -68.68 163.25 37.81 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.569 2.846 . . . . 0.0 112.956 -171.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.402 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -57.82 -25.85 61.2 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.008 -171.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.434 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 13.4 ptt? -66.84 -3.01 5.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.543 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 t 72.29 4.4 4.99 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.545 0.738 . . . . 0.0 112.51 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -158.92 107.78 1.58 Allowed Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 121.579 0.704 . . . . 0.0 110.543 175.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.667 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 58.8 Cg_endo -72.82 -29.95 11.93 Favored 'Trans proline' 0 C--N 1.325 -0.662 0 C-N-CA 122.976 2.451 . . . . 0.0 112.511 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -76.28 -4.06 39.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.927 -170.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.85 -17.66 55.96 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.534 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.411 ' CG2' ' HE1' ' A' ' 64' ' ' MET . 7.3 t -124.39 174.31 7.84 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.005 0.431 . . . . 0.0 110.666 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -118.52 3.56 11.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.574 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.4 m -134.15 112.77 11.4 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.643 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.667 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 44.6 m0 -105.88 136.19 45.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.439 -177.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -113.07 127.31 56.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.928 0.394 . . . . 0.0 110.724 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.699 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 62.2 m-85 -132.27 173.91 10.78 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.524 HG13 ' H ' ' A' ' 77' ' ' PHE . 2.0 t -129.09 178.15 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.551 ' CG ' ' HB2' ' A' ' 40' ' ' ALA . 7.6 m-30 . . . . . 0 C--N 1.319 -0.758 0 CA-C-O 120.514 0.197 . . . . 0.0 110.54 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.442 -0.846 0 CA-C-O 120.804 0.335 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.902 HD23 HG21 ' A' ' 43' ' ' VAL . 20.0 tp -91.24 119.25 31.15 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.696 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 90.4 m -110.49 106.86 16.32 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.978 ' HG ' HD22 ' A' ' 101' ' ' LEU . 7.1 tp -91.39 123.63 34.96 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.725 -174.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.7 m -103.2 121.71 43.23 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.844 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.602 ' CZ ' HD22 ' A' ' 93' ' ' LEU . 71.6 m-85 -116.71 138.91 51.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.893 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.502 HD22 ' HB ' ' A' ' 100' ' ' VAL . 33.4 p30 -75.61 -173.46 2.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.794 175.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.6 m -51.29 -44.36 61.86 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -174.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.505 ' HB3' HG23 ' A' ' 100' ' ' VAL . 33.6 t -79.78 -15.9 56.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.469 . . . . 0.0 111.068 -174.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 52' ' ' GLN . . . 96.83 29.49 8.1 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -176.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.505 HG23 ' HB3' ' A' ' 98' ' ' SER . 14.0 t -98.24 134.68 35.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.978 HD22 ' HG ' ' A' ' 93' ' ' LEU . 6.7 mt -59.9 125.02 22.01 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.262 0.553 . . . . 0.0 112.04 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.453 HG22 ' HB3' ' A' ' 96' ' ' ASN . 5.7 p -112.78 -39.48 4.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.15 176.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -143.72 148.28 35.46 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.359 0.599 . . . . 0.0 111.908 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.605 HG22 HD11 ' A' ' 91' ' ' LEU . 4.7 mm -111.92 95.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.696 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 35.5 t0 -86.59 95.34 9.72 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.718 -174.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -102.86 104.09 14.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.704 0.764 . . . . 0.0 109.645 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 63.4 pttt . . . . . 0 C--N 1.312 -1.035 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.733 -176.466 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.62 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 1.3 tp . . . . . 0 N--CA 1.457 -0.097 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.0 p -126.12 -176.27 3.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.048 0.452 . . . . 0.0 111.995 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.475 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -62.56 -37.8 87.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.909 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -59.8 -43.27 94.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.373 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.604 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 10.5 m-20 -68.44 -29.6 68.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.962 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 1.073 HG21 HD23 ' A' ' 91' ' ' LEU . 85.6 t -59.79 -36.95 69.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.207 0.527 . . . . 0.0 110.45 175.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -61.26 -19.05 61.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.427 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -70.99 -42.13 70.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.794 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.712 HG22 HD11 ' A' ' 59' ' ' LEU . 41.6 pt -84.7 -178.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.747 0.784 . . . . 0.0 112.268 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.551 ' HD2' ' HE3' ' A' ' 50' ' ' MET . 0.0 OUTLIER -171.68 152.33 3.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.326 -175.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.452 HG21 HD12 ' A' ' 104' ' ' ILE . 0.7 OUTLIER -72.82 145.62 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.697 -179.246 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.41 -30.6 5.93 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.346 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.573 ' HE1' HG23 ' A' ' 46' ' ' ILE . 16.0 ptt? -90.06 178.18 6.26 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.285 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.86 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 31.1 p -95.23 -174.07 3.11 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.013 -170.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.462 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 97.8 mt-30 -63.89 -47.51 80.33 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.774 172.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.406 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 9.9 pt20 -64.56 -36.5 84.42 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.305 0.574 . . . . 0.0 109.811 -175.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.86 ' HG3' ' H ' ' A' ' 51' ' ' THR . 9.4 mm-40 -58.0 -52.47 65.38 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.323 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.611 HG13 ' CD2' ' A' ' 93' ' ' LEU . 72.2 t -67.11 -41.56 87.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.714 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.456 ' HB3' HG21 ' A' ' 61' ' ' THR . . . -64.52 -25.68 68.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.164 0.507 . . . . 0.0 110.727 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -81.28 -35.53 30.97 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.013 0.435 . . . . 0.0 111.323 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.9 -46.14 25.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.393 0.616 . . . . 0.0 111.705 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.712 HD11 HG22 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -92.56 -21.15 20.26 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.815 -173.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.91 131.07 6.98 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -172.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.499 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 37.9 p -56.75 135.27 78.61 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.959 0.409 . . . . 0.0 111.118 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 51.8 Cg_exo -59.12 171.65 2.15 Favored 'Trans proline' 0 N--CA 1.471 0.157 0 C-N-CA 124.131 3.221 . . . . 0.0 115.131 -171.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.469 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 8.3 mt -55.49 -41.69 73.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.257 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.739 ' HE1' HG22 ' A' ' 70' ' ' THR . 0.0 OUTLIER -60.19 -0.24 0.22 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.547 176.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 63' ' ' LEU . 33.5 p 58.86 5.44 0.5 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.214 1.006 . . . . 0.0 112.815 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -150.17 103.58 3.15 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 121.54 0.686 . . . . 0.0 109.753 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.477 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 36.0 Cg_endo -68.06 -33.03 26.62 Favored 'Trans proline' 0 C--N 1.327 -0.555 0 C-N-CA 123.245 2.63 . . . . 0.0 113.177 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -76.22 4.51 8.55 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -170.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.33 -24.72 21.03 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.086 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.739 HG22 ' HE1' ' A' ' 64' ' ' MET . 14.3 t -125.51 174.38 8.26 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.902 0.382 . . . . 0.0 110.236 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -125.78 12.52 7.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.862 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.9 m -133.55 108.81 8.83 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.21 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.477 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 42.7 m0 -109.18 130.34 55.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.412 -174.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -109.46 120.89 43.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.024 0.44 . . . . 0.0 110.967 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.554 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 50.1 m-85 -129.24 173.88 10.1 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.515 HG11 ' H ' ' A' ' 77' ' ' PHE . 2.9 t -123.42 175.29 6.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -176.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.515 ' H ' HG11 ' A' ' 76' ' ' VAL . 5.7 m-30 . . . . . 0 C--N 1.32 -0.697 0 CA-C-O 121.045 0.45 . . . . 0.0 110.721 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 120.848 0.356 . . . . 0.0 111.53 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.073 HD23 HG21 ' A' ' 43' ' ' VAL . 39.8 tp -91.8 122.94 34.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 172.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.536 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 89.9 m -117.49 103.91 10.55 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.842 ' HG ' HD22 ' A' ' 101' ' ' LEU . 7.1 tp -85.18 125.18 32.62 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.286 -174.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 21.5 m -107.35 122.87 47.46 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.264 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 52' ' ' GLN . 32.5 m-85 -110.54 146.45 36.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.894 0.854 . . . . 0.0 112.695 -175.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -73.94 -179.61 3.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.646 -1.615 . . . . 0.0 111.171 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.4 p -59.32 -43.03 92.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.698 0.285 . . . . 0.0 111.583 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.468 ' HB3' HG23 ' A' ' 100' ' ' VAL . 35.0 t -77.69 -8.66 58.25 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.958 0.409 . . . . 0.0 110.694 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.88 31.06 10.35 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.459 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 98' ' ' SER . 22.0 t -100.77 141.64 17.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.842 HD22 ' HG ' ' A' ' 93' ' ' LEU . 6.0 mt -62.29 123.99 19.69 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.084 0.469 . . . . 0.0 111.597 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 74.1 p -111.8 -43.55 3.6 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.642 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.492 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 2.6 m-20 -136.24 150.08 48.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.812 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.935 HG22 HD11 ' A' ' 91' ' ' LEU . 2.2 mm -116.46 92.43 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 170.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.536 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 25.2 t70 -87.42 96.78 10.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.131 0.491 . . . . 0.0 111.032 -170.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -106.84 104.75 14.5 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 122.032 0.92 . . . . 0.0 110.333 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.438 ' H ' ' HD3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.762 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.973 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.696 ' HB3' ' HB3' ' A' ' 75' ' ' TYR . 2.3 tp . . . . . 0 C--O 1.231 0.105 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.6 p -126.05 -179.28 4.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.258 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.8 -32.75 74.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.345 0.593 . . . . 0.0 110.596 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -62.34 -43.11 99.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.86 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.619 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 30.1 m-20 -69.11 -30.9 69.27 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.969 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.877 HG21 HD23 ' A' ' 91' ' ' LEU . 70.9 t -59.82 -37.83 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.042 0.448 . . . . 0.0 110.574 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.6 t -58.42 -21.97 52.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.557 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -70.28 -29.67 66.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.65 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.619 HG22 HD11 ' A' ' 59' ' ' LEU . 36.7 pt -98.42 -178.14 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.812 0.815 . . . . 0.0 112.413 -178.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.25 151.27 3.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.38 -176.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.26 145.49 12.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.13 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.56 -35.9 3.57 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.792 -177.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.528 ' HE1' HG23 ' A' ' 46' ' ' ILE . 19.0 ptt? -85.27 176.81 8.11 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.165 0.507 . . . . 0.0 111.263 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.863 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 32.6 p -95.29 -174.95 3.35 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.991 -170.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.661 ' OE1' ' HA ' ' A' ' 68' ' ' PHE . 78.9 mt-30 -62.73 -48.06 80.88 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.533 172.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.517 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -64.65 -33.13 75.21 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.301 0.572 . . . . 0.0 109.843 -174.228 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.863 ' HG3' ' H ' ' A' ' 51' ' ' THR . 9.1 mm-40 -60.99 -53.08 61.62 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.562 174.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.684 HG13 HD21 ' A' ' 93' ' ' LEU . 75.2 t -69.43 -39.9 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.597 -176.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.635 ' HB2' HG21 ' A' ' 61' ' ' THR . . . -59.56 -32.26 70.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.452 0.644 . . . . 0.0 110.002 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -80.87 -36.82 30.83 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.272 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.57 -49.11 19.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.941 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.64 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -90.44 -32.89 16.21 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.978 -172.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 114.25 127.69 4.5 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.274 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.635 HG21 ' HB2' ' A' ' 56' ' ' ALA . 28.4 p -60.85 132.22 91.76 Favored Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-O 121.244 0.545 . . . . 0.0 111.004 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 11.6 Cg_exo -70.77 162.27 43.16 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.529 2.82 . . . . 0.0 112.768 -173.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.444 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 1.7 mt -54.47 -33.89 60.52 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.094 -1.412 . . . . 0.0 112.235 -169.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.629 ' HE1' HG23 ' A' ' 70' ' ' THR . 12.2 ptt? -64.16 -1.92 1.82 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.19 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.1 p 62.13 2.38 0.81 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.374 1.07 . . . . 0.0 113.534 172.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -136.76 92.53 14.59 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.462 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 37.9 Cg_endo -67.75 -34.1 25.6 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.745 1.63 . . . . 0.0 111.524 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.661 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -79.41 10.24 3.98 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.508 -177.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.02 -26.3 16.89 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.607 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.629 HG23 ' HE1' ' A' ' 64' ' ' MET . 15.1 t -124.66 175.95 6.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.959 0.409 . . . . 0.0 110.432 -177.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -126.99 13.55 7.31 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.8 m -132.57 109.78 10.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.665 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.481 ' O ' ' HA ' ' A' ' 92' ' ' THR . 46.2 m0 -107.29 149.85 27.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.594 -175.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -123.1 115.23 21.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.08 0.467 . . . . 0.0 111.051 -175.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.696 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 88.3 m-85 -127.06 174.47 8.86 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.474 HG12 ' H ' ' A' ' 77' ' ' PHE . 4.7 t -120.97 170.19 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 118.066 0.394 . . . . 0.0 110.204 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.474 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 121.406 0.622 . . . . 0.0 112.24 -175.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.439 -1.023 0 CA-C-O 121.197 0.522 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.92 HD11 HG22 ' A' ' 104' ' ' ILE . 19.3 tp -91.18 105.64 17.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.577 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 32.1 m -101.81 102.46 13.07 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.87 ' HG ' HD22 ' A' ' 101' ' ' LEU . 7.9 tp -83.72 126.16 32.61 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.256 -173.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.4 m -107.91 119.9 40.76 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.263 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -110.08 147.8 32.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.797 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.522 HD22 ' HB ' ' A' ' 100' ' ' VAL . 4.1 p30 -72.06 -87.35 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 55.0 m -150.73 -30.2 0.19 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.887 0.375 . . . . 0.0 110.75 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.511 ' HB3' HG23 ' A' ' 100' ' ' VAL . 16.6 t -82.27 -6.03 58.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.423 0.63 . . . . 0.0 109.452 177.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.457 ' HA2' HE21 ' A' ' 52' ' ' GLN . . . 89.77 29.65 15.32 Favored Glycine 0 CA--C 1.503 -0.702 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.522 ' HB ' HD22 ' A' ' 96' ' ' ASN . 25.8 t -108.25 137.13 41.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.613 -0.793 . . . . 0.0 109.458 -178.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.87 HD22 ' HG ' ' A' ' 93' ' ' LEU . 9.3 mt -61.37 130.74 47.61 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.197 0.522 . . . . 0.0 112.35 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 96' ' ' ASN . 10.8 p -114.18 -37.25 4.46 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.126 175.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -150.06 152.96 35.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.631 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.92 HG22 HD11 ' A' ' 91' ' ' LEU . 3.3 mm -112.96 93.83 2.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 173.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 92' ' ' THR . 5.6 m-20 -80.6 96.62 6.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.688 0.28 . . . . 0.0 111.449 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -106.77 104.19 13.81 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.88 0.847 . . . . 0.0 109.917 175.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.869 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.206 -176.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.64 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 5.0 tp . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.911 0.386 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.3 p -127.84 -174.1 3.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.986 175.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.18 -38.87 86.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.362 0.601 . . . . 0.0 110.869 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -62.12 -41.74 98.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.468 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.51 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 10.7 m-20 -63.85 -36.75 84.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.491 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.736 HG21 HD23 ' A' ' 91' ' ' LEU . 77.0 t -59.26 -38.05 72.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.167 0.508 . . . . 0.0 110.582 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.9 t -63.03 -20.62 65.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.089 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 46.0 mtpt -70.17 -33.92 72.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.654 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.706 HG22 HD11 ' A' ' 59' ' ' LEU . 42.9 pt -89.76 -179.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.784 0.802 . . . . 0.0 112.439 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.43 149.9 2.24 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.665 -176.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -70.98 142.29 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.722 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.69 -27.97 6.35 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.708 -176.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.616 ' HE3' ' HA ' ' A' ' 46' ' ' ILE . 21.8 ptt? -94.08 171.56 8.77 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.76 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.596 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 23.5 p -91.18 -172.83 3.43 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.723 -168.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.45 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 99.0 mt-30 -63.89 -46.81 83.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.143 173.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.422 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 10.4 pt20 -64.95 -35.3 80.73 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.376 0.608 . . . . 0.0 110.061 -175.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.596 ' HG3' ' H ' ' A' ' 51' ' ' THR . 1.7 mm100 -68.14 -40.58 82.38 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.303 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.637 HG13 ' CD2' ' A' ' 93' ' ' LEU . 53.9 t -74.8 -47.15 39.0 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.578 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.688 ' HB3' HG21 ' A' ' 61' ' ' THR . . . -63.58 -24.83 67.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.874 0.368 . . . . 0.0 110.796 -176.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -79.82 -41.27 26.76 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.65 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.56 -44.19 71.38 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.558 0.694 . . . . 0.0 111.271 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.706 HD11 HG22 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -88.27 -39.94 14.02 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.366 -173.044 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.6 122.87 4.07 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -171.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.688 HG21 ' HB3' ' A' ' 56' ' ' ALA . 40.2 p -57.09 133.16 80.5 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.11 0.481 . . . . 0.0 111.032 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 22.6 Cg_exo -63.28 161.78 29.38 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.582 2.855 . . . . 0.0 113.332 -170.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.84 -27.63 60.47 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 113.776 -1.556 . . . . 0.0 112.09 -171.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.812 ' HE1' HG22 ' A' ' 70' ' ' THR . 13.2 ptt? -68.14 2.62 2.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.772 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.9 t 66.48 11.0 7.77 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.818 0.447 . . . . 0.0 112.03 172.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -162.78 104.63 1.04 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.703 0.763 . . . . 0.0 110.458 178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.526 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 74.3 Cg_endo -77.29 -36.25 1.39 Allowed 'Trans proline' 0 C--N 1.326 -0.649 0 C-N-CA 123.171 2.581 . . . . 0.0 113.704 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -77.2 -11.62 59.84 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -166.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.32 -8.85 70.72 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.961 -173.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.812 HG22 ' HE1' ' A' ' 64' ' ' MET . 11.1 t -124.09 174.51 7.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.954 0.407 . . . . 0.0 110.467 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -119.34 1.62 11.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.117 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.3 m -131.62 113.87 14.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.898 -175.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.564 ' O ' ' HA ' ' A' ' 92' ' ' THR . 44.4 m0 -108.69 147.12 32.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.489 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 27.1 m-85 -127.68 125.26 39.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.954 0.407 . . . . 0.0 111.16 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.529 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 73.4 m-85 -133.92 173.61 11.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.798 178.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.5 t -121.27 161.62 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 . . . . . 0 C--N 1.321 -0.633 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 174.087 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.736 HD23 HG21 ' A' ' 43' ' ' VAL . 13.9 tp -90.08 111.5 22.63 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.65 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 34.6 m -106.65 104.2 13.83 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.898 ' HG ' HD22 ' A' ' 101' ' ' LEU . 6.7 tp -88.41 119.28 28.69 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.032 -174.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.8 m -102.43 122.26 43.95 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.557 -175.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -114.63 138.11 51.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.986 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.524 ' HB3' HG22 ' A' ' 102' ' ' THR . 32.5 p30 -75.0 -172.08 1.53 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.121 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.5 m -62.19 -30.97 71.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.557 ' HB3' HG23 ' A' ' 100' ' ' VAL . 35.6 t -83.46 -11.87 56.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.777 0.323 . . . . 0.0 111.133 -174.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.78 28.94 14.34 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.557 HG23 ' HB3' ' A' ' 98' ' ' SER . 6.7 t -107.87 142.91 19.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.031 -0.585 . . . . 0.0 109.648 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.898 HD22 ' HG ' ' A' ' 93' ' ' LEU . 6.5 mt -62.97 126.74 28.33 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.176 0.512 . . . . 0.0 112.204 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.524 HG22 ' HB3' ' A' ' 96' ' ' ASN . 10.8 p -113.13 -42.93 3.44 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.0 175.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -138.2 150.73 47.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.359 0.6 . . . . 0.0 111.584 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.655 HG22 HD11 ' A' ' 91' ' ' LEU . 4.7 mm -113.03 93.08 2.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 168.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.65 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 32.8 t70 -90.56 98.69 11.92 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.465 -169.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.443 ' HA ' ' O ' ' A' ' 90' ' ' THR . 4.8 p30 -110.98 101.72 10.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.201 1.001 . . . . 0.0 110.744 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.415 ' HZ1' ' CG ' ' A' ' 105' ' ' ASP . 23.5 mttp . . . . . 0 C--N 1.317 -0.812 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.716 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.731 HD12 ' HG ' ' A' ' 59' ' ' LEU . 1.8 mm? . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 121.831 0.824 . . . . 0.0 112.562 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 43' ' ' VAL . 17.3 p -131.21 -172.46 2.84 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.352 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.62 -47.57 83.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -67.82 -32.64 73.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.968 0.413 . . . . 0.0 110.959 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.507 ' HB3' HD11 ' A' ' 38' ' ' LEU . 10.6 m-20 -62.76 -37.61 87.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.321 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.933 HG21 HD23 ' A' ' 91' ' ' LEU . 78.4 t -60.61 -37.73 76.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.121 0.486 . . . . 0.0 110.966 178.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.9 t -60.57 -22.84 64.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.257 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 49.8 mtpt -68.57 -34.4 75.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.648 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.674 HG22 HD11 ' A' ' 59' ' ' LEU . 44.6 pt -93.63 175.67 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 121.934 0.873 . . . . 0.0 112.51 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.65 150.96 6.1 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.955 -1.475 . . . . 0.0 109.505 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.426 HG21 ' CG1' ' A' ' 104' ' ' ILE . 0.5 OUTLIER -72.41 141.59 16.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.888 -177.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.3 -24.1 7.42 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.246 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.62 ' HE1' HG23 ' A' ' 46' ' ' ILE . 19.0 ptt? -96.57 178.12 5.44 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.226 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.2 p -95.03 -178.91 4.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.71 -169.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.49 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 27.1 mt-30 -65.56 -43.38 90.03 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.866 173.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.444 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 9.4 pt20 -64.35 -38.11 89.87 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.674 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.444 ' N ' ' HG3' ' A' ' 53' ' ' GLN . 49.3 mt-30 -66.77 -45.62 77.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.115 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.676 HG13 ' CD2' ' A' ' 93' ' ' LEU . 62.8 t -68.86 -47.64 74.94 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.561 ' HB3' HG21 ' A' ' 61' ' ' THR . . . -62.86 -26.32 68.71 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.488 -177.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -81.33 -39.12 25.63 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.392 176.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.25 -51.93 47.07 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.105 0.955 . . . . 0.0 110.85 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.731 ' HG ' HD12 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -81.55 -49.61 10.36 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.328 -173.011 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.88 124.16 2.75 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -171.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.561 HG21 ' HB3' ' A' ' 56' ' ' ALA . 44.3 p -57.41 134.06 81.66 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.877 0.37 . . . . 0.0 110.69 -177.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.508 ' CD ' ' HB3' ' A' ' 67' ' ' PRO . 35.1 Cg_exo -60.41 157.04 37.88 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 123.498 2.799 . . . . 0.0 112.645 -172.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 mt -59.93 -27.99 67.23 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.502 -1.227 . . . . 0.0 111.307 -171.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.433 ' HE1' ' CG2' ' A' ' 70' ' ' THR . 12.5 ptt? -62.85 -4.8 2.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.862 175.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 t 71.65 -3.01 2.27 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.459 0.703 . . . . 0.0 111.695 172.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.46 99.78 7.76 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-O 121.708 0.766 . . . . 0.0 110.427 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.508 ' HB3' ' CD ' ' A' ' 62' ' ' PRO . 73.0 Cg_endo -79.32 -28.43 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.712 2.275 . . . . 0.0 112.598 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -86.03 -5.31 59.24 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -168.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.79 -17.79 53.21 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.89 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.433 ' CG2' ' HE1' ' A' ' 64' ' ' MET . 9.0 t -123.62 172.16 9.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.914 0.388 . . . . 0.0 110.069 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -128.06 20.65 6.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.322 0.582 . . . . 0.0 109.465 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 17.9 m -143.65 111.92 6.3 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.696 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.54 ' O ' ' HA ' ' A' ' 92' ' ' THR . 51.4 m0 -107.84 147.15 31.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.613 -175.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -125.68 115.27 19.83 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 111.268 -174.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.535 ' HD2' HD22 ' A' ' 91' ' ' LEU . 27.7 m-85 -128.53 176.26 7.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.512 HG21 ' H ' ' A' ' 77' ' ' PHE . 4.2 p -124.32 175.13 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -176.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.512 ' H ' HG21 ' A' ' 76' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.486 0 CA-C-O 121.241 0.543 . . . . 0.0 111.622 -175.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 21.6 p . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 121.136 0.493 . . . . 0.0 112.228 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.933 HD23 HG21 ' A' ' 43' ' ' VAL . 24.7 tp -91.51 113.1 25.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.142 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.708 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 25.5 m -106.39 105.05 14.9 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.86 ' HG ' HD22 ' A' ' 101' ' ' LEU . 6.9 tp -90.83 121.65 32.87 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.401 -174.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.7 m -104.55 124.15 48.78 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.945 -176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.454 ' CE1' ' HG ' ' A' ' 101' ' ' LEU . 73.9 m-85 -117.32 139.37 50.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.44 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.484 ' HB3' HG22 ' A' ' 102' ' ' THR . 32.0 p30 -76.59 -174.36 2.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.168 174.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.0 p -57.48 -35.89 70.77 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -175.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.64 ' HB3' HG23 ' A' ' 100' ' ' VAL . 21.0 t -81.15 -4.93 56.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.189 0.518 . . . . 0.0 110.88 -174.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.53 27.95 37.45 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.45 -0.881 . . . . 0.0 110.902 -177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.64 HG23 ' HB3' ' A' ' 98' ' ' SER . 16.7 t -104.6 138.17 30.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.235 -0.482 . . . . 0.0 109.733 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.86 HD22 ' HG ' ' A' ' 93' ' ' LEU . 7.3 mt -58.97 127.75 33.79 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.215 0.531 . . . . 0.0 111.987 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 96' ' ' ASN . 7.6 p -114.3 -35.51 4.96 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.223 176.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -149.43 149.03 30.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.204 0.526 . . . . 0.0 111.915 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.791 HG22 HD11 ' A' ' 91' ' ' LEU . 3.4 mm -113.09 94.38 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.708 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 18.4 t70 -94.91 97.25 9.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.862 0.363 . . . . 0.0 111.674 -169.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' A' ' 90' ' ' THR . 28.6 t-20 -107.69 103.37 12.65 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.723 0.773 . . . . 0.0 110.973 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.533 ' HE3' ' OD1' ' A' ' 105' ' ' ASP . 67.1 mttt . . . . . 0 C--N 1.316 -0.864 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.09 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.721 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 10.4 tp . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.874 0.369 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.49 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 40.4 p -129.21 -179.11 4.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.033 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.409 ' O ' ' HB ' ' A' ' 43' ' ' VAL . . . -65.07 -44.34 89.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.62 -32.58 71.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.397 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 5.7 m-20 -75.33 -27.77 59.37 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.857 176.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.848 HG21 HD23 ' A' ' 91' ' ' LEU . 54.4 t -60.38 -36.34 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.321 0.581 . . . . 0.0 110.05 173.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.4 t -61.8 -19.89 63.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.317 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 46.6 mtpt -74.69 -24.99 58.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.496 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.713 HG22 HD11 ' A' ' 59' ' ' LEU . 34.4 pt -101.24 176.53 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 122.068 0.937 . . . . 0.0 112.585 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.06 153.35 3.12 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.027 -176.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.434 HG21 HD12 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -71.31 144.73 13.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.961 -177.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.49 -29.6 5.63 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.448 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.651 ' HE1' HG23 ' A' ' 46' ' ' ILE . 13.5 ptt? -92.86 178.14 5.86 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.19 176.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.805 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 30.0 p -96.07 -174.1 3.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.776 -169.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.454 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 75.6 mt-30 -61.51 -47.78 84.03 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.246 173.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.659 ' HG2' ' HG1' ' A' ' 51' ' ' THR . 7.7 pt20 -63.59 -40.32 96.65 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.21 0.529 . . . . 0.0 109.977 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.805 ' HG3' ' H ' ' A' ' 51' ' ' THR . 7.3 mm-40 -60.09 -50.43 73.72 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.059 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.633 HG13 ' CD2' ' A' ' 93' ' ' LEU . 56.9 t -64.76 -48.83 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.676 -177.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.625 ' HB3' HG21 ' A' ' 61' ' ' THR . . . -63.31 -26.25 68.68 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.756 -176.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -81.89 -33.73 30.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.972 0.415 . . . . 0.0 111.81 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.67 -40.61 63.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.833 0.825 . . . . 0.0 111.058 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.721 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 0.7 OUTLIER -91.92 -41.6 10.5 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.64 -171.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.9 123.87 4.52 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 -168.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.625 HG21 ' HB3' ' A' ' 56' ' ' ALA . 33.2 p -56.35 136.45 75.84 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.981 0.42 . . . . 0.0 111.051 -175.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.559 ' CD ' ' HB3' ' A' ' 67' ' ' PRO . 34.3 Cg_exo -60.57 167.07 8.75 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.759 2.973 . . . . 0.0 113.556 -171.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.27 -30.44 64.68 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 113.637 -1.619 . . . . 0.0 111.961 -171.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.62 ' HE1' ' CG2' ' A' ' 70' ' ' THR . 11.4 ptt? -71.15 2.29 4.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.778 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.8 t 71.1 1.79 3.96 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.266 0.626 . . . . 0.0 112.234 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -157.62 108.59 1.82 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.73 0.776 . . . . 0.0 110.716 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.693 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 74.1 Cg_endo -75.49 -34.73 3.23 Favored 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 123.559 2.84 . . . . 0.0 113.653 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.451 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 14.4 m-85 -75.14 2.48 10.69 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -166.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.78 -20.09 45.13 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.937 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.62 ' CG2' ' HE1' ' A' ' 64' ' ' MET . 11.8 t -125.61 175.28 7.67 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.839 0.352 . . . . 0.0 110.443 -178.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -123.35 8.15 9.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.5 m -129.14 107.38 9.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.994 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.693 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 47.9 m0 -104.59 144.93 31.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.946 -173.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -122.19 120.38 34.02 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.571 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 72.1 m-85 -127.2 173.61 9.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.522 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.6 t -115.76 152.06 17.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.09 0.471 . . . . 0.0 110.096 -173.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.73 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.443 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.443 -0.799 0 CA-C-O 120.851 0.358 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.848 HD23 HG21 ' A' ' 43' ' ' VAL . 13.2 tp -91.29 108.57 19.97 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.663 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 22.3 m -105.57 98.17 7.91 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.453 0.644 . . . . 0.0 109.647 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.849 ' HG ' HD22 ' A' ' 101' ' ' LEU . 6.9 tp -83.25 128.45 34.51 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.568 -173.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.0 m -114.44 124.61 52.36 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.078 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.436 ' CE1' ' HG ' ' A' ' 101' ' ' LEU . 87.5 m-85 -114.41 140.64 48.52 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.316 -178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.524 ' HB3' HG22 ' A' ' 102' ' ' THR . 31.6 p30 -75.27 -174.07 2.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.148 176.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.2 m -53.59 -36.62 62.14 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.534 ' HB3' HG23 ' A' ' 100' ' ' VAL . 22.9 t -85.96 -0.09 54.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.99 0.424 . . . . 0.0 110.797 -173.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.37 29.84 51.77 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.734 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.534 HG23 ' HB3' ' A' ' 98' ' ' SER . 5.6 t -105.66 140.48 23.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.849 HD22 ' HG ' ' A' ' 93' ' ' LEU . 6.5 mt -59.89 126.37 27.31 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.219 0.533 . . . . 0.0 112.264 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.524 HG22 ' HB3' ' A' ' 96' ' ' ASN . 11.4 p -111.85 -43.52 3.6 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.812 174.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -136.82 152.29 50.11 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.446 0.641 . . . . 0.0 111.335 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.66 HG22 HD11 ' A' ' 91' ' ' LEU . 4.8 mm -114.57 92.23 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 169.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.663 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 18.6 t70 -86.89 95.08 9.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.141 0.496 . . . . 0.0 110.921 -170.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -106.89 104.17 13.78 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.636 0.731 . . . . 0.0 109.967 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.473 ' HD2' ' OD2' ' A' ' 105' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.842 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.98 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.651 HD12 HD12 ' A' ' 59' ' ' LEU . 10.7 tp . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.613 0.244 . . . . 0.0 110.571 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.459 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 43.4 p -127.41 177.25 6.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.128 172.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.77 -30.02 65.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 0.0 110.238 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -53.49 -45.93 69.83 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.788 0.804 . . . . 0.0 109.759 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.66 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 19.9 m-20 -70.54 -30.5 67.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.334 -178.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.969 HG21 HD23 ' A' ' 91' ' ' LEU . 60.2 t -64.87 -41.84 93.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.257 0.551 . . . . 0.0 109.775 174.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.0 t -61.32 -32.01 71.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.315 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.66 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 34.3 mtpt -63.07 -43.52 98.36 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.754 176.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.539 HG22 HD11 ' A' ' 59' ' ' LEU . 43.6 pt -80.91 174.99 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-O 121.723 0.773 . . . . 0.0 111.901 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.44 ' O ' ' HG2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -163.43 143.43 8.71 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.228 -174.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.406 HG21 ' CG1' ' A' ' 104' ' ' ILE . 0.7 OUTLIER -70.34 140.76 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.491 -179.16 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.95 -27.09 6.9 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.965 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.502 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 23.4 ptt? -90.73 174.39 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.255 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.831 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 39.8 p -92.82 -173.78 3.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.888 -171.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.468 ' OE1' ' HA ' ' A' ' 68' ' ' PHE . 83.4 mt-30 -65.57 -44.33 87.08 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.515 172.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.638 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -64.97 -33.67 76.58 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.316 0.579 . . . . 0.0 110.18 -175.543 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.831 ' HG3' ' H ' ' A' ' 51' ' ' THR . 6.3 mm-40 -62.27 -53.01 61.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.222 175.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.755 HG13 HD21 ' A' ' 93' ' ' LEU . 69.1 t -69.96 -40.24 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.676 -176.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.654 ' HB2' HG22 ' A' ' 61' ' ' THR . . . -57.44 -33.45 67.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.433 0.635 . . . . 0.0 110.053 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -81.48 -36.56 29.15 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.744 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.23 -43.3 52.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.132 0.492 . . . . 0.0 111.968 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.651 HD12 HD12 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -94.86 -14.89 24.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.079 -172.625 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.02 124.16 3.27 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -175.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.654 HG22 ' HB2' ' A' ' 56' ' ' ALA . 18.6 p -60.11 121.21 57.45 Favored Pre-proline 0 N--CA 1.432 -1.339 0 CA-C-O 122.295 1.045 . . . . 0.0 111.666 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 75.4 Cg_exo -52.54 159.25 4.82 Favored 'Trans proline' 0 C--N 1.327 -0.602 1 C-N-CA 125.436 4.091 . . . . 0.0 113.965 -176.623 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.524 ' C ' ' H ' ' A' ' 65' ' ' SER . 0.5 OUTLIER -75.12 -21.1 59.1 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.953 -171.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.765 ' HE1' HG22 ' A' ' 70' ' ' THR . 16.9 ptt? -70.49 23.51 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.715 175.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 63' ' ' LEU . 44.5 t 77.07 -56.73 0.53 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 165.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.402 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 8.3 m-20 -126.29 99.92 30.22 Favored Pre-proline 0 C--N 1.304 -1.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.655 -171.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.493 ' HG3' HG22 ' A' ' 61' ' ' THR . 12.5 Cg_endo -58.75 -34.55 99.04 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.408 2.072 . . . . 0.0 111.655 176.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 53' ' ' GLN . 9.4 m-85 -78.99 2.48 20.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.81 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.0 -15.55 44.76 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.873 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.765 HG22 ' HE1' ' A' ' 64' ' ' MET . 6.1 t -124.81 175.5 7.22 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -127.39 7.82 6.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.293 0.568 . . . . 0.0 109.953 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 m -134.69 113.09 11.34 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.677 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.431 ' O ' ' HA ' ' A' ' 92' ' ' THR . 40.0 m0 -103.97 141.39 36.26 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.069 -176.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -116.41 114.64 24.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.372 0.606 . . . . 0.0 110.946 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.623 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 93.2 m-85 -129.41 176.61 7.82 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.525 177.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.528 HG22 ' H ' ' A' ' 77' ' ' PHE . 1.4 p -143.27 -177.86 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.528 ' H ' HG22 ' A' ' 76' ' ' VAL . 15.5 m-30 . . . . . 0 C--N 1.328 -0.366 0 CA-C-O 121.14 0.495 . . . . 0.0 112.162 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.49 HG22 HG21 ' A' ' 76' ' ' VAL . 3.9 p . . . . . 0 N--CA 1.437 -1.122 0 CA-C-O 121.402 0.62 . . . . 0.0 111.966 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 1.055 HD11 HG22 ' A' ' 104' ' ' ILE . 42.5 tp -91.71 118.77 30.96 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.88 174.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 51.1 m -110.61 103.0 11.53 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.876 ' HG ' HD22 ' A' ' 101' ' ' LEU . 6.7 tp -83.11 118.32 23.48 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.055 -174.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 72.7 m -101.17 120.85 40.83 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.531 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -111.96 144.92 40.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.856 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.519 ' HB3' HG22 ' A' ' 102' ' ' THR . 27.2 p30 -75.64 -174.09 2.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.273 173.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.1 m -65.01 -24.93 67.65 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.506 ' HB3' HG23 ' A' ' 100' ' ' VAL . 18.1 t -85.1 -13.6 49.76 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.786 -177.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.26 30.68 8.53 Favored Glycine 0 CA--C 1.508 -0.348 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.008 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.506 HG23 ' HB3' ' A' ' 98' ' ' SER . 5.2 t -112.23 138.59 40.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.797 -0.702 . . . . 0.0 109.525 -177.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.876 HD22 ' HG ' ' A' ' 93' ' ' LEU . 8.5 mt -59.26 124.35 19.72 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.297 0.57 . . . . 0.0 112.442 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 96' ' ' ASN . 19.3 p -111.23 -37.78 5.21 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.164 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -149.65 149.42 30.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.479 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 1.055 HG22 HD11 ' A' ' 91' ' ' LEU . 2.4 mm -110.19 93.32 2.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 173.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.593 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 34.0 t0 -87.76 96.0 10.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.007 0.432 . . . . 0.0 111.4 -170.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -107.89 104.11 13.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.587 0.708 . . . . 0.0 111.277 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.226 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.719 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 4.8 tp . . . . . 0 CA--C 1.521 -0.141 0 CA-C-O 120.618 0.247 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.6 p -126.87 -174.76 3.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.079 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.499 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -67.34 -34.43 77.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.443 0.639 . . . . 0.0 110.574 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -64.67 -42.07 95.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.821 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.93 -27.97 66.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.025 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.795 HG21 HD23 ' A' ' 91' ' ' LEU . 58.8 t -59.84 -36.71 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.15 0.5 . . . . 0.0 110.76 176.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.9 t -59.33 -20.54 55.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.373 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -75.58 -19.24 59.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.819 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.699 HG22 HD11 ' A' ' 59' ' ' LEU . 30.0 pt -107.01 177.95 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.646 0.736 . . . . 0.0 112.46 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.92 150.69 4.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.729 -177.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.462 HG21 HD12 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -72.74 141.81 15.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.999 -179.045 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.69 -29.83 5.51 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.11 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.619 ' HE1' HG23 ' A' ' 46' ' ' ILE . 18.6 ptt? -88.54 178.36 6.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.184 0.492 . . . . 0.0 111.133 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.83 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 39.9 p -95.09 -174.3 3.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.207 -170.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.417 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 45.7 mt-30 -66.72 -44.12 82.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.866 174.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.619 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -65.92 -34.52 78.32 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.422 0.63 . . . . 0.0 109.823 -176.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.83 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.9 mm-40 -61.0 -57.03 14.32 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.464 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.614 HG13 ' CD2' ' A' ' 93' ' ' LEU . 90.9 t -63.42 -42.53 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.725 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.458 ' HB2' HG21 ' A' ' 61' ' ' THR . . . -58.72 -35.82 73.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.082 0.468 . . . . 0.0 110.161 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -80.88 -37.22 30.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.515 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.64 -46.39 66.28 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.616 0.722 . . . . 0.0 111.215 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.719 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 0.7 OUTLIER -88.14 -42.79 12.11 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.594 -172.103 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.79 122.01 3.76 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -171.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.504 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 17.9 p -54.7 136.51 64.0 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.499 0.666 . . . . 0.0 111.795 -175.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.56 ' HB2' ' HG2' ' A' ' 64' ' ' MET . 23.1 Cg_exo -64.49 165.03 21.44 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.847 3.031 . . . . 0.0 113.197 -172.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.14 -24.63 67.27 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.483 -173.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.56 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 14.6 ptt? -68.22 -1.29 5.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.806 175.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 t 71.56 6.63 5.77 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.459 0.704 . . . . 0.0 112.471 170.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -165.33 110.93 0.79 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 121.738 0.78 . . . . 0.0 110.674 176.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 60.4 Cg_endo -73.67 -24.54 15.73 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.303 2.669 . . . . 0.0 113.525 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -80.53 -5.6 56.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -170.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.75 -18.76 59.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.733 -176.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.5 t -125.0 175.28 7.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.348 0.594 . . . . 0.0 111.624 -173.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -117.49 0.34 12.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.658 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.4 m -128.99 111.86 13.44 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.789 -178.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.633 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 43.8 m0 -104.03 137.36 42.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.606 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -113.28 110.09 19.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.224 0.535 . . . . 0.0 111.21 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.582 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 53.8 m-85 -125.8 175.83 7.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.512 HG23 ' H ' ' A' ' 77' ' ' PHE . 2.3 p -141.89 179.99 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.536 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.512 ' H ' HG23 ' A' ' 76' ' ' VAL . 2.9 m-30 . . . . . 0 C--N 1.326 -0.436 0 C-N-CA 122.599 0.36 . . . . 0.0 111.632 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.443 -0.784 0 CA-C-O 120.812 0.339 . . . . 0.0 110.902 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.795 HD23 HG21 ' A' ' 43' ' ' VAL . 13.9 tp -90.92 108.35 19.8 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.715 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 19.2 m -103.22 104.5 14.64 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.853 ' HG ' HD22 ' A' ' 101' ' ' LEU . 7.0 tp -88.71 128.71 35.62 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.423 -173.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.2 m -115.82 123.06 47.23 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.077 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.409 ' CE2' ' HG ' ' A' ' 101' ' ' LEU . 93.1 m-85 -112.41 137.31 50.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.43 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.513 ' HB3' HG22 ' A' ' 102' ' ' THR . 6.1 p30 -57.22 -82.7 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -175.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.4 t -155.38 -34.3 0.09 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.508 ' HB2' HG23 ' A' ' 100' ' ' VAL . 16.9 m -78.99 -8.11 58.65 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.243 0.544 . . . . 0.0 110.436 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.47 32.18 8.37 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.508 HG23 ' HB2' ' A' ' 98' ' ' SER . 18.5 t -112.35 134.17 55.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.178 -0.511 . . . . 0.0 109.689 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.853 HD22 ' HG ' ' A' ' 93' ' ' LEU . 6.2 mt -61.52 125.88 25.36 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.249 0.547 . . . . 0.0 112.319 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.513 HG22 ' HB3' ' A' ' 96' ' ' ASN . 11.2 p -111.73 -42.55 3.8 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.913 175.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -136.05 151.89 50.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.57 0.7 . . . . 0.0 111.49 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.69 HG22 HD11 ' A' ' 91' ' ' LEU . 3.1 mm -115.75 93.65 2.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 168.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.715 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 7.5 t70 -87.34 95.04 9.85 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.133 0.492 . . . . 0.0 110.415 -170.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -112.3 111.38 22.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.842 0.83 . . . . 0.0 111.437 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.915 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.609 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.656 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 4.9 tp . . . . . 0 CA--C 1.518 -0.282 0 CA-C-O 121.044 0.449 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 43.1 p -128.77 -174.29 3.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.589 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.25 -46.48 76.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.381 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.52 -27.43 69.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.155 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 14.4 m-20 -70.9 -37.0 72.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.441 173.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.877 HG21 HD23 ' A' ' 91' ' ' LEU . 67.3 t -59.63 -36.99 68.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.217 0.532 . . . . 0.0 110.784 176.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.0 t -64.77 -15.05 61.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.113 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 47.0 mtpt -81.82 -8.63 59.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.332 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.657 HG22 HD11 ' A' ' 59' ' ' LEU . 24.8 pt -112.67 178.38 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.713 0.768 . . . . 0.0 112.131 176.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.16 151.05 4.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.484 -177.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.465 HG21 HD12 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -72.76 144.41 12.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.101 -177.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.25 -29.05 6.32 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.197 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.543 ' HE1' HG23 ' A' ' 46' ' ' ILE . 19.2 ptt? -90.24 174.79 7.41 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.119 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.837 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 31.2 p -91.61 -176.66 4.56 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.049 -170.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -61.46 -47.05 87.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.704 170.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -37.7 75.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.271 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.837 ' HG3' ' H ' ' A' ' 51' ' ' THR . 5.3 mm-40 -67.45 -54.38 20.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.19 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.585 HG13 ' CD2' ' A' ' 93' ' ' LEU . 73.5 t -62.11 -44.49 99.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.822 -178.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.567 ' HB2' HG21 ' A' ' 61' ' ' THR . . . -58.31 -34.75 70.92 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.046 0.451 . . . . 0.0 110.104 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -82.15 -36.56 27.29 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.196 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.51 -43.34 77.01 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.772 0.796 . . . . 0.0 111.023 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.657 HD11 HG22 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -89.4 -54.74 3.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.183 -173.39 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 127.15 118.75 2.2 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.567 HG21 ' HB2' ' A' ' 56' ' ' ALA . 32.8 p -55.27 130.54 69.09 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.082 0.468 . . . . 0.0 111.128 -176.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.517 ' HG3' ' HH ' ' A' ' 75' ' ' TYR . 18.6 Cg_exo -64.95 172.41 7.26 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.871 3.048 . . . . 0.0 113.843 -169.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.9 mt -49.91 -43.24 49.49 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.877 0.735 . . . . 0.0 111.89 -173.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.504 ' HE1' ' CG2' ' A' ' 70' ' ' THR . 15.0 ptt? -63.16 -3.54 1.86 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.328 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 p 59.54 3.25 0.4 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.618 1.167 . . . . 0.0 113.495 174.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -136.45 90.15 17.86 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.226 0.536 . . . . 0.0 109.866 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.6 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 72.1 Cg_endo -74.74 -32.0 6.18 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.856 2.371 . . . . 0.0 112.128 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -77.97 7.26 6.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.2 -171.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.35 -19.76 17.57 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.085 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.504 ' CG2' ' HE1' ' A' ' 64' ' ' MET . 4.9 t -124.2 165.53 17.43 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -177.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -117.96 12.81 13.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.292 0.568 . . . . 0.0 110.31 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.9 m -136.69 106.89 6.37 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.933 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.686 ' O ' ' HA ' ' A' ' 92' ' ' THR . 47.7 m0 -103.79 147.21 27.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 -173.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -124.42 124.94 43.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.063 0.459 . . . . 0.0 110.764 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.576 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 80.6 m-85 -130.28 173.42 10.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.722 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.7 t -112.07 158.04 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.956 0.407 . . . . 0.0 110.021 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.69 176.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.447 -0.581 0 CA-C-O 121.061 0.457 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.877 HD23 HG21 ' A' ' 43' ' ' VAL . 17.5 tp -90.52 111.71 23.1 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.719 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.686 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 81.0 m -107.14 108.55 20.06 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.899 ' HG ' HD22 ' A' ' 101' ' ' LEU . 7.5 tp -91.81 126.71 36.99 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.615 -173.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 20.0 m -104.33 122.13 44.8 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.996 -177.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -114.37 139.33 49.56 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.962 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.521 ' HB3' HG22 ' A' ' 102' ' ' THR . 33.4 p30 -76.08 -175.75 3.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.432 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.9 m -52.01 -36.24 49.38 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.516 ' HB3' HG23 ' A' ' 100' ' ' VAL . 10.4 t -89.19 -0.03 57.13 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.161 -0.337 . . . . 0.0 111.182 -171.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.79 29.33 39.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.451 -0.881 . . . . 0.0 111.179 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.516 HG23 ' HB3' ' A' ' 98' ' ' SER . 21.8 t -105.88 138.92 28.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.004 -0.598 . . . . 0.0 109.667 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.899 HD22 ' HG ' ' A' ' 93' ' ' LEU . 5.9 mt -60.9 125.5 23.94 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.175 0.512 . . . . 0.0 112.026 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.521 HG22 ' HB3' ' A' ' 96' ' ' ASN . 11.2 p -112.52 -43.35 3.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.93 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.407 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 1.9 m-20 -137.53 154.3 49.86 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.3 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.677 HG22 HD11 ' A' ' 91' ' ' LEU . 3.6 mm -115.41 92.47 2.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 169.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 92' ' ' THR . 15.4 m-20 -89.38 96.98 10.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.971 0.415 . . . . 0.0 111.441 -172.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -107.3 109.11 20.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.486 0.66 . . . . 0.0 110.516 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.609 ' H ' ' HE3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.843 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.259 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.785 HD12 ' HG ' ' A' ' 59' ' ' LEU . 2.5 mm? . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 121.583 0.706 . . . . 0.0 111.792 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.6 p -128.64 -174.94 3.38 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.66 174.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.35 -35.0 71.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.804 0.812 . . . . 0.0 109.813 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -61.54 -43.88 98.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.388 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.483 ' HB2' HD11 ' A' ' 38' ' ' LEU . 35.0 m-20 -72.02 -30.77 65.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.073 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.922 HG21 HD23 ' A' ' 91' ' ' LEU . 54.6 t -57.87 -36.68 56.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.134 0.492 . . . . 0.0 110.289 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.2 t -61.85 -18.3 59.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.578 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 46.1 mtpt -74.33 -36.15 63.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.768 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.717 HG22 HD11 ' A' ' 59' ' ' LEU . 39.3 pt -87.64 178.61 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.848 0.832 . . . . 0.0 112.268 -177.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.401 ' HD2' ' HE3' ' A' ' 50' ' ' MET . 0.0 OUTLIER -172.68 150.9 2.23 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.467 -175.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.436 HG21 HD12 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -70.74 144.09 13.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.206 -177.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.41 -32.74 4.58 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.776 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.582 ' HE1' HG23 ' A' ' 46' ' ' ILE . 13.1 ptt? -87.35 177.64 7.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.017 0.437 . . . . 0.0 111.053 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.782 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 22.2 p -92.57 -174.76 3.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.904 -171.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.481 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 26.3 mt-30 -64.64 -43.88 92.28 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.921 173.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.532 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -66.46 -35.1 79.45 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.216 0.531 . . . . 0.0 109.996 -175.417 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.782 ' HG3' ' H ' ' A' ' 51' ' ' THR . 11.4 mm-40 -59.86 -51.12 71.06 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.729 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.606 HG13 ' CD2' ' A' ' 93' ' ' LEU . 70.5 t -68.75 -42.78 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.663 -176.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.432 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -63.98 -25.67 68.23 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.388 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -81.7 -40.93 22.06 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.555 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.41 -45.16 69.89 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.591 0.71 . . . . 0.0 111.332 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.785 ' HG ' HD12 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -90.58 -44.09 9.78 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.232 -174.365 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.57 132.24 4.01 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -171.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.486 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 16.7 p -59.96 134.32 90.01 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.028 0.442 . . . . 0.0 110.684 -177.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.496 ' HG3' ' OH ' ' A' ' 75' ' ' TYR . 20.4 Cg_exo -64.16 171.97 6.94 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.902 3.068 . . . . 0.0 114.358 -169.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 7.2 mt -50.03 -47.45 53.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.244 -175.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.777 ' HE1' HG22 ' A' ' 70' ' ' THR . 0.0 OUTLIER -54.98 -12.92 0.93 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.957 179.018 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.4 t 70.75 1.58 3.78 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.292 0.568 . . . . 0.0 111.332 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -144.38 102.23 4.71 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-O 121.592 0.71 . . . . 0.0 109.435 174.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.499 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 43.5 Cg_endo -68.45 -25.8 35.16 Favored 'Trans proline' 0 C--N 1.327 -0.565 0 C-N-CA 123.198 2.599 . . . . 0.0 112.608 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -86.63 12.36 10.78 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.547 -173.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -102.39 -20.25 12.54 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.241 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.777 HG22 ' HE1' ' A' ' 64' ' ' MET . 6.6 t -126.25 172.61 9.94 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -122.03 10.14 10.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.187 0.518 . . . . 0.0 109.867 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.2 m -139.4 112.52 8.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.171 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.534 ' O ' ' HA ' ' A' ' 92' ' ' THR . 44.7 m0 -104.34 144.83 31.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.736 -176.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -121.87 112.88 18.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 110.644 -176.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.584 ' CE2' HD23 ' A' ' 59' ' ' LEU . 33.2 m-85 -125.4 174.69 8.0 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.477 HG21 ' H ' ' A' ' 77' ' ' PHE . 5.8 p -137.15 168.56 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.858 -174.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.477 ' H ' HG21 ' A' ' 76' ' ' VAL . 2.0 m-30 . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.049 -176.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.442 -0.827 0 CA-C-O 121.269 0.557 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.922 HD23 HG21 ' A' ' 43' ' ' VAL . 16.8 tp -97.81 104.0 15.99 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.716 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.655 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 24.9 m -99.51 105.18 17.06 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.826 ' HG ' HD22 ' A' ' 101' ' ' LEU . 7.7 tp -88.03 123.61 32.9 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.582 -174.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.458 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 21.6 m -105.48 123.67 48.27 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.971 -176.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -111.29 151.28 28.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.894 0.854 . . . . 0.0 112.966 -175.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -75.17 -176.01 2.87 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.292 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.7 p -67.02 -41.04 87.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.848 0.356 . . . . 0.0 111.097 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.504 ' HB3' HG23 ' A' ' 100' ' ' VAL . 38.2 t -74.95 -13.82 60.57 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.112 0.482 . . . . 0.0 110.592 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' A' ' 52' ' ' GLN . . . 95.04 31.01 7.9 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -176.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.504 HG23 ' HB3' ' A' ' 98' ' ' SER . 21.9 t -101.42 140.25 20.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.826 HD22 ' HG ' ' A' ' 93' ' ' LEU . 5.5 mt -60.17 126.18 26.53 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.133 0.492 . . . . 0.0 111.356 177.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 70.9 p -113.39 -45.06 3.16 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.854 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.458 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 3.4 m-20 -136.85 153.66 50.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.501 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.592 HG22 HD11 ' A' ' 91' ' ' LEU . 3.6 mm -120.13 93.52 2.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 172.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.655 ' HB2' ' HB ' ' A' ' 92' ' ' THR . 6.9 m-20 -78.23 96.41 5.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.962 0.41 . . . . 0.0 110.716 -176.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -111.2 104.33 12.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.579 0.704 . . . . 0.0 110.081 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.429 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.315 -0.906 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.712 -176.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.685 HD12 HD12 ' A' ' 59' ' ' LEU . 6.4 tp . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 121.172 0.511 . . . . 0.0 111.259 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.8 p -128.62 -178.07 4.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.292 177.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.49 -36.61 83.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.935 0.874 . . . . 0.0 110.209 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -61.94 -41.4 97.92 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.382 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 16.7 m-20 -69.89 -27.01 64.45 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.238 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.894 HG21 HD23 ' A' ' 91' ' ' LEU . 63.0 t -62.75 -37.03 78.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.322 0.582 . . . . 0.0 110.391 174.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -65.63 -16.55 63.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.807 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 45.5 mtpt -73.76 -29.51 62.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.656 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.642 HG22 HD11 ' A' ' 59' ' ' LEU . 40.3 pt -92.7 -178.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.795 0.807 . . . . 0.0 111.798 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.41 149.74 5.93 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.424 -177.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.472 HG21 HD12 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -71.48 148.0 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.505 -178.886 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.86 -30.22 7.58 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.215 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.507 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 19.9 ptt? -84.97 173.03 10.86 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.938 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.809 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 19.1 p -89.72 -174.32 4.26 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.438 -170.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 95' ' ' PHE . 37.1 mt-30 -64.89 -43.15 93.83 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.855 174.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.647 ' HG2' ' HG1' ' A' ' 51' ' ' THR . 11.3 pt20 -65.8 -35.75 81.57 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.448 0.642 . . . . 0.0 109.913 -175.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.809 ' HG3' ' H ' ' A' ' 51' ' ' THR . 9.8 mm-40 -58.91 -55.22 37.92 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.297 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.65 HG13 HD21 ' A' ' 93' ' ' LEU . 92.8 t -66.73 -41.05 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.492 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.684 ' HB2' HG21 ' A' ' 61' ' ' THR . . . -58.56 -34.45 71.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.184 0.516 . . . . 0.0 110.103 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -82.47 -38.81 23.39 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.755 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.58 -46.66 65.82 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.546 0.688 . . . . 0.0 111.343 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.685 HD12 HD12 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -92.1 -29.67 16.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.751 -173.08 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.55 127.85 6.02 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.684 HG21 ' HB2' ' A' ' 56' ' ' ALA . 34.9 p -59.9 134.09 89.79 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-O 121.237 0.541 . . . . 0.0 110.794 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 21.2 Cg_exo -65.85 162.12 36.33 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.189 2.592 . . . . 0.0 111.699 -174.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 mt -49.14 -33.53 12.25 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.57 -168.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.744 ' HE1' HG22 ' A' ' 70' ' ' THR . 9.7 ptt? -62.55 -6.39 3.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.8 p 58.92 8.71 1.02 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.392 1.077 . . . . 0.0 112.503 177.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.421 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 1.9 t70 -141.21 94.77 7.62 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 122.021 0.915 . . . . 0.0 109.749 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.599 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 74.3 Cg_endo -75.26 -34.56 3.52 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.294 2.663 . . . . 0.0 113.356 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -79.55 2.94 20.34 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -174.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.08 -23.95 42.89 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.539 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.744 HG22 ' HE1' ' A' ' 64' ' ' MET . 11.8 t -124.23 174.89 7.39 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -177.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -123.57 4.25 8.96 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.8 m -125.61 109.64 12.88 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.19 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.599 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 45.2 m0 -108.18 140.25 41.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.55 -176.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -117.17 112.45 20.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.34 0.591 . . . . 0.0 111.24 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.626 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 88.1 m-85 -113.31 174.92 5.67 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.982 174.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 38' ' ' LEU . 2.5 p -122.28 150.51 25.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.206 0.526 . . . . 0.0 110.038 -174.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.315 -0.905 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.427 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.4 p . . . . . 0 N--CA 1.441 -0.879 0 CA-C-O 121.025 0.441 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.894 HD23 HG21 ' A' ' 43' ' ' VAL . 22.1 tp -89.54 107.51 19.12 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.527 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 23.8 m -99.03 101.53 12.94 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.88 ' HG ' HD22 ' A' ' 101' ' ' LEU . 8.0 tp -87.12 122.96 31.65 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.985 -174.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 27.6 m -104.14 118.13 35.91 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.077 -176.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 52' ' ' GLN . 31.4 m-85 -105.63 149.29 26.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.737 0.78 . . . . 0.0 111.862 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -73.92 173.13 10.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.557 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.5 m -57.64 -36.87 72.43 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.794 0.331 . . . . 0.0 110.664 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.513 ' HB3' HG23 ' A' ' 100' ' ' VAL . 18.7 t -80.98 -4.1 53.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.927 0.394 . . . . 0.0 110.885 -177.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.36 30.01 26.02 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.402 -179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 98' ' ' SER . 21.4 t -105.99 138.88 29.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.88 HD22 ' HG ' ' A' ' 93' ' ' LEU . 5.9 mt -61.76 124.09 19.78 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.075 0.464 . . . . 0.0 111.747 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.0 p -114.02 -39.72 3.88 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.11 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.47 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 5.1 m-20 -136.76 154.6 50.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.554 0.692 . . . . 0.0 111.54 177.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.707 HG22 HD11 ' A' ' 91' ' ' LEU . 3.0 mm -118.73 92.38 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 168.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 92' ' ' THR . 13.3 m-20 -86.84 95.86 10.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.838 0.351 . . . . 0.0 110.947 -174.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -99.18 101.06 12.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.146 0.974 . . . . 0.0 109.634 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.467 ' HE3' ' HB3' ' A' ' 105' ' ' ASP . 71.2 mttt . . . . . 0 C--N 1.318 -0.787 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.289 -172.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.718 HD12 ' HG ' ' A' ' 59' ' ' LEU . 3.0 tp . . . . . 0 CA--C 1.519 -0.231 0 CA-C-O 121.418 0.628 . . . . 0.0 111.568 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 43.8 p -128.17 -175.24 3.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.93 177.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.55 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -65.65 -33.29 75.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.058 0.456 . . . . 0.0 110.811 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -59.47 -43.46 93.25 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.739 0.78 . . . . 0.0 109.717 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.405 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 6.9 m-20 -70.17 -34.29 72.82 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.633 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.931 HG21 HD23 ' A' ' 91' ' ' LEU . 55.9 t -55.59 -36.51 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.046 0.45 . . . . 0.0 111.154 177.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 t -64.27 -11.43 31.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.64 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 47.8 mtpt -80.53 -26.34 38.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.733 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.729 HG22 HD11 ' A' ' 59' ' ' LEU . 38.4 pt -95.49 -178.5 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.797 0.808 . . . . 0.0 112.305 -178.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.25 152.7 3.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.585 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.73 144.07 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.265 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.19 -32.47 4.72 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.954 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.559 ' HE1' HG23 ' A' ' 46' ' ' ILE . 18.4 ptt? -90.07 177.14 6.53 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.488 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.878 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 62.4 p -94.0 -174.97 3.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.467 -170.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.474 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 97.9 mt-30 -64.79 -42.26 95.18 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.581 172.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.415 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 9.2 pt20 -67.01 -37.97 85.15 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.705 -177.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.878 ' HG3' ' H ' ' A' ' 51' ' ' THR . 5.7 mm-40 -58.98 -53.2 61.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.966 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.619 HG13 ' CD2' ' A' ' 93' ' ' LEU . 74.7 t -66.5 -46.39 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.997 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.446 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -64.33 -26.61 68.55 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.636 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -81.48 -37.28 28.18 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.614 177.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.98 -48.87 41.87 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.922 0.868 . . . . 0.0 110.78 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.729 HD11 HG22 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -84.21 -55.37 4.22 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.16 -173.351 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.72 133.35 3.23 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 -172.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.498 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 39.4 p -68.32 130.91 92.04 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-O 121.238 0.542 . . . . 0.0 110.386 -177.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.577 ' HG2' ' HE2' ' A' ' 64' ' ' MET . 6.9 Cg_exo -69.75 160.89 48.01 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.177 2.584 . . . . 0.0 113.062 -170.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.78 -28.33 69.38 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.506 -171.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.577 ' HE2' ' HG2' ' A' ' 62' ' ' PRO . 10.7 ptt? -61.79 -4.28 1.44 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.111 177.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.4 t 73.54 -4.0 2.34 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 170.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -146.86 99.71 4.01 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-O 120.907 0.384 . . . . 0.0 110.954 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.429 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 39.6 Cg_endo -70.13 -30.95 19.76 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.074 1.85 . . . . 0.0 111.527 175.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -85.72 12.02 9.8 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.535 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.82 -20.27 13.33 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.884 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.441 HG21 ' HE1' ' A' ' 64' ' ' MET . 5.7 t -125.84 174.0 8.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.646 0.26 . . . . 0.0 110.375 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -117.95 -1.09 11.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.266 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.8 m -125.26 111.42 15.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.542 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.474 ' HH2' ' O ' ' A' ' 52' ' ' GLN . 42.7 m0 -104.12 141.3 36.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.366 -177.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -118.68 118.97 33.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.113 0.482 . . . . 0.0 110.844 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.569 ' HB3' HD21 ' A' ' 38' ' ' LEU . 63.9 m-85 -127.87 174.41 9.18 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 176.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.497 HG23 ' H ' ' A' ' 77' ' ' PHE . 2.7 p -129.15 167.54 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.127 -173.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.55 ' CG ' ' HB2' ' A' ' 40' ' ' ALA . 7.2 m-30 . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.265 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.444 -0.739 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.931 HD23 HG21 ' A' ' 43' ' ' VAL . 16.3 tp -95.71 123.52 39.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.192 174.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.665 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 34.4 m -114.53 101.26 8.95 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.843 ' HG ' HD22 ' A' ' 101' ' ' LEU . 7.2 tp -88.3 126.34 35.13 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.996 -173.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.8 m -112.4 123.22 49.81 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.889 -175.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.416 ' CE1' ' HG ' ' A' ' 101' ' ' LEU . 80.2 m-85 -113.27 141.25 47.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.884 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.515 ' HB3' HG22 ' A' ' 102' ' ' THR . 32.1 p30 -75.41 -173.63 2.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.903 175.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.4 m -56.29 -35.1 67.11 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -174.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.487 ' HB3' HG23 ' A' ' 100' ' ' VAL . 20.8 t -88.83 9.74 23.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.814 0.34 . . . . 0.0 111.059 -175.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.75 33.85 76.62 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.091 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 98' ' ' SER . 7.6 t -106.12 140.06 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.843 HD22 ' HG ' ' A' ' 93' ' ' LEU . 6.3 mt -62.17 124.42 20.8 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.43 0.633 . . . . 0.0 112.246 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.515 HG22 ' HB3' ' A' ' 96' ' ' ASN . 18.0 p -111.03 -43.94 3.68 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.612 -1.177 . . . . 0.0 109.965 175.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -136.67 152.75 50.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.745 0.783 . . . . 0.0 111.692 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.672 HG22 HD11 ' A' ' 91' ' ' LEU . 3.6 mm -117.86 93.61 2.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 170.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.665 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 23.4 t70 -87.03 96.47 10.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.948 0.404 . . . . 0.0 110.624 -173.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -105.62 104.31 14.0 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.85 0.834 . . . . 0.0 109.898 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.5 pttm . . . . . 0 C--N 1.314 -0.94 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.773 -176.791 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.612 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 4.5 tp . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 121.224 0.535 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.7 p -127.7 -175.78 3.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.631 174.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.19 -31.53 69.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.053 0.454 . . . . 0.0 110.904 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -60.05 -41.19 91.79 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.563 0.696 . . . . 0.0 109.776 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 11.4 m-20 -67.9 -37.11 81.32 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.887 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.85 HG21 HD23 ' A' ' 91' ' ' LEU . 81.2 t -60.04 -40.66 83.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.77 0.319 . . . . 0.0 111.094 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.1 p -64.5 -18.93 65.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.025 0.441 . . . . 0.0 111.028 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.43 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 30.1 mtpp -77.54 -28.42 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.987 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.5 HG22 HD11 ' A' ' 59' ' ' LEU . 43.5 pt -89.56 174.08 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 121.758 0.79 . . . . 0.0 111.822 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.421 ' O ' ' HG2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -163.4 143.33 8.71 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.719 -176.252 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.402 HG21 ' CG1' ' A' ' 104' ' ' ILE . 0.9 OUTLIER -69.61 142.27 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.484 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.19 -30.69 5.55 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.86 -175.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.498 ' HE1' HG23 ' A' ' 46' ' ' ILE . 21.2 ptt? -87.11 175.12 8.24 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.813 176.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.801 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 23.6 p -92.99 -170.0 2.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.846 -171.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.4 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 94.9 mt-30 -67.51 -46.33 73.19 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.611 173.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.663 ' HG2' ' HG1' ' A' ' 51' ' ' THR . 11.9 pt20 -61.98 -38.8 89.96 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.832 -176.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.801 ' HG3' ' H ' ' A' ' 51' ' ' THR . 7.1 mm-40 -59.52 -46.37 89.04 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.303 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.661 HG13 ' CD2' ' A' ' 93' ' ' LEU . 58.4 t -73.24 -43.46 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.834 -176.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.532 ' HB3' HG21 ' A' ' 61' ' ' THR . . . -63.11 -24.01 67.7 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.261 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -80.04 -39.47 29.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.773 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.66 -44.06 44.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.008 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.612 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -93.07 -10.03 37.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.917 -172.531 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.66 129.14 1.57 Allowed Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.532 HG21 ' HB3' ' A' ' 56' ' ' ALA . 41.3 p -56.11 131.52 74.56 Favored Pre-proline 0 N--CA 1.439 -0.986 0 CA-C-O 122.028 0.918 . . . . 0.0 111.835 -176.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 67' ' ' PRO . 74.8 Cg_exo -50.6 165.94 0.37 Allowed 'Trans proline' 0 C--N 1.332 -0.333 1 C-N-CA 125.742 4.295 . . . . 0.0 115.431 -176.381 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.1 mt -51.7 -49.28 62.77 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.655 -177.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.742 ' HE1' HG22 ' A' ' 70' ' ' THR . 0.0 OUTLIER -54.1 -13.55 0.85 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.986 179.543 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.0 t 76.11 -17.79 0.51 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.359 0.664 . . . . 0.0 112.066 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 64' ' ' MET . 5.8 p-10 -122.21 92.96 48.81 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-O 121.971 0.891 . . . . 0.0 109.819 174.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.545 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 29.0 Cg_endo -64.49 -30.59 61.76 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.619 2.212 . . . . 0.0 112.493 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -81.35 13.84 2.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.718 -173.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -102.93 -25.15 7.68 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.091 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.742 HG22 ' HE1' ' A' ' 64' ' ' MET . 6.6 t -124.13 169.23 11.91 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -120.52 1.64 10.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.651 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.8 m -118.15 109.08 15.96 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.959 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.42 ' O ' ' HA ' ' A' ' 92' ' ' THR . 46.9 m0 -106.84 134.34 50.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.687 -176.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -113.36 125.92 54.79 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.161 0.288 . . . . 0.0 110.661 -177.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.537 ' CE2' HD23 ' A' ' 59' ' ' LEU . 60.8 m-85 -135.14 174.93 10.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.424 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.38 162.99 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 120.849 0.357 . . . . 0.0 110.264 -177.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.464 -176.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.442 -0.859 0 CA-C-O 121.234 0.54 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.85 HD23 HG21 ' A' ' 43' ' ' VAL . 21.3 tp -90.16 115.48 27.43 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.056 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.686 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 11.8 m -109.2 95.62 5.75 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.775 ' HG ' HD22 ' A' ' 101' ' ' LEU . 8.3 tp -81.39 125.1 29.99 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.38 -171.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 37.2 m -107.45 121.64 45.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.178 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.435 ' CE1' ' HG ' ' A' ' 101' ' ' LEU . 77.3 m-85 -115.28 139.71 49.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.537 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.537 ' HB3' HG22 ' A' ' 102' ' ' THR . 32.0 p30 -74.52 -176.38 2.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.614 175.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.2 t -55.13 -37.21 66.64 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -176.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.521 ' HB3' HG23 ' A' ' 100' ' ' VAL . 19.0 t -82.17 2.29 32.31 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.784 0.326 . . . . 0.0 111.059 -174.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.99 31.16 56.21 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.922 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.521 HG23 ' HB3' ' A' ' 98' ' ' SER . 6.7 t -107.57 139.78 28.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.775 HD22 ' HG ' ' A' ' 93' ' ' LEU . 7.3 mt -60.87 124.8 21.51 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.237 0.541 . . . . 0.0 112.0 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 96' ' ' ASN . 10.1 p -113.01 -35.92 5.27 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.049 176.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -148.76 148.46 30.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.441 0.639 . . . . 0.0 111.932 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.775 HG22 HD11 ' A' ' 91' ' ' LEU . 5.6 mm -106.01 93.21 2.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 170.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.686 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 17.6 t70 -81.58 97.3 7.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.141 0.496 . . . . 0.0 110.643 -171.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -105.38 110.78 23.26 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.363 0.601 . . . . 0.0 109.814 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? . . . . . 0 C--N 1.313 -0.994 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.823 179.928 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.1 m -67.08 -41.59 86.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.03 0.443 . . . . 0.0 110.134 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -83.01 71.82 10.1 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.0 tpt -78.11 -23.54 47.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.663 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.2 m -51.73 111.2 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.062 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 m -106.46 38.61 2.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.758 0.79 . . . . 0.0 109.413 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.4 tp -81.59 -34.1 31.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.564 -174.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -75.05 135.21 41.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.198 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -164.41 11.8 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.978 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.4 t 69.87 -66.55 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.976 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -147.59 176.97 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -70.88 99.14 1.7 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 120.957 0.408 . . . . 0.0 111.036 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -129.01 81.58 70.55 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 121.448 0.642 . . . . 0.0 109.549 174.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -70.12 139.53 39.2 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.752 2.968 . . . . 0.0 114.344 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -176.88 -70.37 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.56 170.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.672 HG23 ' H ' ' A' ' 34' ' ' GLN . 29.0 mm -100.95 146.6 9.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 114.359 -1.292 . . . . 0.0 111.55 174.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -98.1 -21.21 16.88 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.631 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.672 ' H ' HG23 ' A' ' 32' ' ' ILE . 11.0 pt20 -88.29 1.9 53.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.382 -170.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 175.32 174.26 41.77 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 119.797 -1.192 . . . . 0.0 113.706 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -125.44 18.64 8.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 122.198 0.999 . . . . 0.0 109.032 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -100.58 -167.91 1.5 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.479 -176.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.639 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 5.5 tp -70.96 152.61 43.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.712 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.627 HG22 HG13 ' A' ' 32' ' ' ILE . 28.2 p -127.7 -174.38 3.17 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.486 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.406 ' H ' ' HB2' ' A' ' 78' ' ' ARG . . . -66.69 -34.87 78.8 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.939 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -56.2 -46.43 79.45 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.509 0.671 . . . . 0.0 110.353 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.596 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.3 m-20 -74.13 -28.44 61.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.308 -176.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.913 HG21 HD23 ' A' ' 91' ' ' LEU . 84.0 t -62.94 -40.56 89.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.406 0.622 . . . . 0.0 109.82 172.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.2 t -64.93 -22.88 67.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.564 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.596 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 42.9 mtpt -70.41 -46.35 64.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.35 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.601 HG23 ' HE1' ' A' ' 50' ' ' MET . 22.8 pt -75.77 173.04 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-O 122.01 0.909 . . . . 0.0 112.728 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.69 148.24 10.59 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.469 -176.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -71.1 143.03 14.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.65 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.96 -32.69 4.5 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.31 -0.947 . . . . 0.0 112.608 -176.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.601 ' HE1' HG23 ' A' ' 46' ' ' ILE . 16.3 ptt? -85.65 177.91 7.54 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 117.371 0.586 . . . . 0.0 111.126 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.76 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 38.9 p -91.9 -171.38 2.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.979 -172.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.462 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 97.1 mt-30 -68.74 -46.26 69.32 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.094 172.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.482 ' HA ' ' HE1' ' A' ' 68' ' ' PHE . 9.9 pt20 -63.4 -35.03 79.05 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.448 0.642 . . . . 0.0 110.171 -175.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.76 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.5 mm-40 -61.43 -56.97 14.28 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.246 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.614 HG13 ' CD2' ' A' ' 93' ' ' LEU . 80.2 t -61.91 -41.78 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.813 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.524 ' HB2' HG21 ' A' ' 61' ' ' THR . . . -56.4 -36.93 69.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.147 0.499 . . . . 0.0 110.228 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -82.26 -34.18 28.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.15 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.66 -41.67 71.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.527 0.679 . . . . 0.0 111.006 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.639 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -92.31 -44.26 8.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.425 -1.262 . . . . 0.0 111.428 -173.343 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.18 122.94 4.16 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -170.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.536 HG21 ' HG3' ' A' ' 67' ' ' PRO . 58.5 p -58.86 135.92 87.11 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 120.963 0.411 . . . . 0.0 111.235 -175.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 23.0 Cg_exo -63.27 172.91 4.64 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.71 2.94 . . . . 0.0 113.585 -172.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.471 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 11.5 mt -47.66 -48.64 28.85 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.024 -174.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.522 ' HE1' HG22 ' A' ' 70' ' ' THR . 10.7 ptt? -53.67 -19.57 4.21 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.364 178.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.6 t 73.13 -4.82 2.08 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.749 0.82 . . . . 0.0 111.75 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -124.12 90.97 50.18 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-O 121.998 0.904 . . . . 0.0 110.044 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.56 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 57.4 Cg_endo -70.62 -32.92 14.18 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.462 2.108 . . . . 0.0 112.075 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.482 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 10.5 m-85 -78.09 9.46 3.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.848 -175.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.33 -23.32 19.74 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.841 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.522 HG22 ' HE1' ' A' ' 64' ' ' MET . 10.7 t -124.83 174.37 7.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.818 0.342 . . . . 0.0 110.816 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -119.73 5.38 11.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.357 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.4 m -133.95 110.89 10.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.162 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.56 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 48.6 m0 -104.18 138.84 40.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -175.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -116.45 120.97 40.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.868 0.366 . . . . 0.0 110.632 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.574 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 68.1 m-85 -132.15 174.79 9.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.214 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.482 HG11 ' H ' ' A' ' 77' ' ' PHE . 2.7 t -122.23 169.09 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -172.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.482 ' H ' HG11 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -100.36 164.25 12.01 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.406 ' HB2' ' H ' ' A' ' 40' ' ' ALA . 28.5 ttt180 -68.0 160.42 28.76 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.966 -175.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.639 ' HA ' ' NE2' ' A' ' 34' ' ' GLN . 18.8 tt0 -39.11 102.67 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.824 0.85 . . . . 0.0 112.192 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 4.1 pp0? -128.74 151.7 77.6 Favored Pre-proline 0 N--CA 1.445 -0.689 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.017 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 45.4 Cg_exo -56.42 -27.99 70.8 Favored 'Trans proline' 0 N--CA 1.48 0.687 0 C-N-CA 124.386 3.39 . . . . 0.0 115.257 -172.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.6 61.47 6.78 Favored Glycine 0 C--N 1.309 -0.945 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.334 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.02 37.84 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.689 ' HG2' ' H ' ' A' ' 85' ' ' GLY . 2.7 tt0 -149.29 -177.34 5.79 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.689 ' H ' ' HG2' ' A' ' 84' ' ' GLU . . . -61.81 -44.36 97.98 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 171.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.54 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 86.8 t -91.42 145.54 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 167.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.458 HG21 ' H ' ' A' ' 88' ' ' GLN . 2.4 t -104.53 -61.66 1.43 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.283 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.458 ' H ' HG21 ' A' ' 87' ' ' THR . 0.0 OUTLIER -82.34 168.37 17.62 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.914 0.864 . . . . 0.0 112.722 -172.423 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -127.31 121.59 31.51 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.545 173.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.1 p -90.35 141.16 29.01 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.913 HD23 HG21 ' A' ' 43' ' ' VAL . 13.7 tp -99.64 117.47 34.06 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 173.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.58 ' OG1' ' HE2' ' A' ' 107' ' ' LYS . 78.9 m -111.59 107.2 16.27 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.865 ' HG ' HD22 ' A' ' 101' ' ' LEU . 7.2 tp -88.54 125.41 34.77 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.613 -174.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.7 m -106.91 124.34 49.48 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.886 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -114.69 141.54 47.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.96 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.576 ' HB3' HG22 ' A' ' 102' ' ' THR . 30.2 p30 -75.69 -175.31 2.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.354 176.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.5 m -57.65 -35.19 70.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.636 ' HB3' HG23 ' A' ' 100' ' ' VAL . 30.2 t -76.8 -19.84 57.11 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.995 0.426 . . . . 0.0 110.904 -175.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.79 26.86 9.4 Favored Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.636 HG23 ' HB3' ' A' ' 98' ' ' SER . 4.4 t -106.83 142.06 20.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.944 -0.628 . . . . 0.0 109.672 -177.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.865 HD22 ' HG ' ' A' ' 93' ' ' LEU . 5.8 mt -60.86 123.95 19.05 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.21 0.529 . . . . 0.0 111.837 178.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.576 HG22 ' HB3' ' A' ' 96' ' ' ASN . 19.2 p -109.69 -41.72 4.47 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.327 176.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -148.95 145.85 27.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.249 0.547 . . . . 0.0 112.016 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.748 HG22 HD11 ' A' ' 91' ' ' LEU . 3.9 mm -106.27 94.73 3.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 174.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.579 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 9.3 t70 -86.74 98.81 11.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.897 0.38 . . . . 0.0 110.916 -171.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -106.88 106.36 16.85 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.925 0.869 . . . . 0.0 110.29 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.58 ' HE2' ' OG1' ' A' ' 92' ' ' THR . 0.2 OUTLIER -133.68 169.54 13.66 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.054 -178.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.549 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 28.9 Cg_endo -67.22 150.79 81.73 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 121.952 1.768 . . . . 0.0 112.588 -173.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.83 -166.22 1.34 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 122.177 0.989 . . . . 0.0 112.355 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.4 mt -65.2 162.89 16.25 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.275 -1.784 . . . . 0.0 108.911 167.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 5.5 m -72.13 -2.26 17.96 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.162 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.2 -142.13 3.31 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.709 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 . . . . . 0 C--O 1.246 0.913 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 176.637 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.815 0 N-CA-C 111.986 -0.445 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.2 m 56.59 70.14 0.68 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.604 0.362 . . . . 0.0 111.023 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.539 ' C ' ' H ' ' A' ' 21' ' ' SER . 52.2 t-80 -59.73 114.38 2.74 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.422 ' HE1' ' NH2' ' A' ' 29' ' ' ARG . 21.0 ttt 72.0 -23.49 0.19 Allowed 'General case' 0 CA--C 1.534 0.361 0 O-C-N 124.037 0.835 . . . . 0.0 111.085 -177.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.539 ' H ' ' C ' ' A' ' 19' ' ' HIS . 23.2 m 69.9 -62.5 0.42 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.037 0.935 . . . . 0.0 112.08 173.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 t -118.15 133.58 55.77 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.908 0.385 . . . . 0.0 110.265 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.1 mt -100.97 86.88 3.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.444 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -97.85 115.45 28.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.45 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.525 ' HD2' ' N ' ' A' ' 25' ' ' ARG . 4.0 mpt_? 54.45 77.6 0.19 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.776 0.672 . . . . 0.0 111.132 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.7 m -76.74 57.8 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.515 0.674 . . . . 0.0 111.393 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 p -79.82 171.44 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.192 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -61.93 140.98 58.27 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.814 0.34 . . . . 0.0 110.652 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.422 ' NH2' ' HE1' ' A' ' 20' ' ' MET . 61.1 mtt180 -126.78 99.26 29.68 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.96 0.41 . . . . 0.0 111.017 -176.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -65.01 147.1 88.8 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.963 2.442 . . . . 0.0 111.985 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -103.86 -26.38 12.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.247 0.546 . . . . 0.0 111.508 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.527 HG23 ' H ' ' A' ' 34' ' ' GLN . 29.0 mm -55.86 -56.75 10.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.698 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.522 ' HB3' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER 89.12 -40.59 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.469 -1.696 . . . . 0.0 110.388 -178.685 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.541 ' NE2' ' H ' ' A' ' 79' ' ' GLN . 7.7 pt20 -94.48 21.57 7.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.685 0.755 . . . . 0.0 110.497 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.5 94.84 0.24 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.763 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -170.85 -41.42 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.629 0.728 . . . . 0.0 109.104 -176.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.414 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 0.6 OUTLIER -115.73 -165.29 1.02 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.409 174.307 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.688 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 3.2 tp -75.37 142.88 43.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.853 0.359 . . . . 0.0 110.564 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 43.1 p -127.0 -173.49 2.9 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.107 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.594 ' HB2' ' H ' ' A' ' 78' ' ' ARG . . . -62.65 -37.86 88.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.354 0.597 . . . . 0.0 111.379 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -62.05 -42.45 99.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.795 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.505 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 16.7 m-20 -70.25 -32.68 70.63 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.842 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.853 HG21 HD23 ' A' ' 91' ' ' LEU . 58.6 t -58.58 -36.03 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.089 0.471 . . . . 0.0 111.128 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.8 t -62.22 -16.29 52.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.552 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 46.1 mtpt -74.07 -24.02 59.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.643 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.714 HG22 HD11 ' A' ' 59' ' ' LEU . 37.8 pt -100.73 175.83 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.619 0.723 . . . . 0.0 112.244 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -164.13 150.8 11.45 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.079 -177.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -73.12 143.06 14.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.655 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.76 -21.97 8.85 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.352 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.661 ' HE1' HG23 ' A' ' 46' ' ' ILE . 16.0 ptt? -96.46 178.24 5.42 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.164 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.795 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 41.5 p -92.78 -175.49 3.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.96 -171.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.471 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 77.3 mt-30 -63.05 -46.81 85.75 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.528 171.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.512 ' HA ' ' HE1' ' A' ' 68' ' ' PHE . 9.7 pt20 -65.25 -35.34 80.73 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.334 0.588 . . . . 0.0 109.84 -173.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.795 ' HG3' ' H ' ' A' ' 51' ' ' THR . 7.7 mm-40 -60.25 -51.87 67.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.177 176.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.644 HG13 HD21 ' A' ' 93' ' ' LEU . 69.5 t -66.94 -45.0 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.9 -175.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.71 ' HB3' HG21 ' A' ' 61' ' ' THR . . . -64.08 -25.11 67.96 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.436 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -80.9 -42.35 21.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.029 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.78 76.95 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.653 0.74 . . . . 0.0 111.342 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.714 HD11 HG22 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -90.12 -36.4 14.86 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.563 -172.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.6 127.76 5.76 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -170.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.71 HG21 ' HB3' ' A' ' 56' ' ' ALA . 56.9 p -59.15 136.21 88.12 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-O 120.93 0.395 . . . . 0.0 110.659 -177.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.512 ' CD ' ' HB3' ' A' ' 67' ' ' PRO . 22.2 Cg_exo -62.07 171.96 4.51 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.478 2.785 . . . . 0.0 113.309 -172.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.5 mt -51.08 -43.68 61.07 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.038 0.535 . . . . 0.0 111.606 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.1 ptt? -58.66 -12.23 3.94 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.423 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.2 t 68.98 -0.59 2.37 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.513 0.725 . . . . 0.0 111.827 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -134.72 91.52 20.86 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.605 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 90.6 Cg_endo -77.85 -29.07 4.63 Favored 'Trans proline' 0 C--N 1.327 -0.554 0 C-N-CA 123.268 2.645 . . . . 0.0 113.15 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.512 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 13.0 m-85 -80.59 21.62 0.63 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.038 -172.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.7 -17.41 8.02 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.989 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 t -124.81 172.27 9.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.732 0.301 . . . . 0.0 110.385 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -125.01 15.57 8.51 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.282 0.563 . . . . 0.0 109.975 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.6 m -138.88 109.24 6.49 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.495 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.605 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 50.3 m0 -104.48 143.23 33.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.707 -175.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -118.06 115.03 24.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.156 0.503 . . . . 0.0 111.241 -176.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.578 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 57.2 m-85 -129.93 176.46 8.03 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.2 p -128.87 153.57 38.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.598 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.419 ' CE1' HG22 ' A' ' 43' ' ' VAL . 1.5 m-30 -90.35 159.08 16.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.301 176.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.594 ' H ' ' HB2' ' A' ' 40' ' ' ALA . 4.1 tmt_? -63.01 107.84 1.09 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.773 ' HG3' ' H ' ' A' ' 80' ' ' GLN . 4.7 tp-100 -167.64 -150.91 0.11 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.332 -172.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.773 ' H ' ' HG3' ' A' ' 79' ' ' GLN . 3.5 pt20 -54.39 149.2 21.08 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 121.465 0.65 . . . . 0.0 112.051 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.481 ' HD2' ' OE2' ' A' ' 84' ' ' GLU . 12.3 Cg_exo -71.0 -9.01 24.86 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.402 2.735 . . . . 0.0 112.202 174.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.84 6.98 56.9 Favored Glycine 0 C--N 1.32 -0.334 0 CA-C-N 115.245 -0.889 . . . . 0.0 114.232 169.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -109.31 31.63 5.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.863 0.832 . . . . 0.0 110.5 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.588 ' HB2' ' NE2' ' A' ' 80' ' ' GLN . 42.8 mp0 -122.37 -166.22 1.39 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.398 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.87 94.28 0.29 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.6 t -41.07 122.57 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 122.06 0.933 . . . . 0.0 112.983 -171.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 t -152.0 11.09 0.55 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 113.608 -1.633 . . . . 0.0 108.996 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.4 130.21 45.81 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.376 -1.283 . . . . 0.0 111.536 -175.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 50.8 mt-30 -81.03 107.3 13.73 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.964 0.411 . . . . 0.0 109.906 174.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.9 p -89.99 142.27 27.87 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.26 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.853 HD23 HG21 ' A' ' 43' ' ' VAL . 14.1 tp -93.0 112.55 24.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.875 174.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.686 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 10.6 m -107.09 105.98 16.25 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.884 ' HG ' HD22 ' A' ' 101' ' ' LEU . 7.0 tp -87.37 118.21 26.66 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.515 -175.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 38.6 m -101.64 122.68 44.32 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.127 -174.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -116.13 140.88 48.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.241 -178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.514 HD22 ' HB ' ' A' ' 100' ' ' VAL . 30.1 p30 -76.43 -177.19 4.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.16 175.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.0 t -54.42 -38.31 66.1 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.475 ' HB2' HG23 ' A' ' 100' ' ' VAL . 49.8 m -80.2 -3.8 50.51 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -174.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.33 28.0 34.68 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.824 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.514 ' HB ' HD22 ' A' ' 96' ' ' ASN . 6.6 t -106.41 140.86 23.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.884 HD22 ' HG ' ' A' ' 93' ' ' LEU . 7.3 mt -59.91 126.2 26.62 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.328 0.585 . . . . 0.0 112.195 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.507 HG22 ' HB3' ' A' ' 96' ' ' ASN . 18.0 p -111.18 -36.7 5.53 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.365 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -152.95 152.98 32.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.325 0.583 . . . . 0.0 111.673 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.811 HG22 HD11 ' A' ' 91' ' ' LEU . 3.3 mm -108.41 92.6 2.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 171.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.686 ' HB2' ' HB ' ' A' ' 92' ' ' THR . 2.3 m-20 -78.4 96.33 5.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.574 0.226 . . . . 0.0 110.989 -174.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -112.07 107.42 16.36 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.829 0.824 . . . . 0.0 110.49 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.428 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -148.3 168.48 11.03 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.445 -178.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 19.3 Cg_endo -72.62 147.3 45.29 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.83 1.687 . . . . 0.0 111.589 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.42 173.93 8.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.959 0.885 . . . . 0.0 112.376 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.5 mt -89.77 111.52 22.54 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.035 -1.438 . . . . 0.0 110.945 -170.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.4 m -85.71 4.5 36.41 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.213 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.94 -100.72 2.62 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.803 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.3 p30 . . . . . 0 C--N 1.311 -1.067 0 CA-C-O 118.566 -0.73 . . . . 0.0 109.98 178.671 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.5 m 61.84 -175.26 0.13 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.076 0.465 . . . . 0.0 111.989 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.1 m170 61.37 30.75 19.15 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.311 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.6 ptp -95.27 27.31 3.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.626 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.47 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 23.8 m -76.95 74.95 3.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.444 177.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.2 m -63.1 107.3 1.0 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.177 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 21' ' ' SER . 81.7 mt -108.43 -44.25 4.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.225 -174.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -92.74 127.99 38.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.969 0.414 . . . . 0.0 110.978 -174.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.62 ' O ' HG22 ' A' ' 26' ' ' VAL . 1.1 ptm180 -86.2 63.52 8.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.032 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 25' ' ' ARG . 2.0 m 59.97 172.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.734 1.214 . . . . 0.0 110.994 -173.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 28' ' ' TYR . 1.4 p -140.02 -179.12 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.432 ' H ' HG22 ' A' ' 27' ' ' VAL . 90.0 m-85 -49.17 145.67 4.11 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.884 0.474 . . . . 0.0 111.596 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -74.47 117.14 59.65 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.668 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.41 133.49 48.75 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 123.736 2.957 . . . . 0.0 113.292 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -112.61 -118.06 0.31 Allowed 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 172.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.789 HG23 ' H ' ' A' ' 34' ' ' GLN . 23.8 mm -98.98 143.53 13.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-O 120.898 0.38 . . . . 0.0 110.515 170.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -79.61 -22.81 43.19 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.844 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.789 ' H ' HG23 ' A' ' 32' ' ' ILE . 11.3 pt20 -114.3 67.52 0.68 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.779 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.54 -146.35 5.28 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.28 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.0 t30 72.57 -48.58 0.69 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.635 0.774 . . . . 0.0 110.899 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -107.12 -170.21 1.67 Allowed 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.624 HD12 HD12 ' A' ' 59' ' ' LEU . 2.5 tp -89.46 152.44 21.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.743 0.306 . . . . 0.0 110.88 -176.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.613 HG22 HG21 ' A' ' 32' ' ' ILE . 43.6 p -127.14 -174.66 3.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.171 175.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HB2' ' H ' ' A' ' 78' ' ' ARG . . . -66.82 -38.19 85.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.332 0.586 . . . . 0.0 110.606 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.542 ' ND2' HD11 ' A' ' 32' ' ' ILE . 2.8 m-20 -54.31 -40.7 68.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.44 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.565 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 12.9 m-20 -73.92 -33.35 63.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.783 -1.098 . . . . 0.0 111.209 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.789 HG21 HD23 ' A' ' 91' ' ' LEU . 74.0 t -60.71 -37.73 76.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.314 0.578 . . . . 0.0 110.211 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.7 t -58.54 -22.39 55.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.126 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.443 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 45.2 mtpt -71.61 -40.59 69.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.78 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.602 HG22 HD11 ' A' ' 59' ' ' LEU . 41.6 pt -85.58 179.2 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-O 121.938 0.875 . . . . 0.0 112.925 -175.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.445 ' N ' ' HD3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -168.26 147.2 4.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.464 -175.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.431 HG21 ' CG1' ' A' ' 104' ' ' ILE . 0.8 OUTLIER -72.61 144.22 13.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.742 -179.353 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.98 -31.75 5.03 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.861 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.533 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 21.7 ptt? -86.39 175.14 8.56 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.976 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.876 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 26.0 p -93.29 -170.77 2.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.974 -171.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -66.69 -46.04 76.89 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.616 172.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.491 ' OE1' ' HG2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -66.73 -29.31 69.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.469 0.652 . . . . 0.0 110.47 -175.242 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.876 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.0 mm-40 -63.19 -56.59 15.43 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.397 174.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.613 HG13 ' CD2' ' A' ' 93' ' ' LEU . 82.9 t -67.51 -38.82 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.455 -177.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.655 ' HB2' HG21 ' A' ' 61' ' ' THR . . . -58.7 -32.17 68.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.182 0.515 . . . . 0.0 110.109 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -82.26 -39.17 23.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.589 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.79 -44.94 63.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.167 0.508 . . . . 0.0 111.881 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.624 HD12 HD12 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -95.73 -12.63 25.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.411 -174.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.77 129.33 2.28 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.255 -0.974 . . . . 0.0 110.876 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.655 HG21 ' HB2' ' A' ' 56' ' ' ALA . 22.1 p -55.3 133.4 69.64 Favored Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-O 121.466 0.65 . . . . 0.0 111.284 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 34.8 Cg_exo -63.49 166.93 14.14 Favored 'Trans proline' 0 C--O 1.23 0.092 0 C-N-CA 123.753 2.969 . . . . 0.0 113.377 -171.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.448 ' C ' ' H ' ' A' ' 65' ' ' SER . 1.5 mt -54.08 -33.16 56.84 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.104 -170.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.628 ' HE1' HG22 ' A' ' 70' ' ' THR . 0.0 OUTLIER -63.68 3.33 0.36 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.39 176.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.448 ' H ' ' C ' ' A' ' 63' ' ' LEU . 27.7 p 53.94 24.81 4.87 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.8 0.84 . . . . 0.0 111.593 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -169.9 105.11 0.45 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.41 -178.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.577 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 83.6 Cg_endo -80.07 -23.03 6.85 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 122.833 2.355 . . . . 0.0 113.201 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -82.8 -6.75 59.57 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -171.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.28 -20.68 51.66 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.328 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.628 HG22 ' HE1' ' A' ' 64' ' ' MET . 14.6 t -125.16 174.74 7.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.993 0.425 . . . . 0.0 110.228 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -129.24 14.01 6.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.366 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.7 m -131.2 110.32 11.05 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.84 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.595 ' O ' ' HA ' ' A' ' 92' ' ' THR . 46.3 m0 -108.66 149.08 29.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.885 -175.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -125.13 123.22 39.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.544 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.575 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 86.6 m-85 -133.01 173.75 11.08 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.9 t -113.24 164.82 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -175.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.433 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -105.02 164.42 11.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.252 -178.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.571 ' HD2' ' N ' ' A' ' 79' ' ' GLN . 1.6 tmm_? -66.56 145.57 55.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.451 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.571 ' N ' ' HD2' ' A' ' 78' ' ' ARG . 54.7 tt0 -32.15 101.68 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.498 1.124 . . . . 0.0 113.547 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 17.7 mm-40 -92.38 154.19 42.81 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.888 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 11.3 Cg_exo -70.63 105.32 1.61 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 124.129 3.22 . . . . 0.0 111.872 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.626 ' HA2' HG22 ' A' ' 87' ' ' THR . . . -67.16 115.81 7.5 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.007 -175.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -127.4 -3.39 6.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.885 0.374 . . . . 0.0 110.67 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.554 ' HG2' ' H ' ' A' ' 85' ' ' GLY . 22.7 tt0 -142.85 -179.81 6.56 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.554 ' H ' ' HG2' ' A' ' 84' ' ' GLU . . . -51.09 -55.04 20.52 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 176.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.66 ' HB ' ' HB2' ' A' ' 111' ' ' SER . 38.6 t -123.5 141.85 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 170.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.626 HG22 ' HA2' ' A' ' 82' ' ' GLY . 13.0 t -133.66 4.83 3.65 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.928 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.67 172.95 13.09 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.41 0.624 . . . . 0.0 110.492 177.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.488 ' HB3' ' HA ' ' A' ' 108' ' ' PRO . 3.2 pt20 -148.04 128.05 13.64 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.186 174.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p -90.35 142.62 27.55 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.887 -175.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.789 HD23 HG21 ' A' ' 43' ' ' VAL . 14.4 tp -90.02 110.95 21.91 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.95 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 24.4 m -103.68 105.01 15.12 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.83 ' HG ' HD22 ' A' ' 101' ' ' LEU . 8.2 tp -88.36 124.27 33.76 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.37 -173.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 42.1 m -104.16 120.98 42.29 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.978 -176.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -114.5 137.73 51.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.744 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.554 ' HB3' HG22 ' A' ' 102' ' ' THR . 33.3 p30 -75.26 -171.96 1.58 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.45 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.1 m -55.61 -37.99 68.86 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.52 ' HB3' HG23 ' A' ' 100' ' ' VAL . 22.8 t -84.2 -3.61 58.28 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.985 0.422 . . . . 0.0 110.869 -173.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.59 31.85 35.59 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.621 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.52 HG23 ' HB3' ' A' ' 98' ' ' SER . 11.2 t -107.02 141.47 22.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.83 HD22 ' HG ' ' A' ' 93' ' ' LEU . 7.0 mt -62.68 122.88 16.97 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.559 0.695 . . . . 0.0 112.254 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.554 HG22 ' HB3' ' A' ' 96' ' ' ASN . 21.1 p -109.62 -42.09 4.39 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.711 175.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.527 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 5.3 m-20 -137.06 154.83 50.25 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.271 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.76 HG22 HD11 ' A' ' 91' ' ' LEU . 5.0 mm -116.7 91.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 167.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 92' ' ' THR . 5.6 m-20 -83.55 94.91 8.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.039 0.447 . . . . 0.0 110.752 -172.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -100.78 102.85 14.03 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.755 0.788 . . . . 0.0 109.414 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 21.1 mttt -125.69 156.71 70.56 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.482 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.488 ' HA ' ' HB3' ' A' ' 89' ' ' GLN . 12.1 Cg_endo -69.22 145.84 61.6 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.97 2.447 . . . . 0.0 112.028 -175.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.604 ' HB1' HG13 ' A' ' 86' ' ' VAL . . . -71.26 170.94 12.0 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.488 0.661 . . . . 0.0 110.996 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.429 HD22 HD22 ' A' ' 113' ' ' ASN . 9.6 mt -73.36 99.32 2.9 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.219 -168.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.66 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 14.3 t -121.61 11.04 10.49 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.215 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 153.46 119.85 0.77 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.821 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.429 HD22 HD22 ' A' ' 110' ' ' LEU . 89.8 m-20 . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.671 -0.681 . . . . 0.0 110.341 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.509 ' HB2' ' OG1' ' A' ' 22' ' ' THR . 57.6 m -78.23 -17.15 57.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.96 0.38 . . . . 0.0 110.685 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 77.5 -22.87 0.26 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.433 0.693 . . . . 0.0 111.99 173.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.7 tpt -147.51 126.57 12.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.59 0.233 . . . . 0.0 110.91 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 m 60.39 42.04 15.26 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.483 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' A' ' 18' ' ' SER . 7.1 m -86.18 -49.83 7.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.142 0.496 . . . . 0.0 111.262 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.1 mt -93.01 -2.86 55.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.455 -171.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -101.61 4.74 41.19 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.192 -176.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -132.68 103.81 6.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.124 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.713 HG23 ' H ' ' A' ' 27' ' ' VAL . 2.7 m -84.75 -91.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.891 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.713 ' H ' HG23 ' A' ' 26' ' ' VAL . 2.3 p -164.34 176.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.401 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 54.3 t80 -55.12 136.76 47.98 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.822 0.344 . . . . 0.0 110.501 175.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -97.29 111.56 58.55 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.209 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 28' ' ' TYR . 50.5 Cg_exo -53.8 148.46 37.03 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.176 2.584 . . . . 0.0 112.073 174.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -63.99 -71.02 0.19 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.78 0.8 . . . . 0.0 111.208 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.464 HD13 ' HD2' ' A' ' 78' ' ' ARG . 37.0 mm -87.81 141.24 14.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.29 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -77.85 -36.15 50.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.055 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.441 ' NE2' ' H ' ' A' ' 79' ' ' GLN . 18.1 pt20 -98.53 44.89 1.02 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.49 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.54 41.18 2.78 Favored Glycine 0 C--N 1.314 -0.64 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.35 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -89.39 -23.56 22.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.153 0.501 . . . . 0.0 110.037 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -122.08 -166.5 1.41 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.338 176.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.69 HD12 HD12 ' A' ' 59' ' ' LEU . 11.4 tp -76.46 161.55 28.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.129 0.49 . . . . 0.0 110.975 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 78' ' ' ARG . 33.5 p -127.71 177.19 6.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.156 170.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.43 -30.61 66.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.009 0.433 . . . . 0.0 110.495 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.672 HD22 ' HD3' ' A' ' 78' ' ' ARG . 27.0 m-80 -55.69 -45.04 77.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.714 176.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.66 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 22.7 m-20 -67.2 -26.35 66.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.231 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 1.028 HG21 HD23 ' A' ' 91' ' ' LEU . 79.3 t -64.32 -37.28 79.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.172 0.511 . . . . 0.0 110.026 176.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.3 t -66.54 -20.84 66.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.452 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.66 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 36.4 mtpt -71.34 -32.28 68.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.92 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.602 HG23 ' HE1' ' A' ' 50' ' ' MET . 30.9 pt -94.76 177.6 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-O 121.895 0.855 . . . . 0.0 112.032 177.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.414 ' HE ' ' HB3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -172.3 154.31 3.24 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.417 -174.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.442 HG21 HD12 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -71.95 144.99 12.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.048 -178.378 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.38 -36.81 3.16 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.163 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.602 ' HE1' HG23 ' A' ' 46' ' ' ILE . 5.6 ptt? -85.25 171.61 11.8 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.191 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.798 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 44.0 p -86.07 -172.49 4.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.007 -172.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.492 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 39.5 mt-30 -68.31 -42.59 79.19 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.216 173.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.532 ' HA ' ' HE1' ' A' ' 68' ' ' PHE . 9.0 pt20 -66.36 -36.03 81.85 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.264 -175.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.798 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.8 mm-40 -58.26 -54.21 49.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.889 176.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.597 HG13 ' CD2' ' A' ' 93' ' ' LEU . 85.6 t -65.58 -41.3 90.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.793 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.429 ' HB2' HG22 ' A' ' 61' ' ' THR . . . -57.67 -33.12 67.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.385 0.612 . . . . 0.0 110.096 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -81.3 -36.78 29.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.825 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.35 -42.07 55.12 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.249 0.547 . . . . 0.0 111.764 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.69 HD12 HD12 ' A' ' 38' ' ' LEU . 0.3 OUTLIER -95.24 -16.94 22.12 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.83 -173.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.95 130.46 5.43 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.305 -0.95 . . . . 0.0 110.756 -174.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.452 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 4.5 p -65.11 134.95 96.09 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 121.343 0.592 . . . . 0.0 111.304 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 22.0 Cg_exo -67.59 171.41 12.0 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.998 3.132 . . . . 0.0 113.14 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.439 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 7.7 mt -49.09 -48.23 44.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.518 -178.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.759 ' HE1' HG22 ' A' ' 70' ' ' THR . 12.5 ptt? -59.59 144.73 46.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.757 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.3 p -73.02 1.72 8.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -154.44 108.59 2.4 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-O 121.345 0.593 . . . . 0.0 110.528 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.644 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 59.2 Cg_endo -73.29 -25.39 15.67 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.078 2.519 . . . . 0.0 113.048 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.532 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 8.3 m-85 -81.57 -5.44 58.02 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -170.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.21 -8.17 63.2 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.71 -174.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.759 HG22 ' HE1' ' A' ' 64' ' ' MET . 9.2 t -123.58 171.96 9.14 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -119.38 1.25 11.23 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 m -126.64 115.2 19.1 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.555 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.644 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 44.6 m0 -109.36 141.68 41.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.708 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -119.12 120.71 37.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.477 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.618 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 90.3 m-85 -128.03 175.56 8.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.228 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.491 HG12 ' CD ' ' A' ' 88' ' ' GLN . 39.9 t -124.26 152.66 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -172.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.433 ' CE1' HG22 ' A' ' 43' ' ' VAL . 7.3 m-30 -97.54 152.92 18.53 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 171.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.672 ' HD3' HD22 ' A' ' 41' ' ' ASN . 27.6 ptt180 -79.32 149.51 31.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.15 -172.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.441 ' H ' ' NE2' ' A' ' 34' ' ' GLN . 8.5 tt0 52.89 60.14 3.99 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.795 0.807 . . . . 0.0 111.693 173.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.604 ' HG3' ' NE2' ' A' ' 88' ' ' GLN . 11.4 mm-40 -117.63 167.0 11.93 Favored Pre-proline 0 N--CA 1.446 -0.673 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.268 172.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' A' ' 80' ' ' GLN . 18.7 Cg_endo -64.72 -63.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 121.708 1.606 . . . . 0.0 111.783 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.54 -58.34 3.76 Favored Glycine 0 C--N 1.313 -0.722 0 CA-C-N 114.696 -1.138 . . . . 0.0 113.37 173.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -72.44 -71.66 0.28 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.882 0.372 . . . . 0.0 110.374 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -100.91 141.74 33.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.689 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.39 67.27 2.08 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.497 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.1 127.1 25.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.414 0.626 . . . . 0.0 110.704 -175.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.0 t -171.9 13.68 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.328 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.604 ' NE2' ' HG3' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -56.65 120.36 7.66 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.52 178.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.884 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 28.7 mt-30 -76.52 104.41 7.01 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.674 -0.41 . . . . 0.0 109.985 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.0 p -89.36 146.88 24.39 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.104 -177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.028 HD23 HG21 ' A' ' 43' ' ' VAL . 38.7 tp -91.11 110.76 22.03 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 28.7 m -105.27 102.69 12.15 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.786 ' HG ' HD22 ' A' ' 101' ' ' LEU . 8.9 tp -88.39 126.78 35.38 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.547 -171.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.5 m -103.8 121.24 42.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.008 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.486 ' CZ ' ' HA ' ' A' ' 52' ' ' GLN . 25.8 m-85 -111.92 148.52 33.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.914 0.864 . . . . 0.0 112.503 -175.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -73.8 173.1 10.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.874 -1.512 . . . . 0.0 110.451 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.8 m -62.34 -30.07 70.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.17 0.509 . . . . 0.0 110.862 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.472 ' HB3' HG23 ' A' ' 100' ' ' VAL . 30.8 t -87.55 4.43 43.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.793 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.11 34.53 55.17 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.954 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' A' ' 98' ' ' SER . 15.4 t -107.37 139.31 29.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.786 HD22 ' HG ' ' A' ' 93' ' ' LEU . 6.3 mt -60.73 127.5 31.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.393 0.616 . . . . 0.0 111.673 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 66.5 p -116.38 -39.94 3.3 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.136 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -144.7 149.56 35.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.854 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.812 HG22 HD11 ' A' ' 91' ' ' LEU . 3.8 mm -112.6 94.06 2.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 173.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.594 ' HB2' ' O ' ' A' ' 92' ' ' THR . 4.5 m-20 -80.48 95.49 6.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.024 0.44 . . . . 0.0 110.523 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -106.57 102.78 12.14 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.72 0.771 . . . . 0.0 110.269 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.529 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -151.91 171.06 7.02 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.62 -176.819 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.884 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 31.9 Cg_endo -71.03 157.06 58.88 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.5 1.467 . . . . 0.0 111.945 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.5 -179.81 2.68 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.577 174.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.5 mt -54.54 101.82 0.05 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.754 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.8 t -111.31 -24.5 10.19 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.639 -174.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.7 157.83 9.75 Favored Glycine 0 C--N 1.311 -0.848 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.546 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.6 t30 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.954 -178.018 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . . . . . . 0 N--CA 1.48 1.576 0 N-CA-C 112.084 -0.406 . . . . 0.0 112.084 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 m -68.87 144.85 54.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.63 0.252 . . . . 0.0 111.149 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.432 ' HB2' ' OG1' ' A' ' 22' ' ' THR . 35.6 m80 64.08 -166.61 0.22 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.614 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -76.11 -52.49 10.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.679 0.276 . . . . 0.0 111.544 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.0 t -141.42 37.59 1.69 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.976 0.417 . . . . 0.0 111.458 -176.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.585 HG23 HD23 ' A' ' 23' ' ' LEU . 91.6 m -72.87 -45.41 58.42 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.585 HD23 HG23 ' A' ' 22' ' ' THR . 3.5 mm? -116.24 92.62 3.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.079 175.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -90.84 141.23 29.04 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 -126.74 -26.29 3.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.227 -173.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.49 126.99 50.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.157 0.503 . . . . 0.0 110.49 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 28' ' ' TYR . 1.7 p -95.96 -177.73 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.318 -176.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.428 ' H ' HG22 ' A' ' 27' ' ' VAL . 84.0 m-85 -57.97 166.5 1.48 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.693 0.759 . . . . 0.0 112.562 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -103.69 142.47 24.66 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.446 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -43.82 137.43 6.57 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.904 3.069 . . . . 0.0 113.893 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -80.93 68.11 7.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.642 -176.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.598 HG23 ' H ' ' A' ' 34' ' ' GLN . 39.5 mm -68.22 139.37 20.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.792 173.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.31 -20.9 27.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.398 0.618 . . . . 0.0 110.192 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.598 ' H ' HG23 ' A' ' 32' ' ' ILE . 14.7 pt20 -118.08 88.95 3.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.681 0.753 . . . . 0.0 111.489 -175.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.17 35.72 3.55 Favored Glycine 0 C--N 1.314 -0.689 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.283 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -79.48 -27.35 41.52 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.016 0.436 . . . . 0.0 110.876 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -122.46 -169.2 1.86 Allowed 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.892 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.649 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 3.1 tp -75.51 150.33 38.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.925 0.393 . . . . 0.0 110.459 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.403 ' HB ' ' HA ' ' A' ' 78' ' ' ARG . 32.3 p -127.41 -178.36 4.43 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.079 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.15 -35.54 79.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.383 0.611 . . . . 0.0 110.552 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -59.32 -46.46 88.52 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.985 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.565 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 14.9 m-20 -69.31 -32.14 71.06 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.798 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.779 HG21 HD23 ' A' ' 91' ' ' LEU . 68.0 t -57.92 -38.18 64.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.109 0.481 . . . . 0.0 110.525 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -59.24 -21.59 59.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.154 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 45.9 mtpt -70.85 -29.3 65.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.982 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.718 HG22 HD11 ' A' ' 59' ' ' LEU . 38.9 pt -95.48 176.11 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.787 0.803 . . . . 0.0 112.257 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.441 ' HE ' ' HB3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -164.71 148.42 8.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.775 -177.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -70.79 140.14 18.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.332 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.43 -17.57 8.94 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.488 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.549 ' HE1' HG23 ' A' ' 46' ' ' ILE . 17.6 ptt? -102.43 173.09 6.51 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.109 174.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.654 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 12.7 p -88.08 -173.35 4.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.007 -172.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.517 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 13.2 mt-30 -69.44 -41.93 75.62 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.562 175.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.549 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -65.5 -33.19 75.35 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.609 0.719 . . . . 0.0 109.591 -175.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.654 ' HG3' ' H ' ' A' ' 51' ' ' THR . 11.2 mm-40 -61.61 -55.93 25.38 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.598 175.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.6 HG13 ' CD2' ' A' ' 93' ' ' LEU . 82.5 t -66.03 -40.4 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.387 -176.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.628 ' HB2' HG21 ' A' ' 61' ' ' THR . . . -58.74 -34.2 71.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.278 0.561 . . . . 0.0 110.012 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -81.16 -39.97 24.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.769 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.27 -49.68 53.86 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.782 0.801 . . . . 0.0 111.402 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.718 HD11 HG22 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -86.07 -45.07 11.75 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.189 -173.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.02 126.8 3.46 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -174.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.628 HG21 ' HB2' ' A' ' 56' ' ' ALA . 47.6 p -59.84 132.09 89.15 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-O 121.15 0.5 . . . . 0.0 110.934 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.476 ' CD ' ' HB3' ' A' ' 67' ' ' PRO . 28.0 Cg_exo -63.59 164.18 21.84 Favored 'Trans proline' 0 CA--C 1.52 -0.208 0 C-N-CA 123.745 2.963 . . . . 0.0 112.554 -172.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 mt -52.72 -32.96 45.63 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.47 -168.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.569 ' HE1' HG22 ' A' ' 70' ' ' THR . 10.8 ptt? -62.48 -9.87 9.92 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.685 0.616 . . . . 0.0 111.926 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 t 72.27 -2.3 2.63 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.669 0.788 . . . . 0.0 112.466 173.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -138.12 91.97 12.66 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-O 121.159 0.504 . . . . 0.0 109.999 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.556 ' HG3' HG21 ' A' ' 61' ' ' THR . 74.0 Cg_endo -74.0 -30.25 9.22 Favored 'Trans proline' 0 CA--C 1.529 0.247 0 C-N-CA 123.193 2.595 . . . . 0.0 112.964 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.49 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 12.7 m-85 -76.78 3.6 11.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.105 -172.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.49 -25.7 25.07 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.881 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.569 HG22 ' HE1' ' A' ' 64' ' ' MET . 8.4 t -123.78 174.21 7.65 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -175.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -122.33 2.58 9.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.107 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.4 m -123.07 108.66 13.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.813 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.578 ' O ' ' HA ' ' A' ' 92' ' ' THR . 47.0 m0 -105.58 148.68 27.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.875 -174.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -124.48 118.2 26.1 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.976 0.417 . . . . 0.0 111.249 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.601 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 80.3 m-85 -128.9 175.5 8.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.274 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.8 t -122.85 165.74 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -93.69 -178.13 4.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.65 0.262 . . . . 0.0 110.632 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.571 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 16.4 ptt180 -71.01 171.23 11.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.083 -173.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.505 ' HB3' HD13 ' A' ' 32' ' ' ILE . 28.1 tt0 -46.55 94.39 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 O-C-N 124.022 0.826 . . . . 0.0 112.843 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 10.7 pt20 -141.93 161.41 51.43 Favored Pre-proline 0 N--CA 1.444 -0.749 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.698 175.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -50.05 107.88 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.412 2.741 . . . . 0.0 113.248 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.456 ' HA2' HG11 ' A' ' 86' ' ' VAL . . . -115.73 6.47 20.27 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.611 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -122.95 147.9 46.09 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 59.4 -90.26 0.03 OUTLIER 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.824 0.702 . . . . 0.0 111.465 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -84.75 72.15 2.84 Favored Glycine 0 C--N 1.302 -1.327 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.096 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.456 HG11 ' HA2' ' A' ' 82' ' ' GLY . 14.7 t -68.57 136.16 26.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.261 0.553 . . . . 0.0 111.387 -175.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -136.29 -3.28 2.19 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.309 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.548 ' HG2' ' HG3' ' A' ' 80' ' ' GLN . 7.7 mm-40 -55.81 139.79 44.36 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.687 0.756 . . . . 0.0 112.492 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 45.7 mt-30 -124.66 131.42 53.47 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.252 175.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.8 p -89.08 146.67 24.68 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.311 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.779 HD23 HG21 ' A' ' 43' ' ' VAL . 13.8 tp -89.66 103.39 16.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 18.2 m -98.21 100.62 11.93 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.903 ' HG ' HD22 ' A' ' 101' ' ' LEU . 8.4 tp -86.01 121.58 28.83 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.256 -172.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.4 m -101.54 119.6 39.02 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.018 -175.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.435 ' CE1' ' HG ' ' A' ' 101' ' ' LEU . 72.2 m-85 -113.22 142.36 45.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.492 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.54 ' HB3' HG22 ' A' ' 102' ' ' THR . 30.1 p30 -75.85 -177.72 3.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.96 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.2 m -56.61 -30.55 63.36 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.492 ' HB3' HG23 ' A' ' 100' ' ' VAL . 34.2 t -85.91 -3.86 59.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.701 0.286 . . . . 0.0 111.257 -173.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.48 32.72 27.17 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.424 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.492 HG23 ' HB3' ' A' ' 98' ' ' SER . 5.0 t -113.7 139.21 40.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.794 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.903 HD22 ' HG ' ' A' ' 93' ' ' LEU . 6.7 mt -61.14 123.14 16.84 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.276 0.56 . . . . 0.0 112.307 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.54 HG22 ' HB3' ' A' ' 96' ' ' ASN . 12.4 p -110.29 -39.14 5.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.025 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -148.92 150.63 33.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.481 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.622 ' CG2' HD11 ' A' ' 91' ' ' LEU . 5.6 mm -105.35 92.76 2.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 171.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 92' ' ' THR . 7.2 m-20 -83.94 94.88 8.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.284 0.564 . . . . 0.0 110.259 -177.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -95.25 102.08 13.86 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.881 0.848 . . . . 0.0 108.978 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.519 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 20.6 mmtm -129.16 151.93 78.55 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.873 -172.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 107' ' ' LYS . 17.8 Cg_endo -65.49 147.14 86.56 Favored 'Trans proline' 0 C--N 1.33 -0.408 0 C-N-CA 123.818 3.012 . . . . 0.0 113.557 -167.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.02 139.47 35.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.268 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.6 mt 34.13 -96.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 O-C-N 125.066 1.479 . . . . 0.0 113.706 177.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.6 m -85.87 68.78 10.46 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.737 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' A' ' 108' ' ' PRO . . . -77.41 -38.63 28.3 Favored Glycine 0 CA--C 1.504 -0.617 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.215 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 . . . . . 0 C--N 1.307 -1.251 0 CA-C-N 114.621 -0.79 . . . . 0.0 109.345 179.634 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.5 t 65.38 16.54 10.58 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.973 0.509 . . . . 0.0 111.737 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -130.71 86.18 2.35 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.1 mtm -71.63 -52.78 16.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.397 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.1 p -111.29 33.68 4.53 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.133 0.492 . . . . 0.0 109.915 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.0 m 70.43 -64.02 0.38 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.841 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.02 144.55 25.33 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -80.72 44.28 0.72 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.403 0.621 . . . . 0.0 111.169 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -88.09 -5.02 58.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.172 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 26' ' ' VAL . 13.1 p -88.3 34.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 122.149 0.976 . . . . 0.0 110.054 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.07 165.02 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.166 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -82.48 147.04 28.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.803 0.335 . . . . 0.0 110.821 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -98.33 150.69 36.98 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.75 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.25 172.22 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.729 2.953 . . . . 0.0 113.145 174.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.1 t70 68.44 101.26 0.05 Allowed 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.766 0.793 . . . . 0.0 111.254 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.73 HG23 ' H ' ' A' ' 34' ' ' GLN . 11.1 mm 53.94 150.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 113.567 -1.651 . . . . 0.0 115.001 -176.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -102.15 22.62 12.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.484 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.73 ' H ' HG23 ' A' ' 32' ' ' ILE . 2.8 pt20 -148.73 45.21 1.02 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.456 1.122 . . . . 0.0 109.826 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.59 -151.36 7.47 Favored Glycine 0 C--N 1.314 -0.682 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.223 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 60.1 t30 75.88 -45.67 0.54 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.526 0.73 . . . . 0.0 110.903 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -108.94 -167.47 1.22 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 175.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.759 HD12 ' HG ' ' A' ' 59' ' ' LEU . 3.6 mm? -79.26 152.2 30.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.727 0.775 . . . . 0.0 112.4 -176.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.829 ' HB ' ' HB2' ' A' ' 78' ' ' ARG . 30.7 p -128.92 -177.9 4.4 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.516 170.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.463 ' HB2' ' H ' ' A' ' 78' ' ' ARG . . . -65.04 -44.33 89.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.861 0.362 . . . . 0.0 111.624 -176.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.457 ' N ' HD21 ' A' ' 41' ' ' ASN . 0.9 OUTLIER -61.16 -40.58 94.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.569 -177.533 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -68.74 -33.44 73.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.572 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.587 HG21 HD23 ' A' ' 91' ' ' LEU . 54.9 t -57.32 -37.7 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.811 0.339 . . . . 0.0 111.475 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.7 p -64.09 -12.42 39.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.149 0.499 . . . . 0.0 111.627 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 43.8 mtpt -77.2 -14.19 59.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.246 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.731 HG22 HD11 ' A' ' 59' ' ' LEU . 35.3 pt -104.21 -176.9 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 121.894 0.854 . . . . 0.0 112.808 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.557 ' HD2' ' HE3' ' A' ' 50' ' ' MET . 0.0 OUTLIER -172.64 150.47 2.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.009 -1.45 . . . . 0.0 109.055 -177.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.491 HG21 HD12 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -71.09 144.48 13.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.15 -178.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.15 -32.31 4.78 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.473 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.671 ' HE1' HG23 ' A' ' 46' ' ' ILE . 14.4 ptt? -88.3 178.39 6.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 111.415 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.822 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 34.9 p -90.77 -177.04 4.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.793 -171.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.476 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 36.7 mt-30 -66.18 -42.63 88.63 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.506 171.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -37.34 77.48 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.147 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.822 ' HG3' ' H ' ' A' ' 51' ' ' THR . 5.4 mm-40 -67.83 -52.03 41.63 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.318 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.681 HG11 HG21 ' A' ' 46' ' ' ILE . 78.6 t -64.94 -40.84 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.741 -177.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.512 ' HB2' HG21 ' A' ' 61' ' ' THR . . . -58.41 -33.33 69.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 110.181 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -81.87 -40.28 22.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.098 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.44 -42.4 75.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.686 0.755 . . . . 0.0 111.11 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.759 ' HG ' HD12 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -92.63 -54.94 3.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.992 -174.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.2 134.94 3.61 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -171.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.512 HG21 ' HB2' ' A' ' 56' ' ' ALA . 28.7 p -66.92 135.92 94.28 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-O 121.224 0.535 . . . . 0.0 111.308 -177.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 17.0 Cg_exo -65.79 174.72 5.24 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 C-N-CA 124.19 3.26 . . . . 0.0 113.411 -174.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.448 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 8.2 mt -46.3 -48.47 18.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.353 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.707 ' HE1' HG22 ' A' ' 70' ' ' THR . 0.0 OUTLIER -66.22 126.88 30.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.572 170.226 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 t -68.78 -7.25 32.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 0.0 111.726 -173.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.434 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 11.1 p-10 -122.14 92.49 48.87 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-O 121.714 0.768 . . . . 0.0 110.199 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.525 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 18.7 Cg_endo -60.05 -36.11 90.53 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.864 2.376 . . . . 0.0 112.186 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -83.48 8.89 12.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.803 -177.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.1 -17.33 57.85 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.707 HG22 ' HE1' ' A' ' 64' ' ' MET . 11.8 t -124.45 175.14 7.32 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -125.1 8.04 7.95 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.818 0.342 . . . . 0.0 110.127 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.7 m -131.36 111.82 12.19 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.313 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.676 ' O ' ' HA ' ' A' ' 92' ' ' THR . 48.8 m0 -106.0 142.95 34.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.582 -176.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -123.44 116.32 23.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.75 0.31 . . . . 0.0 110.543 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.553 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 31.1 m-85 -124.72 170.25 11.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.523 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 77' ' ' PHE . 41.3 t -120.69 158.63 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -175.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.441 ' N ' HG13 ' A' ' 76' ' ' VAL . 1.3 m-30 -87.51 161.16 17.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.338 . . . . 0.0 110.788 176.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.829 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 21.1 ttm180 -84.07 121.88 28.03 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.368 -169.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 59.65 86.96 0.09 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.559 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.816 ' HG2' ' HG2' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -111.41 159.55 32.6 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.973 176.417 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.529 ' HG2' HG22 ' A' ' 87' ' ' THR . 66.0 Cg_exo -54.31 -66.33 0.1 Allowed 'Trans proline' 0 CA--C 1.52 -0.201 0 C-N-CA 122.531 2.154 . . . . 0.0 112.205 173.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.74 -147.86 47.32 Favored Glycine 0 C--N 1.313 -0.718 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.494 -175.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 39.2 m80 61.64 -92.35 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 122.71 0.404 . . . . 0.0 110.993 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -140.12 143.11 36.06 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.05 39.3 46.01 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -171.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.604 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 40.7 t -60.7 142.22 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 114.743 -0.728 . . . . 0.0 110.941 -174.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.529 HG22 ' HG2' ' A' ' 81' ' ' PRO . 14.0 t -130.77 11.02 5.16 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.84 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.816 ' HG2' ' HG2' ' A' ' 80' ' ' GLN . 52.9 mt-30 -36.43 107.13 0.05 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 174.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -80.48 105.37 11.68 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 19.2 p -89.59 143.19 27.01 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.65 -173.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.915 HD13 HG22 ' A' ' 104' ' ' ILE . 14.7 tp -93.6 111.69 23.41 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.862 174.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.692 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 40.2 m -106.9 103.45 12.88 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.889 ' HG ' HD22 ' A' ' 101' ' ' LEU . 7.2 tp -90.21 122.82 33.49 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.254 -173.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -109.72 124.22 50.86 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.394 -176.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.5 ' CE1' ' HG ' ' A' ' 101' ' ' LEU . 92.0 m-85 -112.27 144.97 40.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.296 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.519 ' HB3' HG22 ' A' ' 102' ' ' THR . 29.7 p30 -74.88 -173.96 2.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.172 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.1 p -54.59 -32.17 58.22 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.555 ' HB3' HG23 ' A' ' 100' ' ' VAL . 9.7 t -89.45 -3.03 58.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.054 0.454 . . . . 0.0 111.245 -173.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.62 32.98 32.14 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.597 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.555 HG23 ' HB3' ' A' ' 98' ' ' SER . 7.3 t -108.82 138.86 33.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.889 HD22 ' HG ' ' A' ' 93' ' ' LEU . 5.7 mt -60.07 124.91 21.68 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.648 0.737 . . . . 0.0 112.102 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 96' ' ' ASN . 34.0 p -112.85 -45.0 3.23 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.348 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -136.52 152.75 50.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.247 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.915 HG22 HD13 ' A' ' 91' ' ' LEU . 3.7 mm -116.08 93.36 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 171.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.692 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 8.0 t70 -89.53 97.34 11.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.04 0.447 . . . . 0.0 111.052 -169.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 90' ' ' THR . 29.0 t-20 -117.64 119.52 35.22 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.36 0.6 . . . . 0.0 110.693 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.545 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -155.07 174.64 3.72 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.144 179.229 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.545 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 27.5 Cg_endo -66.62 165.74 24.37 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 121.814 1.676 . . . . 0.0 111.974 -177.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.78 176.65 5.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.191 0.52 . . . . 0.0 112.316 -176.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.3 mt -50.98 -57.51 8.4 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.406 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.9 p -89.95 35.46 0.85 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.134 0.492 . . . . 0.0 110.984 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 86' ' ' VAL . . . -82.51 -164.89 35.7 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.281 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.5 p30 . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.315 -175.886 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.8 p -78.6 -59.9 2.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.02 0.438 . . . . 0.0 110.62 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -95.32 136.26 35.9 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.949 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.902 ' HA ' ' HE3' ' A' ' 20' ' ' MET . 7.9 mmt -98.33 171.87 7.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.382 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.8 m 58.75 71.87 0.56 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.146 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.9 t -108.31 -10.75 15.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.8 175.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.8 mt -122.68 7.44 9.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.238 174.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 48.19 -95.26 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.481 -172.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -139.65 22.08 2.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.8 0.333 . . . . 0.0 110.914 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.74 81.45 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.57 0.7 . . . . 0.0 109.188 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 28' ' ' TYR . 4.3 p -85.24 177.17 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.652 -173.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.412 ' H ' HG22 ' A' ' 27' ' ' VAL . 42.7 t80 -49.44 132.65 20.64 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.773 0.796 . . . . 0.0 112.425 -176.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.554 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 5.8 ppt_? -130.41 170.12 11.87 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.71 177.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 29' ' ' ARG . 75.2 Cg_exo -48.33 176.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.607 2.871 . . . . 0.0 114.017 177.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -64.94 -21.7 66.87 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.732 0.777 . . . . 0.0 110.28 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.752 HG13 ' HB2' ' A' ' 78' ' ' ARG . 48.8 mm -75.17 143.09 13.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.993 176.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -85.94 -12.37 50.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.642 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.624 ' H ' HG23 ' A' ' 32' ' ' ILE . 6.2 mt-30 -99.93 -168.16 1.56 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.012 174.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.25 -152.13 23.98 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.614 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.1 t30 73.43 -57.03 0.64 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.378 0.671 . . . . 0.0 111.518 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -86.63 -162.2 0.74 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.767 HD13 ' HG ' ' A' ' 59' ' ' LEU . 0.5 OUTLIER -70.35 144.01 51.77 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.881 0.848 . . . . 0.0 110.892 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' A' ' 78' ' ' ARG . 44.4 p -130.81 177.93 7.04 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.21 172.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 77' ' ' PHE . . . -70.88 -28.97 64.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.453 0.644 . . . . 0.0 109.904 176.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -59.08 -44.44 91.89 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.525 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.582 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 27.0 m-20 -70.41 -32.85 70.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.697 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.968 HG21 HD23 ' A' ' 91' ' ' LEU . 56.3 t -62.54 -36.24 74.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.859 0.361 . . . . 0.0 110.81 177.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.3 p -68.19 -15.32 63.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.074 0.464 . . . . 0.0 110.525 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.582 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 40.8 mtpt -78.78 -19.53 51.99 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.078 177.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.622 ' HA ' ' HE3' ' A' ' 50' ' ' MET . 44.5 pt -103.38 169.0 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-O 121.735 0.779 . . . . 0.0 112.099 176.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.94 148.76 8.75 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.493 -173.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -72.19 143.17 14.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.074 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.9 -33.8 4.28 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.703 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.622 ' HE3' ' HA ' ' A' ' 46' ' ' ILE . 21.8 ptt? -86.48 175.72 8.22 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.148 0.499 . . . . 0.0 111.189 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.789 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 44.0 p -91.16 -173.38 3.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.081 -170.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.473 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 13.8 mt-30 -65.38 -46.93 78.17 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.385 172.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -64.08 -37.4 87.31 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.98 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.789 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.0 mm-40 -58.34 -49.43 77.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.584 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.602 HG13 ' CD2' ' A' ' 93' ' ' LEU . 61.8 t -69.7 -45.11 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.466 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.587 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -63.45 -25.03 68.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.002 0.43 . . . . 0.0 110.684 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -80.44 -35.77 34.56 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.291 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.81 -39.87 61.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.742 0.782 . . . . 0.0 111.07 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.767 ' HG ' HD13 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -93.24 -32.55 14.31 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.339 -172.461 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.3 119.93 4.45 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -171.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.587 HG22 ' HB3' ' A' ' 56' ' ' ALA . 46.9 p -53.52 134.54 53.7 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 120.968 0.413 . . . . 0.0 111.426 -173.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 32.3 Cg_exo -63.0 164.43 19.37 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.614 2.876 . . . . 0.0 113.278 -172.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.7 mt -53.31 -36.73 61.57 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.164 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.709 ' HE1' HG22 ' A' ' 70' ' ' THR . 8.6 ptt? -62.26 -3.26 1.25 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.164 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.4 t 70.39 2.89 4.22 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.445 0.698 . . . . 0.0 112.259 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 23.5 t70 -152.09 100.52 2.85 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.664 0.745 . . . . 0.0 110.34 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.622 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 38.0 Cg_endo -67.1 -49.71 1.27 Allowed 'Trans proline' 0 C--N 1.332 -0.314 0 C-N-CA 123.63 2.887 . . . . 0.0 113.648 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -80.61 19.1 0.84 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -172.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.36 -19.88 47.6 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 171.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.709 HG22 ' HE1' ' A' ' 64' ' ' MET . 13.4 t -124.25 171.15 10.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.982 -0.609 . . . . 0.0 109.53 177.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -122.72 13.99 10.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.41 0.624 . . . . 0.0 109.681 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 m -139.11 110.53 7.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.022 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.622 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 48.4 m0 -106.94 141.36 38.28 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.941 -175.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -120.04 125.46 48.38 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.18 0.3 . . . . 0.0 110.515 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.55 ' CE2' HD23 ' A' ' 59' ' ' LEU . 60.1 m-85 -135.66 174.69 10.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.53 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.604 HG23 ' CD ' ' A' ' 88' ' ' GLN . 1.6 p -122.5 150.63 26.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.639 -176.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.585 ' HB2' ' NE2' ' A' ' 80' ' ' GLN . 10.0 m-30 -86.9 -177.63 6.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.126 0.489 . . . . 0.0 110.571 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.752 ' HB2' HG13 ' A' ' 32' ' ' ILE . 25.6 ptt180 -77.32 170.18 17.0 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.452 ' HB2' HG22 ' A' ' 32' ' ' ILE . 9.1 tt0 -46.85 102.87 0.03 OUTLIER 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -173.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.585 ' NE2' ' HB2' ' A' ' 77' ' ' PHE . 5.8 pt20 -108.75 137.62 20.09 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.854 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 14.5 Cg_exo -69.47 107.2 1.75 Allowed 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.406 2.738 . . . . 0.0 112.354 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.672 ' HA3' HG23 ' A' ' 87' ' ' THR . . . -110.15 -175.28 20.78 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.486 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -145.48 21.26 1.51 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.613 0.244 . . . . 0.0 111.273 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.52 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 24.9 tt0 -147.43 170.86 16.48 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -173.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.12 -63.44 5.04 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.906 ' HB ' ' HA ' ' A' ' 111' ' ' SER . 41.5 t -118.76 126.3 75.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 166.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.672 HG23 ' HA3' ' A' ' 82' ' ' GLY . 8.2 t -143.5 11.22 1.68 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.569 -176.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.659 ' HG3' HG22 ' A' ' 90' ' ' THR . 1.1 tp-100 -69.75 128.93 38.14 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.204 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.893 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 66.8 mt-30 -83.51 103.72 13.08 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 172.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.659 HG22 ' HG3' ' A' ' 88' ' ' GLN . 6.3 p -87.72 153.26 21.5 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.966 -171.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.968 HD23 HG21 ' A' ' 43' ' ' VAL . 21.3 tp -89.72 114.14 25.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.478 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.626 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 35.9 m -108.25 102.7 11.81 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.923 ' HG ' HD22 ' A' ' 101' ' ' LEU . 7.4 tp -85.59 121.94 29.0 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.5 -173.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.4 m -100.34 119.86 39.07 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.956 -176.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -113.77 136.8 52.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.817 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.482 ' HB3' HG22 ' A' ' 102' ' ' THR . 32.3 p30 -75.27 -177.6 3.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.933 175.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.0 m -52.84 -33.94 51.82 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.648 ' HB3' HG23 ' A' ' 100' ' ' VAL . 8.7 t -83.83 -9.6 58.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.018 0.437 . . . . 0.0 110.849 -173.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.57 29.66 20.92 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.648 HG23 ' HB3' ' A' ' 98' ' ' SER . 21.5 t -107.62 140.19 26.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.742 -0.729 . . . . 0.0 109.323 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.923 HD22 ' HG ' ' A' ' 93' ' ' LEU . 6.5 mt -62.3 125.29 23.4 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.286 0.565 . . . . 0.0 111.885 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.482 HG22 ' HB3' ' A' ' 96' ' ' ASN . 11.1 p -109.6 -45.49 3.67 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.418 174.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -138.33 155.02 48.96 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.63 0.728 . . . . 0.0 111.556 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.71 HG22 HD11 ' A' ' 91' ' ' LEU . 5.3 mm -113.16 93.11 2.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.626 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 30.4 t70 -85.49 96.36 9.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.125 0.488 . . . . 0.0 111.0 -171.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -105.42 102.76 12.21 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.976 0.893 . . . . 0.0 110.106 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -142.96 164.34 32.66 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.275 -175.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.893 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 18.4 Cg_endo -76.48 143.11 24.22 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.445 2.097 . . . . 0.0 112.942 -173.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.66 -176.66 6.14 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 122.113 0.959 . . . . 0.0 112.742 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 112' ' ' GLY . 4.7 mt -100.68 136.03 41.18 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.264 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.906 ' HA ' ' HB ' ' A' ' 86' ' ' VAL . 9.5 t -68.68 7.23 0.68 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 110' ' ' LEU . . . -114.2 23.37 12.71 Favored Glycine 0 CA--C 1.5 -0.873 0 CA-C-O 122.072 0.818 . . . . 0.0 111.812 177.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.303 -1.453 0 CA-C-N 114.104 -1.048 . . . . 0.0 110.227 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.765 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.1 m -90.2 91.46 8.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.978 0.418 . . . . 0.0 110.357 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -75.92 162.62 27.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.091 176.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.3 mtp 60.07 -164.79 0.22 Allowed 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.478 0.486 . . . . 0.0 110.893 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.9 m 57.57 52.16 8.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.846 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.3 m -82.78 77.54 9.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 122.021 0.915 . . . . 0.0 109.448 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.8 mt -90.3 55.74 3.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.086 -174.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.779 ' HG3' ' H ' ' A' ' 25' ' ' ARG . 9.4 pt-20 -150.44 -74.57 0.16 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.578 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.779 ' H ' ' HG3' ' A' ' 24' ' ' GLU . 15.5 mtp180 56.15 47.34 19.71 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.631 0.729 . . . . 0.0 110.607 -177.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 p -151.43 83.64 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 122.293 1.044 . . . . 0.0 108.955 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 28' ' ' TYR . 2.8 p -111.15 -176.6 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.918 -173.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.43 ' H ' HG22 ' A' ' 27' ' ' VAL . 98.8 m-85 -48.36 130.32 16.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.932 0.396 . . . . 0.0 111.514 175.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -66.94 137.79 94.85 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 166.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -40.48 124.41 1.75 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.685 2.923 . . . . 0.0 113.186 -173.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -153.36 101.3 2.51 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.491 -172.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.74 HG23 ' H ' ' A' ' 34' ' ' GLN . 41.4 mm -68.42 141.04 18.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.006 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.06 -20.23 52.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.054 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.74 ' H ' HG23 ' A' ' 32' ' ' ILE . 13.2 pt20 -121.82 178.28 4.93 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.159 -176.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.74 -0.81 5.48 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.953 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -62.67 -25.57 68.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.262 0.554 . . . . 0.0 109.893 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.86 -101.7 0.1 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.693 172.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.699 ' HB3' ' HB3' ' A' ' 75' ' ' TYR . 6.0 tp -140.71 157.08 45.94 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.2 p -127.9 -173.93 3.06 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.106 174.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.551 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -67.82 -47.33 69.35 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.21 0.528 . . . . 0.0 112.007 -173.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.67 -31.68 69.78 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.101 177.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.521 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 63.4 m-20 -72.29 -35.11 68.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.313 176.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.902 HG21 HD23 ' A' ' 91' ' ' LEU . 53.3 t -57.48 -36.61 54.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.206 0.527 . . . . 0.0 110.506 174.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.1 t -61.61 -17.73 56.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.533 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 48.4 mtpt -74.75 -28.73 60.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.849 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.715 HG22 HD11 ' A' ' 59' ' ' LEU . 43.3 pt -97.56 176.32 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 122.108 0.956 . . . . 0.0 113.163 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.54 150.59 6.09 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.516 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.414 HG21 ' CG1' ' A' ' 104' ' ' ILE . 0.7 OUTLIER -70.54 145.6 12.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.125 -178.077 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.93 -35.15 3.92 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.16 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.61 ' HE1' HG23 ' A' ' 46' ' ' ILE . 6.8 ptt? -85.3 165.8 17.0 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.285 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.675 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 12.4 p -83.1 -172.3 4.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.409 -173.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 99' ' ' GLY . 92.2 mt-30 -68.24 -41.84 80.61 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.737 176.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.53 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -66.58 -32.12 73.25 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -175.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.675 ' HG3' ' H ' ' A' ' 51' ' ' THR . 15.8 mm-40 -61.93 -56.58 17.69 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.44 176.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.614 HG13 ' CD2' ' A' ' 93' ' ' LEU . 82.0 t -65.4 -40.45 88.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.57 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.571 ' HB2' HG21 ' A' ' 61' ' ' THR . . . -58.69 -35.55 72.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.163 0.506 . . . . 0.0 110.297 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -81.65 -35.37 30.03 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.088 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.04 -45.15 43.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.554 0.692 . . . . 0.0 111.393 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.715 HD11 HG22 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -90.95 -54.42 3.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.316 -174.231 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.68 130.1 2.91 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.571 HG21 ' HB2' ' A' ' 56' ' ' ALA . 40.5 p -65.34 128.82 94.13 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-O 121.533 0.682 . . . . 0.0 110.687 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 14.6 Cg_exo -68.68 163.25 37.81 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.569 2.846 . . . . 0.0 112.956 -171.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.402 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -57.82 -25.85 61.2 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.008 -171.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.434 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 13.4 ptt? -66.84 -3.01 5.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.543 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 t 72.29 4.4 4.99 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.545 0.738 . . . . 0.0 112.51 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -158.92 107.78 1.58 Allowed Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 121.579 0.704 . . . . 0.0 110.543 175.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.667 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 58.8 Cg_endo -72.82 -29.95 11.93 Favored 'Trans proline' 0 C--N 1.325 -0.662 0 C-N-CA 122.976 2.451 . . . . 0.0 112.511 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -76.28 -4.06 39.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.927 -170.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.85 -17.66 55.96 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.534 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.411 ' CG2' ' HE1' ' A' ' 64' ' ' MET . 7.3 t -124.39 174.31 7.84 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.005 0.431 . . . . 0.0 110.666 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -118.52 3.56 11.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.574 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.4 m -134.15 112.77 11.4 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.643 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.667 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 44.6 m0 -105.88 136.19 45.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.439 -177.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -113.07 127.31 56.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.928 0.394 . . . . 0.0 110.724 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.699 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 62.2 m-85 -132.27 173.91 10.78 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.524 HG13 ' H ' ' A' ' 77' ' ' PHE . 2.0 t -129.09 178.15 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.551 ' CG ' ' HB2' ' A' ' 40' ' ' ALA . 7.6 m-30 -103.08 173.08 6.46 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.514 0.197 . . . . 0.0 110.54 175.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -56.34 148.12 19.58 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 170.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.413 ' HB2' HG22 ' A' ' 32' ' ' ILE . 53.8 tt0 -47.84 105.29 0.07 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.932 177.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.461 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 52.7 mt-30 -83.97 150.93 59.71 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.362 0.601 . . . . 0.0 111.099 -175.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 5.4 Cg_exo -78.23 86.1 1.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.77 2.98 . . . . 0.0 110.975 176.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.75 162.08 13.14 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.559 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -96.79 5.07 51.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.255 0.55 . . . . 0.0 109.815 176.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -119.63 158.84 25.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.486 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.4 -55.54 29.09 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.586 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.6 t -124.35 124.01 67.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.549 0.69 . . . . 0.0 110.733 176.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.7 t -144.89 9.04 1.29 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.401 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -65.71 170.69 4.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.373 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.64 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 53.0 mt-30 -111.35 130.88 55.54 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.214 170.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 109' ' ' ALA . 7.6 p -102.29 142.4 33.58 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.329 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.902 HD23 HG21 ' A' ' 43' ' ' VAL . 20.0 tp -91.24 119.25 31.15 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.696 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 90.4 m -110.49 106.86 16.32 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.978 ' HG ' HD22 ' A' ' 101' ' ' LEU . 7.1 tp -91.39 123.63 34.96 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.725 -174.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.7 m -103.2 121.71 43.23 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.844 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.602 ' CZ ' HD22 ' A' ' 93' ' ' LEU . 71.6 m-85 -116.71 138.91 51.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.893 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.502 HD22 ' HB ' ' A' ' 100' ' ' VAL . 33.4 p30 -75.61 -173.46 2.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.794 175.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.6 m -51.29 -44.36 61.86 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -174.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.505 ' HB3' HG23 ' A' ' 100' ' ' VAL . 33.6 t -79.78 -15.9 56.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.469 . . . . 0.0 111.068 -174.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 52' ' ' GLN . . . 96.83 29.49 8.1 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -176.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.505 HG23 ' HB3' ' A' ' 98' ' ' SER . 14.0 t -98.24 134.68 35.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.978 HD22 ' HG ' ' A' ' 93' ' ' LEU . 6.7 mt -59.9 125.02 22.01 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.262 0.553 . . . . 0.0 112.04 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.453 HG22 ' HB3' ' A' ' 96' ' ' ASN . 5.7 p -112.78 -39.48 4.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.15 176.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -143.72 148.28 35.46 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.359 0.599 . . . . 0.0 111.908 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.605 HG22 HD11 ' A' ' 91' ' ' LEU . 4.7 mm -111.92 95.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.696 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 35.5 t0 -86.59 95.34 9.72 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.718 -174.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -102.86 104.09 14.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.704 0.764 . . . . 0.0 109.645 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.519 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 63.4 pttt -138.91 172.71 6.12 Favored Pre-proline 0 C--N 1.312 -1.035 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.733 -176.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.64 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 38.8 Cg_endo -75.59 153.71 39.22 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.721 1.614 . . . . 0.0 112.231 -177.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.483 ' HB2' HG23 ' A' ' 90' ' ' THR . . . -80.29 -178.38 6.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.206 -177.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.7 mt -61.46 112.85 2.36 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.19 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.2 m -53.78 119.74 5.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.447 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -130.76 129.5 5.83 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.795 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 . . . . . 0 C--O 1.244 0.776 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.907 -179.408 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.4 t 63.4 -91.54 0.03 OUTLIER 'General case' 0 C--O 1.234 0.244 0 C-N-CA 122.922 0.489 . . . . 0.0 110.271 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -83.54 117.76 23.34 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 18.8 ptp -73.82 105.85 5.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.628 0.728 . . . . 0.0 111.242 -175.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.0 p -104.59 3.92 32.29 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.551 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.874 HG21 ' H ' ' A' ' 23' ' ' LEU . 3.8 m 63.75 -157.38 0.32 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.874 ' H ' HG21 ' A' ' 22' ' ' THR . 1.3 tm? 64.99 92.81 0.07 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.312 0.577 . . . . 0.0 109.659 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -62.55 145.93 53.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.912 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 25' ' ' ARG . 5.3 tpm_? -63.93 103.76 0.62 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.608 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.819 HG22 ' H ' ' A' ' 27' ' ' VAL . 8.4 p -74.67 -167.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.522 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.819 ' H ' HG22 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -50.59 153.68 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 121.875 0.845 . . . . 0.0 112.322 -171.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -84.62 117.08 23.53 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.606 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.507 ' H ' ' HD2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -89.97 164.28 28.92 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -179.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.408 ' C ' ' H ' ' A' ' 32' ' ' ILE . 86.5 Cg_exo -46.37 160.51 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.295 2.663 . . . . 0.0 113.039 174.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.82 34.58 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.862 -176.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.869 HG23 ' H ' ' A' ' 34' ' ' GLN . 40.1 mm -85.85 150.2 3.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.37 0.605 . . . . 0.0 111.656 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.524 HD22 ' HB3' ' A' ' 79' ' ' GLN . 24.5 p-10 -65.72 -31.35 72.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.646 174.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.869 ' H ' HG23 ' A' ' 32' ' ' ILE . 27.6 pt20 -108.62 -179.31 3.83 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 173.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.98 77.73 0.19 Allowed Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.114 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -129.7 -61.6 1.0 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.926 0.393 . . . . 0.0 111.177 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -120.1 -171.09 2.09 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.874 -175.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.62 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 1.3 tp -75.95 153.16 36.82 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.725 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.0 p -126.12 -176.27 3.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.048 0.452 . . . . 0.0 111.995 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.475 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -62.56 -37.8 87.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.909 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -59.8 -43.27 94.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.373 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.604 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 10.5 m-20 -68.44 -29.6 68.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.962 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 1.073 HG21 HD23 ' A' ' 91' ' ' LEU . 85.6 t -59.79 -36.95 69.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.207 0.527 . . . . 0.0 110.45 175.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -61.26 -19.05 61.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.427 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -70.99 -42.13 70.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.794 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.712 HG22 HD11 ' A' ' 59' ' ' LEU . 41.6 pt -84.7 -178.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.747 0.784 . . . . 0.0 112.268 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.551 ' HD2' ' HE3' ' A' ' 50' ' ' MET . 0.0 OUTLIER -171.68 152.33 3.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.326 -175.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.452 HG21 HD12 ' A' ' 104' ' ' ILE . 0.7 OUTLIER -72.82 145.62 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.697 -179.246 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.41 -30.6 5.93 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.346 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.573 ' HE1' HG23 ' A' ' 46' ' ' ILE . 16.0 ptt? -90.06 178.18 6.26 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.285 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.86 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 31.1 p -95.23 -174.07 3.11 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.013 -170.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.462 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 97.8 mt-30 -63.89 -47.51 80.33 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.774 172.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.406 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 9.9 pt20 -64.56 -36.5 84.42 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.305 0.574 . . . . 0.0 109.811 -175.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.86 ' HG3' ' H ' ' A' ' 51' ' ' THR . 9.4 mm-40 -58.0 -52.47 65.38 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.323 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.611 HG13 ' CD2' ' A' ' 93' ' ' LEU . 72.2 t -67.11 -41.56 87.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.714 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.456 ' HB3' HG21 ' A' ' 61' ' ' THR . . . -64.52 -25.68 68.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.164 0.507 . . . . 0.0 110.727 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -81.28 -35.53 30.97 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.013 0.435 . . . . 0.0 111.323 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.9 -46.14 25.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.393 0.616 . . . . 0.0 111.705 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.712 HD11 HG22 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -92.56 -21.15 20.26 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.815 -173.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.91 131.07 6.98 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -172.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.499 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 37.9 p -56.75 135.27 78.61 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.959 0.409 . . . . 0.0 111.118 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 51.8 Cg_exo -59.12 171.65 2.15 Favored 'Trans proline' 0 N--CA 1.471 0.157 0 C-N-CA 124.131 3.221 . . . . 0.0 115.131 -171.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.469 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 8.3 mt -55.49 -41.69 73.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.257 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.739 ' HE1' HG22 ' A' ' 70' ' ' THR . 0.0 OUTLIER -60.19 -0.24 0.22 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.547 176.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 63' ' ' LEU . 33.5 p 58.86 5.44 0.5 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.214 1.006 . . . . 0.0 112.815 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -150.17 103.58 3.15 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 121.54 0.686 . . . . 0.0 109.753 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.477 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 36.0 Cg_endo -68.06 -33.03 26.62 Favored 'Trans proline' 0 C--N 1.327 -0.555 0 C-N-CA 123.245 2.63 . . . . 0.0 113.177 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -76.22 4.51 8.55 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -170.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.33 -24.72 21.03 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.086 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.739 HG22 ' HE1' ' A' ' 64' ' ' MET . 14.3 t -125.51 174.38 8.26 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.902 0.382 . . . . 0.0 110.236 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -125.78 12.52 7.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.862 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.9 m -133.55 108.81 8.83 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.21 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.477 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 42.7 m0 -109.18 130.34 55.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.412 -174.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -109.46 120.89 43.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.024 0.44 . . . . 0.0 110.967 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.554 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 50.1 m-85 -129.24 173.88 10.1 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.515 HG11 ' H ' ' A' ' 77' ' ' PHE . 2.9 t -123.42 175.29 6.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -176.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.515 ' H ' HG11 ' A' ' 76' ' ' VAL . 5.7 m-30 -97.86 -178.24 4.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.045 0.45 . . . . 0.0 110.721 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -69.13 137.62 53.56 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.524 ' HB3' HD22 ' A' ' 33' ' ' ASN . 36.4 tt0 -51.11 106.44 0.13 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.173 0.511 . . . . 0.0 111.638 -172.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.474 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -103.36 135.39 19.39 Favored Pre-proline 0 N--CA 1.441 -0.879 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.569 -176.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 14.3 Cg_exo -69.0 119.15 6.16 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 123.028 2.486 . . . . 0.0 112.171 -178.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.738 ' HA3' HG22 ' A' ' 87' ' ' THR . . . -130.3 -168.34 12.25 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -126.5 -25.38 3.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.201 0.524 . . . . 0.0 110.365 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -82.26 176.24 9.63 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.776 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -57.86 -55.82 28.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.306 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.73 134.25 66.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.168 0.509 . . . . 0.0 110.272 175.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.738 HG22 ' HA3' ' A' ' 82' ' ' GLY . 9.4 t -138.31 5.22 2.49 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.205 177.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -76.12 164.93 25.62 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.612 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.494 ' HG2' ' HA ' ' A' ' 108' ' ' PRO . 88.2 mt-30 -108.48 156.17 19.77 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.819 168.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 p -126.86 143.56 51.23 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.848 0.356 . . . . 0.0 111.53 -173.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.073 HD23 HG21 ' A' ' 43' ' ' VAL . 39.8 tp -91.8 122.94 34.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 172.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.536 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 89.9 m -117.49 103.91 10.55 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.842 ' HG ' HD22 ' A' ' 101' ' ' LEU . 7.1 tp -85.18 125.18 32.62 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.286 -174.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 21.5 m -107.35 122.87 47.46 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.264 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 52' ' ' GLN . 32.5 m-85 -110.54 146.45 36.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.894 0.854 . . . . 0.0 112.695 -175.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -73.94 -179.61 3.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.646 -1.615 . . . . 0.0 111.171 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.4 p -59.32 -43.03 92.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.698 0.285 . . . . 0.0 111.583 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.468 ' HB3' HG23 ' A' ' 100' ' ' VAL . 35.0 t -77.69 -8.66 58.25 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.958 0.409 . . . . 0.0 110.694 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.88 31.06 10.35 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.459 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 98' ' ' SER . 22.0 t -100.77 141.64 17.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.842 HD22 ' HG ' ' A' ' 93' ' ' LEU . 6.0 mt -62.29 123.99 19.69 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.084 0.469 . . . . 0.0 111.597 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 74.1 p -111.8 -43.55 3.6 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.642 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.492 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 2.6 m-20 -136.24 150.08 48.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.812 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.935 HG22 HD11 ' A' ' 91' ' ' LEU . 2.2 mm -116.46 92.43 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 170.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.536 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 25.2 t70 -87.42 96.78 10.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.131 0.491 . . . . 0.0 111.032 -170.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -106.84 104.75 14.5 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 122.032 0.92 . . . . 0.0 110.333 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.438 ' H ' ' HD3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -139.31 174.36 4.2 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.973 -178.659 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.494 ' HA ' ' HG2' ' A' ' 89' ' ' GLN . 51.8 Cg_exo -59.3 154.76 44.59 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.648 2.232 . . . . 0.0 112.115 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.45 170.3 15.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.298 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.4 mt -49.14 -60.24 2.96 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.857 -175.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.4 t 59.64 50.5 7.19 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.731 0.776 . . . . 0.0 109.407 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 160.91 -141.09 7.1 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.098 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.154 179.532 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.844 0 N-CA-C 112.116 -0.394 . . . . 0.0 112.116 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.4 m -70.56 -25.06 62.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.124 0.488 . . . . 0.0 111.021 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -124.77 74.97 1.38 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.5 ttt -84.32 40.33 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.449 0.642 . . . . 0.0 110.868 -174.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 m -85.1 108.86 17.87 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.9 p 46.85 46.12 15.26 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.871 0.732 . . . . 0.0 111.574 -173.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.6 tp -90.64 90.68 8.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.141 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 56.92 -156.0 0.31 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.494 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -128.61 37.06 4.17 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.3 m -77.91 154.27 5.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.256 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.05 169.58 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-O 121.213 0.53 . . . . 0.0 110.648 -177.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -71.62 125.64 27.62 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.003 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -115.23 102.13 54.56 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.845 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -65.68 171.09 10.17 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.751 2.301 . . . . 0.0 111.874 173.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -63.34 -58.94 5.48 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.609 0.718 . . . . 0.0 110.344 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.554 HG22 ' OE1' ' A' ' 34' ' ' GLN . 36.5 mm -77.6 142.3 14.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.848 174.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.426 ' ND2' ' HG3' ' A' ' 34' ' ' GLN . 0.6 OUTLIER -110.24 -22.14 11.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.612 178.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.554 ' OE1' HG22 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -95.41 -169.15 1.91 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.623 179.374 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 167.76 92.95 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.811 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -179.5 -43.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.401 ' CD1' ' HB ' ' A' ' 76' ' ' VAL . 1.6 p90 -118.02 -171.41 2.06 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.971 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.696 ' HB3' ' HB3' ' A' ' 75' ' ' TYR . 2.3 tp -73.5 157.9 35.9 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.925 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.6 p -126.05 -179.28 4.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.258 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.8 -32.75 74.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.345 0.593 . . . . 0.0 110.596 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.497 ' OD1' ' HD3' ' A' ' 78' ' ' ARG . 71.7 m-20 -62.34 -43.11 99.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.86 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.619 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 30.1 m-20 -69.11 -30.9 69.27 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.969 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.877 HG21 HD23 ' A' ' 91' ' ' LEU . 70.9 t -59.82 -37.83 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.042 0.448 . . . . 0.0 110.574 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.6 t -58.42 -21.97 52.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.557 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -70.28 -29.67 66.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.65 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.619 HG22 HD11 ' A' ' 59' ' ' LEU . 36.7 pt -98.42 -178.14 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.812 0.815 . . . . 0.0 112.413 -178.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.25 151.27 3.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.38 -176.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.26 145.49 12.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.13 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.56 -35.9 3.57 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.792 -177.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.528 ' HE1' HG23 ' A' ' 46' ' ' ILE . 19.0 ptt? -85.27 176.81 8.11 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.165 0.507 . . . . 0.0 111.263 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.863 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 32.6 p -95.29 -174.95 3.35 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.991 -170.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.661 ' OE1' ' HA ' ' A' ' 68' ' ' PHE . 78.9 mt-30 -62.73 -48.06 80.88 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.533 172.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.517 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -64.65 -33.13 75.21 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.301 0.572 . . . . 0.0 109.843 -174.228 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.863 ' HG3' ' H ' ' A' ' 51' ' ' THR . 9.1 mm-40 -60.99 -53.08 61.62 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.562 174.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.684 HG13 HD21 ' A' ' 93' ' ' LEU . 75.2 t -69.43 -39.9 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.597 -176.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.635 ' HB2' HG21 ' A' ' 61' ' ' THR . . . -59.56 -32.26 70.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.452 0.644 . . . . 0.0 110.002 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -80.87 -36.82 30.83 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.272 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.57 -49.11 19.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.941 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.64 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -90.44 -32.89 16.21 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.978 -172.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 114.25 127.69 4.5 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.274 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.635 HG21 ' HB2' ' A' ' 56' ' ' ALA . 28.4 p -60.85 132.22 91.76 Favored Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-O 121.244 0.545 . . . . 0.0 111.004 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 11.6 Cg_exo -70.77 162.27 43.16 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.529 2.82 . . . . 0.0 112.768 -173.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.444 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 1.7 mt -54.47 -33.89 60.52 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.094 -1.412 . . . . 0.0 112.235 -169.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.629 ' HE1' HG23 ' A' ' 70' ' ' THR . 12.2 ptt? -64.16 -1.92 1.82 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.19 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.1 p 62.13 2.38 0.81 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.374 1.07 . . . . 0.0 113.534 172.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -136.76 92.53 14.59 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.462 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 37.9 Cg_endo -67.75 -34.1 25.6 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.745 1.63 . . . . 0.0 111.524 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.661 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -79.41 10.24 3.98 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.508 -177.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.02 -26.3 16.89 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.607 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.629 HG23 ' HE1' ' A' ' 64' ' ' MET . 15.1 t -124.66 175.95 6.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.959 0.409 . . . . 0.0 110.432 -177.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -126.99 13.55 7.31 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.8 m -132.57 109.78 10.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.665 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.481 ' O ' ' HA ' ' A' ' 92' ' ' THR . 46.2 m0 -107.29 149.85 27.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.594 -175.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -123.1 115.23 21.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.08 0.467 . . . . 0.0 111.051 -175.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.696 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 88.3 m-85 -127.06 174.47 8.86 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.661 HG12 ' NE2' ' A' ' 80' ' ' GLN . 4.7 t -120.97 170.19 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 118.066 0.394 . . . . 0.0 110.204 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.544 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -95.26 -175.97 3.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.406 0.622 . . . . 0.0 112.24 -175.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.497 ' HD3' ' OD1' ' A' ' 41' ' ' ASN . 23.7 ttp180 -94.12 112.91 24.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.261 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.412 ' H ' ' NE2' ' A' ' 34' ' ' GLN . 10.4 tt0 53.64 79.92 0.12 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.862 0.839 . . . . 0.0 112.321 172.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.866 ' HG3' ' HG2' ' A' ' 88' ' ' GLN . 0.4 OUTLIER -115.89 158.69 41.62 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.373 -178.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.593 ' HB2' HG22 ' A' ' 87' ' ' THR . 50.5 Cg_exo -58.92 108.06 0.39 Allowed 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.975 2.45 . . . . 0.0 111.927 173.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.64 -156.23 9.94 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.193 177.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 63.59 -83.56 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.966 0.413 . . . . 0.0 111.28 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -115.71 133.0 56.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.803 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.42 60.32 6.4 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.411 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.2 t -65.81 134.02 30.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.262 0.553 . . . . 0.0 110.798 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.593 HG22 ' HB2' ' A' ' 81' ' ' PRO . 10.7 t -142.27 17.43 2.07 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.589 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.866 ' HG2' ' HG3' ' A' ' 80' ' ' GLN . 49.0 mt-30 -34.69 110.52 0.1 Allowed 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.981 0.912 . . . . 0.0 113.379 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.676 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 50.1 mt-30 -67.07 104.29 1.38 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.6 p -90.04 142.97 27.19 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.077 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.92 HD11 HG22 ' A' ' 104' ' ' ILE . 19.3 tp -91.18 105.64 17.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.577 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 32.1 m -101.81 102.46 13.07 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.87 ' HG ' HD22 ' A' ' 101' ' ' LEU . 7.9 tp -83.72 126.16 32.61 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.256 -173.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.4 m -107.91 119.9 40.76 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.263 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -110.08 147.8 32.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.797 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.522 HD22 ' HB ' ' A' ' 100' ' ' VAL . 4.1 p30 -72.06 -87.35 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 55.0 m -150.73 -30.2 0.19 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.887 0.375 . . . . 0.0 110.75 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.511 ' HB3' HG23 ' A' ' 100' ' ' VAL . 16.6 t -82.27 -6.03 58.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.423 0.63 . . . . 0.0 109.452 177.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.457 ' HA2' HE21 ' A' ' 52' ' ' GLN . . . 89.77 29.65 15.32 Favored Glycine 0 CA--C 1.503 -0.702 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.522 ' HB ' HD22 ' A' ' 96' ' ' ASN . 25.8 t -108.25 137.13 41.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.613 -0.793 . . . . 0.0 109.458 -178.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.87 HD22 ' HG ' ' A' ' 93' ' ' LEU . 9.3 mt -61.37 130.74 47.61 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.197 0.522 . . . . 0.0 112.35 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 96' ' ' ASN . 10.8 p -114.18 -37.25 4.46 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.126 175.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -150.06 152.96 35.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.631 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.92 HG22 HD11 ' A' ' 91' ' ' LEU . 3.3 mm -112.96 93.83 2.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 173.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 92' ' ' THR . 5.6 m-20 -80.6 96.62 6.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.688 0.28 . . . . 0.0 111.449 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -106.77 104.19 13.81 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.88 0.847 . . . . 0.0 109.917 175.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.68 164.99 21.07 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.206 -176.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.676 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 57.8 Cg_endo -77.06 158.35 34.11 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.372 2.048 . . . . 0.0 112.702 -173.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.18 178.44 7.59 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.647 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 111' ' ' SER . 9.6 mt -78.1 -90.33 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.52 -172.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 8.9 t 174.7 148.86 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 82.54 133.77 1.94 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.943 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.784 -0.627 . . . . 0.0 109.901 178.334 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 112.019 -0.433 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.3 m -96.44 -0.76 48.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.722 0.296 . . . . 0.0 110.992 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -88.22 -65.7 0.99 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.794 0.33 . . . . 0.0 110.76 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.1 mtm -106.24 26.86 9.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.78 -174.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 t -162.0 41.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.503 0.668 . . . . 0.0 110.241 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.6 t -95.12 123.44 38.61 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.196 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.4 mt 55.63 38.16 29.81 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.289 0.566 . . . . 0.0 110.512 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -66.52 -69.1 0.32 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.236 -174.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.449 ' HG3' HG13 ' A' ' 26' ' ' VAL . 14.2 ptt-85 -115.79 -25.51 7.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.924 0.392 . . . . 0.0 110.994 -177.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.449 HG13 ' HG3' ' A' ' 25' ' ' ARG . 10.8 p -173.76 166.18 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.42 ' N ' HG23 ' A' ' 26' ' ' VAL . 0.6 OUTLIER -73.43 177.55 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 120.663 0.268 . . . . 0.0 110.673 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -62.28 162.54 9.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.182 0.515 . . . . 0.0 112.02 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -112.92 106.73 55.02 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.569 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -57.79 152.1 51.91 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.143 2.562 . . . . 0.0 112.189 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -127.76 78.43 1.82 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.613 0.72 . . . . 0.0 111.225 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.894 HG23 ' H ' ' A' ' 34' ' ' GLN . 36.1 mm -83.26 146.53 6.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.903 173.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -71.45 -4.26 25.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.992 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.894 ' H ' HG23 ' A' ' 32' ' ' ILE . 16.3 pt20 -144.19 -177.08 5.28 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.405 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.23 44.57 0.27 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -100.86 -62.94 1.18 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.091 -0.555 . . . . 0.0 110.311 -172.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -111.88 -165.7 1.01 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.845 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.64 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 5.0 tp -78.87 152.19 31.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.911 0.386 . . . . 0.0 111.005 -176.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.521 ' HB ' ' HA ' ' A' ' 78' ' ' ARG . 29.3 p -127.84 -174.1 3.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.986 175.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.18 -38.87 86.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.362 0.601 . . . . 0.0 110.869 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.545 ' ND2' HD11 ' A' ' 32' ' ' ILE . 53.9 m-80 -62.12 -41.74 98.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.468 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.51 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 10.7 m-20 -63.85 -36.75 84.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.491 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.736 HG21 HD23 ' A' ' 91' ' ' LEU . 77.0 t -59.26 -38.05 72.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.167 0.508 . . . . 0.0 110.582 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.9 t -63.03 -20.62 65.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.089 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 46.0 mtpt -70.17 -33.92 72.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.654 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.706 HG22 HD11 ' A' ' 59' ' ' LEU . 42.9 pt -89.76 -179.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.784 0.802 . . . . 0.0 112.439 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.43 149.9 2.24 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.665 -176.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -70.98 142.29 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.722 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.69 -27.97 6.35 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.708 -176.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.616 ' HE3' ' HA ' ' A' ' 46' ' ' ILE . 21.8 ptt? -94.08 171.56 8.77 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.76 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.596 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 23.5 p -91.18 -172.83 3.43 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.723 -168.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.45 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 99.0 mt-30 -63.89 -46.81 83.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.143 173.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.422 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 10.4 pt20 -64.95 -35.3 80.73 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.376 0.608 . . . . 0.0 110.061 -175.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.596 ' HG3' ' H ' ' A' ' 51' ' ' THR . 1.7 mm100 -68.14 -40.58 82.38 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.303 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.637 HG13 ' CD2' ' A' ' 93' ' ' LEU . 53.9 t -74.8 -47.15 39.0 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.578 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.688 ' HB3' HG21 ' A' ' 61' ' ' THR . . . -63.58 -24.83 67.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.874 0.368 . . . . 0.0 110.796 -176.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -79.82 -41.27 26.76 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.65 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.56 -44.19 71.38 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.558 0.694 . . . . 0.0 111.271 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.706 HD11 HG22 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -88.27 -39.94 14.02 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.366 -173.044 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.6 122.87 4.07 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -171.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.688 HG21 ' HB3' ' A' ' 56' ' ' ALA . 40.2 p -57.09 133.16 80.5 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.11 0.481 . . . . 0.0 111.032 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 22.6 Cg_exo -63.28 161.78 29.38 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.582 2.855 . . . . 0.0 113.332 -170.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.84 -27.63 60.47 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 113.776 -1.556 . . . . 0.0 112.09 -171.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.812 ' HE1' HG22 ' A' ' 70' ' ' THR . 13.2 ptt? -68.14 2.62 2.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.772 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.9 t 66.48 11.0 7.77 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.818 0.447 . . . . 0.0 112.03 172.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -162.78 104.63 1.04 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.703 0.763 . . . . 0.0 110.458 178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.526 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 74.3 Cg_endo -77.29 -36.25 1.39 Allowed 'Trans proline' 0 C--N 1.326 -0.649 0 C-N-CA 123.171 2.581 . . . . 0.0 113.704 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -77.2 -11.62 59.84 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -166.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.32 -8.85 70.72 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.961 -173.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.812 HG22 ' HE1' ' A' ' 64' ' ' MET . 11.1 t -124.09 174.51 7.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.954 0.407 . . . . 0.0 110.467 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -119.34 1.62 11.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.117 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.3 m -131.62 113.87 14.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.898 -175.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.564 ' O ' ' HA ' ' A' ' 92' ' ' THR . 44.4 m0 -108.69 147.12 32.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.489 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 27.1 m-85 -127.68 125.26 39.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.954 0.407 . . . . 0.0 111.16 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.529 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 73.4 m-85 -133.92 173.61 11.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.798 178.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.5 t -121.27 161.62 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -88.36 -177.24 5.6 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.568 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 0.4 OUTLIER -50.34 136.94 19.36 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.751 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.552 ' HB2' ' NE2' ' A' ' 34' ' ' GLN . 5.9 tt0 -56.58 99.16 0.03 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.246 0.546 . . . . 0.0 111.94 -173.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.868 HE21 HG23 ' A' ' 87' ' ' THR . 9.1 pt20 -124.41 168.78 12.15 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.322 -178.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 80' ' ' GLN . 32.0 Cg_exo -38.13 128.1 0.96 Allowed 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 124.063 3.176 . . . . 0.0 114.397 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 1.018 ' HA2' ' HA ' ' A' ' 86' ' ' VAL . . . -157.59 -143.29 3.62 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.257 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 66.04 -83.94 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.246 0.618 . . . . 0.0 111.65 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -93.7 -16.21 24.48 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 122.111 0.958 . . . . 0.0 111.064 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.14 86.93 0.13 Allowed Glycine 0 C--N 1.296 -1.659 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.381 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 1.018 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 21.3 t -83.51 140.87 15.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.228 0.537 . . . . 0.0 110.993 -173.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.868 HG23 HE21 ' A' ' 80' ' ' GLN . 13.1 t -120.35 -3.16 9.98 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.453 176.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.442 ' HB2' ' CG1' ' A' ' 86' ' ' VAL . 2.6 mp0 -54.87 152.69 7.02 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 174.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -107.49 125.07 50.81 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.209 160.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -89.25 135.37 33.61 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.834 -179.004 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.736 HD23 HG21 ' A' ' 43' ' ' VAL . 13.9 tp -90.08 111.5 22.63 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.65 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 34.6 m -106.65 104.2 13.83 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.898 ' HG ' HD22 ' A' ' 101' ' ' LEU . 6.7 tp -88.41 119.28 28.69 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.032 -174.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.8 m -102.43 122.26 43.95 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.557 -175.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -114.63 138.11 51.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.986 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.524 ' HB3' HG22 ' A' ' 102' ' ' THR . 32.5 p30 -75.0 -172.08 1.53 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.121 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.5 m -62.19 -30.97 71.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.557 ' HB3' HG23 ' A' ' 100' ' ' VAL . 35.6 t -83.46 -11.87 56.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.777 0.323 . . . . 0.0 111.133 -174.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.78 28.94 14.34 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.557 HG23 ' HB3' ' A' ' 98' ' ' SER . 6.7 t -107.87 142.91 19.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.031 -0.585 . . . . 0.0 109.648 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.898 HD22 ' HG ' ' A' ' 93' ' ' LEU . 6.5 mt -62.97 126.74 28.33 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.176 0.512 . . . . 0.0 112.204 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.524 HG22 ' HB3' ' A' ' 96' ' ' ASN . 10.8 p -113.13 -42.93 3.44 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.0 175.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -138.2 150.73 47.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.359 0.6 . . . . 0.0 111.584 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.655 HG22 HD11 ' A' ' 91' ' ' LEU . 4.7 mm -113.03 93.08 2.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 168.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.65 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 32.8 t70 -90.56 98.69 11.92 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.465 -169.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.443 ' HA ' ' O ' ' A' ' 90' ' ' THR . 4.8 p30 -110.98 101.72 10.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.201 1.001 . . . . 0.0 110.744 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.57 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 23.5 mttp -118.16 163.21 26.0 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.716 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 107' ' ' LYS . 2.7 Cg_endo -63.82 137.25 57.36 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.053 1.835 . . . . 0.0 110.912 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.442 ' HB1' HG13 ' A' ' 86' ' ' VAL . . . -65.63 173.36 2.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.804 0.811 . . . . 0.0 112.912 -171.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.6 mt -52.26 -65.78 0.5 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.762 -172.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.66 ' HB2' HG23 ' A' ' 86' ' ' VAL . 8.0 m -77.12 61.08 1.99 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.969 0.414 . . . . 0.0 111.617 -177.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -133.63 -154.14 7.28 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.102 -0.952 . . . . 0.0 110.565 179.836 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.878 0 N-CA-C 112.606 -0.198 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.5 m -71.91 78.14 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -84.31 -50.65 7.65 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 170.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 62.3 mtm -120.96 -7.76 9.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.398 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.9 m -80.9 99.26 8.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.711 -176.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.7 m 64.84 93.78 0.06 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.38 0.61 . . . . 0.0 111.453 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 87.0 mt -107.8 79.86 1.32 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.304 -175.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -124.16 -86.29 0.64 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.376 0.608 . . . . 0.0 109.826 172.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -157.07 66.15 0.51 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.604 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.2 p -79.53 83.4 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 122.275 1.036 . . . . 0.0 110.628 -175.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -83.53 173.25 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.056 -177.37 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.497 ' O ' HG13 ' A' ' 27' ' ' VAL . 83.2 m-85 -75.3 148.45 39.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.39 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -71.99 123.34 89.32 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 171.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -42.42 123.78 2.91 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.882 3.055 . . . . 0.0 113.742 -176.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -152.56 31.13 0.52 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.672 HD13 ' HG2' ' A' ' 78' ' ' ARG . 23.7 mm -75.6 145.14 11.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.392 -1.277 . . . . 0.0 111.377 -170.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -85.03 -33.55 22.48 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.5 ' N ' HG23 ' A' ' 32' ' ' ILE . 14.8 mp0 -71.72 -156.67 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 113.56 -1.655 . . . . 0.0 109.392 172.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.58 -24.04 29.75 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.434 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -75.39 -39.44 59.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.485 0.659 . . . . 0.0 109.618 176.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -113.24 -166.51 1.09 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.399 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.731 HD12 ' HG ' ' A' ' 59' ' ' LEU . 1.8 mm? -70.92 140.39 50.97 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.831 0.824 . . . . 0.0 112.562 -177.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.695 ' HB ' ' HB2' ' A' ' 78' ' ' ARG . 17.3 p -131.21 -172.46 2.84 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.352 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.474 ' HB2' ' H ' ' A' ' 78' ' ' ARG . . . -62.62 -47.57 83.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -67.82 -32.64 73.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.968 0.413 . . . . 0.0 110.959 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.507 ' HB3' HD11 ' A' ' 38' ' ' LEU . 10.6 m-20 -62.76 -37.61 87.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.321 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.933 HG21 HD23 ' A' ' 91' ' ' LEU . 78.4 t -60.61 -37.73 76.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.121 0.486 . . . . 0.0 110.966 178.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.9 t -60.57 -22.84 64.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.257 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 49.8 mtpt -68.57 -34.4 75.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.648 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.674 HG22 HD11 ' A' ' 59' ' ' LEU . 44.6 pt -93.63 175.67 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 121.934 0.873 . . . . 0.0 112.51 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.65 150.96 6.1 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.955 -1.475 . . . . 0.0 109.505 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.426 HG21 ' CG1' ' A' ' 104' ' ' ILE . 0.5 OUTLIER -72.41 141.59 16.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.888 -177.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.3 -24.1 7.42 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.246 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.62 ' HE1' HG23 ' A' ' 46' ' ' ILE . 19.0 ptt? -96.57 178.12 5.44 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.226 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.2 p -95.03 -178.91 4.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.71 -169.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.49 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 27.1 mt-30 -65.56 -43.38 90.03 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.866 173.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.444 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 9.4 pt20 -64.35 -38.11 89.87 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.674 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.444 ' N ' ' HG3' ' A' ' 53' ' ' GLN . 49.3 mt-30 -66.77 -45.62 77.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.115 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.676 HG13 ' CD2' ' A' ' 93' ' ' LEU . 62.8 t -68.86 -47.64 74.94 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.561 ' HB3' HG21 ' A' ' 61' ' ' THR . . . -62.86 -26.32 68.71 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.488 -177.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -81.33 -39.12 25.63 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.392 176.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.25 -51.93 47.07 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.105 0.955 . . . . 0.0 110.85 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.731 ' HG ' HD12 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -81.55 -49.61 10.36 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.328 -173.011 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.88 124.16 2.75 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -171.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.561 HG21 ' HB3' ' A' ' 56' ' ' ALA . 44.3 p -57.41 134.06 81.66 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.877 0.37 . . . . 0.0 110.69 -177.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.508 ' CD ' ' HB3' ' A' ' 67' ' ' PRO . 35.1 Cg_exo -60.41 157.04 37.88 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 123.498 2.799 . . . . 0.0 112.645 -172.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 mt -59.93 -27.99 67.23 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.502 -1.227 . . . . 0.0 111.307 -171.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.433 ' HE1' ' CG2' ' A' ' 70' ' ' THR . 12.5 ptt? -62.85 -4.8 2.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.862 175.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 t 71.65 -3.01 2.27 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.459 0.703 . . . . 0.0 111.695 172.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.46 99.78 7.76 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-O 121.708 0.766 . . . . 0.0 110.427 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.508 ' HB3' ' CD ' ' A' ' 62' ' ' PRO . 73.0 Cg_endo -79.32 -28.43 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.712 2.275 . . . . 0.0 112.598 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -86.03 -5.31 59.24 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -168.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.79 -17.79 53.21 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.89 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.433 ' CG2' ' HE1' ' A' ' 64' ' ' MET . 9.0 t -123.62 172.16 9.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.914 0.388 . . . . 0.0 110.069 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -128.06 20.65 6.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.322 0.582 . . . . 0.0 109.465 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 17.9 m -143.65 111.92 6.3 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.696 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.54 ' O ' ' HA ' ' A' ' 92' ' ' THR . 51.4 m0 -107.84 147.15 31.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.613 -175.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -125.68 115.27 19.83 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 111.268 -174.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.535 ' HD2' HD22 ' A' ' 91' ' ' LEU . 27.7 m-85 -128.53 176.26 7.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.512 HG21 ' H ' ' A' ' 77' ' ' PHE . 4.2 p -124.32 175.13 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -176.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.512 ' H ' HG21 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -98.51 166.49 11.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.241 0.543 . . . . 0.0 111.622 -175.212 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.695 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -91.53 112.7 24.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.104 -177.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 51.67 74.56 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.854 0.835 . . . . 0.0 110.997 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.596 ' NE2' ' H ' ' A' ' 80' ' ' GLN . 0.5 OUTLIER -95.66 139.51 21.93 Favored Pre-proline 0 N--CA 1.442 -0.834 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.245 -178.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 26.9 Cg_exo -62.52 108.57 0.73 Allowed 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 123.034 2.489 . . . . 0.0 111.531 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.598 ' HA2' HG22 ' A' ' 87' ' ' THR . . . -89.82 -105.15 1.17 Allowed Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.534 -175.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.7 t60 73.6 -32.57 0.24 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.679 0.792 . . . . 0.0 110.947 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 82' ' ' GLY . 43.2 mt-10 -85.91 -171.57 3.65 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 173.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.77 -53.84 4.14 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.414 HG12 ' HB1' ' A' ' 109' ' ' ALA . 14.8 t -129.54 141.37 46.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 175.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.598 HG22 ' HA2' ' A' ' 82' ' ' GLY . 13.4 t -167.04 1.41 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.552 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.577 ' HA ' ' HG3' ' A' ' 80' ' ' GLN . 36.8 mt-30 -58.69 129.95 44.53 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.355 0.598 . . . . 0.0 111.913 -174.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.668 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 74.8 mt-30 -81.87 106.61 13.93 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.846 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 21.6 p -89.94 143.35 26.86 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.228 -174.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.933 HD23 HG21 ' A' ' 43' ' ' VAL . 24.7 tp -91.51 113.1 25.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.142 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.708 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 25.5 m -106.39 105.05 14.9 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.86 ' HG ' HD22 ' A' ' 101' ' ' LEU . 6.9 tp -90.83 121.65 32.87 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.401 -174.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.7 m -104.55 124.15 48.78 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.945 -176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.454 ' CE1' ' HG ' ' A' ' 101' ' ' LEU . 73.9 m-85 -117.32 139.37 50.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.44 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.484 ' HB3' HG22 ' A' ' 102' ' ' THR . 32.0 p30 -76.59 -174.36 2.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.168 174.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.0 p -57.48 -35.89 70.77 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -175.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.64 ' HB3' HG23 ' A' ' 100' ' ' VAL . 21.0 t -81.15 -4.93 56.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.189 0.518 . . . . 0.0 110.88 -174.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.53 27.95 37.45 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.45 -0.881 . . . . 0.0 110.902 -177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.64 HG23 ' HB3' ' A' ' 98' ' ' SER . 16.7 t -104.6 138.17 30.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.235 -0.482 . . . . 0.0 109.733 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.86 HD22 ' HG ' ' A' ' 93' ' ' LEU . 7.3 mt -58.97 127.75 33.79 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.215 0.531 . . . . 0.0 111.987 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 96' ' ' ASN . 7.6 p -114.3 -35.51 4.96 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.223 176.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -149.43 149.03 30.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.204 0.526 . . . . 0.0 111.915 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.791 HG22 HD11 ' A' ' 91' ' ' LEU . 3.4 mm -113.09 94.38 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.708 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 18.4 t70 -94.91 97.25 9.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.862 0.363 . . . . 0.0 111.674 -169.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' A' ' 90' ' ' THR . 28.6 t-20 -107.69 103.37 12.65 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.723 0.773 . . . . 0.0 110.973 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.533 ' HE3' ' OD1' ' A' ' 105' ' ' ASP . 67.1 mttt -126.98 154.12 76.41 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.09 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.668 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 19.4 Cg_endo -75.56 146.44 30.71 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.939 2.426 . . . . 0.0 111.799 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.414 ' HB1' HG12 ' A' ' 86' ' ' VAL . . . -73.12 -179.58 3.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.285 -178.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.8 mt -52.87 104.59 0.09 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.312 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.7 m -73.75 141.21 46.32 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.272 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 145.23 163.35 10.09 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.5 t30 . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.232 -179.854 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.0 t -163.92 150.73 11.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.804 0.335 . . . . 0.0 110.459 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -172.86 -54.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.779 ' HG3' ' H ' ' A' ' 21' ' ' SER . 10.9 tpt -142.59 -163.87 1.71 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.779 ' H ' ' HG3' ' A' ' 20' ' ' MET . 6.0 p -56.22 -44.8 79.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.926 0.33 . . . . 0.0 110.733 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 m 57.33 67.81 0.93 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.105 0.478 . . . . 0.0 112.231 173.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -111.95 177.73 4.55 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -56.64 -61.3 2.52 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -161.92 -61.86 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.5 m -133.63 135.72 55.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.747 171.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 28' ' ' TYR . 1.3 p -102.58 178.79 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -174.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.412 ' H ' HG22 ' A' ' 27' ' ' VAL . 77.0 m-85 -50.01 141.88 10.15 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 122.477 0.311 . . . . 0.0 110.998 176.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -74.08 156.32 87.81 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -41.09 124.0 1.99 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.985 2.457 . . . . 0.0 112.002 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -159.85 99.26 1.38 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -171.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.844 HG23 ' H ' ' A' ' 34' ' ' GLN . 34.4 mm -58.02 144.93 9.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.614 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -55.08 -32.36 61.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.641 175.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.844 ' H ' HG23 ' A' ' 32' ' ' ILE . 27.7 pt20 -112.13 25.14 11.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 122.014 0.912 . . . . 0.0 110.126 176.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -84.88 57.08 5.02 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.665 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -91.73 -29.2 16.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 170.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -105.96 -165.26 1.08 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.752 169.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.721 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 10.4 tp -79.29 151.77 30.9 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.929 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.49 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 40.4 p -129.21 -179.11 4.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.033 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.409 ' O ' ' HB ' ' A' ' 43' ' ' VAL . . . -65.07 -44.34 89.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.595 ' OD1' ' HD2' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -60.62 -32.58 71.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.397 179.312 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 5.7 m-20 -75.33 -27.77 59.37 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.857 176.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.848 HG21 HD23 ' A' ' 91' ' ' LEU . 54.4 t -60.38 -36.34 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.321 0.581 . . . . 0.0 110.05 173.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.4 t -61.8 -19.89 63.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.317 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 46.6 mtpt -74.69 -24.99 58.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.496 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.713 HG22 HD11 ' A' ' 59' ' ' LEU . 34.4 pt -101.24 176.53 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 122.068 0.937 . . . . 0.0 112.585 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.06 153.35 3.12 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.027 -176.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.434 HG21 HD12 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -71.31 144.73 13.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.961 -177.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.49 -29.6 5.63 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.448 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.651 ' HE1' HG23 ' A' ' 46' ' ' ILE . 13.5 ptt? -92.86 178.14 5.86 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.19 176.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.805 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 30.0 p -96.07 -174.1 3.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.776 -169.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.454 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 75.6 mt-30 -61.51 -47.78 84.03 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.246 173.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.659 ' HG2' ' HG1' ' A' ' 51' ' ' THR . 7.7 pt20 -63.59 -40.32 96.65 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.21 0.529 . . . . 0.0 109.977 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.805 ' HG3' ' H ' ' A' ' 51' ' ' THR . 7.3 mm-40 -60.09 -50.43 73.72 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.059 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.633 HG13 ' CD2' ' A' ' 93' ' ' LEU . 56.9 t -64.76 -48.83 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.676 -177.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.625 ' HB3' HG21 ' A' ' 61' ' ' THR . . . -63.31 -26.25 68.68 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.756 -176.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -81.89 -33.73 30.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.972 0.415 . . . . 0.0 111.81 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.67 -40.61 63.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.833 0.825 . . . . 0.0 111.058 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.721 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 0.7 OUTLIER -91.92 -41.6 10.5 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.64 -171.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.9 123.87 4.52 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 -168.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.625 HG21 ' HB3' ' A' ' 56' ' ' ALA . 33.2 p -56.35 136.45 75.84 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.981 0.42 . . . . 0.0 111.051 -175.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.559 ' CD ' ' HB3' ' A' ' 67' ' ' PRO . 34.3 Cg_exo -60.57 167.07 8.75 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.759 2.973 . . . . 0.0 113.556 -171.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.27 -30.44 64.68 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 113.637 -1.619 . . . . 0.0 111.961 -171.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.62 ' HE1' ' CG2' ' A' ' 70' ' ' THR . 11.4 ptt? -71.15 2.29 4.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.778 178.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.8 t 71.1 1.79 3.96 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.266 0.626 . . . . 0.0 112.234 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -157.62 108.59 1.82 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.73 0.776 . . . . 0.0 110.716 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.693 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 74.1 Cg_endo -75.49 -34.73 3.23 Favored 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 123.559 2.84 . . . . 0.0 113.653 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.451 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 14.4 m-85 -75.14 2.48 10.69 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -166.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.78 -20.09 45.13 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.937 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.62 ' CG2' ' HE1' ' A' ' 64' ' ' MET . 11.8 t -125.61 175.28 7.67 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.839 0.352 . . . . 0.0 110.443 -178.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -123.35 8.15 9.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.5 m -129.14 107.38 9.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.994 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.693 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 47.9 m0 -104.59 144.93 31.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.946 -173.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -122.19 120.38 34.02 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.571 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 72.1 m-85 -127.2 173.61 9.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.522 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.414 HG11 ' NE2' ' A' ' 88' ' ' GLN . 38.6 t -115.76 152.06 17.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.09 0.471 . . . . 0.0 110.096 -173.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.14 161.2 16.61 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.443 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.595 ' HD2' ' OD1' ' A' ' 41' ' ' ASN . 14.5 ttt180 -74.83 124.98 27.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.63 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 52.99 87.0 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.514 0.674 . . . . 0.0 111.331 -177.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 3.0 pp0? -119.66 144.81 37.77 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.358 -174.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.48 ' HB2' HG22 ' A' ' 87' ' ' THR . 13.5 Cg_exo -71.82 115.23 4.22 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 123.188 2.592 . . . . 0.0 111.922 174.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -132.32 -139.76 4.36 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.882 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 68.64 -85.65 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.189 0.596 . . . . 0.0 110.108 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -132.15 140.85 48.91 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.68 57.66 7.8 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -172.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.467 HG11 ' H ' ' A' ' 88' ' ' GLN . 20.8 t -70.76 138.82 21.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.061 0.458 . . . . 0.0 110.573 -175.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.48 HG22 ' HB2' ' A' ' 81' ' ' PRO . 15.2 t -142.44 18.45 2.05 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.926 0.87 . . . . 0.0 109.493 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.553 ' HG3' HG22 ' A' ' 90' ' ' THR . 0.0 OUTLIER -51.99 122.09 7.83 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.666 179.627 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 43.0 mt-30 -82.04 104.45 12.39 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.695 0.759 . . . . 0.0 109.93 175.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.553 HG22 ' HG3' ' A' ' 88' ' ' GLN . 8.2 p -88.12 144.55 26.42 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.727 -172.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.848 HD23 HG21 ' A' ' 43' ' ' VAL . 13.2 tp -91.29 108.57 19.97 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.663 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 22.3 m -105.57 98.17 7.91 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.453 0.644 . . . . 0.0 109.647 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.849 ' HG ' HD22 ' A' ' 101' ' ' LEU . 6.9 tp -83.25 128.45 34.51 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.568 -173.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.0 m -114.44 124.61 52.36 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.078 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.436 ' CE1' ' HG ' ' A' ' 101' ' ' LEU . 87.5 m-85 -114.41 140.64 48.52 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.316 -178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.524 ' HB3' HG22 ' A' ' 102' ' ' THR . 31.6 p30 -75.27 -174.07 2.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.148 176.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.2 m -53.59 -36.62 62.14 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.534 ' HB3' HG23 ' A' ' 100' ' ' VAL . 22.9 t -85.96 -0.09 54.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.99 0.424 . . . . 0.0 110.797 -173.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.37 29.84 51.77 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.734 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.534 HG23 ' HB3' ' A' ' 98' ' ' SER . 5.6 t -105.66 140.48 23.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.849 HD22 ' HG ' ' A' ' 93' ' ' LEU . 6.5 mt -59.89 126.37 27.31 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.219 0.533 . . . . 0.0 112.264 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.524 HG22 ' HB3' ' A' ' 96' ' ' ASN . 11.4 p -111.85 -43.52 3.6 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.812 174.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -136.82 152.29 50.11 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.446 0.641 . . . . 0.0 111.335 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.66 HG22 HD11 ' A' ' 91' ' ' LEU . 4.8 mm -114.57 92.23 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 169.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.663 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 18.6 t70 -86.89 95.08 9.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.141 0.496 . . . . 0.0 110.921 -170.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -106.89 104.17 13.78 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.636 0.731 . . . . 0.0 109.967 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.541 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -145.96 168.75 11.01 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.98 -177.407 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 39.7 Cg_endo -69.87 165.96 29.34 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 122.068 1.845 . . . . 0.0 112.691 -175.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.25 -165.35 0.18 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.939 0.876 . . . . 0.0 111.656 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 28.6 mt -68.2 105.88 2.25 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.801 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.0 t 69.01 -168.37 0.18 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.483 -177.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.7 158.39 21.56 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.711 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.8 m120 . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.484 -0.77 . . . . 0.0 110.18 178.46 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.914 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.9 m -84.88 124.01 31.13 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.696 0.284 . . . . 0.0 110.826 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 62.0 71.22 0.55 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.412 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 79.2 mtp -126.12 -70.51 0.73 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.907 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.9 t 57.14 74.48 0.41 Allowed 'General case' 0 C--O 1.233 0.189 0 O-C-N 123.783 0.677 . . . . 0.0 110.255 -178.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 m -70.7 107.3 3.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.48 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.2 mt -88.65 144.66 26.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.898 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -83.41 72.66 10.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.312 0.577 . . . . 0.0 110.724 -173.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -89.48 144.89 25.69 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.748 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.0 p -78.16 122.61 33.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.147 0.499 . . . . 0.0 110.077 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.42 167.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.081 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -69.2 138.91 54.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.093 0.473 . . . . 0.0 110.589 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -71.9 129.22 88.38 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.18 -177.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.436 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 53.2 Cg_exo -55.6 169.96 1.04 Allowed 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 123.77 2.98 . . . . 0.0 112.296 171.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 30' ' ' PRO . 26.6 t70 73.51 114.32 0.06 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 122.073 0.939 . . . . 0.0 110.369 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.523 HG13 ' CG2' ' A' ' 39' ' ' THR . 44.5 mm -56.96 139.92 15.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.063 -1.426 . . . . 0.0 112.595 -174.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.728 ' N ' HD21 ' A' ' 33' ' ' ASN . 0.5 OUTLIER -78.41 -31.19 48.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.737 -176.625 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.402 ' O ' HG23 ' A' ' 32' ' ' ILE . 11.4 pt20 -87.75 170.37 11.29 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 173.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.91 97.01 0.15 Allowed Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.046 -1.074 . . . . 0.0 112.663 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -149.16 -60.47 0.22 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.91 -167.42 1.19 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.716 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.651 HD12 HD12 ' A' ' 59' ' ' LEU . 10.7 tp -85.27 166.71 16.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.571 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.523 ' CG2' HG13 ' A' ' 32' ' ' ILE . 43.4 p -127.41 177.25 6.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.128 172.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.77 -30.02 65.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 0.0 110.238 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.426 ' ND2' HD11 ' A' ' 32' ' ' ILE . 46.0 m-80 -53.49 -45.93 69.83 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.788 0.804 . . . . 0.0 109.759 175.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.66 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 19.9 m-20 -70.54 -30.5 67.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.334 -178.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.969 HG21 HD23 ' A' ' 91' ' ' LEU . 60.2 t -64.87 -41.84 93.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.257 0.551 . . . . 0.0 109.775 174.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.0 t -61.32 -32.01 71.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.315 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.66 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 34.3 mtpt -63.07 -43.52 98.36 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.754 176.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.539 HG22 HD11 ' A' ' 59' ' ' LEU . 43.6 pt -80.91 174.99 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-O 121.723 0.773 . . . . 0.0 111.901 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.44 ' O ' ' HG2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -163.43 143.43 8.71 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.228 -174.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.406 HG21 ' CG1' ' A' ' 104' ' ' ILE . 0.7 OUTLIER -70.34 140.76 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.491 -179.16 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.95 -27.09 6.9 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.965 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.502 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 23.4 ptt? -90.73 174.39 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.255 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.831 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 39.8 p -92.82 -173.78 3.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.888 -171.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.468 ' OE1' ' HA ' ' A' ' 68' ' ' PHE . 83.4 mt-30 -65.57 -44.33 87.08 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.515 172.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.638 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -64.97 -33.67 76.58 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.316 0.579 . . . . 0.0 110.18 -175.543 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.831 ' HG3' ' H ' ' A' ' 51' ' ' THR . 6.3 mm-40 -62.27 -53.01 61.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.222 175.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.755 HG13 HD21 ' A' ' 93' ' ' LEU . 69.1 t -69.96 -40.24 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.676 -176.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.654 ' HB2' HG22 ' A' ' 61' ' ' THR . . . -57.44 -33.45 67.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.433 0.635 . . . . 0.0 110.053 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -81.48 -36.56 29.15 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.744 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.23 -43.3 52.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.132 0.492 . . . . 0.0 111.968 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.651 HD12 HD12 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -94.86 -14.89 24.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.079 -172.625 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.02 124.16 3.27 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -175.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.654 HG22 ' HB2' ' A' ' 56' ' ' ALA . 18.6 p -60.11 121.21 57.45 Favored Pre-proline 0 N--CA 1.432 -1.339 0 CA-C-O 122.295 1.045 . . . . 0.0 111.666 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 75.4 Cg_exo -52.54 159.25 4.82 Favored 'Trans proline' 0 C--N 1.327 -0.602 1 C-N-CA 125.436 4.091 . . . . 0.0 113.965 -176.623 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.524 ' C ' ' H ' ' A' ' 65' ' ' SER . 0.5 OUTLIER -75.12 -21.1 59.1 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.953 -171.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.765 ' HE1' HG22 ' A' ' 70' ' ' THR . 16.9 ptt? -70.49 23.51 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.715 175.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 63' ' ' LEU . 44.5 t 77.07 -56.73 0.53 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 165.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.402 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 8.3 m-20 -126.29 99.92 30.22 Favored Pre-proline 0 C--N 1.304 -1.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.655 -171.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.493 ' HG3' HG22 ' A' ' 61' ' ' THR . 12.5 Cg_endo -58.75 -34.55 99.04 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.408 2.072 . . . . 0.0 111.655 176.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 53' ' ' GLN . 9.4 m-85 -78.99 2.48 20.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.81 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.0 -15.55 44.76 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.873 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.765 HG22 ' HE1' ' A' ' 64' ' ' MET . 6.1 t -124.81 175.5 7.22 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -127.39 7.82 6.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.293 0.568 . . . . 0.0 109.953 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 m -134.69 113.09 11.34 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.677 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.431 ' O ' ' HA ' ' A' ' 92' ' ' THR . 40.0 m0 -103.97 141.39 36.26 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.069 -176.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -116.41 114.64 24.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.372 0.606 . . . . 0.0 110.946 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.623 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 93.2 m-85 -129.41 176.61 7.82 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.525 177.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.551 HG23 ' HB3' ' A' ' 88' ' ' GLN . 1.4 p -143.27 -177.86 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.528 ' H ' HG22 ' A' ' 76' ' ' VAL . 15.5 m-30 -101.75 179.74 4.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.14 0.495 . . . . 0.0 112.162 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -61.81 133.13 55.11 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.575 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 30.28 65.96 0.13 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.24 1.016 . . . . 0.0 113.372 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.696 ' CB ' ' HG2' ' A' ' 88' ' ' GLN . 33.0 mm-40 -82.55 159.31 64.36 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 121.747 0.784 . . . . 0.0 112.407 -177.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 11.2 Cg_exo -72.05 102.57 1.36 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 124.248 3.299 . . . . 0.0 111.446 175.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -128.11 35.42 2.73 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.159 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -130.24 -68.75 0.69 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -93.38 123.12 36.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.106 175.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.92 69.1 1.14 Allowed Glycine 0 N--CA 1.452 -0.278 0 O-C-N 124.182 0.926 . . . . 0.0 112.417 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.3 t -53.54 130.3 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.444 0.64 . . . . 0.0 110.758 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.9 t -152.13 14.19 0.61 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.646 -175.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.696 ' HG2' ' CB ' ' A' ' 80' ' ' GLN . 50.5 mt-30 -36.65 118.58 0.58 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.679 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.659 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 89.6 mt-30 -69.62 102.41 1.85 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.608 0.718 . . . . 0.0 109.298 178.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.49 HG22 HG21 ' A' ' 76' ' ' VAL . 3.9 p -91.07 137.11 32.62 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.966 -175.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 1.055 HD11 HG22 ' A' ' 104' ' ' ILE . 42.5 tp -91.71 118.77 30.96 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.88 174.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 51.1 m -110.61 103.0 11.53 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.876 ' HG ' HD22 ' A' ' 101' ' ' LEU . 6.7 tp -83.11 118.32 23.48 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.055 -174.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 72.7 m -101.17 120.85 40.83 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.531 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -111.96 144.92 40.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.856 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.519 ' HB3' HG22 ' A' ' 102' ' ' THR . 27.2 p30 -75.64 -174.09 2.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.273 173.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.1 m -65.01 -24.93 67.65 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.506 ' HB3' HG23 ' A' ' 100' ' ' VAL . 18.1 t -85.1 -13.6 49.76 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.786 -177.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.26 30.68 8.53 Favored Glycine 0 CA--C 1.508 -0.348 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.008 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.506 HG23 ' HB3' ' A' ' 98' ' ' SER . 5.2 t -112.23 138.59 40.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.797 -0.702 . . . . 0.0 109.525 -177.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.876 HD22 ' HG ' ' A' ' 93' ' ' LEU . 8.5 mt -59.26 124.35 19.72 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.297 0.57 . . . . 0.0 112.442 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 96' ' ' ASN . 19.3 p -111.23 -37.78 5.21 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.164 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -149.65 149.42 30.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.479 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 1.055 HG22 HD11 ' A' ' 91' ' ' LEU . 2.4 mm -110.19 93.32 2.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 173.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.593 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 34.0 t0 -87.76 96.0 10.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.007 0.432 . . . . 0.0 111.4 -170.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -107.89 104.11 13.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.587 0.708 . . . . 0.0 111.277 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.542 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -143.31 168.48 12.85 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.226 178.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 42.5 Cg_endo -70.48 162.33 42.83 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.069 1.846 . . . . 0.0 112.27 -174.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.87 177.04 0.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.012 0.91 . . . . 0.0 112.674 -177.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.566 ' O ' ' HB2' ' A' ' 111' ' ' SER . 70.1 mt -47.27 -34.46 6.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.077 -1.874 . . . . 0.0 114.222 -169.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.566 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 62.1 m 80.77 160.5 0.16 Allowed 'General case' 0 C--N 1.332 -0.193 0 O-C-N 124.593 1.183 . . . . 0.0 111.443 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.44 -161.27 9.66 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 176.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.5 p30 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.625 -0.702 . . . . 0.0 109.559 177.926 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.768 0 N-CA-C 111.899 -0.481 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.6 t 57.29 57.35 4.52 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.265 0.555 . . . . 0.0 109.955 -177.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -66.2 -49.55 66.93 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.147 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -140.69 7.2 2.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.029 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.2 t -169.94 134.26 1.28 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.619 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 m -87.25 -24.83 24.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.28 0.562 . . . . 0.0 109.854 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.9 mt -84.22 -36.57 22.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.627 -176.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -73.98 -21.82 59.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.845 0.355 . . . . 0.0 111.056 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 25' ' ' ARG . 32.7 ttm180 62.25 24.98 14.91 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.768 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 25' ' ' ARG . 94.0 t 74.79 133.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.144 -175.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -57.11 152.61 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.454 0.645 . . . . 0.0 112.011 -173.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -61.61 163.44 7.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.025 -0.989 . . . . 0.0 113.349 -176.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.63 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 4.9 ptp180 -74.79 173.49 6.73 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.241 172.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.63 ' HD2' ' HB2' ' A' ' 29' ' ' ARG . 95.0 Cg_exo -41.75 129.87 3.97 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.487 2.125 . . . . 0.0 111.878 174.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -145.21 100.48 3.47 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.806 0.812 . . . . 0.0 111.068 -169.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.781 HG23 ' H ' ' A' ' 34' ' ' GLN . 39.6 mm -63.78 143.98 15.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.107 172.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.29 -18.9 61.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.039 0.447 . . . . 0.0 110.003 -178.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.781 ' H ' HG23 ' A' ' 32' ' ' ILE . 12.9 pt20 -117.15 -174.12 2.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.844 176.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 168.45 52.03 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 175.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -102.94 -43.09 5.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.954 0.407 . . . . 0.0 110.305 -175.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -113.31 -168.72 1.37 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.653 175.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.719 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 4.8 tp -80.1 152.98 29.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.618 0.247 . . . . 0.0 110.925 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.523 ' HB ' ' HA ' ' A' ' 78' ' ' ARG . 20.6 p -126.87 -174.76 3.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.079 176.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.499 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -67.34 -34.43 77.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.443 0.639 . . . . 0.0 110.574 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -64.67 -42.07 95.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.821 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.93 -27.97 66.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.025 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.795 HG21 HD23 ' A' ' 91' ' ' LEU . 58.8 t -59.84 -36.71 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.15 0.5 . . . . 0.0 110.76 176.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.9 t -59.33 -20.54 55.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.373 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -75.58 -19.24 59.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.819 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.699 HG22 HD11 ' A' ' 59' ' ' LEU . 30.0 pt -107.01 177.95 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.646 0.736 . . . . 0.0 112.46 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.92 150.69 4.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.729 -177.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.462 HG21 HD12 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -72.74 141.81 15.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.999 -179.045 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.69 -29.83 5.51 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.11 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.619 ' HE1' HG23 ' A' ' 46' ' ' ILE . 18.6 ptt? -88.54 178.36 6.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.184 0.492 . . . . 0.0 111.133 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.83 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 39.9 p -95.09 -174.3 3.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.207 -170.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.417 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 45.7 mt-30 -66.72 -44.12 82.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.866 174.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.619 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -65.92 -34.52 78.32 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.422 0.63 . . . . 0.0 109.823 -176.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.83 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.9 mm-40 -61.0 -57.03 14.32 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.464 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.614 HG13 ' CD2' ' A' ' 93' ' ' LEU . 90.9 t -63.42 -42.53 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.725 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.458 ' HB2' HG21 ' A' ' 61' ' ' THR . . . -58.72 -35.82 73.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.082 0.468 . . . . 0.0 110.161 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -80.88 -37.22 30.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.515 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.64 -46.39 66.28 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.616 0.722 . . . . 0.0 111.215 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.719 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 0.7 OUTLIER -88.14 -42.79 12.11 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.594 -172.103 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.79 122.01 3.76 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -171.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.504 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 17.9 p -54.7 136.51 64.0 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.499 0.666 . . . . 0.0 111.795 -175.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.56 ' HB2' ' HG2' ' A' ' 64' ' ' MET . 23.1 Cg_exo -64.49 165.03 21.44 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.847 3.031 . . . . 0.0 113.197 -172.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.14 -24.63 67.27 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.483 -173.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.56 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 14.6 ptt? -68.22 -1.29 5.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.806 175.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 t 71.56 6.63 5.77 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.459 0.704 . . . . 0.0 112.471 170.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -165.33 110.93 0.79 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 121.738 0.78 . . . . 0.0 110.674 176.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 60.4 Cg_endo -73.67 -24.54 15.73 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.303 2.669 . . . . 0.0 113.525 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -80.53 -5.6 56.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -170.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.75 -18.76 59.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.733 -176.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.5 t -125.0 175.28 7.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.348 0.594 . . . . 0.0 111.624 -173.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -117.49 0.34 12.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.658 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.4 m -128.99 111.86 13.44 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.789 -178.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.633 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 43.8 m0 -104.03 137.36 42.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.606 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -113.28 110.09 19.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.224 0.535 . . . . 0.0 111.21 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.582 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 53.8 m-85 -125.8 175.83 7.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.516 HG23 ' NE2' ' A' ' 88' ' ' GLN . 2.3 p -141.89 179.99 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.536 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.512 ' H ' HG23 ' A' ' 76' ' ' VAL . 2.9 m-30 -87.91 -172.92 4.05 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 122.599 0.36 . . . . 0.0 111.632 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.592 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 7.4 mtp180 -48.18 169.43 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.536 173.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.486 ' HB2' ' HG2' ' A' ' 34' ' ' GLN . 0.7 OUTLIER -62.97 84.79 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 172.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.836 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 6.7 mm100 -101.61 164.46 15.86 Favored Pre-proline 0 N--CA 1.444 -0.764 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.728 177.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.634 ' HD2' HG22 ' A' ' 87' ' ' THR . 51.2 Cg_exo -57.75 116.68 3.4 Favored 'Trans proline' 0 C--N 1.33 -0.416 0 C-N-CA 123.468 2.778 . . . . 0.0 112.537 174.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 83' ' ' HIS . . . -110.73 170.48 13.97 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 173.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.408 ' HB3' ' O ' ' A' ' 82' ' ' GLY . 38.9 t60 71.6 -62.55 0.45 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.807 0.443 . . . . 0.0 110.638 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -118.38 134.92 54.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.712 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 51.53 52.6 32.49 Favored Glycine 0 N--CA 1.453 -0.196 0 O-C-N 124.07 0.856 . . . . 0.0 111.731 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 81' ' ' PRO . 17.4 t -67.14 135.85 27.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.604 0.716 . . . . 0.0 111.339 -172.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.641 HG21 ' HB3' ' A' ' 80' ' ' GLN . 13.2 t -134.1 5.19 3.55 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.45 173.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.836 ' HG2' ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -65.81 128.66 36.88 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.328 174.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 79.3 mt-30 -113.36 130.75 56.21 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.175 176.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER -90.8 131.1 36.65 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.902 -179.2 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.795 HD23 HG21 ' A' ' 43' ' ' VAL . 13.9 tp -90.92 108.35 19.8 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.715 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 19.2 m -103.22 104.5 14.64 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.853 ' HG ' HD22 ' A' ' 101' ' ' LEU . 7.0 tp -88.71 128.71 35.62 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.423 -173.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.2 m -115.82 123.06 47.23 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.077 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.409 ' CE2' ' HG ' ' A' ' 101' ' ' LEU . 93.1 m-85 -112.41 137.31 50.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.43 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.513 ' HB3' HG22 ' A' ' 102' ' ' THR . 6.1 p30 -57.22 -82.7 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -175.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.4 t -155.38 -34.3 0.09 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.508 ' HB2' HG23 ' A' ' 100' ' ' VAL . 16.9 m -78.99 -8.11 58.65 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.243 0.544 . . . . 0.0 110.436 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.47 32.18 8.37 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.508 HG23 ' HB2' ' A' ' 98' ' ' SER . 18.5 t -112.35 134.17 55.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.178 -0.511 . . . . 0.0 109.689 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.853 HD22 ' HG ' ' A' ' 93' ' ' LEU . 6.2 mt -61.52 125.88 25.36 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.249 0.547 . . . . 0.0 112.319 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.513 HG22 ' HB3' ' A' ' 96' ' ' ASN . 11.2 p -111.73 -42.55 3.8 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.913 175.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -136.05 151.89 50.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.57 0.7 . . . . 0.0 111.49 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.69 HG22 HD11 ' A' ' 91' ' ' LEU . 3.1 mm -115.75 93.65 2.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 168.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.715 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 7.5 t70 -87.34 95.04 9.85 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.133 0.492 . . . . 0.0 110.415 -170.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -112.3 111.38 22.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.842 0.83 . . . . 0.0 111.437 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.567 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -147.38 170.7 7.32 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.609 177.282 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.567 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 20.3 Cg_endo -64.93 151.17 86.74 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 121.731 1.62 . . . . 0.0 112.967 -172.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.9 130.91 43.5 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.435 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.419 ' C ' ' HG ' ' A' ' 111' ' ' SER . 35.5 mt 35.14 -92.4 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 125.135 1.522 . . . . 0.0 112.722 -176.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.419 ' HG ' ' C ' ' A' ' 110' ' ' LEU . 82.6 p 52.31 32.96 11.79 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.754 0.822 . . . . 0.0 112.704 176.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.59 117.05 4.28 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.858 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 . . . . . 0 C--N 1.316 -0.849 0 CA-C-O 118.531 -0.747 . . . . 0.0 109.719 178.364 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.476 ' O ' ' HD2' ' A' ' 19' ' ' HIS . . . . . . . . 0 N--CA 1.482 1.701 0 N-CA-C 112.393 -0.283 . . . . 0.0 112.393 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t 71.4 21.6 4.52 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.433 0.693 . . . . 0.0 111.414 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.476 ' HD2' ' O ' ' A' ' 17' ' ' GLY . 7.7 p80 -163.63 112.52 1.24 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -104.79 6.36 33.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.721 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 p 47.89 -99.22 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 O-C-N 124.021 0.825 . . . . 0.0 111.972 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.837 HG21 ' H ' ' A' ' 23' ' ' LEU . 2.1 m 60.3 -166.8 0.19 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.705 0.288 . . . . 0.0 110.369 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.837 ' H ' HG21 ' A' ' 22' ' ' THR . 1.0 OUTLIER -147.91 88.23 1.66 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -83.89 63.03 7.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.341 0.591 . . . . 0.0 110.079 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.54 ' HB2' HD22 ' A' ' 23' ' ' LEU . 78.5 ttt180 -72.0 -64.04 1.02 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.062 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.507 HG21 ' HG2' ' A' ' 25' ' ' ARG . 61.9 t -116.92 -56.01 3.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.917 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.426 HG21 ' H ' ' A' ' 28' ' ' TYR . 2.6 p -144.79 -178.66 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.863 -177.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.426 ' H ' HG21 ' A' ' 27' ' ' VAL . 98.7 m-85 -49.07 158.27 0.36 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.323 0.582 . . . . 0.0 112.088 175.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.527 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 16.1 mmm180 -114.63 172.47 3.58 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -178.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 29' ' ' ARG . 87.7 Cg_exo -47.24 153.41 1.75 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.9 2.4 . . . . 0.0 112.579 172.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.96 -30.87 67.27 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.367 0.603 . . . . 0.0 111.05 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.817 HG23 ' H ' ' A' ' 34' ' ' GLN . 28.8 mm -91.82 146.76 5.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.213 172.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.493 ' OD1' ' HB2' ' A' ' 79' ' ' GLN . 6.2 p-10 -71.26 -1.39 12.54 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.764 175.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.817 ' H ' HG23 ' A' ' 32' ' ' ILE . 3.6 pt20 -154.03 -178.51 7.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.302 -175.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 175.82 45.11 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.806 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -108.88 -60.26 1.77 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.34 0.591 . . . . 0.0 110.983 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -102.77 -168.51 1.53 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.917 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.656 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 4.9 tp -70.56 150.56 45.97 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.044 0.449 . . . . 0.0 110.121 178.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 43.1 p -128.77 -174.29 3.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.589 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.25 -46.48 76.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.381 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.52 -27.43 69.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.155 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 14.4 m-20 -70.9 -37.0 72.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.441 173.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.877 HG21 HD23 ' A' ' 91' ' ' LEU . 67.3 t -59.63 -36.99 68.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.217 0.532 . . . . 0.0 110.784 176.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.0 t -64.77 -15.05 61.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.113 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 47.0 mtpt -81.82 -8.63 59.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.332 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.657 HG22 HD11 ' A' ' 59' ' ' LEU . 24.8 pt -112.67 178.38 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.713 0.768 . . . . 0.0 112.131 176.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.16 151.05 4.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.484 -177.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.465 HG21 HD12 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -72.76 144.41 12.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.101 -177.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.25 -29.05 6.32 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.197 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.543 ' HE1' HG23 ' A' ' 46' ' ' ILE . 19.2 ptt? -90.24 174.79 7.41 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.119 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.837 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 31.2 p -91.61 -176.66 4.56 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.049 -170.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -61.46 -47.05 87.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.704 170.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -37.7 75.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.271 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.837 ' HG3' ' H ' ' A' ' 51' ' ' THR . 5.3 mm-40 -67.45 -54.38 20.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.19 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.585 HG13 ' CD2' ' A' ' 93' ' ' LEU . 73.5 t -62.11 -44.49 99.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.822 -178.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.567 ' HB2' HG21 ' A' ' 61' ' ' THR . . . -58.31 -34.75 70.92 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.046 0.451 . . . . 0.0 110.104 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -82.15 -36.56 27.29 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.196 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.51 -43.34 77.01 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.772 0.796 . . . . 0.0 111.023 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.657 HD11 HG22 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -89.4 -54.74 3.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.183 -173.39 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 127.15 118.75 2.2 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.567 HG21 ' HB2' ' A' ' 56' ' ' ALA . 32.8 p -55.27 130.54 69.09 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.082 0.468 . . . . 0.0 111.128 -176.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.517 ' HG3' ' HH ' ' A' ' 75' ' ' TYR . 18.6 Cg_exo -64.95 172.41 7.26 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.871 3.048 . . . . 0.0 113.843 -169.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.9 mt -49.91 -43.24 49.49 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.877 0.735 . . . . 0.0 111.89 -173.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.504 ' HE1' ' CG2' ' A' ' 70' ' ' THR . 15.0 ptt? -63.16 -3.54 1.86 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.328 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 p 59.54 3.25 0.4 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.618 1.167 . . . . 0.0 113.495 174.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -136.45 90.15 17.86 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.226 0.536 . . . . 0.0 109.866 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.6 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 72.1 Cg_endo -74.74 -32.0 6.18 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.856 2.371 . . . . 0.0 112.128 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -77.97 7.26 6.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.2 -171.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.35 -19.76 17.57 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.085 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.504 ' CG2' ' HE1' ' A' ' 64' ' ' MET . 4.9 t -124.2 165.53 17.43 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -177.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -117.96 12.81 13.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.292 0.568 . . . . 0.0 110.31 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.9 m -136.69 106.89 6.37 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.933 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.686 ' O ' ' HA ' ' A' ' 92' ' ' THR . 47.7 m0 -103.79 147.21 27.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 -173.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -124.42 124.94 43.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.063 0.459 . . . . 0.0 110.764 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.576 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 80.6 m-85 -130.28 173.42 10.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.722 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.7 t -112.07 158.04 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.956 0.407 . . . . 0.0 110.021 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -96.25 165.36 12.25 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.69 176.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.4 ' O ' ' HB3' ' A' ' 79' ' ' GLN . 3.5 tmm_? -65.22 114.05 4.43 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.493 ' HB2' ' OD1' ' A' ' 33' ' ' ASN . 43.0 tt0 67.49 110.68 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 124.227 0.954 . . . . 0.0 112.193 -178.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.543 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 44.3 mt-30 -79.76 135.27 56.1 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 172.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.636 ' HG2' HG21 ' A' ' 87' ' ' THR . 3.5 Cg_exo -79.09 66.19 8.79 Favored 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 124.503 3.469 . . . . 0.0 112.429 -174.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.07 144.49 9.07 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.704 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -89.19 -22.67 22.68 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -126.98 131.0 51.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.641 175.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.33 54.97 4.48 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -171.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.7 t -71.34 138.05 22.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.339 0.59 . . . . 0.0 111.435 -173.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.636 HG21 ' HG2' ' A' ' 81' ' ' PRO . 8.8 t -139.09 20.54 2.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.372 177.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.537 ' HG3' HG21 ' A' ' 90' ' ' THR . 0.0 OUTLIER -54.27 116.99 2.91 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.617 179.64 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.68 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 3.1 pm0 -75.14 104.01 5.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.762 0.792 . . . . 0.0 109.94 175.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.537 HG21 ' HG3' ' A' ' 88' ' ' GLN . 1.2 p -88.87 151.58 22.26 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.664 -172.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.877 HD23 HG21 ' A' ' 43' ' ' VAL . 17.5 tp -90.52 111.71 23.1 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.719 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.686 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 81.0 m -107.14 108.55 20.06 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.899 ' HG ' HD22 ' A' ' 101' ' ' LEU . 7.5 tp -91.81 126.71 36.99 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.615 -173.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 20.0 m -104.33 122.13 44.8 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.996 -177.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -114.37 139.33 49.56 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.962 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.521 ' HB3' HG22 ' A' ' 102' ' ' THR . 33.4 p30 -76.08 -175.75 3.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.432 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.9 m -52.01 -36.24 49.38 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.516 ' HB3' HG23 ' A' ' 100' ' ' VAL . 10.4 t -89.19 -0.03 57.13 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.161 -0.337 . . . . 0.0 111.182 -171.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.79 29.33 39.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.451 -0.881 . . . . 0.0 111.179 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.516 HG23 ' HB3' ' A' ' 98' ' ' SER . 21.8 t -105.88 138.92 28.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.004 -0.598 . . . . 0.0 109.667 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.899 HD22 ' HG ' ' A' ' 93' ' ' LEU . 5.9 mt -60.9 125.5 23.94 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.175 0.512 . . . . 0.0 112.026 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.521 HG22 ' HB3' ' A' ' 96' ' ' ASN . 11.2 p -112.52 -43.35 3.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.93 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.407 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 1.9 m-20 -137.53 154.3 49.86 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.3 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.677 HG22 HD11 ' A' ' 91' ' ' LEU . 3.6 mm -115.41 92.47 2.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 169.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 92' ' ' THR . 15.4 m-20 -89.38 96.98 10.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.971 0.415 . . . . 0.0 111.441 -172.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -107.3 109.11 20.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.486 0.66 . . . . 0.0 110.516 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.609 ' H ' ' HE3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -143.86 169.31 10.58 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.259 -179.014 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.68 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 25.9 Cg_endo -66.44 154.21 75.14 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 121.844 1.696 . . . . 0.0 112.715 -173.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.21 149.66 21.68 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.211 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.6 mt 52.24 -88.44 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 O-C-N 124.625 1.203 . . . . 0.0 112.875 175.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.8 t -154.15 109.7 3.18 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.52 -122.42 0.48 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.665 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.2 t30 . . . . . 0 C--N 1.313 -1.003 0 CA-C-O 118.723 -0.656 . . . . 0.0 109.681 176.585 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.826 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.6 p -109.09 -32.0 7.39 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -175.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -117.79 47.61 1.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.303 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.8 ttt 62.39 80.75 0.22 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.346 0.593 . . . . 0.0 110.3 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.1 t -84.05 140.43 31.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.697 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.8 p -80.21 59.6 3.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.199 0.523 . . . . 0.0 111.566 -178.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.9 mt -125.94 78.3 1.74 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.799 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -104.98 -46.07 4.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.698 -176.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.471 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.8 mmp_? -84.41 57.59 4.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.87 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.98 148.76 18.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.25 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.95 172.94 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.198 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -74.48 118.43 17.43 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.228 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -110.28 105.04 56.83 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -48.02 128.29 16.33 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.062 2.508 . . . . 0.0 112.416 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -161.78 105.31 1.22 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -175.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.495 HG23 ' H ' ' A' ' 34' ' ' GLN . 37.4 mm -56.89 138.42 17.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.942 -175.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -30.41 49.95 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.57 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.495 ' H ' HG23 ' A' ' 32' ' ' ILE . 6.1 pt20 -102.32 -171.89 2.04 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.118 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.88 -1.93 0.72 Allowed Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.122 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -72.45 -39.83 67.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.205 0.526 . . . . 0.0 109.95 176.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -109.27 -167.59 1.23 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.423 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.785 HD12 ' HG ' ' A' ' 59' ' ' LEU . 2.5 mm? -77.76 153.22 33.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.583 0.706 . . . . 0.0 111.792 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.6 p -128.64 -174.94 3.38 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.66 174.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.35 -35.0 71.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.804 0.812 . . . . 0.0 109.813 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -61.54 -43.88 98.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.388 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.483 ' HB2' HD11 ' A' ' 38' ' ' LEU . 35.0 m-20 -72.02 -30.77 65.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.073 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.922 HG21 HD23 ' A' ' 91' ' ' LEU . 54.6 t -57.87 -36.68 56.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.134 0.492 . . . . 0.0 110.289 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.2 t -61.85 -18.3 59.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.578 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 46.1 mtpt -74.33 -36.15 63.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.768 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.717 HG22 HD11 ' A' ' 59' ' ' LEU . 39.3 pt -87.64 178.61 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.848 0.832 . . . . 0.0 112.268 -177.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.401 ' HD2' ' HE3' ' A' ' 50' ' ' MET . 0.0 OUTLIER -172.68 150.9 2.23 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.467 -175.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.436 HG21 HD12 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -70.74 144.09 13.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.206 -177.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.41 -32.74 4.58 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.776 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.582 ' HE1' HG23 ' A' ' 46' ' ' ILE . 13.1 ptt? -87.35 177.64 7.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.017 0.437 . . . . 0.0 111.053 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.782 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 22.2 p -92.57 -174.76 3.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.904 -171.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.481 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 26.3 mt-30 -64.64 -43.88 92.28 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.921 173.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.532 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -66.46 -35.1 79.45 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.216 0.531 . . . . 0.0 109.996 -175.417 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.782 ' HG3' ' H ' ' A' ' 51' ' ' THR . 11.4 mm-40 -59.86 -51.12 71.06 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.729 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.606 HG13 ' CD2' ' A' ' 93' ' ' LEU . 70.5 t -68.75 -42.78 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.663 -176.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.432 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -63.98 -25.67 68.23 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.388 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -81.7 -40.93 22.06 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.555 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.41 -45.16 69.89 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.591 0.71 . . . . 0.0 111.332 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.785 ' HG ' HD12 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -90.58 -44.09 9.78 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.232 -174.365 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.57 132.24 4.01 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -171.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.486 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 16.7 p -59.96 134.32 90.01 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.028 0.442 . . . . 0.0 110.684 -177.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.496 ' HG3' ' OH ' ' A' ' 75' ' ' TYR . 20.4 Cg_exo -64.16 171.97 6.94 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.902 3.068 . . . . 0.0 114.358 -169.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 7.2 mt -50.03 -47.45 53.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.244 -175.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.777 ' HE1' HG22 ' A' ' 70' ' ' THR . 0.0 OUTLIER -54.98 -12.92 0.93 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.957 179.018 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.4 t 70.75 1.58 3.78 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.292 0.568 . . . . 0.0 111.332 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -144.38 102.23 4.71 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-O 121.592 0.71 . . . . 0.0 109.435 174.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.499 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 43.5 Cg_endo -68.45 -25.8 35.16 Favored 'Trans proline' 0 C--N 1.327 -0.565 0 C-N-CA 123.198 2.599 . . . . 0.0 112.608 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -86.63 12.36 10.78 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.547 -173.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -102.39 -20.25 12.54 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.241 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.777 HG22 ' HE1' ' A' ' 64' ' ' MET . 6.6 t -126.25 172.61 9.94 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -122.03 10.14 10.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.187 0.518 . . . . 0.0 109.867 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.2 m -139.4 112.52 8.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.171 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.534 ' O ' ' HA ' ' A' ' 92' ' ' THR . 44.7 m0 -104.34 144.83 31.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.736 -176.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -121.87 112.88 18.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 110.644 -176.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.584 ' CE2' HD23 ' A' ' 59' ' ' LEU . 33.2 m-85 -125.4 174.69 8.0 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.477 HG21 ' H ' ' A' ' 77' ' ' PHE . 5.8 p -137.15 168.56 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.858 -174.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.477 ' H ' HG21 ' A' ' 76' ' ' VAL . 2.0 m-30 -95.04 166.19 12.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.049 -176.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.43 ' HG3' HD13 ' A' ' 32' ' ' ILE . 13.2 ttt180 -56.95 133.64 54.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.126 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 44.83 67.68 0.67 Allowed 'General case' 0 C--O 1.234 0.282 0 O-C-N 124.194 0.933 . . . . 0.0 111.461 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.594 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -78.93 141.13 58.57 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.194 -179.187 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 12.0 Cg_exo -73.32 93.85 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.838 2.359 . . . . 0.0 111.301 174.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.26 -12.15 14.23 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.875 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -57.29 -52.81 63.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.823 0.344 . . . . 0.0 110.805 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -155.2 143.32 20.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.236 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.14 60.85 7.0 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.683 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 111' ' ' SER . 43.2 t -53.66 128.15 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.565 0.698 . . . . 0.0 111.086 -177.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.416 ' CG2' ' HG2' ' A' ' 81' ' ' PRO . 11.6 t -140.04 16.05 2.45 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.311 -177.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.594 ' HG2' ' HB2' ' A' ' 80' ' ' GLN . 77.7 mt-30 -35.71 111.95 0.15 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.548 -1.205 . . . . 0.0 113.557 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.68 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 95.5 mt-30 -73.85 104.12 4.62 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 172.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.6 p -97.58 143.9 27.8 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.972 -170.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.922 HD23 HG21 ' A' ' 43' ' ' VAL . 16.8 tp -97.81 104.0 15.99 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.716 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.655 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 24.9 m -99.51 105.18 17.06 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.826 ' HG ' HD22 ' A' ' 101' ' ' LEU . 7.7 tp -88.03 123.61 32.9 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.582 -174.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.458 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 21.6 m -105.48 123.67 48.27 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.971 -176.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -111.29 151.28 28.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.894 0.854 . . . . 0.0 112.966 -175.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -75.17 -176.01 2.87 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.292 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.7 p -67.02 -41.04 87.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.848 0.356 . . . . 0.0 111.097 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.504 ' HB3' HG23 ' A' ' 100' ' ' VAL . 38.2 t -74.95 -13.82 60.57 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.112 0.482 . . . . 0.0 110.592 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' A' ' 52' ' ' GLN . . . 95.04 31.01 7.9 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -176.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.504 HG23 ' HB3' ' A' ' 98' ' ' SER . 21.9 t -101.42 140.25 20.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.826 HD22 ' HG ' ' A' ' 93' ' ' LEU . 5.5 mt -60.17 126.18 26.53 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.133 0.492 . . . . 0.0 111.356 177.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 70.9 p -113.39 -45.06 3.16 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.854 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.458 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 3.4 m-20 -136.85 153.66 50.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.501 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.592 HG22 HD11 ' A' ' 91' ' ' LEU . 3.6 mm -120.13 93.52 2.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 172.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.655 ' HB2' ' HB ' ' A' ' 92' ' ' THR . 6.9 m-20 -78.23 96.41 5.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.962 0.41 . . . . 0.0 110.716 -176.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -111.2 104.33 12.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.579 0.704 . . . . 0.0 110.081 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.429 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -150.82 166.54 14.87 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.712 -176.069 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.68 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 36.9 Cg_endo -83.47 155.23 14.1 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.639 2.226 . . . . 0.0 111.929 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.63 170.3 16.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.005 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 47.7 mt -49.17 -37.67 23.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.463 -167.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 55.2 m 69.48 37.68 1.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.652 175.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.08 113.42 3.68 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.297 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 . . . . . 0 C--N 1.314 -0.967 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.944 179.528 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 112.126 -0.39 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.2 m -66.28 144.99 56.25 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.847 0.356 . . . . 0.0 110.589 177.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -84.46 55.38 3.36 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.099 0.476 . . . . 0.0 111.581 -173.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 47.9 ttm -176.78 42.67 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.3 t -79.59 77.19 6.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.833 -176.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 t -79.81 108.6 13.5 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.582 0.706 . . . . 0.0 109.318 175.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 99.1 mt -105.64 142.11 35.95 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.658 -174.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -79.77 49.35 1.04 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.243 178.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 69.55 147.93 0.07 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.248 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.4 m -80.33 122.35 35.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.397 0.618 . . . . 0.0 111.861 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 28' ' ' TYR . 3.0 p -81.62 -171.92 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.436 ' H ' HG22 ' A' ' 27' ' ' VAL . 94.5 m-85 -48.06 126.05 10.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.171 0.51 . . . . 0.0 111.479 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -82.94 155.91 67.52 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.25 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -52.18 152.91 13.82 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.479 2.786 . . . . 0.0 111.807 171.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.8 t70 67.62 103.54 0.05 OUTLIER 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.765 0.793 . . . . 0.0 109.215 -172.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.945 HG23 ' H ' ' A' ' 34' ' ' GLN . 45.2 mm -54.49 139.87 12.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.179 -1.373 . . . . 0.0 113.028 -168.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -68.07 -12.51 60.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.775 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.945 ' H ' HG23 ' A' ' 32' ' ' ILE . 23.4 pt20 -134.24 178.3 7.08 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.583 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.44 28.9 0.12 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.853 177.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -77.93 -26.47 48.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.062 0.458 . . . . 0.0 110.625 -175.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.34 -165.72 2.29 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.851 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.685 HD12 HD12 ' A' ' 59' ' ' LEU . 6.4 tp -70.41 154.97 41.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.172 0.511 . . . . 0.0 111.259 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.8 p -128.62 -178.07 4.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.292 177.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.511 ' HB2' ' H ' ' A' ' 78' ' ' ARG . . . -66.49 -36.61 83.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.935 0.874 . . . . 0.0 110.209 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.662 ' OD1' HD11 ' A' ' 32' ' ' ILE . 9.2 m120 -61.94 -41.4 97.92 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.382 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 16.7 m-20 -69.89 -27.01 64.45 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.238 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.894 HG21 HD23 ' A' ' 91' ' ' LEU . 63.0 t -62.75 -37.03 78.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.322 0.582 . . . . 0.0 110.391 174.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -65.63 -16.55 63.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.807 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 45.5 mtpt -73.76 -29.51 62.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.656 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.642 HG22 HD11 ' A' ' 59' ' ' LEU . 40.3 pt -92.7 -178.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.795 0.807 . . . . 0.0 111.798 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.41 149.74 5.93 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.424 -177.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.472 HG21 HD12 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -71.48 148.0 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.505 -178.886 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.86 -30.22 7.58 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.215 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.507 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 19.9 ptt? -84.97 173.03 10.86 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.938 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.809 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 19.1 p -89.72 -174.32 4.26 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.438 -170.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 95' ' ' PHE . 37.1 mt-30 -64.89 -43.15 93.83 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.855 174.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.647 ' HG2' ' HG1' ' A' ' 51' ' ' THR . 11.3 pt20 -65.8 -35.75 81.57 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.448 0.642 . . . . 0.0 109.913 -175.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.809 ' HG3' ' H ' ' A' ' 51' ' ' THR . 9.8 mm-40 -58.91 -55.22 37.92 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.297 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.65 HG13 HD21 ' A' ' 93' ' ' LEU . 92.8 t -66.73 -41.05 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.492 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.684 ' HB2' HG21 ' A' ' 61' ' ' THR . . . -58.56 -34.45 71.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.184 0.516 . . . . 0.0 110.103 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -82.47 -38.81 23.39 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.755 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.58 -46.66 65.82 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.546 0.688 . . . . 0.0 111.343 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.685 HD12 HD12 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -92.1 -29.67 16.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.751 -173.08 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.55 127.85 6.02 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.684 HG21 ' HB2' ' A' ' 56' ' ' ALA . 34.9 p -59.9 134.09 89.79 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-O 121.237 0.541 . . . . 0.0 110.794 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 21.2 Cg_exo -65.85 162.12 36.33 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.189 2.592 . . . . 0.0 111.699 -174.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 mt -49.14 -33.53 12.25 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.57 -168.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.744 ' HE1' HG22 ' A' ' 70' ' ' THR . 9.7 ptt? -62.55 -6.39 3.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.8 p 58.92 8.71 1.02 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.392 1.077 . . . . 0.0 112.503 177.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.421 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 1.9 t70 -141.21 94.77 7.62 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 122.021 0.915 . . . . 0.0 109.749 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.599 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 74.3 Cg_endo -75.26 -34.56 3.52 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.294 2.663 . . . . 0.0 113.356 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -79.55 2.94 20.34 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -174.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.08 -23.95 42.89 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.539 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.744 HG22 ' HE1' ' A' ' 64' ' ' MET . 11.8 t -124.23 174.89 7.39 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -177.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -123.57 4.25 8.96 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.8 m -125.61 109.64 12.88 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.19 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.599 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 45.2 m0 -108.18 140.25 41.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.55 -176.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -117.17 112.45 20.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.34 0.591 . . . . 0.0 111.24 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.626 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 88.1 m-85 -113.31 174.92 5.67 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.982 174.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.501 HG21 ' CD ' ' A' ' 88' ' ' GLN . 2.5 p -122.28 150.51 25.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.206 0.526 . . . . 0.0 110.038 -174.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.53 -176.86 6.01 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.427 -175.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.693 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 62.9 ttt180 -50.03 147.72 3.8 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.146 174.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -46.61 95.31 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -175.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.693 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 7.7 mm100 -106.35 162.77 18.64 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.508 172.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.13 101.16 0.18 Allowed 'Trans proline' 0 C--N 1.33 -0.417 0 C-N-CA 123.437 2.758 . . . . 0.0 111.941 173.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.07 30.19 4.88 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.823 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -96.19 -49.58 5.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.358 0.599 . . . . 0.0 109.669 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -146.89 136.59 23.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.489 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.5 62.61 6.07 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -173.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 88' ' ' GLN . 20.9 t -55.8 133.9 19.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.686 0.755 . . . . 0.0 112.352 -171.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.4 t -127.63 11.2 6.72 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.178 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.501 ' CD ' HG21 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -68.4 132.94 47.91 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.563 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.634 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 27.2 mt-30 -102.8 107.57 18.48 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 173.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.4 p -86.45 150.98 23.9 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.898 -172.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.894 HD23 HG21 ' A' ' 43' ' ' VAL . 22.1 tp -89.54 107.51 19.12 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.527 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 23.8 m -99.03 101.53 12.94 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.88 ' HG ' HD22 ' A' ' 101' ' ' LEU . 8.0 tp -87.12 122.96 31.65 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.985 -174.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 27.6 m -104.14 118.13 35.91 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.077 -176.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 52' ' ' GLN . 31.4 m-85 -105.63 149.29 26.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.737 0.78 . . . . 0.0 111.862 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -73.92 173.13 10.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.557 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.5 m -57.64 -36.87 72.43 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.794 0.331 . . . . 0.0 110.664 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.513 ' HB3' HG23 ' A' ' 100' ' ' VAL . 18.7 t -80.98 -4.1 53.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.927 0.394 . . . . 0.0 110.885 -177.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.36 30.01 26.02 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.402 -179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 98' ' ' SER . 21.4 t -105.99 138.88 29.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.88 HD22 ' HG ' ' A' ' 93' ' ' LEU . 5.9 mt -61.76 124.09 19.78 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.075 0.464 . . . . 0.0 111.747 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.0 p -114.02 -39.72 3.88 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.11 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.47 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 5.1 m-20 -136.76 154.6 50.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.554 0.692 . . . . 0.0 111.54 177.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.707 HG22 HD11 ' A' ' 91' ' ' LEU . 3.0 mm -118.73 92.38 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 168.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 92' ' ' THR . 13.3 m-20 -86.84 95.86 10.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.838 0.351 . . . . 0.0 110.947 -174.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -99.18 101.06 12.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.146 0.974 . . . . 0.0 109.634 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.467 ' HE3' ' HB3' ' A' ' 105' ' ' ASP . 71.2 mttt -137.06 154.7 76.14 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.289 -172.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 1.0 OUTLIER -60.41 132.67 44.8 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.681 2.254 . . . . 0.0 111.892 -174.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.97 134.83 51.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.438 -172.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.9 mt 28.09 -90.15 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 O-C-N 125.553 1.783 . . . . 0.0 114.23 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.9 m -82.68 40.59 0.68 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 122.951 0.501 . . . . 0.0 112.192 -174.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -98.82 -157.6 29.41 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.716 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.5 t30 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.778 -0.629 . . . . 0.0 110.064 179.167 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.645 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.7 t 64.86 23.22 12.62 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.911 0.484 . . . . 0.0 111.46 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.53 80.28 1.29 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.102 0.477 . . . . 0.0 109.859 177.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -151.39 175.65 12.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.926 -177.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 75.6 m 59.59 45.96 12.58 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.612 0.57 . . . . 0.0 110.953 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.91 -40.8 53.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.647 178.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.6 tp 57.82 97.35 0.02 OUTLIER 'General case' 0 C--O 1.237 0.418 0 O-C-N 123.813 0.695 . . . . 0.0 112.582 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -76.0 -176.69 3.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.965 174.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -66.95 -82.51 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t 66.26 -67.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.524 HG21 ' H ' ' A' ' 28' ' ' TYR . 3.1 p -135.86 -160.09 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -171.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.524 ' H ' HG21 ' A' ' 27' ' ' VAL . 95.4 m-85 -46.88 111.02 0.34 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.981 0.419 . . . . 0.0 111.06 176.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -91.61 113.65 59.34 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.665 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.28 129.02 29.62 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.616 2.211 . . . . 0.0 111.075 172.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -69.15 -30.6 68.87 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.779 0.799 . . . . 0.0 110.247 -176.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.792 HG23 ' H ' ' A' ' 34' ' ' GLN . 41.0 mm -83.81 142.21 13.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.941 176.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -77.76 0.79 22.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.786 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.792 ' H ' HG23 ' A' ' 32' ' ' ILE . 9.8 pt20 -145.81 29.7 1.1 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.872 0.844 . . . . 0.0 110.325 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.57 58.4 4.71 Favored Glycine 0 C--N 1.318 -0.432 0 CA-C-N 114.266 -1.333 . . . . 0.0 112.317 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -128.1 -42.91 1.51 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -100.65 -164.94 1.16 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.633 -0.876 . . . . 0.0 108.633 172.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.718 HD12 ' HG ' ' A' ' 59' ' ' LEU . 3.0 tp -81.36 143.31 32.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.418 0.628 . . . . 0.0 111.568 -175.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.723 ' HB ' ' HB3' ' A' ' 78' ' ' ARG . 43.8 p -128.17 -175.24 3.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.93 177.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.55 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -65.65 -33.29 75.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.058 0.456 . . . . 0.0 110.811 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -59.47 -43.46 93.25 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.739 0.78 . . . . 0.0 109.717 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.405 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 6.9 m-20 -70.17 -34.29 72.82 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.633 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.931 HG21 HD23 ' A' ' 91' ' ' LEU . 55.9 t -55.59 -36.51 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.046 0.45 . . . . 0.0 111.154 177.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 t -64.27 -11.43 31.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.64 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 47.8 mtpt -80.53 -26.34 38.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.733 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.729 HG22 HD11 ' A' ' 59' ' ' LEU . 38.4 pt -95.49 -178.5 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.797 0.808 . . . . 0.0 112.305 -178.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.25 152.7 3.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.585 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.73 144.07 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.265 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.19 -32.47 4.72 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.954 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.559 ' HE1' HG23 ' A' ' 46' ' ' ILE . 18.4 ptt? -90.07 177.14 6.53 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.488 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.878 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 62.4 p -94.0 -174.97 3.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.467 -170.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.474 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 97.9 mt-30 -64.79 -42.26 95.18 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.581 172.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.415 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 9.2 pt20 -67.01 -37.97 85.15 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.705 -177.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.878 ' HG3' ' H ' ' A' ' 51' ' ' THR . 5.7 mm-40 -58.98 -53.2 61.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.966 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.619 HG13 ' CD2' ' A' ' 93' ' ' LEU . 74.7 t -66.5 -46.39 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.997 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.446 ' HB3' HG22 ' A' ' 61' ' ' THR . . . -64.33 -26.61 68.55 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.636 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -81.48 -37.28 28.18 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.614 177.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.98 -48.87 41.87 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.922 0.868 . . . . 0.0 110.78 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.729 HD11 HG22 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -84.21 -55.37 4.22 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.16 -173.351 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.72 133.35 3.23 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 -172.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.498 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 39.4 p -68.32 130.91 92.04 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-O 121.238 0.542 . . . . 0.0 110.386 -177.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.577 ' HG2' ' HE2' ' A' ' 64' ' ' MET . 6.9 Cg_exo -69.75 160.89 48.01 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.177 2.584 . . . . 0.0 113.062 -170.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.78 -28.33 69.38 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.506 -171.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.577 ' HE2' ' HG2' ' A' ' 62' ' ' PRO . 10.7 ptt? -61.79 -4.28 1.44 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.111 177.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.4 t 73.54 -4.0 2.34 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 170.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -146.86 99.71 4.01 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-O 120.907 0.384 . . . . 0.0 110.954 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.429 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 39.6 Cg_endo -70.13 -30.95 19.76 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.074 1.85 . . . . 0.0 111.527 175.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -85.72 12.02 9.8 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.535 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.82 -20.27 13.33 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.884 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.441 HG21 ' HE1' ' A' ' 64' ' ' MET . 5.7 t -125.84 174.0 8.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.646 0.26 . . . . 0.0 110.375 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -117.95 -1.09 11.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.266 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.8 m -125.26 111.42 15.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.542 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.474 ' HH2' ' O ' ' A' ' 52' ' ' GLN . 42.7 m0 -104.12 141.3 36.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.366 -177.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -118.68 118.97 33.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.113 0.482 . . . . 0.0 110.844 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.569 ' HB3' HD21 ' A' ' 38' ' ' LEU . 63.9 m-85 -127.87 174.41 9.18 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 176.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.497 HG23 ' H ' ' A' ' 77' ' ' PHE . 2.7 p -129.15 167.54 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.127 -173.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.55 ' CG ' ' HB2' ' A' ' 40' ' ' ALA . 7.2 m-30 -107.13 141.11 38.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.265 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.723 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -72.28 130.3 40.46 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.792 -175.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.554 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 7.4 tp-100 172.43 -105.19 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.486 -177.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.472 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 22.1 pt20 -83.56 140.1 41.27 Favored Pre-proline 0 C--N 1.303 -1.456 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.915 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 4.3 Cg_exo -75.77 99.79 1.31 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.074 2.516 . . . . 0.0 110.425 173.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.39 45.89 3.57 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.921 -170.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -89.3 77.55 7.41 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 172.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.697 ' HG2' ' H ' ' A' ' 85' ' ' GLY . 22.3 tt0 -178.31 -151.36 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -169.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.697 ' H ' ' HG2' ' A' ' 84' ' ' GLU . . . -72.38 80.07 0.64 Allowed Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 167.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.6 t -36.3 123.71 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 O-C-N 124.729 0.899 . . . . 0.0 112.904 -170.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 111' ' ' SER . 8.9 t -139.59 12.81 2.53 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.509 -175.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.446 HE21 ' HB3' ' A' ' 88' ' ' GLN . 0.6 OUTLIER -66.83 -157.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.726 1.25 . . . . 0.0 111.782 178.153 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 90.7 mt-30 -118.34 143.95 46.23 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.553 -1.658 . . . . 0.0 107.506 167.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.3 p -131.73 143.99 50.65 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -170.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.931 HD23 HG21 ' A' ' 43' ' ' VAL . 16.3 tp -95.71 123.52 39.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.192 174.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.665 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 34.4 m -114.53 101.26 8.95 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.843 ' HG ' HD22 ' A' ' 101' ' ' LEU . 7.2 tp -88.3 126.34 35.13 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.996 -173.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.8 m -112.4 123.22 49.81 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.889 -175.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.416 ' CE1' ' HG ' ' A' ' 101' ' ' LEU . 80.2 m-85 -113.27 141.25 47.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.884 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.515 ' HB3' HG22 ' A' ' 102' ' ' THR . 32.1 p30 -75.41 -173.63 2.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.903 175.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.4 m -56.29 -35.1 67.11 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -174.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.487 ' HB3' HG23 ' A' ' 100' ' ' VAL . 20.8 t -88.83 9.74 23.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.814 0.34 . . . . 0.0 111.059 -175.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.75 33.85 76.62 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.091 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 98' ' ' SER . 7.6 t -106.12 140.06 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.843 HD22 ' HG ' ' A' ' 93' ' ' LEU . 6.3 mt -62.17 124.42 20.8 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.43 0.633 . . . . 0.0 112.246 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.515 HG22 ' HB3' ' A' ' 96' ' ' ASN . 18.0 p -111.03 -43.94 3.68 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.612 -1.177 . . . . 0.0 109.965 175.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -136.67 152.75 50.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.745 0.783 . . . . 0.0 111.692 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.672 HG22 HD11 ' A' ' 91' ' ' LEU . 3.6 mm -117.86 93.61 2.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 170.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.665 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 23.4 t70 -87.03 96.47 10.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.948 0.404 . . . . 0.0 110.624 -173.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -105.62 104.31 14.0 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.85 0.834 . . . . 0.0 109.898 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.602 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 22.5 pttm -140.75 177.95 1.76 Allowed Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.773 -176.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.602 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 56.2 Cg_endo -72.51 173.42 13.27 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 121.231 1.287 . . . . 0.0 112.258 -177.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.88 -176.93 3.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.549 0.69 . . . . 0.0 112.237 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.4 mt -58.01 -52.58 64.92 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.139 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 87' ' ' THR . 41.9 t -123.33 164.21 19.26 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.085 -172.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.86 96.65 0.94 Allowed Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.53 173.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.6 m120 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.812 176.046 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.8 m -69.24 -35.71 76.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.979 0.39 . . . . 0.0 110.509 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -157.84 21.12 0.27 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.499 172.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.403 ' HB3' ' H ' ' A' ' 21' ' ' SER . 0.0 OUTLIER 179.42 -81.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 175.323 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.403 ' H ' ' HB3' ' A' ' 20' ' ' MET . 11.7 p -121.73 -67.31 0.97 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.819 HG23 ' HG2' ' A' ' 24' ' ' GLU . 2.1 m 61.99 91.54 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.466 172.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.8 mp -83.34 65.16 8.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.014 -175.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.819 ' HG2' HG23 ' A' ' 22' ' ' THR . 19.8 mm-40 -86.69 71.82 10.3 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.102 0.477 . . . . 0.0 110.956 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -97.52 93.27 6.35 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.046 0.451 . . . . 0.0 109.939 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.32 -178.48 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.717 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.411 HG21 ' H ' ' A' ' 28' ' ' TYR . 2.3 p -131.96 178.31 5.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.02 -177.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.411 ' H ' HG21 ' A' ' 27' ' ' VAL . 83.2 m-85 -49.08 130.65 18.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.1 0.476 . . . . 0.0 112.176 176.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -130.84 121.72 19.12 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.62 170.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.38 122.45 11.25 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.699 2.266 . . . . 0.0 112.28 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.4 t70 179.29 97.5 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.27 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.764 HG23 ' H ' ' A' ' 34' ' ' GLN . 31.3 mm -73.56 140.07 18.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.212 0.53 . . . . 0.0 111.055 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -99.29 -8.54 24.8 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.798 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.764 ' H ' HG23 ' A' ' 32' ' ' ILE . 9.2 pt20 -127.22 48.97 2.14 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.626 -165.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.19 52.09 3.99 Favored Glycine 0 C--N 1.313 -0.749 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.316 172.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -121.03 -48.03 2.25 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -107.18 -162.43 0.84 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.743 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.612 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 4.5 tp -82.76 151.54 26.11 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.114 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.7 p -127.7 -175.78 3.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.631 174.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.45 ' HB2' ' H ' ' A' ' 78' ' ' ARG . . . -70.19 -31.53 69.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.053 0.454 . . . . 0.0 110.904 178.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -60.05 -41.19 91.79 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.563 0.696 . . . . 0.0 109.776 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 11.4 m-20 -67.9 -37.11 81.32 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.887 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.85 HG21 HD23 ' A' ' 91' ' ' LEU . 81.2 t -60.04 -40.66 83.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.77 0.319 . . . . 0.0 111.094 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.1 p -64.5 -18.93 65.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.025 0.441 . . . . 0.0 111.028 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.43 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 30.1 mtpp -77.54 -28.42 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.987 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.5 HG22 HD11 ' A' ' 59' ' ' LEU . 43.5 pt -89.56 174.08 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 121.758 0.79 . . . . 0.0 111.822 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.421 ' O ' ' HG2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -163.4 143.33 8.71 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.719 -176.252 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.402 HG21 ' CG1' ' A' ' 104' ' ' ILE . 0.9 OUTLIER -69.61 142.27 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.484 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.19 -30.69 5.55 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.86 -175.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.498 ' HE1' HG23 ' A' ' 46' ' ' ILE . 21.2 ptt? -87.11 175.12 8.24 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.813 176.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.801 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 23.6 p -92.99 -170.0 2.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.846 -171.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.4 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 94.9 mt-30 -67.51 -46.33 73.19 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.611 173.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.663 ' HG2' ' HG1' ' A' ' 51' ' ' THR . 11.9 pt20 -61.98 -38.8 89.96 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.832 -176.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.801 ' HG3' ' H ' ' A' ' 51' ' ' THR . 7.1 mm-40 -59.52 -46.37 89.04 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.303 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.661 HG13 ' CD2' ' A' ' 93' ' ' LEU . 58.4 t -73.24 -43.46 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.834 -176.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.532 ' HB3' HG21 ' A' ' 61' ' ' THR . . . -63.11 -24.01 67.7 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.261 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -80.04 -39.47 29.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.773 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.66 -44.06 44.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.008 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.612 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -93.07 -10.03 37.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.917 -172.531 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.66 129.14 1.57 Allowed Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.532 HG21 ' HB3' ' A' ' 56' ' ' ALA . 41.3 p -56.11 131.52 74.56 Favored Pre-proline 0 N--CA 1.439 -0.986 0 CA-C-O 122.028 0.918 . . . . 0.0 111.835 -176.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 67' ' ' PRO . 74.8 Cg_exo -50.6 165.94 0.37 Allowed 'Trans proline' 0 C--N 1.332 -0.333 1 C-N-CA 125.742 4.295 . . . . 0.0 115.431 -176.381 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.1 mt -51.7 -49.28 62.77 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.655 -177.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.742 ' HE1' HG22 ' A' ' 70' ' ' THR . 0.0 OUTLIER -54.1 -13.55 0.85 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.986 179.543 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.0 t 76.11 -17.79 0.51 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.359 0.664 . . . . 0.0 112.066 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 64' ' ' MET . 5.8 p-10 -122.21 92.96 48.81 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-O 121.971 0.891 . . . . 0.0 109.819 174.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.545 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 29.0 Cg_endo -64.49 -30.59 61.76 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.619 2.212 . . . . 0.0 112.493 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -81.35 13.84 2.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.718 -173.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -102.93 -25.15 7.68 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.091 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.742 HG22 ' HE1' ' A' ' 64' ' ' MET . 6.6 t -124.13 169.23 11.91 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -120.52 1.64 10.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.651 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.8 m -118.15 109.08 15.96 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.959 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.42 ' O ' ' HA ' ' A' ' 92' ' ' THR . 46.9 m0 -106.84 134.34 50.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.687 -176.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -113.36 125.92 54.79 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.161 0.288 . . . . 0.0 110.661 -177.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.537 ' CE2' HD23 ' A' ' 59' ' ' LEU . 60.8 m-85 -135.14 174.93 10.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.424 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.43 HG12 ' OE1' ' A' ' 88' ' ' GLN . 0.1 OUTLIER -118.38 162.99 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 120.849 0.357 . . . . 0.0 110.264 -177.106 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -98.71 -176.43 3.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.464 -176.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.45 ' H ' ' HB2' ' A' ' 40' ' ' ALA . 8.2 ttm180 -65.0 119.39 10.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.727 178.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.691 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . 9.0 tt0 63.36 119.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 O-C-N 124.341 1.026 . . . . 0.0 113.253 177.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 1.071 ' HA ' ' HG2' ' A' ' 88' ' ' GLN . 30.4 mt-30 -75.38 169.61 19.62 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.243 174.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.79 ' HD2' ' HB3' ' A' ' 80' ' ' GLN . 11.0 Cg_exo -34.24 115.92 0.1 OUTLIER 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 123.818 3.012 . . . . 0.0 113.021 -174.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.39 -77.8 0.44 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 114.469 -1.242 . . . . 0.0 113.204 -171.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -135.45 -66.32 0.57 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -117.48 131.02 56.8 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 171.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.84 125.51 1.39 Allowed Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.7 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 88' ' ' GLN . 58.6 t -73.04 126.26 33.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.297 0.57 . . . . 0.0 110.415 177.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.8 t -103.73 0.97 31.21 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.924 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 1.071 ' HG2' ' HA ' ' A' ' 80' ' ' GLN . 13.9 mm-40 -73.46 152.87 40.59 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.916 0.865 . . . . 0.0 112.435 177.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -145.2 125.7 14.06 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.712 -1.585 . . . . 0.0 108.636 175.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.93 128.58 36.25 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.234 0.54 . . . . 0.0 110.911 -175.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.85 HD23 HG21 ' A' ' 43' ' ' VAL . 21.3 tp -90.16 115.48 27.43 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.056 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.686 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 11.8 m -109.2 95.62 5.75 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.775 ' HG ' HD22 ' A' ' 101' ' ' LEU . 8.3 tp -81.39 125.1 29.99 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.38 -171.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 37.2 m -107.45 121.64 45.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.178 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.435 ' CE1' ' HG ' ' A' ' 101' ' ' LEU . 77.3 m-85 -115.28 139.71 49.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.537 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.537 ' HB3' HG22 ' A' ' 102' ' ' THR . 32.0 p30 -74.52 -176.38 2.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.614 175.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.2 t -55.13 -37.21 66.64 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -176.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.521 ' HB3' HG23 ' A' ' 100' ' ' VAL . 19.0 t -82.17 2.29 32.31 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.784 0.326 . . . . 0.0 111.059 -174.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.99 31.16 56.21 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.922 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.521 HG23 ' HB3' ' A' ' 98' ' ' SER . 6.7 t -107.57 139.78 28.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.775 HD22 ' HG ' ' A' ' 93' ' ' LEU . 7.3 mt -60.87 124.8 21.51 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.237 0.541 . . . . 0.0 112.0 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 96' ' ' ASN . 10.1 p -113.01 -35.92 5.27 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.049 176.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -148.76 148.46 30.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.441 0.639 . . . . 0.0 111.932 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.775 HG22 HD11 ' A' ' 91' ' ' LEU . 5.6 mm -106.01 93.21 2.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 170.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.686 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 17.6 t70 -81.58 97.3 7.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.141 0.496 . . . . 0.0 110.643 -171.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -105.38 110.78 23.26 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.363 0.601 . . . . 0.0 109.814 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.515 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 13.3 ptmm? -136.3 174.91 3.96 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.823 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 30.1 Cg_endo -79.62 155.8 24.39 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.898 1.732 . . . . 0.0 111.265 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.92 172.36 12.85 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.627 0.727 . . . . 0.0 112.418 -175.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mt -85.57 -55.28 4.07 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.401 -175.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 21.9 t -138.98 -162.68 1.35 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.397 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 133.2 -22.53 3.97 Favored Glycine 0 CA--C 1.498 -1.03 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 . . . . . 0 C--N 1.305 -1.353 0 CA-C-N 113.775 -1.213 . . . . 0.0 109.664 176.941 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.649 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 5.5 tp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.881 0.372 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.512 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 28.2 p -127.7 -174.38 3.17 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.486 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.69 -34.87 78.8 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.939 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -56.2 -46.43 79.45 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.509 0.671 . . . . 0.0 110.353 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.608 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.3 m-20 -74.13 -28.44 61.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.308 -176.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.876 HG22 HD22 ' A' ' 91' ' ' LEU . 84.0 t -62.94 -40.56 89.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.406 0.622 . . . . 0.0 109.82 172.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.2 t -64.93 -22.88 67.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.564 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.608 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 42.9 mtpt -70.41 -46.35 64.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.35 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.561 HG23 HD13 ' A' ' 59' ' ' LEU . 22.8 pt -75.77 173.04 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-O 122.01 0.909 . . . . 0.0 112.728 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.69 148.24 10.59 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.469 -176.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.444 ' H ' HG23 ' A' ' 48' ' ' VAL . 0.7 OUTLIER -71.1 143.03 14.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.65 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.96 -32.69 4.5 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.31 -0.947 . . . . 0.0 112.608 -176.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.53 ' HE3' HG22 ' A' ' 46' ' ' ILE . 16.3 ptt? -85.65 177.91 7.54 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 117.371 0.586 . . . . 0.0 111.126 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.811 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 38.9 p -91.9 -171.38 2.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.979 -172.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.458 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 97.1 mt-30 -68.74 -46.26 69.32 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.094 172.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.5 ' HA ' ' HE1' ' A' ' 68' ' ' PHE . 9.9 pt20 -63.4 -35.03 79.05 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.448 0.642 . . . . 0.0 110.171 -175.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.811 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.5 mm-40 -61.43 -56.97 14.28 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.246 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.651 HG11 ' CD2' ' A' ' 93' ' ' LEU . 80.2 t -61.91 -41.78 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.813 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.701 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -56.4 -36.93 69.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.147 0.499 . . . . 0.0 110.228 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -82.26 -34.18 28.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.15 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.66 -41.67 71.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.527 0.679 . . . . 0.0 111.006 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.649 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -92.31 -44.26 8.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.425 -1.262 . . . . 0.0 111.428 -173.343 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.18 122.94 4.16 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -170.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.701 HG22 ' HB1' ' A' ' 56' ' ' ALA . 58.5 p -58.86 135.92 87.11 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 120.963 0.411 . . . . 0.0 111.235 -175.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 23.0 Cg_exo -63.27 172.91 4.64 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.71 2.94 . . . . 0.0 113.585 -172.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 mt -47.66 -48.64 28.85 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.024 -174.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -53.67 -19.57 4.21 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.364 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.6 t 73.13 -4.82 2.08 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.749 0.82 . . . . 0.0 111.75 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -124.12 90.97 50.18 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-O 121.998 0.904 . . . . 0.0 110.044 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HG3' HG22 ' A' ' 61' ' ' THR . 57.4 Cg_endo -70.62 -32.92 14.18 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.462 2.108 . . . . 0.0 112.075 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.5 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 10.5 m-85 -78.09 9.46 3.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.848 -175.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.33 -23.32 19.74 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.841 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.7 t -124.83 174.37 7.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.818 0.342 . . . . 0.0 110.816 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -119.73 5.38 11.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.357 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.4 m -133.95 110.89 10.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.162 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.568 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 48.6 m0 -104.18 138.84 40.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -175.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -116.45 120.97 40.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.868 0.366 . . . . 0.0 110.632 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.61 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 68.1 m-85 -132.15 174.79 9.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.214 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 77' ' ' PHE . 2.7 t -122.23 169.09 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -172.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.476 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.929 HD11 HG22 ' A' ' 104' ' ' ILE . 13.7 tp -99.64 117.47 34.06 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 173.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 78.9 m -111.59 107.2 16.27 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.857 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.2 tp -88.54 125.41 34.77 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.613 -174.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.7 m -106.91 124.34 49.48 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.886 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.481 ' CE2' HD23 ' A' ' 93' ' ' LEU . 77.7 m-85 -114.69 141.54 47.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.96 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.509 HD21 ' HB ' ' A' ' 100' ' ' VAL . 30.2 p30 -75.69 -175.31 2.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.354 176.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.5 m -57.65 -35.19 70.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.588 ' HB3' HG23 ' A' ' 100' ' ' VAL . 30.2 t -76.8 -19.84 57.11 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.995 0.426 . . . . 0.0 110.904 -175.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.79 26.86 9.4 Favored Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.588 HG23 ' HB3' ' A' ' 98' ' ' SER . 4.4 t -106.83 142.06 20.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.944 -0.628 . . . . 0.0 109.672 -177.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.857 HD21 ' HG ' ' A' ' 93' ' ' LEU . 5.8 mt -60.86 123.95 19.05 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.21 0.529 . . . . 0.0 111.837 178.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.493 HG21 ' HB3' ' A' ' 96' ' ' ASN . 19.2 p -109.69 -41.72 4.47 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.327 176.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -148.95 145.85 27.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.249 0.547 . . . . 0.0 112.016 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.929 HG22 HD11 ' A' ' 91' ' ' LEU . 3.9 mm -106.27 94.73 3.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 174.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.601 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 9.3 t70 -86.74 98.81 11.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.897 0.38 . . . . 0.0 110.916 -171.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -106.88 106.36 16.85 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.925 0.869 . . . . 0.0 110.29 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.588 ' HE2' ' OG1' ' A' ' 92' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.799 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.054 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.698 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 3.2 tp . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.853 0.359 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 43' ' ' VAL . 43.1 p -127.0 -173.49 2.9 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.107 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.65 -37.86 88.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.354 0.597 . . . . 0.0 111.379 -178.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -62.05 -42.45 99.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.795 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.519 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 16.7 m-20 -70.25 -32.68 70.63 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.842 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.782 HG22 HD22 ' A' ' 91' ' ' LEU . 58.6 t -58.58 -36.03 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.089 0.471 . . . . 0.0 111.128 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.8 t -62.22 -16.29 52.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.552 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -74.07 -24.02 59.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.643 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.816 HG23 HD13 ' A' ' 59' ' ' LEU . 37.8 pt -100.73 175.83 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.619 0.723 . . . . 0.0 112.244 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.13 150.8 11.45 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.079 -177.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.451 HG22 HG12 ' A' ' 104' ' ' ILE . 0.7 OUTLIER -73.12 143.06 14.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.655 -178.692 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.76 -21.97 8.85 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.352 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.482 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 16.0 ptt? -96.46 178.24 5.42 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.164 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.835 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 41.5 p -92.78 -175.49 3.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.96 -171.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.464 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 77.3 mt-30 -63.05 -46.81 85.75 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.528 171.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.524 ' HA ' ' HE1' ' A' ' 68' ' ' PHE . 9.7 pt20 -65.25 -35.34 80.73 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.334 0.588 . . . . 0.0 109.84 -173.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.835 ' HG3' ' H ' ' A' ' 51' ' ' THR . 7.7 mm-40 -60.25 -51.87 67.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.177 176.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.677 HG11 ' CD2' ' A' ' 93' ' ' LEU . 69.5 t -66.94 -45.0 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.9 -175.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.707 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -64.08 -25.11 67.96 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.436 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -80.9 -42.35 21.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.029 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.78 76.95 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.653 0.74 . . . . 0.0 111.342 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.816 HD13 HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -90.12 -36.4 14.86 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.563 -172.625 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.6 127.76 5.76 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -170.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.707 HG22 ' HB1' ' A' ' 56' ' ' ALA . 56.9 p -59.15 136.21 88.12 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-O 120.93 0.395 . . . . 0.0 110.659 -177.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.509 ' CD ' ' HB3' ' A' ' 67' ' ' PRO . 22.2 Cg_exo -62.07 171.96 4.51 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.478 2.785 . . . . 0.0 113.309 -172.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.412 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 5.5 mt -51.08 -43.68 61.07 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.038 0.535 . . . . 0.0 111.606 -172.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.1 ptt? -58.66 -12.23 3.94 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.423 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.2 t 68.98 -0.59 2.37 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.513 0.725 . . . . 0.0 111.827 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -134.72 91.52 20.86 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.611 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 90.6 Cg_endo -77.85 -29.07 4.63 Favored 'Trans proline' 0 C--N 1.327 -0.554 0 C-N-CA 123.268 2.645 . . . . 0.0 113.15 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.524 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 13.0 m-85 -80.59 21.62 0.63 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.038 -172.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.7 -17.41 8.02 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.989 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 t -124.81 172.27 9.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.732 0.301 . . . . 0.0 110.385 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -125.01 15.57 8.51 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.282 0.563 . . . . 0.0 109.975 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.6 m -138.88 109.24 6.49 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.495 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.611 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 50.3 m0 -104.48 143.23 33.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.707 -175.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -118.06 115.03 24.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.156 0.503 . . . . 0.0 111.241 -176.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.619 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 57.2 m-85 -129.93 176.46 8.03 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.2 p -128.87 153.57 38.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.598 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.474 ' HE1' HG21 ' A' ' 43' ' ' VAL . 1.5 m-30 . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.301 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.438 -1.064 0 CA-C-O 121.22 0.533 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.989 HD11 HG22 ' A' ' 104' ' ' ILE . 14.1 tp -93.0 112.55 24.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.875 174.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.725 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 10.6 m -107.09 105.98 16.25 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.866 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.0 tp -87.37 118.21 26.66 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.515 -175.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 38.6 m -101.64 122.68 44.32 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.127 -174.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.519 ' CE2' HD23 ' A' ' 93' ' ' LEU . 72.9 m-85 -116.13 140.88 48.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.241 -178.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.534 HD21 ' HB ' ' A' ' 100' ' ' VAL . 30.1 p30 -76.43 -177.19 4.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.16 175.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.0 t -54.42 -38.31 66.1 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.434 ' HB2' HG23 ' A' ' 100' ' ' VAL . 49.8 m -80.2 -3.8 50.51 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -174.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.33 28.0 34.68 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.824 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.534 ' HB ' HD21 ' A' ' 96' ' ' ASN . 6.6 t -106.41 140.86 23.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.866 HD21 ' HG ' ' A' ' 93' ' ' LEU . 7.3 mt -59.91 126.2 26.62 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.328 0.585 . . . . 0.0 112.195 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.416 HG21 ' HB3' ' A' ' 96' ' ' ASN . 18.0 p -111.18 -36.7 5.53 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.365 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -152.95 152.98 32.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.325 0.583 . . . . 0.0 111.673 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.989 HG22 HD11 ' A' ' 91' ' ' LEU . 3.3 mm -108.41 92.6 2.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 171.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.725 ' HB2' ' HB ' ' A' ' 92' ' ' THR . 2.3 m-20 -78.4 96.33 5.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.574 0.226 . . . . 0.0 110.989 -174.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -112.07 107.42 16.36 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.829 0.824 . . . . 0.0 110.49 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.875 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.445 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.584 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 2.5 tp . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.743 0.306 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 43.6 p -127.14 -174.66 3.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.171 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.82 -38.19 85.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.332 0.586 . . . . 0.0 110.606 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -54.31 -40.7 68.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.44 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.57 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 12.9 m-20 -73.92 -33.35 63.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.783 -1.098 . . . . 0.0 111.209 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.784 HG22 HD22 ' A' ' 91' ' ' LEU . 74.0 t -60.71 -37.73 76.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.314 0.578 . . . . 0.0 110.211 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.7 t -58.54 -22.39 55.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.126 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 45.2 mtpt -71.61 -40.59 69.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.78 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.681 HG23 HD13 ' A' ' 59' ' ' LEU . 41.6 pt -85.58 179.2 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-O 121.938 0.875 . . . . 0.0 112.925 -175.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.443 ' N ' ' HD3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -168.26 147.2 4.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.464 -175.449 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.467 HG22 ' CG1' ' A' ' 104' ' ' ILE . 0.8 OUTLIER -72.61 144.22 13.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.742 -179.353 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.98 -31.75 5.03 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.861 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.553 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 21.7 ptt? -86.39 175.14 8.56 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.976 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.943 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 26.0 p -93.29 -170.77 2.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.974 -171.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -66.69 -46.04 76.89 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.616 172.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.503 ' OE1' ' HG2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -66.73 -29.31 69.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.469 0.652 . . . . 0.0 110.47 -175.242 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.943 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.0 mm-40 -63.19 -56.59 15.43 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.397 174.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.651 HG11 ' CD2' ' A' ' 93' ' ' LEU . 82.9 t -67.51 -38.82 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.455 -177.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.689 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.7 -32.17 68.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.182 0.515 . . . . 0.0 110.109 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -82.26 -39.17 23.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.589 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.79 -44.94 63.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.167 0.508 . . . . 0.0 111.881 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.681 HD13 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -95.73 -12.63 25.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.411 -174.348 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.77 129.33 2.28 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.255 -0.974 . . . . 0.0 110.876 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.689 HG22 ' HB1' ' A' ' 56' ' ' ALA . 22.1 p -55.3 133.4 69.64 Favored Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-O 121.466 0.65 . . . . 0.0 111.284 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 34.8 Cg_exo -63.49 166.93 14.14 Favored 'Trans proline' 0 C--O 1.23 0.092 0 C-N-CA 123.753 2.969 . . . . 0.0 113.377 -171.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.419 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 1.5 mt -54.08 -33.16 56.84 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.104 -170.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.461 ' SD ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -63.68 3.33 0.36 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.39 176.548 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 63' ' ' LEU . 27.7 p 53.94 24.81 4.87 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.8 0.84 . . . . 0.0 111.593 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -169.9 105.11 0.45 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.41 -178.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.585 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 83.6 Cg_endo -80.07 -23.03 6.85 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 122.833 2.355 . . . . 0.0 113.201 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -82.8 -6.75 59.57 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -171.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.28 -20.68 51.66 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.328 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 t -125.16 174.74 7.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.993 0.425 . . . . 0.0 110.228 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -129.24 14.01 6.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.366 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.7 m -131.2 110.32 11.05 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.84 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.593 ' O ' ' HA ' ' A' ' 92' ' ' THR . 46.3 m0 -108.66 149.08 29.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.885 -175.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -125.13 123.22 39.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.544 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.617 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 86.6 m-85 -133.01 173.75 11.08 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.9 t -113.24 164.82 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -175.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.218 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.252 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.438 -1.033 0 CA-C-O 121.28 0.562 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.955 HD11 HG22 ' A' ' 104' ' ' ILE . 14.4 tp -90.02 110.95 21.91 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.95 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 24.4 m -103.68 105.01 15.12 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.83 ' HG ' HD21 ' A' ' 101' ' ' LEU . 8.2 tp -88.36 124.27 33.76 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.37 -173.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.558 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 42.1 m -104.16 120.98 42.29 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.978 -176.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.53 ' CE2' HD23 ' A' ' 93' ' ' LEU . 66.1 m-85 -114.5 137.73 51.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.744 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.559 ' HB3' HG21 ' A' ' 102' ' ' THR . 33.3 p30 -75.26 -171.96 1.58 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.45 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.1 m -55.61 -37.99 68.86 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.465 ' HB3' HG23 ' A' ' 100' ' ' VAL . 22.8 t -84.2 -3.61 58.28 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.985 0.422 . . . . 0.0 110.869 -173.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.59 31.85 35.59 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.621 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.488 ' HB ' HD21 ' A' ' 96' ' ' ASN . 11.2 t -107.02 141.47 22.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.83 HD21 ' HG ' ' A' ' 93' ' ' LEU . 7.0 mt -62.68 122.88 16.97 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.559 0.695 . . . . 0.0 112.254 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.559 HG21 ' HB3' ' A' ' 96' ' ' ASN . 21.1 p -109.62 -42.09 4.39 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.711 175.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.558 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 5.3 m-20 -137.06 154.83 50.25 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.271 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.955 HG22 HD11 ' A' ' 91' ' ' LEU . 5.0 mm -116.7 91.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 167.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 92' ' ' THR . 5.6 m-20 -83.55 94.91 8.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.039 0.447 . . . . 0.0 110.752 -172.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -100.78 102.85 14.03 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.755 0.788 . . . . 0.0 109.414 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.1 mttt . . . . . 0 C--N 1.314 -0.963 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.482 -177.386 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.542 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 11.4 tp . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 121.129 0.49 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.5 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 33.5 p -127.71 177.19 6.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.156 170.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.43 -30.61 66.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.009 0.433 . . . . 0.0 110.495 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -55.69 -45.04 77.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.714 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.683 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 22.7 m-20 -67.2 -26.35 66.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.231 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.968 HG22 HD22 ' A' ' 91' ' ' LEU . 79.3 t -64.32 -37.28 79.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.172 0.511 . . . . 0.0 110.026 176.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.3 t -66.54 -20.84 66.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.452 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.683 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 36.4 mtpt -71.34 -32.28 68.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.92 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.623 HG23 HD13 ' A' ' 59' ' ' LEU . 30.9 pt -94.76 177.6 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-O 121.895 0.855 . . . . 0.0 112.032 177.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.41 ' HE ' ' HB3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -172.3 154.31 3.24 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.417 -174.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.426 HG22 HD11 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -71.95 144.99 12.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.048 -178.378 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.38 -36.81 3.16 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.163 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.609 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 5.6 ptt? -85.25 171.61 11.8 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.191 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.851 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 44.0 p -86.07 -172.49 4.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.007 -172.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.5 ' HA ' ' CZ ' ' A' ' 95' ' ' PHE . 39.5 mt-30 -68.31 -42.59 79.19 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.216 173.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.558 ' HA ' ' HE1' ' A' ' 68' ' ' PHE . 9.0 pt20 -66.36 -36.03 81.85 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.264 -175.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.851 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.8 mm-40 -58.26 -54.21 49.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.889 176.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.657 HG11 ' CD2' ' A' ' 93' ' ' LEU . 85.6 t -65.58 -41.3 90.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.793 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.566 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -57.67 -33.12 67.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.385 0.612 . . . . 0.0 110.096 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -81.3 -36.78 29.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.825 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.35 -42.07 55.12 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.249 0.547 . . . . 0.0 111.764 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.623 HD13 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -95.24 -16.94 22.12 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.83 -173.241 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.95 130.46 5.43 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.305 -0.95 . . . . 0.0 110.756 -174.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.566 HG22 ' HB1' ' A' ' 56' ' ' ALA . 4.5 p -65.11 134.95 96.09 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 121.343 0.592 . . . . 0.0 111.304 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 22.0 Cg_exo -67.59 171.41 12.0 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.998 3.132 . . . . 0.0 113.14 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.427 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 7.7 mt -49.09 -48.23 44.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.518 -178.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -59.59 144.73 46.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.757 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.3 p -73.02 1.72 8.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -154.44 108.59 2.4 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-O 121.345 0.593 . . . . 0.0 110.528 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.65 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 59.2 Cg_endo -73.29 -25.39 15.67 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.078 2.519 . . . . 0.0 113.048 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.558 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 8.3 m-85 -81.57 -5.44 58.02 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -170.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.21 -8.17 63.2 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.71 -174.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.2 t -123.58 171.96 9.14 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -119.38 1.25 11.23 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 m -126.64 115.2 19.1 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.555 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.65 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 44.6 m0 -109.36 141.68 41.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.708 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -119.12 120.71 37.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.477 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.657 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 90.3 m-85 -128.03 175.56 8.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.228 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.9 t -124.26 152.66 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -172.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 . . . . . 0 C--N 1.323 -0.567 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 171.097 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.44 -0.956 0 CA-C-O 121.216 0.531 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.986 HD11 HG22 ' A' ' 104' ' ' ILE . 38.7 tp -91.11 110.76 22.03 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 28.7 m -105.27 102.69 12.15 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.763 ' HG ' HD21 ' A' ' 101' ' ' LEU . 8.9 tp -88.39 126.78 35.38 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.547 -171.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.5 m -103.8 121.24 42.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.008 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.59 ' CE2' HD23 ' A' ' 93' ' ' LEU . 25.8 m-85 -111.92 148.52 33.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.914 0.864 . . . . 0.0 112.503 -175.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -73.8 173.1 10.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.874 -1.512 . . . . 0.0 110.451 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.8 m -62.34 -30.07 70.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.17 0.509 . . . . 0.0 110.862 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.407 ' HB3' HG23 ' A' ' 100' ' ' VAL . 30.8 t -87.55 4.43 43.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.793 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.11 34.53 55.17 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.954 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' A' ' 98' ' ' SER . 15.4 t -107.37 139.31 29.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.763 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.3 mt -60.73 127.5 31.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.393 0.616 . . . . 0.0 111.673 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 66.5 p -116.38 -39.94 3.3 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.136 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -144.7 149.56 35.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.854 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.986 HG22 HD11 ' A' ' 91' ' ' LEU . 3.8 mm -112.6 94.06 2.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 173.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.593 ' HB2' ' O ' ' A' ' 92' ' ' THR . 4.5 m-20 -80.48 95.49 6.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.024 0.44 . . . . 0.0 110.523 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -106.57 102.78 12.14 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.72 0.771 . . . . 0.0 110.269 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.959 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.62 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.659 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 3.1 tp . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.925 0.393 . . . . 0.0 110.459 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 43' ' ' VAL . 32.3 p -127.41 -178.36 4.43 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.079 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.15 -35.54 79.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.383 0.611 . . . . 0.0 110.552 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -59.32 -46.46 88.52 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.985 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.578 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 14.9 m-20 -69.31 -32.14 71.06 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.798 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.721 HG22 HD22 ' A' ' 91' ' ' LEU . 68.0 t -57.92 -38.18 64.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.109 0.481 . . . . 0.0 110.525 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -59.24 -21.59 59.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.154 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 45.9 mtpt -70.85 -29.3 65.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.982 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.803 HG23 HD13 ' A' ' 59' ' ' LEU . 38.9 pt -95.48 176.11 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.787 0.803 . . . . 0.0 112.257 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.431 ' HE ' ' HB3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -164.71 148.42 8.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.775 -177.472 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.445 HG22 HD11 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -70.79 140.14 18.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.332 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.43 -17.57 8.94 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.488 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.471 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 17.6 ptt? -102.43 173.09 6.51 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.109 174.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.713 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 12.7 p -88.08 -173.35 4.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.007 -172.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.511 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 13.2 mt-30 -69.44 -41.93 75.62 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.562 175.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.567 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 1.5 pp0? -65.5 -33.19 75.35 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.609 0.719 . . . . 0.0 109.591 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.713 ' HG3' ' H ' ' A' ' 51' ' ' THR . 11.2 mm-40 -61.61 -55.93 25.38 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.598 175.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.645 HG11 ' CD2' ' A' ' 93' ' ' LEU . 82.5 t -66.03 -40.4 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.387 -176.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.733 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.74 -34.2 71.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.278 0.561 . . . . 0.0 110.012 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -81.16 -39.97 24.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.769 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.27 -49.68 53.86 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.782 0.801 . . . . 0.0 111.402 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.803 HD13 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -86.07 -45.07 11.75 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.189 -173.773 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.02 126.8 3.46 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -174.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.733 HG22 ' HB1' ' A' ' 56' ' ' ALA . 47.6 p -59.84 132.09 89.15 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-O 121.15 0.5 . . . . 0.0 110.934 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 28.0 Cg_exo -63.59 164.18 21.84 Favored 'Trans proline' 0 CA--C 1.52 -0.208 0 C-N-CA 123.745 2.963 . . . . 0.0 112.554 -172.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.431 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 1.9 mt -52.72 -32.96 45.63 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.47 -168.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.409 ' HG2' ' H ' ' A' ' 64' ' ' MET . 10.8 ptt? -62.48 -9.87 9.92 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.685 0.616 . . . . 0.0 111.926 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 t 72.27 -2.3 2.63 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.669 0.788 . . . . 0.0 112.466 173.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -138.12 91.97 12.66 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-O 121.159 0.504 . . . . 0.0 109.999 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.707 ' HG3' HG22 ' A' ' 61' ' ' THR . 74.0 Cg_endo -74.0 -30.25 9.22 Favored 'Trans proline' 0 CA--C 1.529 0.247 0 C-N-CA 123.193 2.595 . . . . 0.0 112.964 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.497 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 12.7 m-85 -76.78 3.6 11.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.105 -172.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.49 -25.7 25.07 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.881 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.4 t -123.78 174.21 7.65 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.413 ' HB2' ' HB2' ' A' ' 95' ' ' PHE . 26.3 p-10 -122.33 2.58 9.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.107 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.4 m -123.07 108.66 13.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.813 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.576 ' O ' ' HA ' ' A' ' 92' ' ' THR . 47.0 m0 -105.58 148.68 27.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.875 -174.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -124.48 118.2 26.1 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.976 0.417 . . . . 0.0 111.249 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.641 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 80.3 m-85 -128.9 175.5 8.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.274 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.8 t -122.85 165.74 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 120.65 0.262 . . . . 0.0 110.632 176.386 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.439 -1.021 0 CA-C-O 120.876 0.369 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.751 HD11 ' CG2' ' A' ' 104' ' ' ILE . 13.8 tp -89.66 103.39 16.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 18.2 m -98.21 100.62 11.93 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.902 ' HG ' HD21 ' A' ' 101' ' ' LEU . 8.4 tp -86.01 121.58 28.83 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.256 -172.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.4 m -101.54 119.6 39.02 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.018 -175.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.453 ' CE2' HD23 ' A' ' 93' ' ' LEU . 72.2 m-85 -113.22 142.36 45.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.492 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.503 ' HB3' HG21 ' A' ' 102' ' ' THR . 30.1 p30 -75.85 -177.72 3.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.96 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.2 m -56.61 -30.55 63.36 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.2 t -85.91 -3.86 59.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.701 0.286 . . . . 0.0 111.257 -173.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.48 32.72 27.17 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.424 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.48 ' HB ' HD21 ' A' ' 96' ' ' ASN . 5.0 t -113.7 139.21 40.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.794 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.902 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.7 mt -61.14 123.14 16.84 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.276 0.56 . . . . 0.0 112.307 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.503 HG21 ' HB3' ' A' ' 96' ' ' ASN . 12.4 p -110.29 -39.14 5.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.025 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -148.92 150.63 33.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.481 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.751 ' CG2' HD11 ' A' ' 91' ' ' LEU . 5.6 mm -105.35 92.76 2.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 171.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 92' ' ' THR . 7.2 m-20 -83.94 94.88 8.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.284 0.564 . . . . 0.0 110.259 -177.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -95.25 102.08 13.86 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.881 0.848 . . . . 0.0 108.978 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm . . . . . 0 C--N 1.316 -0.885 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.873 -172.218 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.729 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 3.6 mm? . . . . . 0 CA--C 1.511 -0.545 0 CA-C-O 121.727 0.775 . . . . 0.0 112.4 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.554 ' O ' HG23 ' A' ' 43' ' ' VAL . 30.7 p -128.92 -177.9 4.4 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.516 170.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.445 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -65.04 -44.33 89.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.861 0.362 . . . . 0.0 111.624 -176.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -61.16 -40.58 94.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.569 -177.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -68.74 -33.44 73.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.572 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.691 ' HA ' HD11 ' A' ' 59' ' ' LEU . 54.9 t -57.32 -37.7 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.811 0.339 . . . . 0.0 111.475 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.7 p -64.09 -12.42 39.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.149 0.499 . . . . 0.0 111.627 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 43.8 mtpt -77.2 -14.19 59.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.246 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.865 HG23 HD13 ' A' ' 59' ' ' LEU . 35.3 pt -104.21 -176.9 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 121.894 0.854 . . . . 0.0 112.808 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.402 ' H ' ' HE2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -172.64 150.47 2.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.009 -1.45 . . . . 0.0 109.055 -177.394 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.554 HG22 HD11 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -71.09 144.48 13.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.15 -178.694 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.15 -32.31 4.78 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.473 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.538 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 14.4 ptt? -88.3 178.39 6.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 111.415 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.857 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 34.9 p -90.77 -177.04 4.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.793 -171.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.472 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 36.7 mt-30 -66.18 -42.63 88.63 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.506 171.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.3 -37.34 77.48 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.147 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.857 ' HG3' ' H ' ' A' ' 51' ' ' THR . 5.4 mm-40 -67.83 -52.03 41.63 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.318 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.685 HG13 HG21 ' A' ' 46' ' ' ILE . 78.6 t -64.94 -40.84 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.741 -177.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.612 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.41 -33.33 69.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 110.181 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -81.87 -40.28 22.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.098 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.44 -42.4 75.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.686 0.755 . . . . 0.0 111.11 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.865 HD13 HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -92.63 -54.94 3.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.992 -174.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.2 134.94 3.61 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -171.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.612 HG22 ' HB1' ' A' ' 56' ' ' ALA . 28.7 p -66.92 135.92 94.28 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-O 121.224 0.535 . . . . 0.0 111.308 -177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 17.0 Cg_exo -65.79 174.72 5.24 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 C-N-CA 124.19 3.26 . . . . 0.0 113.411 -174.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.409 ' HG ' ' H ' ' A' ' 63' ' ' LEU . 8.2 mt -46.3 -48.47 18.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.353 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.22 126.88 30.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.572 170.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 t -68.78 -7.25 32.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 0.0 111.726 -173.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.456 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 11.1 p-10 -122.14 92.49 48.87 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-O 121.714 0.768 . . . . 0.0 110.199 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.538 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 18.7 Cg_endo -60.05 -36.11 90.53 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.864 2.376 . . . . 0.0 112.186 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -83.48 8.89 12.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.803 -177.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.1 -17.33 57.85 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.8 t -124.45 175.14 7.32 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -125.1 8.04 7.95 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.818 0.342 . . . . 0.0 110.127 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.7 m -131.36 111.82 12.19 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.313 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.675 ' O ' ' HA ' ' A' ' 92' ' ' THR . 48.8 m0 -106.0 142.95 34.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.582 -176.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -123.44 116.32 23.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.75 0.31 . . . . 0.0 110.543 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.587 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 31.1 m-85 -124.72 170.25 11.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.523 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.3 t -120.69 158.63 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.445 ' CG ' ' HB2' ' A' ' 40' ' ' ALA . 1.3 m-30 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.338 . . . . 0.0 110.788 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 19.2 p . . . . . 0 N--CA 1.442 -0.845 0 CA-C-O 121.226 0.536 . . . . 0.0 111.65 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.9 HD11 HG22 ' A' ' 104' ' ' ILE . 14.7 tp -93.6 111.69 23.41 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.862 174.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.715 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 40.2 m -106.9 103.45 12.88 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.906 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.2 tp -90.21 122.82 33.49 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.254 -173.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -109.72 124.22 50.86 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.394 -176.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.51 ' CE1' ' HG ' ' A' ' 101' ' ' LEU . 92.0 m-85 -112.27 144.97 40.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.296 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.541 ' HB3' HG21 ' A' ' 102' ' ' THR . 29.7 p30 -74.88 -173.96 2.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.172 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.1 p -54.59 -32.17 58.22 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.484 ' HB3' HG23 ' A' ' 100' ' ' VAL . 9.7 t -89.45 -3.03 58.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.054 0.454 . . . . 0.0 111.245 -173.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.62 32.98 32.14 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.597 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.491 ' HB ' HD21 ' A' ' 96' ' ' ASN . 7.3 t -108.82 138.86 33.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.906 HD21 ' HG ' ' A' ' 93' ' ' LEU . 5.7 mt -60.07 124.91 21.68 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.648 0.737 . . . . 0.0 112.102 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.541 HG21 ' HB3' ' A' ' 96' ' ' ASN . 34.0 p -112.85 -45.0 3.23 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.348 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -136.52 152.75 50.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.247 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.9 HG22 HD11 ' A' ' 91' ' ' LEU . 3.7 mm -116.08 93.36 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 171.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.715 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 8.0 t70 -89.53 97.34 11.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.04 0.447 . . . . 0.0 111.052 -169.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 90' ' ' THR . 29.0 t-20 -117.64 119.52 35.22 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.36 0.6 . . . . 0.0 110.693 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.541 ' HE2' ' N ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.858 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.144 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.805 HD11 ' HG ' ' A' ' 59' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.508 -0.647 0 CA-C-O 121.881 0.848 . . . . 0.0 110.892 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.4 p -130.81 177.93 7.04 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.21 172.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HB2' ' HB3' ' A' ' 77' ' ' PHE . . . -70.88 -28.97 64.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.453 0.644 . . . . 0.0 109.904 176.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -59.08 -44.44 91.89 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.525 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.62 ' HB2' HD13 ' A' ' 38' ' ' LEU . 27.0 m-20 -70.41 -32.85 70.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.697 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.928 HG22 HD22 ' A' ' 91' ' ' LEU . 56.3 t -62.54 -36.24 74.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.859 0.361 . . . . 0.0 110.81 177.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.3 p -68.19 -15.32 63.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.074 0.464 . . . . 0.0 110.525 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.606 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 40.8 mtpt -78.78 -19.53 51.99 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.078 177.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.667 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 44.5 pt -103.38 169.0 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-O 121.735 0.779 . . . . 0.0 112.099 176.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -164.94 148.76 8.75 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.493 -173.169 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.465 HG23 ' H ' ' A' ' 48' ' ' VAL . 0.6 OUTLIER -72.19 143.17 14.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.074 -177.014 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.9 -33.8 4.28 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.703 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.667 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 21.8 ptt? -86.48 175.72 8.22 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.148 0.499 . . . . 0.0 111.189 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.831 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 44.0 p -91.16 -173.38 3.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.081 -170.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.468 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 84.4 mt-30 -65.38 -46.93 78.17 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.385 172.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 9.8 pt20 -64.08 -37.4 87.31 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.98 -175.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.831 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.0 mm-40 -58.34 -49.43 77.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.584 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.645 HG11 ' CD2' ' A' ' 93' ' ' LEU . 61.8 t -69.7 -45.11 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.466 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.706 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.45 -25.03 68.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.002 0.43 . . . . 0.0 110.684 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -80.44 -35.77 34.56 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.291 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.81 -39.87 61.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.742 0.782 . . . . 0.0 111.07 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.805 ' HG ' HD11 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -93.24 -32.55 14.31 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.339 -172.461 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.3 119.93 4.45 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -171.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.706 HG22 ' HB1' ' A' ' 56' ' ' ALA . 46.9 p -53.52 134.54 53.7 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 120.968 0.413 . . . . 0.0 111.426 -173.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 32.3 Cg_exo -63.0 164.43 19.37 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.614 2.876 . . . . 0.0 113.278 -172.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.429 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 3.7 mt -53.31 -36.73 61.57 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.164 -169.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.433 ' H ' ' HG2' ' A' ' 64' ' ' MET . 8.6 ptt? -62.26 -3.26 1.25 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.164 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.4 t 70.39 2.89 4.22 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.445 0.698 . . . . 0.0 112.259 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.417 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 23.5 t70 -152.09 100.52 2.85 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.664 0.745 . . . . 0.0 110.34 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.63 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 38.0 Cg_endo -67.1 -49.71 1.27 Allowed 'Trans proline' 0 C--N 1.332 -0.314 0 C-N-CA 123.63 2.887 . . . . 0.0 113.648 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -80.61 19.1 0.84 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -172.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.36 -19.88 47.6 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 171.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.4 t -124.25 171.15 10.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.982 -0.609 . . . . 0.0 109.53 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -122.72 13.99 10.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.41 0.624 . . . . 0.0 109.681 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 m -139.11 110.53 7.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.022 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.63 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 48.4 m0 -106.94 141.36 38.28 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.941 -175.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -120.04 125.46 48.38 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.18 0.3 . . . . 0.0 110.515 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.55 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 60.1 m-85 -135.66 174.69 10.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.53 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 77' ' ' PHE . 1.6 p -122.5 150.63 26.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.639 -176.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.535 ' HE1' HG21 ' A' ' 43' ' ' VAL . 10.0 m-30 . . . . . 0 C--N 1.322 -0.598 0 CA-C-O 121.126 0.489 . . . . 0.0 110.571 177.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.447 -0.604 0 CA-C-O 121.153 0.501 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.945 HD11 HG22 ' A' ' 104' ' ' ILE . 21.3 tp -89.72 114.14 25.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.478 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 35.9 m -108.25 102.7 11.81 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.906 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.4 tp -85.59 121.94 29.0 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.5 -173.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.4 m -100.34 119.86 39.07 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.956 -176.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.539 ' CE2' HD23 ' A' ' 93' ' ' LEU . 67.5 m-85 -113.77 136.8 52.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.817 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.481 HD21 ' HB ' ' A' ' 100' ' ' VAL . 32.3 p30 -75.27 -177.6 3.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.933 175.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.0 m -52.84 -33.94 51.82 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.593 ' HB3' HG23 ' A' ' 100' ' ' VAL . 8.7 t -83.83 -9.6 58.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.018 0.437 . . . . 0.0 110.849 -173.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.57 29.66 20.92 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.593 HG23 ' HB3' ' A' ' 98' ' ' SER . 21.5 t -107.62 140.19 26.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.742 -0.729 . . . . 0.0 109.323 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.906 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.5 mt -62.3 125.29 23.4 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.286 0.565 . . . . 0.0 111.885 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.439 HG21 ' HB3' ' A' ' 96' ' ' ASN . 11.1 p -109.6 -45.49 3.67 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.418 174.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -138.33 155.02 48.96 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.63 0.728 . . . . 0.0 111.556 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.945 HG22 HD11 ' A' ' 91' ' ' LEU . 5.3 mm -113.16 93.11 2.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.637 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 30.4 t70 -85.49 96.36 9.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.125 0.488 . . . . 0.0 111.0 -171.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -105.42 102.76 12.21 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.976 0.893 . . . . 0.0 110.106 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.6 pttm . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.275 -175.491 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.711 ' HB3' ' HB3' ' A' ' 75' ' ' TYR . 6.0 tp . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.2 p -127.9 -173.93 3.06 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.106 174.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.585 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -67.82 -47.33 69.35 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.21 0.528 . . . . 0.0 112.007 -173.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.67 -31.68 69.78 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.101 177.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.537 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 63.4 m-20 -72.29 -35.11 68.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.313 176.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.828 HG22 HD22 ' A' ' 91' ' ' LEU . 53.3 t -57.48 -36.61 54.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.206 0.527 . . . . 0.0 110.506 174.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.1 t -61.61 -17.73 56.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.533 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 48.4 mtpt -74.75 -28.73 60.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.849 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.822 HG23 HD13 ' A' ' 59' ' ' LEU . 43.3 pt -97.56 176.32 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 122.108 0.956 . . . . 0.0 113.163 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.54 150.59 6.09 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.516 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.441 HG22 ' CG1' ' A' ' 104' ' ' ILE . 0.7 OUTLIER -70.54 145.6 12.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.125 -178.077 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.93 -35.15 3.92 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.16 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.607 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 6.8 ptt? -85.3 165.8 17.0 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.285 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.72 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 12.4 p -83.1 -172.3 4.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.409 -173.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 99' ' ' GLY . 92.2 mt-30 -68.24 -41.84 80.61 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.737 176.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.551 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 1.5 pp0? -66.58 -32.12 73.25 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -175.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.72 ' HG3' ' H ' ' A' ' 51' ' ' THR . 15.8 mm-40 -61.93 -56.58 17.69 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.44 176.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.673 HG11 ' CD2' ' A' ' 93' ' ' LEU . 82.0 t -65.4 -40.45 88.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.57 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.619 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.69 -35.55 72.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.163 0.506 . . . . 0.0 110.297 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -81.65 -35.37 30.03 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.088 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.04 -45.15 43.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.554 0.692 . . . . 0.0 111.393 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.822 HD13 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -90.95 -54.42 3.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.316 -174.231 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.68 130.1 2.91 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.619 HG22 ' HB1' ' A' ' 56' ' ' ALA . 40.5 p -65.34 128.82 94.13 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-O 121.533 0.682 . . . . 0.0 110.687 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 14.6 Cg_exo -68.68 163.25 37.81 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.569 2.846 . . . . 0.0 112.956 -171.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.82 -25.85 61.2 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.008 -171.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.468 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 13.4 ptt? -66.84 -3.01 5.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.543 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 t 72.29 4.4 4.99 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.545 0.738 . . . . 0.0 112.51 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -158.92 107.78 1.58 Allowed Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 121.579 0.704 . . . . 0.0 110.543 175.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.674 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 58.8 Cg_endo -72.82 -29.95 11.93 Favored 'Trans proline' 0 C--N 1.325 -0.662 0 C-N-CA 122.976 2.451 . . . . 0.0 112.511 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -76.28 -4.06 39.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.927 -170.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.85 -17.66 55.96 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.534 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.3 t -124.39 174.31 7.84 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.005 0.431 . . . . 0.0 110.666 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -118.52 3.56 11.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.574 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.4 m -134.15 112.77 11.4 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.643 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.674 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 44.6 m0 -105.88 136.19 45.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.439 -177.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -113.07 127.31 56.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.928 0.394 . . . . 0.0 110.724 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.711 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 62.2 m-85 -132.27 173.91 10.78 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 77' ' ' PHE . 2.0 t -129.09 178.15 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.585 ' CG ' ' HB2' ' A' ' 40' ' ' ALA . 7.6 m-30 . . . . . 0 C--N 1.319 -0.758 0 CA-C-O 120.514 0.197 . . . . 0.0 110.54 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.442 -0.846 0 CA-C-O 120.804 0.335 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.901 HD11 HG22 ' A' ' 104' ' ' ILE . 20.0 tp -91.24 119.25 31.15 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.718 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 90.4 m -110.49 106.86 16.32 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.945 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.1 tp -91.39 123.63 34.96 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.725 -174.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.7 m -103.2 121.71 43.23 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.844 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.47 ' CE1' ' HG ' ' A' ' 101' ' ' LEU . 71.6 m-85 -116.71 138.91 51.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.893 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.52 HD21 ' HB ' ' A' ' 100' ' ' VAL . 33.4 p30 -75.61 -173.46 2.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.794 175.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.6 m -51.29 -44.36 61.86 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -174.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.463 ' HB3' HG23 ' A' ' 100' ' ' VAL . 33.6 t -79.78 -15.9 56.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.469 . . . . 0.0 111.068 -174.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.424 ' O ' ' HG3' ' A' ' 52' ' ' GLN . . . 96.83 29.49 8.1 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -176.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.52 ' HB ' HD21 ' A' ' 96' ' ' ASN . 14.0 t -98.24 134.68 35.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.945 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.7 mt -59.9 125.02 22.01 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.262 0.553 . . . . 0.0 112.04 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.427 HG21 ' HB3' ' A' ' 96' ' ' ASN . 5.7 p -112.78 -39.48 4.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.15 176.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -143.72 148.28 35.46 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.359 0.599 . . . . 0.0 111.908 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.901 HG22 HD11 ' A' ' 91' ' ' LEU . 4.7 mm -111.92 95.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.718 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 35.5 t0 -86.59 95.34 9.72 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.718 -174.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -102.86 104.09 14.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.704 0.764 . . . . 0.0 109.645 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 63.4 pttt . . . . . 0 C--N 1.312 -1.035 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.733 -176.466 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.63 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 1.3 tp . . . . . 0 N--CA 1.457 -0.097 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 26.0 p -126.12 -176.27 3.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.048 0.452 . . . . 0.0 111.995 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.494 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -62.56 -37.8 87.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.909 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -59.8 -43.27 94.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.373 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.614 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 10.5 m-20 -68.44 -29.6 68.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.962 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.011 HG22 HD22 ' A' ' 91' ' ' LEU . 85.6 t -59.79 -36.95 69.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.207 0.527 . . . . 0.0 110.45 175.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -61.26 -19.05 61.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.427 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -70.99 -42.13 70.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.794 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.789 HG23 HD13 ' A' ' 59' ' ' LEU . 41.6 pt -84.7 -178.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.747 0.784 . . . . 0.0 112.268 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.406 ' HD2' ' N ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -171.68 152.33 3.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.326 -175.617 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.458 HG23 ' H ' ' A' ' 48' ' ' VAL . 0.7 OUTLIER -72.82 145.62 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.697 -179.246 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.41 -30.6 5.93 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.346 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.492 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 16.0 ptt? -90.06 178.18 6.26 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.285 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.912 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 31.1 p -95.23 -174.07 3.11 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.013 -170.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.456 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 97.8 mt-30 -63.89 -47.51 80.33 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.774 172.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.415 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 9.9 pt20 -64.56 -36.5 84.42 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.305 0.574 . . . . 0.0 109.811 -175.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.912 ' HG3' ' H ' ' A' ' 51' ' ' THR . 9.4 mm-40 -58.0 -52.47 65.38 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.323 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.652 HG11 ' CD2' ' A' ' 93' ' ' LEU . 72.2 t -67.11 -41.56 87.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.714 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.527 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -64.52 -25.68 68.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.164 0.507 . . . . 0.0 110.727 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -81.28 -35.53 30.97 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.013 0.435 . . . . 0.0 111.323 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.9 -46.14 25.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.393 0.616 . . . . 0.0 111.705 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.789 HD13 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -92.56 -21.15 20.26 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.815 -173.153 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.91 131.07 6.98 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -172.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.527 HG22 ' HB1' ' A' ' 56' ' ' ALA . 37.9 p -56.75 135.27 78.61 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.959 0.409 . . . . 0.0 111.118 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 51.8 Cg_exo -59.12 171.65 2.15 Favored 'Trans proline' 0 N--CA 1.471 0.157 0 C-N-CA 124.131 3.221 . . . . 0.0 115.131 -171.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.451 ' HG ' ' H ' ' A' ' 63' ' ' LEU . 8.3 mt -55.49 -41.69 73.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.257 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.463 ' HE3' HG21 ' A' ' 70' ' ' THR . 0.0 OUTLIER -60.19 -0.24 0.22 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.547 176.619 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 63' ' ' LEU . 33.5 p 58.86 5.44 0.5 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.214 1.006 . . . . 0.0 112.815 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -150.17 103.58 3.15 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 121.54 0.686 . . . . 0.0 109.753 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.487 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 36.0 Cg_endo -68.06 -33.03 26.62 Favored 'Trans proline' 0 C--N 1.327 -0.555 0 C-N-CA 123.245 2.63 . . . . 0.0 113.177 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -76.22 4.51 8.55 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -170.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.33 -24.72 21.03 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.086 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.463 HG21 ' HE3' ' A' ' 64' ' ' MET . 14.3 t -125.51 174.38 8.26 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.902 0.382 . . . . 0.0 110.236 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -125.78 12.52 7.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.862 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.9 m -133.55 108.81 8.83 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.21 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.487 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 42.7 m0 -109.18 130.34 55.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.412 -174.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -109.46 120.89 43.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.024 0.44 . . . . 0.0 110.967 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.583 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 50.1 m-85 -129.24 173.88 10.1 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 77' ' ' PHE . 2.9 t -123.42 175.29 6.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -176.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.573 ' H ' HG12 ' A' ' 76' ' ' VAL . 5.7 m-30 . . . . . 0 C--N 1.32 -0.697 0 CA-C-O 121.045 0.45 . . . . 0.0 110.721 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 120.848 0.356 . . . . 0.0 111.53 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.083 HD11 HG22 ' A' ' 104' ' ' ILE . 39.8 tp -91.8 122.94 34.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 172.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 89.9 m -117.49 103.91 10.55 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.823 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.1 tp -85.18 125.18 32.62 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.286 -174.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 21.5 m -107.35 122.87 47.46 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.264 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.597 ' CE2' HD23 ' A' ' 93' ' ' LEU . 32.5 m-85 -110.54 146.45 36.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.894 0.854 . . . . 0.0 112.695 -175.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -73.94 -179.61 3.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.646 -1.615 . . . . 0.0 111.171 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.4 p -59.32 -43.03 92.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.698 0.285 . . . . 0.0 111.583 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.432 ' HB3' HG23 ' A' ' 100' ' ' VAL . 35.0 t -77.69 -8.66 58.25 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.958 0.409 . . . . 0.0 110.694 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.88 31.06 10.35 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.459 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 98' ' ' SER . 22.0 t -100.77 141.64 17.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.823 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.0 mt -62.29 123.99 19.69 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.084 0.469 . . . . 0.0 111.597 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 74.1 p -111.8 -43.55 3.6 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.642 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.522 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 2.6 m-20 -136.24 150.08 48.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.812 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.083 HG22 HD11 ' A' ' 91' ' ' LEU . 2.2 mm -116.46 92.43 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 170.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.547 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 25.2 t70 -87.42 96.78 10.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.131 0.491 . . . . 0.0 111.032 -170.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.418 ' HB2' ' HZ ' ' A' ' 77' ' ' PHE . 4.4 p30 -106.84 104.75 14.5 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 122.032 0.92 . . . . 0.0 110.333 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.505 ' H ' ' HD3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.762 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.973 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.715 ' HB3' ' HB3' ' A' ' 75' ' ' TYR . 2.3 tp . . . . . 0 C--O 1.231 0.105 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 43' ' ' VAL . 41.6 p -126.05 -179.28 4.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.258 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.8 -32.75 74.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.345 0.593 . . . . 0.0 110.596 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -62.34 -43.11 99.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.86 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.633 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 30.1 m-20 -69.11 -30.9 69.27 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.969 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.877 HG22 HD22 ' A' ' 91' ' ' LEU . 70.9 t -59.82 -37.83 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.042 0.448 . . . . 0.0 110.574 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.6 t -58.42 -21.97 52.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.557 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -70.28 -29.67 66.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.65 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.697 HG23 HD13 ' A' ' 59' ' ' LEU . 36.7 pt -98.42 -178.14 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.812 0.815 . . . . 0.0 112.413 -178.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.25 151.27 3.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.38 -176.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.433 HG22 HD11 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -72.26 145.49 12.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.13 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.56 -35.9 3.57 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.792 -177.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.519 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 19.0 ptt? -85.27 176.81 8.11 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.165 0.507 . . . . 0.0 111.263 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.889 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 32.6 p -95.29 -174.95 3.35 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.991 -170.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.672 ' OE1' ' HA ' ' A' ' 68' ' ' PHE . 78.9 mt-30 -62.73 -48.06 80.88 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.533 172.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.535 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 1.4 pp0? -64.65 -33.13 75.21 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.301 0.572 . . . . 0.0 109.843 -174.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.889 ' HG3' ' H ' ' A' ' 51' ' ' THR . 9.1 mm-40 -60.99 -53.08 61.62 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.562 174.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.688 HG11 ' CD2' ' A' ' 93' ' ' LEU . 75.2 t -69.43 -39.9 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.597 -176.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.689 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -59.56 -32.26 70.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.452 0.644 . . . . 0.0 110.002 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -80.87 -36.82 30.83 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.272 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.57 -49.11 19.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.941 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.697 HD13 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -90.44 -32.89 16.21 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.978 -172.687 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 114.25 127.69 4.5 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.274 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.689 HG22 ' HB1' ' A' ' 56' ' ' ALA . 28.4 p -60.85 132.22 91.76 Favored Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-O 121.244 0.545 . . . . 0.0 111.004 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 11.6 Cg_exo -70.77 162.27 43.16 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.529 2.82 . . . . 0.0 112.768 -173.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.48 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 1.7 mt -54.47 -33.89 60.52 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.094 -1.412 . . . . 0.0 112.235 -169.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.439 ' H ' ' HG2' ' A' ' 64' ' ' MET . 12.2 ptt? -64.16 -1.92 1.82 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.19 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.1 p 62.13 2.38 0.81 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.374 1.07 . . . . 0.0 113.534 172.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -136.76 92.53 14.59 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.501 ' HG3' HG22 ' A' ' 61' ' ' THR . 37.9 Cg_endo -67.75 -34.1 25.6 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.745 1.63 . . . . 0.0 111.524 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.672 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -79.41 10.24 3.98 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.508 -177.037 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.02 -26.3 16.89 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.607 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -124.66 175.95 6.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.959 0.409 . . . . 0.0 110.432 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -126.99 13.55 7.31 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.8 m -132.57 109.78 10.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.665 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.481 ' O ' ' HA ' ' A' ' 92' ' ' THR . 46.2 m0 -107.29 149.85 27.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.594 -175.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -123.1 115.23 21.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.08 0.467 . . . . 0.0 111.051 -175.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.715 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 88.3 m-85 -127.06 174.47 8.86 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 77' ' ' PHE . 4.7 t -120.97 170.19 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 118.066 0.394 . . . . 0.0 110.204 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.567 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 121.406 0.622 . . . . 0.0 112.24 -175.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.439 -1.023 0 CA-C-O 121.197 0.522 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.049 HD11 HG22 ' A' ' 104' ' ' ILE . 19.3 tp -91.18 105.64 17.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 32.1 m -101.81 102.46 13.07 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.871 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.9 tp -83.72 126.16 32.61 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.256 -173.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.4 m -107.91 119.9 40.76 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.263 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.505 ' CE2' HD23 ' A' ' 93' ' ' LEU . 95.5 m-85 -110.08 147.8 32.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.797 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.55 HD21 ' HB ' ' A' ' 100' ' ' VAL . 4.1 p30 -72.06 -87.35 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 55.0 m -150.73 -30.2 0.19 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.887 0.375 . . . . 0.0 110.75 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.471 ' HB3' HG23 ' A' ' 100' ' ' VAL . 16.6 t -82.27 -6.03 58.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.423 0.63 . . . . 0.0 109.452 177.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.52 ' HA2' HE21 ' A' ' 52' ' ' GLN . . . 89.77 29.65 15.32 Favored Glycine 0 CA--C 1.503 -0.702 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.55 ' HB ' HD21 ' A' ' 96' ' ' ASN . 25.8 t -108.25 137.13 41.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.613 -0.793 . . . . 0.0 109.458 -178.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.871 HD21 ' HG ' ' A' ' 93' ' ' LEU . 9.3 mt -61.37 130.74 47.61 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.197 0.522 . . . . 0.0 112.35 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.8 p -114.18 -37.25 4.46 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.126 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -150.06 152.96 35.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.631 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.049 HG22 HD11 ' A' ' 91' ' ' LEU . 3.3 mm -112.96 93.83 2.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 173.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.581 ' HB2' ' O ' ' A' ' 92' ' ' THR . 5.6 m-20 -80.6 96.62 6.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.688 0.28 . . . . 0.0 111.449 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -106.77 104.19 13.81 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.88 0.847 . . . . 0.0 109.917 175.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.433 ' H ' ' HD3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.869 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.206 -176.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.648 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 5.0 tp . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.911 0.386 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 43' ' ' VAL . 29.3 p -127.84 -174.1 3.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.986 175.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.18 -38.87 86.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.362 0.601 . . . . 0.0 110.869 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -62.12 -41.74 98.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.468 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.518 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 10.7 m-20 -63.85 -36.75 84.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.491 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.674 HG22 HD22 ' A' ' 91' ' ' LEU . 77.0 t -59.26 -38.05 72.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.167 0.508 . . . . 0.0 110.582 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.9 t -63.03 -20.62 65.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.089 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 46.0 mtpt -70.17 -33.92 72.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.654 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.776 HG23 HD13 ' A' ' 59' ' ' LEU . 42.9 pt -89.76 -179.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.784 0.802 . . . . 0.0 112.439 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.43 149.9 2.24 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.665 -176.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.454 ' H ' HG23 ' A' ' 48' ' ' VAL . 0.6 OUTLIER -70.98 142.29 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.722 -179.212 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.69 -27.97 6.35 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.708 -176.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.522 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 21.8 ptt? -94.08 171.56 8.77 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.76 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.655 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 23.5 p -91.18 -172.83 3.43 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.723 -168.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.444 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 99.0 mt-30 -63.89 -46.81 83.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.143 173.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.429 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 10.4 pt20 -64.95 -35.3 80.73 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.376 0.608 . . . . 0.0 110.061 -175.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.655 ' HG3' ' H ' ' A' ' 51' ' ' THR . 1.7 mm100 -68.14 -40.58 82.38 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.303 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.665 HG11 ' CD2' ' A' ' 93' ' ' LEU . 53.9 t -74.8 -47.15 39.0 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.578 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.637 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.58 -24.83 67.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.874 0.368 . . . . 0.0 110.796 -176.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -79.82 -41.27 26.76 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.65 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.56 -44.19 71.38 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.558 0.694 . . . . 0.0 111.271 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.776 HD13 HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -88.27 -39.94 14.02 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.366 -173.044 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.6 122.87 4.07 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -171.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.637 HG22 ' HB1' ' A' ' 56' ' ' ALA . 40.2 p -57.09 133.16 80.5 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.11 0.481 . . . . 0.0 111.032 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 22.6 Cg_exo -63.28 161.78 29.38 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.582 2.855 . . . . 0.0 113.332 -170.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.409 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -56.84 -27.63 60.47 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 113.776 -1.556 . . . . 0.0 112.09 -171.584 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 13.2 ptt? -68.14 2.62 2.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.772 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.9 t 66.48 11.0 7.77 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.818 0.447 . . . . 0.0 112.03 172.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -162.78 104.63 1.04 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.703 0.763 . . . . 0.0 110.458 178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.534 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 74.3 Cg_endo -77.29 -36.25 1.39 Allowed 'Trans proline' 0 C--N 1.326 -0.649 0 C-N-CA 123.171 2.581 . . . . 0.0 113.704 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -77.2 -11.62 59.84 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -166.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.32 -8.85 70.72 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.961 -173.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.1 t -124.09 174.51 7.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.954 0.407 . . . . 0.0 110.467 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -119.34 1.62 11.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.117 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.3 m -131.62 113.87 14.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.898 -175.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.563 ' O ' ' HA ' ' A' ' 92' ' ' THR . 44.4 m0 -108.69 147.12 32.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.489 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 27.1 m-85 -127.68 125.26 39.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.954 0.407 . . . . 0.0 111.16 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.559 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 73.4 m-85 -133.92 173.61 11.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.798 178.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.5 t -121.27 161.62 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 . . . . . 0 C--N 1.321 -0.633 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 174.087 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.899 HD11 HG22 ' A' ' 104' ' ' ILE . 13.9 tp -90.08 111.5 22.63 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.666 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 34.6 m -106.65 104.2 13.83 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.906 ' HG ' HD21 ' A' ' 101' ' ' LEU . 6.7 tp -88.41 119.28 28.69 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.032 -174.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.8 m -102.43 122.26 43.95 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.557 -175.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.506 ' CE2' HD23 ' A' ' 93' ' ' LEU . 67.0 m-85 -114.63 138.11 51.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.986 -178.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.494 HD21 ' HB ' ' A' ' 100' ' ' VAL . 32.5 p30 -75.0 -172.08 1.53 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.121 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.5 m -62.19 -30.97 71.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.498 ' HB3' HG23 ' A' ' 100' ' ' VAL . 35.6 t -83.46 -11.87 56.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.777 0.323 . . . . 0.0 111.133 -174.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.78 28.94 14.34 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 98' ' ' SER . 6.7 t -107.87 142.91 19.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.031 -0.585 . . . . 0.0 109.648 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.906 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.5 mt -62.97 126.74 28.33 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.176 0.512 . . . . 0.0 112.204 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.486 HG21 ' HB3' ' A' ' 96' ' ' ASN . 10.8 p -113.13 -42.93 3.44 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.0 175.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -138.2 150.73 47.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.359 0.6 . . . . 0.0 111.584 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.899 HG22 HD11 ' A' ' 91' ' ' LEU . 4.7 mm -113.03 93.08 2.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 168.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.666 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 32.8 t70 -90.56 98.69 11.92 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.465 -169.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 90' ' ' THR . 4.8 p30 -110.98 101.72 10.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.201 1.001 . . . . 0.0 110.744 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.5 mttp . . . . . 0 C--N 1.317 -0.812 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.716 -178.547 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.744 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 1.8 mm? . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 121.831 0.824 . . . . 0.0 112.562 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 43' ' ' VAL . 17.3 p -131.21 -172.46 2.84 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.352 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.413 ' O ' ' HB ' ' A' ' 43' ' ' VAL . . . -62.62 -47.57 83.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -67.82 -32.64 73.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.968 0.413 . . . . 0.0 110.959 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.567 ' HB3' HD12 ' A' ' 38' ' ' LEU . 10.6 m-20 -62.76 -37.61 87.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.321 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.897 HG22 HD22 ' A' ' 91' ' ' LEU . 78.4 t -60.61 -37.73 76.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.121 0.486 . . . . 0.0 110.966 178.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.9 t -60.57 -22.84 64.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.257 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 49.8 mtpt -68.57 -34.4 75.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.648 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.81 HG23 HD13 ' A' ' 59' ' ' LEU . 44.6 pt -93.63 175.67 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 121.934 0.873 . . . . 0.0 112.51 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.65 150.96 6.1 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.955 -1.475 . . . . 0.0 109.505 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.46 HG22 ' CG1' ' A' ' 104' ' ' ILE . 0.5 OUTLIER -72.41 141.59 16.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.888 -177.754 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.3 -24.1 7.42 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.246 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.482 ' HE3' HG22 ' A' ' 46' ' ' ILE . 19.0 ptt? -96.57 178.12 5.44 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.226 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.2 p -95.03 -178.91 4.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.71 -169.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.486 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 27.1 mt-30 -65.56 -43.38 90.03 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.866 173.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.459 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 9.4 pt20 -64.35 -38.11 89.87 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.674 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.459 ' N ' ' HG3' ' A' ' 53' ' ' GLN . 50.5 mt-30 -66.77 -45.62 77.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.115 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.706 HG11 ' CD2' ' A' ' 93' ' ' LEU . 62.8 t -68.86 -47.64 74.94 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.598 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -62.86 -26.32 68.71 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.488 -177.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -81.33 -39.12 25.63 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.392 176.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.25 -51.93 47.07 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.105 0.955 . . . . 0.0 110.85 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.81 HD13 HG23 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -81.55 -49.61 10.36 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.328 -173.011 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.88 124.16 2.75 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -171.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.598 HG22 ' HB1' ' A' ' 56' ' ' ALA . 44.3 p -57.41 134.06 81.66 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.877 0.37 . . . . 0.0 110.69 -177.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.505 ' CD ' ' HB3' ' A' ' 67' ' ' PRO . 35.1 Cg_exo -60.41 157.04 37.88 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 123.498 2.799 . . . . 0.0 112.645 -172.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 1.7 mt -59.93 -27.99 67.23 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.502 -1.227 . . . . 0.0 111.307 -171.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.454 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 12.5 ptt? -62.85 -4.8 2.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.862 175.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 t 71.65 -3.01 2.27 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.459 0.703 . . . . 0.0 111.695 172.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.46 99.78 7.76 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-O 121.708 0.766 . . . . 0.0 110.427 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.505 ' HB3' ' CD ' ' A' ' 62' ' ' PRO . 73.0 Cg_endo -79.32 -28.43 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.712 2.275 . . . . 0.0 112.598 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -86.03 -5.31 59.24 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -168.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.79 -17.79 53.21 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.89 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.401 HG21 ' HE1' ' A' ' 64' ' ' MET . 9.0 t -123.62 172.16 9.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.914 0.388 . . . . 0.0 110.069 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -128.06 20.65 6.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.322 0.582 . . . . 0.0 109.465 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 17.9 m -143.65 111.92 6.3 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.696 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.535 ' O ' ' HA ' ' A' ' 92' ' ' THR . 51.4 m0 -107.84 147.15 31.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.613 -175.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -125.68 115.27 19.83 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 111.268 -174.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.586 ' HD2' HD23 ' A' ' 91' ' ' LEU . 27.7 m-85 -128.53 176.26 7.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.639 HG22 ' H ' ' A' ' 77' ' ' PHE . 4.2 p -124.32 175.13 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -176.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.639 ' H ' HG22 ' A' ' 76' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.486 0 CA-C-O 121.241 0.543 . . . . 0.0 111.622 -175.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 21.6 p . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 121.136 0.493 . . . . 0.0 112.228 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.993 HD11 HG22 ' A' ' 104' ' ' ILE . 24.7 tp -91.51 113.1 25.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.142 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.721 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 25.5 m -106.39 105.05 14.9 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.853 ' HG ' HD21 ' A' ' 101' ' ' LEU . 6.9 tp -90.83 121.65 32.87 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.401 -174.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.7 m -104.55 124.15 48.78 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.945 -176.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.501 ' CE2' HD23 ' A' ' 93' ' ' LEU . 73.9 m-85 -117.32 139.37 50.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.44 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.481 HD21 ' HB ' ' A' ' 100' ' ' VAL . 32.0 p30 -76.59 -174.36 2.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.168 174.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.0 p -57.48 -35.89 70.77 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -175.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.588 ' HB3' HG23 ' A' ' 100' ' ' VAL . 21.0 t -81.15 -4.93 56.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.189 0.518 . . . . 0.0 110.88 -174.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.53 27.95 37.45 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.45 -0.881 . . . . 0.0 110.902 -177.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.588 HG23 ' HB3' ' A' ' 98' ' ' SER . 16.7 t -104.6 138.17 30.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.235 -0.482 . . . . 0.0 109.733 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.853 HD21 ' HG ' ' A' ' 93' ' ' LEU . 7.3 mt -58.97 127.75 33.79 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.215 0.531 . . . . 0.0 111.987 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.416 HG21 ' HB3' ' A' ' 96' ' ' ASN . 7.6 p -114.3 -35.51 4.96 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.223 176.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -149.43 149.03 30.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.204 0.526 . . . . 0.0 111.915 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.993 HG22 HD11 ' A' ' 91' ' ' LEU . 3.4 mm -113.09 94.38 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.721 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 18.4 t70 -94.91 97.25 9.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.862 0.363 . . . . 0.0 111.674 -169.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 90' ' ' THR . 28.6 t-20 -107.69 103.37 12.65 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.723 0.773 . . . . 0.0 110.973 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.538 ' HE3' ' OD1' ' A' ' 105' ' ' ASP . 67.1 mttt . . . . . 0 C--N 1.316 -0.864 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.09 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.75 HD13 ' HG ' ' A' ' 59' ' ' LEU . 10.4 tp . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.874 0.369 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.495 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 40.4 p -129.21 -179.11 4.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.033 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.435 ' O ' ' HB ' ' A' ' 43' ' ' VAL . . . -65.07 -44.34 89.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.62 -32.58 71.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.397 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 5.7 m-20 -75.33 -27.77 59.37 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.857 176.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.766 HG22 HD22 ' A' ' 91' ' ' LEU . 54.4 t -60.38 -36.34 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.321 0.581 . . . . 0.0 110.05 173.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.4 t -61.8 -19.89 63.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.317 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 46.6 mtpt -74.69 -24.99 58.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.496 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.793 HG23 HD13 ' A' ' 59' ' ' LEU . 34.4 pt -101.24 176.53 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 122.068 0.937 . . . . 0.0 112.585 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.06 153.35 3.12 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.027 -176.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.461 HG22 HD11 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -71.31 144.73 13.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.961 -177.887 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.49 -29.6 5.63 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.448 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.648 ' HE3' HG22 ' A' ' 46' ' ' ILE . 13.5 ptt? -92.86 178.14 5.86 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.19 176.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.855 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 30.0 p -96.07 -174.1 3.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.776 -169.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.452 ' OE1' ' HA ' ' A' ' 68' ' ' PHE . 75.6 mt-30 -61.51 -47.78 84.03 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.246 173.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.534 ' HG2' ' OG1' ' A' ' 51' ' ' THR . 7.7 pt20 -63.59 -40.32 96.65 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.21 0.529 . . . . 0.0 109.977 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.855 ' HG3' ' H ' ' A' ' 51' ' ' THR . 7.3 mm-40 -60.09 -50.43 73.72 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.059 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.657 HG11 ' CD2' ' A' ' 93' ' ' LEU . 56.9 t -64.76 -48.83 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.676 -177.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.604 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.31 -26.25 68.68 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.756 -176.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -81.89 -33.73 30.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.972 0.415 . . . . 0.0 111.81 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.67 -40.61 63.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.833 0.825 . . . . 0.0 111.058 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.793 HD13 HG23 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -91.92 -41.6 10.5 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.64 -171.756 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.9 123.87 4.52 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 -168.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.604 HG22 ' HB1' ' A' ' 56' ' ' ALA . 33.2 p -56.35 136.45 75.84 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.981 0.42 . . . . 0.0 111.051 -175.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.553 ' CD ' ' HB3' ' A' ' 67' ' ' PRO . 34.3 Cg_exo -60.57 167.07 8.75 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.759 2.973 . . . . 0.0 113.556 -171.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.405 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -57.27 -30.44 64.68 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 113.637 -1.619 . . . . 0.0 111.961 -171.093 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -71.15 2.29 4.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.778 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.8 t 71.1 1.79 3.96 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.266 0.626 . . . . 0.0 112.234 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -157.62 108.59 1.82 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.73 0.776 . . . . 0.0 110.716 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.71 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 74.1 Cg_endo -75.49 -34.73 3.23 Favored 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 123.559 2.84 . . . . 0.0 113.653 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.452 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 14.4 m-85 -75.14 2.48 10.69 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -166.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.78 -20.09 45.13 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.937 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.8 t -125.61 175.28 7.67 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.839 0.352 . . . . 0.0 110.443 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -123.35 8.15 9.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.5 m -129.14 107.38 9.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.994 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.71 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 47.9 m0 -104.59 144.93 31.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.946 -173.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -122.19 120.38 34.02 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.605 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 72.1 m-85 -127.2 173.61 9.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.522 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.6 t -115.76 152.06 17.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.09 0.471 . . . . 0.0 110.096 -173.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.73 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.443 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.443 -0.799 0 CA-C-O 120.851 0.358 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.857 HD11 HG22 ' A' ' 104' ' ' ILE . 13.2 tp -91.29 108.57 19.97 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.691 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 22.3 m -105.57 98.17 7.91 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.453 0.644 . . . . 0.0 109.647 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.866 ' HG ' HD21 ' A' ' 101' ' ' LEU . 6.9 tp -83.25 128.45 34.51 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.568 -173.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.0 m -114.44 124.61 52.36 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.078 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.477 ' CE2' HD23 ' A' ' 93' ' ' LEU . 87.5 m-85 -114.41 140.64 48.52 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.316 -178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.496 ' HB3' HG21 ' A' ' 102' ' ' THR . 31.6 p30 -75.27 -174.07 2.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.148 176.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.2 m -53.59 -36.62 62.14 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.485 ' HB3' HG23 ' A' ' 100' ' ' VAL . 22.9 t -85.96 -0.09 54.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.99 0.424 . . . . 0.0 110.797 -173.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.37 29.84 51.77 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.734 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 98' ' ' SER . 5.6 t -105.66 140.48 23.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.866 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.5 mt -59.89 126.37 27.31 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.219 0.533 . . . . 0.0 112.264 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.496 HG21 ' HB3' ' A' ' 96' ' ' ASN . 11.4 p -111.85 -43.52 3.6 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.812 174.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -136.82 152.29 50.11 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.446 0.641 . . . . 0.0 111.335 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.857 HG22 HD11 ' A' ' 91' ' ' LEU . 4.8 mm -114.57 92.23 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 169.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.691 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 18.6 t70 -86.89 95.08 9.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.141 0.496 . . . . 0.0 110.921 -170.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -106.89 104.17 13.78 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.636 0.731 . . . . 0.0 109.967 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.472 ' HD2' ' OD2' ' A' ' 105' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.842 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.98 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.609 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 10.7 tp . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.613 0.244 . . . . 0.0 110.571 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.476 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 43.4 p -127.41 177.25 6.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.128 172.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.77 -30.02 65.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 0.0 110.238 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -53.49 -45.93 69.83 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.788 0.804 . . . . 0.0 109.759 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.666 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 19.9 m-20 -70.54 -30.5 67.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.334 -178.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.979 HG22 HD22 ' A' ' 91' ' ' LEU . 60.2 t -64.87 -41.84 93.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.257 0.551 . . . . 0.0 109.775 174.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.0 t -61.32 -32.01 71.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.315 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.666 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 34.3 mtpt -63.07 -43.52 98.36 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.754 176.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.587 HG23 HD13 ' A' ' 59' ' ' LEU . 43.6 pt -80.91 174.99 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-O 121.723 0.773 . . . . 0.0 111.901 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.457 ' O ' ' HG2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -163.43 143.43 8.71 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.228 -174.811 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.446 HG22 HD11 ' A' ' 104' ' ' ILE . 0.7 OUTLIER -70.34 140.76 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.491 -179.16 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.95 -27.09 6.9 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.965 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.537 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 23.4 ptt? -90.73 174.39 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.255 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.875 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 39.8 p -92.82 -173.78 3.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.888 -171.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.473 ' OE1' ' HA ' ' A' ' 68' ' ' PHE . 83.4 mt-30 -65.57 -44.33 87.08 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.515 172.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.657 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 1.5 pp0? -64.97 -33.67 76.58 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.316 0.579 . . . . 0.0 110.18 -175.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.875 ' HG3' ' H ' ' A' ' 51' ' ' THR . 6.3 mm-40 -62.27 -53.01 61.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.222 175.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.733 HG11 HD22 ' A' ' 93' ' ' LEU . 69.1 t -69.96 -40.24 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.676 -176.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.762 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -57.44 -33.45 67.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.433 0.635 . . . . 0.0 110.053 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -81.48 -36.56 29.15 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.744 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.23 -43.3 52.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.132 0.492 . . . . 0.0 111.968 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.609 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -94.86 -14.89 24.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.079 -172.625 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.02 124.16 3.27 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -175.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.762 HG22 ' HB1' ' A' ' 56' ' ' ALA . 18.6 p -60.11 121.21 57.45 Favored Pre-proline 0 N--CA 1.432 -1.339 0 CA-C-O 122.295 1.045 . . . . 0.0 111.666 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 75.4 Cg_exo -52.54 159.25 4.82 Favored 'Trans proline' 0 C--N 1.327 -0.602 1 C-N-CA 125.436 4.091 . . . . 0.0 113.965 -176.623 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 65' ' ' SER . 0.5 OUTLIER -75.12 -21.1 59.1 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.953 -171.618 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.534 ' HE1' HG21 ' A' ' 70' ' ' THR . 16.9 ptt? -70.49 23.51 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.715 175.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 63' ' ' LEU . 44.5 t 77.07 -56.73 0.53 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 165.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 8.3 m-20 -126.29 99.92 30.22 Favored Pre-proline 0 C--N 1.304 -1.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.655 -171.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.539 ' HG3' HG22 ' A' ' 61' ' ' THR . 12.5 Cg_endo -58.75 -34.55 99.04 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.408 2.072 . . . . 0.0 111.655 176.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.522 ' CZ ' ' HB3' ' A' ' 53' ' ' GLN . 9.4 m-85 -78.99 2.48 20.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.81 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.0 -15.55 44.76 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.873 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.534 HG21 ' HE1' ' A' ' 64' ' ' MET . 6.1 t -124.81 175.5 7.22 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -127.39 7.82 6.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.293 0.568 . . . . 0.0 109.953 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 m -134.69 113.09 11.34 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.677 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.428 ' O ' ' HA ' ' A' ' 92' ' ' THR . 40.0 m0 -103.97 141.39 36.26 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.069 -176.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -116.41 114.64 24.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.372 0.606 . . . . 0.0 110.946 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.675 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 93.2 m-85 -129.41 176.61 7.82 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.525 177.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.515 HG22 ' H ' ' A' ' 77' ' ' PHE . 1.4 p -143.27 -177.86 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.515 ' H ' HG22 ' A' ' 76' ' ' VAL . 15.5 m-30 . . . . . 0 C--N 1.328 -0.366 0 CA-C-O 121.14 0.495 . . . . 0.0 112.162 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.437 -1.122 0 CA-C-O 121.402 0.62 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.044 HD11 HG22 ' A' ' 104' ' ' ILE . 42.5 tp -91.71 118.77 30.96 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.88 174.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.608 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 51.1 m -110.61 103.0 11.53 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.864 ' HG ' HD21 ' A' ' 101' ' ' LEU . 6.7 tp -83.11 118.32 23.48 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.055 -174.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 72.7 m -101.17 120.85 40.83 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.531 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.546 ' CE2' HD23 ' A' ' 93' ' ' LEU . 79.2 m-85 -111.96 144.92 40.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.856 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.503 HD21 ' HB ' ' A' ' 100' ' ' VAL . 27.2 p30 -75.64 -174.09 2.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.273 173.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.1 m -65.01 -24.93 67.65 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.43 ' HB3' HG23 ' A' ' 100' ' ' VAL . 18.1 t -85.1 -13.6 49.76 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.786 -177.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.26 30.68 8.53 Favored Glycine 0 CA--C 1.508 -0.348 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.008 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.503 ' HB ' HD21 ' A' ' 96' ' ' ASN . 5.2 t -112.23 138.59 40.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.797 -0.702 . . . . 0.0 109.525 -177.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.864 HD21 ' HG ' ' A' ' 93' ' ' LEU . 8.5 mt -59.26 124.35 19.72 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.297 0.57 . . . . 0.0 112.442 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.468 HG21 ' HB3' ' A' ' 96' ' ' ASN . 19.3 p -111.23 -37.78 5.21 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.164 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -149.65 149.42 30.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.479 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.044 HG22 HD11 ' A' ' 91' ' ' LEU . 2.4 mm -110.19 93.32 2.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 173.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.608 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 34.0 t0 -87.76 96.0 10.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.007 0.432 . . . . 0.0 111.4 -170.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -107.89 104.11 13.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.587 0.708 . . . . 0.0 111.277 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.226 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.732 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 4.8 tp . . . . . 0 CA--C 1.521 -0.141 0 CA-C-O 120.618 0.247 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 43' ' ' VAL . 20.6 p -126.87 -174.76 3.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.079 176.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.513 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -67.34 -34.43 77.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.443 0.639 . . . . 0.0 110.574 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -64.67 -42.07 95.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.821 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.93 -27.97 66.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.025 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.784 HG22 HD22 ' A' ' 91' ' ' LEU . 58.8 t -59.84 -36.71 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.15 0.5 . . . . 0.0 110.76 176.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.9 t -59.33 -20.54 55.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.373 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 47.9 mtpt -75.58 -19.24 59.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.819 -176.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.778 HG23 HD13 ' A' ' 59' ' ' LEU . 30.0 pt -107.01 177.95 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.646 0.736 . . . . 0.0 112.46 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.92 150.69 4.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.729 -177.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.54 HG22 HD11 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -72.74 141.81 15.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.999 -179.045 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.69 -29.83 5.51 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.11 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.591 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 18.6 ptt? -88.54 178.36 6.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.184 0.492 . . . . 0.0 111.133 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.884 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 39.9 p -95.09 -174.3 3.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.207 -170.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.412 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 45.7 mt-30 -66.72 -44.12 82.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.866 174.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.64 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -65.92 -34.52 78.32 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.422 0.63 . . . . 0.0 109.823 -176.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.884 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.9 mm-40 -61.0 -57.03 14.32 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.464 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.645 HG11 ' CD2' ' A' ' 93' ' ' LEU . 90.9 t -63.42 -42.53 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.725 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.537 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.72 -35.82 73.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.082 0.468 . . . . 0.0 110.161 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -80.88 -37.22 30.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.515 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.64 -46.39 66.28 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.616 0.722 . . . . 0.0 111.215 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.778 HD13 HG23 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -88.14 -42.79 12.11 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.594 -172.103 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.79 122.01 3.76 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -171.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.537 HG22 ' HB1' ' A' ' 56' ' ' ALA . 17.9 p -54.7 136.51 64.0 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.499 0.666 . . . . 0.0 111.795 -175.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.588 ' HB2' ' HG2' ' A' ' 64' ' ' MET . 23.1 Cg_exo -64.49 165.03 21.44 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.847 3.031 . . . . 0.0 113.197 -172.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.14 -24.63 67.27 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.483 -173.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.588 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 14.6 ptt? -68.22 -1.29 5.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.806 175.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 t 71.56 6.63 5.77 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.459 0.704 . . . . 0.0 112.471 170.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -165.33 110.93 0.79 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 121.738 0.78 . . . . 0.0 110.674 176.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.642 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 60.4 Cg_endo -73.67 -24.54 15.73 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.303 2.669 . . . . 0.0 113.525 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -80.53 -5.6 56.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -170.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.75 -18.76 59.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.733 -176.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.5 t -125.0 175.28 7.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.348 0.594 . . . . 0.0 111.624 -173.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -117.49 0.34 12.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.658 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.4 m -128.99 111.86 13.44 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.789 -178.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.642 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 43.8 m0 -104.03 137.36 42.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.606 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -113.28 110.09 19.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.224 0.535 . . . . 0.0 111.21 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.621 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 53.8 m-85 -125.8 175.83 7.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.602 HG22 ' H ' ' A' ' 77' ' ' PHE . 2.3 p -141.89 179.99 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.536 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.602 ' H ' HG22 ' A' ' 76' ' ' VAL . 2.9 m-30 . . . . . 0 C--N 1.326 -0.436 0 C-N-CA 122.599 0.36 . . . . 0.0 111.632 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.443 -0.784 0 CA-C-O 120.812 0.339 . . . . 0.0 110.902 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.895 HD11 HG22 ' A' ' 104' ' ' ILE . 13.9 tp -90.92 108.35 19.8 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.742 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 19.2 m -103.22 104.5 14.64 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.871 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.0 tp -88.71 128.71 35.62 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.423 -173.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.2 m -115.82 123.06 47.23 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.077 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.453 ' CE1' HD23 ' A' ' 93' ' ' LEU . 93.1 m-85 -112.41 137.31 50.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.43 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.49 ' HB3' HG21 ' A' ' 102' ' ' THR . 6.1 p30 -57.22 -82.7 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -175.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.4 t -155.38 -34.3 0.09 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 100' ' ' VAL . 16.9 m -78.99 -8.11 58.65 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.243 0.544 . . . . 0.0 110.436 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.47 32.18 8.37 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.487 ' HB ' HD21 ' A' ' 96' ' ' ASN . 18.5 t -112.35 134.17 55.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.178 -0.511 . . . . 0.0 109.689 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.871 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.2 mt -61.52 125.88 25.36 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.249 0.547 . . . . 0.0 112.319 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 96' ' ' ASN . 11.2 p -111.73 -42.55 3.8 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.913 175.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -136.05 151.89 50.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.57 0.7 . . . . 0.0 111.49 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.895 HG22 HD11 ' A' ' 91' ' ' LEU . 3.1 mm -115.75 93.65 2.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 168.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.742 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 7.5 t70 -87.34 95.04 9.85 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.133 0.492 . . . . 0.0 110.415 -170.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.471 ' HB3' HD12 ' A' ' 91' ' ' LEU . 18.6 p-10 -112.3 111.38 22.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.842 0.83 . . . . 0.0 111.437 -176.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.915 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.609 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.669 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 4.9 tp . . . . . 0 CA--C 1.518 -0.282 0 CA-C-O 121.044 0.449 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 43.1 p -128.77 -174.29 3.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.589 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.25 -46.48 76.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.381 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.52 -27.43 69.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.155 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.503 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 14.4 m-20 -70.9 -37.0 72.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.441 173.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.851 HG22 HD22 ' A' ' 91' ' ' LEU . 67.3 t -59.63 -36.99 68.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.217 0.532 . . . . 0.0 110.784 176.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.0 t -64.77 -15.05 61.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.113 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 47.0 mtpt -81.82 -8.63 59.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.332 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.735 HG23 HD13 ' A' ' 59' ' ' LEU . 24.8 pt -112.67 178.38 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.713 0.768 . . . . 0.0 112.131 176.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.16 151.05 4.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.484 -177.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.552 HG22 HD11 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -72.76 144.41 12.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.101 -177.962 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.25 -29.05 6.32 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.197 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.566 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 19.2 ptt? -90.24 174.79 7.41 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.119 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.875 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 31.2 p -91.61 -176.66 4.56 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.049 -170.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -61.46 -47.05 87.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.704 170.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.41 -37.7 75.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.271 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.875 ' HG3' ' H ' ' A' ' 51' ' ' THR . 5.3 mm-40 -67.45 -54.38 20.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.19 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.63 HG11 ' CD2' ' A' ' 93' ' ' LEU . 73.5 t -62.11 -44.49 99.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.822 -178.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.642 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.31 -34.75 70.92 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.046 0.451 . . . . 0.0 110.104 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -82.15 -36.56 27.29 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.196 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.51 -43.34 77.01 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.772 0.796 . . . . 0.0 111.023 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.735 HD13 HG23 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -89.4 -54.74 3.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.183 -173.39 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 127.15 118.75 2.2 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.713 HG22 ' HG3' ' A' ' 67' ' ' PRO . 32.8 p -55.27 130.54 69.09 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.082 0.468 . . . . 0.0 111.128 -176.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 18.6 Cg_exo -64.95 172.41 7.26 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.871 3.048 . . . . 0.0 113.843 -169.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.433 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 3.9 mt -49.91 -43.24 49.49 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.877 0.735 . . . . 0.0 111.89 -173.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.0 ptt? -63.16 -3.54 1.86 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.328 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 p 59.54 3.25 0.4 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.618 1.167 . . . . 0.0 113.495 174.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -136.45 90.15 17.86 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.226 0.536 . . . . 0.0 109.866 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.713 ' HG3' HG22 ' A' ' 61' ' ' THR . 72.1 Cg_endo -74.74 -32.0 6.18 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.856 2.371 . . . . 0.0 112.128 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -77.97 7.26 6.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.2 -171.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.35 -19.76 17.57 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.085 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.9 t -124.2 165.53 17.43 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -177.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -117.96 12.81 13.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.292 0.568 . . . . 0.0 110.31 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.9 m -136.69 106.89 6.37 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.933 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.692 ' O ' ' HA ' ' A' ' 92' ' ' THR . 47.7 m0 -103.79 147.21 27.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 -173.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -124.42 124.94 43.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.063 0.459 . . . . 0.0 110.764 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.617 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 80.6 m-85 -130.28 173.42 10.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.722 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.7 t -112.07 158.04 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.956 0.407 . . . . 0.0 110.021 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.69 176.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.447 -0.581 0 CA-C-O 121.061 0.457 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.906 HD11 HG22 ' A' ' 104' ' ' ILE . 17.5 tp -90.52 111.71 23.1 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.719 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.692 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 81.0 m -107.14 108.55 20.06 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.884 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.5 tp -91.81 126.71 36.99 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.615 -173.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 20.0 m -104.33 122.13 44.8 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.996 -177.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.52 ' CE2' HD23 ' A' ' 93' ' ' LEU . 67.2 m-85 -114.37 139.33 49.56 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.962 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.497 HD21 ' HB ' ' A' ' 100' ' ' VAL . 33.4 p30 -76.08 -175.75 3.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.432 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.9 m -52.01 -36.24 49.38 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.469 ' HB3' HG23 ' A' ' 100' ' ' VAL . 10.4 t -89.19 -0.03 57.13 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.161 -0.337 . . . . 0.0 111.182 -171.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.79 29.33 39.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.451 -0.881 . . . . 0.0 111.179 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.497 ' HB ' HD21 ' A' ' 96' ' ' ASN . 21.8 t -105.88 138.92 28.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.004 -0.598 . . . . 0.0 109.667 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.884 HD21 ' HG ' ' A' ' 93' ' ' LEU . 5.9 mt -60.9 125.5 23.94 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.175 0.512 . . . . 0.0 112.026 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.492 HG21 ' HB3' ' A' ' 96' ' ' ASN . 11.2 p -112.52 -43.35 3.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.93 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.427 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 1.9 m-20 -137.53 154.3 49.86 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.3 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.906 HG22 HD11 ' A' ' 91' ' ' LEU . 3.6 mm -115.41 92.47 2.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 169.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 92' ' ' THR . 15.4 m-20 -89.38 96.98 10.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.971 0.415 . . . . 0.0 111.441 -172.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -107.3 109.11 20.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.486 0.66 . . . . 0.0 110.516 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.711 ' H ' ' HE3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.843 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.259 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.718 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 2.5 mm? . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 121.583 0.706 . . . . 0.0 111.792 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 43' ' ' VAL . 30.6 p -128.64 -174.94 3.38 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.66 174.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -71.35 -35.0 71.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.804 0.812 . . . . 0.0 109.813 176.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -61.54 -43.88 98.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.388 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.426 ' HB2' HD12 ' A' ' 38' ' ' LEU . 35.0 m-20 -72.02 -30.77 65.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.073 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.876 HG22 HD22 ' A' ' 91' ' ' LEU . 54.6 t -57.87 -36.68 56.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.134 0.492 . . . . 0.0 110.289 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.2 t -61.85 -18.3 59.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.578 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 46.1 mtpt -74.33 -36.15 63.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.768 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.784 HG23 HD13 ' A' ' 59' ' ' LEU . 39.3 pt -87.64 178.61 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.848 0.832 . . . . 0.0 112.268 -177.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.68 150.9 2.23 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.467 -175.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.479 HG22 HD11 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -70.74 144.09 13.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.206 -177.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.41 -32.74 4.58 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.776 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.512 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 13.1 ptt? -87.35 177.64 7.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.017 0.437 . . . . 0.0 111.053 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.835 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 22.2 p -92.57 -174.76 3.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.904 -171.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.476 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 95.4 mt-30 -64.64 -43.88 92.28 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.921 173.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.554 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 1.5 pp0? -66.46 -35.1 79.45 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.216 0.531 . . . . 0.0 109.996 -175.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.835 ' HG3' ' H ' ' A' ' 51' ' ' THR . 11.4 mm-40 -59.86 -51.12 71.06 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.729 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.658 HG11 ' CD2' ' A' ' 93' ' ' LEU . 70.5 t -68.75 -42.78 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.663 -176.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.536 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.98 -25.67 68.23 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.388 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -81.7 -40.93 22.06 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.555 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.41 -45.16 69.89 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.591 0.71 . . . . 0.0 111.332 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.784 HD13 HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -90.58 -44.09 9.78 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.232 -174.365 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.57 132.24 4.01 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -171.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.536 HG22 ' HB1' ' A' ' 56' ' ' ALA . 16.7 p -59.96 134.32 90.01 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.028 0.442 . . . . 0.0 110.684 -177.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.493 ' HG3' ' OH ' ' A' ' 75' ' ' TYR . 20.4 Cg_exo -64.16 171.97 6.94 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.902 3.068 . . . . 0.0 114.358 -169.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.499 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 7.2 mt -50.03 -47.45 53.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.244 -175.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.473 ' HE3' HG21 ' A' ' 70' ' ' THR . 0.0 OUTLIER -54.98 -12.92 0.93 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.957 179.018 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.4 t 70.75 1.58 3.78 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.292 0.568 . . . . 0.0 111.332 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -144.38 102.23 4.71 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-O 121.592 0.71 . . . . 0.0 109.435 174.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.509 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 43.5 Cg_endo -68.45 -25.8 35.16 Favored 'Trans proline' 0 C--N 1.327 -0.565 0 C-N-CA 123.198 2.599 . . . . 0.0 112.608 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -86.63 12.36 10.78 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.547 -173.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -102.39 -20.25 12.54 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.241 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.473 HG21 ' HE3' ' A' ' 64' ' ' MET . 6.6 t -126.25 172.61 9.94 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -122.03 10.14 10.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.187 0.518 . . . . 0.0 109.867 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.2 m -139.4 112.52 8.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.171 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.534 ' O ' ' HA ' ' A' ' 92' ' ' THR . 44.7 m0 -104.34 144.83 31.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.736 -176.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -121.87 112.88 18.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 110.644 -176.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.612 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 33.2 m-85 -125.4 174.69 8.0 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.54 HG22 ' H ' ' A' ' 77' ' ' PHE . 5.8 p -137.15 168.56 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.858 -174.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.54 ' H ' HG22 ' A' ' 76' ' ' VAL . 2.0 m-30 . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.049 -176.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.442 -0.827 0 CA-C-O 121.269 0.557 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.876 HD22 HG22 ' A' ' 43' ' ' VAL . 16.8 tp -97.81 104.0 15.99 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.716 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.691 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 24.9 m -99.51 105.18 17.06 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.839 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.7 tp -88.03 123.61 32.9 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.582 -174.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 21.6 m -105.48 123.67 48.27 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.971 -176.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.507 ' CE2' HD23 ' A' ' 93' ' ' LEU . 33.7 m-85 -111.29 151.28 28.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.894 0.854 . . . . 0.0 112.966 -175.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -75.17 -176.01 2.87 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.292 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.7 p -67.02 -41.04 87.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.848 0.356 . . . . 0.0 111.097 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.46 ' HB3' HG23 ' A' ' 100' ' ' VAL . 38.2 t -74.95 -13.82 60.57 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.112 0.482 . . . . 0.0 110.592 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 52' ' ' GLN . . . 95.04 31.01 7.9 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -176.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.46 HG23 ' HB3' ' A' ' 98' ' ' SER . 21.9 t -101.42 140.25 20.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.839 HD21 ' HG ' ' A' ' 93' ' ' LEU . 5.5 mt -60.17 126.18 26.53 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.133 0.492 . . . . 0.0 111.356 177.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 70.9 p -113.39 -45.06 3.16 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.854 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.486 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 3.4 m-20 -136.85 153.66 50.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.501 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.858 HG22 HD11 ' A' ' 91' ' ' LEU . 3.6 mm -120.13 93.52 2.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 172.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.691 ' HB2' ' HB ' ' A' ' 92' ' ' THR . 6.9 m-20 -78.23 96.41 5.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.962 0.41 . . . . 0.0 110.716 -176.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -111.2 104.33 12.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.579 0.704 . . . . 0.0 110.081 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.438 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.315 -0.906 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.712 -176.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.528 ' CD2' ' HG ' ' A' ' 59' ' ' LEU . 6.4 tp . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 121.172 0.511 . . . . 0.0 111.259 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.4 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 44.8 p -128.62 -178.07 4.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.292 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' A' ' 43' ' ' VAL . . . -66.49 -36.61 83.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.935 0.874 . . . . 0.0 110.209 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -61.94 -41.4 97.92 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.382 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.574 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 16.7 m-20 -69.89 -27.01 64.45 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.238 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.862 HG22 HD22 ' A' ' 91' ' ' LEU . 63.0 t -62.75 -37.03 78.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.322 0.582 . . . . 0.0 110.391 174.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -65.63 -16.55 63.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.807 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.574 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 45.5 mtpt -73.76 -29.51 62.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.656 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.742 HG23 HD13 ' A' ' 59' ' ' LEU . 40.3 pt -92.7 -178.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.795 0.807 . . . . 0.0 111.798 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.41 149.74 5.93 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.424 -177.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.542 HG22 HD11 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -71.48 148.0 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.505 -178.886 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.86 -30.22 7.58 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.215 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.523 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 19.9 ptt? -84.97 173.03 10.86 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.938 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.852 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 19.1 p -89.72 -174.32 4.26 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.438 -170.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 95' ' ' PHE . 37.1 mt-30 -64.89 -43.15 93.83 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.855 174.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 11.3 pt20 -65.8 -35.75 81.57 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.448 0.642 . . . . 0.0 109.913 -175.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.852 ' HG3' ' H ' ' A' ' 51' ' ' THR . 9.8 mm-40 -58.91 -55.22 37.92 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.297 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.682 HG11 HD22 ' A' ' 93' ' ' LEU . 92.8 t -66.73 -41.05 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.492 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.709 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.56 -34.45 71.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.184 0.516 . . . . 0.0 110.103 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -82.47 -38.81 23.39 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.755 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.58 -46.66 65.82 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.546 0.688 . . . . 0.0 111.343 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.742 HD13 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -92.1 -29.67 16.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.751 -173.08 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.55 127.85 6.02 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.709 HG22 ' HB1' ' A' ' 56' ' ' ALA . 34.9 p -59.9 134.09 89.79 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-O 121.237 0.541 . . . . 0.0 110.794 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 21.2 Cg_exo -65.85 162.12 36.33 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.189 2.592 . . . . 0.0 111.699 -174.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.438 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 1.2 mt -49.14 -33.53 12.25 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.57 -168.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.434 ' H ' ' HG2' ' A' ' 64' ' ' MET . 9.7 ptt? -62.55 -6.39 3.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.8 p 58.92 8.71 1.02 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.392 1.077 . . . . 0.0 112.503 177.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.434 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 1.9 t70 -141.21 94.77 7.62 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 122.021 0.915 . . . . 0.0 109.749 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.604 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 74.3 Cg_endo -75.26 -34.56 3.52 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.294 2.663 . . . . 0.0 113.356 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -79.55 2.94 20.34 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -174.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.08 -23.95 42.89 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.539 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.8 t -124.23 174.89 7.39 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -123.57 4.25 8.96 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.8 m -125.61 109.64 12.88 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.19 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.604 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 45.2 m0 -108.18 140.25 41.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.55 -176.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -117.17 112.45 20.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.34 0.591 . . . . 0.0 111.24 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.673 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 88.1 m-85 -113.31 174.92 5.67 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.982 174.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 38' ' ' LEU . 2.5 p -122.28 150.51 25.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.206 0.526 . . . . 0.0 110.038 -174.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.315 -0.905 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.427 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.4 p . . . . . 0 N--CA 1.441 -0.879 0 CA-C-O 121.025 0.441 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.966 HD11 HG22 ' A' ' 104' ' ' ILE . 22.1 tp -89.54 107.51 19.12 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.527 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 23.8 m -99.03 101.53 12.94 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.865 ' HG ' HD21 ' A' ' 101' ' ' LEU . 8.0 tp -87.12 122.96 31.65 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.985 -174.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 27.6 m -104.14 118.13 35.91 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.077 -176.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.605 ' CE2' HD23 ' A' ' 93' ' ' LEU . 31.4 m-85 -105.63 149.29 26.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.737 0.78 . . . . 0.0 111.862 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -73.92 173.13 10.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.557 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.5 m -57.64 -36.87 72.43 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.794 0.331 . . . . 0.0 110.664 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.462 ' HB3' HG23 ' A' ' 100' ' ' VAL . 18.7 t -80.98 -4.1 53.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.927 0.394 . . . . 0.0 110.885 -177.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.36 30.01 26.02 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.402 -179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 98' ' ' SER . 21.4 t -105.99 138.88 29.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.865 HD21 ' HG ' ' A' ' 93' ' ' LEU . 5.9 mt -61.76 124.09 19.78 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.075 0.464 . . . . 0.0 111.747 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.0 p -114.02 -39.72 3.88 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.11 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.5 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 5.1 m-20 -136.76 154.6 50.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.554 0.692 . . . . 0.0 111.54 177.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.966 HG22 HD11 ' A' ' 91' ' ' LEU . 3.0 mm -118.73 92.38 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 168.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 92' ' ' THR . 13.3 m-20 -86.84 95.86 10.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.838 0.351 . . . . 0.0 110.947 -174.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -99.18 101.06 12.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.146 0.974 . . . . 0.0 109.634 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.459 ' HE3' ' HB3' ' A' ' 105' ' ' ASP . 71.2 mttt . . . . . 0 C--N 1.318 -0.787 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.289 -172.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.676 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 3.0 tp . . . . . 0 CA--C 1.519 -0.231 0 CA-C-O 121.418 0.628 . . . . 0.0 111.568 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 43.8 p -128.17 -175.24 3.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.93 177.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.561 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -65.65 -33.29 75.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.058 0.456 . . . . 0.0 110.811 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -59.47 -43.46 93.25 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.739 0.78 . . . . 0.0 109.717 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.409 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 6.9 m-20 -70.17 -34.29 72.82 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.633 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.793 HG22 HD22 ' A' ' 91' ' ' LEU . 55.9 t -55.59 -36.51 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.046 0.45 . . . . 0.0 111.154 177.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 t -64.27 -11.43 31.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.64 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.446 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 47.8 mtpt -80.53 -26.34 38.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.733 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.81 HG23 HD13 ' A' ' 59' ' ' LEU . 38.4 pt -95.49 -178.5 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.797 0.808 . . . . 0.0 112.305 -178.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.25 152.7 3.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.585 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.457 ' H ' HG23 ' A' ' 48' ' ' VAL . 0.5 OUTLIER -72.73 144.07 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.265 -178.835 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.19 -32.47 4.72 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.954 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.53 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 18.4 ptt? -90.07 177.14 6.53 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.488 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.912 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 62.4 p -94.0 -174.97 3.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.467 -170.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.47 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 97.9 mt-30 -64.79 -42.26 95.18 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.581 172.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.423 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 9.2 pt20 -67.01 -37.97 85.15 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.705 -177.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.912 ' HG3' ' H ' ' A' ' 51' ' ' THR . 5.7 mm-40 -58.98 -53.2 61.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.966 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.645 HG11 ' CD2' ' A' ' 93' ' ' LEU . 74.7 t -66.5 -46.39 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.997 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.595 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -64.33 -26.61 68.55 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.636 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -81.48 -37.28 28.18 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.614 177.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.98 -48.87 41.87 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.922 0.868 . . . . 0.0 110.78 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.81 HD13 HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -84.21 -55.37 4.22 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.16 -173.351 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.72 133.35 3.23 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 -172.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.595 HG22 ' HB1' ' A' ' 56' ' ' ALA . 39.4 p -68.32 130.91 92.04 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-O 121.238 0.542 . . . . 0.0 110.386 -177.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.532 ' HG2' ' HE2' ' A' ' 64' ' ' MET . 6.9 Cg_exo -69.75 160.89 48.01 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.177 2.584 . . . . 0.0 113.062 -170.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.78 -28.33 69.38 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.506 -171.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.532 ' HE2' ' HG2' ' A' ' 62' ' ' PRO . 10.7 ptt? -61.79 -4.28 1.44 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.111 177.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.4 t 73.54 -4.0 2.34 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 170.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -146.86 99.71 4.01 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-O 120.907 0.384 . . . . 0.0 110.954 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.432 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 39.6 Cg_endo -70.13 -30.95 19.76 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.074 1.85 . . . . 0.0 111.527 175.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -85.72 12.02 9.8 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.535 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.82 -20.27 13.33 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.884 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.7 t -125.84 174.0 8.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.646 0.26 . . . . 0.0 110.375 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -117.95 -1.09 11.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.266 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.8 m -125.26 111.42 15.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.542 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.47 ' HH2' ' O ' ' A' ' 52' ' ' GLN . 42.7 m0 -104.12 141.3 36.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.366 -177.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -118.68 118.97 33.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.113 0.482 . . . . 0.0 110.844 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.599 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 63.9 m-85 -127.87 174.41 9.18 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 176.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.489 HG22 ' H ' ' A' ' 77' ' ' PHE . 2.7 p -129.15 167.54 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.127 -173.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.561 ' CG ' ' HB2' ' A' ' 40' ' ' ALA . 7.2 m-30 . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.265 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.444 -0.739 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.965 HD11 HG22 ' A' ' 104' ' ' ILE . 16.3 tp -95.71 123.52 39.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.192 174.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.685 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 34.4 m -114.53 101.26 8.95 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.845 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.2 tp -88.3 126.34 35.13 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.996 -173.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.8 m -112.4 123.22 49.81 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.889 -175.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.537 ' CE2' HD23 ' A' ' 93' ' ' LEU . 80.2 m-85 -113.27 141.25 47.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.884 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.495 ' HB3' HG21 ' A' ' 102' ' ' THR . 32.1 p30 -75.41 -173.63 2.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.903 175.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.4 m -56.29 -35.1 67.11 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -174.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.427 ' HB3' HG23 ' A' ' 100' ' ' VAL . 20.8 t -88.83 9.74 23.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.814 0.34 . . . . 0.0 111.059 -175.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.75 33.85 76.62 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.091 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.48 ' HB ' HD21 ' A' ' 96' ' ' ASN . 7.6 t -106.12 140.06 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.845 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.3 mt -62.17 124.42 20.8 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.43 0.633 . . . . 0.0 112.246 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.495 HG21 ' HB3' ' A' ' 96' ' ' ASN . 18.0 p -111.03 -43.94 3.68 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.612 -1.177 . . . . 0.0 109.965 175.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -136.67 152.75 50.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.745 0.783 . . . . 0.0 111.692 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.965 HG22 HD11 ' A' ' 91' ' ' LEU . 3.6 mm -117.86 93.61 2.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 170.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.685 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 23.4 t70 -87.03 96.47 10.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.948 0.404 . . . . 0.0 110.624 -173.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -105.62 104.31 14.0 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.85 0.834 . . . . 0.0 109.898 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.5 pttm . . . . . 0 C--N 1.314 -0.94 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.773 -176.791 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.62 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 4.5 tp . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 121.224 0.535 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.7 p -127.7 -175.78 3.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.631 174.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.19 -31.53 69.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.053 0.454 . . . . 0.0 110.904 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -60.05 -41.19 91.79 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.563 0.696 . . . . 0.0 109.776 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 11.4 m-20 -67.9 -37.11 81.32 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.887 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.857 HG22 HD22 ' A' ' 91' ' ' LEU . 81.2 t -60.04 -40.66 83.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.77 0.319 . . . . 0.0 111.094 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.1 p -64.5 -18.93 65.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.025 0.441 . . . . 0.0 111.028 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 30.1 mtpp -77.54 -28.42 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.987 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.587 HG23 HD13 ' A' ' 59' ' ' LEU . 43.5 pt -89.56 174.08 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 121.758 0.79 . . . . 0.0 111.822 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -163.4 143.33 8.71 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.719 -176.252 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.467 HG22 HG12 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -69.61 142.27 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.484 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.19 -30.69 5.55 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.86 -175.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.553 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 21.2 ptt? -87.11 175.12 8.24 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.813 176.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.839 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 23.6 p -92.99 -170.0 2.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.846 -171.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -67.51 -46.33 73.19 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.611 173.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.449 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 11.9 pt20 -61.98 -38.8 89.96 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.832 -176.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.839 ' HG3' ' H ' ' A' ' 51' ' ' THR . 7.1 mm-40 -59.52 -46.37 89.04 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.303 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.692 HG11 ' CD2' ' A' ' 93' ' ' LEU . 58.4 t -73.24 -43.46 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.834 -176.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.6 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.11 -24.01 67.7 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.261 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -80.04 -39.47 29.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.773 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.66 -44.06 44.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.008 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.62 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -93.07 -10.03 37.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.917 -172.531 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.66 129.14 1.57 Allowed Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.6 HG22 ' HB1' ' A' ' 56' ' ' ALA . 41.3 p -56.11 131.52 74.56 Favored Pre-proline 0 N--CA 1.439 -0.986 0 CA-C-O 122.028 0.918 . . . . 0.0 111.835 -176.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 67' ' ' PRO . 74.8 Cg_exo -50.6 165.94 0.37 Allowed 'Trans proline' 0 C--N 1.332 -0.333 1 C-N-CA 125.742 4.295 . . . . 0.0 115.431 -176.381 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.478 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 8.1 mt -51.7 -49.28 62.77 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.655 -177.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.471 ' HE3' HG21 ' A' ' 70' ' ' THR . 0.0 OUTLIER -54.1 -13.55 0.85 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.986 179.543 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.0 t 76.11 -17.79 0.51 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.359 0.664 . . . . 0.0 112.066 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -122.21 92.96 48.81 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-O 121.971 0.891 . . . . 0.0 109.819 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.57 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 29.0 Cg_endo -64.49 -30.59 61.76 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.619 2.212 . . . . 0.0 112.493 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -81.35 13.84 2.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.718 -173.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -102.93 -25.15 7.68 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.091 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.471 HG21 ' HE3' ' A' ' 64' ' ' MET . 6.6 t -124.13 169.23 11.91 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -120.52 1.64 10.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.651 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.8 m -118.15 109.08 15.96 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.959 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.416 ' O ' ' HA ' ' A' ' 92' ' ' THR . 46.9 m0 -106.84 134.34 50.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.687 -176.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -113.36 125.92 54.79 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.161 0.288 . . . . 0.0 110.661 -177.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.562 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 60.8 m-85 -135.14 174.93 10.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.424 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.38 162.99 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 120.849 0.357 . . . . 0.0 110.264 -177.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.464 -176.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.442 -0.859 0 CA-C-O 121.234 0.54 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.052 HD11 HG22 ' A' ' 104' ' ' ILE . 21.3 tp -90.16 115.48 27.43 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.056 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.718 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 11.8 m -109.2 95.62 5.75 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.766 ' HG ' HD21 ' A' ' 101' ' ' LEU . 8.3 tp -81.39 125.1 29.99 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.38 -171.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 37.2 m -107.45 121.64 45.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.178 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.532 ' CE2' HD23 ' A' ' 93' ' ' LEU . 77.3 m-85 -115.28 139.71 49.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.537 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.499 ' HB3' HG21 ' A' ' 102' ' ' THR . 32.0 p30 -74.52 -176.38 2.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.614 175.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.2 t -55.13 -37.21 66.64 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -176.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.452 ' HB3' HG23 ' A' ' 100' ' ' VAL . 19.0 t -82.17 2.29 32.31 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.784 0.326 . . . . 0.0 111.059 -174.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.99 31.16 56.21 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.922 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.472 ' HB ' HD21 ' A' ' 96' ' ' ASN . 6.7 t -107.57 139.78 28.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.766 HD21 ' HG ' ' A' ' 93' ' ' LEU . 7.3 mt -60.87 124.8 21.51 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.237 0.541 . . . . 0.0 112.0 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.499 HG21 ' HB3' ' A' ' 96' ' ' ASN . 10.1 p -113.01 -35.92 5.27 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.049 176.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -148.76 148.46 30.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.441 0.639 . . . . 0.0 111.932 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.052 HG22 HD11 ' A' ' 91' ' ' LEU . 5.6 mm -106.01 93.21 2.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 170.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.718 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 17.6 t70 -81.58 97.3 7.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.141 0.496 . . . . 0.0 110.643 -171.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -105.38 110.78 23.26 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.363 0.601 . . . . 0.0 109.814 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? . . . . . 0 C--N 1.313 -0.994 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.823 179.928 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.1 m -67.08 -41.59 86.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.03 0.443 . . . . 0.0 110.134 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -83.01 71.82 10.1 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.0 tpt -78.11 -23.54 47.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.663 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.2 m -51.73 111.2 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.062 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 m -106.46 38.61 2.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.758 0.79 . . . . 0.0 109.413 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.4 tp -81.59 -34.1 31.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.564 -174.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -75.05 135.21 41.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.198 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -164.41 11.8 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.978 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.4 t 69.87 -66.55 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.976 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -147.59 176.97 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -70.88 99.14 1.7 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 120.957 0.408 . . . . 0.0 111.036 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -129.01 81.58 70.55 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 121.448 0.642 . . . . 0.0 109.549 174.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -70.12 139.53 39.2 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.752 2.968 . . . . 0.0 114.344 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -176.88 -70.37 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.56 170.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.844 HG22 ' H ' ' A' ' 34' ' ' GLN . 29.0 mm -100.95 146.6 9.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 114.359 -1.292 . . . . 0.0 111.55 174.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -98.1 -21.21 16.88 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.631 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.844 ' H ' HG22 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -88.29 1.9 53.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.382 -170.423 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 175.32 174.26 41.77 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 119.797 -1.192 . . . . 0.0 113.706 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -125.44 18.64 8.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 122.198 0.999 . . . . 0.0 109.032 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -100.58 -167.91 1.5 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.479 -176.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.649 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 5.5 tp -70.96 152.61 43.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.712 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.512 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 28.2 p -127.7 -174.38 3.17 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.486 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.486 ' H ' ' HB2' ' A' ' 78' ' ' ARG . . . -66.69 -34.87 78.8 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.939 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -56.2 -46.43 79.45 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.509 0.671 . . . . 0.0 110.353 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.608 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.3 m-20 -74.13 -28.44 61.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.308 -176.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.876 HG22 HD22 ' A' ' 91' ' ' LEU . 84.0 t -62.94 -40.56 89.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.406 0.622 . . . . 0.0 109.82 172.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.2 t -64.93 -22.88 67.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.564 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.608 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 42.9 mtpt -70.41 -46.35 64.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.35 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.561 HG23 HD13 ' A' ' 59' ' ' LEU . 22.8 pt -75.77 173.04 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-O 122.01 0.909 . . . . 0.0 112.728 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.69 148.24 10.59 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.469 -176.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.444 ' H ' HG23 ' A' ' 48' ' ' VAL . 0.7 OUTLIER -71.1 143.03 14.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.65 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.96 -32.69 4.5 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.31 -0.947 . . . . 0.0 112.608 -176.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.53 ' HE3' HG22 ' A' ' 46' ' ' ILE . 16.3 ptt? -85.65 177.91 7.54 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 117.371 0.586 . . . . 0.0 111.126 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.811 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 38.9 p -91.9 -171.38 2.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.979 -172.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.458 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 97.1 mt-30 -68.74 -46.26 69.32 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.094 172.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.5 ' HA ' ' HE1' ' A' ' 68' ' ' PHE . 9.9 pt20 -63.4 -35.03 79.05 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.448 0.642 . . . . 0.0 110.171 -175.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.811 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.5 mm-40 -61.43 -56.97 14.28 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.246 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.651 HG11 ' CD2' ' A' ' 93' ' ' LEU . 80.2 t -61.91 -41.78 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.813 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.701 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -56.4 -36.93 69.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.147 0.499 . . . . 0.0 110.228 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -82.26 -34.18 28.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.15 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.66 -41.67 71.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.527 0.679 . . . . 0.0 111.006 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.649 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -92.31 -44.26 8.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.425 -1.262 . . . . 0.0 111.428 -173.343 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.18 122.94 4.16 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -170.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.701 HG22 ' HB1' ' A' ' 56' ' ' ALA . 58.5 p -58.86 135.92 87.11 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 120.963 0.411 . . . . 0.0 111.235 -175.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 23.0 Cg_exo -63.27 172.91 4.64 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.71 2.94 . . . . 0.0 113.585 -172.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 mt -47.66 -48.64 28.85 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.024 -174.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -53.67 -19.57 4.21 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.364 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.6 t 73.13 -4.82 2.08 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.749 0.82 . . . . 0.0 111.75 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -124.12 90.97 50.18 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-O 121.998 0.904 . . . . 0.0 110.044 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HG3' HG22 ' A' ' 61' ' ' THR . 57.4 Cg_endo -70.62 -32.92 14.18 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.462 2.108 . . . . 0.0 112.075 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.5 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 10.5 m-85 -78.09 9.46 3.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.848 -175.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.33 -23.32 19.74 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.841 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.7 t -124.83 174.37 7.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.818 0.342 . . . . 0.0 110.816 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -119.73 5.38 11.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.357 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.4 m -133.95 110.89 10.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.162 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.568 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 48.6 m0 -104.18 138.84 40.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -175.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -116.45 120.97 40.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.868 0.366 . . . . 0.0 110.632 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.61 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 68.1 m-85 -132.15 174.79 9.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.214 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 77' ' ' PHE . 2.7 t -122.23 169.09 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -172.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.476 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -100.36 164.25 12.01 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.486 ' HB2' ' H ' ' A' ' 40' ' ' ALA . 28.5 ttt180 -68.0 160.42 28.76 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.966 -175.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.642 ' HB2' HG23 ' A' ' 32' ' ' ILE . 18.8 tt0 -39.11 102.67 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.824 0.85 . . . . 0.0 112.192 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.47 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 4.1 pp0? -128.74 151.7 77.6 Favored Pre-proline 0 N--CA 1.445 -0.689 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.017 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 45.4 Cg_exo -56.42 -27.99 70.8 Favored 'Trans proline' 0 N--CA 1.48 0.687 0 C-N-CA 124.386 3.39 . . . . 0.0 115.257 -172.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.6 61.47 6.78 Favored Glycine 0 C--N 1.309 -0.945 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.334 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.02 37.84 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.665 ' HG2' ' H ' ' A' ' 85' ' ' GLY . 2.7 tt0 -149.29 -177.34 5.79 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.665 ' H ' ' HG2' ' A' ' 84' ' ' GLU . . . -61.81 -44.36 97.98 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 171.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.549 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 86.8 t -91.42 145.54 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 167.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.462 HG23 ' H ' ' A' ' 88' ' ' GLN . 2.4 t -104.53 -61.66 1.43 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.283 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.462 ' H ' HG23 ' A' ' 87' ' ' THR . 15.2 mm-40 -82.34 168.37 17.62 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.914 0.864 . . . . 0.0 112.722 -172.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -127.31 121.59 31.51 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.545 173.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.1 p -90.35 141.16 29.01 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.929 HD11 HG22 ' A' ' 104' ' ' ILE . 13.7 tp -99.64 117.47 34.06 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 173.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 78.9 m -111.59 107.2 16.27 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.857 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.2 tp -88.54 125.41 34.77 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.613 -174.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.7 m -106.91 124.34 49.48 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.886 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.481 ' CE2' HD23 ' A' ' 93' ' ' LEU . 77.7 m-85 -114.69 141.54 47.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.96 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.509 HD21 ' HB ' ' A' ' 100' ' ' VAL . 30.2 p30 -75.69 -175.31 2.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.354 176.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.5 m -57.65 -35.19 70.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.588 ' HB3' HG23 ' A' ' 100' ' ' VAL . 30.2 t -76.8 -19.84 57.11 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.995 0.426 . . . . 0.0 110.904 -175.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.79 26.86 9.4 Favored Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.588 HG23 ' HB3' ' A' ' 98' ' ' SER . 4.4 t -106.83 142.06 20.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.944 -0.628 . . . . 0.0 109.672 -177.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.857 HD21 ' HG ' ' A' ' 93' ' ' LEU . 5.8 mt -60.86 123.95 19.05 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.21 0.529 . . . . 0.0 111.837 178.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.493 HG21 ' HB3' ' A' ' 96' ' ' ASN . 19.2 p -109.69 -41.72 4.47 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.327 176.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -148.95 145.85 27.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.249 0.547 . . . . 0.0 112.016 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.929 HG22 HD11 ' A' ' 91' ' ' LEU . 3.9 mm -106.27 94.73 3.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 174.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.601 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 9.3 t70 -86.74 98.81 11.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.897 0.38 . . . . 0.0 110.916 -171.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -106.88 106.36 16.85 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.925 0.869 . . . . 0.0 110.29 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.588 ' HE2' ' OG1' ' A' ' 92' ' ' THR . 0.2 OUTLIER -133.68 169.54 13.66 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.054 -178.086 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.574 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 28.9 Cg_endo -67.22 150.79 81.73 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 121.952 1.768 . . . . 0.0 112.588 -173.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.83 -166.22 1.34 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 122.177 0.989 . . . . 0.0 112.355 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.41 ' O ' HG13 ' A' ' 86' ' ' VAL . 18.4 mt -65.2 162.89 16.25 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.275 -1.784 . . . . 0.0 108.911 167.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 5.5 m -72.13 -2.26 17.96 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.162 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.2 -142.13 3.31 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.709 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 . . . . . 0 C--O 1.246 0.913 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 176.637 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.815 0 N-CA-C 111.986 -0.445 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.2 m 56.59 70.14 0.68 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.604 0.362 . . . . 0.0 111.023 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.505 ' C ' ' H ' ' A' ' 21' ' ' SER . 52.2 t-80 -59.73 114.38 2.74 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.0 ttt 72.0 -23.49 0.19 Allowed 'General case' 0 CA--C 1.534 0.361 0 O-C-N 124.037 0.835 . . . . 0.0 111.085 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.505 ' H ' ' C ' ' A' ' 19' ' ' HIS . 23.2 m 69.9 -62.5 0.42 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.037 0.935 . . . . 0.0 112.08 173.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 t -118.15 133.58 55.77 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.908 0.385 . . . . 0.0 110.265 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.1 mt -100.97 86.88 3.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.444 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -97.85 115.45 28.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.45 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.53 ' HD2' ' N ' ' A' ' 25' ' ' ARG . 4.0 mpt_? 54.45 77.6 0.19 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.776 0.672 . . . . 0.0 111.132 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.7 m -76.74 57.8 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.515 0.674 . . . . 0.0 111.393 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 28' ' ' TYR . 1.9 p -79.82 171.44 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.192 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.412 ' H ' HG22 ' A' ' 27' ' ' VAL . 32.0 t80 -61.93 140.98 58.27 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.814 0.34 . . . . 0.0 110.652 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -126.78 99.26 29.68 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.96 0.41 . . . . 0.0 111.017 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -65.01 147.1 88.8 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.963 2.442 . . . . 0.0 111.985 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -103.86 -26.38 12.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.247 0.546 . . . . 0.0 111.508 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.613 HG22 ' H ' ' A' ' 34' ' ' GLN . 29.0 mm -55.86 -56.75 10.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.698 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.51 ' HB3' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER 89.12 -40.59 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.469 -1.696 . . . . 0.0 110.388 -178.685 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.613 ' H ' HG22 ' A' ' 32' ' ' ILE . 7.7 pt20 -94.48 21.57 7.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.685 0.755 . . . . 0.0 110.497 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.5 94.84 0.24 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.763 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -170.85 -41.42 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.629 0.728 . . . . 0.0 109.104 -176.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.423 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 0.6 OUTLIER -115.73 -165.29 1.02 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.409 174.307 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.698 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 3.2 tp -75.37 142.88 43.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.853 0.359 . . . . 0.0 110.564 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 43' ' ' VAL . 43.1 p -127.0 -173.49 2.9 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.107 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' HB2' ' H ' ' A' ' 78' ' ' ARG . . . -62.65 -37.86 88.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.354 0.597 . . . . 0.0 111.379 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -62.05 -42.45 99.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.795 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.519 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 16.7 m-20 -70.25 -32.68 70.63 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.842 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.782 HG22 HD22 ' A' ' 91' ' ' LEU . 58.6 t -58.58 -36.03 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.089 0.471 . . . . 0.0 111.128 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.8 t -62.22 -16.29 52.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.552 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -74.07 -24.02 59.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.643 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.816 HG23 HD13 ' A' ' 59' ' ' LEU . 37.8 pt -100.73 175.83 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.619 0.723 . . . . 0.0 112.244 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.13 150.8 11.45 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.079 -177.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.451 HG22 HG12 ' A' ' 104' ' ' ILE . 0.7 OUTLIER -73.12 143.06 14.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.655 -178.692 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.76 -21.97 8.85 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.352 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.482 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 16.0 ptt? -96.46 178.24 5.42 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.164 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.835 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 41.5 p -92.78 -175.49 3.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.96 -171.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.464 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 77.3 mt-30 -63.05 -46.81 85.75 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.528 171.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.524 ' HA ' ' HE1' ' A' ' 68' ' ' PHE . 9.7 pt20 -65.25 -35.34 80.73 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.334 0.588 . . . . 0.0 109.84 -173.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.835 ' HG3' ' H ' ' A' ' 51' ' ' THR . 7.7 mm-40 -60.25 -51.87 67.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.177 176.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.677 HG11 ' CD2' ' A' ' 93' ' ' LEU . 69.5 t -66.94 -45.0 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.9 -175.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.707 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -64.08 -25.11 67.96 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.436 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -80.9 -42.35 21.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.029 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.78 76.95 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.653 0.74 . . . . 0.0 111.342 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.816 HD13 HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -90.12 -36.4 14.86 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.563 -172.625 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.6 127.76 5.76 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -170.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.707 HG22 ' HB1' ' A' ' 56' ' ' ALA . 56.9 p -59.15 136.21 88.12 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-O 120.93 0.395 . . . . 0.0 110.659 -177.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.509 ' CD ' ' HB3' ' A' ' 67' ' ' PRO . 22.2 Cg_exo -62.07 171.96 4.51 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.478 2.785 . . . . 0.0 113.309 -172.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.412 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 5.5 mt -51.08 -43.68 61.07 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.038 0.535 . . . . 0.0 111.606 -172.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.1 ptt? -58.66 -12.23 3.94 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.423 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.2 t 68.98 -0.59 2.37 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.513 0.725 . . . . 0.0 111.827 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -134.72 91.52 20.86 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.611 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 90.6 Cg_endo -77.85 -29.07 4.63 Favored 'Trans proline' 0 C--N 1.327 -0.554 0 C-N-CA 123.268 2.645 . . . . 0.0 113.15 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.524 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 13.0 m-85 -80.59 21.62 0.63 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.038 -172.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.7 -17.41 8.02 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.989 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 t -124.81 172.27 9.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.732 0.301 . . . . 0.0 110.385 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -125.01 15.57 8.51 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.282 0.563 . . . . 0.0 109.975 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.6 m -138.88 109.24 6.49 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.495 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.611 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 50.3 m0 -104.48 143.23 33.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.707 -175.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -118.06 115.03 24.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.156 0.503 . . . . 0.0 111.241 -176.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.619 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 57.2 m-85 -129.93 176.46 8.03 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.2 p -128.87 153.57 38.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.598 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.474 ' HE1' HG21 ' A' ' 43' ' ' VAL . 1.5 m-30 -90.35 159.08 16.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.301 176.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.528 ' H ' ' HB2' ' A' ' 40' ' ' ALA . 4.1 tmt_? -63.01 107.84 1.09 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.772 ' HG3' ' H ' ' A' ' 80' ' ' GLN . 4.7 tp-100 -167.64 -150.91 0.11 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.332 -172.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.772 ' H ' ' HG3' ' A' ' 79' ' ' GLN . 3.5 pt20 -54.39 149.2 21.08 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 121.465 0.65 . . . . 0.0 112.051 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 12.3 Cg_exo -71.0 -9.01 24.86 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.402 2.735 . . . . 0.0 112.202 174.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.84 6.98 56.9 Favored Glycine 0 C--N 1.32 -0.334 0 CA-C-N 115.245 -0.889 . . . . 0.0 114.232 169.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -109.31 31.63 5.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.863 0.832 . . . . 0.0 110.5 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.596 ' HB2' ' NE2' ' A' ' 80' ' ' GLN . 42.8 mp0 -122.37 -166.22 1.39 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.398 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.87 94.28 0.29 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.6 t -41.07 122.57 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 122.06 0.933 . . . . 0.0 112.983 -171.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 t -152.0 11.09 0.55 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 113.608 -1.633 . . . . 0.0 108.996 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.4 130.21 45.81 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.376 -1.283 . . . . 0.0 111.536 -175.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 50.8 mt-30 -81.03 107.3 13.73 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.964 0.411 . . . . 0.0 109.906 174.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.9 p -89.99 142.27 27.87 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.26 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.989 HD11 HG22 ' A' ' 104' ' ' ILE . 14.1 tp -93.0 112.55 24.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.875 174.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.725 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 10.6 m -107.09 105.98 16.25 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.866 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.0 tp -87.37 118.21 26.66 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.515 -175.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 38.6 m -101.64 122.68 44.32 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.127 -174.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.519 ' CE2' HD23 ' A' ' 93' ' ' LEU . 72.9 m-85 -116.13 140.88 48.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.241 -178.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.534 HD21 ' HB ' ' A' ' 100' ' ' VAL . 30.1 p30 -76.43 -177.19 4.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.16 175.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.0 t -54.42 -38.31 66.1 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.434 ' HB2' HG23 ' A' ' 100' ' ' VAL . 49.8 m -80.2 -3.8 50.51 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -174.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.33 28.0 34.68 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.824 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.534 ' HB ' HD21 ' A' ' 96' ' ' ASN . 6.6 t -106.41 140.86 23.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.866 HD21 ' HG ' ' A' ' 93' ' ' LEU . 7.3 mt -59.91 126.2 26.62 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.328 0.585 . . . . 0.0 112.195 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.416 HG21 ' HB3' ' A' ' 96' ' ' ASN . 18.0 p -111.18 -36.7 5.53 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.365 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -152.95 152.98 32.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.325 0.583 . . . . 0.0 111.673 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.989 HG22 HD11 ' A' ' 91' ' ' LEU . 3.3 mm -108.41 92.6 2.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 171.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.725 ' HB2' ' HB ' ' A' ' 92' ' ' THR . 2.3 m-20 -78.4 96.33 5.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.574 0.226 . . . . 0.0 110.989 -174.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -112.07 107.42 16.36 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.829 0.824 . . . . 0.0 110.49 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.449 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -148.3 168.48 11.03 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.445 -178.684 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 19.3 Cg_endo -72.62 147.3 45.29 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.83 1.687 . . . . 0.0 111.589 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.42 173.93 8.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.959 0.885 . . . . 0.0 112.376 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.5 mt -89.77 111.52 22.54 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.035 -1.438 . . . . 0.0 110.945 -170.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.4 m -85.71 4.5 36.41 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.213 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.94 -100.72 2.62 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.803 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.3 p30 . . . . . 0 C--N 1.311 -1.067 0 CA-C-O 118.566 -0.73 . . . . 0.0 109.98 178.671 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.5 m 61.84 -175.26 0.13 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.076 0.465 . . . . 0.0 111.989 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.1 m170 61.37 30.75 19.15 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.311 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.6 ptp -95.27 27.31 3.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.626 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.481 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 23.8 m -76.95 74.95 3.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.444 177.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.2 m -63.1 107.3 1.0 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.177 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 21' ' ' SER . 81.7 mt -108.43 -44.25 4.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.225 -174.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -92.74 127.99 38.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.969 0.414 . . . . 0.0 110.978 -174.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.623 ' O ' HG22 ' A' ' 26' ' ' VAL . 1.1 ptm180 -86.2 63.52 8.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.032 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 25' ' ' ARG . 2.0 m 59.97 172.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.734 1.214 . . . . 0.0 110.994 -173.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.523 HG22 ' H ' ' A' ' 28' ' ' TYR . 1.4 p -140.02 -179.12 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.523 ' H ' HG22 ' A' ' 27' ' ' VAL . 90.0 m-85 -49.17 145.67 4.11 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.884 0.474 . . . . 0.0 111.596 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -74.47 117.14 59.65 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.668 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.41 133.49 48.75 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 123.736 2.957 . . . . 0.0 113.292 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -112.61 -118.06 0.31 Allowed 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 172.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.907 HG22 ' H ' ' A' ' 34' ' ' GLN . 23.8 mm -98.98 143.53 13.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-O 120.898 0.38 . . . . 0.0 110.515 170.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -79.61 -22.81 43.19 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.844 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.907 ' H ' HG22 ' A' ' 32' ' ' ILE . 11.3 pt20 -114.3 67.52 0.68 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.779 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.54 -146.35 5.28 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.28 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.0 t30 72.57 -48.58 0.69 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.635 0.774 . . . . 0.0 110.899 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.421 ' OH ' ' HB2' ' A' ' 34' ' ' GLN . 8.5 p90 -107.12 -170.21 1.67 Allowed 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.584 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 2.5 tp -89.46 152.44 21.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.743 0.306 . . . . 0.0 110.88 -176.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.767 HG21 HG21 ' A' ' 32' ' ' ILE . 43.6 p -127.14 -174.66 3.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.171 175.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.419 ' H ' ' N ' ' A' ' 78' ' ' ARG . . . -66.82 -38.19 85.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.332 0.586 . . . . 0.0 110.606 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.536 ' ND2' HD11 ' A' ' 32' ' ' ILE . 2.8 m-20 -54.31 -40.7 68.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.44 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.57 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 12.9 m-20 -73.92 -33.35 63.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.783 -1.098 . . . . 0.0 111.209 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.784 HG22 HD22 ' A' ' 91' ' ' LEU . 74.0 t -60.71 -37.73 76.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.314 0.578 . . . . 0.0 110.211 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.7 t -58.54 -22.39 55.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.126 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 45.2 mtpt -71.61 -40.59 69.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.78 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.681 HG23 HD13 ' A' ' 59' ' ' LEU . 41.6 pt -85.58 179.2 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-O 121.938 0.875 . . . . 0.0 112.925 -175.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.443 ' N ' ' HD3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -168.26 147.2 4.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.464 -175.449 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.467 HG22 ' CG1' ' A' ' 104' ' ' ILE . 0.8 OUTLIER -72.61 144.22 13.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.742 -179.353 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.98 -31.75 5.03 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.861 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.553 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 21.7 ptt? -86.39 175.14 8.56 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.976 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.943 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 26.0 p -93.29 -170.77 2.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.974 -171.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -66.69 -46.04 76.89 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.616 172.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.503 ' OE1' ' HG2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -66.73 -29.31 69.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.469 0.652 . . . . 0.0 110.47 -175.242 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.943 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.0 mm-40 -63.19 -56.59 15.43 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.397 174.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.651 HG11 ' CD2' ' A' ' 93' ' ' LEU . 82.9 t -67.51 -38.82 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.455 -177.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.689 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.7 -32.17 68.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.182 0.515 . . . . 0.0 110.109 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -82.26 -39.17 23.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.589 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.79 -44.94 63.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.167 0.508 . . . . 0.0 111.881 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.681 HD13 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -95.73 -12.63 25.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.411 -174.348 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.77 129.33 2.28 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.255 -0.974 . . . . 0.0 110.876 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.689 HG22 ' HB1' ' A' ' 56' ' ' ALA . 22.1 p -55.3 133.4 69.64 Favored Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-O 121.466 0.65 . . . . 0.0 111.284 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 34.8 Cg_exo -63.49 166.93 14.14 Favored 'Trans proline' 0 C--O 1.23 0.092 0 C-N-CA 123.753 2.969 . . . . 0.0 113.377 -171.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.419 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 1.5 mt -54.08 -33.16 56.84 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.104 -170.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.461 ' SD ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -63.68 3.33 0.36 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.39 176.548 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 63' ' ' LEU . 27.7 p 53.94 24.81 4.87 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.8 0.84 . . . . 0.0 111.593 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -169.9 105.11 0.45 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.41 -178.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.585 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 83.6 Cg_endo -80.07 -23.03 6.85 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 122.833 2.355 . . . . 0.0 113.201 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -82.8 -6.75 59.57 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -171.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.28 -20.68 51.66 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.328 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 t -125.16 174.74 7.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.993 0.425 . . . . 0.0 110.228 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -129.24 14.01 6.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.366 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.7 m -131.2 110.32 11.05 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.84 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.593 ' O ' ' HA ' ' A' ' 92' ' ' THR . 46.3 m0 -108.66 149.08 29.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.885 -175.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -125.13 123.22 39.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.544 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.617 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 86.6 m-85 -133.01 173.75 11.08 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.9 t -113.24 164.82 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -175.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -105.02 164.42 11.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.252 -178.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.572 ' HD2' ' N ' ' A' ' 79' ' ' GLN . 1.6 tmm_? -66.56 145.57 55.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.451 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.572 ' N ' ' HD2' ' A' ' 78' ' ' ARG . 54.7 tt0 -32.15 101.68 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.498 1.124 . . . . 0.0 113.547 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 17.7 mm-40 -92.38 154.19 42.81 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.888 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 11.3 Cg_exo -70.63 105.32 1.61 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 124.129 3.22 . . . . 0.0 111.872 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.62 ' HA2' HG21 ' A' ' 87' ' ' THR . . . -67.16 115.81 7.5 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.007 -175.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -127.4 -3.39 6.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.885 0.374 . . . . 0.0 110.67 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.563 ' HG2' ' H ' ' A' ' 85' ' ' GLY . 22.7 tt0 -142.85 -179.81 6.56 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.563 ' H ' ' HG2' ' A' ' 84' ' ' GLU . . . -51.09 -55.04 20.52 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 176.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.673 ' HB ' ' HB2' ' A' ' 111' ' ' SER . 38.6 t -123.5 141.85 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 170.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.62 HG21 ' HA2' ' A' ' 82' ' ' GLY . 13.0 t -133.66 4.83 3.65 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.928 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.67 172.95 13.09 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.41 0.624 . . . . 0.0 110.492 177.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.474 ' HB3' ' HA ' ' A' ' 108' ' ' PRO . 3.2 pt20 -148.04 128.05 13.64 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.186 174.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p -90.35 142.62 27.55 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.887 -175.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.955 HD11 HG22 ' A' ' 104' ' ' ILE . 14.4 tp -90.02 110.95 21.91 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.95 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 24.4 m -103.68 105.01 15.12 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.83 ' HG ' HD21 ' A' ' 101' ' ' LEU . 8.2 tp -88.36 124.27 33.76 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.37 -173.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.558 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 42.1 m -104.16 120.98 42.29 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.978 -176.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.53 ' CE2' HD23 ' A' ' 93' ' ' LEU . 66.1 m-85 -114.5 137.73 51.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.744 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.559 ' HB3' HG21 ' A' ' 102' ' ' THR . 33.3 p30 -75.26 -171.96 1.58 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.45 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.1 m -55.61 -37.99 68.86 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.465 ' HB3' HG23 ' A' ' 100' ' ' VAL . 22.8 t -84.2 -3.61 58.28 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.985 0.422 . . . . 0.0 110.869 -173.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.59 31.85 35.59 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.621 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.488 ' HB ' HD21 ' A' ' 96' ' ' ASN . 11.2 t -107.02 141.47 22.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.83 HD21 ' HG ' ' A' ' 93' ' ' LEU . 7.0 mt -62.68 122.88 16.97 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.559 0.695 . . . . 0.0 112.254 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.559 HG21 ' HB3' ' A' ' 96' ' ' ASN . 21.1 p -109.62 -42.09 4.39 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.711 175.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.558 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 5.3 m-20 -137.06 154.83 50.25 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.271 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.955 HG22 HD11 ' A' ' 91' ' ' LEU . 5.0 mm -116.7 91.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 167.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 92' ' ' THR . 5.6 m-20 -83.55 94.91 8.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.039 0.447 . . . . 0.0 110.752 -172.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -100.78 102.85 14.03 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.755 0.788 . . . . 0.0 109.414 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.431 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 21.1 mttt -125.69 156.71 70.56 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.482 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.474 ' HA ' ' HB3' ' A' ' 89' ' ' GLN . 12.1 Cg_endo -69.22 145.84 61.6 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.97 2.447 . . . . 0.0 112.028 -175.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.499 ' HB3' HG11 ' A' ' 86' ' ' VAL . . . -71.26 170.94 12.0 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.488 0.661 . . . . 0.0 110.996 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.6 mt -73.36 99.32 2.9 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.219 -168.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.673 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 14.3 t -121.61 11.04 10.49 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.215 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 153.46 119.85 0.77 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.821 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.3 m120 . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.671 -0.681 . . . . 0.0 110.341 -178.793 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.514 ' HB2' ' OG1' ' A' ' 22' ' ' THR . 57.6 m -78.23 -17.15 57.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.96 0.38 . . . . 0.0 110.685 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 77.5 -22.87 0.26 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.433 0.693 . . . . 0.0 111.99 173.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.7 tpt -147.51 126.57 12.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.59 0.233 . . . . 0.0 110.91 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 m 60.39 42.04 15.26 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.483 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.514 ' OG1' ' HB2' ' A' ' 18' ' ' SER . 7.1 m -86.18 -49.83 7.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.142 0.496 . . . . 0.0 111.262 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.1 mt -93.01 -2.86 55.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.455 -171.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -101.61 4.74 41.19 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.192 -176.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -132.68 103.81 6.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.124 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.743 HG23 ' H ' ' A' ' 27' ' ' VAL . 2.7 m -84.75 -91.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.891 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.743 ' H ' HG23 ' A' ' 26' ' ' VAL . 2.3 p -164.34 176.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.433 ' H ' HG22 ' A' ' 27' ' ' VAL . 54.3 t80 -55.12 136.76 47.98 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.822 0.344 . . . . 0.0 110.501 175.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -97.29 111.56 58.55 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.209 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 28' ' ' TYR . 50.5 Cg_exo -53.8 148.46 37.03 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.176 2.584 . . . . 0.0 112.073 174.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -63.99 -71.02 0.19 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.78 0.8 . . . . 0.0 111.208 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.541 HG22 ' H ' ' A' ' 34' ' ' GLN . 37.0 mm -87.81 141.24 14.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.29 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -77.85 -36.15 50.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.055 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.541 ' H ' HG22 ' A' ' 32' ' ' ILE . 11.0 pt20 -98.53 44.89 1.02 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.49 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.54 41.18 2.78 Favored Glycine 0 C--N 1.314 -0.64 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.35 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -89.39 -23.56 22.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.153 0.501 . . . . 0.0 110.037 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -122.08 -166.5 1.41 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.338 176.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.542 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 11.4 tp -76.46 161.55 28.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.129 0.49 . . . . 0.0 110.975 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 78' ' ' ARG . 33.5 p -127.71 177.19 6.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.156 170.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.43 -30.61 66.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.009 0.433 . . . . 0.0 110.495 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -55.69 -45.04 77.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.714 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.683 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 22.7 m-20 -67.2 -26.35 66.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.231 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.968 HG22 HD22 ' A' ' 91' ' ' LEU . 79.3 t -64.32 -37.28 79.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.172 0.511 . . . . 0.0 110.026 176.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.3 t -66.54 -20.84 66.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.452 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.683 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 36.4 mtpt -71.34 -32.28 68.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.92 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.623 HG23 HD13 ' A' ' 59' ' ' LEU . 30.9 pt -94.76 177.6 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-O 121.895 0.855 . . . . 0.0 112.032 177.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.41 ' HE ' ' HB3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -172.3 154.31 3.24 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.417 -174.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.426 HG22 HD11 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -71.95 144.99 12.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.048 -178.378 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.38 -36.81 3.16 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.163 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.609 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 5.6 ptt? -85.25 171.61 11.8 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.191 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.851 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 44.0 p -86.07 -172.49 4.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.007 -172.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.5 ' HA ' ' CZ ' ' A' ' 95' ' ' PHE . 39.5 mt-30 -68.31 -42.59 79.19 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.216 173.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.558 ' HA ' ' HE1' ' A' ' 68' ' ' PHE . 9.0 pt20 -66.36 -36.03 81.85 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.264 -175.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.851 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.8 mm-40 -58.26 -54.21 49.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.889 176.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.657 HG11 ' CD2' ' A' ' 93' ' ' LEU . 85.6 t -65.58 -41.3 90.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.793 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.566 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -57.67 -33.12 67.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.385 0.612 . . . . 0.0 110.096 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -81.3 -36.78 29.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.825 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.35 -42.07 55.12 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.249 0.547 . . . . 0.0 111.764 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.623 HD13 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -95.24 -16.94 22.12 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.83 -173.241 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.95 130.46 5.43 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.305 -0.95 . . . . 0.0 110.756 -174.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.566 HG22 ' HB1' ' A' ' 56' ' ' ALA . 4.5 p -65.11 134.95 96.09 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 121.343 0.592 . . . . 0.0 111.304 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 22.0 Cg_exo -67.59 171.41 12.0 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.998 3.132 . . . . 0.0 113.14 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.427 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 7.7 mt -49.09 -48.23 44.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.518 -178.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -59.59 144.73 46.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.757 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.3 p -73.02 1.72 8.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -154.44 108.59 2.4 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-O 121.345 0.593 . . . . 0.0 110.528 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.65 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 59.2 Cg_endo -73.29 -25.39 15.67 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.078 2.519 . . . . 0.0 113.048 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.558 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 8.3 m-85 -81.57 -5.44 58.02 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -170.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.21 -8.17 63.2 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.71 -174.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.2 t -123.58 171.96 9.14 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -119.38 1.25 11.23 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 m -126.64 115.2 19.1 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.555 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.65 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 44.6 m0 -109.36 141.68 41.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.708 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -119.12 120.71 37.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.477 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.657 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 90.3 m-85 -128.03 175.56 8.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.228 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.466 HG13 ' CD ' ' A' ' 88' ' ' GLN . 39.9 t -124.26 152.66 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -172.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 -97.54 152.92 18.53 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 171.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.515 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 27.6 ptt180 -79.32 149.51 31.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.15 -172.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 52.89 60.14 3.99 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.795 0.807 . . . . 0.0 111.693 173.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.61 ' HG3' ' NE2' ' A' ' 88' ' ' GLN . 11.4 mm-40 -117.63 167.0 11.93 Favored Pre-proline 0 N--CA 1.446 -0.673 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.268 172.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.58 ' HD2' ' HB3' ' A' ' 80' ' ' GLN . 18.7 Cg_endo -64.72 -63.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 121.708 1.606 . . . . 0.0 111.783 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.54 -58.34 3.76 Favored Glycine 0 C--N 1.313 -0.722 0 CA-C-N 114.696 -1.138 . . . . 0.0 113.37 173.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -72.44 -71.66 0.28 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.882 0.372 . . . . 0.0 110.374 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -100.91 141.74 33.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.689 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.39 67.27 2.08 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.497 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.1 127.1 25.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.414 0.626 . . . . 0.0 110.704 -175.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.0 t -171.9 13.68 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.328 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.61 ' NE2' ' HG3' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -56.65 120.36 7.66 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.52 178.517 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.89 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 75.8 mt-30 -76.52 104.41 7.01 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.674 -0.41 . . . . 0.0 109.985 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.436 HG23 ' HG3' ' A' ' 88' ' ' GLN . 18.0 p -89.36 146.88 24.39 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.104 -177.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.986 HD11 HG22 ' A' ' 104' ' ' ILE . 38.7 tp -91.11 110.76 22.03 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 28.7 m -105.27 102.69 12.15 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.763 ' HG ' HD21 ' A' ' 101' ' ' LEU . 8.9 tp -88.39 126.78 35.38 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.547 -171.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.5 m -103.8 121.24 42.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.008 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.59 ' CE2' HD23 ' A' ' 93' ' ' LEU . 25.8 m-85 -111.92 148.52 33.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.914 0.864 . . . . 0.0 112.503 -175.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -73.8 173.1 10.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.874 -1.512 . . . . 0.0 110.451 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.8 m -62.34 -30.07 70.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.17 0.509 . . . . 0.0 110.862 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.407 ' HB3' HG23 ' A' ' 100' ' ' VAL . 30.8 t -87.55 4.43 43.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.793 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.11 34.53 55.17 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.954 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' A' ' 98' ' ' SER . 15.4 t -107.37 139.31 29.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.763 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.3 mt -60.73 127.5 31.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.393 0.616 . . . . 0.0 111.673 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 66.5 p -116.38 -39.94 3.3 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.136 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -144.7 149.56 35.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.854 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.986 HG22 HD11 ' A' ' 91' ' ' LEU . 3.8 mm -112.6 94.06 2.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 173.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.593 ' HB2' ' O ' ' A' ' 92' ' ' THR . 4.5 m-20 -80.48 95.49 6.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.024 0.44 . . . . 0.0 110.523 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -106.57 102.78 12.14 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.72 0.771 . . . . 0.0 110.269 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.548 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -151.91 171.06 7.02 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.62 -176.819 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.89 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 31.9 Cg_endo -71.03 157.06 58.88 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.5 1.467 . . . . 0.0 111.945 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.5 -179.81 2.68 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.577 174.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.417 ' HG ' ' H ' ' A' ' 110' ' ' LEU . 19.5 mt -54.54 101.82 0.05 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.754 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.8 t -111.31 -24.5 10.19 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.639 -174.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.7 157.83 9.75 Favored Glycine 0 C--N 1.311 -0.848 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.546 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.6 t30 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.954 -178.018 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.448 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . . . . . . 0 N--CA 1.48 1.576 0 N-CA-C 112.084 -0.406 . . . . 0.0 112.084 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 m -68.87 144.85 54.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.63 0.252 . . . . 0.0 111.149 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.436 ' HB2' ' OG1' ' A' ' 22' ' ' THR . 35.6 m80 64.08 -166.61 0.22 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.614 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -76.11 -52.49 10.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.679 0.276 . . . . 0.0 111.544 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.0 t -141.42 37.59 1.69 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.976 0.417 . . . . 0.0 111.458 -176.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.59 HG22 HD22 ' A' ' 23' ' ' LEU . 91.6 m -72.87 -45.41 58.42 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.59 HD22 HG22 ' A' ' 22' ' ' THR . 3.5 mm? -116.24 92.62 3.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.079 175.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -90.84 141.23 29.04 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 -126.74 -26.29 3.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.227 -173.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.49 126.99 50.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.157 0.503 . . . . 0.0 110.49 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.59 HG22 ' H ' ' A' ' 28' ' ' TYR . 1.7 p -95.96 -177.73 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.318 -176.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.59 ' H ' HG22 ' A' ' 27' ' ' VAL . 84.0 m-85 -57.97 166.5 1.48 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.693 0.759 . . . . 0.0 112.562 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -103.69 142.47 24.66 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.446 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -43.82 137.43 6.57 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.904 3.069 . . . . 0.0 113.893 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -80.93 68.11 7.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.642 -176.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.775 HG22 ' H ' ' A' ' 34' ' ' GLN . 39.5 mm -68.22 139.37 20.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.792 173.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.31 -20.9 27.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.398 0.618 . . . . 0.0 110.192 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.775 ' H ' HG22 ' A' ' 32' ' ' ILE . 9.6 pt20 -118.08 88.95 3.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.681 0.753 . . . . 0.0 111.489 -175.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.17 35.72 3.55 Favored Glycine 0 C--N 1.314 -0.689 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.283 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -79.48 -27.35 41.52 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.016 0.436 . . . . 0.0 110.876 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -122.46 -169.2 1.86 Allowed 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.892 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.659 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 3.1 tp -75.51 150.33 38.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.925 0.393 . . . . 0.0 110.459 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 43' ' ' VAL . 32.3 p -127.41 -178.36 4.43 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.079 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.15 -35.54 79.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.383 0.611 . . . . 0.0 110.552 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -59.32 -46.46 88.52 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.985 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.578 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 14.9 m-20 -69.31 -32.14 71.06 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.798 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.721 HG22 HD22 ' A' ' 91' ' ' LEU . 68.0 t -57.92 -38.18 64.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.109 0.481 . . . . 0.0 110.525 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -59.24 -21.59 59.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.154 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 45.9 mtpt -70.85 -29.3 65.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.982 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.803 HG23 HD13 ' A' ' 59' ' ' LEU . 38.9 pt -95.48 176.11 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.787 0.803 . . . . 0.0 112.257 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.431 ' HE ' ' HB3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -164.71 148.42 8.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.775 -177.472 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.445 HG22 HD11 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -70.79 140.14 18.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.332 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.43 -17.57 8.94 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.488 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.471 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 17.6 ptt? -102.43 173.09 6.51 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.109 174.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.713 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 12.7 p -88.08 -173.35 4.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.007 -172.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.511 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 13.2 mt-30 -69.44 -41.93 75.62 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.562 175.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.567 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 1.5 pp0? -65.5 -33.19 75.35 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.609 0.719 . . . . 0.0 109.591 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.713 ' HG3' ' H ' ' A' ' 51' ' ' THR . 11.2 mm-40 -61.61 -55.93 25.38 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.598 175.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.645 HG11 ' CD2' ' A' ' 93' ' ' LEU . 82.5 t -66.03 -40.4 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.387 -176.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.733 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.74 -34.2 71.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.278 0.561 . . . . 0.0 110.012 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -81.16 -39.97 24.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.769 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.27 -49.68 53.86 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.782 0.801 . . . . 0.0 111.402 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.803 HD13 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -86.07 -45.07 11.75 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.189 -173.773 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.02 126.8 3.46 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -174.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.733 HG22 ' HB1' ' A' ' 56' ' ' ALA . 47.6 p -59.84 132.09 89.15 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-O 121.15 0.5 . . . . 0.0 110.934 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 28.0 Cg_exo -63.59 164.18 21.84 Favored 'Trans proline' 0 CA--C 1.52 -0.208 0 C-N-CA 123.745 2.963 . . . . 0.0 112.554 -172.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.431 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 1.9 mt -52.72 -32.96 45.63 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.47 -168.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.409 ' HG2' ' H ' ' A' ' 64' ' ' MET . 10.8 ptt? -62.48 -9.87 9.92 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.685 0.616 . . . . 0.0 111.926 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 t 72.27 -2.3 2.63 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.669 0.788 . . . . 0.0 112.466 173.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -138.12 91.97 12.66 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-O 121.159 0.504 . . . . 0.0 109.999 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.707 ' HG3' HG22 ' A' ' 61' ' ' THR . 74.0 Cg_endo -74.0 -30.25 9.22 Favored 'Trans proline' 0 CA--C 1.529 0.247 0 C-N-CA 123.193 2.595 . . . . 0.0 112.964 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.497 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 12.7 m-85 -76.78 3.6 11.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.105 -172.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.49 -25.7 25.07 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.881 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.4 t -123.78 174.21 7.65 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.413 ' HB2' ' HB2' ' A' ' 95' ' ' PHE . 26.3 p-10 -122.33 2.58 9.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.107 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.4 m -123.07 108.66 13.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.813 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.576 ' O ' ' HA ' ' A' ' 92' ' ' THR . 47.0 m0 -105.58 148.68 27.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.875 -174.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -124.48 118.2 26.1 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.976 0.417 . . . . 0.0 111.249 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.641 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 80.3 m-85 -128.9 175.5 8.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.274 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.8 t -122.85 165.74 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.404 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 6.1 m-30 -93.69 -178.13 4.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.65 0.262 . . . . 0.0 110.632 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.569 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 16.4 ptt180 -71.01 171.23 11.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.083 -173.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.605 ' HB3' HD12 ' A' ' 32' ' ' ILE . 28.1 tt0 -46.55 94.39 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 O-C-N 124.022 0.826 . . . . 0.0 112.843 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 10.7 pt20 -141.93 161.41 51.43 Favored Pre-proline 0 N--CA 1.444 -0.749 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.698 175.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -50.05 107.88 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.412 2.741 . . . . 0.0 113.248 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.484 ' HA2' HG13 ' A' ' 86' ' ' VAL . . . -115.73 6.47 20.27 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.611 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -122.95 147.9 46.09 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 59.4 -90.26 0.03 OUTLIER 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.824 0.702 . . . . 0.0 111.465 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -84.75 72.15 2.84 Favored Glycine 0 C--N 1.302 -1.327 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.096 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.484 HG13 ' HA2' ' A' ' 82' ' ' GLY . 14.7 t -68.57 136.16 26.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.261 0.553 . . . . 0.0 111.387 -175.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -136.29 -3.28 2.19 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.309 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.559 ' HG2' ' HG3' ' A' ' 80' ' ' GLN . 7.7 mm-40 -55.81 139.79 44.36 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.687 0.756 . . . . 0.0 112.492 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.592 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 45.7 mt-30 -124.66 131.42 53.47 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.252 175.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.8 p -89.08 146.67 24.68 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.311 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.751 HD11 ' CG2' ' A' ' 104' ' ' ILE . 13.8 tp -89.66 103.39 16.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 18.2 m -98.21 100.62 11.93 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.902 ' HG ' HD21 ' A' ' 101' ' ' LEU . 8.4 tp -86.01 121.58 28.83 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.256 -172.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.4 m -101.54 119.6 39.02 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.018 -175.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.453 ' CE2' HD23 ' A' ' 93' ' ' LEU . 72.2 m-85 -113.22 142.36 45.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.492 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.503 ' HB3' HG21 ' A' ' 102' ' ' THR . 30.1 p30 -75.85 -177.72 3.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.96 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.2 m -56.61 -30.55 63.36 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.2 t -85.91 -3.86 59.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.701 0.286 . . . . 0.0 111.257 -173.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.48 32.72 27.17 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.424 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.48 ' HB ' HD21 ' A' ' 96' ' ' ASN . 5.0 t -113.7 139.21 40.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.794 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.902 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.7 mt -61.14 123.14 16.84 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.276 0.56 . . . . 0.0 112.307 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.503 HG21 ' HB3' ' A' ' 96' ' ' ASN . 12.4 p -110.29 -39.14 5.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.025 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -148.92 150.63 33.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.481 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.751 ' CG2' HD11 ' A' ' 91' ' ' LEU . 5.6 mm -105.35 92.76 2.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 171.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 92' ' ' THR . 7.2 m-20 -83.94 94.88 8.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.284 0.564 . . . . 0.0 110.259 -177.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -95.25 102.08 13.86 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.881 0.848 . . . . 0.0 108.978 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.509 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 20.6 mmtm -129.16 151.93 78.55 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.873 -172.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 17.8 Cg_endo -65.49 147.14 86.56 Favored 'Trans proline' 0 C--N 1.33 -0.408 0 C-N-CA 123.818 3.012 . . . . 0.0 113.557 -167.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.02 139.47 35.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.268 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.6 mt 34.13 -96.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 O-C-N 125.066 1.479 . . . . 0.0 113.706 177.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.6 m -85.87 68.78 10.46 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.737 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.556 ' HA3' ' HB2' ' A' ' 108' ' ' PRO . . . -77.41 -38.63 28.3 Favored Glycine 0 CA--C 1.504 -0.617 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.215 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 . . . . . 0 C--N 1.307 -1.251 0 CA-C-N 114.621 -0.79 . . . . 0.0 109.345 179.634 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.5 t 65.38 16.54 10.58 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.973 0.509 . . . . 0.0 111.737 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -130.71 86.18 2.35 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.1 mtm -71.63 -52.78 16.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.397 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.1 p -111.29 33.68 4.53 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.133 0.492 . . . . 0.0 109.915 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.0 m 70.43 -64.02 0.38 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.841 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.02 144.55 25.33 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 24' ' ' GLU . 8.2 pt-20 -80.72 44.28 0.72 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.403 0.621 . . . . 0.0 111.169 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -88.09 -5.02 58.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.172 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 26' ' ' VAL . 13.1 p -88.3 34.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 122.149 0.976 . . . . 0.0 110.054 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.07 165.02 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.166 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -82.48 147.04 28.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.803 0.335 . . . . 0.0 110.821 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -98.33 150.69 36.98 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.75 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.25 172.22 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.729 2.953 . . . . 0.0 113.145 174.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.1 t70 68.44 101.26 0.05 Allowed 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.766 0.793 . . . . 0.0 111.254 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.842 HG22 ' H ' ' A' ' 34' ' ' GLN . 11.1 mm 53.94 150.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 113.567 -1.651 . . . . 0.0 115.001 -176.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -102.15 22.62 12.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.484 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.842 ' H ' HG22 ' A' ' 32' ' ' ILE . 2.8 pt20 -148.73 45.21 1.02 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.456 1.122 . . . . 0.0 109.826 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.59 -151.36 7.47 Favored Glycine 0 C--N 1.314 -0.682 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.223 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 60.1 t30 75.88 -45.67 0.54 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.526 0.73 . . . . 0.0 110.903 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -108.94 -167.47 1.22 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 175.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.729 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 3.6 mm? -79.26 152.2 30.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.727 0.775 . . . . 0.0 112.4 -176.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.833 ' HB ' ' HB2' ' A' ' 78' ' ' ARG . 30.7 p -128.92 -177.9 4.4 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.516 170.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.506 ' H ' ' N ' ' A' ' 78' ' ' ARG . . . -65.04 -44.33 89.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.861 0.362 . . . . 0.0 111.624 -176.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -61.16 -40.58 94.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.569 -177.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -68.74 -33.44 73.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.572 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.691 ' HA ' HD11 ' A' ' 59' ' ' LEU . 54.9 t -57.32 -37.7 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.811 0.339 . . . . 0.0 111.475 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.7 p -64.09 -12.42 39.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.149 0.499 . . . . 0.0 111.627 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 43.8 mtpt -77.2 -14.19 59.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.246 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.865 HG23 HD13 ' A' ' 59' ' ' LEU . 35.3 pt -104.21 -176.9 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 121.894 0.854 . . . . 0.0 112.808 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.402 ' H ' ' HE2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -172.64 150.47 2.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.009 -1.45 . . . . 0.0 109.055 -177.394 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.554 HG22 HD11 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -71.09 144.48 13.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.15 -178.694 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.15 -32.31 4.78 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.473 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.538 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 14.4 ptt? -88.3 178.39 6.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 111.415 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.857 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 34.9 p -90.77 -177.04 4.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.793 -171.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.472 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 36.7 mt-30 -66.18 -42.63 88.63 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.506 171.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.3 -37.34 77.48 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.147 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.857 ' HG3' ' H ' ' A' ' 51' ' ' THR . 5.4 mm-40 -67.83 -52.03 41.63 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.318 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.685 HG13 HG21 ' A' ' 46' ' ' ILE . 78.6 t -64.94 -40.84 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.741 -177.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.612 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.41 -33.33 69.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 110.181 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -81.87 -40.28 22.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.098 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.44 -42.4 75.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.686 0.755 . . . . 0.0 111.11 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.865 HD13 HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -92.63 -54.94 3.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.992 -174.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.2 134.94 3.61 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -171.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.612 HG22 ' HB1' ' A' ' 56' ' ' ALA . 28.7 p -66.92 135.92 94.28 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-O 121.224 0.535 . . . . 0.0 111.308 -177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 17.0 Cg_exo -65.79 174.72 5.24 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 C-N-CA 124.19 3.26 . . . . 0.0 113.411 -174.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.409 ' HG ' ' H ' ' A' ' 63' ' ' LEU . 8.2 mt -46.3 -48.47 18.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.353 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.22 126.88 30.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.572 170.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 t -68.78 -7.25 32.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 0.0 111.726 -173.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.456 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 11.1 p-10 -122.14 92.49 48.87 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-O 121.714 0.768 . . . . 0.0 110.199 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.538 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 18.7 Cg_endo -60.05 -36.11 90.53 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.864 2.376 . . . . 0.0 112.186 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -83.48 8.89 12.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.803 -177.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.1 -17.33 57.85 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.8 t -124.45 175.14 7.32 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -125.1 8.04 7.95 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.818 0.342 . . . . 0.0 110.127 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.7 m -131.36 111.82 12.19 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.313 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.675 ' O ' ' HA ' ' A' ' 92' ' ' THR . 48.8 m0 -106.0 142.95 34.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.582 -176.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -123.44 116.32 23.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.75 0.31 . . . . 0.0 110.543 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.587 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 31.1 m-85 -124.72 170.25 11.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.523 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.3 t -120.69 158.63 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.445 ' CG ' ' HB2' ' A' ' 40' ' ' ALA . 1.3 m-30 -87.51 161.16 17.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.338 . . . . 0.0 110.788 176.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.833 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 21.1 ttm180 -84.07 121.88 28.03 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.368 -169.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 59.65 86.96 0.09 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.559 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.845 ' HG2' ' HG2' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -111.41 159.55 32.6 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.973 176.417 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.491 ' HG2' HG22 ' A' ' 87' ' ' THR . 66.0 Cg_exo -54.31 -66.33 0.1 Allowed 'Trans proline' 0 CA--C 1.52 -0.201 0 C-N-CA 122.531 2.154 . . . . 0.0 112.205 173.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.74 -147.86 47.32 Favored Glycine 0 C--N 1.313 -0.718 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.494 -175.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 39.2 m80 61.64 -92.35 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 122.71 0.404 . . . . 0.0 110.993 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -140.12 143.11 36.06 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.05 39.3 46.01 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -171.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.616 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 40.7 t -60.7 142.22 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 114.743 -0.728 . . . . 0.0 110.941 -174.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.491 HG22 ' HG2' ' A' ' 81' ' ' PRO . 14.0 t -130.77 11.02 5.16 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.84 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.845 ' HG2' ' HG2' ' A' ' 80' ' ' GLN . 14.9 mt-30 -36.43 107.13 0.05 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 174.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -80.48 105.37 11.68 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 19.2 p -89.59 143.19 27.01 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.65 -173.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.9 HD11 HG22 ' A' ' 104' ' ' ILE . 14.7 tp -93.6 111.69 23.41 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.862 174.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.715 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 40.2 m -106.9 103.45 12.88 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.906 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.2 tp -90.21 122.82 33.49 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.254 -173.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -109.72 124.22 50.86 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.394 -176.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.51 ' CE1' ' HG ' ' A' ' 101' ' ' LEU . 92.0 m-85 -112.27 144.97 40.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.296 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.541 ' HB3' HG21 ' A' ' 102' ' ' THR . 29.7 p30 -74.88 -173.96 2.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.172 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.1 p -54.59 -32.17 58.22 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.484 ' HB3' HG23 ' A' ' 100' ' ' VAL . 9.7 t -89.45 -3.03 58.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.054 0.454 . . . . 0.0 111.245 -173.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.62 32.98 32.14 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.597 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.491 ' HB ' HD21 ' A' ' 96' ' ' ASN . 7.3 t -108.82 138.86 33.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.906 HD21 ' HG ' ' A' ' 93' ' ' LEU . 5.7 mt -60.07 124.91 21.68 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.648 0.737 . . . . 0.0 112.102 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.541 HG21 ' HB3' ' A' ' 96' ' ' ASN . 34.0 p -112.85 -45.0 3.23 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.348 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -136.52 152.75 50.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.247 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.9 HG22 HD11 ' A' ' 91' ' ' LEU . 3.7 mm -116.08 93.36 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 171.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.715 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 8.0 t70 -89.53 97.34 11.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.04 0.447 . . . . 0.0 111.052 -169.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 90' ' ' THR . 29.0 t-20 -117.64 119.52 35.22 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.36 0.6 . . . . 0.0 110.693 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.569 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -155.07 174.64 3.72 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.144 179.229 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.569 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 27.5 Cg_endo -66.62 165.74 24.37 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 121.814 1.676 . . . . 0.0 111.974 -177.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.78 176.65 5.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.191 0.52 . . . . 0.0 112.316 -176.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.3 mt -50.98 -57.51 8.4 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.406 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.9 p -89.95 35.46 0.85 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.134 0.492 . . . . 0.0 110.984 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.616 ' HA2' ' O ' ' A' ' 86' ' ' VAL . . . -82.51 -164.89 35.7 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.281 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.5 p30 . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.315 -175.886 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.8 p -78.6 -59.9 2.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.02 0.438 . . . . 0.0 110.62 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -95.32 136.26 35.9 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.949 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.56 ' HA ' ' CE ' ' A' ' 20' ' ' MET . 7.9 mmt -98.33 171.87 7.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.382 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.8 m 58.75 71.87 0.56 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.146 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.9 t -108.31 -10.75 15.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.8 175.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.8 mt -122.68 7.44 9.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.238 174.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 48.19 -95.26 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.481 -172.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -139.65 22.08 2.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.8 0.333 . . . . 0.0 110.914 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.74 81.45 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.57 0.7 . . . . 0.0 109.188 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.628 HG22 ' H ' ' A' ' 28' ' ' TYR . 4.3 p -85.24 177.17 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.652 -173.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.628 ' H ' HG22 ' A' ' 27' ' ' VAL . 42.7 t80 -49.44 132.65 20.64 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.773 0.796 . . . . 0.0 112.425 -176.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.58 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 5.8 ppt_? -130.41 170.12 11.87 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.71 177.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.58 ' HD2' ' HB2' ' A' ' 29' ' ' ARG . 75.2 Cg_exo -48.33 176.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.607 2.871 . . . . 0.0 114.017 177.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -64.94 -21.7 66.87 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.732 0.777 . . . . 0.0 110.28 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.92 HG22 ' H ' ' A' ' 34' ' ' GLN . 48.8 mm -75.17 143.09 13.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.993 176.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -85.94 -12.37 50.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.642 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.92 ' H ' HG22 ' A' ' 32' ' ' ILE . 5.2 mt-30 -99.93 -168.16 1.56 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.012 174.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.25 -152.13 23.98 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.614 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.1 t30 73.43 -57.03 0.64 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.378 0.671 . . . . 0.0 111.518 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -86.63 -162.2 0.74 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.805 HD11 ' HG ' ' A' ' 59' ' ' LEU . 0.5 OUTLIER -70.35 144.01 51.77 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.881 0.848 . . . . 0.0 110.892 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.453 ' HB ' ' HB3' ' A' ' 78' ' ' ARG . 44.4 p -130.81 177.93 7.04 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.21 172.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.423 ' H ' ' N ' ' A' ' 78' ' ' ARG . . . -70.88 -28.97 64.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.453 0.644 . . . . 0.0 109.904 176.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -59.08 -44.44 91.89 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.525 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.62 ' HB2' HD13 ' A' ' 38' ' ' LEU . 27.0 m-20 -70.41 -32.85 70.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.697 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.928 HG22 HD22 ' A' ' 91' ' ' LEU . 56.3 t -62.54 -36.24 74.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.859 0.361 . . . . 0.0 110.81 177.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.3 p -68.19 -15.32 63.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.074 0.464 . . . . 0.0 110.525 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.606 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 40.8 mtpt -78.78 -19.53 51.99 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.078 177.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.667 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 44.5 pt -103.38 169.0 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-O 121.735 0.779 . . . . 0.0 112.099 176.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -164.94 148.76 8.75 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.493 -173.169 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.465 HG23 ' H ' ' A' ' 48' ' ' VAL . 0.6 OUTLIER -72.19 143.17 14.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.074 -177.014 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.9 -33.8 4.28 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.703 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.667 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 21.8 ptt? -86.48 175.72 8.22 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.148 0.499 . . . . 0.0 111.189 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.831 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 44.0 p -91.16 -173.38 3.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.081 -170.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.468 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 84.4 mt-30 -65.38 -46.93 78.17 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.385 172.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 9.8 pt20 -64.08 -37.4 87.31 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.98 -175.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.831 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.0 mm-40 -58.34 -49.43 77.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.584 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.645 HG11 ' CD2' ' A' ' 93' ' ' LEU . 61.8 t -69.7 -45.11 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.466 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.706 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.45 -25.03 68.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.002 0.43 . . . . 0.0 110.684 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -80.44 -35.77 34.56 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.291 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.81 -39.87 61.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.742 0.782 . . . . 0.0 111.07 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.805 ' HG ' HD11 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -93.24 -32.55 14.31 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.339 -172.461 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.3 119.93 4.45 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -171.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.706 HG22 ' HB1' ' A' ' 56' ' ' ALA . 46.9 p -53.52 134.54 53.7 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 120.968 0.413 . . . . 0.0 111.426 -173.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 32.3 Cg_exo -63.0 164.43 19.37 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.614 2.876 . . . . 0.0 113.278 -172.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.429 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 3.7 mt -53.31 -36.73 61.57 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.164 -169.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.433 ' H ' ' HG2' ' A' ' 64' ' ' MET . 8.6 ptt? -62.26 -3.26 1.25 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.164 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.4 t 70.39 2.89 4.22 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.445 0.698 . . . . 0.0 112.259 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.417 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 23.5 t70 -152.09 100.52 2.85 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.664 0.745 . . . . 0.0 110.34 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.63 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 38.0 Cg_endo -67.1 -49.71 1.27 Allowed 'Trans proline' 0 C--N 1.332 -0.314 0 C-N-CA 123.63 2.887 . . . . 0.0 113.648 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -80.61 19.1 0.84 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -172.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.36 -19.88 47.6 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 171.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.4 t -124.25 171.15 10.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.982 -0.609 . . . . 0.0 109.53 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -122.72 13.99 10.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.41 0.624 . . . . 0.0 109.681 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 m -139.11 110.53 7.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.022 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.63 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 48.4 m0 -106.94 141.36 38.28 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.941 -175.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -120.04 125.46 48.38 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.18 0.3 . . . . 0.0 110.515 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.55 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 60.1 m-85 -135.66 174.69 10.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.53 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.645 HG23 ' CD ' ' A' ' 88' ' ' GLN . 1.6 p -122.5 150.63 26.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.639 -176.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.638 ' HB2' HE21 ' A' ' 80' ' ' GLN . 10.0 m-30 -86.9 -177.63 6.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.126 0.489 . . . . 0.0 110.571 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.763 ' HB2' HG13 ' A' ' 32' ' ' ILE . 25.6 ptt180 -77.32 170.18 17.0 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.569 ' HB2' HG23 ' A' ' 32' ' ' ILE . 9.1 tt0 -46.85 102.87 0.03 OUTLIER 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -173.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.638 HE21 ' HB2' ' A' ' 77' ' ' PHE . 5.8 pt20 -108.75 137.62 20.09 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.854 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 14.5 Cg_exo -69.47 107.2 1.75 Allowed 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.406 2.738 . . . . 0.0 112.354 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.682 ' HA3' HG21 ' A' ' 87' ' ' THR . . . -110.15 -175.28 20.78 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.486 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -145.48 21.26 1.51 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.613 0.244 . . . . 0.0 111.273 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.544 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 24.9 tt0 -147.43 170.86 16.48 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -173.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.12 -63.44 5.04 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.936 ' HB ' ' HA ' ' A' ' 111' ' ' SER . 41.5 t -118.76 126.3 75.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 166.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.682 HG21 ' HA3' ' A' ' 82' ' ' GLY . 8.2 t -143.5 11.22 1.68 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.569 -176.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.645 ' CD ' HG23 ' A' ' 76' ' ' VAL . 1.1 tp-100 -69.75 128.93 38.14 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.204 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.906 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 66.8 mt-30 -83.51 103.72 13.08 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 172.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.502 HG23 ' HG3' ' A' ' 88' ' ' GLN . 6.3 p -87.72 153.26 21.5 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.966 -171.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.945 HD11 HG22 ' A' ' 104' ' ' ILE . 21.3 tp -89.72 114.14 25.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.478 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 35.9 m -108.25 102.7 11.81 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.906 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.4 tp -85.59 121.94 29.0 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.5 -173.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.4 m -100.34 119.86 39.07 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.956 -176.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.539 ' CE2' HD23 ' A' ' 93' ' ' LEU . 67.5 m-85 -113.77 136.8 52.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.817 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.481 HD21 ' HB ' ' A' ' 100' ' ' VAL . 32.3 p30 -75.27 -177.6 3.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.933 175.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.0 m -52.84 -33.94 51.82 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.593 ' HB3' HG23 ' A' ' 100' ' ' VAL . 8.7 t -83.83 -9.6 58.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.018 0.437 . . . . 0.0 110.849 -173.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.57 29.66 20.92 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.593 HG23 ' HB3' ' A' ' 98' ' ' SER . 21.5 t -107.62 140.19 26.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.742 -0.729 . . . . 0.0 109.323 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.906 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.5 mt -62.3 125.29 23.4 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.286 0.565 . . . . 0.0 111.885 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.439 HG21 ' HB3' ' A' ' 96' ' ' ASN . 11.1 p -109.6 -45.49 3.67 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.418 174.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -138.33 155.02 48.96 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.63 0.728 . . . . 0.0 111.556 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.945 HG22 HD11 ' A' ' 91' ' ' LEU . 5.3 mm -113.16 93.11 2.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.637 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 30.4 t70 -85.49 96.36 9.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.125 0.488 . . . . 0.0 111.0 -171.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -105.42 102.76 12.21 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.976 0.893 . . . . 0.0 110.106 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -142.96 164.34 32.66 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.275 -175.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.906 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 18.4 Cg_endo -76.48 143.11 24.22 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.445 2.097 . . . . 0.0 112.942 -173.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.66 -176.66 6.14 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 122.113 0.959 . . . . 0.0 112.742 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.7 mt -100.68 136.03 41.18 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.264 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.936 ' HA ' ' HB ' ' A' ' 86' ' ' VAL . 9.5 t -68.68 7.23 0.68 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -114.2 23.37 12.71 Favored Glycine 0 CA--C 1.5 -0.873 0 CA-C-O 122.072 0.818 . . . . 0.0 111.812 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 C--N 1.303 -1.453 0 CA-C-N 114.104 -1.048 . . . . 0.0 110.227 179.861 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.765 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.1 m -90.2 91.46 8.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.978 0.418 . . . . 0.0 110.357 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -75.92 162.62 27.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.091 176.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.3 mtp 60.07 -164.79 0.22 Allowed 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.478 0.486 . . . . 0.0 110.893 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.9 m 57.57 52.16 8.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.846 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.3 m -82.78 77.54 9.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 122.021 0.915 . . . . 0.0 109.448 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.8 mt -90.3 55.74 3.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.086 -174.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.771 ' HG3' ' H ' ' A' ' 25' ' ' ARG . 9.4 pt-20 -150.44 -74.57 0.16 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.578 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.771 ' H ' ' HG3' ' A' ' 24' ' ' GLU . 15.5 mtp180 56.15 47.34 19.71 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.631 0.729 . . . . 0.0 110.607 -177.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 p -151.43 83.64 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 122.293 1.044 . . . . 0.0 108.955 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.613 HG22 ' H ' ' A' ' 28' ' ' TYR . 2.8 p -111.15 -176.6 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.918 -173.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.613 ' H ' HG22 ' A' ' 27' ' ' VAL . 98.8 m-85 -48.36 130.32 16.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.932 0.396 . . . . 0.0 111.514 175.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 29' ' ' ARG . 18.6 mtp180 -66.94 137.79 94.85 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 166.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -40.48 124.41 1.75 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.685 2.923 . . . . 0.0 113.186 -173.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -153.36 101.3 2.51 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.491 -172.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.885 HG22 ' H ' ' A' ' 34' ' ' GLN . 41.4 mm -68.42 141.04 18.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.006 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.06 -20.23 52.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.054 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.885 ' H ' HG22 ' A' ' 32' ' ' ILE . 13.2 pt20 -121.82 178.28 4.93 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.159 -176.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.74 -0.81 5.48 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.953 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -62.67 -25.57 68.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.262 0.554 . . . . 0.0 109.893 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.86 -101.7 0.1 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.693 172.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.711 ' HB3' ' HB3' ' A' ' 75' ' ' TYR . 6.0 tp -140.71 157.08 45.94 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.2 p -127.9 -173.93 3.06 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.106 174.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.585 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -67.82 -47.33 69.35 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.21 0.528 . . . . 0.0 112.007 -173.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.67 -31.68 69.78 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.101 177.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.537 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 63.4 m-20 -72.29 -35.11 68.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.313 176.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.828 HG22 HD22 ' A' ' 91' ' ' LEU . 53.3 t -57.48 -36.61 54.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.206 0.527 . . . . 0.0 110.506 174.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.1 t -61.61 -17.73 56.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.533 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 48.4 mtpt -74.75 -28.73 60.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.849 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.822 HG23 HD13 ' A' ' 59' ' ' LEU . 43.3 pt -97.56 176.32 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 122.108 0.956 . . . . 0.0 113.163 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.54 150.59 6.09 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.516 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.441 HG22 ' CG1' ' A' ' 104' ' ' ILE . 0.7 OUTLIER -70.54 145.6 12.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.125 -178.077 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.93 -35.15 3.92 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.16 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.607 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 6.8 ptt? -85.3 165.8 17.0 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.285 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.72 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 12.4 p -83.1 -172.3 4.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.409 -173.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 99' ' ' GLY . 92.2 mt-30 -68.24 -41.84 80.61 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.737 176.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.551 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 1.5 pp0? -66.58 -32.12 73.25 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -175.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.72 ' HG3' ' H ' ' A' ' 51' ' ' THR . 15.8 mm-40 -61.93 -56.58 17.69 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.44 176.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.673 HG11 ' CD2' ' A' ' 93' ' ' LEU . 82.0 t -65.4 -40.45 88.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.57 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.619 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.69 -35.55 72.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.163 0.506 . . . . 0.0 110.297 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -81.65 -35.37 30.03 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.088 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.04 -45.15 43.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.554 0.692 . . . . 0.0 111.393 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.822 HD13 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -90.95 -54.42 3.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.316 -174.231 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.68 130.1 2.91 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.619 HG22 ' HB1' ' A' ' 56' ' ' ALA . 40.5 p -65.34 128.82 94.13 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-O 121.533 0.682 . . . . 0.0 110.687 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 14.6 Cg_exo -68.68 163.25 37.81 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.569 2.846 . . . . 0.0 112.956 -171.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.82 -25.85 61.2 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.008 -171.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.468 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 13.4 ptt? -66.84 -3.01 5.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.543 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 t 72.29 4.4 4.99 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.545 0.738 . . . . 0.0 112.51 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -158.92 107.78 1.58 Allowed Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 121.579 0.704 . . . . 0.0 110.543 175.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.674 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 58.8 Cg_endo -72.82 -29.95 11.93 Favored 'Trans proline' 0 C--N 1.325 -0.662 0 C-N-CA 122.976 2.451 . . . . 0.0 112.511 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -76.28 -4.06 39.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.927 -170.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.85 -17.66 55.96 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.534 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.3 t -124.39 174.31 7.84 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.005 0.431 . . . . 0.0 110.666 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -118.52 3.56 11.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.574 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.4 m -134.15 112.77 11.4 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.643 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.674 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 44.6 m0 -105.88 136.19 45.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.439 -177.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -113.07 127.31 56.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.928 0.394 . . . . 0.0 110.724 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.711 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 62.2 m-85 -132.27 173.91 10.78 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 77' ' ' PHE . 2.0 t -129.09 178.15 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.585 ' CG ' ' HB2' ' A' ' 40' ' ' ALA . 7.6 m-30 -103.08 173.08 6.46 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.514 0.197 . . . . 0.0 110.54 175.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -56.34 148.12 19.58 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 170.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.485 ' HB3' HD12 ' A' ' 32' ' ' ILE . 53.8 tt0 -47.84 105.29 0.07 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.932 177.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.5 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 52.7 mt-30 -83.97 150.93 59.71 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.362 0.601 . . . . 0.0 111.099 -175.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 5.4 Cg_exo -78.23 86.1 1.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.77 2.98 . . . . 0.0 110.975 176.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.75 162.08 13.14 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.559 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -96.79 5.07 51.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.255 0.55 . . . . 0.0 109.815 176.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -119.63 158.84 25.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.486 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.4 -55.54 29.09 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.586 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.6 t -124.35 124.01 67.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.549 0.69 . . . . 0.0 110.733 176.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.7 t -144.89 9.04 1.29 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.401 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.415 HE21 ' HG3' ' A' ' 80' ' ' GLN . 17.9 mt-30 -65.71 170.69 4.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.373 -176.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.701 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 53.0 mt-30 -111.35 130.88 55.54 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.214 170.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.5 HG23 ' HB2' ' A' ' 109' ' ' ALA . 7.6 p -102.29 142.4 33.58 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.329 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.901 HD11 HG22 ' A' ' 104' ' ' ILE . 20.0 tp -91.24 119.25 31.15 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.718 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 90.4 m -110.49 106.86 16.32 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.945 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.1 tp -91.39 123.63 34.96 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.725 -174.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.7 m -103.2 121.71 43.23 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.844 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.47 ' CE1' ' HG ' ' A' ' 101' ' ' LEU . 71.6 m-85 -116.71 138.91 51.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.893 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.52 HD21 ' HB ' ' A' ' 100' ' ' VAL . 33.4 p30 -75.61 -173.46 2.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.794 175.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.6 m -51.29 -44.36 61.86 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -174.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.463 ' HB3' HG23 ' A' ' 100' ' ' VAL . 33.6 t -79.78 -15.9 56.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.469 . . . . 0.0 111.068 -174.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.424 ' O ' ' HG3' ' A' ' 52' ' ' GLN . . . 96.83 29.49 8.1 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -176.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.52 ' HB ' HD21 ' A' ' 96' ' ' ASN . 14.0 t -98.24 134.68 35.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.945 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.7 mt -59.9 125.02 22.01 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.262 0.553 . . . . 0.0 112.04 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.427 HG21 ' HB3' ' A' ' 96' ' ' ASN . 5.7 p -112.78 -39.48 4.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.15 176.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -143.72 148.28 35.46 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.359 0.599 . . . . 0.0 111.908 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.901 HG22 HD11 ' A' ' 91' ' ' LEU . 4.7 mm -111.92 95.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.718 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 35.5 t0 -86.59 95.34 9.72 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.718 -174.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -102.86 104.09 14.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.704 0.764 . . . . 0.0 109.645 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.544 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 63.4 pttt -138.91 172.71 6.12 Favored Pre-proline 0 C--N 1.312 -1.035 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.733 -176.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.701 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 38.8 Cg_endo -75.59 153.71 39.22 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.721 1.614 . . . . 0.0 112.231 -177.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.5 ' HB2' HG23 ' A' ' 90' ' ' THR . . . -80.29 -178.38 6.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.206 -177.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.7 mt -61.46 112.85 2.36 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.19 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.2 m -53.78 119.74 5.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.447 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -130.76 129.5 5.83 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.795 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 . . . . . 0 C--O 1.244 0.776 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.907 -179.408 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.4 t 63.4 -91.54 0.03 OUTLIER 'General case' 0 C--O 1.234 0.244 0 C-N-CA 122.922 0.489 . . . . 0.0 110.271 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -83.54 117.76 23.34 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 18.8 ptp -73.82 105.85 5.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.628 0.728 . . . . 0.0 111.242 -175.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.0 p -104.59 3.92 32.29 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.551 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.87 HG22 ' H ' ' A' ' 23' ' ' LEU . 3.8 m 63.75 -157.38 0.32 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.87 ' H ' HG22 ' A' ' 22' ' ' THR . 1.3 tm? 64.99 92.81 0.07 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.312 0.577 . . . . 0.0 109.659 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -62.55 145.93 53.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.912 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 25' ' ' ARG . 5.3 tpm_? -63.93 103.76 0.62 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.608 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.843 HG22 ' H ' ' A' ' 27' ' ' VAL . 8.4 p -74.67 -167.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.522 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.843 ' H ' HG22 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -50.59 153.68 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 121.875 0.845 . . . . 0.0 112.322 -171.662 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -84.62 117.08 23.53 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.606 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.572 ' H ' ' HD2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -89.97 164.28 28.92 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -179.387 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 29' ' ' ARG . 86.5 Cg_exo -46.37 160.51 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.295 2.663 . . . . 0.0 113.039 174.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.82 34.58 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.862 -176.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.961 HG22 ' H ' ' A' ' 34' ' ' GLN . 40.1 mm -85.85 150.2 3.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.37 0.605 . . . . 0.0 111.656 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.53 HD21 ' HB3' ' A' ' 79' ' ' GLN . 24.5 p-10 -65.72 -31.35 72.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.646 174.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.961 ' H ' HG22 ' A' ' 32' ' ' ILE . 27.6 pt20 -108.62 -179.31 3.83 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 173.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.98 77.73 0.19 Allowed Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.114 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -129.7 -61.6 1.0 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.926 0.393 . . . . 0.0 111.177 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -120.1 -171.09 2.09 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.874 -175.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.63 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 1.3 tp -75.95 153.16 36.82 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.725 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 26.0 p -126.12 -176.27 3.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.048 0.452 . . . . 0.0 111.995 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.494 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -62.56 -37.8 87.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.909 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -59.8 -43.27 94.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.373 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.614 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 10.5 m-20 -68.44 -29.6 68.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.962 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.011 HG22 HD22 ' A' ' 91' ' ' LEU . 85.6 t -59.79 -36.95 69.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.207 0.527 . . . . 0.0 110.45 175.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -61.26 -19.05 61.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.427 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -70.99 -42.13 70.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.794 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.789 HG23 HD13 ' A' ' 59' ' ' LEU . 41.6 pt -84.7 -178.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.747 0.784 . . . . 0.0 112.268 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.406 ' HD2' ' N ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -171.68 152.33 3.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.326 -175.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.458 HG23 ' H ' ' A' ' 48' ' ' VAL . 0.7 OUTLIER -72.82 145.62 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.697 -179.246 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.41 -30.6 5.93 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.346 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.492 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 16.0 ptt? -90.06 178.18 6.26 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.285 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.912 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 31.1 p -95.23 -174.07 3.11 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.013 -170.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.456 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 97.8 mt-30 -63.89 -47.51 80.33 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.774 172.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.415 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 9.9 pt20 -64.56 -36.5 84.42 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.305 0.574 . . . . 0.0 109.811 -175.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.912 ' HG3' ' H ' ' A' ' 51' ' ' THR . 9.4 mm-40 -58.0 -52.47 65.38 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.323 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.652 HG11 ' CD2' ' A' ' 93' ' ' LEU . 72.2 t -67.11 -41.56 87.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.714 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.527 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -64.52 -25.68 68.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.164 0.507 . . . . 0.0 110.727 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -81.28 -35.53 30.97 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.013 0.435 . . . . 0.0 111.323 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.9 -46.14 25.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.393 0.616 . . . . 0.0 111.705 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.789 HD13 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -92.56 -21.15 20.26 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.815 -173.153 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.91 131.07 6.98 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -172.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.527 HG22 ' HB1' ' A' ' 56' ' ' ALA . 37.9 p -56.75 135.27 78.61 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.959 0.409 . . . . 0.0 111.118 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 51.8 Cg_exo -59.12 171.65 2.15 Favored 'Trans proline' 0 N--CA 1.471 0.157 0 C-N-CA 124.131 3.221 . . . . 0.0 115.131 -171.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.451 ' HG ' ' H ' ' A' ' 63' ' ' LEU . 8.3 mt -55.49 -41.69 73.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.257 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.463 ' HE3' HG21 ' A' ' 70' ' ' THR . 0.0 OUTLIER -60.19 -0.24 0.22 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.547 176.619 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 63' ' ' LEU . 33.5 p 58.86 5.44 0.5 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.214 1.006 . . . . 0.0 112.815 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -150.17 103.58 3.15 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 121.54 0.686 . . . . 0.0 109.753 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.487 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 36.0 Cg_endo -68.06 -33.03 26.62 Favored 'Trans proline' 0 C--N 1.327 -0.555 0 C-N-CA 123.245 2.63 . . . . 0.0 113.177 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -76.22 4.51 8.55 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -170.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.33 -24.72 21.03 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.086 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.463 HG21 ' HE3' ' A' ' 64' ' ' MET . 14.3 t -125.51 174.38 8.26 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.902 0.382 . . . . 0.0 110.236 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -125.78 12.52 7.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.862 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.9 m -133.55 108.81 8.83 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.21 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.487 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 42.7 m0 -109.18 130.34 55.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.412 -174.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -109.46 120.89 43.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.024 0.44 . . . . 0.0 110.967 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.583 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 50.1 m-85 -129.24 173.88 10.1 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 77' ' ' PHE . 2.9 t -123.42 175.29 6.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -176.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.573 ' H ' HG12 ' A' ' 76' ' ' VAL . 5.7 m-30 -97.86 -178.24 4.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.045 0.45 . . . . 0.0 110.721 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -69.13 137.62 53.56 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.53 ' HB3' HD21 ' A' ' 33' ' ' ASN . 36.4 tt0 -51.11 106.44 0.13 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.173 0.511 . . . . 0.0 111.638 -172.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.491 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -103.36 135.39 19.39 Favored Pre-proline 0 N--CA 1.441 -0.879 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.569 -176.779 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 14.3 Cg_exo -69.0 119.15 6.16 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 123.028 2.486 . . . . 0.0 112.171 -178.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.796 ' HA3' HG21 ' A' ' 87' ' ' THR . . . -130.3 -168.34 12.25 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -126.5 -25.38 3.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.201 0.524 . . . . 0.0 110.365 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -82.26 176.24 9.63 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.776 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -57.86 -55.82 28.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.306 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.73 134.25 66.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.168 0.509 . . . . 0.0 110.272 175.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.796 HG21 ' HA3' ' A' ' 82' ' ' GLY . 9.4 t -138.31 5.22 2.49 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.205 177.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -76.12 164.93 25.62 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.612 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 26.0 mt-30 -108.48 156.17 19.77 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.819 168.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 p -126.86 143.56 51.23 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.848 0.356 . . . . 0.0 111.53 -173.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.083 HD11 HG22 ' A' ' 104' ' ' ILE . 39.8 tp -91.8 122.94 34.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 172.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 89.9 m -117.49 103.91 10.55 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.823 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.1 tp -85.18 125.18 32.62 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.286 -174.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 21.5 m -107.35 122.87 47.46 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.264 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.597 ' CE2' HD23 ' A' ' 93' ' ' LEU . 32.5 m-85 -110.54 146.45 36.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.894 0.854 . . . . 0.0 112.695 -175.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -73.94 -179.61 3.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.646 -1.615 . . . . 0.0 111.171 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.4 p -59.32 -43.03 92.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.698 0.285 . . . . 0.0 111.583 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.432 ' HB3' HG23 ' A' ' 100' ' ' VAL . 35.0 t -77.69 -8.66 58.25 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.958 0.409 . . . . 0.0 110.694 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.88 31.06 10.35 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.459 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 98' ' ' SER . 22.0 t -100.77 141.64 17.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.823 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.0 mt -62.29 123.99 19.69 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.084 0.469 . . . . 0.0 111.597 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 74.1 p -111.8 -43.55 3.6 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.642 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.522 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 2.6 m-20 -136.24 150.08 48.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.812 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.083 HG22 HD11 ' A' ' 91' ' ' LEU . 2.2 mm -116.46 92.43 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 170.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.547 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 25.2 t70 -87.42 96.78 10.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.131 0.491 . . . . 0.0 111.032 -170.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.418 ' HB2' ' HZ ' ' A' ' 77' ' ' PHE . 4.4 p30 -106.84 104.75 14.5 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 122.032 0.92 . . . . 0.0 110.333 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.505 ' H ' ' HD3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -139.31 174.36 4.2 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.973 -178.659 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 51.8 Cg_exo -59.3 154.76 44.59 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.648 2.232 . . . . 0.0 112.115 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.45 170.3 15.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.298 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.446 ' HG ' ' H ' ' A' ' 110' ' ' LEU . 18.4 mt -49.14 -60.24 2.96 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.857 -175.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.4 t 59.64 50.5 7.19 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.731 0.776 . . . . 0.0 109.407 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 160.91 -141.09 7.1 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.098 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 57.3 t30 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.154 179.532 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.844 0 N-CA-C 112.116 -0.394 . . . . 0.0 112.116 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.4 m -70.56 -25.06 62.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.124 0.488 . . . . 0.0 111.021 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -124.77 74.97 1.38 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.5 ttt -84.32 40.33 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.449 0.642 . . . . 0.0 110.868 -174.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 m -85.1 108.86 17.87 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.9 p 46.85 46.12 15.26 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.871 0.732 . . . . 0.0 111.574 -173.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.6 tp -90.64 90.68 8.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.141 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 56.92 -156.0 0.31 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.494 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -128.61 37.06 4.17 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.3 m -77.91 154.27 5.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.256 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.05 169.58 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-O 121.213 0.53 . . . . 0.0 110.648 -177.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -71.62 125.64 27.62 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.003 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -115.23 102.13 54.56 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.845 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -65.68 171.09 10.17 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.751 2.301 . . . . 0.0 111.874 173.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -63.34 -58.94 5.48 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.609 0.718 . . . . 0.0 110.344 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.471 HD13 ' HG3' ' A' ' 78' ' ' ARG . 36.5 mm -77.6 142.3 14.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.848 174.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.24 -22.14 11.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.612 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.455 ' OE1' HG23 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -95.41 -169.15 1.91 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.623 179.374 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 167.76 92.95 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.811 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -179.5 -43.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.4 ' CD1' ' HB ' ' A' ' 76' ' ' VAL . 1.6 p90 -118.02 -171.41 2.06 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.971 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.715 ' HB3' ' HB3' ' A' ' 75' ' ' TYR . 2.3 tp -73.5 157.9 35.9 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.925 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 43' ' ' VAL . 41.6 p -126.05 -179.28 4.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.258 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . . . -65.8 -32.75 74.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.345 0.593 . . . . 0.0 110.596 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.511 ' OD1' ' HD3' ' A' ' 78' ' ' ARG . 71.7 m-20 -62.34 -43.11 99.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.86 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.633 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 30.1 m-20 -69.11 -30.9 69.27 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.969 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.877 HG22 HD22 ' A' ' 91' ' ' LEU . 70.9 t -59.82 -37.83 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.042 0.448 . . . . 0.0 110.574 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.6 t -58.42 -21.97 52.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.557 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -70.28 -29.67 66.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.65 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.697 HG23 HD13 ' A' ' 59' ' ' LEU . 36.7 pt -98.42 -178.14 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.812 0.815 . . . . 0.0 112.413 -178.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.25 151.27 3.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.38 -176.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.433 HG22 HD11 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -72.26 145.49 12.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.13 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.56 -35.9 3.57 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.792 -177.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.519 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 19.0 ptt? -85.27 176.81 8.11 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.165 0.507 . . . . 0.0 111.263 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.889 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 32.6 p -95.29 -174.95 3.35 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.991 -170.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.672 ' OE1' ' HA ' ' A' ' 68' ' ' PHE . 78.9 mt-30 -62.73 -48.06 80.88 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.533 172.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.535 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 1.4 pp0? -64.65 -33.13 75.21 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.301 0.572 . . . . 0.0 109.843 -174.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.889 ' HG3' ' H ' ' A' ' 51' ' ' THR . 9.1 mm-40 -60.99 -53.08 61.62 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.562 174.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.688 HG11 ' CD2' ' A' ' 93' ' ' LEU . 75.2 t -69.43 -39.9 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.597 -176.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.689 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -59.56 -32.26 70.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.452 0.644 . . . . 0.0 110.002 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -80.87 -36.82 30.83 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.272 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.57 -49.11 19.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.941 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.697 HD13 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -90.44 -32.89 16.21 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.978 -172.687 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 114.25 127.69 4.5 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.274 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.689 HG22 ' HB1' ' A' ' 56' ' ' ALA . 28.4 p -60.85 132.22 91.76 Favored Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-O 121.244 0.545 . . . . 0.0 111.004 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 11.6 Cg_exo -70.77 162.27 43.16 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.529 2.82 . . . . 0.0 112.768 -173.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.48 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 1.7 mt -54.47 -33.89 60.52 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.094 -1.412 . . . . 0.0 112.235 -169.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.439 ' H ' ' HG2' ' A' ' 64' ' ' MET . 12.2 ptt? -64.16 -1.92 1.82 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.19 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.1 p 62.13 2.38 0.81 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.374 1.07 . . . . 0.0 113.534 172.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -136.76 92.53 14.59 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.501 ' HG3' HG22 ' A' ' 61' ' ' THR . 37.9 Cg_endo -67.75 -34.1 25.6 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.745 1.63 . . . . 0.0 111.524 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.672 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -79.41 10.24 3.98 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.508 -177.037 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.02 -26.3 16.89 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.607 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -124.66 175.95 6.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.959 0.409 . . . . 0.0 110.432 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -126.99 13.55 7.31 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.8 m -132.57 109.78 10.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.665 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.481 ' O ' ' HA ' ' A' ' 92' ' ' THR . 46.2 m0 -107.29 149.85 27.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.594 -175.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -123.1 115.23 21.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.08 0.467 . . . . 0.0 111.051 -175.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.715 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 88.3 m-85 -127.06 174.47 8.86 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.642 HG12 ' NE2' ' A' ' 80' ' ' GLN . 4.7 t -120.97 170.19 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 118.066 0.394 . . . . 0.0 110.204 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.567 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -95.26 -175.97 3.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.406 0.622 . . . . 0.0 112.24 -175.117 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.511 ' HD3' ' OD1' ' A' ' 41' ' ' ASN . 23.7 ttp180 -94.12 112.91 24.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.261 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.451 ' H ' ' NE2' ' A' ' 34' ' ' GLN . 10.4 tt0 53.64 79.92 0.12 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.862 0.839 . . . . 0.0 112.321 172.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.886 ' HG3' ' HG2' ' A' ' 88' ' ' GLN . 0.4 OUTLIER -115.89 158.69 41.62 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.373 -178.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.564 ' HB2' HG22 ' A' ' 87' ' ' THR . 50.5 Cg_exo -58.92 108.06 0.39 Allowed 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.975 2.45 . . . . 0.0 111.927 173.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.64 -156.23 9.94 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.193 177.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 63.59 -83.56 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.966 0.413 . . . . 0.0 111.28 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -115.71 133.0 56.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.803 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.42 60.32 6.4 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.411 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.2 t -65.81 134.02 30.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.262 0.553 . . . . 0.0 110.798 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.564 HG22 ' HB2' ' A' ' 81' ' ' PRO . 10.7 t -142.27 17.43 2.07 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.589 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.886 ' HG2' ' HG3' ' A' ' 80' ' ' GLN . 15.8 mt-30 -34.69 110.52 0.1 Allowed 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.981 0.912 . . . . 0.0 113.379 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.712 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 50.1 mt-30 -67.07 104.29 1.38 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.6 p -90.04 142.97 27.19 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.077 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.049 HD11 HG22 ' A' ' 104' ' ' ILE . 19.3 tp -91.18 105.64 17.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 32.1 m -101.81 102.46 13.07 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.871 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.9 tp -83.72 126.16 32.61 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.256 -173.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.4 m -107.91 119.9 40.76 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.263 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.505 ' CE2' HD23 ' A' ' 93' ' ' LEU . 95.5 m-85 -110.08 147.8 32.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.797 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.55 HD21 ' HB ' ' A' ' 100' ' ' VAL . 4.1 p30 -72.06 -87.35 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 55.0 m -150.73 -30.2 0.19 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.887 0.375 . . . . 0.0 110.75 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.471 ' HB3' HG23 ' A' ' 100' ' ' VAL . 16.6 t -82.27 -6.03 58.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.423 0.63 . . . . 0.0 109.452 177.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.52 ' HA2' HE21 ' A' ' 52' ' ' GLN . . . 89.77 29.65 15.32 Favored Glycine 0 CA--C 1.503 -0.702 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.55 ' HB ' HD21 ' A' ' 96' ' ' ASN . 25.8 t -108.25 137.13 41.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.613 -0.793 . . . . 0.0 109.458 -178.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.871 HD21 ' HG ' ' A' ' 93' ' ' LEU . 9.3 mt -61.37 130.74 47.61 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.197 0.522 . . . . 0.0 112.35 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.8 p -114.18 -37.25 4.46 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.126 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -150.06 152.96 35.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.631 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.049 HG22 HD11 ' A' ' 91' ' ' LEU . 3.3 mm -112.96 93.83 2.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 173.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.581 ' HB2' ' O ' ' A' ' 92' ' ' THR . 5.6 m-20 -80.6 96.62 6.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.688 0.28 . . . . 0.0 111.449 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -106.77 104.19 13.81 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.88 0.847 . . . . 0.0 109.917 175.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.433 ' H ' ' HD3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -146.68 164.99 21.07 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.206 -176.676 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.712 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 57.8 Cg_endo -77.06 158.35 34.11 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.372 2.048 . . . . 0.0 112.702 -173.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.18 178.44 7.59 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.647 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.477 ' HB2' ' H ' ' A' ' 111' ' ' SER . 9.6 mt -78.1 -90.33 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.52 -172.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.477 ' H ' ' HB2' ' A' ' 110' ' ' LEU . 8.9 t 174.7 148.86 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 82.54 133.77 1.94 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.943 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.784 -0.627 . . . . 0.0 109.901 178.334 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 112.019 -0.433 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.3 m -96.44 -0.76 48.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.722 0.296 . . . . 0.0 110.992 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -88.22 -65.7 0.99 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.794 0.33 . . . . 0.0 110.76 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.1 mtm -106.24 26.86 9.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.78 -174.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 t -162.0 41.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.503 0.668 . . . . 0.0 110.241 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.6 t -95.12 123.44 38.61 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.196 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.4 mt 55.63 38.16 29.81 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.289 0.566 . . . . 0.0 110.512 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -66.52 -69.1 0.32 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.236 -174.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.495 ' HG3' HG12 ' A' ' 26' ' ' VAL . 14.2 ptt-85 -115.79 -25.51 7.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.924 0.392 . . . . 0.0 110.994 -177.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.495 HG12 ' HG3' ' A' ' 25' ' ' ARG . 10.8 p -173.76 166.18 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.479 HG22 ' H ' ' A' ' 28' ' ' TYR . 0.6 OUTLIER -73.43 177.55 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 120.663 0.268 . . . . 0.0 110.673 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.479 ' H ' HG22 ' A' ' 27' ' ' VAL . 94.1 m-85 -62.28 162.54 9.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.182 0.515 . . . . 0.0 112.02 179.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -112.92 106.73 55.02 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.569 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -57.79 152.1 51.91 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.143 2.562 . . . . 0.0 112.189 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -127.76 78.43 1.82 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.613 0.72 . . . . 0.0 111.225 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.01 HG22 ' H ' ' A' ' 34' ' ' GLN . 36.1 mm -83.26 146.53 6.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.903 173.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -71.45 -4.26 25.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.992 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 1.01 ' H ' HG22 ' A' ' 32' ' ' ILE . 16.3 pt20 -144.19 -177.08 5.28 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.405 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.23 44.57 0.27 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -100.86 -62.94 1.18 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.091 -0.555 . . . . 0.0 110.311 -172.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -111.88 -165.7 1.01 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.845 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.648 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 5.0 tp -78.87 152.19 31.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.911 0.386 . . . . 0.0 111.005 -176.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.463 ' HB ' ' HA ' ' A' ' 78' ' ' ARG . 29.3 p -127.84 -174.1 3.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.986 175.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.18 -38.87 86.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.362 0.601 . . . . 0.0 110.869 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.465 ' OD1' HD11 ' A' ' 32' ' ' ILE . 24.8 m120 -62.12 -41.74 98.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.468 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.518 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 10.7 m-20 -63.85 -36.75 84.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.491 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.674 HG22 HD22 ' A' ' 91' ' ' LEU . 77.0 t -59.26 -38.05 72.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.167 0.508 . . . . 0.0 110.582 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.9 t -63.03 -20.62 65.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.089 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 46.0 mtpt -70.17 -33.92 72.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.654 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.776 HG23 HD13 ' A' ' 59' ' ' LEU . 42.9 pt -89.76 -179.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.784 0.802 . . . . 0.0 112.439 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.43 149.9 2.24 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.665 -176.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.454 ' H ' HG23 ' A' ' 48' ' ' VAL . 0.6 OUTLIER -70.98 142.29 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.722 -179.212 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.69 -27.97 6.35 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.708 -176.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.522 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 21.8 ptt? -94.08 171.56 8.77 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.76 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.655 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 23.5 p -91.18 -172.83 3.43 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.723 -168.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.444 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 99.0 mt-30 -63.89 -46.81 83.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.143 173.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.429 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 10.4 pt20 -64.95 -35.3 80.73 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.376 0.608 . . . . 0.0 110.061 -175.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.655 ' HG3' ' H ' ' A' ' 51' ' ' THR . 1.7 mm100 -68.14 -40.58 82.38 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.303 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.665 HG11 ' CD2' ' A' ' 93' ' ' LEU . 53.9 t -74.8 -47.15 39.0 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.578 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.637 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.58 -24.83 67.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.874 0.368 . . . . 0.0 110.796 -176.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -79.82 -41.27 26.76 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.65 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.56 -44.19 71.38 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.558 0.694 . . . . 0.0 111.271 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.776 HD13 HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -88.27 -39.94 14.02 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.366 -173.044 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.6 122.87 4.07 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -171.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.637 HG22 ' HB1' ' A' ' 56' ' ' ALA . 40.2 p -57.09 133.16 80.5 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.11 0.481 . . . . 0.0 111.032 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 22.6 Cg_exo -63.28 161.78 29.38 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.582 2.855 . . . . 0.0 113.332 -170.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.409 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -56.84 -27.63 60.47 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 113.776 -1.556 . . . . 0.0 112.09 -171.584 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 13.2 ptt? -68.14 2.62 2.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.772 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.9 t 66.48 11.0 7.77 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.818 0.447 . . . . 0.0 112.03 172.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -162.78 104.63 1.04 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.703 0.763 . . . . 0.0 110.458 178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.534 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 74.3 Cg_endo -77.29 -36.25 1.39 Allowed 'Trans proline' 0 C--N 1.326 -0.649 0 C-N-CA 123.171 2.581 . . . . 0.0 113.704 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -77.2 -11.62 59.84 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -166.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.32 -8.85 70.72 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.961 -173.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.1 t -124.09 174.51 7.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.954 0.407 . . . . 0.0 110.467 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -119.34 1.62 11.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.117 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.3 m -131.62 113.87 14.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.898 -175.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.563 ' O ' ' HA ' ' A' ' 92' ' ' THR . 44.4 m0 -108.69 147.12 32.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.489 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 27.1 m-85 -127.68 125.26 39.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.954 0.407 . . . . 0.0 111.16 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.559 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 73.4 m-85 -133.92 173.61 11.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.798 178.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.5 t -121.27 161.62 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -88.36 -177.24 5.6 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.552 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 0.4 OUTLIER -50.34 136.94 19.36 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.751 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.569 ' HB2' ' NE2' ' A' ' 34' ' ' GLN . 39.7 tt0 -56.58 99.16 0.03 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.246 0.546 . . . . 0.0 111.94 -173.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.559 ' HB2' ' HD2' ' A' ' 81' ' ' PRO . 6.3 pt20 -124.41 168.78 12.15 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.322 -178.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.559 ' HD2' ' HB2' ' A' ' 80' ' ' GLN . 32.0 Cg_exo -38.13 128.1 0.96 Allowed 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 124.063 3.176 . . . . 0.0 114.397 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 1.055 ' HA2' ' HA ' ' A' ' 86' ' ' VAL . . . -157.59 -143.29 3.62 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.257 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 66.04 -83.94 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.246 0.618 . . . . 0.0 111.65 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -93.7 -16.21 24.48 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 122.111 0.958 . . . . 0.0 111.064 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.14 86.93 0.13 Allowed Glycine 0 C--N 1.296 -1.659 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.381 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 1.055 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 21.3 t -83.51 140.87 15.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.228 0.537 . . . . 0.0 110.993 -173.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.1 t -120.35 -3.16 9.98 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.453 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.465 ' H ' HG12 ' A' ' 86' ' ' VAL . 2.6 mp0 -54.87 152.69 7.02 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 174.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 107' ' ' LYS . 39.5 mt-30 -107.49 125.07 50.81 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.209 160.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -89.25 135.37 33.61 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.834 -179.004 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.899 HD11 HG22 ' A' ' 104' ' ' ILE . 13.9 tp -90.08 111.5 22.63 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.666 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 34.6 m -106.65 104.2 13.83 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.906 ' HG ' HD21 ' A' ' 101' ' ' LEU . 6.7 tp -88.41 119.28 28.69 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.032 -174.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.8 m -102.43 122.26 43.95 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.557 -175.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.506 ' CE2' HD23 ' A' ' 93' ' ' LEU . 67.0 m-85 -114.63 138.11 51.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.986 -178.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.494 HD21 ' HB ' ' A' ' 100' ' ' VAL . 32.5 p30 -75.0 -172.08 1.53 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.121 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.5 m -62.19 -30.97 71.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.498 ' HB3' HG23 ' A' ' 100' ' ' VAL . 35.6 t -83.46 -11.87 56.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.777 0.323 . . . . 0.0 111.133 -174.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.78 28.94 14.34 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 98' ' ' SER . 6.7 t -107.87 142.91 19.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.031 -0.585 . . . . 0.0 109.648 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.906 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.5 mt -62.97 126.74 28.33 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.176 0.512 . . . . 0.0 112.204 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.486 HG21 ' HB3' ' A' ' 96' ' ' ASN . 10.8 p -113.13 -42.93 3.44 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.0 175.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -138.2 150.73 47.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.359 0.6 . . . . 0.0 111.584 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.899 HG22 HD11 ' A' ' 91' ' ' LEU . 4.7 mm -113.03 93.08 2.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 168.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.666 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 32.8 t70 -90.56 98.69 11.92 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.465 -169.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 90' ' ' THR . 4.8 p30 -110.98 101.72 10.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.201 1.001 . . . . 0.0 110.744 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.585 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 23.5 mttp -118.16 163.21 26.0 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.716 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' ' 107' ' ' LYS . 2.7 Cg_endo -63.82 137.25 57.36 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.053 1.835 . . . . 0.0 110.912 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.417 ' HB3' HG11 ' A' ' 86' ' ' VAL . . . -65.63 173.36 2.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.804 0.811 . . . . 0.0 112.912 -171.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.6 mt -52.26 -65.78 0.5 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.762 -172.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.646 ' HB2' HG23 ' A' ' 86' ' ' VAL . 8.0 m -77.12 61.08 1.99 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.969 0.414 . . . . 0.0 111.617 -177.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -133.63 -154.14 7.28 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.102 -0.952 . . . . 0.0 110.565 179.836 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.878 0 N-CA-C 112.606 -0.198 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.5 m -71.91 78.14 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -84.31 -50.65 7.65 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 170.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 62.3 mtm -120.96 -7.76 9.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.398 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.9 m -80.9 99.26 8.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.711 -176.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.7 m 64.84 93.78 0.06 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.38 0.61 . . . . 0.0 111.453 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 87.0 mt -107.8 79.86 1.32 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.304 -175.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -124.16 -86.29 0.64 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.376 0.608 . . . . 0.0 109.826 172.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -157.07 66.15 0.51 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.604 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.2 p -79.53 83.4 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 122.275 1.036 . . . . 0.0 110.628 -175.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -83.53 173.25 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.056 -177.37 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.5 ' O ' HG13 ' A' ' 27' ' ' VAL . 83.2 m-85 -75.3 148.45 39.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.39 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -71.99 123.34 89.32 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 171.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -42.42 123.78 2.91 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.882 3.055 . . . . 0.0 113.742 -176.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -152.56 31.13 0.52 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.583 HD12 ' HG2' ' A' ' 78' ' ' ARG . 23.7 mm -75.6 145.14 11.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.392 -1.277 . . . . 0.0 111.377 -170.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -85.03 -33.55 22.48 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.547 ' N ' HG22 ' A' ' 32' ' ' ILE . 14.8 mp0 -71.72 -156.67 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 113.56 -1.655 . . . . 0.0 109.392 172.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.58 -24.04 29.75 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.434 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -75.39 -39.44 59.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.485 0.659 . . . . 0.0 109.618 176.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -113.24 -166.51 1.09 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.399 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.744 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 1.8 mm? -70.92 140.39 50.97 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.831 0.824 . . . . 0.0 112.562 -177.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.692 ' HB ' ' HB2' ' A' ' 78' ' ' ARG . 17.3 p -131.21 -172.46 2.84 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.352 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . . . -62.62 -47.57 83.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -67.82 -32.64 73.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.968 0.413 . . . . 0.0 110.959 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.567 ' HB3' HD12 ' A' ' 38' ' ' LEU . 10.6 m-20 -62.76 -37.61 87.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.321 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.897 HG22 HD22 ' A' ' 91' ' ' LEU . 78.4 t -60.61 -37.73 76.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.121 0.486 . . . . 0.0 110.966 178.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.9 t -60.57 -22.84 64.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.257 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 49.8 mtpt -68.57 -34.4 75.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.648 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.81 HG23 HD13 ' A' ' 59' ' ' LEU . 44.6 pt -93.63 175.67 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 121.934 0.873 . . . . 0.0 112.51 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.65 150.96 6.1 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.955 -1.475 . . . . 0.0 109.505 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.46 HG22 ' CG1' ' A' ' 104' ' ' ILE . 0.5 OUTLIER -72.41 141.59 16.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.888 -177.754 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.3 -24.1 7.42 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.246 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.482 ' HE3' HG22 ' A' ' 46' ' ' ILE . 19.0 ptt? -96.57 178.12 5.44 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.226 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.2 p -95.03 -178.91 4.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.71 -169.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.486 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 27.1 mt-30 -65.56 -43.38 90.03 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.866 173.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.459 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 9.4 pt20 -64.35 -38.11 89.87 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.674 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.459 ' N ' ' HG3' ' A' ' 53' ' ' GLN . 50.5 mt-30 -66.77 -45.62 77.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.115 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.706 HG11 ' CD2' ' A' ' 93' ' ' LEU . 62.8 t -68.86 -47.64 74.94 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.598 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -62.86 -26.32 68.71 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.488 -177.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -81.33 -39.12 25.63 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.392 176.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.25 -51.93 47.07 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.105 0.955 . . . . 0.0 110.85 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.81 HD13 HG23 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -81.55 -49.61 10.36 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.328 -173.011 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.88 124.16 2.75 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -171.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.598 HG22 ' HB1' ' A' ' 56' ' ' ALA . 44.3 p -57.41 134.06 81.66 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.877 0.37 . . . . 0.0 110.69 -177.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.505 ' CD ' ' HB3' ' A' ' 67' ' ' PRO . 35.1 Cg_exo -60.41 157.04 37.88 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 123.498 2.799 . . . . 0.0 112.645 -172.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 1.7 mt -59.93 -27.99 67.23 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.502 -1.227 . . . . 0.0 111.307 -171.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.454 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 12.5 ptt? -62.85 -4.8 2.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.862 175.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 t 71.65 -3.01 2.27 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.459 0.703 . . . . 0.0 111.695 172.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.46 99.78 7.76 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-O 121.708 0.766 . . . . 0.0 110.427 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.505 ' HB3' ' CD ' ' A' ' 62' ' ' PRO . 73.0 Cg_endo -79.32 -28.43 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.712 2.275 . . . . 0.0 112.598 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -86.03 -5.31 59.24 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -168.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.79 -17.79 53.21 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.89 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.401 HG21 ' HE1' ' A' ' 64' ' ' MET . 9.0 t -123.62 172.16 9.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.914 0.388 . . . . 0.0 110.069 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -128.06 20.65 6.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.322 0.582 . . . . 0.0 109.465 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 17.9 m -143.65 111.92 6.3 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.696 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.535 ' O ' ' HA ' ' A' ' 92' ' ' THR . 51.4 m0 -107.84 147.15 31.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.613 -175.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -125.68 115.27 19.83 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 111.268 -174.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.586 ' HD2' HD23 ' A' ' 91' ' ' LEU . 27.7 m-85 -128.53 176.26 7.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.639 HG22 ' H ' ' A' ' 77' ' ' PHE . 4.2 p -124.32 175.13 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -176.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.639 ' H ' HG22 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -98.51 166.49 11.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.241 0.543 . . . . 0.0 111.622 -175.212 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.692 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -91.53 112.7 24.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.104 -177.727 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.415 ' H ' ' NE2' ' A' ' 34' ' ' GLN . 35.1 tt0 51.67 74.56 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.854 0.835 . . . . 0.0 110.997 177.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.654 ' NE2' ' H ' ' A' ' 80' ' ' GLN . 0.5 OUTLIER -95.66 139.51 21.93 Favored Pre-proline 0 N--CA 1.442 -0.834 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.245 -178.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 26.9 Cg_exo -62.52 108.57 0.73 Allowed 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 123.034 2.489 . . . . 0.0 111.531 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.591 ' HA2' HG21 ' A' ' 87' ' ' THR . . . -89.82 -105.15 1.17 Allowed Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.534 -175.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.7 t60 73.6 -32.57 0.24 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.679 0.792 . . . . 0.0 110.947 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 82' ' ' GLY . 43.2 mt-10 -85.91 -171.57 3.65 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 173.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.77 -53.84 4.14 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.8 t -129.54 141.37 46.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 175.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.591 HG21 ' HA2' ' A' ' 82' ' ' GLY . 13.4 t -167.04 1.41 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.552 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.591 ' HA ' ' HG3' ' A' ' 80' ' ' GLN . 33.6 mt-30 -58.69 129.95 44.53 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.355 0.598 . . . . 0.0 111.913 -174.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.679 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 74.8 mt-30 -81.87 106.61 13.93 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.846 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 21.6 p -89.94 143.35 26.86 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.228 -174.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.993 HD11 HG22 ' A' ' 104' ' ' ILE . 24.7 tp -91.51 113.1 25.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.142 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.721 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 25.5 m -106.39 105.05 14.9 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.853 ' HG ' HD21 ' A' ' 101' ' ' LEU . 6.9 tp -90.83 121.65 32.87 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.401 -174.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.7 m -104.55 124.15 48.78 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.945 -176.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.501 ' CE2' HD23 ' A' ' 93' ' ' LEU . 73.9 m-85 -117.32 139.37 50.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.44 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.481 HD21 ' HB ' ' A' ' 100' ' ' VAL . 32.0 p30 -76.59 -174.36 2.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.168 174.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.0 p -57.48 -35.89 70.77 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -175.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.588 ' HB3' HG23 ' A' ' 100' ' ' VAL . 21.0 t -81.15 -4.93 56.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.189 0.518 . . . . 0.0 110.88 -174.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.53 27.95 37.45 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.45 -0.881 . . . . 0.0 110.902 -177.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.588 HG23 ' HB3' ' A' ' 98' ' ' SER . 16.7 t -104.6 138.17 30.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.235 -0.482 . . . . 0.0 109.733 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.853 HD21 ' HG ' ' A' ' 93' ' ' LEU . 7.3 mt -58.97 127.75 33.79 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.215 0.531 . . . . 0.0 111.987 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.416 HG21 ' HB3' ' A' ' 96' ' ' ASN . 7.6 p -114.3 -35.51 4.96 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.223 176.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -149.43 149.03 30.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.204 0.526 . . . . 0.0 111.915 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.993 HG22 HD11 ' A' ' 91' ' ' LEU . 3.4 mm -113.09 94.38 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.721 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 18.4 t70 -94.91 97.25 9.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.862 0.363 . . . . 0.0 111.674 -169.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 90' ' ' THR . 28.6 t-20 -107.69 103.37 12.65 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.723 0.773 . . . . 0.0 110.973 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.538 ' HE3' ' OD1' ' A' ' 105' ' ' ASP . 67.1 mttt -126.98 154.12 76.41 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.09 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 19.4 Cg_endo -75.56 146.44 30.71 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.939 2.426 . . . . 0.0 111.799 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.12 -179.58 3.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.285 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.8 mt -52.87 104.59 0.09 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.312 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.7 m -73.75 141.21 46.32 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.272 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 145.23 163.35 10.09 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.5 t30 . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.232 -179.854 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.0 t -163.92 150.73 11.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.804 0.335 . . . . 0.0 110.459 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -172.86 -54.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.757 ' HG3' ' H ' ' A' ' 21' ' ' SER . 10.9 tpt -142.59 -163.87 1.71 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.757 ' H ' ' HG3' ' A' ' 20' ' ' MET . 6.0 p -56.22 -44.8 79.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.926 0.33 . . . . 0.0 110.733 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 m 57.33 67.81 0.93 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.105 0.478 . . . . 0.0 112.231 173.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -111.95 177.73 4.55 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -56.64 -61.3 2.52 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -161.92 -61.86 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.5 m -133.63 135.72 55.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.747 171.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.518 HG22 ' H ' ' A' ' 28' ' ' TYR . 1.3 p -102.58 178.79 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -174.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.518 ' H ' HG22 ' A' ' 27' ' ' VAL . 77.0 m-85 -50.01 141.88 10.15 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 122.477 0.311 . . . . 0.0 110.998 176.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -74.08 156.32 87.81 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -41.09 124.0 1.99 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.985 2.457 . . . . 0.0 112.002 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -159.85 99.26 1.38 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -171.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.947 HG22 ' H ' ' A' ' 34' ' ' GLN . 34.4 mm -58.02 144.93 9.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.614 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -55.08 -32.36 61.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.641 175.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.947 ' H ' HG22 ' A' ' 32' ' ' ILE . 27.7 pt20 -112.13 25.14 11.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 122.014 0.912 . . . . 0.0 110.126 176.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -84.88 57.08 5.02 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.665 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -91.73 -29.2 16.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 170.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -105.96 -165.26 1.08 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.752 169.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.75 HD13 ' HG ' ' A' ' 59' ' ' LEU . 10.4 tp -79.29 151.77 30.9 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.929 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.495 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 40.4 p -129.21 -179.11 4.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.033 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.435 ' O ' ' HB ' ' A' ' 43' ' ' VAL . . . -65.07 -44.34 89.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.601 ' OD1' ' HD2' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -60.62 -32.58 71.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.397 179.312 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 5.7 m-20 -75.33 -27.77 59.37 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.857 176.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.766 HG22 HD22 ' A' ' 91' ' ' LEU . 54.4 t -60.38 -36.34 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.321 0.581 . . . . 0.0 110.05 173.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.4 t -61.8 -19.89 63.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.317 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 46.6 mtpt -74.69 -24.99 58.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.496 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.793 HG23 HD13 ' A' ' 59' ' ' LEU . 34.4 pt -101.24 176.53 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 122.068 0.937 . . . . 0.0 112.585 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.06 153.35 3.12 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.027 -176.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.461 HG22 HD11 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -71.31 144.73 13.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.961 -177.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.49 -29.6 5.63 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.448 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.648 ' HE3' HG22 ' A' ' 46' ' ' ILE . 13.5 ptt? -92.86 178.14 5.86 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.19 176.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.855 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 30.0 p -96.07 -174.1 3.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.776 -169.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.452 ' OE1' ' HA ' ' A' ' 68' ' ' PHE . 75.6 mt-30 -61.51 -47.78 84.03 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.246 173.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.534 ' HG2' ' OG1' ' A' ' 51' ' ' THR . 7.7 pt20 -63.59 -40.32 96.65 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.21 0.529 . . . . 0.0 109.977 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.855 ' HG3' ' H ' ' A' ' 51' ' ' THR . 7.3 mm-40 -60.09 -50.43 73.72 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.059 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.657 HG11 ' CD2' ' A' ' 93' ' ' LEU . 56.9 t -64.76 -48.83 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.676 -177.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.604 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.31 -26.25 68.68 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.756 -176.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -81.89 -33.73 30.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.972 0.415 . . . . 0.0 111.81 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.67 -40.61 63.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.833 0.825 . . . . 0.0 111.058 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.793 HD13 HG23 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -91.92 -41.6 10.5 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.64 -171.756 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.9 123.87 4.52 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 -168.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.604 HG22 ' HB1' ' A' ' 56' ' ' ALA . 33.2 p -56.35 136.45 75.84 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.981 0.42 . . . . 0.0 111.051 -175.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.553 ' CD ' ' HB3' ' A' ' 67' ' ' PRO . 34.3 Cg_exo -60.57 167.07 8.75 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.759 2.973 . . . . 0.0 113.556 -171.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.405 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -57.27 -30.44 64.68 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 113.637 -1.619 . . . . 0.0 111.961 -171.093 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -71.15 2.29 4.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.778 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.8 t 71.1 1.79 3.96 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.266 0.626 . . . . 0.0 112.234 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -157.62 108.59 1.82 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.73 0.776 . . . . 0.0 110.716 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.71 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 74.1 Cg_endo -75.49 -34.73 3.23 Favored 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 123.559 2.84 . . . . 0.0 113.653 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.452 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 14.4 m-85 -75.14 2.48 10.69 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -166.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.78 -20.09 45.13 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.937 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.8 t -125.61 175.28 7.67 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.839 0.352 . . . . 0.0 110.443 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -123.35 8.15 9.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.5 m -129.14 107.38 9.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.994 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.71 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 47.9 m0 -104.59 144.93 31.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.946 -173.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -122.19 120.38 34.02 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.605 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 72.1 m-85 -127.2 173.61 9.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.522 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.6 t -115.76 152.06 17.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.09 0.471 . . . . 0.0 110.096 -173.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.14 161.2 16.61 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.443 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.601 ' HD2' ' OD1' ' A' ' 41' ' ' ASN . 14.5 ttt180 -74.83 124.98 27.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.63 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 52.99 87.0 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.514 0.674 . . . . 0.0 111.331 -177.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.481 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 3.0 pp0? -119.66 144.81 37.77 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.358 -174.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.509 ' HB2' HG22 ' A' ' 87' ' ' THR . 13.5 Cg_exo -71.82 115.23 4.22 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 123.188 2.592 . . . . 0.0 111.922 174.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -132.32 -139.76 4.36 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.882 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 68.64 -85.65 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.189 0.596 . . . . 0.0 110.108 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -132.15 140.85 48.91 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.68 57.66 7.8 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -172.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.8 t -70.76 138.82 21.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.061 0.458 . . . . 0.0 110.573 -175.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.509 HG22 ' HB2' ' A' ' 81' ' ' PRO . 15.2 t -142.44 18.45 2.05 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.926 0.87 . . . . 0.0 109.493 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.578 ' HG3' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -51.99 122.09 7.83 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.666 179.627 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.58 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 43.0 mt-30 -82.04 104.45 12.39 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.695 0.759 . . . . 0.0 109.93 175.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.578 HG23 ' HG3' ' A' ' 88' ' ' GLN . 8.2 p -88.12 144.55 26.42 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.727 -172.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.857 HD11 HG22 ' A' ' 104' ' ' ILE . 13.2 tp -91.29 108.57 19.97 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.691 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 22.3 m -105.57 98.17 7.91 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.453 0.644 . . . . 0.0 109.647 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.866 ' HG ' HD21 ' A' ' 101' ' ' LEU . 6.9 tp -83.25 128.45 34.51 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.568 -173.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.0 m -114.44 124.61 52.36 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.078 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.477 ' CE2' HD23 ' A' ' 93' ' ' LEU . 87.5 m-85 -114.41 140.64 48.52 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.316 -178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.496 ' HB3' HG21 ' A' ' 102' ' ' THR . 31.6 p30 -75.27 -174.07 2.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.148 176.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.2 m -53.59 -36.62 62.14 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.485 ' HB3' HG23 ' A' ' 100' ' ' VAL . 22.9 t -85.96 -0.09 54.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.99 0.424 . . . . 0.0 110.797 -173.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.37 29.84 51.77 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.734 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 98' ' ' SER . 5.6 t -105.66 140.48 23.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.866 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.5 mt -59.89 126.37 27.31 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.219 0.533 . . . . 0.0 112.264 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.496 HG21 ' HB3' ' A' ' 96' ' ' ASN . 11.4 p -111.85 -43.52 3.6 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.812 174.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -136.82 152.29 50.11 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.446 0.641 . . . . 0.0 111.335 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.857 HG22 HD11 ' A' ' 91' ' ' LEU . 4.8 mm -114.57 92.23 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 169.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.691 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 18.6 t70 -86.89 95.08 9.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.141 0.496 . . . . 0.0 110.921 -170.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -106.89 104.17 13.78 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.636 0.731 . . . . 0.0 109.967 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.561 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -145.96 168.75 11.01 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.98 -177.407 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 39.7 Cg_endo -69.87 165.96 29.34 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 122.068 1.845 . . . . 0.0 112.691 -175.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.25 -165.35 0.18 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.939 0.876 . . . . 0.0 111.656 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 28.6 mt -68.2 105.88 2.25 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.801 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.0 t 69.01 -168.37 0.18 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.483 -177.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.7 158.39 21.56 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.711 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.8 m120 . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.484 -0.77 . . . . 0.0 110.18 178.46 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.914 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.9 m -84.88 124.01 31.13 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.696 0.284 . . . . 0.0 110.826 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 62.0 71.22 0.55 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.412 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 79.2 mtp -126.12 -70.51 0.73 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.907 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.9 t 57.14 74.48 0.41 Allowed 'General case' 0 C--O 1.233 0.189 0 O-C-N 123.783 0.677 . . . . 0.0 110.255 -178.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 m -70.7 107.3 3.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.48 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.2 mt -88.65 144.66 26.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.898 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -83.41 72.66 10.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.312 0.577 . . . . 0.0 110.724 -173.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -89.48 144.89 25.69 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.748 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.0 p -78.16 122.61 33.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.147 0.499 . . . . 0.0 110.077 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.42 167.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.081 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -69.2 138.91 54.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.093 0.473 . . . . 0.0 110.589 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -71.9 129.22 88.38 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.18 -177.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.446 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 53.2 Cg_exo -55.6 169.96 1.04 Allowed 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 123.77 2.98 . . . . 0.0 112.296 171.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 30' ' ' PRO . 26.6 t70 73.51 114.32 0.06 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 122.073 0.939 . . . . 0.0 110.369 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.908 HG13 HG21 ' A' ' 39' ' ' THR . 44.5 mm -56.96 139.92 15.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.063 -1.426 . . . . 0.0 112.595 -174.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -78.41 -31.19 48.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.737 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.456 ' N ' HG22 ' A' ' 32' ' ' ILE . 11.4 pt20 -87.75 170.37 11.29 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 173.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.91 97.01 0.15 Allowed Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.046 -1.074 . . . . 0.0 112.663 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -149.16 -60.47 0.22 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.91 -167.42 1.19 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.716 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.609 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 10.7 tp -85.27 166.71 16.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.571 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.908 HG21 HG13 ' A' ' 32' ' ' ILE . 43.4 p -127.41 177.25 6.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.128 172.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.77 -30.02 65.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 0.0 110.238 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -53.49 -45.93 69.83 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.788 0.804 . . . . 0.0 109.759 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.666 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 19.9 m-20 -70.54 -30.5 67.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.334 -178.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.979 HG22 HD22 ' A' ' 91' ' ' LEU . 60.2 t -64.87 -41.84 93.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.257 0.551 . . . . 0.0 109.775 174.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.0 t -61.32 -32.01 71.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.315 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.666 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 34.3 mtpt -63.07 -43.52 98.36 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.754 176.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.587 HG23 HD13 ' A' ' 59' ' ' LEU . 43.6 pt -80.91 174.99 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-O 121.723 0.773 . . . . 0.0 111.901 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.457 ' O ' ' HG2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -163.43 143.43 8.71 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.228 -174.811 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.446 HG22 HD11 ' A' ' 104' ' ' ILE . 0.7 OUTLIER -70.34 140.76 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.491 -179.16 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.95 -27.09 6.9 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.965 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.537 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 23.4 ptt? -90.73 174.39 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.255 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.875 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 39.8 p -92.82 -173.78 3.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.888 -171.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.473 ' OE1' ' HA ' ' A' ' 68' ' ' PHE . 83.4 mt-30 -65.57 -44.33 87.08 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.515 172.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.657 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 1.5 pp0? -64.97 -33.67 76.58 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.316 0.579 . . . . 0.0 110.18 -175.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.875 ' HG3' ' H ' ' A' ' 51' ' ' THR . 6.3 mm-40 -62.27 -53.01 61.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.222 175.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.733 HG11 HD22 ' A' ' 93' ' ' LEU . 69.1 t -69.96 -40.24 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.676 -176.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.762 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -57.44 -33.45 67.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.433 0.635 . . . . 0.0 110.053 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -81.48 -36.56 29.15 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.744 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.23 -43.3 52.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.132 0.492 . . . . 0.0 111.968 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.609 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -94.86 -14.89 24.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.079 -172.625 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.02 124.16 3.27 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -175.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.762 HG22 ' HB1' ' A' ' 56' ' ' ALA . 18.6 p -60.11 121.21 57.45 Favored Pre-proline 0 N--CA 1.432 -1.339 0 CA-C-O 122.295 1.045 . . . . 0.0 111.666 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 75.4 Cg_exo -52.54 159.25 4.82 Favored 'Trans proline' 0 C--N 1.327 -0.602 1 C-N-CA 125.436 4.091 . . . . 0.0 113.965 -176.623 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 65' ' ' SER . 0.5 OUTLIER -75.12 -21.1 59.1 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.953 -171.618 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.534 ' HE1' HG21 ' A' ' 70' ' ' THR . 16.9 ptt? -70.49 23.51 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.715 175.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 63' ' ' LEU . 44.5 t 77.07 -56.73 0.53 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 165.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 8.3 m-20 -126.29 99.92 30.22 Favored Pre-proline 0 C--N 1.304 -1.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.655 -171.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.539 ' HG3' HG22 ' A' ' 61' ' ' THR . 12.5 Cg_endo -58.75 -34.55 99.04 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.408 2.072 . . . . 0.0 111.655 176.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.522 ' CZ ' ' HB3' ' A' ' 53' ' ' GLN . 9.4 m-85 -78.99 2.48 20.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.81 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.0 -15.55 44.76 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.873 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.534 HG21 ' HE1' ' A' ' 64' ' ' MET . 6.1 t -124.81 175.5 7.22 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -127.39 7.82 6.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.293 0.568 . . . . 0.0 109.953 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 m -134.69 113.09 11.34 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.677 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.428 ' O ' ' HA ' ' A' ' 92' ' ' THR . 40.0 m0 -103.97 141.39 36.26 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.069 -176.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -116.41 114.64 24.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.372 0.606 . . . . 0.0 110.946 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.675 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 93.2 m-85 -129.41 176.61 7.82 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.525 177.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.575 HG21 ' HB3' ' A' ' 88' ' ' GLN . 1.4 p -143.27 -177.86 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.515 ' H ' HG22 ' A' ' 76' ' ' VAL . 15.5 m-30 -101.75 179.74 4.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.14 0.495 . . . . 0.0 112.162 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -61.81 133.13 55.11 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.575 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.437 ' H ' ' NE2' ' A' ' 34' ' ' GLN . 44.2 tt0 30.28 65.96 0.13 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.24 1.016 . . . . 0.0 113.372 176.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.698 ' CB ' ' HG2' ' A' ' 88' ' ' GLN . 33.0 mm-40 -82.55 159.31 64.36 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 121.747 0.784 . . . . 0.0 112.407 -177.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 11.2 Cg_exo -72.05 102.57 1.36 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 124.248 3.299 . . . . 0.0 111.446 175.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -128.11 35.42 2.73 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.159 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -130.24 -68.75 0.69 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -93.38 123.12 36.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.106 175.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.92 69.1 1.14 Allowed Glycine 0 N--CA 1.452 -0.278 0 O-C-N 124.182 0.926 . . . . 0.0 112.417 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.3 t -53.54 130.3 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.444 0.64 . . . . 0.0 110.758 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.9 t -152.13 14.19 0.61 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.646 -175.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.698 ' HG2' ' CB ' ' A' ' 80' ' ' GLN . 41.6 mt-30 -36.65 118.58 0.58 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.679 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.697 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 89.6 mt-30 -69.62 102.41 1.85 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.608 0.718 . . . . 0.0 109.298 178.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.9 p -91.07 137.11 32.62 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.966 -175.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.044 HD11 HG22 ' A' ' 104' ' ' ILE . 42.5 tp -91.71 118.77 30.96 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.88 174.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.608 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 51.1 m -110.61 103.0 11.53 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.864 ' HG ' HD21 ' A' ' 101' ' ' LEU . 6.7 tp -83.11 118.32 23.48 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.055 -174.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 72.7 m -101.17 120.85 40.83 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.531 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.546 ' CE2' HD23 ' A' ' 93' ' ' LEU . 79.2 m-85 -111.96 144.92 40.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.856 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.503 HD21 ' HB ' ' A' ' 100' ' ' VAL . 27.2 p30 -75.64 -174.09 2.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.273 173.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.1 m -65.01 -24.93 67.65 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.43 ' HB3' HG23 ' A' ' 100' ' ' VAL . 18.1 t -85.1 -13.6 49.76 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.786 -177.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.26 30.68 8.53 Favored Glycine 0 CA--C 1.508 -0.348 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.008 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.503 ' HB ' HD21 ' A' ' 96' ' ' ASN . 5.2 t -112.23 138.59 40.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.797 -0.702 . . . . 0.0 109.525 -177.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.864 HD21 ' HG ' ' A' ' 93' ' ' LEU . 8.5 mt -59.26 124.35 19.72 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.297 0.57 . . . . 0.0 112.442 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.468 HG21 ' HB3' ' A' ' 96' ' ' ASN . 19.3 p -111.23 -37.78 5.21 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.164 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -149.65 149.42 30.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.479 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.044 HG22 HD11 ' A' ' 91' ' ' LEU . 2.4 mm -110.19 93.32 2.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 173.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.608 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 34.0 t0 -87.76 96.0 10.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.007 0.432 . . . . 0.0 111.4 -170.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -107.89 104.11 13.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.587 0.708 . . . . 0.0 111.277 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.566 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -143.31 168.48 12.85 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.226 178.736 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.697 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 42.5 Cg_endo -70.48 162.33 42.83 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.069 1.846 . . . . 0.0 112.27 -174.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.87 177.04 0.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.012 0.91 . . . . 0.0 112.674 -177.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 111' ' ' SER . 70.1 mt -47.27 -34.46 6.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.077 -1.874 . . . . 0.0 114.222 -169.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.535 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 62.1 m 80.77 160.5 0.16 Allowed 'General case' 0 C--N 1.332 -0.193 0 O-C-N 124.593 1.183 . . . . 0.0 111.443 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.44 -161.27 9.66 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 176.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.5 p30 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.625 -0.702 . . . . 0.0 109.559 177.926 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.768 0 N-CA-C 111.899 -0.481 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.6 t 57.29 57.35 4.52 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.265 0.555 . . . . 0.0 109.955 -177.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -66.2 -49.55 66.93 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.147 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -140.69 7.2 2.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.029 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.2 t -169.94 134.26 1.28 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.619 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 m -87.25 -24.83 24.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.28 0.562 . . . . 0.0 109.854 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.9 mt -84.22 -36.57 22.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.627 -176.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -73.98 -21.82 59.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.845 0.355 . . . . 0.0 111.056 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.462 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 32.7 ttm180 62.25 24.98 14.91 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.768 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 25' ' ' ARG . 94.0 t 74.79 133.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.144 -175.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -57.11 152.61 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.454 0.645 . . . . 0.0 112.011 -173.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -61.61 163.44 7.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.025 -0.989 . . . . 0.0 113.349 -176.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.654 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 4.9 ptp180 -74.79 173.49 6.73 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.241 172.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.654 ' HD2' ' HB2' ' A' ' 29' ' ' ARG . 95.0 Cg_exo -41.75 129.87 3.97 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.487 2.125 . . . . 0.0 111.878 174.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -145.21 100.48 3.47 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.806 0.812 . . . . 0.0 111.068 -169.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.929 HG22 ' H ' ' A' ' 34' ' ' GLN . 39.6 mm -63.78 143.98 15.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.107 172.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.29 -18.9 61.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.039 0.447 . . . . 0.0 110.003 -178.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.929 ' H ' HG22 ' A' ' 32' ' ' ILE . 12.9 pt20 -117.15 -174.12 2.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.844 176.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 168.45 52.03 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 175.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -102.94 -43.09 5.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.954 0.407 . . . . 0.0 110.305 -175.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -113.31 -168.72 1.37 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.653 175.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.732 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 4.8 tp -80.1 152.98 29.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.618 0.247 . . . . 0.0 110.925 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.544 ' HB ' ' HA ' ' A' ' 78' ' ' ARG . 20.6 p -126.87 -174.76 3.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.079 176.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.513 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -67.34 -34.43 77.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.443 0.639 . . . . 0.0 110.574 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -64.67 -42.07 95.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.821 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.93 -27.97 66.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.025 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.784 HG22 HD22 ' A' ' 91' ' ' LEU . 58.8 t -59.84 -36.71 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.15 0.5 . . . . 0.0 110.76 176.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.9 t -59.33 -20.54 55.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.373 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 47.9 mtpt -75.58 -19.24 59.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.819 -176.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.778 HG23 HD13 ' A' ' 59' ' ' LEU . 30.0 pt -107.01 177.95 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.646 0.736 . . . . 0.0 112.46 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.92 150.69 4.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.729 -177.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.54 HG22 HD11 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -72.74 141.81 15.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.999 -179.045 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.69 -29.83 5.51 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.11 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.591 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 18.6 ptt? -88.54 178.36 6.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.184 0.492 . . . . 0.0 111.133 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.884 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 39.9 p -95.09 -174.3 3.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.207 -170.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.412 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 45.7 mt-30 -66.72 -44.12 82.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.866 174.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.64 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -65.92 -34.52 78.32 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.422 0.63 . . . . 0.0 109.823 -176.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.884 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.9 mm-40 -61.0 -57.03 14.32 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.464 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.645 HG11 ' CD2' ' A' ' 93' ' ' LEU . 90.9 t -63.42 -42.53 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.725 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.537 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.72 -35.82 73.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.082 0.468 . . . . 0.0 110.161 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -80.88 -37.22 30.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.515 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.64 -46.39 66.28 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.616 0.722 . . . . 0.0 111.215 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.778 HD13 HG23 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -88.14 -42.79 12.11 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.594 -172.103 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.79 122.01 3.76 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -171.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.537 HG22 ' HB1' ' A' ' 56' ' ' ALA . 17.9 p -54.7 136.51 64.0 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.499 0.666 . . . . 0.0 111.795 -175.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.588 ' HB2' ' HG2' ' A' ' 64' ' ' MET . 23.1 Cg_exo -64.49 165.03 21.44 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.847 3.031 . . . . 0.0 113.197 -172.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.14 -24.63 67.27 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.483 -173.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.588 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 14.6 ptt? -68.22 -1.29 5.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.806 175.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 t 71.56 6.63 5.77 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.459 0.704 . . . . 0.0 112.471 170.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -165.33 110.93 0.79 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 121.738 0.78 . . . . 0.0 110.674 176.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.642 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 60.4 Cg_endo -73.67 -24.54 15.73 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.303 2.669 . . . . 0.0 113.525 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -80.53 -5.6 56.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -170.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.75 -18.76 59.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.733 -176.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.5 t -125.0 175.28 7.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.348 0.594 . . . . 0.0 111.624 -173.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -117.49 0.34 12.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.658 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.4 m -128.99 111.86 13.44 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.789 -178.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.642 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 43.8 m0 -104.03 137.36 42.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.606 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -113.28 110.09 19.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.224 0.535 . . . . 0.0 111.21 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.621 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 53.8 m-85 -125.8 175.83 7.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.602 HG22 ' H ' ' A' ' 77' ' ' PHE . 2.3 p -141.89 179.99 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.536 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.602 ' H ' HG22 ' A' ' 76' ' ' VAL . 2.9 m-30 -87.91 -172.92 4.05 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 122.599 0.36 . . . . 0.0 111.632 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.601 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 7.4 mtp180 -48.18 169.43 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.536 173.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.488 ' HB2' ' HG2' ' A' ' 34' ' ' GLN . 0.4 OUTLIER -62.97 84.79 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 172.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.851 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 6.7 mm100 -101.61 164.46 15.86 Favored Pre-proline 0 N--CA 1.444 -0.764 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.728 177.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.619 ' HD2' HG22 ' A' ' 87' ' ' THR . 51.2 Cg_exo -57.75 116.68 3.4 Favored 'Trans proline' 0 C--N 1.33 -0.416 0 C-N-CA 123.468 2.778 . . . . 0.0 112.537 174.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 83' ' ' HIS . . . -110.73 170.48 13.97 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 173.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.421 ' HB3' ' O ' ' A' ' 82' ' ' GLY . 38.9 t60 71.6 -62.55 0.45 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.807 0.443 . . . . 0.0 110.638 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -118.38 134.92 54.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.712 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 51.53 52.6 32.49 Favored Glycine 0 N--CA 1.453 -0.196 0 O-C-N 124.07 0.856 . . . . 0.0 111.731 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 81' ' ' PRO . 17.4 t -67.14 135.85 27.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.604 0.716 . . . . 0.0 111.339 -172.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.642 HG23 ' HB3' ' A' ' 80' ' ' GLN . 13.2 t -134.1 5.19 3.55 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.45 173.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.851 ' HG2' ' HB2' ' A' ' 80' ' ' GLN . 10.4 mm-40 -65.81 128.66 36.88 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.328 174.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.633 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 79.3 mt-30 -113.36 130.75 56.21 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.175 176.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER -90.8 131.1 36.65 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.902 -179.2 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.895 HD11 HG22 ' A' ' 104' ' ' ILE . 13.9 tp -90.92 108.35 19.8 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.742 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 19.2 m -103.22 104.5 14.64 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.871 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.0 tp -88.71 128.71 35.62 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.423 -173.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.2 m -115.82 123.06 47.23 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.077 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.453 ' CE1' HD23 ' A' ' 93' ' ' LEU . 93.1 m-85 -112.41 137.31 50.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.43 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.49 ' HB3' HG21 ' A' ' 102' ' ' THR . 6.1 p30 -57.22 -82.7 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -175.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.4 t -155.38 -34.3 0.09 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 100' ' ' VAL . 16.9 m -78.99 -8.11 58.65 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.243 0.544 . . . . 0.0 110.436 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.47 32.18 8.37 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.487 ' HB ' HD21 ' A' ' 96' ' ' ASN . 18.5 t -112.35 134.17 55.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.178 -0.511 . . . . 0.0 109.689 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.871 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.2 mt -61.52 125.88 25.36 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.249 0.547 . . . . 0.0 112.319 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 96' ' ' ASN . 11.2 p -111.73 -42.55 3.8 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.913 175.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -136.05 151.89 50.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.57 0.7 . . . . 0.0 111.49 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.895 HG22 HD11 ' A' ' 91' ' ' LEU . 3.1 mm -115.75 93.65 2.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 168.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.742 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 7.5 t70 -87.34 95.04 9.85 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.133 0.492 . . . . 0.0 110.415 -170.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.471 ' HB3' HD12 ' A' ' 91' ' ' LEU . 18.6 p-10 -112.3 111.38 22.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.842 0.83 . . . . 0.0 111.437 -176.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.604 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -147.38 170.7 7.32 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.609 177.282 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.633 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 20.3 Cg_endo -64.93 151.17 86.74 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 121.731 1.62 . . . . 0.0 112.967 -172.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.9 130.91 43.5 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.435 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.5 mt 35.14 -92.4 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 125.135 1.522 . . . . 0.0 112.722 -176.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 82.6 p 52.31 32.96 11.79 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.754 0.822 . . . . 0.0 112.704 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.59 117.05 4.28 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.858 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 . . . . . 0 C--N 1.316 -0.849 0 CA-C-O 118.531 -0.747 . . . . 0.0 109.719 178.364 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.701 0 N-CA-C 112.393 -0.283 . . . . 0.0 112.393 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t 71.4 21.6 4.52 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.433 0.693 . . . . 0.0 111.414 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -163.63 112.52 1.24 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -104.79 6.36 33.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.721 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 p 47.89 -99.22 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 O-C-N 124.021 0.825 . . . . 0.0 111.972 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.836 HG22 ' H ' ' A' ' 23' ' ' LEU . 2.1 m 60.3 -166.8 0.19 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.705 0.288 . . . . 0.0 110.369 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.836 ' H ' HG22 ' A' ' 22' ' ' THR . 1.0 OUTLIER -147.91 88.23 1.66 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.88 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -83.89 63.03 7.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.341 0.591 . . . . 0.0 110.079 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.566 ' HB2' HD22 ' A' ' 23' ' ' LEU . 78.5 ttt180 -72.0 -64.04 1.02 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.062 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.51 HG23 ' HG2' ' A' ' 25' ' ' ARG . 61.9 t -116.92 -56.01 3.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.917 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.574 HG22 ' H ' ' A' ' 28' ' ' TYR . 2.6 p -144.79 -178.66 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.863 -177.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.574 ' H ' HG22 ' A' ' 27' ' ' VAL . 98.7 m-85 -49.07 158.27 0.36 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.323 0.582 . . . . 0.0 112.088 175.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.554 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 16.1 mmm180 -114.63 172.47 3.58 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -178.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 29' ' ' ARG . 87.7 Cg_exo -47.24 153.41 1.75 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.9 2.4 . . . . 0.0 112.579 172.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.96 -30.87 67.27 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.367 0.603 . . . . 0.0 111.05 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.853 HG22 ' H ' ' A' ' 34' ' ' GLN . 28.8 mm -91.82 146.76 5.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.213 172.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.504 ' OD1' ' HB2' ' A' ' 79' ' ' GLN . 6.2 p-10 -71.26 -1.39 12.54 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.764 175.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.853 ' H ' HG22 ' A' ' 32' ' ' ILE . 3.6 pt20 -154.03 -178.51 7.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.302 -175.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 175.82 45.11 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.806 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -108.88 -60.26 1.77 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.34 0.591 . . . . 0.0 110.983 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -102.77 -168.51 1.53 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.917 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.669 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 4.9 tp -70.56 150.56 45.97 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.044 0.449 . . . . 0.0 110.121 178.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 43.1 p -128.77 -174.29 3.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.589 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.25 -46.48 76.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.381 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.52 -27.43 69.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.155 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.503 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 14.4 m-20 -70.9 -37.0 72.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.441 173.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.851 HG22 HD22 ' A' ' 91' ' ' LEU . 67.3 t -59.63 -36.99 68.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.217 0.532 . . . . 0.0 110.784 176.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.0 t -64.77 -15.05 61.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.113 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 47.0 mtpt -81.82 -8.63 59.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.332 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.735 HG23 HD13 ' A' ' 59' ' ' LEU . 24.8 pt -112.67 178.38 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.713 0.768 . . . . 0.0 112.131 176.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.16 151.05 4.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.484 -177.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.552 HG22 HD11 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -72.76 144.41 12.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.101 -177.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.25 -29.05 6.32 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.197 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.566 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 19.2 ptt? -90.24 174.79 7.41 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.119 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.875 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 31.2 p -91.61 -176.66 4.56 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.049 -170.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -61.46 -47.05 87.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.704 170.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.41 -37.7 75.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.271 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.875 ' HG3' ' H ' ' A' ' 51' ' ' THR . 5.3 mm-40 -67.45 -54.38 20.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.19 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.63 HG11 ' CD2' ' A' ' 93' ' ' LEU . 73.5 t -62.11 -44.49 99.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.822 -178.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.642 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.31 -34.75 70.92 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.046 0.451 . . . . 0.0 110.104 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -82.15 -36.56 27.29 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.196 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.51 -43.34 77.01 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.772 0.796 . . . . 0.0 111.023 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.735 HD13 HG23 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -89.4 -54.74 3.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.183 -173.39 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 127.15 118.75 2.2 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.713 HG22 ' HG3' ' A' ' 67' ' ' PRO . 32.8 p -55.27 130.54 69.09 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.082 0.468 . . . . 0.0 111.128 -176.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 18.6 Cg_exo -64.95 172.41 7.26 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.871 3.048 . . . . 0.0 113.843 -169.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.433 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 3.9 mt -49.91 -43.24 49.49 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.877 0.735 . . . . 0.0 111.89 -173.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.0 ptt? -63.16 -3.54 1.86 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.328 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 p 59.54 3.25 0.4 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.618 1.167 . . . . 0.0 113.495 174.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -136.45 90.15 17.86 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.226 0.536 . . . . 0.0 109.866 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.713 ' HG3' HG22 ' A' ' 61' ' ' THR . 72.1 Cg_endo -74.74 -32.0 6.18 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.856 2.371 . . . . 0.0 112.128 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -77.97 7.26 6.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.2 -171.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.35 -19.76 17.57 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.085 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.9 t -124.2 165.53 17.43 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -177.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -117.96 12.81 13.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.292 0.568 . . . . 0.0 110.31 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.9 m -136.69 106.89 6.37 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.933 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.692 ' O ' ' HA ' ' A' ' 92' ' ' THR . 47.7 m0 -103.79 147.21 27.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 -173.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -124.42 124.94 43.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.063 0.459 . . . . 0.0 110.764 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.617 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 80.6 m-85 -130.28 173.42 10.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.722 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.7 t -112.07 158.04 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.956 0.407 . . . . 0.0 110.021 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -96.25 165.36 12.25 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.69 176.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.424 ' HG3' HD12 ' A' ' 32' ' ' ILE . 3.5 tmm_? -65.22 114.05 4.43 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.504 ' HB2' ' OD1' ' A' ' 33' ' ' ASN . 43.0 tt0 67.49 110.68 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 124.227 0.954 . . . . 0.0 112.193 -178.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.528 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 44.3 mt-30 -79.76 135.27 56.1 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 172.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.535 ' HG2' HG23 ' A' ' 87' ' ' THR . 3.5 Cg_exo -79.09 66.19 8.79 Favored 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 124.503 3.469 . . . . 0.0 112.429 -174.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.07 144.49 9.07 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.704 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -89.19 -22.67 22.68 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -126.98 131.0 51.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.641 175.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.33 54.97 4.48 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -171.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 88' ' ' GLN . 29.7 t -71.34 138.05 22.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.339 0.59 . . . . 0.0 111.435 -173.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.535 HG23 ' HG2' ' A' ' 81' ' ' PRO . 8.8 t -139.09 20.54 2.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.372 177.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.588 ' HG3' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -54.27 116.99 2.91 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.617 179.64 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.706 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 3.1 pm0 -75.14 104.01 5.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.762 0.792 . . . . 0.0 109.94 175.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.588 HG23 ' HG3' ' A' ' 88' ' ' GLN . 1.2 p -88.87 151.58 22.26 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.664 -172.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.906 HD11 HG22 ' A' ' 104' ' ' ILE . 17.5 tp -90.52 111.71 23.1 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.719 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.692 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 81.0 m -107.14 108.55 20.06 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.884 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.5 tp -91.81 126.71 36.99 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.615 -173.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 20.0 m -104.33 122.13 44.8 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.996 -177.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.52 ' CE2' HD23 ' A' ' 93' ' ' LEU . 67.2 m-85 -114.37 139.33 49.56 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.962 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.497 HD21 ' HB ' ' A' ' 100' ' ' VAL . 33.4 p30 -76.08 -175.75 3.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.432 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.9 m -52.01 -36.24 49.38 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.469 ' HB3' HG23 ' A' ' 100' ' ' VAL . 10.4 t -89.19 -0.03 57.13 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.161 -0.337 . . . . 0.0 111.182 -171.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.79 29.33 39.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.451 -0.881 . . . . 0.0 111.179 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.497 ' HB ' HD21 ' A' ' 96' ' ' ASN . 21.8 t -105.88 138.92 28.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.004 -0.598 . . . . 0.0 109.667 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.884 HD21 ' HG ' ' A' ' 93' ' ' LEU . 5.9 mt -60.9 125.5 23.94 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.175 0.512 . . . . 0.0 112.026 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.492 HG21 ' HB3' ' A' ' 96' ' ' ASN . 11.2 p -112.52 -43.35 3.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.93 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.427 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 1.9 m-20 -137.53 154.3 49.86 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.3 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.906 HG22 HD11 ' A' ' 91' ' ' LEU . 3.6 mm -115.41 92.47 2.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 169.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 92' ' ' THR . 15.4 m-20 -89.38 96.98 10.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.971 0.415 . . . . 0.0 111.441 -172.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -107.3 109.11 20.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.486 0.66 . . . . 0.0 110.516 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.711 ' H ' ' HE3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -143.86 169.31 10.58 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.259 -179.014 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.706 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 25.9 Cg_endo -66.44 154.21 75.14 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 121.844 1.696 . . . . 0.0 112.715 -173.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.21 149.66 21.68 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.211 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.6 mt 52.24 -88.44 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 O-C-N 124.625 1.203 . . . . 0.0 112.875 175.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.8 t -154.15 109.7 3.18 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.52 -122.42 0.48 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.665 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.2 t30 . . . . . 0 C--N 1.313 -1.003 0 CA-C-O 118.723 -0.656 . . . . 0.0 109.681 176.585 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.826 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.6 p -109.09 -32.0 7.39 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -175.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -117.79 47.61 1.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.303 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.8 ttt 62.39 80.75 0.22 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.346 0.593 . . . . 0.0 110.3 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.1 t -84.05 140.43 31.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.697 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.8 p -80.21 59.6 3.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.199 0.523 . . . . 0.0 111.566 -178.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.9 mt -125.94 78.3 1.74 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.799 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -104.98 -46.07 4.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.698 -176.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.478 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.8 mmp_? -84.41 57.59 4.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.87 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.98 148.76 18.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.25 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.95 172.94 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.198 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -74.48 118.43 17.43 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.228 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -110.28 105.04 56.83 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -48.02 128.29 16.33 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.062 2.508 . . . . 0.0 112.416 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -161.78 105.31 1.22 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -175.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.66 HG22 ' H ' ' A' ' 34' ' ' GLN . 37.4 mm -56.89 138.42 17.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.942 -175.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -30.41 49.95 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.57 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.66 ' H ' HG22 ' A' ' 32' ' ' ILE . 6.1 pt20 -102.32 -171.89 2.04 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.118 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.88 -1.93 0.72 Allowed Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.122 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -72.45 -39.83 67.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.205 0.526 . . . . 0.0 109.95 176.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -109.27 -167.59 1.23 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.423 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.718 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 2.5 mm? -77.76 153.22 33.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.583 0.706 . . . . 0.0 111.792 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 43' ' ' VAL . 30.6 p -128.64 -174.94 3.38 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.66 174.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -71.35 -35.0 71.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.804 0.812 . . . . 0.0 109.813 176.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -61.54 -43.88 98.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.388 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.426 ' HB2' HD12 ' A' ' 38' ' ' LEU . 35.0 m-20 -72.02 -30.77 65.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.073 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.876 HG22 HD22 ' A' ' 91' ' ' LEU . 54.6 t -57.87 -36.68 56.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.134 0.492 . . . . 0.0 110.289 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.2 t -61.85 -18.3 59.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.578 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 46.1 mtpt -74.33 -36.15 63.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.768 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.784 HG23 HD13 ' A' ' 59' ' ' LEU . 39.3 pt -87.64 178.61 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.848 0.832 . . . . 0.0 112.268 -177.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.68 150.9 2.23 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.467 -175.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.479 HG22 HD11 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -70.74 144.09 13.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.206 -177.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.41 -32.74 4.58 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.776 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.512 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 13.1 ptt? -87.35 177.64 7.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.017 0.437 . . . . 0.0 111.053 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.835 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 22.2 p -92.57 -174.76 3.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.904 -171.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.476 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 95.4 mt-30 -64.64 -43.88 92.28 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.921 173.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.554 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 1.5 pp0? -66.46 -35.1 79.45 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.216 0.531 . . . . 0.0 109.996 -175.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.835 ' HG3' ' H ' ' A' ' 51' ' ' THR . 11.4 mm-40 -59.86 -51.12 71.06 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.729 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.658 HG11 ' CD2' ' A' ' 93' ' ' LEU . 70.5 t -68.75 -42.78 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.663 -176.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.536 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.98 -25.67 68.23 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.388 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -81.7 -40.93 22.06 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.555 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.41 -45.16 69.89 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.591 0.71 . . . . 0.0 111.332 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.784 HD13 HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -90.58 -44.09 9.78 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.232 -174.365 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.57 132.24 4.01 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -171.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.536 HG22 ' HB1' ' A' ' 56' ' ' ALA . 16.7 p -59.96 134.32 90.01 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.028 0.442 . . . . 0.0 110.684 -177.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.493 ' HG3' ' OH ' ' A' ' 75' ' ' TYR . 20.4 Cg_exo -64.16 171.97 6.94 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.902 3.068 . . . . 0.0 114.358 -169.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.499 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 7.2 mt -50.03 -47.45 53.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.244 -175.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.473 ' HE3' HG21 ' A' ' 70' ' ' THR . 0.0 OUTLIER -54.98 -12.92 0.93 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.957 179.018 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.4 t 70.75 1.58 3.78 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.292 0.568 . . . . 0.0 111.332 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -144.38 102.23 4.71 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-O 121.592 0.71 . . . . 0.0 109.435 174.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.509 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 43.5 Cg_endo -68.45 -25.8 35.16 Favored 'Trans proline' 0 C--N 1.327 -0.565 0 C-N-CA 123.198 2.599 . . . . 0.0 112.608 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -86.63 12.36 10.78 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.547 -173.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -102.39 -20.25 12.54 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.241 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.473 HG21 ' HE3' ' A' ' 64' ' ' MET . 6.6 t -126.25 172.61 9.94 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -122.03 10.14 10.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.187 0.518 . . . . 0.0 109.867 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.2 m -139.4 112.52 8.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.171 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.534 ' O ' ' HA ' ' A' ' 92' ' ' THR . 44.7 m0 -104.34 144.83 31.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.736 -176.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -121.87 112.88 18.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 110.644 -176.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.612 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 33.2 m-85 -125.4 174.69 8.0 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.54 HG22 ' H ' ' A' ' 77' ' ' PHE . 5.8 p -137.15 168.56 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.858 -174.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.54 ' H ' HG22 ' A' ' 76' ' ' VAL . 2.0 m-30 -95.04 166.19 12.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.049 -176.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.427 ' HG3' HD12 ' A' ' 32' ' ' ILE . 13.2 ttt180 -56.95 133.64 54.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.126 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.427 ' H ' ' NE2' ' A' ' 34' ' ' GLN . 6.2 tp-100 44.83 67.68 0.67 Allowed 'General case' 0 C--O 1.234 0.282 0 O-C-N 124.194 0.933 . . . . 0.0 111.461 176.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.63 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 1.5 pp0? -78.93 141.13 58.57 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.194 -179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 12.0 Cg_exo -73.32 93.85 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.838 2.359 . . . . 0.0 111.301 174.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.26 -12.15 14.23 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.875 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -57.29 -52.81 63.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.823 0.344 . . . . 0.0 110.805 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -155.2 143.32 20.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.236 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . 63.14 60.85 7.0 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.683 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 111' ' ' SER . 43.2 t -53.66 128.15 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.565 0.698 . . . . 0.0 111.086 -177.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.403 ' CG2' ' HG2' ' A' ' 81' ' ' PRO . 11.6 t -140.04 16.05 2.45 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.311 -177.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.63 ' HG2' ' HB2' ' A' ' 80' ' ' GLN . 20.7 mt-30 -35.71 111.95 0.15 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.548 -1.205 . . . . 0.0 113.557 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.731 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 95.5 mt-30 -73.85 104.12 4.62 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 172.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.6 p -97.58 143.9 27.8 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.972 -170.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.876 HD22 HG22 ' A' ' 43' ' ' VAL . 16.8 tp -97.81 104.0 15.99 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.716 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.691 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 24.9 m -99.51 105.18 17.06 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.839 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.7 tp -88.03 123.61 32.9 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.582 -174.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 21.6 m -105.48 123.67 48.27 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.971 -176.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.507 ' CE2' HD23 ' A' ' 93' ' ' LEU . 33.7 m-85 -111.29 151.28 28.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.894 0.854 . . . . 0.0 112.966 -175.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -75.17 -176.01 2.87 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.292 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.7 p -67.02 -41.04 87.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.848 0.356 . . . . 0.0 111.097 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.46 ' HB3' HG23 ' A' ' 100' ' ' VAL . 38.2 t -74.95 -13.82 60.57 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.112 0.482 . . . . 0.0 110.592 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 52' ' ' GLN . . . 95.04 31.01 7.9 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -176.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.46 HG23 ' HB3' ' A' ' 98' ' ' SER . 21.9 t -101.42 140.25 20.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.839 HD21 ' HG ' ' A' ' 93' ' ' LEU . 5.5 mt -60.17 126.18 26.53 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.133 0.492 . . . . 0.0 111.356 177.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 70.9 p -113.39 -45.06 3.16 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.854 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.486 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 3.4 m-20 -136.85 153.66 50.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.501 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.858 HG22 HD11 ' A' ' 91' ' ' LEU . 3.6 mm -120.13 93.52 2.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 172.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.691 ' HB2' ' HB ' ' A' ' 92' ' ' THR . 6.9 m-20 -78.23 96.41 5.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.962 0.41 . . . . 0.0 110.716 -176.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -111.2 104.33 12.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.579 0.704 . . . . 0.0 110.081 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.438 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -150.82 166.54 14.87 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.712 -176.069 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.731 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 36.9 Cg_endo -83.47 155.23 14.1 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.639 2.226 . . . . 0.0 111.929 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.63 170.3 16.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.005 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 47.7 mt -49.17 -37.67 23.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.463 -167.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 55.2 m 69.48 37.68 1.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.652 175.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.08 113.42 3.68 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.297 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.402 ' HB2' ' HA2' ' A' ' 85' ' ' GLY . 29.2 t-20 . . . . . 0 C--N 1.314 -0.967 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.944 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 112.126 -0.39 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.2 m -66.28 144.99 56.25 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.847 0.356 . . . . 0.0 110.589 177.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -84.46 55.38 3.36 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.099 0.476 . . . . 0.0 111.581 -173.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 47.9 ttm -176.78 42.67 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.3 t -79.59 77.19 6.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.833 -176.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 t -79.81 108.6 13.5 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.582 0.706 . . . . 0.0 109.318 175.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 99.1 mt -105.64 142.11 35.95 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.658 -174.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -79.77 49.35 1.04 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.243 178.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 69.55 147.93 0.07 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.248 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.4 m -80.33 122.35 35.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.397 0.618 . . . . 0.0 111.861 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.627 HG22 ' H ' ' A' ' 28' ' ' TYR . 3.0 p -81.62 -171.92 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.627 ' H ' HG22 ' A' ' 27' ' ' VAL . 94.5 m-85 -48.06 126.05 10.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.171 0.51 . . . . 0.0 111.479 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -82.94 155.91 67.52 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.25 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -52.18 152.91 13.82 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.479 2.786 . . . . 0.0 111.807 171.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.8 t70 67.62 103.54 0.05 OUTLIER 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.765 0.793 . . . . 0.0 109.215 -172.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.01 HG22 ' H ' ' A' ' 34' ' ' GLN . 45.2 mm -54.49 139.87 12.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.179 -1.373 . . . . 0.0 113.028 -168.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -68.07 -12.51 60.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.775 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 1.01 ' H ' HG22 ' A' ' 32' ' ' ILE . 23.4 pt20 -134.24 178.3 7.08 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.583 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.44 28.9 0.12 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.853 177.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -77.93 -26.47 48.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.062 0.458 . . . . 0.0 110.625 -175.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.34 -165.72 2.29 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.851 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.528 ' CD2' ' HG ' ' A' ' 59' ' ' LEU . 6.4 tp -70.41 154.97 41.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.172 0.511 . . . . 0.0 111.259 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.4 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 44.8 p -128.62 -178.07 4.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.292 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.509 ' HB2' ' H ' ' A' ' 78' ' ' ARG . . . -66.49 -36.61 83.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.935 0.874 . . . . 0.0 110.209 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.682 ' OD1' HD11 ' A' ' 32' ' ' ILE . 9.2 m120 -61.94 -41.4 97.92 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.382 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.574 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 16.7 m-20 -69.89 -27.01 64.45 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.238 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.862 HG22 HD22 ' A' ' 91' ' ' LEU . 63.0 t -62.75 -37.03 78.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.322 0.582 . . . . 0.0 110.391 174.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -65.63 -16.55 63.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.807 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.574 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 45.5 mtpt -73.76 -29.51 62.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.656 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.742 HG23 HD13 ' A' ' 59' ' ' LEU . 40.3 pt -92.7 -178.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.795 0.807 . . . . 0.0 111.798 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.41 149.74 5.93 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.424 -177.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.542 HG22 HD11 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -71.48 148.0 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.505 -178.886 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.86 -30.22 7.58 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.215 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.523 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 19.9 ptt? -84.97 173.03 10.86 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.938 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.852 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 19.1 p -89.72 -174.32 4.26 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.438 -170.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 95' ' ' PHE . 37.1 mt-30 -64.89 -43.15 93.83 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.855 174.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 11.3 pt20 -65.8 -35.75 81.57 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.448 0.642 . . . . 0.0 109.913 -175.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.852 ' HG3' ' H ' ' A' ' 51' ' ' THR . 9.8 mm-40 -58.91 -55.22 37.92 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.297 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.682 HG11 HD22 ' A' ' 93' ' ' LEU . 92.8 t -66.73 -41.05 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.492 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.709 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.56 -34.45 71.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.184 0.516 . . . . 0.0 110.103 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -82.47 -38.81 23.39 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.755 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.58 -46.66 65.82 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.546 0.688 . . . . 0.0 111.343 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.742 HD13 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -92.1 -29.67 16.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.751 -173.08 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.55 127.85 6.02 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.709 HG22 ' HB1' ' A' ' 56' ' ' ALA . 34.9 p -59.9 134.09 89.79 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-O 121.237 0.541 . . . . 0.0 110.794 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 21.2 Cg_exo -65.85 162.12 36.33 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.189 2.592 . . . . 0.0 111.699 -174.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.438 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 1.2 mt -49.14 -33.53 12.25 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.57 -168.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.434 ' H ' ' HG2' ' A' ' 64' ' ' MET . 9.7 ptt? -62.55 -6.39 3.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.8 p 58.92 8.71 1.02 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.392 1.077 . . . . 0.0 112.503 177.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.434 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 1.9 t70 -141.21 94.77 7.62 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 122.021 0.915 . . . . 0.0 109.749 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.604 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 74.3 Cg_endo -75.26 -34.56 3.52 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.294 2.663 . . . . 0.0 113.356 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -79.55 2.94 20.34 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -174.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.08 -23.95 42.89 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.539 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.8 t -124.23 174.89 7.39 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -123.57 4.25 8.96 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.8 m -125.61 109.64 12.88 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.19 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.604 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 45.2 m0 -108.18 140.25 41.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.55 -176.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -117.17 112.45 20.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.34 0.591 . . . . 0.0 111.24 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.673 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 88.1 m-85 -113.31 174.92 5.67 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.982 174.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.504 HG23 ' CD ' ' A' ' 88' ' ' GLN . 2.5 p -122.28 150.51 25.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.206 0.526 . . . . 0.0 110.038 -174.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.53 -176.86 6.01 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.427 -175.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.705 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 62.9 ttt180 -50.03 147.72 3.8 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.146 174.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.5 tm0? -46.61 95.31 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -175.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.705 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 7.7 mm100 -106.35 162.77 18.64 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.508 172.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.13 101.16 0.18 Allowed 'Trans proline' 0 C--N 1.33 -0.417 0 C-N-CA 123.437 2.758 . . . . 0.0 111.941 173.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.07 30.19 4.88 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.823 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -96.19 -49.58 5.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.358 0.599 . . . . 0.0 109.669 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -146.89 136.59 23.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.489 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.5 62.61 6.07 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -173.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 88' ' ' GLN . 20.9 t -55.8 133.9 19.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.686 0.755 . . . . 0.0 112.352 -171.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.4 t -127.63 11.2 6.72 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.178 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.504 ' CD ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -68.4 132.94 47.91 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.563 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.678 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 94.8 mt-30 -102.8 107.57 18.48 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 173.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.403 HG23 ' HB2' ' A' ' 109' ' ' ALA . 3.4 p -86.45 150.98 23.9 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.898 -172.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.966 HD11 HG22 ' A' ' 104' ' ' ILE . 22.1 tp -89.54 107.51 19.12 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.527 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 23.8 m -99.03 101.53 12.94 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.865 ' HG ' HD21 ' A' ' 101' ' ' LEU . 8.0 tp -87.12 122.96 31.65 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.985 -174.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 27.6 m -104.14 118.13 35.91 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.077 -176.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.605 ' CE2' HD23 ' A' ' 93' ' ' LEU . 31.4 m-85 -105.63 149.29 26.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.737 0.78 . . . . 0.0 111.862 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -73.92 173.13 10.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.557 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.5 m -57.64 -36.87 72.43 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.794 0.331 . . . . 0.0 110.664 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.462 ' HB3' HG23 ' A' ' 100' ' ' VAL . 18.7 t -80.98 -4.1 53.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.927 0.394 . . . . 0.0 110.885 -177.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.36 30.01 26.02 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.402 -179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 98' ' ' SER . 21.4 t -105.99 138.88 29.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.865 HD21 ' HG ' ' A' ' 93' ' ' LEU . 5.9 mt -61.76 124.09 19.78 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.075 0.464 . . . . 0.0 111.747 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.0 p -114.02 -39.72 3.88 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.11 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.5 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 5.1 m-20 -136.76 154.6 50.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.554 0.692 . . . . 0.0 111.54 177.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.966 HG22 HD11 ' A' ' 91' ' ' LEU . 3.0 mm -118.73 92.38 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 168.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 92' ' ' THR . 13.3 m-20 -86.84 95.86 10.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.838 0.351 . . . . 0.0 110.947 -174.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -99.18 101.06 12.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.146 0.974 . . . . 0.0 109.634 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.459 ' HE3' ' HB3' ' A' ' 105' ' ' ASP . 71.2 mttt -137.06 154.7 76.14 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.289 -172.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.678 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 1.0 OUTLIER -60.41 132.67 44.8 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.681 2.254 . . . . 0.0 111.892 -174.73 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.403 ' HB2' HG23 ' A' ' 90' ' ' THR . . . -67.97 134.83 51.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.438 -172.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.9 mt 28.09 -90.15 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 O-C-N 125.553 1.783 . . . . 0.0 114.23 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.9 m -82.68 40.59 0.68 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 122.951 0.501 . . . . 0.0 112.192 -174.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -98.82 -157.6 29.41 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.716 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.5 t30 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.778 -0.629 . . . . 0.0 110.064 179.167 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.645 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.7 t 64.86 23.22 12.62 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.911 0.484 . . . . 0.0 111.46 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.53 80.28 1.29 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.102 0.477 . . . . 0.0 109.859 177.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -151.39 175.65 12.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.926 -177.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 75.6 m 59.59 45.96 12.58 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.612 0.57 . . . . 0.0 110.953 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.91 -40.8 53.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.647 178.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.6 tp 57.82 97.35 0.02 OUTLIER 'General case' 0 C--O 1.237 0.418 0 O-C-N 123.813 0.695 . . . . 0.0 112.582 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -76.0 -176.69 3.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.965 174.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -66.95 -82.51 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t 66.26 -67.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.61 HG22 ' H ' ' A' ' 28' ' ' TYR . 3.1 p -135.86 -160.09 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -171.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.61 ' H ' HG22 ' A' ' 27' ' ' VAL . 95.4 m-85 -46.88 111.02 0.34 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.981 0.419 . . . . 0.0 111.06 176.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -91.61 113.65 59.34 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.665 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.28 129.02 29.62 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.616 2.211 . . . . 0.0 111.075 172.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -69.15 -30.6 68.87 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.779 0.799 . . . . 0.0 110.247 -176.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.885 HG22 ' H ' ' A' ' 34' ' ' GLN . 41.0 mm -83.81 142.21 13.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.941 176.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -77.76 0.79 22.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.786 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.885 ' H ' HG22 ' A' ' 32' ' ' ILE . 9.8 pt20 -145.81 29.7 1.1 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.872 0.844 . . . . 0.0 110.325 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.57 58.4 4.71 Favored Glycine 0 C--N 1.318 -0.432 0 CA-C-N 114.266 -1.333 . . . . 0.0 112.317 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -128.1 -42.91 1.51 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -100.65 -164.94 1.16 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.633 -0.876 . . . . 0.0 108.633 172.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.676 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 3.0 tp -81.36 143.31 32.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.418 0.628 . . . . 0.0 111.568 -175.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.721 ' HB ' ' HB3' ' A' ' 78' ' ' ARG . 43.8 p -128.17 -175.24 3.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.93 177.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.561 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -65.65 -33.29 75.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.058 0.456 . . . . 0.0 110.811 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -59.47 -43.46 93.25 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.739 0.78 . . . . 0.0 109.717 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.409 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 6.9 m-20 -70.17 -34.29 72.82 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.633 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.793 HG22 HD22 ' A' ' 91' ' ' LEU . 55.9 t -55.59 -36.51 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.046 0.45 . . . . 0.0 111.154 177.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 t -64.27 -11.43 31.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.64 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.446 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 47.8 mtpt -80.53 -26.34 38.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.733 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.81 HG23 HD13 ' A' ' 59' ' ' LEU . 38.4 pt -95.49 -178.5 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.797 0.808 . . . . 0.0 112.305 -178.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.25 152.7 3.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.585 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.457 ' H ' HG23 ' A' ' 48' ' ' VAL . 0.5 OUTLIER -72.73 144.07 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.265 -178.835 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.19 -32.47 4.72 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.954 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.53 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 18.4 ptt? -90.07 177.14 6.53 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.488 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.912 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 62.4 p -94.0 -174.97 3.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.467 -170.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.47 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 97.9 mt-30 -64.79 -42.26 95.18 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.581 172.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.423 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 9.2 pt20 -67.01 -37.97 85.15 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.705 -177.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.912 ' HG3' ' H ' ' A' ' 51' ' ' THR . 5.7 mm-40 -58.98 -53.2 61.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.966 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.645 HG11 ' CD2' ' A' ' 93' ' ' LEU . 74.7 t -66.5 -46.39 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.997 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.595 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -64.33 -26.61 68.55 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.636 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -81.48 -37.28 28.18 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.614 177.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.98 -48.87 41.87 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.922 0.868 . . . . 0.0 110.78 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.81 HD13 HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -84.21 -55.37 4.22 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.16 -173.351 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.72 133.35 3.23 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 -172.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.595 HG22 ' HB1' ' A' ' 56' ' ' ALA . 39.4 p -68.32 130.91 92.04 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-O 121.238 0.542 . . . . 0.0 110.386 -177.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.532 ' HG2' ' HE2' ' A' ' 64' ' ' MET . 6.9 Cg_exo -69.75 160.89 48.01 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.177 2.584 . . . . 0.0 113.062 -170.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.78 -28.33 69.38 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.506 -171.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.532 ' HE2' ' HG2' ' A' ' 62' ' ' PRO . 10.7 ptt? -61.79 -4.28 1.44 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.111 177.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.4 t 73.54 -4.0 2.34 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 170.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -146.86 99.71 4.01 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-O 120.907 0.384 . . . . 0.0 110.954 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.432 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 39.6 Cg_endo -70.13 -30.95 19.76 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.074 1.85 . . . . 0.0 111.527 175.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -85.72 12.02 9.8 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.535 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.82 -20.27 13.33 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.884 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.7 t -125.84 174.0 8.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.646 0.26 . . . . 0.0 110.375 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -117.95 -1.09 11.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.266 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.8 m -125.26 111.42 15.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.542 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.47 ' HH2' ' O ' ' A' ' 52' ' ' GLN . 42.7 m0 -104.12 141.3 36.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.366 -177.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -118.68 118.97 33.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.113 0.482 . . . . 0.0 110.844 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.599 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 63.9 m-85 -127.87 174.41 9.18 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 176.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.489 HG22 ' H ' ' A' ' 77' ' ' PHE . 2.7 p -129.15 167.54 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.127 -173.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.561 ' CG ' ' HB2' ' A' ' 40' ' ' ALA . 7.2 m-30 -107.13 141.11 38.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.265 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.721 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -72.28 130.3 40.46 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.792 -175.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 41.7 tp60 172.43 -105.19 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.486 -177.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.488 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 22.1 pt20 -83.56 140.1 41.27 Favored Pre-proline 0 C--N 1.303 -1.456 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.915 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 4.3 Cg_exo -75.77 99.79 1.31 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.074 2.516 . . . . 0.0 110.425 173.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.39 45.89 3.57 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.921 -170.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -89.3 77.55 7.41 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 172.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.709 ' HG2' ' H ' ' A' ' 85' ' ' GLY . 22.3 tt0 -178.31 -151.36 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -169.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.709 ' H ' ' HG2' ' A' ' 84' ' ' GLU . . . -72.38 80.07 0.64 Allowed Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 167.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.6 t -36.3 123.71 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 O-C-N 124.729 0.899 . . . . 0.0 112.904 -170.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 111' ' ' SER . 8.9 t -139.59 12.81 2.53 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.509 -175.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.457 HE21 ' HB3' ' A' ' 88' ' ' GLN . 0.6 OUTLIER -66.83 -157.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.726 1.25 . . . . 0.0 111.782 178.153 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 90.7 mt-30 -118.34 143.95 46.23 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.553 -1.658 . . . . 0.0 107.506 167.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.3 p -131.73 143.99 50.65 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -170.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.965 HD11 HG22 ' A' ' 104' ' ' ILE . 16.3 tp -95.71 123.52 39.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.192 174.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.685 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 34.4 m -114.53 101.26 8.95 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.845 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.2 tp -88.3 126.34 35.13 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.996 -173.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.8 m -112.4 123.22 49.81 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.889 -175.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.537 ' CE2' HD23 ' A' ' 93' ' ' LEU . 80.2 m-85 -113.27 141.25 47.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.884 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.495 ' HB3' HG21 ' A' ' 102' ' ' THR . 32.1 p30 -75.41 -173.63 2.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.903 175.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.4 m -56.29 -35.1 67.11 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -174.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.427 ' HB3' HG23 ' A' ' 100' ' ' VAL . 20.8 t -88.83 9.74 23.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.814 0.34 . . . . 0.0 111.059 -175.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.75 33.85 76.62 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.091 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.48 ' HB ' HD21 ' A' ' 96' ' ' ASN . 7.6 t -106.12 140.06 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.845 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.3 mt -62.17 124.42 20.8 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.43 0.633 . . . . 0.0 112.246 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.495 HG21 ' HB3' ' A' ' 96' ' ' ASN . 18.0 p -111.03 -43.94 3.68 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.612 -1.177 . . . . 0.0 109.965 175.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -136.67 152.75 50.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.745 0.783 . . . . 0.0 111.692 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.965 HG22 HD11 ' A' ' 91' ' ' LEU . 3.6 mm -117.86 93.61 2.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 170.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.685 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 23.4 t70 -87.03 96.47 10.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.948 0.404 . . . . 0.0 110.624 -173.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -105.62 104.31 14.0 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.85 0.834 . . . . 0.0 109.898 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.637 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 22.5 pttm -140.75 177.95 1.76 Allowed Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.773 -176.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.637 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 56.2 Cg_endo -72.51 173.42 13.27 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 121.231 1.287 . . . . 0.0 112.258 -177.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.88 -176.93 3.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.549 0.69 . . . . 0.0 112.237 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.4 mt -58.01 -52.58 64.92 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.139 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 87' ' ' THR . 41.9 t -123.33 164.21 19.26 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.085 -172.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.86 96.65 0.94 Allowed Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.53 173.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.812 176.046 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.8 m -69.24 -35.71 76.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.979 0.39 . . . . 0.0 110.509 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -157.84 21.12 0.27 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.499 172.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.42 -81.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 175.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.7 p -121.73 -67.31 0.97 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.857 HG22 ' HG2' ' A' ' 24' ' ' GLU . 2.1 m 61.99 91.54 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.466 172.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 23' ' ' LEU . 5.8 mp -83.34 65.16 8.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.014 -175.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.857 ' HG2' HG22 ' A' ' 22' ' ' THR . 19.8 mm-40 -86.69 71.82 10.3 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.102 0.477 . . . . 0.0 110.956 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -97.52 93.27 6.35 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.046 0.451 . . . . 0.0 109.939 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.32 -178.48 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.717 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.528 HG22 ' H ' ' A' ' 28' ' ' TYR . 2.3 p -131.96 178.31 5.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.02 -177.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.528 ' H ' HG22 ' A' ' 27' ' ' VAL . 83.2 m-85 -49.08 130.65 18.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.1 0.476 . . . . 0.0 112.176 176.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -130.84 121.72 19.12 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.62 170.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.38 122.45 11.25 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.699 2.266 . . . . 0.0 112.28 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.4 t70 179.29 97.5 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.27 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.938 HG22 ' H ' ' A' ' 34' ' ' GLN . 31.3 mm -73.56 140.07 18.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.212 0.53 . . . . 0.0 111.055 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -99.29 -8.54 24.8 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.798 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.938 ' H ' HG22 ' A' ' 32' ' ' ILE . 9.2 pt20 -127.22 48.97 2.14 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.626 -165.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.19 52.09 3.99 Favored Glycine 0 C--N 1.313 -0.749 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.316 172.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -121.03 -48.03 2.25 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -107.18 -162.43 0.84 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.743 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.62 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 4.5 tp -82.76 151.54 26.11 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.114 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.7 p -127.7 -175.78 3.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.631 174.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . . . -70.19 -31.53 69.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.053 0.454 . . . . 0.0 110.904 178.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -60.05 -41.19 91.79 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.563 0.696 . . . . 0.0 109.776 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 11.4 m-20 -67.9 -37.11 81.32 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.887 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.857 HG22 HD22 ' A' ' 91' ' ' LEU . 81.2 t -60.04 -40.66 83.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.77 0.319 . . . . 0.0 111.094 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.1 p -64.5 -18.93 65.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.025 0.441 . . . . 0.0 111.028 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 30.1 mtpp -77.54 -28.42 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.987 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.587 HG23 HD13 ' A' ' 59' ' ' LEU . 43.5 pt -89.56 174.08 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 121.758 0.79 . . . . 0.0 111.822 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -163.4 143.33 8.71 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.719 -176.252 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.467 HG22 HG12 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -69.61 142.27 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.484 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.19 -30.69 5.55 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.86 -175.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.553 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 21.2 ptt? -87.11 175.12 8.24 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.813 176.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.839 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 23.6 p -92.99 -170.0 2.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.846 -171.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -67.51 -46.33 73.19 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.611 173.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.449 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 11.9 pt20 -61.98 -38.8 89.96 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.832 -176.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.839 ' HG3' ' H ' ' A' ' 51' ' ' THR . 7.1 mm-40 -59.52 -46.37 89.04 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.303 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.692 HG11 ' CD2' ' A' ' 93' ' ' LEU . 58.4 t -73.24 -43.46 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.834 -176.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.6 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.11 -24.01 67.7 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.261 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -80.04 -39.47 29.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.773 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.66 -44.06 44.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.008 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.62 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -93.07 -10.03 37.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.917 -172.531 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.66 129.14 1.57 Allowed Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.6 HG22 ' HB1' ' A' ' 56' ' ' ALA . 41.3 p -56.11 131.52 74.56 Favored Pre-proline 0 N--CA 1.439 -0.986 0 CA-C-O 122.028 0.918 . . . . 0.0 111.835 -176.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 67' ' ' PRO . 74.8 Cg_exo -50.6 165.94 0.37 Allowed 'Trans proline' 0 C--N 1.332 -0.333 1 C-N-CA 125.742 4.295 . . . . 0.0 115.431 -176.381 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.478 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 8.1 mt -51.7 -49.28 62.77 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.655 -177.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.471 ' HE3' HG21 ' A' ' 70' ' ' THR . 0.0 OUTLIER -54.1 -13.55 0.85 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.986 179.543 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.0 t 76.11 -17.79 0.51 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.359 0.664 . . . . 0.0 112.066 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -122.21 92.96 48.81 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-O 121.971 0.891 . . . . 0.0 109.819 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.57 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 29.0 Cg_endo -64.49 -30.59 61.76 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.619 2.212 . . . . 0.0 112.493 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -81.35 13.84 2.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.718 -173.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -102.93 -25.15 7.68 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.091 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.471 HG21 ' HE3' ' A' ' 64' ' ' MET . 6.6 t -124.13 169.23 11.91 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -120.52 1.64 10.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.651 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.8 m -118.15 109.08 15.96 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.959 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.416 ' O ' ' HA ' ' A' ' 92' ' ' THR . 46.9 m0 -106.84 134.34 50.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.687 -176.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -113.36 125.92 54.79 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.161 0.288 . . . . 0.0 110.661 -177.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.562 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 60.8 m-85 -135.14 174.93 10.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.424 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.426 HG12 ' OE1' ' A' ' 88' ' ' GLN . 0.1 OUTLIER -118.38 162.99 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 120.849 0.357 . . . . 0.0 110.264 -177.106 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.414 ' HB2' ' H ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -98.71 -176.43 3.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.464 -176.516 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.449 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 8.2 ttm180 -65.0 119.39 10.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.727 178.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.708 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . 60.6 tt0 63.36 119.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 O-C-N 124.341 1.026 . . . . 0.0 113.253 177.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 1.109 ' HA ' ' HG2' ' A' ' 88' ' ' GLN . 27.4 mt-30 -75.38 169.61 19.62 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.243 174.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.818 ' HD2' ' HB3' ' A' ' 80' ' ' GLN . 11.0 Cg_exo -34.24 115.92 0.1 OUTLIER 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 123.818 3.012 . . . . 0.0 113.021 -174.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.39 -77.8 0.44 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 114.469 -1.242 . . . . 0.0 113.204 -171.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -135.45 -66.32 0.57 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -117.48 131.02 56.8 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 171.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.84 125.51 1.39 Allowed Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.7 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 88' ' ' GLN . 58.6 t -73.04 126.26 33.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.297 0.57 . . . . 0.0 110.415 177.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.8 t -103.73 0.97 31.21 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.924 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 1.109 ' HG2' ' HA ' ' A' ' 80' ' ' GLN . 13.9 mm-40 -73.46 152.87 40.59 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.916 0.865 . . . . 0.0 112.435 177.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.414 ' H ' ' HB2' ' A' ' 77' ' ' PHE . 36.0 mt-30 -145.2 125.7 14.06 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.712 -1.585 . . . . 0.0 108.636 175.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.93 128.58 36.25 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.234 0.54 . . . . 0.0 110.911 -175.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.052 HD11 HG22 ' A' ' 104' ' ' ILE . 21.3 tp -90.16 115.48 27.43 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.056 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.718 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 11.8 m -109.2 95.62 5.75 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.766 ' HG ' HD21 ' A' ' 101' ' ' LEU . 8.3 tp -81.39 125.1 29.99 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.38 -171.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 37.2 m -107.45 121.64 45.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.178 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.532 ' CE2' HD23 ' A' ' 93' ' ' LEU . 77.3 m-85 -115.28 139.71 49.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.537 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.499 ' HB3' HG21 ' A' ' 102' ' ' THR . 32.0 p30 -74.52 -176.38 2.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.614 175.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.2 t -55.13 -37.21 66.64 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -176.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.452 ' HB3' HG23 ' A' ' 100' ' ' VAL . 19.0 t -82.17 2.29 32.31 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.784 0.326 . . . . 0.0 111.059 -174.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.99 31.16 56.21 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.922 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.472 ' HB ' HD21 ' A' ' 96' ' ' ASN . 6.7 t -107.57 139.78 28.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.766 HD21 ' HG ' ' A' ' 93' ' ' LEU . 7.3 mt -60.87 124.8 21.51 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.237 0.541 . . . . 0.0 112.0 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.499 HG21 ' HB3' ' A' ' 96' ' ' ASN . 10.1 p -113.01 -35.92 5.27 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.049 176.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -148.76 148.46 30.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.441 0.639 . . . . 0.0 111.932 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.052 HG22 HD11 ' A' ' 91' ' ' LEU . 5.6 mm -106.01 93.21 2.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 170.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.718 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 17.6 t70 -81.58 97.3 7.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.141 0.496 . . . . 0.0 110.643 -171.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -105.38 110.78 23.26 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.363 0.601 . . . . 0.0 109.814 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.538 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 13.3 ptmm? -136.3 174.91 3.96 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.823 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 30.1 Cg_endo -79.62 155.8 24.39 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.898 1.732 . . . . 0.0 111.265 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.92 172.36 12.85 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.627 0.727 . . . . 0.0 112.418 -175.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mt -85.57 -55.28 4.07 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.401 -175.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 21.9 t -138.98 -162.68 1.35 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.397 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 133.2 -22.53 3.97 Favored Glycine 0 CA--C 1.498 -1.03 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 63.3 t30 . . . . . 0 C--N 1.305 -1.353 0 CA-C-N 113.775 -1.213 . . . . 0.0 109.664 176.941 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.649 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 5.5 tp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.881 0.372 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.512 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 28.2 p -127.7 -174.38 3.17 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.486 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.69 -34.87 78.8 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.939 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -56.2 -46.43 79.45 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.509 0.671 . . . . 0.0 110.353 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.608 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.3 m-20 -74.13 -28.44 61.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.308 -176.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.876 HG22 HD22 ' A' ' 91' ' ' LEU . 84.0 t -62.94 -40.56 89.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.406 0.622 . . . . 0.0 109.82 172.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.2 t -64.93 -22.88 67.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.564 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.608 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 42.9 mtpt -70.41 -46.35 64.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.35 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.561 HG23 HD13 ' A' ' 59' ' ' LEU . 22.8 pt -75.77 173.04 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-O 122.01 0.909 . . . . 0.0 112.728 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.69 148.24 10.59 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.469 -176.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.444 ' H ' HG23 ' A' ' 48' ' ' VAL . 0.7 OUTLIER -71.1 143.03 14.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.65 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.96 -32.69 4.5 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.31 -0.947 . . . . 0.0 112.608 -176.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.53 ' HE3' HG22 ' A' ' 46' ' ' ILE . 16.3 ptt? -85.65 177.91 7.54 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 117.371 0.586 . . . . 0.0 111.126 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.811 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 38.9 p -91.9 -171.38 2.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.979 -172.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.458 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 97.1 mt-30 -68.74 -46.26 69.32 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.094 172.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.5 ' HA ' ' HE1' ' A' ' 68' ' ' PHE . 9.9 pt20 -63.4 -35.03 79.05 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.448 0.642 . . . . 0.0 110.171 -175.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.811 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.5 mm-40 -61.43 -56.97 14.28 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.246 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.651 HG11 ' CD2' ' A' ' 93' ' ' LEU . 80.2 t -61.91 -41.78 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.813 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.701 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -56.4 -36.93 69.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.147 0.499 . . . . 0.0 110.228 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -82.26 -34.18 28.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.15 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.66 -41.67 71.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.527 0.679 . . . . 0.0 111.006 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.649 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -92.31 -44.26 8.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.425 -1.262 . . . . 0.0 111.428 -173.343 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.18 122.94 4.16 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -170.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.701 HG22 ' HB1' ' A' ' 56' ' ' ALA . 58.5 p -58.86 135.92 87.11 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 120.963 0.411 . . . . 0.0 111.235 -175.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 23.0 Cg_exo -63.27 172.91 4.64 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.71 2.94 . . . . 0.0 113.585 -172.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 mt -47.66 -48.64 28.85 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.024 -174.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -53.67 -19.57 4.21 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.364 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.6 t 73.13 -4.82 2.08 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.749 0.82 . . . . 0.0 111.75 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -124.12 90.97 50.18 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-O 121.998 0.904 . . . . 0.0 110.044 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HG3' HG22 ' A' ' 61' ' ' THR . 57.4 Cg_endo -70.62 -32.92 14.18 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.462 2.108 . . . . 0.0 112.075 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.5 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 10.5 m-85 -78.09 9.46 3.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.848 -175.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.33 -23.32 19.74 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.841 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.7 t -124.83 174.37 7.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.818 0.342 . . . . 0.0 110.816 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -119.73 5.38 11.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.357 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.4 m -133.95 110.89 10.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.162 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.568 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 48.6 m0 -104.18 138.84 40.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -175.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -116.45 120.97 40.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.868 0.366 . . . . 0.0 110.632 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.61 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 68.1 m-85 -132.15 174.79 9.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.214 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 77' ' ' PHE . 2.7 t -122.23 169.09 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -172.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.476 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.929 HD11 HG22 ' A' ' 104' ' ' ILE . 13.7 tp -99.64 117.47 34.06 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 173.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 78.9 m -111.59 107.2 16.27 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.857 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.2 tp -88.54 125.41 34.77 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.613 -174.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.7 m -106.91 124.34 49.48 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.886 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.481 ' CE2' HD23 ' A' ' 93' ' ' LEU . 77.7 m-85 -114.69 141.54 47.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.96 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.509 HD21 ' HB ' ' A' ' 100' ' ' VAL . 30.2 p30 -75.69 -175.31 2.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.354 176.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.5 m -57.65 -35.19 70.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.588 ' HB3' HG23 ' A' ' 100' ' ' VAL . 30.2 t -76.8 -19.84 57.11 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.995 0.426 . . . . 0.0 110.904 -175.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.79 26.86 9.4 Favored Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.588 HG23 ' HB3' ' A' ' 98' ' ' SER . 4.4 t -106.83 142.06 20.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.944 -0.628 . . . . 0.0 109.672 -177.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.857 HD21 ' HG ' ' A' ' 93' ' ' LEU . 5.8 mt -60.86 123.95 19.05 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.21 0.529 . . . . 0.0 111.837 178.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.493 HG21 ' HB3' ' A' ' 96' ' ' ASN . 19.2 p -109.69 -41.72 4.47 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.327 176.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -148.95 145.85 27.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.249 0.547 . . . . 0.0 112.016 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.929 HG22 HD11 ' A' ' 91' ' ' LEU . 3.9 mm -106.27 94.73 3.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 174.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.601 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 9.3 t70 -86.74 98.81 11.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.897 0.38 . . . . 0.0 110.916 -171.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -106.88 106.36 16.85 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.925 0.869 . . . . 0.0 110.29 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.588 ' HE2' ' OG1' ' A' ' 92' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.799 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.054 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.698 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 3.2 tp . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.853 0.359 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 43' ' ' VAL . 43.1 p -127.0 -173.49 2.9 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.107 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.65 -37.86 88.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.354 0.597 . . . . 0.0 111.379 -178.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -62.05 -42.45 99.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.795 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.519 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 16.7 m-20 -70.25 -32.68 70.63 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.842 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.782 HG22 HD22 ' A' ' 91' ' ' LEU . 58.6 t -58.58 -36.03 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.089 0.471 . . . . 0.0 111.128 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.8 t -62.22 -16.29 52.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.552 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -74.07 -24.02 59.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.643 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.816 HG23 HD13 ' A' ' 59' ' ' LEU . 37.8 pt -100.73 175.83 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.619 0.723 . . . . 0.0 112.244 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.13 150.8 11.45 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.079 -177.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.451 HG22 HG12 ' A' ' 104' ' ' ILE . 0.7 OUTLIER -73.12 143.06 14.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.655 -178.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.76 -21.97 8.85 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.352 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.482 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 16.0 ptt? -96.46 178.24 5.42 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.164 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.835 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 41.5 p -92.78 -175.49 3.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.96 -171.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.464 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 77.3 mt-30 -63.05 -46.81 85.75 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.528 171.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.524 ' HA ' ' HE1' ' A' ' 68' ' ' PHE . 9.7 pt20 -65.25 -35.34 80.73 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.334 0.588 . . . . 0.0 109.84 -173.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.835 ' HG3' ' H ' ' A' ' 51' ' ' THR . 7.7 mm-40 -60.25 -51.87 67.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.177 176.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.677 HG11 ' CD2' ' A' ' 93' ' ' LEU . 69.5 t -66.94 -45.0 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.9 -175.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.707 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -64.08 -25.11 67.96 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.436 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -80.9 -42.35 21.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.029 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.78 76.95 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.653 0.74 . . . . 0.0 111.342 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.816 HD13 HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -90.12 -36.4 14.86 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.563 -172.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.6 127.76 5.76 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -170.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.707 HG22 ' HB1' ' A' ' 56' ' ' ALA . 56.9 p -59.15 136.21 88.12 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-O 120.93 0.395 . . . . 0.0 110.659 -177.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.509 ' CD ' ' HB3' ' A' ' 67' ' ' PRO . 22.2 Cg_exo -62.07 171.96 4.51 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.478 2.785 . . . . 0.0 113.309 -172.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.412 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 5.5 mt -51.08 -43.68 61.07 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.038 0.535 . . . . 0.0 111.606 -172.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.1 ptt? -58.66 -12.23 3.94 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.423 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.2 t 68.98 -0.59 2.37 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.513 0.725 . . . . 0.0 111.827 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -134.72 91.52 20.86 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.611 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 90.6 Cg_endo -77.85 -29.07 4.63 Favored 'Trans proline' 0 C--N 1.327 -0.554 0 C-N-CA 123.268 2.645 . . . . 0.0 113.15 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.524 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 13.0 m-85 -80.59 21.62 0.63 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.038 -172.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.7 -17.41 8.02 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.989 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 t -124.81 172.27 9.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.732 0.301 . . . . 0.0 110.385 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -125.01 15.57 8.51 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.282 0.563 . . . . 0.0 109.975 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.6 m -138.88 109.24 6.49 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.495 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.611 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 50.3 m0 -104.48 143.23 33.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.707 -175.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -118.06 115.03 24.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.156 0.503 . . . . 0.0 111.241 -176.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.619 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 57.2 m-85 -129.93 176.46 8.03 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.2 p -128.87 153.57 38.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.598 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.474 ' HE1' HG21 ' A' ' 43' ' ' VAL . 1.5 m-30 . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.301 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.438 -1.064 0 CA-C-O 121.22 0.533 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.989 HD11 HG22 ' A' ' 104' ' ' ILE . 14.1 tp -93.0 112.55 24.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.875 174.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.725 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 10.6 m -107.09 105.98 16.25 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.866 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.0 tp -87.37 118.21 26.66 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.515 -175.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 38.6 m -101.64 122.68 44.32 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.127 -174.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.519 ' CE2' HD23 ' A' ' 93' ' ' LEU . 72.9 m-85 -116.13 140.88 48.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.241 -178.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.534 HD21 ' HB ' ' A' ' 100' ' ' VAL . 30.1 p30 -76.43 -177.19 4.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.16 175.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.0 t -54.42 -38.31 66.1 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.434 ' HB2' HG23 ' A' ' 100' ' ' VAL . 49.8 m -80.2 -3.8 50.51 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -174.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.33 28.0 34.68 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.824 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.534 ' HB ' HD21 ' A' ' 96' ' ' ASN . 6.6 t -106.41 140.86 23.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.866 HD21 ' HG ' ' A' ' 93' ' ' LEU . 7.3 mt -59.91 126.2 26.62 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.328 0.585 . . . . 0.0 112.195 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.416 HG21 ' HB3' ' A' ' 96' ' ' ASN . 18.0 p -111.18 -36.7 5.53 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.365 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -152.95 152.98 32.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.325 0.583 . . . . 0.0 111.673 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.989 HG22 HD11 ' A' ' 91' ' ' LEU . 3.3 mm -108.41 92.6 2.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 171.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.725 ' HB2' ' HB ' ' A' ' 92' ' ' THR . 2.3 m-20 -78.4 96.33 5.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.574 0.226 . . . . 0.0 110.989 -174.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -112.07 107.42 16.36 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.829 0.824 . . . . 0.0 110.49 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.875 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.445 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.584 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 2.5 tp . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.743 0.306 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 43.6 p -127.14 -174.66 3.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.171 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.82 -38.19 85.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.332 0.586 . . . . 0.0 110.606 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -54.31 -40.7 68.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.44 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.57 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 12.9 m-20 -73.92 -33.35 63.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.783 -1.098 . . . . 0.0 111.209 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.784 HG22 HD22 ' A' ' 91' ' ' LEU . 74.0 t -60.71 -37.73 76.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.314 0.578 . . . . 0.0 110.211 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.7 t -58.54 -22.39 55.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.126 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 45.2 mtpt -71.61 -40.59 69.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.78 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.681 HG23 HD13 ' A' ' 59' ' ' LEU . 41.6 pt -85.58 179.2 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-O 121.938 0.875 . . . . 0.0 112.925 -175.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.443 ' N ' ' HD3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -168.26 147.2 4.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.464 -175.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.467 HG22 ' CG1' ' A' ' 104' ' ' ILE . 0.8 OUTLIER -72.61 144.22 13.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.742 -179.353 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.98 -31.75 5.03 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.861 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.553 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 21.7 ptt? -86.39 175.14 8.56 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.976 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.943 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 26.0 p -93.29 -170.77 2.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.974 -171.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -66.69 -46.04 76.89 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.616 172.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.503 ' OE1' ' HG2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -66.73 -29.31 69.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.469 0.652 . . . . 0.0 110.47 -175.242 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.943 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.0 mm-40 -63.19 -56.59 15.43 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.397 174.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.651 HG11 ' CD2' ' A' ' 93' ' ' LEU . 82.9 t -67.51 -38.82 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.455 -177.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.689 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.7 -32.17 68.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.182 0.515 . . . . 0.0 110.109 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -82.26 -39.17 23.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.589 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.79 -44.94 63.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.167 0.508 . . . . 0.0 111.881 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.681 HD13 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -95.73 -12.63 25.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.411 -174.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.77 129.33 2.28 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.255 -0.974 . . . . 0.0 110.876 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.689 HG22 ' HB1' ' A' ' 56' ' ' ALA . 22.1 p -55.3 133.4 69.64 Favored Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-O 121.466 0.65 . . . . 0.0 111.284 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 34.8 Cg_exo -63.49 166.93 14.14 Favored 'Trans proline' 0 C--O 1.23 0.092 0 C-N-CA 123.753 2.969 . . . . 0.0 113.377 -171.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.419 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 1.5 mt -54.08 -33.16 56.84 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.104 -170.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.461 ' SD ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -63.68 3.33 0.36 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.39 176.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 63' ' ' LEU . 27.7 p 53.94 24.81 4.87 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.8 0.84 . . . . 0.0 111.593 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -169.9 105.11 0.45 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.41 -178.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.585 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 83.6 Cg_endo -80.07 -23.03 6.85 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 122.833 2.355 . . . . 0.0 113.201 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -82.8 -6.75 59.57 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -171.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.28 -20.68 51.66 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.328 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 t -125.16 174.74 7.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.993 0.425 . . . . 0.0 110.228 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -129.24 14.01 6.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.366 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.7 m -131.2 110.32 11.05 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.84 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.593 ' O ' ' HA ' ' A' ' 92' ' ' THR . 46.3 m0 -108.66 149.08 29.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.885 -175.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -125.13 123.22 39.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.544 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.617 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 86.6 m-85 -133.01 173.75 11.08 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.9 t -113.24 164.82 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -175.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.218 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.252 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.438 -1.033 0 CA-C-O 121.28 0.562 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.955 HD11 HG22 ' A' ' 104' ' ' ILE . 14.4 tp -90.02 110.95 21.91 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.95 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 24.4 m -103.68 105.01 15.12 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.83 ' HG ' HD21 ' A' ' 101' ' ' LEU . 8.2 tp -88.36 124.27 33.76 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.37 -173.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.558 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 42.1 m -104.16 120.98 42.29 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.978 -176.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.53 ' CE2' HD23 ' A' ' 93' ' ' LEU . 66.1 m-85 -114.5 137.73 51.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.744 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.559 ' HB3' HG21 ' A' ' 102' ' ' THR . 33.3 p30 -75.26 -171.96 1.58 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.45 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.1 m -55.61 -37.99 68.86 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.465 ' HB3' HG23 ' A' ' 100' ' ' VAL . 22.8 t -84.2 -3.61 58.28 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.985 0.422 . . . . 0.0 110.869 -173.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.59 31.85 35.59 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.621 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.488 ' HB ' HD21 ' A' ' 96' ' ' ASN . 11.2 t -107.02 141.47 22.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.83 HD21 ' HG ' ' A' ' 93' ' ' LEU . 7.0 mt -62.68 122.88 16.97 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.559 0.695 . . . . 0.0 112.254 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.559 HG21 ' HB3' ' A' ' 96' ' ' ASN . 21.1 p -109.62 -42.09 4.39 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.711 175.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.558 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 5.3 m-20 -137.06 154.83 50.25 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.271 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.955 HG22 HD11 ' A' ' 91' ' ' LEU . 5.0 mm -116.7 91.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 167.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 92' ' ' THR . 5.6 m-20 -83.55 94.91 8.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.039 0.447 . . . . 0.0 110.752 -172.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -100.78 102.85 14.03 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.755 0.788 . . . . 0.0 109.414 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.1 mttt . . . . . 0 C--N 1.314 -0.963 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.482 -177.386 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.542 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 11.4 tp . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 121.129 0.49 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.5 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 33.5 p -127.71 177.19 6.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.156 170.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.43 -30.61 66.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.009 0.433 . . . . 0.0 110.495 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -55.69 -45.04 77.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.714 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.683 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 22.7 m-20 -67.2 -26.35 66.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.231 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.968 HG22 HD22 ' A' ' 91' ' ' LEU . 79.3 t -64.32 -37.28 79.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.172 0.511 . . . . 0.0 110.026 176.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.3 t -66.54 -20.84 66.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.452 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.683 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 36.4 mtpt -71.34 -32.28 68.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.92 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.623 HG23 HD13 ' A' ' 59' ' ' LEU . 30.9 pt -94.76 177.6 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-O 121.895 0.855 . . . . 0.0 112.032 177.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.41 ' HE ' ' HB3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -172.3 154.31 3.24 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.417 -174.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.426 HG22 HD11 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -71.95 144.99 12.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.048 -178.378 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.38 -36.81 3.16 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.163 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.609 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 5.6 ptt? -85.25 171.61 11.8 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.191 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.851 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 44.0 p -86.07 -172.49 4.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.007 -172.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.5 ' HA ' ' CZ ' ' A' ' 95' ' ' PHE . 39.5 mt-30 -68.31 -42.59 79.19 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.216 173.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.558 ' HA ' ' HE1' ' A' ' 68' ' ' PHE . 9.0 pt20 -66.36 -36.03 81.85 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.264 -175.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.851 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.8 mm-40 -58.26 -54.21 49.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.889 176.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.657 HG11 ' CD2' ' A' ' 93' ' ' LEU . 85.6 t -65.58 -41.3 90.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.793 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.566 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -57.67 -33.12 67.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.385 0.612 . . . . 0.0 110.096 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -81.3 -36.78 29.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.825 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.35 -42.07 55.12 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.249 0.547 . . . . 0.0 111.764 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.623 HD13 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -95.24 -16.94 22.12 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.83 -173.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.95 130.46 5.43 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.305 -0.95 . . . . 0.0 110.756 -174.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.566 HG22 ' HB1' ' A' ' 56' ' ' ALA . 4.5 p -65.11 134.95 96.09 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 121.343 0.592 . . . . 0.0 111.304 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 22.0 Cg_exo -67.59 171.41 12.0 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.998 3.132 . . . . 0.0 113.14 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.427 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 7.7 mt -49.09 -48.23 44.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.518 -178.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -59.59 144.73 46.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.757 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.3 p -73.02 1.72 8.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -154.44 108.59 2.4 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-O 121.345 0.593 . . . . 0.0 110.528 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.65 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 59.2 Cg_endo -73.29 -25.39 15.67 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.078 2.519 . . . . 0.0 113.048 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.558 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 8.3 m-85 -81.57 -5.44 58.02 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -170.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.21 -8.17 63.2 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.71 -174.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.2 t -123.58 171.96 9.14 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -119.38 1.25 11.23 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 m -126.64 115.2 19.1 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.555 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.65 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 44.6 m0 -109.36 141.68 41.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.708 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -119.12 120.71 37.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.477 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.657 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 90.3 m-85 -128.03 175.56 8.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.228 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.9 t -124.26 152.66 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -172.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 . . . . . 0 C--N 1.323 -0.567 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 171.097 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.44 -0.956 0 CA-C-O 121.216 0.531 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.986 HD11 HG22 ' A' ' 104' ' ' ILE . 38.7 tp -91.11 110.76 22.03 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 28.7 m -105.27 102.69 12.15 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.763 ' HG ' HD21 ' A' ' 101' ' ' LEU . 8.9 tp -88.39 126.78 35.38 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.547 -171.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.5 m -103.8 121.24 42.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.008 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.59 ' CE2' HD23 ' A' ' 93' ' ' LEU . 25.8 m-85 -111.92 148.52 33.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.914 0.864 . . . . 0.0 112.503 -175.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -73.8 173.1 10.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.874 -1.512 . . . . 0.0 110.451 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.8 m -62.34 -30.07 70.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.17 0.509 . . . . 0.0 110.862 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.407 ' HB3' HG23 ' A' ' 100' ' ' VAL . 30.8 t -87.55 4.43 43.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.793 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.11 34.53 55.17 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.954 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' A' ' 98' ' ' SER . 15.4 t -107.37 139.31 29.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.763 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.3 mt -60.73 127.5 31.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.393 0.616 . . . . 0.0 111.673 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 66.5 p -116.38 -39.94 3.3 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.136 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -144.7 149.56 35.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.854 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.986 HG22 HD11 ' A' ' 91' ' ' LEU . 3.8 mm -112.6 94.06 2.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 173.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.593 ' HB2' ' O ' ' A' ' 92' ' ' THR . 4.5 m-20 -80.48 95.49 6.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.024 0.44 . . . . 0.0 110.523 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -106.57 102.78 12.14 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.72 0.771 . . . . 0.0 110.269 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.959 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.62 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.659 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 3.1 tp . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.925 0.393 . . . . 0.0 110.459 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 43' ' ' VAL . 32.3 p -127.41 -178.36 4.43 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.079 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.15 -35.54 79.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.383 0.611 . . . . 0.0 110.552 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -59.32 -46.46 88.52 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.985 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.578 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 14.9 m-20 -69.31 -32.14 71.06 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.798 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.721 HG22 HD22 ' A' ' 91' ' ' LEU . 68.0 t -57.92 -38.18 64.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.109 0.481 . . . . 0.0 110.525 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -59.24 -21.59 59.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.154 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 45.9 mtpt -70.85 -29.3 65.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.982 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.803 HG23 HD13 ' A' ' 59' ' ' LEU . 38.9 pt -95.48 176.11 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.787 0.803 . . . . 0.0 112.257 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.431 ' HE ' ' HB3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -164.71 148.42 8.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.775 -177.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.445 HG22 HD11 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -70.79 140.14 18.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.332 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.43 -17.57 8.94 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.488 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.471 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 17.6 ptt? -102.43 173.09 6.51 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.109 174.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.713 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 12.7 p -88.08 -173.35 4.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.007 -172.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.511 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 13.2 mt-30 -69.44 -41.93 75.62 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.562 175.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.567 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -65.5 -33.19 75.35 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.609 0.719 . . . . 0.0 109.591 -175.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.713 ' HG3' ' H ' ' A' ' 51' ' ' THR . 11.2 mm-40 -61.61 -55.93 25.38 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.598 175.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.645 HG11 ' CD2' ' A' ' 93' ' ' LEU . 82.5 t -66.03 -40.4 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.387 -176.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.733 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.74 -34.2 71.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.278 0.561 . . . . 0.0 110.012 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -81.16 -39.97 24.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.769 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.27 -49.68 53.86 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.782 0.801 . . . . 0.0 111.402 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.803 HD13 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -86.07 -45.07 11.75 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.189 -173.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.02 126.8 3.46 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -174.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.733 HG22 ' HB1' ' A' ' 56' ' ' ALA . 47.6 p -59.84 132.09 89.15 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-O 121.15 0.5 . . . . 0.0 110.934 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 28.0 Cg_exo -63.59 164.18 21.84 Favored 'Trans proline' 0 CA--C 1.52 -0.208 0 C-N-CA 123.745 2.963 . . . . 0.0 112.554 -172.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.431 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 1.9 mt -52.72 -32.96 45.63 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.47 -168.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.409 ' HG2' ' H ' ' A' ' 64' ' ' MET . 10.8 ptt? -62.48 -9.87 9.92 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.685 0.616 . . . . 0.0 111.926 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 t 72.27 -2.3 2.63 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.669 0.788 . . . . 0.0 112.466 173.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -138.12 91.97 12.66 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-O 121.159 0.504 . . . . 0.0 109.999 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.707 ' HG3' HG22 ' A' ' 61' ' ' THR . 74.0 Cg_endo -74.0 -30.25 9.22 Favored 'Trans proline' 0 CA--C 1.529 0.247 0 C-N-CA 123.193 2.595 . . . . 0.0 112.964 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.497 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 12.7 m-85 -76.78 3.6 11.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.105 -172.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.49 -25.7 25.07 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.881 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.4 t -123.78 174.21 7.65 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.413 ' HB2' ' HB2' ' A' ' 95' ' ' PHE . 26.3 p-10 -122.33 2.58 9.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.107 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.4 m -123.07 108.66 13.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.813 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.576 ' O ' ' HA ' ' A' ' 92' ' ' THR . 47.0 m0 -105.58 148.68 27.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.875 -174.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -124.48 118.2 26.1 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.976 0.417 . . . . 0.0 111.249 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.641 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 80.3 m-85 -128.9 175.5 8.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.274 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.8 t -122.85 165.74 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 120.65 0.262 . . . . 0.0 110.632 176.386 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.439 -1.021 0 CA-C-O 120.876 0.369 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.751 HD11 ' CG2' ' A' ' 104' ' ' ILE . 13.8 tp -89.66 103.39 16.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 18.2 m -98.21 100.62 11.93 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.902 ' HG ' HD21 ' A' ' 101' ' ' LEU . 8.4 tp -86.01 121.58 28.83 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.256 -172.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.4 m -101.54 119.6 39.02 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.018 -175.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.453 ' CE2' HD23 ' A' ' 93' ' ' LEU . 72.2 m-85 -113.22 142.36 45.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.492 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.503 ' HB3' HG21 ' A' ' 102' ' ' THR . 30.1 p30 -75.85 -177.72 3.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.96 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.2 m -56.61 -30.55 63.36 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.2 t -85.91 -3.86 59.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.701 0.286 . . . . 0.0 111.257 -173.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.48 32.72 27.17 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.424 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.48 ' HB ' HD21 ' A' ' 96' ' ' ASN . 5.0 t -113.7 139.21 40.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.794 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.902 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.7 mt -61.14 123.14 16.84 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.276 0.56 . . . . 0.0 112.307 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.503 HG21 ' HB3' ' A' ' 96' ' ' ASN . 12.4 p -110.29 -39.14 5.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.025 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -148.92 150.63 33.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.481 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.751 ' CG2' HD11 ' A' ' 91' ' ' LEU . 5.6 mm -105.35 92.76 2.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 171.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 92' ' ' THR . 7.2 m-20 -83.94 94.88 8.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.284 0.564 . . . . 0.0 110.259 -177.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -95.25 102.08 13.86 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.881 0.848 . . . . 0.0 108.978 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.6 mmtm . . . . . 0 C--N 1.316 -0.885 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.873 -172.218 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.729 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 3.6 mm? . . . . . 0 CA--C 1.511 -0.545 0 CA-C-O 121.727 0.775 . . . . 0.0 112.4 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.554 ' O ' HG23 ' A' ' 43' ' ' VAL . 30.7 p -128.92 -177.9 4.4 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.516 170.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.445 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -65.04 -44.33 89.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.861 0.362 . . . . 0.0 111.624 -176.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.462 ' N ' HD22 ' A' ' 41' ' ' ASN . 0.9 OUTLIER -61.16 -40.58 94.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.569 -177.533 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -68.74 -33.44 73.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.572 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.691 ' HA ' HD11 ' A' ' 59' ' ' LEU . 54.9 t -57.32 -37.7 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.811 0.339 . . . . 0.0 111.475 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.7 p -64.09 -12.42 39.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.149 0.499 . . . . 0.0 111.627 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 43.8 mtpt -77.2 -14.19 59.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.246 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.865 HG23 HD13 ' A' ' 59' ' ' LEU . 35.3 pt -104.21 -176.9 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 121.894 0.854 . . . . 0.0 112.808 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.402 ' H ' ' HE2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -172.64 150.47 2.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.009 -1.45 . . . . 0.0 109.055 -177.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.554 HG22 HD11 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -71.09 144.48 13.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.15 -178.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.15 -32.31 4.78 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.473 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.538 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 14.4 ptt? -88.3 178.39 6.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 111.415 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.857 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 34.9 p -90.77 -177.04 4.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.793 -171.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.472 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 36.7 mt-30 -66.18 -42.63 88.63 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.506 171.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -37.34 77.48 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.147 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.857 ' HG3' ' H ' ' A' ' 51' ' ' THR . 5.4 mm-40 -67.83 -52.03 41.63 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.318 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.685 HG13 HG21 ' A' ' 46' ' ' ILE . 78.6 t -64.94 -40.84 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.741 -177.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.612 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.41 -33.33 69.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 110.181 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -81.87 -40.28 22.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.098 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.44 -42.4 75.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.686 0.755 . . . . 0.0 111.11 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.865 HD13 HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -92.63 -54.94 3.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.992 -174.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.2 134.94 3.61 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -171.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.612 HG22 ' HB1' ' A' ' 56' ' ' ALA . 28.7 p -66.92 135.92 94.28 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-O 121.224 0.535 . . . . 0.0 111.308 -177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 17.0 Cg_exo -65.79 174.72 5.24 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 C-N-CA 124.19 3.26 . . . . 0.0 113.411 -174.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.409 ' HG ' ' H ' ' A' ' 63' ' ' LEU . 8.2 mt -46.3 -48.47 18.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.353 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.22 126.88 30.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.572 170.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 t -68.78 -7.25 32.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 0.0 111.726 -173.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.456 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 11.1 p-10 -122.14 92.49 48.87 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-O 121.714 0.768 . . . . 0.0 110.199 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.538 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 18.7 Cg_endo -60.05 -36.11 90.53 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.864 2.376 . . . . 0.0 112.186 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -83.48 8.89 12.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.803 -177.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.1 -17.33 57.85 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.8 t -124.45 175.14 7.32 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -125.1 8.04 7.95 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.818 0.342 . . . . 0.0 110.127 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.7 m -131.36 111.82 12.19 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.313 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.675 ' O ' ' HA ' ' A' ' 92' ' ' THR . 48.8 m0 -106.0 142.95 34.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.582 -176.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -123.44 116.32 23.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.75 0.31 . . . . 0.0 110.543 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.587 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 31.1 m-85 -124.72 170.25 11.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.523 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.3 t -120.69 158.63 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.445 ' CG ' ' HB2' ' A' ' 40' ' ' ALA . 1.3 m-30 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.338 . . . . 0.0 110.788 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 19.2 p . . . . . 0 N--CA 1.442 -0.845 0 CA-C-O 121.226 0.536 . . . . 0.0 111.65 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.9 HD11 HG22 ' A' ' 104' ' ' ILE . 14.7 tp -93.6 111.69 23.41 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.862 174.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.715 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 40.2 m -106.9 103.45 12.88 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.906 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.2 tp -90.21 122.82 33.49 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.254 -173.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -109.72 124.22 50.86 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.394 -176.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.51 ' CE1' ' HG ' ' A' ' 101' ' ' LEU . 92.0 m-85 -112.27 144.97 40.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.296 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.541 ' HB3' HG21 ' A' ' 102' ' ' THR . 29.7 p30 -74.88 -173.96 2.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.172 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.1 p -54.59 -32.17 58.22 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.484 ' HB3' HG23 ' A' ' 100' ' ' VAL . 9.7 t -89.45 -3.03 58.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.054 0.454 . . . . 0.0 111.245 -173.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.62 32.98 32.14 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.597 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.491 ' HB ' HD21 ' A' ' 96' ' ' ASN . 7.3 t -108.82 138.86 33.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.906 HD21 ' HG ' ' A' ' 93' ' ' LEU . 5.7 mt -60.07 124.91 21.68 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.648 0.737 . . . . 0.0 112.102 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.541 HG21 ' HB3' ' A' ' 96' ' ' ASN . 34.0 p -112.85 -45.0 3.23 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.348 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -136.52 152.75 50.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.247 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.9 HG22 HD11 ' A' ' 91' ' ' LEU . 3.7 mm -116.08 93.36 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 171.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.715 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 8.0 t70 -89.53 97.34 11.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.04 0.447 . . . . 0.0 111.052 -169.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 90' ' ' THR . 29.0 t-20 -117.64 119.52 35.22 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.36 0.6 . . . . 0.0 110.693 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.541 ' HE2' ' N ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.858 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.144 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.805 HD11 ' HG ' ' A' ' 59' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.508 -0.647 0 CA-C-O 121.881 0.848 . . . . 0.0 110.892 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.4 p -130.81 177.93 7.04 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.21 172.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HB2' ' HB3' ' A' ' 77' ' ' PHE . . . -70.88 -28.97 64.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.453 0.644 . . . . 0.0 109.904 176.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -59.08 -44.44 91.89 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.525 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.62 ' HB2' HD13 ' A' ' 38' ' ' LEU . 27.0 m-20 -70.41 -32.85 70.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.697 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.928 HG22 HD22 ' A' ' 91' ' ' LEU . 56.3 t -62.54 -36.24 74.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.859 0.361 . . . . 0.0 110.81 177.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.3 p -68.19 -15.32 63.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.074 0.464 . . . . 0.0 110.525 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.606 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 40.8 mtpt -78.78 -19.53 51.99 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.078 177.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.667 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 44.5 pt -103.38 169.0 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-O 121.735 0.779 . . . . 0.0 112.099 176.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -164.94 148.76 8.75 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.493 -173.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.465 HG23 ' H ' ' A' ' 48' ' ' VAL . 0.6 OUTLIER -72.19 143.17 14.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.074 -177.014 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.9 -33.8 4.28 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.703 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.667 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 21.8 ptt? -86.48 175.72 8.22 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.148 0.499 . . . . 0.0 111.189 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.831 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 44.0 p -91.16 -173.38 3.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.081 -170.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.468 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 13.8 mt-30 -65.38 -46.93 78.17 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.385 172.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 9.8 pt20 -64.08 -37.4 87.31 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.98 -175.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.831 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.0 mm-40 -58.34 -49.43 77.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.584 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.645 HG11 ' CD2' ' A' ' 93' ' ' LEU . 61.8 t -69.7 -45.11 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.466 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.706 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.45 -25.03 68.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.002 0.43 . . . . 0.0 110.684 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -80.44 -35.77 34.56 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.291 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.81 -39.87 61.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.742 0.782 . . . . 0.0 111.07 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.805 ' HG ' HD11 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -93.24 -32.55 14.31 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.339 -172.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.3 119.93 4.45 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -171.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.706 HG22 ' HB1' ' A' ' 56' ' ' ALA . 46.9 p -53.52 134.54 53.7 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 120.968 0.413 . . . . 0.0 111.426 -173.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 32.3 Cg_exo -63.0 164.43 19.37 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.614 2.876 . . . . 0.0 113.278 -172.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.429 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 3.7 mt -53.31 -36.73 61.57 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.164 -169.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.433 ' H ' ' HG2' ' A' ' 64' ' ' MET . 8.6 ptt? -62.26 -3.26 1.25 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.164 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.4 t 70.39 2.89 4.22 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.445 0.698 . . . . 0.0 112.259 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.417 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 23.5 t70 -152.09 100.52 2.85 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.664 0.745 . . . . 0.0 110.34 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.63 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 38.0 Cg_endo -67.1 -49.71 1.27 Allowed 'Trans proline' 0 C--N 1.332 -0.314 0 C-N-CA 123.63 2.887 . . . . 0.0 113.648 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -80.61 19.1 0.84 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -172.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.36 -19.88 47.6 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 171.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.4 t -124.25 171.15 10.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.982 -0.609 . . . . 0.0 109.53 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -122.72 13.99 10.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.41 0.624 . . . . 0.0 109.681 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 m -139.11 110.53 7.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.022 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.63 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 48.4 m0 -106.94 141.36 38.28 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.941 -175.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -120.04 125.46 48.38 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.18 0.3 . . . . 0.0 110.515 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.55 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 60.1 m-85 -135.66 174.69 10.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.53 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 77' ' ' PHE . 1.6 p -122.5 150.63 26.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.639 -176.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.535 ' HE1' HG21 ' A' ' 43' ' ' VAL . 10.0 m-30 . . . . . 0 C--N 1.322 -0.598 0 CA-C-O 121.126 0.489 . . . . 0.0 110.571 177.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.447 -0.604 0 CA-C-O 121.153 0.501 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.945 HD11 HG22 ' A' ' 104' ' ' ILE . 21.3 tp -89.72 114.14 25.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.478 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 35.9 m -108.25 102.7 11.81 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.906 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.4 tp -85.59 121.94 29.0 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.5 -173.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.4 m -100.34 119.86 39.07 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.956 -176.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.539 ' CE2' HD23 ' A' ' 93' ' ' LEU . 67.5 m-85 -113.77 136.8 52.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.817 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.481 HD21 ' HB ' ' A' ' 100' ' ' VAL . 32.3 p30 -75.27 -177.6 3.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.933 175.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.0 m -52.84 -33.94 51.82 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.593 ' HB3' HG23 ' A' ' 100' ' ' VAL . 8.7 t -83.83 -9.6 58.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.018 0.437 . . . . 0.0 110.849 -173.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.57 29.66 20.92 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.593 HG23 ' HB3' ' A' ' 98' ' ' SER . 21.5 t -107.62 140.19 26.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.742 -0.729 . . . . 0.0 109.323 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.906 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.5 mt -62.3 125.29 23.4 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.286 0.565 . . . . 0.0 111.885 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.439 HG21 ' HB3' ' A' ' 96' ' ' ASN . 11.1 p -109.6 -45.49 3.67 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.418 174.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -138.33 155.02 48.96 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.63 0.728 . . . . 0.0 111.556 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.945 HG22 HD11 ' A' ' 91' ' ' LEU . 5.3 mm -113.16 93.11 2.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.637 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 30.4 t70 -85.49 96.36 9.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.125 0.488 . . . . 0.0 111.0 -171.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -105.42 102.76 12.21 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.976 0.893 . . . . 0.0 110.106 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.6 pttm . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.275 -175.491 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.711 ' HB3' ' HB3' ' A' ' 75' ' ' TYR . 6.0 tp . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.2 p -127.9 -173.93 3.06 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.106 174.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.585 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -67.82 -47.33 69.35 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.21 0.528 . . . . 0.0 112.007 -173.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.67 -31.68 69.78 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.101 177.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.537 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 63.4 m-20 -72.29 -35.11 68.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.313 176.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.828 HG22 HD22 ' A' ' 91' ' ' LEU . 53.3 t -57.48 -36.61 54.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.206 0.527 . . . . 0.0 110.506 174.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.1 t -61.61 -17.73 56.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.533 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 48.4 mtpt -74.75 -28.73 60.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.849 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.822 HG23 HD13 ' A' ' 59' ' ' LEU . 43.3 pt -97.56 176.32 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 122.108 0.956 . . . . 0.0 113.163 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.54 150.59 6.09 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.516 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.441 HG22 ' CG1' ' A' ' 104' ' ' ILE . 0.7 OUTLIER -70.54 145.6 12.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.125 -178.077 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.93 -35.15 3.92 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.16 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.607 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 6.8 ptt? -85.3 165.8 17.0 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.285 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.72 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 12.4 p -83.1 -172.3 4.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.409 -173.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 99' ' ' GLY . 92.2 mt-30 -68.24 -41.84 80.61 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.737 176.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.551 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -66.58 -32.12 73.25 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -175.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.72 ' HG3' ' H ' ' A' ' 51' ' ' THR . 15.8 mm-40 -61.93 -56.58 17.69 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.44 176.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.673 HG11 ' CD2' ' A' ' 93' ' ' LEU . 82.0 t -65.4 -40.45 88.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.57 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.619 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.69 -35.55 72.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.163 0.506 . . . . 0.0 110.297 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -81.65 -35.37 30.03 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.088 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.04 -45.15 43.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.554 0.692 . . . . 0.0 111.393 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.822 HD13 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -90.95 -54.42 3.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.316 -174.231 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.68 130.1 2.91 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.619 HG22 ' HB1' ' A' ' 56' ' ' ALA . 40.5 p -65.34 128.82 94.13 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-O 121.533 0.682 . . . . 0.0 110.687 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 14.6 Cg_exo -68.68 163.25 37.81 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.569 2.846 . . . . 0.0 112.956 -171.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.82 -25.85 61.2 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.008 -171.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.468 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 13.4 ptt? -66.84 -3.01 5.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.543 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 t 72.29 4.4 4.99 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.545 0.738 . . . . 0.0 112.51 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -158.92 107.78 1.58 Allowed Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 121.579 0.704 . . . . 0.0 110.543 175.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.674 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 58.8 Cg_endo -72.82 -29.95 11.93 Favored 'Trans proline' 0 C--N 1.325 -0.662 0 C-N-CA 122.976 2.451 . . . . 0.0 112.511 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -76.28 -4.06 39.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.927 -170.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.85 -17.66 55.96 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.534 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.3 t -124.39 174.31 7.84 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.005 0.431 . . . . 0.0 110.666 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -118.52 3.56 11.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.574 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.4 m -134.15 112.77 11.4 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.643 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.674 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 44.6 m0 -105.88 136.19 45.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.439 -177.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -113.07 127.31 56.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.928 0.394 . . . . 0.0 110.724 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.711 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 62.2 m-85 -132.27 173.91 10.78 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 77' ' ' PHE . 2.0 t -129.09 178.15 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.585 ' CG ' ' HB2' ' A' ' 40' ' ' ALA . 7.6 m-30 . . . . . 0 C--N 1.319 -0.758 0 CA-C-O 120.514 0.197 . . . . 0.0 110.54 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.442 -0.846 0 CA-C-O 120.804 0.335 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.901 HD11 HG22 ' A' ' 104' ' ' ILE . 20.0 tp -91.24 119.25 31.15 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.718 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 90.4 m -110.49 106.86 16.32 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.945 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.1 tp -91.39 123.63 34.96 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.725 -174.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.7 m -103.2 121.71 43.23 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.844 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.47 ' CE1' ' HG ' ' A' ' 101' ' ' LEU . 71.6 m-85 -116.71 138.91 51.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.893 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.52 HD21 ' HB ' ' A' ' 100' ' ' VAL . 33.4 p30 -75.61 -173.46 2.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.794 175.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.6 m -51.29 -44.36 61.86 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -174.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.463 ' HB3' HG23 ' A' ' 100' ' ' VAL . 33.6 t -79.78 -15.9 56.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.469 . . . . 0.0 111.068 -174.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.424 ' O ' ' HG3' ' A' ' 52' ' ' GLN . . . 96.83 29.49 8.1 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -176.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.52 ' HB ' HD21 ' A' ' 96' ' ' ASN . 14.0 t -98.24 134.68 35.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.945 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.7 mt -59.9 125.02 22.01 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.262 0.553 . . . . 0.0 112.04 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.427 HG21 ' HB3' ' A' ' 96' ' ' ASN . 5.7 p -112.78 -39.48 4.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.15 176.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -143.72 148.28 35.46 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.359 0.599 . . . . 0.0 111.908 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.901 HG22 HD11 ' A' ' 91' ' ' LEU . 4.7 mm -111.92 95.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.718 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 35.5 t0 -86.59 95.34 9.72 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.718 -174.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -102.86 104.09 14.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.704 0.764 . . . . 0.0 109.645 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 63.4 pttt . . . . . 0 C--N 1.312 -1.035 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.733 -176.466 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.63 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 1.3 tp . . . . . 0 N--CA 1.457 -0.097 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 26.0 p -126.12 -176.27 3.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.048 0.452 . . . . 0.0 111.995 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.494 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -62.56 -37.8 87.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.909 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -59.8 -43.27 94.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.373 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.614 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 10.5 m-20 -68.44 -29.6 68.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.962 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.011 HG22 HD22 ' A' ' 91' ' ' LEU . 85.6 t -59.79 -36.95 69.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.207 0.527 . . . . 0.0 110.45 175.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -61.26 -19.05 61.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.427 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -70.99 -42.13 70.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.794 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.789 HG23 HD13 ' A' ' 59' ' ' LEU . 41.6 pt -84.7 -178.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.747 0.784 . . . . 0.0 112.268 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.406 ' HD2' ' N ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -171.68 152.33 3.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.326 -175.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.458 HG23 ' H ' ' A' ' 48' ' ' VAL . 0.7 OUTLIER -72.82 145.62 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.697 -179.246 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.41 -30.6 5.93 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.346 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.492 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 16.0 ptt? -90.06 178.18 6.26 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.285 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.912 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 31.1 p -95.23 -174.07 3.11 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.013 -170.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.456 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 97.8 mt-30 -63.89 -47.51 80.33 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.774 172.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.415 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 9.9 pt20 -64.56 -36.5 84.42 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.305 0.574 . . . . 0.0 109.811 -175.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.912 ' HG3' ' H ' ' A' ' 51' ' ' THR . 9.4 mm-40 -58.0 -52.47 65.38 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.323 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.652 HG11 ' CD2' ' A' ' 93' ' ' LEU . 72.2 t -67.11 -41.56 87.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.714 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.527 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -64.52 -25.68 68.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.164 0.507 . . . . 0.0 110.727 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -81.28 -35.53 30.97 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.013 0.435 . . . . 0.0 111.323 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.9 -46.14 25.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.393 0.616 . . . . 0.0 111.705 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.789 HD13 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -92.56 -21.15 20.26 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.815 -173.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.91 131.07 6.98 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -172.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.527 HG22 ' HB1' ' A' ' 56' ' ' ALA . 37.9 p -56.75 135.27 78.61 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.959 0.409 . . . . 0.0 111.118 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 51.8 Cg_exo -59.12 171.65 2.15 Favored 'Trans proline' 0 N--CA 1.471 0.157 0 C-N-CA 124.131 3.221 . . . . 0.0 115.131 -171.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.451 ' HG ' ' H ' ' A' ' 63' ' ' LEU . 8.3 mt -55.49 -41.69 73.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.257 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.463 ' HE3' HG21 ' A' ' 70' ' ' THR . 0.0 OUTLIER -60.19 -0.24 0.22 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.547 176.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 63' ' ' LEU . 33.5 p 58.86 5.44 0.5 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.214 1.006 . . . . 0.0 112.815 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -150.17 103.58 3.15 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 121.54 0.686 . . . . 0.0 109.753 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.487 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 36.0 Cg_endo -68.06 -33.03 26.62 Favored 'Trans proline' 0 C--N 1.327 -0.555 0 C-N-CA 123.245 2.63 . . . . 0.0 113.177 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -76.22 4.51 8.55 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -170.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.33 -24.72 21.03 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.086 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.463 HG21 ' HE3' ' A' ' 64' ' ' MET . 14.3 t -125.51 174.38 8.26 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.902 0.382 . . . . 0.0 110.236 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -125.78 12.52 7.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.862 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.9 m -133.55 108.81 8.83 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.21 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.487 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 42.7 m0 -109.18 130.34 55.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.412 -174.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -109.46 120.89 43.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.024 0.44 . . . . 0.0 110.967 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.583 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 50.1 m-85 -129.24 173.88 10.1 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 77' ' ' PHE . 2.9 t -123.42 175.29 6.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -176.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.573 ' H ' HG12 ' A' ' 76' ' ' VAL . 5.7 m-30 . . . . . 0 C--N 1.32 -0.697 0 CA-C-O 121.045 0.45 . . . . 0.0 110.721 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 120.848 0.356 . . . . 0.0 111.53 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.083 HD11 HG22 ' A' ' 104' ' ' ILE . 39.8 tp -91.8 122.94 34.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 172.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 89.9 m -117.49 103.91 10.55 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.823 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.1 tp -85.18 125.18 32.62 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.286 -174.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 21.5 m -107.35 122.87 47.46 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.264 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.597 ' CE2' HD23 ' A' ' 93' ' ' LEU . 32.5 m-85 -110.54 146.45 36.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.894 0.854 . . . . 0.0 112.695 -175.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -73.94 -179.61 3.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.646 -1.615 . . . . 0.0 111.171 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.4 p -59.32 -43.03 92.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.698 0.285 . . . . 0.0 111.583 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.432 ' HB3' HG23 ' A' ' 100' ' ' VAL . 35.0 t -77.69 -8.66 58.25 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.958 0.409 . . . . 0.0 110.694 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.88 31.06 10.35 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.459 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 98' ' ' SER . 22.0 t -100.77 141.64 17.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.823 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.0 mt -62.29 123.99 19.69 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.084 0.469 . . . . 0.0 111.597 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 74.1 p -111.8 -43.55 3.6 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.642 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.522 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 2.6 m-20 -136.24 150.08 48.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.812 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.083 HG22 HD11 ' A' ' 91' ' ' LEU . 2.2 mm -116.46 92.43 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 170.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.547 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 25.2 t70 -87.42 96.78 10.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.131 0.491 . . . . 0.0 111.032 -170.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.418 ' HB2' ' HZ ' ' A' ' 77' ' ' PHE . 4.4 p30 -106.84 104.75 14.5 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 122.032 0.92 . . . . 0.0 110.333 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.505 ' H ' ' HD3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.762 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.973 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.715 ' HB3' ' HB3' ' A' ' 75' ' ' TYR . 2.3 tp . . . . . 0 C--O 1.231 0.105 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 43' ' ' VAL . 41.6 p -126.05 -179.28 4.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.258 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.8 -32.75 74.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.345 0.593 . . . . 0.0 110.596 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -62.34 -43.11 99.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.86 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.633 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 30.1 m-20 -69.11 -30.9 69.27 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.969 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.877 HG22 HD22 ' A' ' 91' ' ' LEU . 70.9 t -59.82 -37.83 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.042 0.448 . . . . 0.0 110.574 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.6 t -58.42 -21.97 52.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.557 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -70.28 -29.67 66.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.65 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.697 HG23 HD13 ' A' ' 59' ' ' LEU . 36.7 pt -98.42 -178.14 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.812 0.815 . . . . 0.0 112.413 -178.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.25 151.27 3.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.38 -176.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.433 HG22 HD11 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -72.26 145.49 12.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.13 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.56 -35.9 3.57 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.792 -177.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.519 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 19.0 ptt? -85.27 176.81 8.11 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.165 0.507 . . . . 0.0 111.263 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.889 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 32.6 p -95.29 -174.95 3.35 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.991 -170.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.672 ' OE1' ' HA ' ' A' ' 68' ' ' PHE . 78.9 mt-30 -62.73 -48.06 80.88 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.533 172.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.535 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -64.65 -33.13 75.21 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.301 0.572 . . . . 0.0 109.843 -174.228 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.889 ' HG3' ' H ' ' A' ' 51' ' ' THR . 9.1 mm-40 -60.99 -53.08 61.62 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.562 174.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.688 HG11 ' CD2' ' A' ' 93' ' ' LEU . 75.2 t -69.43 -39.9 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.597 -176.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.689 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -59.56 -32.26 70.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.452 0.644 . . . . 0.0 110.002 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -80.87 -36.82 30.83 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.272 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.57 -49.11 19.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.941 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.697 HD13 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -90.44 -32.89 16.21 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.978 -172.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 114.25 127.69 4.5 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.274 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.689 HG22 ' HB1' ' A' ' 56' ' ' ALA . 28.4 p -60.85 132.22 91.76 Favored Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-O 121.244 0.545 . . . . 0.0 111.004 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 11.6 Cg_exo -70.77 162.27 43.16 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.529 2.82 . . . . 0.0 112.768 -173.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.48 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 1.7 mt -54.47 -33.89 60.52 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.094 -1.412 . . . . 0.0 112.235 -169.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.439 ' H ' ' HG2' ' A' ' 64' ' ' MET . 12.2 ptt? -64.16 -1.92 1.82 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.19 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.1 p 62.13 2.38 0.81 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.374 1.07 . . . . 0.0 113.534 172.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -136.76 92.53 14.59 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.501 ' HG3' HG22 ' A' ' 61' ' ' THR . 37.9 Cg_endo -67.75 -34.1 25.6 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.745 1.63 . . . . 0.0 111.524 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.672 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -79.41 10.24 3.98 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.508 -177.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.02 -26.3 16.89 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.607 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -124.66 175.95 6.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.959 0.409 . . . . 0.0 110.432 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -126.99 13.55 7.31 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.8 m -132.57 109.78 10.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.665 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.481 ' O ' ' HA ' ' A' ' 92' ' ' THR . 46.2 m0 -107.29 149.85 27.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.594 -175.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -123.1 115.23 21.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.08 0.467 . . . . 0.0 111.051 -175.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.715 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 88.3 m-85 -127.06 174.47 8.86 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 77' ' ' PHE . 4.7 t -120.97 170.19 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 118.066 0.394 . . . . 0.0 110.204 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.567 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 121.406 0.622 . . . . 0.0 112.24 -175.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.439 -1.023 0 CA-C-O 121.197 0.522 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.049 HD11 HG22 ' A' ' 104' ' ' ILE . 19.3 tp -91.18 105.64 17.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 32.1 m -101.81 102.46 13.07 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.871 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.9 tp -83.72 126.16 32.61 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.256 -173.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.4 m -107.91 119.9 40.76 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.263 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.505 ' CE2' HD23 ' A' ' 93' ' ' LEU . 95.5 m-85 -110.08 147.8 32.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.797 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.55 HD21 ' HB ' ' A' ' 100' ' ' VAL . 4.1 p30 -72.06 -87.35 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 55.0 m -150.73 -30.2 0.19 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.887 0.375 . . . . 0.0 110.75 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.471 ' HB3' HG23 ' A' ' 100' ' ' VAL . 16.6 t -82.27 -6.03 58.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.423 0.63 . . . . 0.0 109.452 177.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.52 ' HA2' HE21 ' A' ' 52' ' ' GLN . . . 89.77 29.65 15.32 Favored Glycine 0 CA--C 1.503 -0.702 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.55 ' HB ' HD21 ' A' ' 96' ' ' ASN . 25.8 t -108.25 137.13 41.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.613 -0.793 . . . . 0.0 109.458 -178.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.871 HD21 ' HG ' ' A' ' 93' ' ' LEU . 9.3 mt -61.37 130.74 47.61 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.197 0.522 . . . . 0.0 112.35 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.8 p -114.18 -37.25 4.46 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.126 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -150.06 152.96 35.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.631 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.049 HG22 HD11 ' A' ' 91' ' ' LEU . 3.3 mm -112.96 93.83 2.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 173.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.581 ' HB2' ' O ' ' A' ' 92' ' ' THR . 5.6 m-20 -80.6 96.62 6.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.688 0.28 . . . . 0.0 111.449 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -106.77 104.19 13.81 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.88 0.847 . . . . 0.0 109.917 175.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.433 ' H ' ' HD3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.869 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.206 -176.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.648 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 5.0 tp . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.911 0.386 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 43' ' ' VAL . 29.3 p -127.84 -174.1 3.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.986 175.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.18 -38.87 86.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.362 0.601 . . . . 0.0 110.869 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -62.12 -41.74 98.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.468 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.518 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 10.7 m-20 -63.85 -36.75 84.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.491 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.674 HG22 HD22 ' A' ' 91' ' ' LEU . 77.0 t -59.26 -38.05 72.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.167 0.508 . . . . 0.0 110.582 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.9 t -63.03 -20.62 65.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.089 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 46.0 mtpt -70.17 -33.92 72.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.654 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.776 HG23 HD13 ' A' ' 59' ' ' LEU . 42.9 pt -89.76 -179.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.784 0.802 . . . . 0.0 112.439 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.43 149.9 2.24 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.665 -176.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.454 ' H ' HG23 ' A' ' 48' ' ' VAL . 0.6 OUTLIER -70.98 142.29 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.722 -179.212 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.69 -27.97 6.35 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.708 -176.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.522 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 21.8 ptt? -94.08 171.56 8.77 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.76 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.655 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 23.5 p -91.18 -172.83 3.43 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.723 -168.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.444 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 99.0 mt-30 -63.89 -46.81 83.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.143 173.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.429 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 10.4 pt20 -64.95 -35.3 80.73 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.376 0.608 . . . . 0.0 110.061 -175.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.655 ' HG3' ' H ' ' A' ' 51' ' ' THR . 1.7 mm100 -68.14 -40.58 82.38 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.303 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.665 HG11 ' CD2' ' A' ' 93' ' ' LEU . 53.9 t -74.8 -47.15 39.0 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.578 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.637 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.58 -24.83 67.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.874 0.368 . . . . 0.0 110.796 -176.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -79.82 -41.27 26.76 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.65 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.56 -44.19 71.38 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.558 0.694 . . . . 0.0 111.271 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.776 HD13 HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -88.27 -39.94 14.02 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.366 -173.044 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.6 122.87 4.07 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -171.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.637 HG22 ' HB1' ' A' ' 56' ' ' ALA . 40.2 p -57.09 133.16 80.5 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.11 0.481 . . . . 0.0 111.032 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 22.6 Cg_exo -63.28 161.78 29.38 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.582 2.855 . . . . 0.0 113.332 -170.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.409 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -56.84 -27.63 60.47 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 113.776 -1.556 . . . . 0.0 112.09 -171.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 13.2 ptt? -68.14 2.62 2.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.772 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.9 t 66.48 11.0 7.77 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.818 0.447 . . . . 0.0 112.03 172.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -162.78 104.63 1.04 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.703 0.763 . . . . 0.0 110.458 178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.534 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 74.3 Cg_endo -77.29 -36.25 1.39 Allowed 'Trans proline' 0 C--N 1.326 -0.649 0 C-N-CA 123.171 2.581 . . . . 0.0 113.704 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -77.2 -11.62 59.84 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -166.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.32 -8.85 70.72 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.961 -173.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.1 t -124.09 174.51 7.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.954 0.407 . . . . 0.0 110.467 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -119.34 1.62 11.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.117 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.3 m -131.62 113.87 14.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.898 -175.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.563 ' O ' ' HA ' ' A' ' 92' ' ' THR . 44.4 m0 -108.69 147.12 32.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.489 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 27.1 m-85 -127.68 125.26 39.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.954 0.407 . . . . 0.0 111.16 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.559 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 73.4 m-85 -133.92 173.61 11.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.798 178.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.5 t -121.27 161.62 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 . . . . . 0 C--N 1.321 -0.633 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 174.087 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.899 HD11 HG22 ' A' ' 104' ' ' ILE . 13.9 tp -90.08 111.5 22.63 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.666 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 34.6 m -106.65 104.2 13.83 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.906 ' HG ' HD21 ' A' ' 101' ' ' LEU . 6.7 tp -88.41 119.28 28.69 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.032 -174.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.8 m -102.43 122.26 43.95 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.557 -175.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.506 ' CE2' HD23 ' A' ' 93' ' ' LEU . 67.0 m-85 -114.63 138.11 51.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.986 -178.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.494 HD21 ' HB ' ' A' ' 100' ' ' VAL . 32.5 p30 -75.0 -172.08 1.53 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.121 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.5 m -62.19 -30.97 71.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.498 ' HB3' HG23 ' A' ' 100' ' ' VAL . 35.6 t -83.46 -11.87 56.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.777 0.323 . . . . 0.0 111.133 -174.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.78 28.94 14.34 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 98' ' ' SER . 6.7 t -107.87 142.91 19.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.031 -0.585 . . . . 0.0 109.648 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.906 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.5 mt -62.97 126.74 28.33 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.176 0.512 . . . . 0.0 112.204 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.486 HG21 ' HB3' ' A' ' 96' ' ' ASN . 10.8 p -113.13 -42.93 3.44 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.0 175.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -138.2 150.73 47.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.359 0.6 . . . . 0.0 111.584 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.899 HG22 HD11 ' A' ' 91' ' ' LEU . 4.7 mm -113.03 93.08 2.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 168.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.666 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 32.8 t70 -90.56 98.69 11.92 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.465 -169.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 90' ' ' THR . 4.8 p30 -110.98 101.72 10.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.201 1.001 . . . . 0.0 110.744 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.5 mttp . . . . . 0 C--N 1.317 -0.812 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.716 -178.547 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.744 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 1.8 mm? . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 121.831 0.824 . . . . 0.0 112.562 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 43' ' ' VAL . 17.3 p -131.21 -172.46 2.84 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.352 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.413 ' O ' ' HB ' ' A' ' 43' ' ' VAL . . . -62.62 -47.57 83.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -67.82 -32.64 73.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.968 0.413 . . . . 0.0 110.959 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.567 ' HB3' HD12 ' A' ' 38' ' ' LEU . 10.6 m-20 -62.76 -37.61 87.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.321 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.897 HG22 HD22 ' A' ' 91' ' ' LEU . 78.4 t -60.61 -37.73 76.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.121 0.486 . . . . 0.0 110.966 178.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.9 t -60.57 -22.84 64.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.257 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 49.8 mtpt -68.57 -34.4 75.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.648 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.81 HG23 HD13 ' A' ' 59' ' ' LEU . 44.6 pt -93.63 175.67 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 121.934 0.873 . . . . 0.0 112.51 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.65 150.96 6.1 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.955 -1.475 . . . . 0.0 109.505 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.46 HG22 ' CG1' ' A' ' 104' ' ' ILE . 0.5 OUTLIER -72.41 141.59 16.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.888 -177.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.3 -24.1 7.42 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.246 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.482 ' HE3' HG22 ' A' ' 46' ' ' ILE . 19.0 ptt? -96.57 178.12 5.44 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.226 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.2 p -95.03 -178.91 4.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.71 -169.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.486 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 27.1 mt-30 -65.56 -43.38 90.03 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.866 173.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.459 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 9.4 pt20 -64.35 -38.11 89.87 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.674 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.459 ' N ' ' HG3' ' A' ' 53' ' ' GLN . 49.3 mt-30 -66.77 -45.62 77.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.115 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.706 HG11 ' CD2' ' A' ' 93' ' ' LEU . 62.8 t -68.86 -47.64 74.94 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.598 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -62.86 -26.32 68.71 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.488 -177.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -81.33 -39.12 25.63 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.392 176.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.25 -51.93 47.07 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.105 0.955 . . . . 0.0 110.85 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.81 HD13 HG23 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -81.55 -49.61 10.36 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.328 -173.011 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.88 124.16 2.75 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -171.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.598 HG22 ' HB1' ' A' ' 56' ' ' ALA . 44.3 p -57.41 134.06 81.66 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.877 0.37 . . . . 0.0 110.69 -177.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.505 ' CD ' ' HB3' ' A' ' 67' ' ' PRO . 35.1 Cg_exo -60.41 157.04 37.88 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 123.498 2.799 . . . . 0.0 112.645 -172.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 1.7 mt -59.93 -27.99 67.23 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.502 -1.227 . . . . 0.0 111.307 -171.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.454 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 12.5 ptt? -62.85 -4.8 2.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.862 175.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 t 71.65 -3.01 2.27 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.459 0.703 . . . . 0.0 111.695 172.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.46 99.78 7.76 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-O 121.708 0.766 . . . . 0.0 110.427 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.505 ' HB3' ' CD ' ' A' ' 62' ' ' PRO . 73.0 Cg_endo -79.32 -28.43 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.712 2.275 . . . . 0.0 112.598 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -86.03 -5.31 59.24 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -168.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.79 -17.79 53.21 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.89 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.401 HG21 ' HE1' ' A' ' 64' ' ' MET . 9.0 t -123.62 172.16 9.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.914 0.388 . . . . 0.0 110.069 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -128.06 20.65 6.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.322 0.582 . . . . 0.0 109.465 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 17.9 m -143.65 111.92 6.3 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.696 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.535 ' O ' ' HA ' ' A' ' 92' ' ' THR . 51.4 m0 -107.84 147.15 31.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.613 -175.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -125.68 115.27 19.83 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 111.268 -174.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.586 ' HD2' HD23 ' A' ' 91' ' ' LEU . 27.7 m-85 -128.53 176.26 7.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.639 HG22 ' H ' ' A' ' 77' ' ' PHE . 4.2 p -124.32 175.13 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -176.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.639 ' H ' HG22 ' A' ' 76' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.486 0 CA-C-O 121.241 0.543 . . . . 0.0 111.622 -175.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 21.6 p . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 121.136 0.493 . . . . 0.0 112.228 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.993 HD11 HG22 ' A' ' 104' ' ' ILE . 24.7 tp -91.51 113.1 25.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.142 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.721 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 25.5 m -106.39 105.05 14.9 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.853 ' HG ' HD21 ' A' ' 101' ' ' LEU . 6.9 tp -90.83 121.65 32.87 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.401 -174.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.7 m -104.55 124.15 48.78 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.945 -176.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.501 ' CE2' HD23 ' A' ' 93' ' ' LEU . 73.9 m-85 -117.32 139.37 50.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.44 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.481 HD21 ' HB ' ' A' ' 100' ' ' VAL . 32.0 p30 -76.59 -174.36 2.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.168 174.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.0 p -57.48 -35.89 70.77 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -175.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.588 ' HB3' HG23 ' A' ' 100' ' ' VAL . 21.0 t -81.15 -4.93 56.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.189 0.518 . . . . 0.0 110.88 -174.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.53 27.95 37.45 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.45 -0.881 . . . . 0.0 110.902 -177.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.588 HG23 ' HB3' ' A' ' 98' ' ' SER . 16.7 t -104.6 138.17 30.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.235 -0.482 . . . . 0.0 109.733 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.853 HD21 ' HG ' ' A' ' 93' ' ' LEU . 7.3 mt -58.97 127.75 33.79 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.215 0.531 . . . . 0.0 111.987 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.416 HG21 ' HB3' ' A' ' 96' ' ' ASN . 7.6 p -114.3 -35.51 4.96 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.223 176.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -149.43 149.03 30.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.204 0.526 . . . . 0.0 111.915 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.993 HG22 HD11 ' A' ' 91' ' ' LEU . 3.4 mm -113.09 94.38 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.721 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 18.4 t70 -94.91 97.25 9.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.862 0.363 . . . . 0.0 111.674 -169.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 90' ' ' THR . 28.6 t-20 -107.69 103.37 12.65 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.723 0.773 . . . . 0.0 110.973 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.538 ' HE3' ' OD1' ' A' ' 105' ' ' ASP . 67.1 mttt . . . . . 0 C--N 1.316 -0.864 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.09 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.75 HD13 ' HG ' ' A' ' 59' ' ' LEU . 10.4 tp . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.874 0.369 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.495 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 40.4 p -129.21 -179.11 4.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.033 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.435 ' O ' ' HB ' ' A' ' 43' ' ' VAL . . . -65.07 -44.34 89.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.62 -32.58 71.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.397 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 5.7 m-20 -75.33 -27.77 59.37 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.857 176.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.766 HG22 HD22 ' A' ' 91' ' ' LEU . 54.4 t -60.38 -36.34 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.321 0.581 . . . . 0.0 110.05 173.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.4 t -61.8 -19.89 63.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.317 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 46.6 mtpt -74.69 -24.99 58.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.496 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.793 HG23 HD13 ' A' ' 59' ' ' LEU . 34.4 pt -101.24 176.53 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 122.068 0.937 . . . . 0.0 112.585 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.06 153.35 3.12 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.027 -176.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.461 HG22 HD11 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -71.31 144.73 13.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.961 -177.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.49 -29.6 5.63 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.448 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.648 ' HE3' HG22 ' A' ' 46' ' ' ILE . 13.5 ptt? -92.86 178.14 5.86 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.19 176.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.855 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 30.0 p -96.07 -174.1 3.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.776 -169.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.452 ' OE1' ' HA ' ' A' ' 68' ' ' PHE . 75.6 mt-30 -61.51 -47.78 84.03 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.246 173.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.534 ' HG2' ' OG1' ' A' ' 51' ' ' THR . 7.7 pt20 -63.59 -40.32 96.65 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.21 0.529 . . . . 0.0 109.977 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.855 ' HG3' ' H ' ' A' ' 51' ' ' THR . 7.3 mm-40 -60.09 -50.43 73.72 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.059 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.657 HG11 ' CD2' ' A' ' 93' ' ' LEU . 56.9 t -64.76 -48.83 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.676 -177.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.604 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.31 -26.25 68.68 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.756 -176.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -81.89 -33.73 30.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.972 0.415 . . . . 0.0 111.81 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.67 -40.61 63.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.833 0.825 . . . . 0.0 111.058 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.793 HD13 HG23 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -91.92 -41.6 10.5 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.64 -171.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.9 123.87 4.52 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 -168.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.604 HG22 ' HB1' ' A' ' 56' ' ' ALA . 33.2 p -56.35 136.45 75.84 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.981 0.42 . . . . 0.0 111.051 -175.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.553 ' CD ' ' HB3' ' A' ' 67' ' ' PRO . 34.3 Cg_exo -60.57 167.07 8.75 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.759 2.973 . . . . 0.0 113.556 -171.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.405 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -57.27 -30.44 64.68 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 113.637 -1.619 . . . . 0.0 111.961 -171.093 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -71.15 2.29 4.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.778 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.8 t 71.1 1.79 3.96 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.266 0.626 . . . . 0.0 112.234 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -157.62 108.59 1.82 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.73 0.776 . . . . 0.0 110.716 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.71 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 74.1 Cg_endo -75.49 -34.73 3.23 Favored 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 123.559 2.84 . . . . 0.0 113.653 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.452 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 14.4 m-85 -75.14 2.48 10.69 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -166.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.78 -20.09 45.13 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.937 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.8 t -125.61 175.28 7.67 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.839 0.352 . . . . 0.0 110.443 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -123.35 8.15 9.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.5 m -129.14 107.38 9.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.994 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.71 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 47.9 m0 -104.59 144.93 31.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.946 -173.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -122.19 120.38 34.02 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.605 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 72.1 m-85 -127.2 173.61 9.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.522 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.6 t -115.76 152.06 17.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.09 0.471 . . . . 0.0 110.096 -173.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.73 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.443 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.443 -0.799 0 CA-C-O 120.851 0.358 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.857 HD11 HG22 ' A' ' 104' ' ' ILE . 13.2 tp -91.29 108.57 19.97 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.691 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 22.3 m -105.57 98.17 7.91 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.453 0.644 . . . . 0.0 109.647 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.866 ' HG ' HD21 ' A' ' 101' ' ' LEU . 6.9 tp -83.25 128.45 34.51 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.568 -173.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.0 m -114.44 124.61 52.36 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.078 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.477 ' CE2' HD23 ' A' ' 93' ' ' LEU . 87.5 m-85 -114.41 140.64 48.52 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.316 -178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.496 ' HB3' HG21 ' A' ' 102' ' ' THR . 31.6 p30 -75.27 -174.07 2.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.148 176.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.2 m -53.59 -36.62 62.14 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.485 ' HB3' HG23 ' A' ' 100' ' ' VAL . 22.9 t -85.96 -0.09 54.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.99 0.424 . . . . 0.0 110.797 -173.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.37 29.84 51.77 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.734 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 98' ' ' SER . 5.6 t -105.66 140.48 23.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.866 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.5 mt -59.89 126.37 27.31 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.219 0.533 . . . . 0.0 112.264 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.496 HG21 ' HB3' ' A' ' 96' ' ' ASN . 11.4 p -111.85 -43.52 3.6 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.812 174.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -136.82 152.29 50.11 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.446 0.641 . . . . 0.0 111.335 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.857 HG22 HD11 ' A' ' 91' ' ' LEU . 4.8 mm -114.57 92.23 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 169.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.691 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 18.6 t70 -86.89 95.08 9.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.141 0.496 . . . . 0.0 110.921 -170.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -106.89 104.17 13.78 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.636 0.731 . . . . 0.0 109.967 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.472 ' HD2' ' OD2' ' A' ' 105' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.842 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.98 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.609 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 10.7 tp . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.613 0.244 . . . . 0.0 110.571 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.476 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 43.4 p -127.41 177.25 6.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.128 172.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.77 -30.02 65.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 0.0 110.238 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -53.49 -45.93 69.83 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.788 0.804 . . . . 0.0 109.759 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.666 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 19.9 m-20 -70.54 -30.5 67.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.334 -178.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.979 HG22 HD22 ' A' ' 91' ' ' LEU . 60.2 t -64.87 -41.84 93.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.257 0.551 . . . . 0.0 109.775 174.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.0 t -61.32 -32.01 71.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.315 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.666 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 34.3 mtpt -63.07 -43.52 98.36 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.754 176.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.587 HG23 HD13 ' A' ' 59' ' ' LEU . 43.6 pt -80.91 174.99 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-O 121.723 0.773 . . . . 0.0 111.901 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.457 ' O ' ' HG2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -163.43 143.43 8.71 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.228 -174.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.446 HG22 HD11 ' A' ' 104' ' ' ILE . 0.7 OUTLIER -70.34 140.76 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.491 -179.16 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.95 -27.09 6.9 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.965 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.537 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 23.4 ptt? -90.73 174.39 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.255 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.875 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 39.8 p -92.82 -173.78 3.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.888 -171.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.473 ' OE1' ' HA ' ' A' ' 68' ' ' PHE . 83.4 mt-30 -65.57 -44.33 87.08 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.515 172.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.657 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -64.97 -33.67 76.58 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.316 0.579 . . . . 0.0 110.18 -175.543 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.875 ' HG3' ' H ' ' A' ' 51' ' ' THR . 6.3 mm-40 -62.27 -53.01 61.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.222 175.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.733 HG11 HD22 ' A' ' 93' ' ' LEU . 69.1 t -69.96 -40.24 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.676 -176.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.762 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -57.44 -33.45 67.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.433 0.635 . . . . 0.0 110.053 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -81.48 -36.56 29.15 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.744 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.23 -43.3 52.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.132 0.492 . . . . 0.0 111.968 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.609 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -94.86 -14.89 24.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.079 -172.625 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.02 124.16 3.27 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -175.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.762 HG22 ' HB1' ' A' ' 56' ' ' ALA . 18.6 p -60.11 121.21 57.45 Favored Pre-proline 0 N--CA 1.432 -1.339 0 CA-C-O 122.295 1.045 . . . . 0.0 111.666 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 75.4 Cg_exo -52.54 159.25 4.82 Favored 'Trans proline' 0 C--N 1.327 -0.602 1 C-N-CA 125.436 4.091 . . . . 0.0 113.965 -176.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 65' ' ' SER . 0.5 OUTLIER -75.12 -21.1 59.1 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.953 -171.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.534 ' HE1' HG21 ' A' ' 70' ' ' THR . 16.9 ptt? -70.49 23.51 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.715 175.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 63' ' ' LEU . 44.5 t 77.07 -56.73 0.53 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 165.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 8.3 m-20 -126.29 99.92 30.22 Favored Pre-proline 0 C--N 1.304 -1.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.655 -171.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.539 ' HG3' HG22 ' A' ' 61' ' ' THR . 12.5 Cg_endo -58.75 -34.55 99.04 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.408 2.072 . . . . 0.0 111.655 176.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.522 ' CZ ' ' HB3' ' A' ' 53' ' ' GLN . 9.4 m-85 -78.99 2.48 20.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.81 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.0 -15.55 44.76 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.873 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.534 HG21 ' HE1' ' A' ' 64' ' ' MET . 6.1 t -124.81 175.5 7.22 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -127.39 7.82 6.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.293 0.568 . . . . 0.0 109.953 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 m -134.69 113.09 11.34 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.677 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.428 ' O ' ' HA ' ' A' ' 92' ' ' THR . 40.0 m0 -103.97 141.39 36.26 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.069 -176.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -116.41 114.64 24.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.372 0.606 . . . . 0.0 110.946 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.675 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 93.2 m-85 -129.41 176.61 7.82 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.525 177.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.515 HG22 ' H ' ' A' ' 77' ' ' PHE . 1.4 p -143.27 -177.86 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.515 ' H ' HG22 ' A' ' 76' ' ' VAL . 15.5 m-30 . . . . . 0 C--N 1.328 -0.366 0 CA-C-O 121.14 0.495 . . . . 0.0 112.162 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.437 -1.122 0 CA-C-O 121.402 0.62 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.044 HD11 HG22 ' A' ' 104' ' ' ILE . 42.5 tp -91.71 118.77 30.96 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.88 174.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.608 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 51.1 m -110.61 103.0 11.53 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.864 ' HG ' HD21 ' A' ' 101' ' ' LEU . 6.7 tp -83.11 118.32 23.48 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.055 -174.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 72.7 m -101.17 120.85 40.83 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.531 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.546 ' CE2' HD23 ' A' ' 93' ' ' LEU . 79.2 m-85 -111.96 144.92 40.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.856 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.503 HD21 ' HB ' ' A' ' 100' ' ' VAL . 27.2 p30 -75.64 -174.09 2.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.273 173.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.1 m -65.01 -24.93 67.65 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.43 ' HB3' HG23 ' A' ' 100' ' ' VAL . 18.1 t -85.1 -13.6 49.76 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.786 -177.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.26 30.68 8.53 Favored Glycine 0 CA--C 1.508 -0.348 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.008 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.503 ' HB ' HD21 ' A' ' 96' ' ' ASN . 5.2 t -112.23 138.59 40.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.797 -0.702 . . . . 0.0 109.525 -177.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.864 HD21 ' HG ' ' A' ' 93' ' ' LEU . 8.5 mt -59.26 124.35 19.72 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.297 0.57 . . . . 0.0 112.442 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.468 HG21 ' HB3' ' A' ' 96' ' ' ASN . 19.3 p -111.23 -37.78 5.21 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.164 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -149.65 149.42 30.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.479 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.044 HG22 HD11 ' A' ' 91' ' ' LEU . 2.4 mm -110.19 93.32 2.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 173.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.608 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 34.0 t0 -87.76 96.0 10.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.007 0.432 . . . . 0.0 111.4 -170.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -107.89 104.11 13.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.587 0.708 . . . . 0.0 111.277 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.226 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.732 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 4.8 tp . . . . . 0 CA--C 1.521 -0.141 0 CA-C-O 120.618 0.247 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 43' ' ' VAL . 20.6 p -126.87 -174.76 3.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.079 176.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.513 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -67.34 -34.43 77.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.443 0.639 . . . . 0.0 110.574 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -64.67 -42.07 95.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.821 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.93 -27.97 66.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.025 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.784 HG22 HD22 ' A' ' 91' ' ' LEU . 58.8 t -59.84 -36.71 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.15 0.5 . . . . 0.0 110.76 176.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.9 t -59.33 -20.54 55.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.373 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 47.9 mtpt -75.58 -19.24 59.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.819 -176.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.778 HG23 HD13 ' A' ' 59' ' ' LEU . 30.0 pt -107.01 177.95 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.646 0.736 . . . . 0.0 112.46 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.92 150.69 4.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.729 -177.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.54 HG22 HD11 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -72.74 141.81 15.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.999 -179.045 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.69 -29.83 5.51 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.11 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.591 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 18.6 ptt? -88.54 178.36 6.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.184 0.492 . . . . 0.0 111.133 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.884 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 39.9 p -95.09 -174.3 3.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.207 -170.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.412 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 45.7 mt-30 -66.72 -44.12 82.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.866 174.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.64 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -65.92 -34.52 78.32 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.422 0.63 . . . . 0.0 109.823 -176.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.884 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.9 mm-40 -61.0 -57.03 14.32 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.464 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.645 HG11 ' CD2' ' A' ' 93' ' ' LEU . 90.9 t -63.42 -42.53 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.725 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.537 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.72 -35.82 73.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.082 0.468 . . . . 0.0 110.161 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -80.88 -37.22 30.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.515 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.64 -46.39 66.28 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.616 0.722 . . . . 0.0 111.215 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.778 HD13 HG23 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -88.14 -42.79 12.11 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.594 -172.103 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.79 122.01 3.76 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -171.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.537 HG22 ' HB1' ' A' ' 56' ' ' ALA . 17.9 p -54.7 136.51 64.0 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.499 0.666 . . . . 0.0 111.795 -175.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.588 ' HB2' ' HG2' ' A' ' 64' ' ' MET . 23.1 Cg_exo -64.49 165.03 21.44 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.847 3.031 . . . . 0.0 113.197 -172.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.14 -24.63 67.27 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.483 -173.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.588 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 14.6 ptt? -68.22 -1.29 5.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.806 175.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 t 71.56 6.63 5.77 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.459 0.704 . . . . 0.0 112.471 170.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -165.33 110.93 0.79 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 121.738 0.78 . . . . 0.0 110.674 176.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.642 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 60.4 Cg_endo -73.67 -24.54 15.73 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.303 2.669 . . . . 0.0 113.525 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -80.53 -5.6 56.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -170.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.75 -18.76 59.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.733 -176.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.5 t -125.0 175.28 7.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.348 0.594 . . . . 0.0 111.624 -173.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -117.49 0.34 12.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.658 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.4 m -128.99 111.86 13.44 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.789 -178.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.642 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 43.8 m0 -104.03 137.36 42.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.606 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -113.28 110.09 19.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.224 0.535 . . . . 0.0 111.21 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.621 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 53.8 m-85 -125.8 175.83 7.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.602 HG22 ' H ' ' A' ' 77' ' ' PHE . 2.3 p -141.89 179.99 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.536 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.602 ' H ' HG22 ' A' ' 76' ' ' VAL . 2.9 m-30 . . . . . 0 C--N 1.326 -0.436 0 C-N-CA 122.599 0.36 . . . . 0.0 111.632 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.443 -0.784 0 CA-C-O 120.812 0.339 . . . . 0.0 110.902 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.895 HD11 HG22 ' A' ' 104' ' ' ILE . 13.9 tp -90.92 108.35 19.8 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.742 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 19.2 m -103.22 104.5 14.64 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.871 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.0 tp -88.71 128.71 35.62 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.423 -173.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.2 m -115.82 123.06 47.23 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.077 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.453 ' CE1' HD23 ' A' ' 93' ' ' LEU . 93.1 m-85 -112.41 137.31 50.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.43 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.49 ' HB3' HG21 ' A' ' 102' ' ' THR . 6.1 p30 -57.22 -82.7 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -175.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.4 t -155.38 -34.3 0.09 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 100' ' ' VAL . 16.9 m -78.99 -8.11 58.65 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.243 0.544 . . . . 0.0 110.436 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.47 32.18 8.37 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.487 ' HB ' HD21 ' A' ' 96' ' ' ASN . 18.5 t -112.35 134.17 55.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.178 -0.511 . . . . 0.0 109.689 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.871 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.2 mt -61.52 125.88 25.36 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.249 0.547 . . . . 0.0 112.319 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 96' ' ' ASN . 11.2 p -111.73 -42.55 3.8 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.913 175.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -136.05 151.89 50.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.57 0.7 . . . . 0.0 111.49 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.895 HG22 HD11 ' A' ' 91' ' ' LEU . 3.1 mm -115.75 93.65 2.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 168.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.742 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 7.5 t70 -87.34 95.04 9.85 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.133 0.492 . . . . 0.0 110.415 -170.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.471 ' HB3' HD12 ' A' ' 91' ' ' LEU . 18.6 p-10 -112.3 111.38 22.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.842 0.83 . . . . 0.0 111.437 -176.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.915 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.609 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.669 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 4.9 tp . . . . . 0 CA--C 1.518 -0.282 0 CA-C-O 121.044 0.449 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 43.1 p -128.77 -174.29 3.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.589 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.25 -46.48 76.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.381 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.52 -27.43 69.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.155 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.503 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 14.4 m-20 -70.9 -37.0 72.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.441 173.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.851 HG22 HD22 ' A' ' 91' ' ' LEU . 67.3 t -59.63 -36.99 68.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.217 0.532 . . . . 0.0 110.784 176.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.0 t -64.77 -15.05 61.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.113 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 47.0 mtpt -81.82 -8.63 59.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.332 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.735 HG23 HD13 ' A' ' 59' ' ' LEU . 24.8 pt -112.67 178.38 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.713 0.768 . . . . 0.0 112.131 176.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.16 151.05 4.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.484 -177.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.552 HG22 HD11 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -72.76 144.41 12.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.101 -177.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.25 -29.05 6.32 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.197 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.566 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 19.2 ptt? -90.24 174.79 7.41 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.119 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.875 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 31.2 p -91.61 -176.66 4.56 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.049 -170.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -61.46 -47.05 87.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.704 170.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -37.7 75.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.271 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.875 ' HG3' ' H ' ' A' ' 51' ' ' THR . 5.3 mm-40 -67.45 -54.38 20.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.19 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.63 HG11 ' CD2' ' A' ' 93' ' ' LEU . 73.5 t -62.11 -44.49 99.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.822 -178.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.642 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.31 -34.75 70.92 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.046 0.451 . . . . 0.0 110.104 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -82.15 -36.56 27.29 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.196 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.51 -43.34 77.01 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.772 0.796 . . . . 0.0 111.023 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.735 HD13 HG23 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -89.4 -54.74 3.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.183 -173.39 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 127.15 118.75 2.2 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.713 HG22 ' HG3' ' A' ' 67' ' ' PRO . 32.8 p -55.27 130.54 69.09 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.082 0.468 . . . . 0.0 111.128 -176.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 18.6 Cg_exo -64.95 172.41 7.26 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.871 3.048 . . . . 0.0 113.843 -169.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.433 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 3.9 mt -49.91 -43.24 49.49 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.877 0.735 . . . . 0.0 111.89 -173.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.0 ptt? -63.16 -3.54 1.86 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.328 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 p 59.54 3.25 0.4 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.618 1.167 . . . . 0.0 113.495 174.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -136.45 90.15 17.86 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.226 0.536 . . . . 0.0 109.866 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.713 ' HG3' HG22 ' A' ' 61' ' ' THR . 72.1 Cg_endo -74.74 -32.0 6.18 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.856 2.371 . . . . 0.0 112.128 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -77.97 7.26 6.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.2 -171.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.35 -19.76 17.57 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.085 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.9 t -124.2 165.53 17.43 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -177.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -117.96 12.81 13.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.292 0.568 . . . . 0.0 110.31 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.9 m -136.69 106.89 6.37 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.933 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.692 ' O ' ' HA ' ' A' ' 92' ' ' THR . 47.7 m0 -103.79 147.21 27.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 -173.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -124.42 124.94 43.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.063 0.459 . . . . 0.0 110.764 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.617 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 80.6 m-85 -130.28 173.42 10.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.722 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.7 t -112.07 158.04 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.956 0.407 . . . . 0.0 110.021 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.69 176.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.447 -0.581 0 CA-C-O 121.061 0.457 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.906 HD11 HG22 ' A' ' 104' ' ' ILE . 17.5 tp -90.52 111.71 23.1 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.719 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.692 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 81.0 m -107.14 108.55 20.06 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.884 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.5 tp -91.81 126.71 36.99 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.615 -173.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 20.0 m -104.33 122.13 44.8 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.996 -177.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.52 ' CE2' HD23 ' A' ' 93' ' ' LEU . 67.2 m-85 -114.37 139.33 49.56 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.962 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.497 HD21 ' HB ' ' A' ' 100' ' ' VAL . 33.4 p30 -76.08 -175.75 3.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.432 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.9 m -52.01 -36.24 49.38 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.469 ' HB3' HG23 ' A' ' 100' ' ' VAL . 10.4 t -89.19 -0.03 57.13 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.161 -0.337 . . . . 0.0 111.182 -171.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.79 29.33 39.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.451 -0.881 . . . . 0.0 111.179 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.497 ' HB ' HD21 ' A' ' 96' ' ' ASN . 21.8 t -105.88 138.92 28.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.004 -0.598 . . . . 0.0 109.667 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.884 HD21 ' HG ' ' A' ' 93' ' ' LEU . 5.9 mt -60.9 125.5 23.94 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.175 0.512 . . . . 0.0 112.026 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.492 HG21 ' HB3' ' A' ' 96' ' ' ASN . 11.2 p -112.52 -43.35 3.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.93 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.427 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 1.9 m-20 -137.53 154.3 49.86 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.3 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.906 HG22 HD11 ' A' ' 91' ' ' LEU . 3.6 mm -115.41 92.47 2.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 169.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 92' ' ' THR . 15.4 m-20 -89.38 96.98 10.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.971 0.415 . . . . 0.0 111.441 -172.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -107.3 109.11 20.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.486 0.66 . . . . 0.0 110.516 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.711 ' H ' ' HE3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.843 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.259 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.718 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 2.5 mm? . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 121.583 0.706 . . . . 0.0 111.792 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 43' ' ' VAL . 30.6 p -128.64 -174.94 3.38 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.66 174.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -71.35 -35.0 71.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.804 0.812 . . . . 0.0 109.813 176.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -61.54 -43.88 98.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.388 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.426 ' HB2' HD12 ' A' ' 38' ' ' LEU . 35.0 m-20 -72.02 -30.77 65.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.073 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.876 HG22 HD22 ' A' ' 91' ' ' LEU . 54.6 t -57.87 -36.68 56.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.134 0.492 . . . . 0.0 110.289 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.2 t -61.85 -18.3 59.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.578 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 46.1 mtpt -74.33 -36.15 63.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.768 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.784 HG23 HD13 ' A' ' 59' ' ' LEU . 39.3 pt -87.64 178.61 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.848 0.832 . . . . 0.0 112.268 -177.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.68 150.9 2.23 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.467 -175.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.479 HG22 HD11 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -70.74 144.09 13.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.206 -177.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.41 -32.74 4.58 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.776 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.512 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 13.1 ptt? -87.35 177.64 7.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.017 0.437 . . . . 0.0 111.053 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.835 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 22.2 p -92.57 -174.76 3.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.904 -171.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.476 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 26.3 mt-30 -64.64 -43.88 92.28 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.921 173.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.554 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -66.46 -35.1 79.45 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.216 0.531 . . . . 0.0 109.996 -175.417 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.835 ' HG3' ' H ' ' A' ' 51' ' ' THR . 11.4 mm-40 -59.86 -51.12 71.06 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.729 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.658 HG11 ' CD2' ' A' ' 93' ' ' LEU . 70.5 t -68.75 -42.78 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.663 -176.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.536 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.98 -25.67 68.23 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.388 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -81.7 -40.93 22.06 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.555 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.41 -45.16 69.89 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.591 0.71 . . . . 0.0 111.332 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.784 HD13 HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -90.58 -44.09 9.78 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.232 -174.365 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.57 132.24 4.01 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -171.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.536 HG22 ' HB1' ' A' ' 56' ' ' ALA . 16.7 p -59.96 134.32 90.01 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.028 0.442 . . . . 0.0 110.684 -177.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.493 ' HG3' ' OH ' ' A' ' 75' ' ' TYR . 20.4 Cg_exo -64.16 171.97 6.94 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.902 3.068 . . . . 0.0 114.358 -169.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.499 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 7.2 mt -50.03 -47.45 53.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.244 -175.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.473 ' HE3' HG21 ' A' ' 70' ' ' THR . 0.0 OUTLIER -54.98 -12.92 0.93 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.957 179.018 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.4 t 70.75 1.58 3.78 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.292 0.568 . . . . 0.0 111.332 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -144.38 102.23 4.71 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-O 121.592 0.71 . . . . 0.0 109.435 174.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.509 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 43.5 Cg_endo -68.45 -25.8 35.16 Favored 'Trans proline' 0 C--N 1.327 -0.565 0 C-N-CA 123.198 2.599 . . . . 0.0 112.608 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -86.63 12.36 10.78 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.547 -173.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -102.39 -20.25 12.54 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.241 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.473 HG21 ' HE3' ' A' ' 64' ' ' MET . 6.6 t -126.25 172.61 9.94 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -122.03 10.14 10.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.187 0.518 . . . . 0.0 109.867 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.2 m -139.4 112.52 8.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.171 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.534 ' O ' ' HA ' ' A' ' 92' ' ' THR . 44.7 m0 -104.34 144.83 31.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.736 -176.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -121.87 112.88 18.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 110.644 -176.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.612 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 33.2 m-85 -125.4 174.69 8.0 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.54 HG22 ' H ' ' A' ' 77' ' ' PHE . 5.8 p -137.15 168.56 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.858 -174.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.54 ' H ' HG22 ' A' ' 76' ' ' VAL . 2.0 m-30 . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.049 -176.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.442 -0.827 0 CA-C-O 121.269 0.557 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.876 HD22 HG22 ' A' ' 43' ' ' VAL . 16.8 tp -97.81 104.0 15.99 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.716 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.691 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 24.9 m -99.51 105.18 17.06 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.839 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.7 tp -88.03 123.61 32.9 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.582 -174.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 21.6 m -105.48 123.67 48.27 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.971 -176.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.507 ' CE2' HD23 ' A' ' 93' ' ' LEU . 33.7 m-85 -111.29 151.28 28.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.894 0.854 . . . . 0.0 112.966 -175.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -75.17 -176.01 2.87 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.292 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.7 p -67.02 -41.04 87.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.848 0.356 . . . . 0.0 111.097 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.46 ' HB3' HG23 ' A' ' 100' ' ' VAL . 38.2 t -74.95 -13.82 60.57 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.112 0.482 . . . . 0.0 110.592 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 52' ' ' GLN . . . 95.04 31.01 7.9 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -176.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.46 HG23 ' HB3' ' A' ' 98' ' ' SER . 21.9 t -101.42 140.25 20.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.839 HD21 ' HG ' ' A' ' 93' ' ' LEU . 5.5 mt -60.17 126.18 26.53 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.133 0.492 . . . . 0.0 111.356 177.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 70.9 p -113.39 -45.06 3.16 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.854 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.486 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 3.4 m-20 -136.85 153.66 50.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.501 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.858 HG22 HD11 ' A' ' 91' ' ' LEU . 3.6 mm -120.13 93.52 2.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 172.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.691 ' HB2' ' HB ' ' A' ' 92' ' ' THR . 6.9 m-20 -78.23 96.41 5.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.962 0.41 . . . . 0.0 110.716 -176.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -111.2 104.33 12.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.579 0.704 . . . . 0.0 110.081 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.438 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.315 -0.906 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.712 -176.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.528 ' CD2' ' HG ' ' A' ' 59' ' ' LEU . 6.4 tp . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 121.172 0.511 . . . . 0.0 111.259 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.4 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 44.8 p -128.62 -178.07 4.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.292 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' A' ' 43' ' ' VAL . . . -66.49 -36.61 83.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.935 0.874 . . . . 0.0 110.209 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -61.94 -41.4 97.92 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.382 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.574 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 16.7 m-20 -69.89 -27.01 64.45 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.238 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.862 HG22 HD22 ' A' ' 91' ' ' LEU . 63.0 t -62.75 -37.03 78.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.322 0.582 . . . . 0.0 110.391 174.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -65.63 -16.55 63.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.807 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.574 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 45.5 mtpt -73.76 -29.51 62.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.656 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.742 HG23 HD13 ' A' ' 59' ' ' LEU . 40.3 pt -92.7 -178.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.795 0.807 . . . . 0.0 111.798 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.41 149.74 5.93 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.424 -177.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.542 HG22 HD11 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -71.48 148.0 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.505 -178.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.86 -30.22 7.58 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.215 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.523 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 19.9 ptt? -84.97 173.03 10.86 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.938 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.852 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 19.1 p -89.72 -174.32 4.26 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.438 -170.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 95' ' ' PHE . 37.1 mt-30 -64.89 -43.15 93.83 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.855 174.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 11.3 pt20 -65.8 -35.75 81.57 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.448 0.642 . . . . 0.0 109.913 -175.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.852 ' HG3' ' H ' ' A' ' 51' ' ' THR . 9.8 mm-40 -58.91 -55.22 37.92 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.297 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.682 HG11 HD22 ' A' ' 93' ' ' LEU . 92.8 t -66.73 -41.05 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.492 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.709 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.56 -34.45 71.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.184 0.516 . . . . 0.0 110.103 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -82.47 -38.81 23.39 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.755 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.58 -46.66 65.82 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.546 0.688 . . . . 0.0 111.343 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.742 HD13 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -92.1 -29.67 16.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.751 -173.08 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.55 127.85 6.02 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.709 HG22 ' HB1' ' A' ' 56' ' ' ALA . 34.9 p -59.9 134.09 89.79 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-O 121.237 0.541 . . . . 0.0 110.794 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 21.2 Cg_exo -65.85 162.12 36.33 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.189 2.592 . . . . 0.0 111.699 -174.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.438 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 1.2 mt -49.14 -33.53 12.25 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.57 -168.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.434 ' H ' ' HG2' ' A' ' 64' ' ' MET . 9.7 ptt? -62.55 -6.39 3.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.8 p 58.92 8.71 1.02 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.392 1.077 . . . . 0.0 112.503 177.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.434 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 1.9 t70 -141.21 94.77 7.62 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 122.021 0.915 . . . . 0.0 109.749 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.604 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 74.3 Cg_endo -75.26 -34.56 3.52 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.294 2.663 . . . . 0.0 113.356 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -79.55 2.94 20.34 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -174.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.08 -23.95 42.89 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.539 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.8 t -124.23 174.89 7.39 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -123.57 4.25 8.96 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.8 m -125.61 109.64 12.88 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.19 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.604 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 45.2 m0 -108.18 140.25 41.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.55 -176.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -117.17 112.45 20.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.34 0.591 . . . . 0.0 111.24 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.673 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 88.1 m-85 -113.31 174.92 5.67 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.982 174.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 38' ' ' LEU . 2.5 p -122.28 150.51 25.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.206 0.526 . . . . 0.0 110.038 -174.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.315 -0.905 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.427 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.4 p . . . . . 0 N--CA 1.441 -0.879 0 CA-C-O 121.025 0.441 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.966 HD11 HG22 ' A' ' 104' ' ' ILE . 22.1 tp -89.54 107.51 19.12 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.527 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 23.8 m -99.03 101.53 12.94 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.865 ' HG ' HD21 ' A' ' 101' ' ' LEU . 8.0 tp -87.12 122.96 31.65 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.985 -174.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 27.6 m -104.14 118.13 35.91 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.077 -176.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.605 ' CE2' HD23 ' A' ' 93' ' ' LEU . 31.4 m-85 -105.63 149.29 26.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.737 0.78 . . . . 0.0 111.862 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -73.92 173.13 10.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.557 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.5 m -57.64 -36.87 72.43 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.794 0.331 . . . . 0.0 110.664 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.462 ' HB3' HG23 ' A' ' 100' ' ' VAL . 18.7 t -80.98 -4.1 53.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.927 0.394 . . . . 0.0 110.885 -177.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.36 30.01 26.02 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.402 -179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 98' ' ' SER . 21.4 t -105.99 138.88 29.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.865 HD21 ' HG ' ' A' ' 93' ' ' LEU . 5.9 mt -61.76 124.09 19.78 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.075 0.464 . . . . 0.0 111.747 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.0 p -114.02 -39.72 3.88 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.11 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.5 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 5.1 m-20 -136.76 154.6 50.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.554 0.692 . . . . 0.0 111.54 177.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.966 HG22 HD11 ' A' ' 91' ' ' LEU . 3.0 mm -118.73 92.38 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 168.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 92' ' ' THR . 13.3 m-20 -86.84 95.86 10.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.838 0.351 . . . . 0.0 110.947 -174.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -99.18 101.06 12.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.146 0.974 . . . . 0.0 109.634 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.459 ' HE3' ' HB3' ' A' ' 105' ' ' ASP . 71.2 mttt . . . . . 0 C--N 1.318 -0.787 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.289 -172.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.676 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 3.0 tp . . . . . 0 CA--C 1.519 -0.231 0 CA-C-O 121.418 0.628 . . . . 0.0 111.568 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 43.8 p -128.17 -175.24 3.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.93 177.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.561 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -65.65 -33.29 75.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.058 0.456 . . . . 0.0 110.811 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -59.47 -43.46 93.25 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.739 0.78 . . . . 0.0 109.717 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.409 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 6.9 m-20 -70.17 -34.29 72.82 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.633 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.793 HG22 HD22 ' A' ' 91' ' ' LEU . 55.9 t -55.59 -36.51 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.046 0.45 . . . . 0.0 111.154 177.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 t -64.27 -11.43 31.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.64 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.446 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 47.8 mtpt -80.53 -26.34 38.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.733 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.81 HG23 HD13 ' A' ' 59' ' ' LEU . 38.4 pt -95.49 -178.5 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.797 0.808 . . . . 0.0 112.305 -178.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.25 152.7 3.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.585 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.457 ' H ' HG23 ' A' ' 48' ' ' VAL . 0.5 OUTLIER -72.73 144.07 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.265 -178.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.19 -32.47 4.72 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.954 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.53 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 18.4 ptt? -90.07 177.14 6.53 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.488 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.912 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 62.4 p -94.0 -174.97 3.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.467 -170.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.47 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 97.9 mt-30 -64.79 -42.26 95.18 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.581 172.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.423 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 9.2 pt20 -67.01 -37.97 85.15 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.705 -177.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.912 ' HG3' ' H ' ' A' ' 51' ' ' THR . 5.7 mm-40 -58.98 -53.2 61.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.966 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.645 HG11 ' CD2' ' A' ' 93' ' ' LEU . 74.7 t -66.5 -46.39 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.997 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.595 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -64.33 -26.61 68.55 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.636 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -81.48 -37.28 28.18 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.614 177.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.98 -48.87 41.87 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.922 0.868 . . . . 0.0 110.78 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.81 HD13 HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -84.21 -55.37 4.22 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.16 -173.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.72 133.35 3.23 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 -172.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.595 HG22 ' HB1' ' A' ' 56' ' ' ALA . 39.4 p -68.32 130.91 92.04 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-O 121.238 0.542 . . . . 0.0 110.386 -177.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.532 ' HG2' ' HE2' ' A' ' 64' ' ' MET . 6.9 Cg_exo -69.75 160.89 48.01 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.177 2.584 . . . . 0.0 113.062 -170.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.78 -28.33 69.38 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.506 -171.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.532 ' HE2' ' HG2' ' A' ' 62' ' ' PRO . 10.7 ptt? -61.79 -4.28 1.44 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.111 177.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.4 t 73.54 -4.0 2.34 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 170.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -146.86 99.71 4.01 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-O 120.907 0.384 . . . . 0.0 110.954 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.432 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 39.6 Cg_endo -70.13 -30.95 19.76 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.074 1.85 . . . . 0.0 111.527 175.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -85.72 12.02 9.8 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.535 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.82 -20.27 13.33 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.884 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.7 t -125.84 174.0 8.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.646 0.26 . . . . 0.0 110.375 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -117.95 -1.09 11.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.266 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.8 m -125.26 111.42 15.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.542 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.47 ' HH2' ' O ' ' A' ' 52' ' ' GLN . 42.7 m0 -104.12 141.3 36.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.366 -177.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -118.68 118.97 33.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.113 0.482 . . . . 0.0 110.844 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.599 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 63.9 m-85 -127.87 174.41 9.18 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 176.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.489 HG22 ' H ' ' A' ' 77' ' ' PHE . 2.7 p -129.15 167.54 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.127 -173.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.561 ' CG ' ' HB2' ' A' ' 40' ' ' ALA . 7.2 m-30 . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.265 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.444 -0.739 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.965 HD11 HG22 ' A' ' 104' ' ' ILE . 16.3 tp -95.71 123.52 39.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.192 174.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.685 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 34.4 m -114.53 101.26 8.95 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.845 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.2 tp -88.3 126.34 35.13 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.996 -173.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.8 m -112.4 123.22 49.81 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.889 -175.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.537 ' CE2' HD23 ' A' ' 93' ' ' LEU . 80.2 m-85 -113.27 141.25 47.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.884 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.495 ' HB3' HG21 ' A' ' 102' ' ' THR . 32.1 p30 -75.41 -173.63 2.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.903 175.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.4 m -56.29 -35.1 67.11 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -174.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.427 ' HB3' HG23 ' A' ' 100' ' ' VAL . 20.8 t -88.83 9.74 23.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.814 0.34 . . . . 0.0 111.059 -175.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.75 33.85 76.62 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.091 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.48 ' HB ' HD21 ' A' ' 96' ' ' ASN . 7.6 t -106.12 140.06 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.845 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.3 mt -62.17 124.42 20.8 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.43 0.633 . . . . 0.0 112.246 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.495 HG21 ' HB3' ' A' ' 96' ' ' ASN . 18.0 p -111.03 -43.94 3.68 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.612 -1.177 . . . . 0.0 109.965 175.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -136.67 152.75 50.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.745 0.783 . . . . 0.0 111.692 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.965 HG22 HD11 ' A' ' 91' ' ' LEU . 3.6 mm -117.86 93.61 2.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 170.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.685 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 23.4 t70 -87.03 96.47 10.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.948 0.404 . . . . 0.0 110.624 -173.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -105.62 104.31 14.0 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.85 0.834 . . . . 0.0 109.898 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.5 pttm . . . . . 0 C--N 1.314 -0.94 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.773 -176.791 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.62 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 4.5 tp . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 121.224 0.535 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.7 p -127.7 -175.78 3.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.631 174.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.19 -31.53 69.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.053 0.454 . . . . 0.0 110.904 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -60.05 -41.19 91.79 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.563 0.696 . . . . 0.0 109.776 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 11.4 m-20 -67.9 -37.11 81.32 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.887 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.857 HG22 HD22 ' A' ' 91' ' ' LEU . 81.2 t -60.04 -40.66 83.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.77 0.319 . . . . 0.0 111.094 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.1 p -64.5 -18.93 65.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.025 0.441 . . . . 0.0 111.028 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 30.1 mtpp -77.54 -28.42 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.987 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.587 HG23 HD13 ' A' ' 59' ' ' LEU . 43.5 pt -89.56 174.08 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 121.758 0.79 . . . . 0.0 111.822 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -163.4 143.33 8.71 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.719 -176.252 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.467 HG22 HG12 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -69.61 142.27 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.484 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.19 -30.69 5.55 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.86 -175.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.553 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 21.2 ptt? -87.11 175.12 8.24 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.813 176.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.839 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 23.6 p -92.99 -170.0 2.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.846 -171.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -67.51 -46.33 73.19 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.611 173.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.449 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 11.9 pt20 -61.98 -38.8 89.96 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.832 -176.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.839 ' HG3' ' H ' ' A' ' 51' ' ' THR . 7.1 mm-40 -59.52 -46.37 89.04 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.303 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.692 HG11 ' CD2' ' A' ' 93' ' ' LEU . 58.4 t -73.24 -43.46 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.834 -176.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.6 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.11 -24.01 67.7 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.261 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -80.04 -39.47 29.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.773 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.66 -44.06 44.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.008 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.62 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -93.07 -10.03 37.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.917 -172.531 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.66 129.14 1.57 Allowed Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.6 HG22 ' HB1' ' A' ' 56' ' ' ALA . 41.3 p -56.11 131.52 74.56 Favored Pre-proline 0 N--CA 1.439 -0.986 0 CA-C-O 122.028 0.918 . . . . 0.0 111.835 -176.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 67' ' ' PRO . 74.8 Cg_exo -50.6 165.94 0.37 Allowed 'Trans proline' 0 C--N 1.332 -0.333 1 C-N-CA 125.742 4.295 . . . . 0.0 115.431 -176.381 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.478 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 8.1 mt -51.7 -49.28 62.77 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.655 -177.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.471 ' HE3' HG21 ' A' ' 70' ' ' THR . 0.0 OUTLIER -54.1 -13.55 0.85 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.986 179.543 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.0 t 76.11 -17.79 0.51 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.359 0.664 . . . . 0.0 112.066 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -122.21 92.96 48.81 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-O 121.971 0.891 . . . . 0.0 109.819 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.57 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 29.0 Cg_endo -64.49 -30.59 61.76 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.619 2.212 . . . . 0.0 112.493 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -81.35 13.84 2.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.718 -173.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -102.93 -25.15 7.68 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.091 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.471 HG21 ' HE3' ' A' ' 64' ' ' MET . 6.6 t -124.13 169.23 11.91 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -120.52 1.64 10.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.651 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.8 m -118.15 109.08 15.96 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.959 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.416 ' O ' ' HA ' ' A' ' 92' ' ' THR . 46.9 m0 -106.84 134.34 50.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.687 -176.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -113.36 125.92 54.79 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.161 0.288 . . . . 0.0 110.661 -177.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.562 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 60.8 m-85 -135.14 174.93 10.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.424 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.38 162.99 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 120.849 0.357 . . . . 0.0 110.264 -177.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.464 -176.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.442 -0.859 0 CA-C-O 121.234 0.54 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.052 HD11 HG22 ' A' ' 104' ' ' ILE . 21.3 tp -90.16 115.48 27.43 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.056 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.718 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 11.8 m -109.2 95.62 5.75 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.766 ' HG ' HD21 ' A' ' 101' ' ' LEU . 8.3 tp -81.39 125.1 29.99 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.38 -171.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 37.2 m -107.45 121.64 45.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.178 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.532 ' CE2' HD23 ' A' ' 93' ' ' LEU . 77.3 m-85 -115.28 139.71 49.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.537 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.499 ' HB3' HG21 ' A' ' 102' ' ' THR . 32.0 p30 -74.52 -176.38 2.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.614 175.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.2 t -55.13 -37.21 66.64 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -176.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.452 ' HB3' HG23 ' A' ' 100' ' ' VAL . 19.0 t -82.17 2.29 32.31 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.784 0.326 . . . . 0.0 111.059 -174.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.99 31.16 56.21 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.922 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.472 ' HB ' HD21 ' A' ' 96' ' ' ASN . 6.7 t -107.57 139.78 28.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.766 HD21 ' HG ' ' A' ' 93' ' ' LEU . 7.3 mt -60.87 124.8 21.51 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.237 0.541 . . . . 0.0 112.0 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.499 HG21 ' HB3' ' A' ' 96' ' ' ASN . 10.1 p -113.01 -35.92 5.27 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.049 176.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -148.76 148.46 30.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.441 0.639 . . . . 0.0 111.932 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.052 HG22 HD11 ' A' ' 91' ' ' LEU . 5.6 mm -106.01 93.21 2.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 170.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.718 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 17.6 t70 -81.58 97.3 7.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.141 0.496 . . . . 0.0 110.643 -171.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -105.38 110.78 23.26 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.363 0.601 . . . . 0.0 109.814 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? . . . . . 0 C--N 1.313 -0.994 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.823 179.928 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.1 m -67.08 -41.59 86.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.03 0.443 . . . . 0.0 110.134 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -83.01 71.82 10.1 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.0 tpt -78.11 -23.54 47.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.663 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.2 m -51.73 111.2 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.062 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 m -106.46 38.61 2.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.758 0.79 . . . . 0.0 109.413 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.4 tp -81.59 -34.1 31.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.564 -174.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -75.05 135.21 41.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.198 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -164.41 11.8 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.978 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.4 t 69.87 -66.55 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.976 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -147.59 176.97 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -70.88 99.14 1.7 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 120.957 0.408 . . . . 0.0 111.036 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -129.01 81.58 70.55 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 121.448 0.642 . . . . 0.0 109.549 174.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -70.12 139.53 39.2 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.752 2.968 . . . . 0.0 114.344 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -176.88 -70.37 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.56 170.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.844 HG22 ' H ' ' A' ' 34' ' ' GLN . 29.0 mm -100.95 146.6 9.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 114.359 -1.292 . . . . 0.0 111.55 174.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -98.1 -21.21 16.88 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.631 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.844 ' H ' HG22 ' A' ' 32' ' ' ILE . 11.0 pt20 -88.29 1.9 53.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.382 -170.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 175.32 174.26 41.77 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 119.797 -1.192 . . . . 0.0 113.706 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -125.44 18.64 8.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 122.198 0.999 . . . . 0.0 109.032 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -100.58 -167.91 1.5 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.479 -176.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.649 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 5.5 tp -70.96 152.61 43.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.712 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.512 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 28.2 p -127.7 -174.38 3.17 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.486 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.486 ' H ' ' HB2' ' A' ' 78' ' ' ARG . . . -66.69 -34.87 78.8 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.939 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -56.2 -46.43 79.45 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.509 0.671 . . . . 0.0 110.353 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.608 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.3 m-20 -74.13 -28.44 61.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.308 -176.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.876 HG22 HD22 ' A' ' 91' ' ' LEU . 84.0 t -62.94 -40.56 89.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.406 0.622 . . . . 0.0 109.82 172.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.2 t -64.93 -22.88 67.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.564 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.608 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 42.9 mtpt -70.41 -46.35 64.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.35 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.561 HG23 HD13 ' A' ' 59' ' ' LEU . 22.8 pt -75.77 173.04 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-O 122.01 0.909 . . . . 0.0 112.728 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.69 148.24 10.59 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.469 -176.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.444 ' H ' HG23 ' A' ' 48' ' ' VAL . 0.7 OUTLIER -71.1 143.03 14.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.65 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.96 -32.69 4.5 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.31 -0.947 . . . . 0.0 112.608 -176.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.53 ' HE3' HG22 ' A' ' 46' ' ' ILE . 16.3 ptt? -85.65 177.91 7.54 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 117.371 0.586 . . . . 0.0 111.126 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.811 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 38.9 p -91.9 -171.38 2.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.979 -172.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.458 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 97.1 mt-30 -68.74 -46.26 69.32 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.094 172.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.5 ' HA ' ' HE1' ' A' ' 68' ' ' PHE . 9.9 pt20 -63.4 -35.03 79.05 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.448 0.642 . . . . 0.0 110.171 -175.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.811 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.5 mm-40 -61.43 -56.97 14.28 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.246 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.651 HG11 ' CD2' ' A' ' 93' ' ' LEU . 80.2 t -61.91 -41.78 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.813 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.701 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -56.4 -36.93 69.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.147 0.499 . . . . 0.0 110.228 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -82.26 -34.18 28.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.15 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.66 -41.67 71.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.527 0.679 . . . . 0.0 111.006 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.649 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -92.31 -44.26 8.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.425 -1.262 . . . . 0.0 111.428 -173.343 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.18 122.94 4.16 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -170.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.701 HG22 ' HB1' ' A' ' 56' ' ' ALA . 58.5 p -58.86 135.92 87.11 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 120.963 0.411 . . . . 0.0 111.235 -175.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 23.0 Cg_exo -63.27 172.91 4.64 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.71 2.94 . . . . 0.0 113.585 -172.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 mt -47.66 -48.64 28.85 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.024 -174.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -53.67 -19.57 4.21 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.364 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.6 t 73.13 -4.82 2.08 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.749 0.82 . . . . 0.0 111.75 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -124.12 90.97 50.18 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-O 121.998 0.904 . . . . 0.0 110.044 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HG3' HG22 ' A' ' 61' ' ' THR . 57.4 Cg_endo -70.62 -32.92 14.18 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.462 2.108 . . . . 0.0 112.075 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.5 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 10.5 m-85 -78.09 9.46 3.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.848 -175.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.33 -23.32 19.74 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.841 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.7 t -124.83 174.37 7.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.818 0.342 . . . . 0.0 110.816 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -119.73 5.38 11.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.357 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.4 m -133.95 110.89 10.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.162 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.568 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 48.6 m0 -104.18 138.84 40.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -175.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -116.45 120.97 40.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.868 0.366 . . . . 0.0 110.632 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.61 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 68.1 m-85 -132.15 174.79 9.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.214 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 77' ' ' PHE . 2.7 t -122.23 169.09 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -172.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.476 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -100.36 164.25 12.01 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.486 ' HB2' ' H ' ' A' ' 40' ' ' ALA . 28.5 ttt180 -68.0 160.42 28.76 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.966 -175.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.644 ' HA ' ' NE2' ' A' ' 34' ' ' GLN . 18.8 tt0 -39.11 102.67 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.824 0.85 . . . . 0.0 112.192 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.47 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 4.1 pp0? -128.74 151.7 77.6 Favored Pre-proline 0 N--CA 1.445 -0.689 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.017 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 45.4 Cg_exo -56.42 -27.99 70.8 Favored 'Trans proline' 0 N--CA 1.48 0.687 0 C-N-CA 124.386 3.39 . . . . 0.0 115.257 -172.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.6 61.47 6.78 Favored Glycine 0 C--N 1.309 -0.945 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.334 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.02 37.84 0.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.665 ' HG2' ' H ' ' A' ' 85' ' ' GLY . 2.7 tt0 -149.29 -177.34 5.79 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.665 ' H ' ' HG2' ' A' ' 84' ' ' GLU . . . -61.81 -44.36 97.98 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 171.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.549 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 86.8 t -91.42 145.54 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 167.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.462 HG23 ' H ' ' A' ' 88' ' ' GLN . 2.4 t -104.53 -61.66 1.43 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.283 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.462 ' H ' HG23 ' A' ' 87' ' ' THR . 0.0 OUTLIER -82.34 168.37 17.62 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.914 0.864 . . . . 0.0 112.722 -172.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -127.31 121.59 31.51 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 114.303 -1.317 . . . . 0.0 108.545 173.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.1 p -90.35 141.16 29.01 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.929 HD11 HG22 ' A' ' 104' ' ' ILE . 13.7 tp -99.64 117.47 34.06 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 173.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 78.9 m -111.59 107.2 16.27 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.857 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.2 tp -88.54 125.41 34.77 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.613 -174.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.7 m -106.91 124.34 49.48 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.886 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.481 ' CE2' HD23 ' A' ' 93' ' ' LEU . 77.7 m-85 -114.69 141.54 47.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.96 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.509 HD21 ' HB ' ' A' ' 100' ' ' VAL . 30.2 p30 -75.69 -175.31 2.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.354 176.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.5 m -57.65 -35.19 70.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.588 ' HB3' HG23 ' A' ' 100' ' ' VAL . 30.2 t -76.8 -19.84 57.11 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.995 0.426 . . . . 0.0 110.904 -175.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 97.79 26.86 9.4 Favored Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.588 HG23 ' HB3' ' A' ' 98' ' ' SER . 4.4 t -106.83 142.06 20.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.944 -0.628 . . . . 0.0 109.672 -177.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.857 HD21 ' HG ' ' A' ' 93' ' ' LEU . 5.8 mt -60.86 123.95 19.05 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 121.21 0.529 . . . . 0.0 111.837 178.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.493 HG21 ' HB3' ' A' ' 96' ' ' ASN . 19.2 p -109.69 -41.72 4.47 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.327 176.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -148.95 145.85 27.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.249 0.547 . . . . 0.0 112.016 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.929 HG22 HD11 ' A' ' 91' ' ' LEU . 3.9 mm -106.27 94.73 3.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 174.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.601 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 9.3 t70 -86.74 98.81 11.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.897 0.38 . . . . 0.0 110.916 -171.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -106.88 106.36 16.85 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.925 0.869 . . . . 0.0 110.29 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.588 ' HE2' ' OG1' ' A' ' 92' ' ' THR . 0.2 OUTLIER -133.68 169.54 13.66 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.054 -178.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.574 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 28.9 Cg_endo -67.22 150.79 81.73 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 121.952 1.768 . . . . 0.0 112.588 -173.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.83 -166.22 1.34 Allowed 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 122.177 0.989 . . . . 0.0 112.355 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.41 ' O ' HG13 ' A' ' 86' ' ' VAL . 18.4 mt -65.2 162.89 16.25 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.275 -1.784 . . . . 0.0 108.911 167.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 5.5 m -72.13 -2.26 17.96 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.162 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.2 -142.13 3.31 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.709 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 . . . . . 0 C--O 1.246 0.913 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 176.637 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.815 0 N-CA-C 111.986 -0.445 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.2 m 56.59 70.14 0.68 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.604 0.362 . . . . 0.0 111.023 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.505 ' C ' ' H ' ' A' ' 21' ' ' SER . 52.2 t-80 -59.73 114.38 2.74 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.0 ttt 72.0 -23.49 0.19 Allowed 'General case' 0 CA--C 1.534 0.361 0 O-C-N 124.037 0.835 . . . . 0.0 111.085 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.505 ' H ' ' C ' ' A' ' 19' ' ' HIS . 23.2 m 69.9 -62.5 0.42 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.037 0.935 . . . . 0.0 112.08 173.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 t -118.15 133.58 55.77 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.908 0.385 . . . . 0.0 110.265 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.1 mt -100.97 86.88 3.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.444 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -97.85 115.45 28.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.45 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.53 ' HD2' ' N ' ' A' ' 25' ' ' ARG . 4.0 mpt_? 54.45 77.6 0.19 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.776 0.672 . . . . 0.0 111.132 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.7 m -76.74 57.8 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.515 0.674 . . . . 0.0 111.393 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 28' ' ' TYR . 1.9 p -79.82 171.44 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.192 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.412 ' H ' HG22 ' A' ' 27' ' ' VAL . 32.0 t80 -61.93 140.98 58.27 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.814 0.34 . . . . 0.0 110.652 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -126.78 99.26 29.68 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.96 0.41 . . . . 0.0 111.017 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -65.01 147.1 88.8 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.963 2.442 . . . . 0.0 111.985 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -103.86 -26.38 12.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.247 0.546 . . . . 0.0 111.508 -176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.613 HG22 ' H ' ' A' ' 34' ' ' GLN . 29.0 mm -55.86 -56.75 10.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.698 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.51 ' HB3' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER 89.12 -40.59 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.469 -1.696 . . . . 0.0 110.388 -178.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.613 ' H ' HG22 ' A' ' 32' ' ' ILE . 7.7 pt20 -94.48 21.57 7.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.685 0.755 . . . . 0.0 110.497 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.5 94.84 0.24 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.763 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -170.85 -41.42 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.629 0.728 . . . . 0.0 109.104 -176.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.423 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 0.6 OUTLIER -115.73 -165.29 1.02 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.409 174.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.698 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 3.2 tp -75.37 142.88 43.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.853 0.359 . . . . 0.0 110.564 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 43' ' ' VAL . 43.1 p -127.0 -173.49 2.9 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.107 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' HB2' ' H ' ' A' ' 78' ' ' ARG . . . -62.65 -37.86 88.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.354 0.597 . . . . 0.0 111.379 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -62.05 -42.45 99.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.795 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.519 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 16.7 m-20 -70.25 -32.68 70.63 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.842 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.782 HG22 HD22 ' A' ' 91' ' ' LEU . 58.6 t -58.58 -36.03 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.089 0.471 . . . . 0.0 111.128 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.8 t -62.22 -16.29 52.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.552 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -74.07 -24.02 59.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.643 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.816 HG23 HD13 ' A' ' 59' ' ' LEU . 37.8 pt -100.73 175.83 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.619 0.723 . . . . 0.0 112.244 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.13 150.8 11.45 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.079 -177.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.451 HG22 HG12 ' A' ' 104' ' ' ILE . 0.7 OUTLIER -73.12 143.06 14.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.655 -178.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.76 -21.97 8.85 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.352 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.482 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 16.0 ptt? -96.46 178.24 5.42 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.164 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.835 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 41.5 p -92.78 -175.49 3.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.96 -171.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.464 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 77.3 mt-30 -63.05 -46.81 85.75 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.528 171.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.524 ' HA ' ' HE1' ' A' ' 68' ' ' PHE . 9.7 pt20 -65.25 -35.34 80.73 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.334 0.588 . . . . 0.0 109.84 -173.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.835 ' HG3' ' H ' ' A' ' 51' ' ' THR . 7.7 mm-40 -60.25 -51.87 67.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.177 176.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.677 HG11 ' CD2' ' A' ' 93' ' ' LEU . 69.5 t -66.94 -45.0 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.9 -175.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.707 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -64.08 -25.11 67.96 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.436 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -80.9 -42.35 21.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.029 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.78 76.95 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.653 0.74 . . . . 0.0 111.342 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.816 HD13 HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -90.12 -36.4 14.86 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.563 -172.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.6 127.76 5.76 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -170.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.707 HG22 ' HB1' ' A' ' 56' ' ' ALA . 56.9 p -59.15 136.21 88.12 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-O 120.93 0.395 . . . . 0.0 110.659 -177.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.509 ' CD ' ' HB3' ' A' ' 67' ' ' PRO . 22.2 Cg_exo -62.07 171.96 4.51 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.478 2.785 . . . . 0.0 113.309 -172.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.412 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 5.5 mt -51.08 -43.68 61.07 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.038 0.535 . . . . 0.0 111.606 -172.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.1 ptt? -58.66 -12.23 3.94 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.423 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.2 t 68.98 -0.59 2.37 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.513 0.725 . . . . 0.0 111.827 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -134.72 91.52 20.86 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.611 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 90.6 Cg_endo -77.85 -29.07 4.63 Favored 'Trans proline' 0 C--N 1.327 -0.554 0 C-N-CA 123.268 2.645 . . . . 0.0 113.15 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.524 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 13.0 m-85 -80.59 21.62 0.63 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.038 -172.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.7 -17.41 8.02 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.989 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 t -124.81 172.27 9.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.732 0.301 . . . . 0.0 110.385 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -125.01 15.57 8.51 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.282 0.563 . . . . 0.0 109.975 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.6 m -138.88 109.24 6.49 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.495 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.611 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 50.3 m0 -104.48 143.23 33.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.707 -175.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -118.06 115.03 24.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.156 0.503 . . . . 0.0 111.241 -176.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.619 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 57.2 m-85 -129.93 176.46 8.03 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.2 p -128.87 153.57 38.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.598 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.474 ' HE1' HG21 ' A' ' 43' ' ' VAL . 1.5 m-30 -90.35 159.08 16.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.301 176.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.528 ' H ' ' HB2' ' A' ' 40' ' ' ALA . 4.1 tmt_? -63.01 107.84 1.09 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.772 ' HG3' ' H ' ' A' ' 80' ' ' GLN . 4.7 tp-100 -167.64 -150.91 0.11 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.332 -172.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.772 ' H ' ' HG3' ' A' ' 79' ' ' GLN . 3.5 pt20 -54.39 149.2 21.08 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 121.465 0.65 . . . . 0.0 112.051 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 12.3 Cg_exo -71.0 -9.01 24.86 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.402 2.735 . . . . 0.0 112.202 174.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.84 6.98 56.9 Favored Glycine 0 C--N 1.32 -0.334 0 CA-C-N 115.245 -0.889 . . . . 0.0 114.232 169.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -109.31 31.63 5.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.863 0.832 . . . . 0.0 110.5 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.596 ' HB2' ' NE2' ' A' ' 80' ' ' GLN . 42.8 mp0 -122.37 -166.22 1.39 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.398 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.87 94.28 0.29 Allowed Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.6 t -41.07 122.57 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 122.06 0.933 . . . . 0.0 112.983 -171.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 t -152.0 11.09 0.55 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 113.608 -1.633 . . . . 0.0 108.996 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.4 130.21 45.81 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.376 -1.283 . . . . 0.0 111.536 -175.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 50.8 mt-30 -81.03 107.3 13.73 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.964 0.411 . . . . 0.0 109.906 174.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.9 p -89.99 142.27 27.87 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.26 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.989 HD11 HG22 ' A' ' 104' ' ' ILE . 14.1 tp -93.0 112.55 24.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.875 174.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.725 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 10.6 m -107.09 105.98 16.25 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.866 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.0 tp -87.37 118.21 26.66 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.515 -175.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 38.6 m -101.64 122.68 44.32 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.127 -174.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.519 ' CE2' HD23 ' A' ' 93' ' ' LEU . 72.9 m-85 -116.13 140.88 48.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.241 -178.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.534 HD21 ' HB ' ' A' ' 100' ' ' VAL . 30.1 p30 -76.43 -177.19 4.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.16 175.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.0 t -54.42 -38.31 66.1 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.434 ' HB2' HG23 ' A' ' 100' ' ' VAL . 49.8 m -80.2 -3.8 50.51 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -174.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.33 28.0 34.68 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.824 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.534 ' HB ' HD21 ' A' ' 96' ' ' ASN . 6.6 t -106.41 140.86 23.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.866 HD21 ' HG ' ' A' ' 93' ' ' LEU . 7.3 mt -59.91 126.2 26.62 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.328 0.585 . . . . 0.0 112.195 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.416 HG21 ' HB3' ' A' ' 96' ' ' ASN . 18.0 p -111.18 -36.7 5.53 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.365 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -152.95 152.98 32.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.325 0.583 . . . . 0.0 111.673 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.989 HG22 HD11 ' A' ' 91' ' ' LEU . 3.3 mm -108.41 92.6 2.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 171.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.725 ' HB2' ' HB ' ' A' ' 92' ' ' THR . 2.3 m-20 -78.4 96.33 5.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.574 0.226 . . . . 0.0 110.989 -174.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -112.07 107.42 16.36 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.829 0.824 . . . . 0.0 110.49 177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.449 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -148.3 168.48 11.03 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.445 -178.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 19.3 Cg_endo -72.62 147.3 45.29 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.83 1.687 . . . . 0.0 111.589 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.42 173.93 8.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.959 0.885 . . . . 0.0 112.376 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.5 mt -89.77 111.52 22.54 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.035 -1.438 . . . . 0.0 110.945 -170.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.4 m -85.71 4.5 36.41 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.213 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.94 -100.72 2.62 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.803 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.3 p30 . . . . . 0 C--N 1.311 -1.067 0 CA-C-O 118.566 -0.73 . . . . 0.0 109.98 178.671 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.5 m 61.84 -175.26 0.13 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.076 0.465 . . . . 0.0 111.989 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.1 m170 61.37 30.75 19.15 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.311 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.6 ptp -95.27 27.31 3.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.626 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.481 ' O ' ' HG ' ' A' ' 23' ' ' LEU . 23.8 m -76.95 74.95 3.54 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.444 177.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.2 m -63.1 107.3 1.0 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.177 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 21' ' ' SER . 81.7 mt -108.43 -44.25 4.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.225 -174.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -92.74 127.99 38.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.969 0.414 . . . . 0.0 110.978 -174.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.623 ' O ' HG22 ' A' ' 26' ' ' VAL . 1.1 ptm180 -86.2 63.52 8.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.032 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 25' ' ' ARG . 2.0 m 59.97 172.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.734 1.214 . . . . 0.0 110.994 -173.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.523 HG22 ' H ' ' A' ' 28' ' ' TYR . 1.4 p -140.02 -179.12 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.523 ' H ' HG22 ' A' ' 27' ' ' VAL . 90.0 m-85 -49.17 145.67 4.11 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.884 0.474 . . . . 0.0 111.596 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -74.47 117.14 59.65 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.668 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.41 133.49 48.75 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 123.736 2.957 . . . . 0.0 113.292 178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -112.61 -118.06 0.31 Allowed 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 172.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.907 HG22 ' H ' ' A' ' 34' ' ' GLN . 23.8 mm -98.98 143.53 13.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-O 120.898 0.38 . . . . 0.0 110.515 170.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -79.61 -22.81 43.19 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.844 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.907 ' H ' HG22 ' A' ' 32' ' ' ILE . 11.3 pt20 -114.3 67.52 0.68 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.779 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.54 -146.35 5.28 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.28 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.0 t30 72.57 -48.58 0.69 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.635 0.774 . . . . 0.0 110.899 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.421 ' OH ' ' HB2' ' A' ' 34' ' ' GLN . 8.5 p90 -107.12 -170.21 1.67 Allowed 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.584 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 2.5 tp -89.46 152.44 21.47 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.743 0.306 . . . . 0.0 110.88 -176.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.767 HG21 HG21 ' A' ' 32' ' ' ILE . 43.6 p -127.14 -174.66 3.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.171 175.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.419 ' H ' ' N ' ' A' ' 78' ' ' ARG . . . -66.82 -38.19 85.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.332 0.586 . . . . 0.0 110.606 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.536 ' ND2' HD11 ' A' ' 32' ' ' ILE . 2.8 m-20 -54.31 -40.7 68.19 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.44 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.57 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 12.9 m-20 -73.92 -33.35 63.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.783 -1.098 . . . . 0.0 111.209 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.784 HG22 HD22 ' A' ' 91' ' ' LEU . 74.0 t -60.71 -37.73 76.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.314 0.578 . . . . 0.0 110.211 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.7 t -58.54 -22.39 55.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.126 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 45.2 mtpt -71.61 -40.59 69.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.78 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.681 HG23 HD13 ' A' ' 59' ' ' LEU . 41.6 pt -85.58 179.2 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-O 121.938 0.875 . . . . 0.0 112.925 -175.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.443 ' N ' ' HD3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -168.26 147.2 4.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.937 -1.483 . . . . 0.0 109.464 -175.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.467 HG22 ' CG1' ' A' ' 104' ' ' ILE . 0.8 OUTLIER -72.61 144.22 13.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.742 -179.353 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.98 -31.75 5.03 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.861 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.553 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 21.7 ptt? -86.39 175.14 8.56 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.976 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.943 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 26.0 p -93.29 -170.77 2.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.974 -171.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -66.69 -46.04 76.89 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.616 172.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.503 ' OE1' ' HG2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -66.73 -29.31 69.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.469 0.652 . . . . 0.0 110.47 -175.242 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.943 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.0 mm-40 -63.19 -56.59 15.43 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.397 174.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.651 HG11 ' CD2' ' A' ' 93' ' ' LEU . 82.9 t -67.51 -38.82 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.455 -177.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.689 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.7 -32.17 68.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.182 0.515 . . . . 0.0 110.109 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -82.26 -39.17 23.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.589 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.79 -44.94 63.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.167 0.508 . . . . 0.0 111.881 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.681 HD13 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -95.73 -12.63 25.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.411 -174.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.77 129.33 2.28 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.255 -0.974 . . . . 0.0 110.876 -173.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.689 HG22 ' HB1' ' A' ' 56' ' ' ALA . 22.1 p -55.3 133.4 69.64 Favored Pre-proline 0 N--CA 1.448 -0.566 0 CA-C-O 121.466 0.65 . . . . 0.0 111.284 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 34.8 Cg_exo -63.49 166.93 14.14 Favored 'Trans proline' 0 C--O 1.23 0.092 0 C-N-CA 123.753 2.969 . . . . 0.0 113.377 -171.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.419 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 1.5 mt -54.08 -33.16 56.84 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.104 -170.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.461 ' SD ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -63.68 3.33 0.36 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.39 176.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 63' ' ' LEU . 27.7 p 53.94 24.81 4.87 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.8 0.84 . . . . 0.0 111.593 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -169.9 105.11 0.45 Allowed Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.41 -178.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.585 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 83.6 Cg_endo -80.07 -23.03 6.85 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 122.833 2.355 . . . . 0.0 113.201 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -82.8 -6.75 59.57 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -171.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.28 -20.68 51.66 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.328 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 t -125.16 174.74 7.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.993 0.425 . . . . 0.0 110.228 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -129.24 14.01 6.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.366 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.7 m -131.2 110.32 11.05 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.84 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.593 ' O ' ' HA ' ' A' ' 92' ' ' THR . 46.3 m0 -108.66 149.08 29.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.885 -175.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -125.13 123.22 39.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.544 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.617 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 86.6 m-85 -133.01 173.75 11.08 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.9 t -113.24 164.82 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -175.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -105.02 164.42 11.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.252 -178.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.572 ' HD2' ' N ' ' A' ' 79' ' ' GLN . 1.6 tmm_? -66.56 145.57 55.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.451 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.572 ' N ' ' HD2' ' A' ' 78' ' ' ARG . 54.7 tt0 -32.15 101.68 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.498 1.124 . . . . 0.0 113.547 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 17.7 mm-40 -92.38 154.19 42.81 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.888 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 11.3 Cg_exo -70.63 105.32 1.61 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 124.129 3.22 . . . . 0.0 111.872 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.62 ' HA2' HG21 ' A' ' 87' ' ' THR . . . -67.16 115.81 7.5 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.007 -175.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -127.4 -3.39 6.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.885 0.374 . . . . 0.0 110.67 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.563 ' HG2' ' H ' ' A' ' 85' ' ' GLY . 22.7 tt0 -142.85 -179.81 6.56 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.563 ' H ' ' HG2' ' A' ' 84' ' ' GLU . . . -51.09 -55.04 20.52 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 176.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.673 ' HB ' ' HB2' ' A' ' 111' ' ' SER . 38.6 t -123.5 141.85 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 170.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.62 HG21 ' HA2' ' A' ' 82' ' ' GLY . 13.0 t -133.66 4.83 3.65 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.928 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.67 172.95 13.09 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 121.41 0.624 . . . . 0.0 110.492 177.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.474 ' HB3' ' HA ' ' A' ' 108' ' ' PRO . 3.2 pt20 -148.04 128.05 13.64 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.186 174.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p -90.35 142.62 27.55 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.887 -175.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.955 HD11 HG22 ' A' ' 104' ' ' ILE . 14.4 tp -90.02 110.95 21.91 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.95 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 24.4 m -103.68 105.01 15.12 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.83 ' HG ' HD21 ' A' ' 101' ' ' LEU . 8.2 tp -88.36 124.27 33.76 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.37 -173.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.558 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 42.1 m -104.16 120.98 42.29 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.978 -176.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.53 ' CE2' HD23 ' A' ' 93' ' ' LEU . 66.1 m-85 -114.5 137.73 51.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.744 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.559 ' HB3' HG21 ' A' ' 102' ' ' THR . 33.3 p30 -75.26 -171.96 1.58 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.45 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.1 m -55.61 -37.99 68.86 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.465 ' HB3' HG23 ' A' ' 100' ' ' VAL . 22.8 t -84.2 -3.61 58.28 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.985 0.422 . . . . 0.0 110.869 -173.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.59 31.85 35.59 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.621 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.488 ' HB ' HD21 ' A' ' 96' ' ' ASN . 11.2 t -107.02 141.47 22.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.83 HD21 ' HG ' ' A' ' 93' ' ' LEU . 7.0 mt -62.68 122.88 16.97 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.559 0.695 . . . . 0.0 112.254 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.559 HG21 ' HB3' ' A' ' 96' ' ' ASN . 21.1 p -109.62 -42.09 4.39 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.711 175.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.558 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 5.3 m-20 -137.06 154.83 50.25 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.271 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.955 HG22 HD11 ' A' ' 91' ' ' LEU . 5.0 mm -116.7 91.72 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 167.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 92' ' ' THR . 5.6 m-20 -83.55 94.91 8.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.039 0.447 . . . . 0.0 110.752 -172.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -100.78 102.85 14.03 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.755 0.788 . . . . 0.0 109.414 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.431 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 21.1 mttt -125.69 156.71 70.56 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.482 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.474 ' HA ' ' HB3' ' A' ' 89' ' ' GLN . 12.1 Cg_endo -69.22 145.84 61.6 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.97 2.447 . . . . 0.0 112.028 -175.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.499 ' HB3' HG11 ' A' ' 86' ' ' VAL . . . -71.26 170.94 12.0 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.488 0.661 . . . . 0.0 110.996 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.579 HD22 HD21 ' A' ' 113' ' ' ASN . 9.6 mt -73.36 99.32 2.9 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.219 -168.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.673 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 14.3 t -121.61 11.04 10.49 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.215 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 153.46 119.85 0.77 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.821 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.579 HD21 HD22 ' A' ' 110' ' ' LEU . 89.8 m-20 . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.671 -0.681 . . . . 0.0 110.341 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.514 ' HB2' ' OG1' ' A' ' 22' ' ' THR . 57.6 m -78.23 -17.15 57.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.96 0.38 . . . . 0.0 110.685 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 77.5 -22.87 0.26 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.433 0.693 . . . . 0.0 111.99 173.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.7 tpt -147.51 126.57 12.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.59 0.233 . . . . 0.0 110.91 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 m 60.39 42.04 15.26 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.483 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.514 ' OG1' ' HB2' ' A' ' 18' ' ' SER . 7.1 m -86.18 -49.83 7.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.142 0.496 . . . . 0.0 111.262 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.1 mt -93.01 -2.86 55.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.455 -171.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -101.61 4.74 41.19 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.192 -176.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -132.68 103.81 6.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.124 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.743 HG23 ' H ' ' A' ' 27' ' ' VAL . 2.7 m -84.75 -91.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.891 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.743 ' H ' HG23 ' A' ' 26' ' ' VAL . 2.3 p -164.34 176.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.433 ' H ' HG22 ' A' ' 27' ' ' VAL . 54.3 t80 -55.12 136.76 47.98 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.822 0.344 . . . . 0.0 110.501 175.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -97.29 111.56 58.55 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.209 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 28' ' ' TYR . 50.5 Cg_exo -53.8 148.46 37.03 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.176 2.584 . . . . 0.0 112.073 174.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -63.99 -71.02 0.19 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.78 0.8 . . . . 0.0 111.208 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.541 HG22 ' H ' ' A' ' 34' ' ' GLN . 37.0 mm -87.81 141.24 14.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.29 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -77.85 -36.15 50.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.055 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.541 ' H ' HG22 ' A' ' 32' ' ' ILE . 18.1 pt20 -98.53 44.89 1.02 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.49 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.54 41.18 2.78 Favored Glycine 0 C--N 1.314 -0.64 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.35 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -89.39 -23.56 22.15 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.153 0.501 . . . . 0.0 110.037 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -122.08 -166.5 1.41 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.338 176.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.542 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 11.4 tp -76.46 161.55 28.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.129 0.49 . . . . 0.0 110.975 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 78' ' ' ARG . 33.5 p -127.71 177.19 6.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.156 170.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.43 -30.61 66.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.009 0.433 . . . . 0.0 110.495 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.736 HD21 ' HD3' ' A' ' 78' ' ' ARG . 27.0 m-80 -55.69 -45.04 77.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.714 176.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.683 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 22.7 m-20 -67.2 -26.35 66.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.231 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.968 HG22 HD22 ' A' ' 91' ' ' LEU . 79.3 t -64.32 -37.28 79.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.172 0.511 . . . . 0.0 110.026 176.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.3 t -66.54 -20.84 66.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.452 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.683 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 36.4 mtpt -71.34 -32.28 68.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.92 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.623 HG23 HD13 ' A' ' 59' ' ' LEU . 30.9 pt -94.76 177.6 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-O 121.895 0.855 . . . . 0.0 112.032 177.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.41 ' HE ' ' HB3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -172.3 154.31 3.24 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.417 -174.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.426 HG22 HD11 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -71.95 144.99 12.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.048 -178.378 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.38 -36.81 3.16 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.163 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.609 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 5.6 ptt? -85.25 171.61 11.8 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.191 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.851 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 44.0 p -86.07 -172.49 4.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.007 -172.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.5 ' HA ' ' CZ ' ' A' ' 95' ' ' PHE . 39.5 mt-30 -68.31 -42.59 79.19 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.216 173.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.558 ' HA ' ' HE1' ' A' ' 68' ' ' PHE . 9.0 pt20 -66.36 -36.03 81.85 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.264 -175.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.851 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.8 mm-40 -58.26 -54.21 49.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.889 176.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.657 HG11 ' CD2' ' A' ' 93' ' ' LEU . 85.6 t -65.58 -41.3 90.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.793 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.566 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -57.67 -33.12 67.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.385 0.612 . . . . 0.0 110.096 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -81.3 -36.78 29.38 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.825 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.35 -42.07 55.12 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.249 0.547 . . . . 0.0 111.764 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.623 HD13 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -95.24 -16.94 22.12 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.83 -173.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.95 130.46 5.43 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.305 -0.95 . . . . 0.0 110.756 -174.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.566 HG22 ' HB1' ' A' ' 56' ' ' ALA . 4.5 p -65.11 134.95 96.09 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 121.343 0.592 . . . . 0.0 111.304 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 22.0 Cg_exo -67.59 171.41 12.0 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.998 3.132 . . . . 0.0 113.14 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.427 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 7.7 mt -49.09 -48.23 44.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.518 -178.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -59.59 144.73 46.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.757 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.3 p -73.02 1.72 8.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -154.44 108.59 2.4 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-O 121.345 0.593 . . . . 0.0 110.528 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.65 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 59.2 Cg_endo -73.29 -25.39 15.67 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.078 2.519 . . . . 0.0 113.048 176.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.558 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 8.3 m-85 -81.57 -5.44 58.02 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -170.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.21 -8.17 63.2 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.71 -174.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.2 t -123.58 171.96 9.14 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -119.38 1.25 11.23 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.0 m -126.64 115.2 19.1 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.555 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.65 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 44.6 m0 -109.36 141.68 41.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.708 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -119.12 120.71 37.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.477 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.657 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 90.3 m-85 -128.03 175.56 8.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.228 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.466 HG13 ' CD ' ' A' ' 88' ' ' GLN . 39.9 t -124.26 152.66 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -172.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 -97.54 152.92 18.53 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 171.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.736 ' HD3' HD21 ' A' ' 41' ' ' ASN . 27.6 ptt180 -79.32 149.51 31.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.15 -172.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.504 ' H ' ' NE2' ' A' ' 34' ' ' GLN . 8.5 tt0 52.89 60.14 3.99 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.795 0.807 . . . . 0.0 111.693 173.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.61 ' HG3' ' NE2' ' A' ' 88' ' ' GLN . 11.4 mm-40 -117.63 167.0 11.93 Favored Pre-proline 0 N--CA 1.446 -0.673 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.268 172.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.58 ' HD2' ' HB3' ' A' ' 80' ' ' GLN . 18.7 Cg_endo -64.72 -63.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 121.708 1.606 . . . . 0.0 111.783 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.54 -58.34 3.76 Favored Glycine 0 C--N 1.313 -0.722 0 CA-C-N 114.696 -1.138 . . . . 0.0 113.37 173.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -72.44 -71.66 0.28 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.882 0.372 . . . . 0.0 110.374 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -100.91 141.74 33.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.689 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.39 67.27 2.08 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.497 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.1 127.1 25.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.414 0.626 . . . . 0.0 110.704 -175.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.0 t -171.9 13.68 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.328 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.61 ' NE2' ' HG3' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -56.65 120.36 7.66 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.52 178.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.89 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 28.7 mt-30 -76.52 104.41 7.01 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.674 -0.41 . . . . 0.0 109.985 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.436 HG23 ' HG3' ' A' ' 88' ' ' GLN . 18.0 p -89.36 146.88 24.39 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.104 -177.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.986 HD11 HG22 ' A' ' 104' ' ' ILE . 38.7 tp -91.11 110.76 22.03 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 28.7 m -105.27 102.69 12.15 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.763 ' HG ' HD21 ' A' ' 101' ' ' LEU . 8.9 tp -88.39 126.78 35.38 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.547 -171.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.5 m -103.8 121.24 42.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.008 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.59 ' CE2' HD23 ' A' ' 93' ' ' LEU . 25.8 m-85 -111.92 148.52 33.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.914 0.864 . . . . 0.0 112.503 -175.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -73.8 173.1 10.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 113.874 -1.512 . . . . 0.0 110.451 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.8 m -62.34 -30.07 70.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.17 0.509 . . . . 0.0 110.862 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.407 ' HB3' HG23 ' A' ' 100' ' ' VAL . 30.8 t -87.55 4.43 43.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.793 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.11 34.53 55.17 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.954 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' A' ' 98' ' ' SER . 15.4 t -107.37 139.31 29.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.763 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.3 mt -60.73 127.5 31.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.393 0.616 . . . . 0.0 111.673 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 66.5 p -116.38 -39.94 3.3 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.136 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -144.7 149.56 35.82 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.854 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.986 HG22 HD11 ' A' ' 91' ' ' LEU . 3.8 mm -112.6 94.06 2.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 173.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.593 ' HB2' ' O ' ' A' ' 92' ' ' THR . 4.5 m-20 -80.48 95.49 6.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.024 0.44 . . . . 0.0 110.523 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -106.57 102.78 12.14 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.72 0.771 . . . . 0.0 110.269 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.548 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -151.91 171.06 7.02 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.62 -176.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.89 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 31.9 Cg_endo -71.03 157.06 58.88 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.5 1.467 . . . . 0.0 111.945 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.5 -179.81 2.68 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.577 174.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.417 ' HG ' ' H ' ' A' ' 110' ' ' LEU . 19.5 mt -54.54 101.82 0.05 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.754 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.8 t -111.31 -24.5 10.19 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.639 -174.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 125.7 157.83 9.75 Favored Glycine 0 C--N 1.311 -0.848 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.546 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.6 t30 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.954 -178.018 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.448 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . . . . . . 0 N--CA 1.48 1.576 0 N-CA-C 112.084 -0.406 . . . . 0.0 112.084 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 m -68.87 144.85 54.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.63 0.252 . . . . 0.0 111.149 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.436 ' HB2' ' OG1' ' A' ' 22' ' ' THR . 35.6 m80 64.08 -166.61 0.22 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.614 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -76.11 -52.49 10.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.679 0.276 . . . . 0.0 111.544 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.0 t -141.42 37.59 1.69 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.976 0.417 . . . . 0.0 111.458 -176.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.59 HG22 HD22 ' A' ' 23' ' ' LEU . 91.6 m -72.87 -45.41 58.42 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.59 HD22 HG22 ' A' ' 22' ' ' THR . 3.5 mm? -116.24 92.62 3.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.079 175.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -90.84 141.23 29.04 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 -126.74 -26.29 3.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.227 -173.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.49 126.99 50.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.157 0.503 . . . . 0.0 110.49 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.59 HG22 ' H ' ' A' ' 28' ' ' TYR . 1.7 p -95.96 -177.73 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.318 -176.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.59 ' H ' HG22 ' A' ' 27' ' ' VAL . 84.0 m-85 -57.97 166.5 1.48 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.693 0.759 . . . . 0.0 112.562 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -103.69 142.47 24.66 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.446 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -43.82 137.43 6.57 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.904 3.069 . . . . 0.0 113.893 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -80.93 68.11 7.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.642 -176.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.775 HG22 ' H ' ' A' ' 34' ' ' GLN . 39.5 mm -68.22 139.37 20.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.792 173.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.31 -20.9 27.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.398 0.618 . . . . 0.0 110.192 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.775 ' H ' HG22 ' A' ' 32' ' ' ILE . 14.7 pt20 -118.08 88.95 3.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.681 0.753 . . . . 0.0 111.489 -175.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.17 35.72 3.55 Favored Glycine 0 C--N 1.314 -0.689 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.283 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -79.48 -27.35 41.52 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.016 0.436 . . . . 0.0 110.876 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -122.46 -169.2 1.86 Allowed 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.892 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.659 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 3.1 tp -75.51 150.33 38.2 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.925 0.393 . . . . 0.0 110.459 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 43' ' ' VAL . 32.3 p -127.41 -178.36 4.43 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.079 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.15 -35.54 79.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.383 0.611 . . . . 0.0 110.552 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -59.32 -46.46 88.52 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.985 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.578 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 14.9 m-20 -69.31 -32.14 71.06 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.798 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.721 HG22 HD22 ' A' ' 91' ' ' LEU . 68.0 t -57.92 -38.18 64.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.109 0.481 . . . . 0.0 110.525 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -59.24 -21.59 59.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.154 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 45.9 mtpt -70.85 -29.3 65.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.982 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.803 HG23 HD13 ' A' ' 59' ' ' LEU . 38.9 pt -95.48 176.11 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 121.787 0.803 . . . . 0.0 112.257 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.431 ' HE ' ' HB3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -164.71 148.42 8.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.775 -177.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.445 HG22 HD11 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -70.79 140.14 18.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.332 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.43 -17.57 8.94 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.488 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.471 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 17.6 ptt? -102.43 173.09 6.51 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.109 174.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.713 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 12.7 p -88.08 -173.35 4.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.007 -172.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.511 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 13.2 mt-30 -69.44 -41.93 75.62 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.562 175.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.567 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -65.5 -33.19 75.35 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.609 0.719 . . . . 0.0 109.591 -175.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.713 ' HG3' ' H ' ' A' ' 51' ' ' THR . 11.2 mm-40 -61.61 -55.93 25.38 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.598 175.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.645 HG11 ' CD2' ' A' ' 93' ' ' LEU . 82.5 t -66.03 -40.4 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.387 -176.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.733 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.74 -34.2 71.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.278 0.561 . . . . 0.0 110.012 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -81.16 -39.97 24.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.769 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.27 -49.68 53.86 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.782 0.801 . . . . 0.0 111.402 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.803 HD13 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -86.07 -45.07 11.75 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.189 -173.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.02 126.8 3.46 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -174.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.733 HG22 ' HB1' ' A' ' 56' ' ' ALA . 47.6 p -59.84 132.09 89.15 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-O 121.15 0.5 . . . . 0.0 110.934 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 28.0 Cg_exo -63.59 164.18 21.84 Favored 'Trans proline' 0 CA--C 1.52 -0.208 0 C-N-CA 123.745 2.963 . . . . 0.0 112.554 -172.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.431 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 1.9 mt -52.72 -32.96 45.63 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.47 -168.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.409 ' HG2' ' H ' ' A' ' 64' ' ' MET . 10.8 ptt? -62.48 -9.87 9.92 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.685 0.616 . . . . 0.0 111.926 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 t 72.27 -2.3 2.63 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.669 0.788 . . . . 0.0 112.466 173.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -138.12 91.97 12.66 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-O 121.159 0.504 . . . . 0.0 109.999 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.707 ' HG3' HG22 ' A' ' 61' ' ' THR . 74.0 Cg_endo -74.0 -30.25 9.22 Favored 'Trans proline' 0 CA--C 1.529 0.247 0 C-N-CA 123.193 2.595 . . . . 0.0 112.964 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.497 ' HE1' ' HA ' ' A' ' 53' ' ' GLN . 12.7 m-85 -76.78 3.6 11.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.105 -172.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.49 -25.7 25.07 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.881 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.4 t -123.78 174.21 7.65 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.413 ' HB2' ' HB2' ' A' ' 95' ' ' PHE . 26.3 p-10 -122.33 2.58 9.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.107 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.4 m -123.07 108.66 13.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.813 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.576 ' O ' ' HA ' ' A' ' 92' ' ' THR . 47.0 m0 -105.58 148.68 27.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.875 -174.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -124.48 118.2 26.1 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.976 0.417 . . . . 0.0 111.249 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.641 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 80.3 m-85 -128.9 175.5 8.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.274 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.8 t -122.85 165.74 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.404 ' HB2' ' OE1' ' A' ' 88' ' ' GLN . 6.1 m-30 -93.69 -178.13 4.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.65 0.262 . . . . 0.0 110.632 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.569 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 16.4 ptt180 -71.01 171.23 11.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.083 -173.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.605 ' HB3' HD12 ' A' ' 32' ' ' ILE . 28.1 tt0 -46.55 94.39 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 O-C-N 124.022 0.826 . . . . 0.0 112.843 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 10.7 pt20 -141.93 161.41 51.43 Favored Pre-proline 0 N--CA 1.444 -0.749 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.698 175.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -50.05 107.88 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.412 2.741 . . . . 0.0 113.248 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.484 ' HA2' HG13 ' A' ' 86' ' ' VAL . . . -115.73 6.47 20.27 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.611 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -122.95 147.9 46.09 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 59.4 -90.26 0.03 OUTLIER 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.824 0.702 . . . . 0.0 111.465 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -84.75 72.15 2.84 Favored Glycine 0 C--N 1.302 -1.327 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.096 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.484 HG13 ' HA2' ' A' ' 82' ' ' GLY . 14.7 t -68.57 136.16 26.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.261 0.553 . . . . 0.0 111.387 -175.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -136.29 -3.28 2.19 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.309 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.559 ' HG2' ' HG3' ' A' ' 80' ' ' GLN . 7.7 mm-40 -55.81 139.79 44.36 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.687 0.756 . . . . 0.0 112.492 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.592 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 45.7 mt-30 -124.66 131.42 53.47 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.252 175.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.8 p -89.08 146.67 24.68 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.311 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.751 HD11 ' CG2' ' A' ' 104' ' ' ILE . 13.8 tp -89.66 103.39 16.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 18.2 m -98.21 100.62 11.93 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.902 ' HG ' HD21 ' A' ' 101' ' ' LEU . 8.4 tp -86.01 121.58 28.83 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.256 -172.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.4 m -101.54 119.6 39.02 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.018 -175.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.453 ' CE2' HD23 ' A' ' 93' ' ' LEU . 72.2 m-85 -113.22 142.36 45.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.492 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.503 ' HB3' HG21 ' A' ' 102' ' ' THR . 30.1 p30 -75.85 -177.72 3.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.96 174.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.2 m -56.61 -30.55 63.36 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.2 t -85.91 -3.86 59.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.701 0.286 . . . . 0.0 111.257 -173.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.48 32.72 27.17 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.424 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.48 ' HB ' HD21 ' A' ' 96' ' ' ASN . 5.0 t -113.7 139.21 40.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.794 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.902 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.7 mt -61.14 123.14 16.84 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.276 0.56 . . . . 0.0 112.307 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.503 HG21 ' HB3' ' A' ' 96' ' ' ASN . 12.4 p -110.29 -39.14 5.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.025 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -148.92 150.63 33.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.481 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.751 ' CG2' HD11 ' A' ' 91' ' ' LEU . 5.6 mm -105.35 92.76 2.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 171.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 92' ' ' THR . 7.2 m-20 -83.94 94.88 8.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.284 0.564 . . . . 0.0 110.259 -177.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -95.25 102.08 13.86 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.881 0.848 . . . . 0.0 108.978 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.509 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 20.6 mmtm -129.16 151.93 78.55 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.873 -172.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 17.8 Cg_endo -65.49 147.14 86.56 Favored 'Trans proline' 0 C--N 1.33 -0.408 0 C-N-CA 123.818 3.012 . . . . 0.0 113.557 -167.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.02 139.47 35.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.268 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.6 mt 34.13 -96.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 O-C-N 125.066 1.479 . . . . 0.0 113.706 177.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.6 m -85.87 68.78 10.46 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.737 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.556 ' HA3' ' HB2' ' A' ' 108' ' ' PRO . . . -77.41 -38.63 28.3 Favored Glycine 0 CA--C 1.504 -0.617 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.215 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 . . . . . 0 C--N 1.307 -1.251 0 CA-C-N 114.621 -0.79 . . . . 0.0 109.345 179.634 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.5 t 65.38 16.54 10.58 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.973 0.509 . . . . 0.0 111.737 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -130.71 86.18 2.35 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.1 mtm -71.63 -52.78 16.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.397 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.1 p -111.29 33.68 4.53 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.133 0.492 . . . . 0.0 109.915 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.0 m 70.43 -64.02 0.38 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.841 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.02 144.55 25.33 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 24' ' ' GLU . 8.2 pt-20 -80.72 44.28 0.72 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.403 0.621 . . . . 0.0 111.169 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -88.09 -5.02 58.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.172 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 26' ' ' VAL . 13.1 p -88.3 34.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 122.149 0.976 . . . . 0.0 110.054 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.07 165.02 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.166 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -82.48 147.04 28.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.803 0.335 . . . . 0.0 110.821 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -98.33 150.69 36.98 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.75 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.25 172.22 0.22 Allowed 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.729 2.953 . . . . 0.0 113.145 174.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.1 t70 68.44 101.26 0.05 Allowed 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.766 0.793 . . . . 0.0 111.254 -175.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.842 HG22 ' H ' ' A' ' 34' ' ' GLN . 11.1 mm 53.94 150.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 113.567 -1.651 . . . . 0.0 115.001 -176.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -102.15 22.62 12.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.484 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.842 ' H ' HG22 ' A' ' 32' ' ' ILE . 2.8 pt20 -148.73 45.21 1.02 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.456 1.122 . . . . 0.0 109.826 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.59 -151.36 7.47 Favored Glycine 0 C--N 1.314 -0.682 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.223 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 60.1 t30 75.88 -45.67 0.54 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.526 0.73 . . . . 0.0 110.903 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -108.94 -167.47 1.22 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 175.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.729 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 3.6 mm? -79.26 152.2 30.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.727 0.775 . . . . 0.0 112.4 -176.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.833 ' HB ' ' HB2' ' A' ' 78' ' ' ARG . 30.7 p -128.92 -177.9 4.4 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.26 -1.336 . . . . 0.0 109.516 170.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.506 ' H ' ' N ' ' A' ' 78' ' ' ARG . . . -65.04 -44.33 89.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.861 0.362 . . . . 0.0 111.624 -176.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.462 ' N ' HD22 ' A' ' 41' ' ' ASN . 0.9 OUTLIER -61.16 -40.58 94.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.569 -177.533 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -68.74 -33.44 73.91 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.572 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.691 ' HA ' HD11 ' A' ' 59' ' ' LEU . 54.9 t -57.32 -37.7 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.811 0.339 . . . . 0.0 111.475 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.7 p -64.09 -12.42 39.03 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.149 0.499 . . . . 0.0 111.627 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 43.8 mtpt -77.2 -14.19 59.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.246 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.865 HG23 HD13 ' A' ' 59' ' ' LEU . 35.3 pt -104.21 -176.9 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 121.894 0.854 . . . . 0.0 112.808 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.402 ' H ' ' HE2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -172.64 150.47 2.2 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.009 -1.45 . . . . 0.0 109.055 -177.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.554 HG22 HD11 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -71.09 144.48 13.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.15 -178.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.15 -32.31 4.78 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.473 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.538 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 14.4 ptt? -88.3 178.39 6.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 111.415 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.857 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 34.9 p -90.77 -177.04 4.88 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.793 -171.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.472 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 36.7 mt-30 -66.18 -42.63 88.63 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.506 171.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -37.34 77.48 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.147 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.857 ' HG3' ' H ' ' A' ' 51' ' ' THR . 5.4 mm-40 -67.83 -52.03 41.63 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.318 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.685 HG13 HG21 ' A' ' 46' ' ' ILE . 78.6 t -64.94 -40.84 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.741 -177.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.612 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.41 -33.33 69.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 110.181 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -81.87 -40.28 22.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.098 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.44 -42.4 75.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.686 0.755 . . . . 0.0 111.11 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.865 HD13 HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -92.63 -54.94 3.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.992 -174.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.2 134.94 3.61 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -171.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.612 HG22 ' HB1' ' A' ' 56' ' ' ALA . 28.7 p -66.92 135.92 94.28 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-O 121.224 0.535 . . . . 0.0 111.308 -177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 17.0 Cg_exo -65.79 174.72 5.24 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 C-N-CA 124.19 3.26 . . . . 0.0 113.411 -174.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.409 ' HG ' ' H ' ' A' ' 63' ' ' LEU . 8.2 mt -46.3 -48.47 18.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.353 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.22 126.88 30.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.572 170.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 t -68.78 -7.25 32.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 0.0 111.726 -173.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.456 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 11.1 p-10 -122.14 92.49 48.87 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-O 121.714 0.768 . . . . 0.0 110.199 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.538 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 18.7 Cg_endo -60.05 -36.11 90.53 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.864 2.376 . . . . 0.0 112.186 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -83.48 8.89 12.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.803 -177.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.1 -17.33 57.85 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.8 t -124.45 175.14 7.32 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -125.1 8.04 7.95 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.818 0.342 . . . . 0.0 110.127 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.7 m -131.36 111.82 12.19 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.313 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.675 ' O ' ' HA ' ' A' ' 92' ' ' THR . 48.8 m0 -106.0 142.95 34.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.582 -176.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -123.44 116.32 23.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.75 0.31 . . . . 0.0 110.543 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.587 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 31.1 m-85 -124.72 170.25 11.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.523 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.3 t -120.69 158.63 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.445 ' CG ' ' HB2' ' A' ' 40' ' ' ALA . 1.3 m-30 -87.51 161.16 17.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.809 0.338 . . . . 0.0 110.788 176.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.833 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 21.1 ttm180 -84.07 121.88 28.03 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.368 -169.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 59.65 86.96 0.09 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.559 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.845 ' HG2' ' HG2' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -111.41 159.55 32.6 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.973 176.417 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.491 ' HG2' HG22 ' A' ' 87' ' ' THR . 66.0 Cg_exo -54.31 -66.33 0.1 Allowed 'Trans proline' 0 CA--C 1.52 -0.201 0 C-N-CA 122.531 2.154 . . . . 0.0 112.205 173.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.74 -147.86 47.32 Favored Glycine 0 C--N 1.313 -0.718 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.494 -175.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 39.2 m80 61.64 -92.35 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 122.71 0.404 . . . . 0.0 110.993 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -140.12 143.11 36.06 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.05 39.3 46.01 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -171.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.616 ' O ' ' HA2' ' A' ' 112' ' ' GLY . 40.7 t -60.7 142.22 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 114.743 -0.728 . . . . 0.0 110.941 -174.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.491 HG22 ' HG2' ' A' ' 81' ' ' PRO . 14.0 t -130.77 11.02 5.16 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.84 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.845 ' HG2' ' HG2' ' A' ' 80' ' ' GLN . 52.9 mt-30 -36.43 107.13 0.05 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 174.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -80.48 105.37 11.68 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 19.2 p -89.59 143.19 27.01 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.65 -173.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.9 HD11 HG22 ' A' ' 104' ' ' ILE . 14.7 tp -93.6 111.69 23.41 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.862 174.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.715 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 40.2 m -106.9 103.45 12.88 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.906 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.2 tp -90.21 122.82 33.49 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.254 -173.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -109.72 124.22 50.86 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.394 -176.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.51 ' CE1' ' HG ' ' A' ' 101' ' ' LEU . 92.0 m-85 -112.27 144.97 40.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.296 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.541 ' HB3' HG21 ' A' ' 102' ' ' THR . 29.7 p30 -74.88 -173.96 2.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.172 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.1 p -54.59 -32.17 58.22 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.484 ' HB3' HG23 ' A' ' 100' ' ' VAL . 9.7 t -89.45 -3.03 58.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.054 0.454 . . . . 0.0 111.245 -173.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.62 32.98 32.14 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.597 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.491 ' HB ' HD21 ' A' ' 96' ' ' ASN . 7.3 t -108.82 138.86 33.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.906 HD21 ' HG ' ' A' ' 93' ' ' LEU . 5.7 mt -60.07 124.91 21.68 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.648 0.737 . . . . 0.0 112.102 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.541 HG21 ' HB3' ' A' ' 96' ' ' ASN . 34.0 p -112.85 -45.0 3.23 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.348 176.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -136.52 152.75 50.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.247 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.9 HG22 HD11 ' A' ' 91' ' ' LEU . 3.7 mm -116.08 93.36 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 171.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.715 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 8.0 t70 -89.53 97.34 11.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.04 0.447 . . . . 0.0 111.052 -169.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 90' ' ' THR . 29.0 t-20 -117.64 119.52 35.22 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.36 0.6 . . . . 0.0 110.693 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.569 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -155.07 174.64 3.72 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.144 179.229 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.569 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 27.5 Cg_endo -66.62 165.74 24.37 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 121.814 1.676 . . . . 0.0 111.974 -177.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.78 176.65 5.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.191 0.52 . . . . 0.0 112.316 -176.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.3 mt -50.98 -57.51 8.4 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.406 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.9 p -89.95 35.46 0.85 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.134 0.492 . . . . 0.0 110.984 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.616 ' HA2' ' O ' ' A' ' 86' ' ' VAL . . . -82.51 -164.89 35.7 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.281 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.5 p30 . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.315 -175.886 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.8 p -78.6 -59.9 2.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.02 0.438 . . . . 0.0 110.62 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -95.32 136.26 35.9 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.949 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.56 ' HA ' ' CE ' ' A' ' 20' ' ' MET . 7.9 mmt -98.33 171.87 7.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.382 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.8 m 58.75 71.87 0.56 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.146 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.9 t -108.31 -10.75 15.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.8 175.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.8 mt -122.68 7.44 9.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.238 174.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 48.19 -95.26 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.481 -172.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -139.65 22.08 2.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.8 0.333 . . . . 0.0 110.914 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.74 81.45 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.57 0.7 . . . . 0.0 109.188 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.628 HG22 ' H ' ' A' ' 28' ' ' TYR . 4.3 p -85.24 177.17 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.652 -173.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.628 ' H ' HG22 ' A' ' 27' ' ' VAL . 42.7 t80 -49.44 132.65 20.64 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.773 0.796 . . . . 0.0 112.425 -176.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.58 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 5.8 ppt_? -130.41 170.12 11.87 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.71 177.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.58 ' HD2' ' HB2' ' A' ' 29' ' ' ARG . 75.2 Cg_exo -48.33 176.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.607 2.871 . . . . 0.0 114.017 177.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -64.94 -21.7 66.87 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.732 0.777 . . . . 0.0 110.28 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.92 HG22 ' H ' ' A' ' 34' ' ' GLN . 48.8 mm -75.17 143.09 13.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.993 176.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -85.94 -12.37 50.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.642 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.92 ' H ' HG22 ' A' ' 32' ' ' ILE . 6.2 mt-30 -99.93 -168.16 1.56 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.012 174.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.25 -152.13 23.98 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.614 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.1 t30 73.43 -57.03 0.64 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.378 0.671 . . . . 0.0 111.518 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -86.63 -162.2 0.74 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.805 HD11 ' HG ' ' A' ' 59' ' ' LEU . 0.5 OUTLIER -70.35 144.01 51.77 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.881 0.848 . . . . 0.0 110.892 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.453 ' HB ' ' HB3' ' A' ' 78' ' ' ARG . 44.4 p -130.81 177.93 7.04 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.21 172.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.423 ' H ' ' N ' ' A' ' 78' ' ' ARG . . . -70.88 -28.97 64.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.453 0.644 . . . . 0.0 109.904 176.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -59.08 -44.44 91.89 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.525 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.62 ' HB2' HD13 ' A' ' 38' ' ' LEU . 27.0 m-20 -70.41 -32.85 70.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.697 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.928 HG22 HD22 ' A' ' 91' ' ' LEU . 56.3 t -62.54 -36.24 74.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.859 0.361 . . . . 0.0 110.81 177.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.3 p -68.19 -15.32 63.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.074 0.464 . . . . 0.0 110.525 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.606 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 40.8 mtpt -78.78 -19.53 51.99 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.078 177.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.667 ' HA ' ' HE1' ' A' ' 50' ' ' MET . 44.5 pt -103.38 169.0 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-O 121.735 0.779 . . . . 0.0 112.099 176.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -164.94 148.76 8.75 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.493 -173.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.465 HG23 ' H ' ' A' ' 48' ' ' VAL . 0.6 OUTLIER -72.19 143.17 14.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.074 -177.014 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.9 -33.8 4.28 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.703 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.667 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 21.8 ptt? -86.48 175.72 8.22 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.148 0.499 . . . . 0.0 111.189 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.831 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 44.0 p -91.16 -173.38 3.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.081 -170.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.468 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 13.8 mt-30 -65.38 -46.93 78.17 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.385 172.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 9.8 pt20 -64.08 -37.4 87.31 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.98 -175.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.831 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.0 mm-40 -58.34 -49.43 77.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.584 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.645 HG11 ' CD2' ' A' ' 93' ' ' LEU . 61.8 t -69.7 -45.11 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.466 -177.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.706 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.45 -25.03 68.09 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.002 0.43 . . . . 0.0 110.684 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -80.44 -35.77 34.56 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.291 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.81 -39.87 61.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.742 0.782 . . . . 0.0 111.07 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.805 ' HG ' HD11 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -93.24 -32.55 14.31 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.339 -172.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.3 119.93 4.45 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -171.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.706 HG22 ' HB1' ' A' ' 56' ' ' ALA . 46.9 p -53.52 134.54 53.7 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 120.968 0.413 . . . . 0.0 111.426 -173.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 32.3 Cg_exo -63.0 164.43 19.37 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.614 2.876 . . . . 0.0 113.278 -172.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.429 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 3.7 mt -53.31 -36.73 61.57 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 113.675 -1.602 . . . . 0.0 112.164 -169.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.433 ' H ' ' HG2' ' A' ' 64' ' ' MET . 8.6 ptt? -62.26 -3.26 1.25 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.164 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.4 t 70.39 2.89 4.22 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.445 0.698 . . . . 0.0 112.259 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.417 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 23.5 t70 -152.09 100.52 2.85 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 121.664 0.745 . . . . 0.0 110.34 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.63 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 38.0 Cg_endo -67.1 -49.71 1.27 Allowed 'Trans proline' 0 C--N 1.332 -0.314 0 C-N-CA 123.63 2.887 . . . . 0.0 113.648 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -80.61 19.1 0.84 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -172.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.36 -19.88 47.6 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 171.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.4 t -124.25 171.15 10.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.982 -0.609 . . . . 0.0 109.53 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -122.72 13.99 10.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.41 0.624 . . . . 0.0 109.681 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 m -139.11 110.53 7.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.022 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.63 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 48.4 m0 -106.94 141.36 38.28 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.941 -175.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -120.04 125.46 48.38 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.18 0.3 . . . . 0.0 110.515 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.55 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 60.1 m-85 -135.66 174.69 10.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.53 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.645 HG23 ' CD ' ' A' ' 88' ' ' GLN . 1.6 p -122.5 150.63 26.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.639 -176.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.638 ' HB2' HE21 ' A' ' 80' ' ' GLN . 10.0 m-30 -86.9 -177.63 6.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.126 0.489 . . . . 0.0 110.571 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.763 ' HB2' HG13 ' A' ' 32' ' ' ILE . 25.6 ptt180 -77.32 170.18 17.0 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.569 ' HB2' HG23 ' A' ' 32' ' ' ILE . 9.1 tt0 -46.85 102.87 0.03 OUTLIER 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -173.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.638 HE21 ' HB2' ' A' ' 77' ' ' PHE . 5.8 pt20 -108.75 137.62 20.09 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.854 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 14.5 Cg_exo -69.47 107.2 1.75 Allowed 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.406 2.738 . . . . 0.0 112.354 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.682 ' HA3' HG21 ' A' ' 87' ' ' THR . . . -110.15 -175.28 20.78 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.486 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -145.48 21.26 1.51 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.613 0.244 . . . . 0.0 111.273 -177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.544 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 24.9 tt0 -147.43 170.86 16.48 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -173.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.12 -63.44 5.04 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.936 ' HB ' ' HA ' ' A' ' 111' ' ' SER . 41.5 t -118.76 126.3 75.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 166.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.682 HG21 ' HA3' ' A' ' 82' ' ' GLY . 8.2 t -143.5 11.22 1.68 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.569 -176.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.645 ' CD ' HG23 ' A' ' 76' ' ' VAL . 1.1 tp-100 -69.75 128.93 38.14 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.204 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.906 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 66.8 mt-30 -83.51 103.72 13.08 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 172.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.502 HG23 ' HG3' ' A' ' 88' ' ' GLN . 6.3 p -87.72 153.26 21.5 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.966 -171.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.945 HD11 HG22 ' A' ' 104' ' ' ILE . 21.3 tp -89.72 114.14 25.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.478 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 35.9 m -108.25 102.7 11.81 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.906 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.4 tp -85.59 121.94 29.0 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.5 -173.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.4 m -100.34 119.86 39.07 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.956 -176.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.539 ' CE2' HD23 ' A' ' 93' ' ' LEU . 67.5 m-85 -113.77 136.8 52.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.817 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.481 HD21 ' HB ' ' A' ' 100' ' ' VAL . 32.3 p30 -75.27 -177.6 3.57 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.933 175.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.0 m -52.84 -33.94 51.82 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.593 ' HB3' HG23 ' A' ' 100' ' ' VAL . 8.7 t -83.83 -9.6 58.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.018 0.437 . . . . 0.0 110.849 -173.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.57 29.66 20.92 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.593 HG23 ' HB3' ' A' ' 98' ' ' SER . 21.5 t -107.62 140.19 26.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.742 -0.729 . . . . 0.0 109.323 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.906 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.5 mt -62.3 125.29 23.4 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.286 0.565 . . . . 0.0 111.885 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.439 HG21 ' HB3' ' A' ' 96' ' ' ASN . 11.1 p -109.6 -45.49 3.67 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.418 174.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -138.33 155.02 48.96 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.63 0.728 . . . . 0.0 111.556 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.945 HG22 HD11 ' A' ' 91' ' ' LEU . 5.3 mm -113.16 93.11 2.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.637 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 30.4 t70 -85.49 96.36 9.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.125 0.488 . . . . 0.0 111.0 -171.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -105.42 102.76 12.21 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.976 0.893 . . . . 0.0 110.106 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -142.96 164.34 32.66 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.275 -175.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.906 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 18.4 Cg_endo -76.48 143.11 24.22 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.445 2.097 . . . . 0.0 112.942 -173.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.66 -176.66 6.14 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 122.113 0.959 . . . . 0.0 112.742 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.7 mt -100.68 136.03 41.18 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.264 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.936 ' HA ' ' HB ' ' A' ' 86' ' ' VAL . 9.5 t -68.68 7.23 0.68 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -114.2 23.37 12.71 Favored Glycine 0 CA--C 1.5 -0.873 0 CA-C-O 122.072 0.818 . . . . 0.0 111.812 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.303 -1.453 0 CA-C-N 114.104 -1.048 . . . . 0.0 110.227 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.765 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.1 m -90.2 91.46 8.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.978 0.418 . . . . 0.0 110.357 -178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -75.92 162.62 27.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.091 176.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.3 mtp 60.07 -164.79 0.22 Allowed 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.478 0.486 . . . . 0.0 110.893 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.9 m 57.57 52.16 8.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.846 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.3 m -82.78 77.54 9.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 122.021 0.915 . . . . 0.0 109.448 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.8 mt -90.3 55.74 3.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.086 -174.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.771 ' HG3' ' H ' ' A' ' 25' ' ' ARG . 9.4 pt-20 -150.44 -74.57 0.16 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.578 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.771 ' H ' ' HG3' ' A' ' 24' ' ' GLU . 15.5 mtp180 56.15 47.34 19.71 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.631 0.729 . . . . 0.0 110.607 -177.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 p -151.43 83.64 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 122.293 1.044 . . . . 0.0 108.955 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.613 HG22 ' H ' ' A' ' 28' ' ' TYR . 2.8 p -111.15 -176.6 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.918 -173.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.613 ' H ' HG22 ' A' ' 27' ' ' VAL . 98.8 m-85 -48.36 130.32 16.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.932 0.396 . . . . 0.0 111.514 175.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 29' ' ' ARG . 18.6 mtp180 -66.94 137.79 94.85 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 166.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -40.48 124.41 1.75 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.685 2.923 . . . . 0.0 113.186 -173.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -153.36 101.3 2.51 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.491 -172.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.885 HG22 ' H ' ' A' ' 34' ' ' GLN . 41.4 mm -68.42 141.04 18.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.006 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.06 -20.23 52.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.054 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.885 ' H ' HG22 ' A' ' 32' ' ' ILE . 13.2 pt20 -121.82 178.28 4.93 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.159 -176.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.74 -0.81 5.48 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.953 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -62.67 -25.57 68.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.262 0.554 . . . . 0.0 109.893 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.86 -101.7 0.1 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.693 172.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.711 ' HB3' ' HB3' ' A' ' 75' ' ' TYR . 6.0 tp -140.71 157.08 45.94 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.2 p -127.9 -173.93 3.06 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.106 174.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.585 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -67.82 -47.33 69.35 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.21 0.528 . . . . 0.0 112.007 -173.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.67 -31.68 69.78 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.101 177.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.537 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 63.4 m-20 -72.29 -35.11 68.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.313 176.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.828 HG22 HD22 ' A' ' 91' ' ' LEU . 53.3 t -57.48 -36.61 54.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.206 0.527 . . . . 0.0 110.506 174.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.1 t -61.61 -17.73 56.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.533 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 48.4 mtpt -74.75 -28.73 60.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.849 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.822 HG23 HD13 ' A' ' 59' ' ' LEU . 43.3 pt -97.56 176.32 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 122.108 0.956 . . . . 0.0 113.163 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.54 150.59 6.09 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.516 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.441 HG22 ' CG1' ' A' ' 104' ' ' ILE . 0.7 OUTLIER -70.54 145.6 12.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.125 -178.077 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.93 -35.15 3.92 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.16 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.607 ' HB2' ' HG3' ' A' ' 54' ' ' GLN . 6.8 ptt? -85.3 165.8 17.0 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.285 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.72 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 12.4 p -83.1 -172.3 4.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.409 -173.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 99' ' ' GLY . 92.2 mt-30 -68.24 -41.84 80.61 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.737 176.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.551 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -66.58 -32.12 73.25 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -175.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.72 ' HG3' ' H ' ' A' ' 51' ' ' THR . 15.8 mm-40 -61.93 -56.58 17.69 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.44 176.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.673 HG11 ' CD2' ' A' ' 93' ' ' LEU . 82.0 t -65.4 -40.45 88.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.57 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.619 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.69 -35.55 72.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.163 0.506 . . . . 0.0 110.297 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -81.65 -35.37 30.03 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.088 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.04 -45.15 43.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.554 0.692 . . . . 0.0 111.393 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.822 HD13 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -90.95 -54.42 3.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.316 -174.231 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.68 130.1 2.91 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.619 HG22 ' HB1' ' A' ' 56' ' ' ALA . 40.5 p -65.34 128.82 94.13 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-O 121.533 0.682 . . . . 0.0 110.687 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 14.6 Cg_exo -68.68 163.25 37.81 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.569 2.846 . . . . 0.0 112.956 -171.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.82 -25.85 61.2 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.263 -1.335 . . . . 0.0 112.008 -171.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.468 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 13.4 ptt? -66.84 -3.01 5.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.543 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 t 72.29 4.4 4.99 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.545 0.738 . . . . 0.0 112.51 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -158.92 107.78 1.58 Allowed Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 121.579 0.704 . . . . 0.0 110.543 175.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.674 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 58.8 Cg_endo -72.82 -29.95 11.93 Favored 'Trans proline' 0 C--N 1.325 -0.662 0 C-N-CA 122.976 2.451 . . . . 0.0 112.511 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -76.28 -4.06 39.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.927 -170.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.85 -17.66 55.96 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.534 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.3 t -124.39 174.31 7.84 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.005 0.431 . . . . 0.0 110.666 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -118.52 3.56 11.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.574 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.4 m -134.15 112.77 11.4 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.643 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.674 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 44.6 m0 -105.88 136.19 45.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.439 -177.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -113.07 127.31 56.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.928 0.394 . . . . 0.0 110.724 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.711 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 62.2 m-85 -132.27 173.91 10.78 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 77' ' ' PHE . 2.0 t -129.09 178.15 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.585 ' CG ' ' HB2' ' A' ' 40' ' ' ALA . 7.6 m-30 -103.08 173.08 6.46 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.514 0.197 . . . . 0.0 110.54 175.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -56.34 148.12 19.58 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 170.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.485 ' HB3' HD12 ' A' ' 32' ' ' ILE . 53.8 tt0 -47.84 105.29 0.07 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.932 177.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.5 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 52.7 mt-30 -83.97 150.93 59.71 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.362 0.601 . . . . 0.0 111.099 -175.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 5.4 Cg_exo -78.23 86.1 1.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.77 2.98 . . . . 0.0 110.975 176.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -117.75 162.08 13.14 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.559 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -96.79 5.07 51.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.255 0.55 . . . . 0.0 109.815 176.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -119.63 158.84 25.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.486 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.4 -55.54 29.09 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.586 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.6 t -124.35 124.01 67.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.549 0.69 . . . . 0.0 110.733 176.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.7 t -144.89 9.04 1.29 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.401 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.415 HE21 ' HG3' ' A' ' 80' ' ' GLN . 17.9 mt-30 -65.71 170.69 4.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.373 -176.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.701 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 53.0 mt-30 -111.35 130.88 55.54 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.214 170.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.5 HG23 ' HB2' ' A' ' 109' ' ' ALA . 7.6 p -102.29 142.4 33.58 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.329 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.901 HD11 HG22 ' A' ' 104' ' ' ILE . 20.0 tp -91.24 119.25 31.15 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.718 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 90.4 m -110.49 106.86 16.32 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.945 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.1 tp -91.39 123.63 34.96 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.725 -174.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.7 m -103.2 121.71 43.23 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.844 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.47 ' CE1' ' HG ' ' A' ' 101' ' ' LEU . 71.6 m-85 -116.71 138.91 51.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.893 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.52 HD21 ' HB ' ' A' ' 100' ' ' VAL . 33.4 p30 -75.61 -173.46 2.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.794 175.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.6 m -51.29 -44.36 61.86 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -174.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.463 ' HB3' HG23 ' A' ' 100' ' ' VAL . 33.6 t -79.78 -15.9 56.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.469 . . . . 0.0 111.068 -174.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.424 ' O ' ' HG3' ' A' ' 52' ' ' GLN . . . 96.83 29.49 8.1 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -176.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.52 ' HB ' HD21 ' A' ' 96' ' ' ASN . 14.0 t -98.24 134.68 35.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.945 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.7 mt -59.9 125.02 22.01 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.262 0.553 . . . . 0.0 112.04 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.427 HG21 ' HB3' ' A' ' 96' ' ' ASN . 5.7 p -112.78 -39.48 4.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.15 176.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -143.72 148.28 35.46 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.359 0.599 . . . . 0.0 111.908 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.901 HG22 HD11 ' A' ' 91' ' ' LEU . 4.7 mm -111.92 95.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 172.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.718 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 35.5 t0 -86.59 95.34 9.72 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.718 -174.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -102.86 104.09 14.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.704 0.764 . . . . 0.0 109.645 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.544 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 63.4 pttt -138.91 172.71 6.12 Favored Pre-proline 0 C--N 1.312 -1.035 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.733 -176.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.701 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 38.8 Cg_endo -75.59 153.71 39.22 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.721 1.614 . . . . 0.0 112.231 -177.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.5 ' HB2' HG23 ' A' ' 90' ' ' THR . . . -80.29 -178.38 6.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.206 -177.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.7 mt -61.46 112.85 2.36 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.19 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.2 m -53.78 119.74 5.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.447 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -130.76 129.5 5.83 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.795 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 . . . . . 0 C--O 1.244 0.776 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.907 -179.408 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.4 t 63.4 -91.54 0.03 OUTLIER 'General case' 0 C--O 1.234 0.244 0 C-N-CA 122.922 0.489 . . . . 0.0 110.271 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -83.54 117.76 23.34 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 18.8 ptp -73.82 105.85 5.29 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.628 0.728 . . . . 0.0 111.242 -175.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.0 p -104.59 3.92 32.29 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.551 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.87 HG22 ' H ' ' A' ' 23' ' ' LEU . 3.8 m 63.75 -157.38 0.32 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.87 ' H ' HG22 ' A' ' 22' ' ' THR . 1.3 tm? 64.99 92.81 0.07 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.312 0.577 . . . . 0.0 109.659 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -62.55 145.93 53.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.912 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 25' ' ' ARG . 5.3 tpm_? -63.93 103.76 0.62 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.608 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.843 HG22 ' H ' ' A' ' 27' ' ' VAL . 8.4 p -74.67 -167.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.522 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.843 ' H ' HG22 ' A' ' 26' ' ' VAL . 0.8 OUTLIER -50.59 153.68 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 121.875 0.845 . . . . 0.0 112.322 -171.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -84.62 117.08 23.53 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.606 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.572 ' H ' ' HD2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -89.97 164.28 28.92 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -179.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 29' ' ' ARG . 86.5 Cg_exo -46.37 160.51 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.295 2.663 . . . . 0.0 113.039 174.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.82 34.58 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.862 -176.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.961 HG22 ' H ' ' A' ' 34' ' ' GLN . 40.1 mm -85.85 150.2 3.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.37 0.605 . . . . 0.0 111.656 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.53 HD21 ' HB3' ' A' ' 79' ' ' GLN . 24.5 p-10 -65.72 -31.35 72.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.646 174.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.961 ' H ' HG22 ' A' ' 32' ' ' ILE . 27.6 pt20 -108.62 -179.31 3.83 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 173.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.98 77.73 0.19 Allowed Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.114 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -129.7 -61.6 1.0 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.926 0.393 . . . . 0.0 111.177 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -120.1 -171.09 2.09 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.874 -175.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.63 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 1.3 tp -75.95 153.16 36.82 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.725 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 26.0 p -126.12 -176.27 3.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.048 0.452 . . . . 0.0 111.995 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.494 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -62.56 -37.8 87.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.909 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -59.8 -43.27 94.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.373 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.614 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 10.5 m-20 -68.44 -29.6 68.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.962 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.011 HG22 HD22 ' A' ' 91' ' ' LEU . 85.6 t -59.79 -36.95 69.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.207 0.527 . . . . 0.0 110.45 175.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -61.26 -19.05 61.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.427 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -70.99 -42.13 70.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.794 178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.789 HG23 HD13 ' A' ' 59' ' ' LEU . 41.6 pt -84.7 -178.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.747 0.784 . . . . 0.0 112.268 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.406 ' HD2' ' N ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -171.68 152.33 3.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.326 -175.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.458 HG23 ' H ' ' A' ' 48' ' ' VAL . 0.7 OUTLIER -72.82 145.62 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.697 -179.246 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.41 -30.6 5.93 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.346 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.492 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 16.0 ptt? -90.06 178.18 6.26 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.285 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.912 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 31.1 p -95.23 -174.07 3.11 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.013 -170.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.456 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 97.8 mt-30 -63.89 -47.51 80.33 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.774 172.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.415 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 9.9 pt20 -64.56 -36.5 84.42 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.305 0.574 . . . . 0.0 109.811 -175.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.912 ' HG3' ' H ' ' A' ' 51' ' ' THR . 9.4 mm-40 -58.0 -52.47 65.38 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.323 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.652 HG11 ' CD2' ' A' ' 93' ' ' LEU . 72.2 t -67.11 -41.56 87.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.714 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.527 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -64.52 -25.68 68.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.164 0.507 . . . . 0.0 110.727 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -81.28 -35.53 30.97 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.013 0.435 . . . . 0.0 111.323 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.9 -46.14 25.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.393 0.616 . . . . 0.0 111.705 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.789 HD13 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -92.56 -21.15 20.26 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.815 -173.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.91 131.07 6.98 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -172.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.527 HG22 ' HB1' ' A' ' 56' ' ' ALA . 37.9 p -56.75 135.27 78.61 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.959 0.409 . . . . 0.0 111.118 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 51.8 Cg_exo -59.12 171.65 2.15 Favored 'Trans proline' 0 N--CA 1.471 0.157 0 C-N-CA 124.131 3.221 . . . . 0.0 115.131 -171.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.451 ' HG ' ' H ' ' A' ' 63' ' ' LEU . 8.3 mt -55.49 -41.69 73.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.257 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.463 ' HE3' HG21 ' A' ' 70' ' ' THR . 0.0 OUTLIER -60.19 -0.24 0.22 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.547 176.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 63' ' ' LEU . 33.5 p 58.86 5.44 0.5 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.214 1.006 . . . . 0.0 112.815 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -150.17 103.58 3.15 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 121.54 0.686 . . . . 0.0 109.753 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.487 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 36.0 Cg_endo -68.06 -33.03 26.62 Favored 'Trans proline' 0 C--N 1.327 -0.555 0 C-N-CA 123.245 2.63 . . . . 0.0 113.177 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -76.22 4.51 8.55 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -170.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.33 -24.72 21.03 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.086 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.463 HG21 ' HE3' ' A' ' 64' ' ' MET . 14.3 t -125.51 174.38 8.26 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.902 0.382 . . . . 0.0 110.236 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -125.78 12.52 7.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.862 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.9 m -133.55 108.81 8.83 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.21 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.487 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 42.7 m0 -109.18 130.34 55.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.412 -174.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -109.46 120.89 43.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.024 0.44 . . . . 0.0 110.967 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.583 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 50.1 m-85 -129.24 173.88 10.1 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 77' ' ' PHE . 2.9 t -123.42 175.29 6.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -176.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.573 ' H ' HG12 ' A' ' 76' ' ' VAL . 5.7 m-30 -97.86 -178.24 4.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.045 0.45 . . . . 0.0 110.721 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -69.13 137.62 53.56 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.53 ' HB3' HD21 ' A' ' 33' ' ' ASN . 36.4 tt0 -51.11 106.44 0.13 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.173 0.511 . . . . 0.0 111.638 -172.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.491 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -103.36 135.39 19.39 Favored Pre-proline 0 N--CA 1.441 -0.879 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.569 -176.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 14.3 Cg_exo -69.0 119.15 6.16 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 123.028 2.486 . . . . 0.0 112.171 -178.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.796 ' HA3' HG21 ' A' ' 87' ' ' THR . . . -130.3 -168.34 12.25 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -126.5 -25.38 3.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.201 0.524 . . . . 0.0 110.365 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -82.26 176.24 9.63 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.776 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -57.86 -55.82 28.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.306 175.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.73 134.25 66.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.168 0.509 . . . . 0.0 110.272 175.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.796 HG21 ' HA3' ' A' ' 82' ' ' GLY . 9.4 t -138.31 5.22 2.49 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.205 177.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -76.12 164.93 25.62 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.612 -177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 88.2 mt-30 -108.48 156.17 19.77 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.221 -0.9 . . . . 0.0 108.819 168.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 p -126.86 143.56 51.23 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.848 0.356 . . . . 0.0 111.53 -173.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.083 HD11 HG22 ' A' ' 104' ' ' ILE . 39.8 tp -91.8 122.94 34.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 172.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 89.9 m -117.49 103.91 10.55 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.823 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.1 tp -85.18 125.18 32.62 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.286 -174.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 21.5 m -107.35 122.87 47.46 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.264 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.597 ' CE2' HD23 ' A' ' 93' ' ' LEU . 32.5 m-85 -110.54 146.45 36.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.894 0.854 . . . . 0.0 112.695 -175.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -73.94 -179.61 3.82 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.646 -1.615 . . . . 0.0 111.171 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.4 p -59.32 -43.03 92.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.698 0.285 . . . . 0.0 111.583 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.432 ' HB3' HG23 ' A' ' 100' ' ' VAL . 35.0 t -77.69 -8.66 58.25 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.958 0.409 . . . . 0.0 110.694 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.88 31.06 10.35 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.459 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 98' ' ' SER . 22.0 t -100.77 141.64 17.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.823 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.0 mt -62.29 123.99 19.69 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.084 0.469 . . . . 0.0 111.597 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 74.1 p -111.8 -43.55 3.6 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.642 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.522 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 2.6 m-20 -136.24 150.08 48.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.812 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.083 HG22 HD11 ' A' ' 91' ' ' LEU . 2.2 mm -116.46 92.43 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 170.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.547 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 25.2 t70 -87.42 96.78 10.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.131 0.491 . . . . 0.0 111.032 -170.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.418 ' HB2' ' HZ ' ' A' ' 77' ' ' PHE . 4.4 p30 -106.84 104.75 14.5 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 122.032 0.92 . . . . 0.0 110.333 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.505 ' H ' ' HD3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -139.31 174.36 4.2 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.973 -178.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 51.8 Cg_exo -59.3 154.76 44.59 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.648 2.232 . . . . 0.0 112.115 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.45 170.3 15.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.298 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.446 ' HG ' ' H ' ' A' ' 110' ' ' LEU . 18.4 mt -49.14 -60.24 2.96 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.857 -175.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.4 t 59.64 50.5 7.19 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.731 0.776 . . . . 0.0 109.407 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 160.91 -141.09 7.1 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.098 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.154 179.532 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.844 0 N-CA-C 112.116 -0.394 . . . . 0.0 112.116 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.4 m -70.56 -25.06 62.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.124 0.488 . . . . 0.0 111.021 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -124.77 74.97 1.38 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.5 ttt -84.32 40.33 0.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.449 0.642 . . . . 0.0 110.868 -174.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 m -85.1 108.86 17.87 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.9 p 46.85 46.12 15.26 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.871 0.732 . . . . 0.0 111.574 -173.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.6 tp -90.64 90.68 8.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.141 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 56.92 -156.0 0.31 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.494 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -128.61 37.06 4.17 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.3 m -77.91 154.27 5.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.256 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.05 169.58 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-O 121.213 0.53 . . . . 0.0 110.648 -177.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -71.62 125.64 27.62 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.003 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -115.23 102.13 54.56 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.845 176.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -65.68 171.09 10.17 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.751 2.301 . . . . 0.0 111.874 173.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -63.34 -58.94 5.48 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.609 0.718 . . . . 0.0 110.344 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.471 HD13 ' HG3' ' A' ' 78' ' ' ARG . 36.5 mm -77.6 142.3 14.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.848 174.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.432 ' ND2' ' HG3' ' A' ' 34' ' ' GLN . 0.6 OUTLIER -110.24 -22.14 11.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.612 178.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.455 ' OE1' HG23 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -95.41 -169.15 1.91 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.623 179.374 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 167.76 92.95 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.846 -0.693 . . . . 0.0 111.811 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -179.5 -43.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.4 ' CD1' ' HB ' ' A' ' 76' ' ' VAL . 1.6 p90 -118.02 -171.41 2.06 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.971 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.715 ' HB3' ' HB3' ' A' ' 75' ' ' TYR . 2.3 tp -73.5 157.9 35.9 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.925 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 43' ' ' VAL . 41.6 p -126.05 -179.28 4.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.258 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . . . -65.8 -32.75 74.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.345 0.593 . . . . 0.0 110.596 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.511 ' OD1' ' HD3' ' A' ' 78' ' ' ARG . 71.7 m-20 -62.34 -43.11 99.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.86 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.633 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 30.1 m-20 -69.11 -30.9 69.27 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.969 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.877 HG22 HD22 ' A' ' 91' ' ' LEU . 70.9 t -59.82 -37.83 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.042 0.448 . . . . 0.0 110.574 175.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.6 t -58.42 -21.97 52.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.557 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -70.28 -29.67 66.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.65 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.697 HG23 HD13 ' A' ' 59' ' ' LEU . 36.7 pt -98.42 -178.14 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.812 0.815 . . . . 0.0 112.413 -178.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.25 151.27 3.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.38 -176.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.433 HG22 HD11 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -72.26 145.49 12.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.13 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.56 -35.9 3.57 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.792 -177.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.519 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 19.0 ptt? -85.27 176.81 8.11 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.165 0.507 . . . . 0.0 111.263 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.889 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 32.6 p -95.29 -174.95 3.35 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.991 -170.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.672 ' OE1' ' HA ' ' A' ' 68' ' ' PHE . 78.9 mt-30 -62.73 -48.06 80.88 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.533 172.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.535 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -64.65 -33.13 75.21 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.301 0.572 . . . . 0.0 109.843 -174.228 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.889 ' HG3' ' H ' ' A' ' 51' ' ' THR . 9.1 mm-40 -60.99 -53.08 61.62 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.562 174.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.688 HG11 ' CD2' ' A' ' 93' ' ' LEU . 75.2 t -69.43 -39.9 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.597 -176.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.689 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -59.56 -32.26 70.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.452 0.644 . . . . 0.0 110.002 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -80.87 -36.82 30.83 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.272 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.57 -49.11 19.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.941 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.697 HD13 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -90.44 -32.89 16.21 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.978 -172.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 114.25 127.69 4.5 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.274 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.689 HG22 ' HB1' ' A' ' 56' ' ' ALA . 28.4 p -60.85 132.22 91.76 Favored Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-O 121.244 0.545 . . . . 0.0 111.004 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 11.6 Cg_exo -70.77 162.27 43.16 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.529 2.82 . . . . 0.0 112.768 -173.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.48 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 1.7 mt -54.47 -33.89 60.52 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.094 -1.412 . . . . 0.0 112.235 -169.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.439 ' H ' ' HG2' ' A' ' 64' ' ' MET . 12.2 ptt? -64.16 -1.92 1.82 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.19 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.1 p 62.13 2.38 0.81 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.374 1.07 . . . . 0.0 113.534 172.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -136.76 92.53 14.59 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.501 ' HG3' HG22 ' A' ' 61' ' ' THR . 37.9 Cg_endo -67.75 -34.1 25.6 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 121.745 1.63 . . . . 0.0 111.524 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.672 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 0.2 OUTLIER -79.41 10.24 3.98 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.508 -177.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.02 -26.3 16.89 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.607 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.1 t -124.66 175.95 6.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.959 0.409 . . . . 0.0 110.432 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -126.99 13.55 7.31 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.8 m -132.57 109.78 10.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.665 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.481 ' O ' ' HA ' ' A' ' 92' ' ' THR . 46.2 m0 -107.29 149.85 27.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.594 -175.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -123.1 115.23 21.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.08 0.467 . . . . 0.0 111.051 -175.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.715 ' HB3' ' HB3' ' A' ' 38' ' ' LEU . 88.3 m-85 -127.06 174.47 8.86 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.642 HG12 ' NE2' ' A' ' 80' ' ' GLN . 4.7 t -120.97 170.19 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 118.066 0.394 . . . . 0.0 110.204 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.567 ' H ' HG12 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -95.26 -175.97 3.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.406 0.622 . . . . 0.0 112.24 -175.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.511 ' HD3' ' OD1' ' A' ' 41' ' ' ASN . 23.7 ttp180 -94.12 112.91 24.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.261 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.451 ' H ' ' NE2' ' A' ' 34' ' ' GLN . 10.4 tt0 53.64 79.92 0.12 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.862 0.839 . . . . 0.0 112.321 172.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.886 ' HG3' ' HG2' ' A' ' 88' ' ' GLN . 0.4 OUTLIER -115.89 158.69 41.62 Favored Pre-proline 0 N--CA 1.443 -0.784 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.373 -178.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.564 ' HB2' HG22 ' A' ' 87' ' ' THR . 50.5 Cg_exo -58.92 108.06 0.39 Allowed 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.975 2.45 . . . . 0.0 111.927 173.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.64 -156.23 9.94 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.193 177.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 63.59 -83.56 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.966 0.413 . . . . 0.0 111.28 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -115.71 133.0 56.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.803 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.42 60.32 6.4 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.411 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.2 t -65.81 134.02 30.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.262 0.553 . . . . 0.0 110.798 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.564 HG22 ' HB2' ' A' ' 81' ' ' PRO . 10.7 t -142.27 17.43 2.07 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.589 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.886 ' HG2' ' HG3' ' A' ' 80' ' ' GLN . 49.0 mt-30 -34.69 110.52 0.1 Allowed 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.981 0.912 . . . . 0.0 113.379 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.712 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 50.1 mt-30 -67.07 104.29 1.38 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.6 p -90.04 142.97 27.19 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.077 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.049 HD11 HG22 ' A' ' 104' ' ' ILE . 19.3 tp -91.18 105.64 17.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 32.1 m -101.81 102.46 13.07 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.871 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.9 tp -83.72 126.16 32.61 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.256 -173.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.4 m -107.91 119.9 40.76 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.263 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.505 ' CE2' HD23 ' A' ' 93' ' ' LEU . 95.5 m-85 -110.08 147.8 32.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.797 177.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.55 HD21 ' HB ' ' A' ' 100' ' ' VAL . 4.1 p30 -72.06 -87.35 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 55.0 m -150.73 -30.2 0.19 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.887 0.375 . . . . 0.0 110.75 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.471 ' HB3' HG23 ' A' ' 100' ' ' VAL . 16.6 t -82.27 -6.03 58.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.423 0.63 . . . . 0.0 109.452 177.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.52 ' HA2' HE21 ' A' ' 52' ' ' GLN . . . 89.77 29.65 15.32 Favored Glycine 0 CA--C 1.503 -0.702 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.55 ' HB ' HD21 ' A' ' 96' ' ' ASN . 25.8 t -108.25 137.13 41.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.613 -0.793 . . . . 0.0 109.458 -178.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.871 HD21 ' HG ' ' A' ' 93' ' ' LEU . 9.3 mt -61.37 130.74 47.61 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.197 0.522 . . . . 0.0 112.35 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.8 p -114.18 -37.25 4.46 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.126 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -150.06 152.96 35.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.631 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.049 HG22 HD11 ' A' ' 91' ' ' LEU . 3.3 mm -112.96 93.83 2.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 173.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.581 ' HB2' ' O ' ' A' ' 92' ' ' THR . 5.6 m-20 -80.6 96.62 6.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.688 0.28 . . . . 0.0 111.449 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -106.77 104.19 13.81 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.88 0.847 . . . . 0.0 109.917 175.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.433 ' H ' ' HD3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -146.68 164.99 21.07 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.206 -176.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.712 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 57.8 Cg_endo -77.06 158.35 34.11 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.372 2.048 . . . . 0.0 112.702 -173.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.18 178.44 7.59 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.647 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.477 ' HB2' ' H ' ' A' ' 111' ' ' SER . 9.6 mt -78.1 -90.33 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.52 -172.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.477 ' H ' ' HB2' ' A' ' 110' ' ' LEU . 8.9 t 174.7 148.86 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 82.54 133.77 1.94 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.943 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.784 -0.627 . . . . 0.0 109.901 178.334 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 112.019 -0.433 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.3 m -96.44 -0.76 48.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.722 0.296 . . . . 0.0 110.992 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -88.22 -65.7 0.99 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.794 0.33 . . . . 0.0 110.76 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 72.1 mtm -106.24 26.86 9.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.78 -174.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 t -162.0 41.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.503 0.668 . . . . 0.0 110.241 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.6 t -95.12 123.44 38.61 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.196 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.4 mt 55.63 38.16 29.81 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.289 0.566 . . . . 0.0 110.512 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -66.52 -69.1 0.32 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.236 -174.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.495 ' HG3' HG12 ' A' ' 26' ' ' VAL . 14.2 ptt-85 -115.79 -25.51 7.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.924 0.392 . . . . 0.0 110.994 -177.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.495 HG12 ' HG3' ' A' ' 25' ' ' ARG . 10.8 p -173.76 166.18 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.479 HG22 ' H ' ' A' ' 28' ' ' TYR . 0.6 OUTLIER -73.43 177.55 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 120.663 0.268 . . . . 0.0 110.673 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.479 ' H ' HG22 ' A' ' 27' ' ' VAL . 94.1 m-85 -62.28 162.54 9.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.182 0.515 . . . . 0.0 112.02 179.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -112.92 106.73 55.02 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.569 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -57.79 152.1 51.91 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.143 2.562 . . . . 0.0 112.189 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -127.76 78.43 1.82 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.613 0.72 . . . . 0.0 111.225 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.01 HG22 ' H ' ' A' ' 34' ' ' GLN . 36.1 mm -83.26 146.53 6.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.903 173.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -71.45 -4.26 25.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.992 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 1.01 ' H ' HG22 ' A' ' 32' ' ' ILE . 16.3 pt20 -144.19 -177.08 5.28 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.405 178.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.23 44.57 0.27 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -100.86 -62.94 1.18 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.091 -0.555 . . . . 0.0 110.311 -172.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -111.88 -165.7 1.01 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.845 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.648 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 5.0 tp -78.87 152.19 31.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.911 0.386 . . . . 0.0 111.005 -176.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.463 ' HB ' ' HA ' ' A' ' 78' ' ' ARG . 29.3 p -127.84 -174.1 3.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.986 175.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.18 -38.87 86.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.362 0.601 . . . . 0.0 110.869 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.598 ' ND2' HD11 ' A' ' 32' ' ' ILE . 53.9 m-80 -62.12 -41.74 98.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.468 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.518 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 10.7 m-20 -63.85 -36.75 84.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.491 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.674 HG22 HD22 ' A' ' 91' ' ' LEU . 77.0 t -59.26 -38.05 72.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.167 0.508 . . . . 0.0 110.582 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.9 t -63.03 -20.62 65.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.089 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 46.0 mtpt -70.17 -33.92 72.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.654 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.776 HG23 HD13 ' A' ' 59' ' ' LEU . 42.9 pt -89.76 -179.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.784 0.802 . . . . 0.0 112.439 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.43 149.9 2.24 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.665 -176.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.454 ' H ' HG23 ' A' ' 48' ' ' VAL . 0.6 OUTLIER -70.98 142.29 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.722 -179.212 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.69 -27.97 6.35 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.708 -176.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.522 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 21.8 ptt? -94.08 171.56 8.77 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.76 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.655 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 23.5 p -91.18 -172.83 3.43 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.723 -168.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.444 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 99.0 mt-30 -63.89 -46.81 83.21 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.143 173.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.429 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 10.4 pt20 -64.95 -35.3 80.73 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.376 0.608 . . . . 0.0 110.061 -175.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.655 ' HG3' ' H ' ' A' ' 51' ' ' THR . 1.7 mm100 -68.14 -40.58 82.38 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.303 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.665 HG11 ' CD2' ' A' ' 93' ' ' LEU . 53.9 t -74.8 -47.15 39.0 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.578 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.637 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.58 -24.83 67.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.874 0.368 . . . . 0.0 110.796 -176.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -79.82 -41.27 26.76 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.65 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.56 -44.19 71.38 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.558 0.694 . . . . 0.0 111.271 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.776 HD13 HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -88.27 -39.94 14.02 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.366 -173.044 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.6 122.87 4.07 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -171.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.637 HG22 ' HB1' ' A' ' 56' ' ' ALA . 40.2 p -57.09 133.16 80.5 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.11 0.481 . . . . 0.0 111.032 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 22.6 Cg_exo -63.28 161.78 29.38 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.582 2.855 . . . . 0.0 113.332 -170.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.409 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -56.84 -27.63 60.47 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 113.776 -1.556 . . . . 0.0 112.09 -171.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 13.2 ptt? -68.14 2.62 2.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.772 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.9 t 66.48 11.0 7.77 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.818 0.447 . . . . 0.0 112.03 172.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -162.78 104.63 1.04 Allowed Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.703 0.763 . . . . 0.0 110.458 178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.534 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 74.3 Cg_endo -77.29 -36.25 1.39 Allowed 'Trans proline' 0 C--N 1.326 -0.649 0 C-N-CA 123.171 2.581 . . . . 0.0 113.704 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -77.2 -11.62 59.84 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 113.107 0.781 . . . . 0.0 113.107 -166.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -88.32 -8.85 70.72 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.961 -173.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.1 t -124.09 174.51 7.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.954 0.407 . . . . 0.0 110.467 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -119.34 1.62 11.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.117 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.3 m -131.62 113.87 14.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.898 -175.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.563 ' O ' ' HA ' ' A' ' 92' ' ' THR . 44.4 m0 -108.69 147.12 32.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.489 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 91' ' ' LEU . 27.1 m-85 -127.68 125.26 39.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.954 0.407 . . . . 0.0 111.16 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.559 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 73.4 m-85 -133.92 173.61 11.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.798 178.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.5 t -121.27 161.62 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -88.36 -177.24 5.6 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.552 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 0.4 OUTLIER -50.34 136.94 19.36 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.751 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.569 ' HB2' ' NE2' ' A' ' 34' ' ' GLN . 5.9 tt0 -56.58 99.16 0.03 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.246 0.546 . . . . 0.0 111.94 -173.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.919 HE21 HG23 ' A' ' 87' ' ' THR . 9.1 pt20 -124.41 168.78 12.15 Favored Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.322 -178.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.559 ' HD2' ' HB2' ' A' ' 80' ' ' GLN . 32.0 Cg_exo -38.13 128.1 0.96 Allowed 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 124.063 3.176 . . . . 0.0 114.397 178.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 1.055 ' HA2' ' HA ' ' A' ' 86' ' ' VAL . . . -157.59 -143.29 3.62 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.257 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 66.04 -83.94 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.246 0.618 . . . . 0.0 111.65 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -93.7 -16.21 24.48 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 122.111 0.958 . . . . 0.0 111.064 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.14 86.93 0.13 Allowed Glycine 0 C--N 1.296 -1.659 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.381 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 1.055 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 21.3 t -83.51 140.87 15.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.228 0.537 . . . . 0.0 110.993 -173.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.919 HG23 HE21 ' A' ' 80' ' ' GLN . 13.1 t -120.35 -3.16 9.98 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.453 176.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.465 ' H ' HG12 ' A' ' 86' ' ' VAL . 2.6 mp0 -54.87 152.69 7.02 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 174.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 107' ' ' LYS . 39.5 mt-30 -107.49 125.07 50.81 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.209 160.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -89.25 135.37 33.61 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.834 -179.004 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.899 HD11 HG22 ' A' ' 104' ' ' ILE . 13.9 tp -90.08 111.5 22.63 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.666 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 34.6 m -106.65 104.2 13.83 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.906 ' HG ' HD21 ' A' ' 101' ' ' LEU . 6.7 tp -88.41 119.28 28.69 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.032 -174.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.8 m -102.43 122.26 43.95 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.557 -175.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.506 ' CE2' HD23 ' A' ' 93' ' ' LEU . 67.0 m-85 -114.63 138.11 51.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.986 -178.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.494 HD21 ' HB ' ' A' ' 100' ' ' VAL . 32.5 p30 -75.0 -172.08 1.53 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.121 176.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.5 m -62.19 -30.97 71.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.498 ' HB3' HG23 ' A' ' 100' ' ' VAL . 35.6 t -83.46 -11.87 56.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.777 0.323 . . . . 0.0 111.133 -174.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.78 28.94 14.34 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 98' ' ' SER . 6.7 t -107.87 142.91 19.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.031 -0.585 . . . . 0.0 109.648 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.906 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.5 mt -62.97 126.74 28.33 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.176 0.512 . . . . 0.0 112.204 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.486 HG21 ' HB3' ' A' ' 96' ' ' ASN . 10.8 p -113.13 -42.93 3.44 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.0 175.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -138.2 150.73 47.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.359 0.6 . . . . 0.0 111.584 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.899 HG22 HD11 ' A' ' 91' ' ' LEU . 4.7 mm -113.03 93.08 2.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 168.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.666 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 32.8 t70 -90.56 98.69 11.92 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.465 -169.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 90' ' ' THR . 4.8 p30 -110.98 101.72 10.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.201 1.001 . . . . 0.0 110.744 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.585 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 23.5 mttp -118.16 163.21 26.0 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.716 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' ' 107' ' ' LYS . 2.7 Cg_endo -63.82 137.25 57.36 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.053 1.835 . . . . 0.0 110.912 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.417 ' HB3' HG11 ' A' ' 86' ' ' VAL . . . -65.63 173.36 2.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.804 0.811 . . . . 0.0 112.912 -171.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.6 mt -52.26 -65.78 0.5 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.762 -172.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.646 ' HB2' HG23 ' A' ' 86' ' ' VAL . 8.0 m -77.12 61.08 1.99 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.969 0.414 . . . . 0.0 111.617 -177.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -133.63 -154.14 7.28 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.102 -0.952 . . . . 0.0 110.565 179.836 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.878 0 N-CA-C 112.606 -0.198 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.5 m -71.91 78.14 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -84.31 -50.65 7.65 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 170.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 62.3 mtm -120.96 -7.76 9.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.398 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.9 m -80.9 99.26 8.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.711 -176.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.7 m 64.84 93.78 0.06 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.38 0.61 . . . . 0.0 111.453 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 87.0 mt -107.8 79.86 1.32 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.304 -175.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -124.16 -86.29 0.64 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.376 0.608 . . . . 0.0 109.826 172.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -157.07 66.15 0.51 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.604 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.2 p -79.53 83.4 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 122.275 1.036 . . . . 0.0 110.628 -175.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -83.53 173.25 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.056 -177.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.5 ' O ' HG13 ' A' ' 27' ' ' VAL . 83.2 m-85 -75.3 148.45 39.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.39 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -71.99 123.34 89.32 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 171.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -42.42 123.78 2.91 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.882 3.055 . . . . 0.0 113.742 -176.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -152.56 31.13 0.52 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.583 HD12 ' HG2' ' A' ' 78' ' ' ARG . 23.7 mm -75.6 145.14 11.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.392 -1.277 . . . . 0.0 111.377 -170.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -85.03 -33.55 22.48 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.547 ' N ' HG22 ' A' ' 32' ' ' ILE . 14.8 mp0 -71.72 -156.67 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 113.56 -1.655 . . . . 0.0 109.392 172.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.58 -24.04 29.75 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.434 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -75.39 -39.44 59.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.485 0.659 . . . . 0.0 109.618 176.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -113.24 -166.51 1.09 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.399 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.744 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 1.8 mm? -70.92 140.39 50.97 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.831 0.824 . . . . 0.0 112.562 -177.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.692 ' HB ' ' HB2' ' A' ' 78' ' ' ARG . 17.3 p -131.21 -172.46 2.84 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.352 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . . . -62.62 -47.57 83.17 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -67.82 -32.64 73.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.968 0.413 . . . . 0.0 110.959 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.567 ' HB3' HD12 ' A' ' 38' ' ' LEU . 10.6 m-20 -62.76 -37.61 87.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.321 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.897 HG22 HD22 ' A' ' 91' ' ' LEU . 78.4 t -60.61 -37.73 76.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.121 0.486 . . . . 0.0 110.966 178.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.9 t -60.57 -22.84 64.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.257 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 49.8 mtpt -68.57 -34.4 75.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.648 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.81 HG23 HD13 ' A' ' 59' ' ' LEU . 44.6 pt -93.63 175.67 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 121.934 0.873 . . . . 0.0 112.51 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.65 150.96 6.1 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.955 -1.475 . . . . 0.0 109.505 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.46 HG22 ' CG1' ' A' ' 104' ' ' ILE . 0.5 OUTLIER -72.41 141.59 16.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.888 -177.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.3 -24.1 7.42 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.246 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.482 ' HE3' HG22 ' A' ' 46' ' ' ILE . 19.0 ptt? -96.57 178.12 5.44 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.226 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.2 p -95.03 -178.91 4.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.71 -169.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.486 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 27.1 mt-30 -65.56 -43.38 90.03 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.866 173.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.459 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 9.4 pt20 -64.35 -38.11 89.87 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.674 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.459 ' N ' ' HG3' ' A' ' 53' ' ' GLN . 49.3 mt-30 -66.77 -45.62 77.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.115 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.706 HG11 ' CD2' ' A' ' 93' ' ' LEU . 62.8 t -68.86 -47.64 74.94 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.598 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -62.86 -26.32 68.71 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.488 -177.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -81.33 -39.12 25.63 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.392 176.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.25 -51.93 47.07 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.105 0.955 . . . . 0.0 110.85 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.81 HD13 HG23 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -81.55 -49.61 10.36 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.044 -1.435 . . . . 0.0 111.328 -173.011 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.88 124.16 2.75 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -171.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.598 HG22 ' HB1' ' A' ' 56' ' ' ALA . 44.3 p -57.41 134.06 81.66 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.877 0.37 . . . . 0.0 110.69 -177.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.505 ' CD ' ' HB3' ' A' ' 67' ' ' PRO . 35.1 Cg_exo -60.41 157.04 37.88 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 123.498 2.799 . . . . 0.0 112.645 -172.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 1.7 mt -59.93 -27.99 67.23 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 114.502 -1.227 . . . . 0.0 111.307 -171.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.454 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 12.5 ptt? -62.85 -4.8 2.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.862 175.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 t 71.65 -3.01 2.27 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.459 0.703 . . . . 0.0 111.695 172.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.46 99.78 7.76 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-O 121.708 0.766 . . . . 0.0 110.427 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.505 ' HB3' ' CD ' ' A' ' 62' ' ' PRO . 73.0 Cg_endo -79.32 -28.43 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.712 2.275 . . . . 0.0 112.598 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -86.03 -5.31 59.24 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -168.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.79 -17.79 53.21 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.89 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.401 HG21 ' HE1' ' A' ' 64' ' ' MET . 9.0 t -123.62 172.16 9.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.914 0.388 . . . . 0.0 110.069 -177.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -128.06 20.65 6.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.322 0.582 . . . . 0.0 109.465 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 17.9 m -143.65 111.92 6.3 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.696 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.535 ' O ' ' HA ' ' A' ' 92' ' ' THR . 51.4 m0 -107.84 147.15 31.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.613 -175.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -125.68 115.27 19.83 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.791 0.329 . . . . 0.0 111.268 -174.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.586 ' HD2' HD23 ' A' ' 91' ' ' LEU . 27.7 m-85 -128.53 176.26 7.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.639 HG22 ' H ' ' A' ' 77' ' ' PHE . 4.2 p -124.32 175.13 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -176.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.639 ' H ' HG22 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -98.51 166.49 11.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.241 0.543 . . . . 0.0 111.622 -175.212 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.692 ' HB2' ' HB ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -91.53 112.7 24.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.104 -177.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.415 ' H ' ' NE2' ' A' ' 34' ' ' GLN . 35.1 tt0 51.67 74.56 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.854 0.835 . . . . 0.0 110.997 177.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.654 ' NE2' ' H ' ' A' ' 80' ' ' GLN . 0.5 OUTLIER -95.66 139.51 21.93 Favored Pre-proline 0 N--CA 1.442 -0.834 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.245 -178.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 26.9 Cg_exo -62.52 108.57 0.73 Allowed 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 123.034 2.489 . . . . 0.0 111.531 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.591 ' HA2' HG21 ' A' ' 87' ' ' THR . . . -89.82 -105.15 1.17 Allowed Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.534 -175.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.7 t60 73.6 -32.57 0.24 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.679 0.792 . . . . 0.0 110.947 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 82' ' ' GLY . 43.2 mt-10 -85.91 -171.57 3.65 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 173.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.77 -53.84 4.14 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.8 t -129.54 141.37 46.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 175.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.591 HG21 ' HA2' ' A' ' 82' ' ' GLY . 13.4 t -167.04 1.41 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.552 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.591 ' HA ' ' HG3' ' A' ' 80' ' ' GLN . 36.8 mt-30 -58.69 129.95 44.53 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.355 0.598 . . . . 0.0 111.913 -174.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.679 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 74.8 mt-30 -81.87 106.61 13.93 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.846 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 21.6 p -89.94 143.35 26.86 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.228 -174.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.993 HD11 HG22 ' A' ' 104' ' ' ILE . 24.7 tp -91.51 113.1 25.28 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.142 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.721 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 25.5 m -106.39 105.05 14.9 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.853 ' HG ' HD21 ' A' ' 101' ' ' LEU . 6.9 tp -90.83 121.65 32.87 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.401 -174.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.7 m -104.55 124.15 48.78 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.945 -176.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.501 ' CE2' HD23 ' A' ' 93' ' ' LEU . 73.9 m-85 -117.32 139.37 50.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.44 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.481 HD21 ' HB ' ' A' ' 100' ' ' VAL . 32.0 p30 -76.59 -174.36 2.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.168 174.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.0 p -57.48 -35.89 70.77 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -175.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.588 ' HB3' HG23 ' A' ' 100' ' ' VAL . 21.0 t -81.15 -4.93 56.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.189 0.518 . . . . 0.0 110.88 -174.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.53 27.95 37.45 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.45 -0.881 . . . . 0.0 110.902 -177.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.588 HG23 ' HB3' ' A' ' 98' ' ' SER . 16.7 t -104.6 138.17 30.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.235 -0.482 . . . . 0.0 109.733 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.853 HD21 ' HG ' ' A' ' 93' ' ' LEU . 7.3 mt -58.97 127.75 33.79 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.215 0.531 . . . . 0.0 111.987 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.416 HG21 ' HB3' ' A' ' 96' ' ' ASN . 7.6 p -114.3 -35.51 4.96 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.223 176.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -149.43 149.03 30.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.204 0.526 . . . . 0.0 111.915 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.993 HG22 HD11 ' A' ' 91' ' ' LEU . 3.4 mm -113.09 94.38 3.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 172.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.721 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 18.4 t70 -94.91 97.25 9.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.862 0.363 . . . . 0.0 111.674 -169.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 90' ' ' THR . 28.6 t-20 -107.69 103.37 12.65 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.723 0.773 . . . . 0.0 110.973 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.538 ' HE3' ' OD1' ' A' ' 105' ' ' ASP . 67.1 mttt -126.98 154.12 76.41 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.09 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 19.4 Cg_endo -75.56 146.44 30.71 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.939 2.426 . . . . 0.0 111.799 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.12 -179.58 3.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.285 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.8 mt -52.87 104.59 0.09 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.312 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.7 m -73.75 141.21 46.32 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.272 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 145.23 163.35 10.09 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.5 t30 . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.456 -0.783 . . . . 0.0 110.232 -179.854 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.0 t -163.92 150.73 11.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.804 0.335 . . . . 0.0 110.459 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -172.86 -54.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.757 ' HG3' ' H ' ' A' ' 21' ' ' SER . 10.9 tpt -142.59 -163.87 1.71 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.757 ' H ' ' HG3' ' A' ' 20' ' ' MET . 6.0 p -56.22 -44.8 79.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.926 0.33 . . . . 0.0 110.733 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.9 m 57.33 67.81 0.93 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.105 0.478 . . . . 0.0 112.231 173.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -111.95 177.73 4.55 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -56.64 -61.3 2.52 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -161.92 -61.86 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.5 m -133.63 135.72 55.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.747 171.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.518 HG22 ' H ' ' A' ' 28' ' ' TYR . 1.3 p -102.58 178.79 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -174.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.518 ' H ' HG22 ' A' ' 27' ' ' VAL . 77.0 m-85 -50.01 141.88 10.15 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 122.477 0.311 . . . . 0.0 110.998 176.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -74.08 156.32 87.81 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 173.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -41.09 124.0 1.99 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.985 2.457 . . . . 0.0 112.002 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -159.85 99.26 1.38 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -171.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.947 HG22 ' H ' ' A' ' 34' ' ' GLN . 34.4 mm -58.02 144.93 9.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.614 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -55.08 -32.36 61.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.641 175.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.947 ' H ' HG22 ' A' ' 32' ' ' ILE . 27.7 pt20 -112.13 25.14 11.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 122.014 0.912 . . . . 0.0 110.126 176.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -84.88 57.08 5.02 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 114.437 -1.256 . . . . 0.0 112.665 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -91.73 -29.2 16.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 170.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -105.96 -165.26 1.08 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.752 169.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.75 HD13 ' HG ' ' A' ' 59' ' ' LEU . 10.4 tp -79.29 151.77 30.9 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.929 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.495 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 40.4 p -129.21 -179.11 4.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.033 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.435 ' O ' ' HB ' ' A' ' 43' ' ' VAL . . . -65.07 -44.34 89.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.601 ' OD1' ' HD2' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -60.62 -32.58 71.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.397 179.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 5.7 m-20 -75.33 -27.77 59.37 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.857 176.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.766 HG22 HD22 ' A' ' 91' ' ' LEU . 54.4 t -60.38 -36.34 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.321 0.581 . . . . 0.0 110.05 173.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.4 t -61.8 -19.89 63.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.317 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 46.6 mtpt -74.69 -24.99 58.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.496 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.793 HG23 HD13 ' A' ' 59' ' ' LEU . 34.4 pt -101.24 176.53 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 122.068 0.937 . . . . 0.0 112.585 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.06 153.35 3.12 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.027 -176.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.461 HG22 HD11 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -71.31 144.73 13.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.961 -177.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.49 -29.6 5.63 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.448 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.648 ' HE3' HG22 ' A' ' 46' ' ' ILE . 13.5 ptt? -92.86 178.14 5.86 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.19 176.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.855 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 30.0 p -96.07 -174.1 3.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.776 -169.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.452 ' OE1' ' HA ' ' A' ' 68' ' ' PHE . 75.6 mt-30 -61.51 -47.78 84.03 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.246 173.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.534 ' HG2' ' OG1' ' A' ' 51' ' ' THR . 7.7 pt20 -63.59 -40.32 96.65 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.21 0.529 . . . . 0.0 109.977 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.855 ' HG3' ' H ' ' A' ' 51' ' ' THR . 7.3 mm-40 -60.09 -50.43 73.72 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.059 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.657 HG11 ' CD2' ' A' ' 93' ' ' LEU . 56.9 t -64.76 -48.83 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.676 -177.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.604 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.31 -26.25 68.68 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.756 -176.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -81.89 -33.73 30.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.972 0.415 . . . . 0.0 111.81 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.67 -40.61 63.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.833 0.825 . . . . 0.0 111.058 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.793 HD13 HG23 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -91.92 -41.6 10.5 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.64 -171.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.9 123.87 4.52 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 -168.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.604 HG22 ' HB1' ' A' ' 56' ' ' ALA . 33.2 p -56.35 136.45 75.84 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 120.981 0.42 . . . . 0.0 111.051 -175.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.553 ' CD ' ' HB3' ' A' ' 67' ' ' PRO . 34.3 Cg_exo -60.57 167.07 8.75 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.759 2.973 . . . . 0.0 113.556 -171.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.405 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -57.27 -30.44 64.68 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 113.637 -1.619 . . . . 0.0 111.961 -171.093 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -71.15 2.29 4.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.778 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.8 t 71.1 1.79 3.96 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.266 0.626 . . . . 0.0 112.234 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -157.62 108.59 1.82 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.73 0.776 . . . . 0.0 110.716 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.71 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 74.1 Cg_endo -75.49 -34.73 3.23 Favored 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 123.559 2.84 . . . . 0.0 113.653 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.452 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 14.4 m-85 -75.14 2.48 10.69 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -166.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.78 -20.09 45.13 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.937 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.8 t -125.61 175.28 7.67 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.839 0.352 . . . . 0.0 110.443 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -123.35 8.15 9.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.5 m -129.14 107.38 9.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.994 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.71 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 47.9 m0 -104.59 144.93 31.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.946 -173.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -122.19 120.38 34.02 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.605 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 72.1 m-85 -127.2 173.61 9.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.522 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.6 t -115.76 152.06 17.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.09 0.471 . . . . 0.0 110.096 -173.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.14 161.2 16.61 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.443 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.601 ' HD2' ' OD1' ' A' ' 41' ' ' ASN . 14.5 ttt180 -74.83 124.98 27.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.63 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 52.99 87.0 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.514 0.674 . . . . 0.0 111.331 -177.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.481 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 3.0 pp0? -119.66 144.81 37.77 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.358 -174.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.509 ' HB2' HG22 ' A' ' 87' ' ' THR . 13.5 Cg_exo -71.82 115.23 4.22 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 123.188 2.592 . . . . 0.0 111.922 174.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -132.32 -139.76 4.36 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.882 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 68.64 -85.65 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.189 0.596 . . . . 0.0 110.108 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -132.15 140.85 48.91 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.68 57.66 7.8 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -172.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.8 t -70.76 138.82 21.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.061 0.458 . . . . 0.0 110.573 -175.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.509 HG22 ' HB2' ' A' ' 81' ' ' PRO . 15.2 t -142.44 18.45 2.05 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.926 0.87 . . . . 0.0 109.493 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.578 ' HG3' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -51.99 122.09 7.83 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.666 179.627 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.58 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 43.0 mt-30 -82.04 104.45 12.39 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.695 0.759 . . . . 0.0 109.93 175.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.578 HG23 ' HG3' ' A' ' 88' ' ' GLN . 8.2 p -88.12 144.55 26.42 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.727 -172.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.857 HD11 HG22 ' A' ' 104' ' ' ILE . 13.2 tp -91.29 108.57 19.97 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.691 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 22.3 m -105.57 98.17 7.91 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.453 0.644 . . . . 0.0 109.647 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.866 ' HG ' HD21 ' A' ' 101' ' ' LEU . 6.9 tp -83.25 128.45 34.51 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.568 -173.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.0 m -114.44 124.61 52.36 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.078 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.477 ' CE2' HD23 ' A' ' 93' ' ' LEU . 87.5 m-85 -114.41 140.64 48.52 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.316 -178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.496 ' HB3' HG21 ' A' ' 102' ' ' THR . 31.6 p30 -75.27 -174.07 2.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.148 176.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.2 m -53.59 -36.62 62.14 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.485 ' HB3' HG23 ' A' ' 100' ' ' VAL . 22.9 t -85.96 -0.09 54.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.99 0.424 . . . . 0.0 110.797 -173.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.37 29.84 51.77 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.734 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 98' ' ' SER . 5.6 t -105.66 140.48 23.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.866 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.5 mt -59.89 126.37 27.31 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.219 0.533 . . . . 0.0 112.264 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.496 HG21 ' HB3' ' A' ' 96' ' ' ASN . 11.4 p -111.85 -43.52 3.6 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.812 174.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -136.82 152.29 50.11 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.446 0.641 . . . . 0.0 111.335 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.857 HG22 HD11 ' A' ' 91' ' ' LEU . 4.8 mm -114.57 92.23 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 169.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.691 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 18.6 t70 -86.89 95.08 9.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.141 0.496 . . . . 0.0 110.921 -170.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -106.89 104.17 13.78 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.636 0.731 . . . . 0.0 109.967 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.561 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -145.96 168.75 11.01 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.98 -177.407 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 39.7 Cg_endo -69.87 165.96 29.34 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 122.068 1.845 . . . . 0.0 112.691 -175.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.25 -165.35 0.18 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.939 0.876 . . . . 0.0 111.656 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 28.6 mt -68.2 105.88 2.25 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.801 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.0 t 69.01 -168.37 0.18 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.483 -177.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 106.7 158.39 21.56 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.711 -178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.8 m120 . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.484 -0.77 . . . . 0.0 110.18 178.46 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.914 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.9 m -84.88 124.01 31.13 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.696 0.284 . . . . 0.0 110.826 -177.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 62.0 71.22 0.55 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.412 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 79.2 mtp -126.12 -70.51 0.73 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.907 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.9 t 57.14 74.48 0.41 Allowed 'General case' 0 C--O 1.233 0.189 0 O-C-N 123.783 0.677 . . . . 0.0 110.255 -178.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 m -70.7 107.3 3.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.48 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.2 mt -88.65 144.66 26.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.898 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -83.41 72.66 10.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.312 0.577 . . . . 0.0 110.724 -173.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -89.48 144.89 25.69 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.748 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.0 p -78.16 122.61 33.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.147 0.499 . . . . 0.0 110.077 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.42 167.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.081 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -69.2 138.91 54.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.093 0.473 . . . . 0.0 110.589 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -71.9 129.22 88.38 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.18 -177.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.446 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 53.2 Cg_exo -55.6 169.96 1.04 Allowed 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 123.77 2.98 . . . . 0.0 112.296 171.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 30' ' ' PRO . 26.6 t70 73.51 114.32 0.06 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 122.073 0.939 . . . . 0.0 110.369 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.908 HG13 HG21 ' A' ' 39' ' ' THR . 44.5 mm -56.96 139.92 15.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.063 -1.426 . . . . 0.0 112.595 -174.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.744 HD22 ' N ' ' A' ' 33' ' ' ASN . 0.5 OUTLIER -78.41 -31.19 48.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.737 -176.625 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.456 ' N ' HG22 ' A' ' 32' ' ' ILE . 11.4 pt20 -87.75 170.37 11.29 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 173.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.91 97.01 0.15 Allowed Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.046 -1.074 . . . . 0.0 112.663 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -149.16 -60.47 0.22 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.91 -167.42 1.19 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.716 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.609 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 10.7 tp -85.27 166.71 16.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.571 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.908 HG21 HG13 ' A' ' 32' ' ' ILE . 43.4 p -127.41 177.25 6.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.128 172.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.77 -30.02 65.11 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 0.0 110.238 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.429 ' ND2' HD11 ' A' ' 32' ' ' ILE . 46.0 m-80 -53.49 -45.93 69.83 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.788 0.804 . . . . 0.0 109.759 175.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.666 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 19.9 m-20 -70.54 -30.5 67.26 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.334 -178.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.979 HG22 HD22 ' A' ' 91' ' ' LEU . 60.2 t -64.87 -41.84 93.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.257 0.551 . . . . 0.0 109.775 174.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.0 t -61.32 -32.01 71.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.315 174.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.666 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 34.3 mtpt -63.07 -43.52 98.36 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.754 176.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.587 HG23 HD13 ' A' ' 59' ' ' LEU . 43.6 pt -80.91 174.99 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-O 121.723 0.773 . . . . 0.0 111.901 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.457 ' O ' ' HG2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -163.43 143.43 8.71 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.228 -174.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.446 HG22 HD11 ' A' ' 104' ' ' ILE . 0.7 OUTLIER -70.34 140.76 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.491 -179.16 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.95 -27.09 6.9 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.965 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.537 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 23.4 ptt? -90.73 174.39 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.255 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.875 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 39.8 p -92.82 -173.78 3.42 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.888 -171.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.473 ' OE1' ' HA ' ' A' ' 68' ' ' PHE . 83.4 mt-30 -65.57 -44.33 87.08 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.515 172.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.657 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -64.97 -33.67 76.58 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.316 0.579 . . . . 0.0 110.18 -175.543 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.875 ' HG3' ' H ' ' A' ' 51' ' ' THR . 6.3 mm-40 -62.27 -53.01 61.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.222 175.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.733 HG11 HD22 ' A' ' 93' ' ' LEU . 69.1 t -69.96 -40.24 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.676 -176.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.762 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -57.44 -33.45 67.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.433 0.635 . . . . 0.0 110.053 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -81.48 -36.56 29.15 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.744 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.23 -43.3 52.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.132 0.492 . . . . 0.0 111.968 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.609 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -94.86 -14.89 24.16 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.079 -172.625 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.02 124.16 3.27 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -175.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.762 HG22 ' HB1' ' A' ' 56' ' ' ALA . 18.6 p -60.11 121.21 57.45 Favored Pre-proline 0 N--CA 1.432 -1.339 0 CA-C-O 122.295 1.045 . . . . 0.0 111.666 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 75.4 Cg_exo -52.54 159.25 4.82 Favored 'Trans proline' 0 C--N 1.327 -0.602 1 C-N-CA 125.436 4.091 . . . . 0.0 113.965 -176.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 65' ' ' SER . 0.5 OUTLIER -75.12 -21.1 59.1 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.953 -171.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.534 ' HE1' HG21 ' A' ' 70' ' ' THR . 16.9 ptt? -70.49 23.51 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.715 175.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 63' ' ' LEU . 44.5 t 77.07 -56.73 0.53 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 165.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 8.3 m-20 -126.29 99.92 30.22 Favored Pre-proline 0 C--N 1.304 -1.388 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.655 -171.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.539 ' HG3' HG22 ' A' ' 61' ' ' THR . 12.5 Cg_endo -58.75 -34.55 99.04 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.408 2.072 . . . . 0.0 111.655 176.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.522 ' CZ ' ' HB3' ' A' ' 53' ' ' GLN . 9.4 m-85 -78.99 2.48 20.25 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.81 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.0 -15.55 44.76 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.873 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.534 HG21 ' HE1' ' A' ' 64' ' ' MET . 6.1 t -124.81 175.5 7.22 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -127.39 7.82 6.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.293 0.568 . . . . 0.0 109.953 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 m -134.69 113.09 11.34 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.677 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.428 ' O ' ' HA ' ' A' ' 92' ' ' THR . 40.0 m0 -103.97 141.39 36.26 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.069 -176.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -116.41 114.64 24.54 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.372 0.606 . . . . 0.0 110.946 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.675 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 93.2 m-85 -129.41 176.61 7.82 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.525 177.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.575 HG21 ' HB3' ' A' ' 88' ' ' GLN . 1.4 p -143.27 -177.86 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.515 ' H ' HG22 ' A' ' 76' ' ' VAL . 15.5 m-30 -101.75 179.74 4.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.14 0.495 . . . . 0.0 112.162 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -61.81 133.13 55.11 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.575 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.437 ' H ' ' NE2' ' A' ' 34' ' ' GLN . 44.2 tt0 30.28 65.96 0.13 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.24 1.016 . . . . 0.0 113.372 176.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.698 ' CB ' ' HG2' ' A' ' 88' ' ' GLN . 33.0 mm-40 -82.55 159.31 64.36 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 121.747 0.784 . . . . 0.0 112.407 -177.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 11.2 Cg_exo -72.05 102.57 1.36 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 124.248 3.299 . . . . 0.0 111.446 175.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -128.11 35.42 2.73 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.159 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -130.24 -68.75 0.69 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -93.38 123.12 36.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.106 175.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.92 69.1 1.14 Allowed Glycine 0 N--CA 1.452 -0.278 0 O-C-N 124.182 0.926 . . . . 0.0 112.417 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.3 t -53.54 130.3 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.444 0.64 . . . . 0.0 110.758 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.9 t -152.13 14.19 0.61 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.646 -175.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.698 ' HG2' ' CB ' ' A' ' 80' ' ' GLN . 50.5 mt-30 -36.65 118.58 0.58 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.679 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.697 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 89.6 mt-30 -69.62 102.41 1.85 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.608 0.718 . . . . 0.0 109.298 178.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.9 p -91.07 137.11 32.62 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.966 -175.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.044 HD11 HG22 ' A' ' 104' ' ' ILE . 42.5 tp -91.71 118.77 30.96 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.88 174.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.608 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 51.1 m -110.61 103.0 11.53 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.864 ' HG ' HD21 ' A' ' 101' ' ' LEU . 6.7 tp -83.11 118.32 23.48 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.055 -174.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 72.7 m -101.17 120.85 40.83 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.531 -175.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.546 ' CE2' HD23 ' A' ' 93' ' ' LEU . 79.2 m-85 -111.96 144.92 40.49 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.856 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.503 HD21 ' HB ' ' A' ' 100' ' ' VAL . 27.2 p30 -75.64 -174.09 2.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.273 173.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.1 m -65.01 -24.93 67.65 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -174.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.43 ' HB3' HG23 ' A' ' 100' ' ' VAL . 18.1 t -85.1 -13.6 49.76 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.786 -177.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.26 30.68 8.53 Favored Glycine 0 CA--C 1.508 -0.348 0 C-N-CA 120.512 -0.851 . . . . 0.0 111.008 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.503 ' HB ' HD21 ' A' ' 96' ' ' ASN . 5.2 t -112.23 138.59 40.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.797 -0.702 . . . . 0.0 109.525 -177.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.864 HD21 ' HG ' ' A' ' 93' ' ' LEU . 8.5 mt -59.26 124.35 19.72 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 121.297 0.57 . . . . 0.0 112.442 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.468 HG21 ' HB3' ' A' ' 96' ' ' ASN . 19.3 p -111.23 -37.78 5.21 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.164 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -149.65 149.42 30.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.479 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.044 HG22 HD11 ' A' ' 91' ' ' LEU . 2.4 mm -110.19 93.32 2.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 173.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.608 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 34.0 t0 -87.76 96.0 10.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.007 0.432 . . . . 0.0 111.4 -170.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -107.89 104.11 13.51 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.587 0.708 . . . . 0.0 111.277 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.566 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -143.31 168.48 12.85 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.226 178.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.697 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 42.5 Cg_endo -70.48 162.33 42.83 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.069 1.846 . . . . 0.0 112.27 -174.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.87 177.04 0.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.012 0.91 . . . . 0.0 112.674 -177.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 111' ' ' SER . 70.1 mt -47.27 -34.46 6.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 113.077 -1.874 . . . . 0.0 114.222 -169.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.535 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 62.1 m 80.77 160.5 0.16 Allowed 'General case' 0 C--N 1.332 -0.193 0 O-C-N 124.593 1.183 . . . . 0.0 111.443 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.44 -161.27 9.66 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 176.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.5 p30 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.625 -0.702 . . . . 0.0 109.559 177.926 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.768 0 N-CA-C 111.899 -0.481 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.6 t 57.29 57.35 4.52 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.265 0.555 . . . . 0.0 109.955 -177.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -66.2 -49.55 66.93 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.147 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -140.69 7.2 2.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.029 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.2 t -169.94 134.26 1.28 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.619 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 m -87.25 -24.83 24.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.28 0.562 . . . . 0.0 109.854 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.9 mt -84.22 -36.57 22.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.627 -176.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -73.98 -21.82 59.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.845 0.355 . . . . 0.0 111.056 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.462 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 32.7 ttm180 62.25 24.98 14.91 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.768 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 25' ' ' ARG . 94.0 t 74.79 133.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.144 -175.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -57.11 152.61 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.454 0.645 . . . . 0.0 112.011 -173.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -61.61 163.44 7.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.025 -0.989 . . . . 0.0 113.349 -176.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.654 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 4.9 ptp180 -74.79 173.49 6.73 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.241 172.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.654 ' HD2' ' HB2' ' A' ' 29' ' ' ARG . 95.0 Cg_exo -41.75 129.87 3.97 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.487 2.125 . . . . 0.0 111.878 174.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -145.21 100.48 3.47 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.806 0.812 . . . . 0.0 111.068 -169.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.929 HG22 ' H ' ' A' ' 34' ' ' GLN . 39.6 mm -63.78 143.98 15.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.107 172.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.29 -18.9 61.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.039 0.447 . . . . 0.0 110.003 -178.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.929 ' H ' HG22 ' A' ' 32' ' ' ILE . 12.9 pt20 -117.15 -174.12 2.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.844 176.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 168.45 52.03 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 175.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -102.94 -43.09 5.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.954 0.407 . . . . 0.0 110.305 -175.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -113.31 -168.72 1.37 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.653 175.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.732 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 4.8 tp -80.1 152.98 29.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.618 0.247 . . . . 0.0 110.925 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.544 ' HB ' ' HA ' ' A' ' 78' ' ' ARG . 20.6 p -126.87 -174.76 3.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.079 176.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.513 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -67.34 -34.43 77.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.443 0.639 . . . . 0.0 110.574 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -64.67 -42.07 95.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.821 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.93 -27.97 66.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.025 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.784 HG22 HD22 ' A' ' 91' ' ' LEU . 58.8 t -59.84 -36.71 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.15 0.5 . . . . 0.0 110.76 176.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.9 t -59.33 -20.54 55.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.373 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 47.9 mtpt -75.58 -19.24 59.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.819 -176.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.778 HG23 HD13 ' A' ' 59' ' ' LEU . 30.0 pt -107.01 177.95 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.646 0.736 . . . . 0.0 112.46 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.92 150.69 4.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.729 -177.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.54 HG22 HD11 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -72.74 141.81 15.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.999 -179.045 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.69 -29.83 5.51 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.11 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.591 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 18.6 ptt? -88.54 178.36 6.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.184 0.492 . . . . 0.0 111.133 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.884 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 39.9 p -95.09 -174.3 3.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.207 -170.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.412 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 45.7 mt-30 -66.72 -44.12 82.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.866 174.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.64 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -65.92 -34.52 78.32 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.422 0.63 . . . . 0.0 109.823 -176.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.884 ' HG3' ' H ' ' A' ' 51' ' ' THR . 10.9 mm-40 -61.0 -57.03 14.32 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.464 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.645 HG11 ' CD2' ' A' ' 93' ' ' LEU . 90.9 t -63.42 -42.53 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.725 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.537 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.72 -35.82 73.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.082 0.468 . . . . 0.0 110.161 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -80.88 -37.22 30.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.515 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.64 -46.39 66.28 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.616 0.722 . . . . 0.0 111.215 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.778 HD13 HG23 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -88.14 -42.79 12.11 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.594 -172.103 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.79 122.01 3.76 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -171.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.537 HG22 ' HB1' ' A' ' 56' ' ' ALA . 17.9 p -54.7 136.51 64.0 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.499 0.666 . . . . 0.0 111.795 -175.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.588 ' HB2' ' HG2' ' A' ' 64' ' ' MET . 23.1 Cg_exo -64.49 165.03 21.44 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.847 3.031 . . . . 0.0 113.197 -172.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.14 -24.63 67.27 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.483 -173.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.588 ' HG2' ' HB2' ' A' ' 62' ' ' PRO . 14.6 ptt? -68.22 -1.29 5.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.806 175.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 t 71.56 6.63 5.77 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.459 0.704 . . . . 0.0 112.471 170.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -165.33 110.93 0.79 Allowed Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 121.738 0.78 . . . . 0.0 110.674 176.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.642 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 60.4 Cg_endo -73.67 -24.54 15.73 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.303 2.669 . . . . 0.0 113.525 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -80.53 -5.6 56.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -170.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.75 -18.76 59.32 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.733 -176.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.5 t -125.0 175.28 7.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.348 0.594 . . . . 0.0 111.624 -173.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -117.49 0.34 12.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.658 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.4 m -128.99 111.86 13.44 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.789 -178.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.642 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 43.8 m0 -104.03 137.36 42.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.606 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -113.28 110.09 19.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.224 0.535 . . . . 0.0 111.21 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.621 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 53.8 m-85 -125.8 175.83 7.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.602 HG22 ' H ' ' A' ' 77' ' ' PHE . 2.3 p -141.89 179.99 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.536 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.602 ' H ' HG22 ' A' ' 76' ' ' VAL . 2.9 m-30 -87.91 -172.92 4.05 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 122.599 0.36 . . . . 0.0 111.632 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.601 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 7.4 mtp180 -48.18 169.43 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.536 173.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.488 ' HB2' ' HG2' ' A' ' 34' ' ' GLN . 0.7 OUTLIER -62.97 84.79 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 172.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.851 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 6.7 mm100 -101.61 164.46 15.86 Favored Pre-proline 0 N--CA 1.444 -0.764 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.728 177.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.619 ' HD2' HG22 ' A' ' 87' ' ' THR . 51.2 Cg_exo -57.75 116.68 3.4 Favored 'Trans proline' 0 C--N 1.33 -0.416 0 C-N-CA 123.468 2.778 . . . . 0.0 112.537 174.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 83' ' ' HIS . . . -110.73 170.48 13.97 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 173.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.421 ' HB3' ' O ' ' A' ' 82' ' ' GLY . 38.9 t60 71.6 -62.55 0.45 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.807 0.443 . . . . 0.0 110.638 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -118.38 134.92 54.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.712 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 51.53 52.6 32.49 Favored Glycine 0 N--CA 1.453 -0.196 0 O-C-N 124.07 0.856 . . . . 0.0 111.731 -177.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 81' ' ' PRO . 17.4 t -67.14 135.85 27.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.604 0.716 . . . . 0.0 111.339 -172.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.642 HG23 ' HB3' ' A' ' 80' ' ' GLN . 13.2 t -134.1 5.19 3.55 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.45 173.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.851 ' HG2' ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -65.81 128.66 36.88 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.328 174.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.633 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 79.3 mt-30 -113.36 130.75 56.21 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.175 176.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER -90.8 131.1 36.65 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.902 -179.2 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.895 HD11 HG22 ' A' ' 104' ' ' ILE . 13.9 tp -90.92 108.35 19.8 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.742 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 19.2 m -103.22 104.5 14.64 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.871 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.0 tp -88.71 128.71 35.62 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.423 -173.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.2 m -115.82 123.06 47.23 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.077 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.453 ' CE1' HD23 ' A' ' 93' ' ' LEU . 93.1 m-85 -112.41 137.31 50.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.43 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.49 ' HB3' HG21 ' A' ' 102' ' ' THR . 6.1 p30 -57.22 -82.7 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -175.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.4 t -155.38 -34.3 0.09 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 100' ' ' VAL . 16.9 m -78.99 -8.11 58.65 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.243 0.544 . . . . 0.0 110.436 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.47 32.18 8.37 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.487 ' HB ' HD21 ' A' ' 96' ' ' ASN . 18.5 t -112.35 134.17 55.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.178 -0.511 . . . . 0.0 109.689 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.871 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.2 mt -61.52 125.88 25.36 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.249 0.547 . . . . 0.0 112.319 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 96' ' ' ASN . 11.2 p -111.73 -42.55 3.8 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.913 175.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -136.05 151.89 50.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.57 0.7 . . . . 0.0 111.49 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.895 HG22 HD11 ' A' ' 91' ' ' LEU . 3.1 mm -115.75 93.65 2.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 168.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.742 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 7.5 t70 -87.34 95.04 9.85 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.133 0.492 . . . . 0.0 110.415 -170.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.471 ' HB3' HD12 ' A' ' 91' ' ' LEU . 18.6 p-10 -112.3 111.38 22.2 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.842 0.83 . . . . 0.0 111.437 -176.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.604 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -147.38 170.7 7.32 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.609 177.282 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.633 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 20.3 Cg_endo -64.93 151.17 86.74 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 121.731 1.62 . . . . 0.0 112.967 -172.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.9 130.91 43.5 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.435 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.5 mt 35.14 -92.4 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 125.135 1.522 . . . . 0.0 112.722 -176.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 82.6 p 52.31 32.96 11.79 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.754 0.822 . . . . 0.0 112.704 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.59 117.05 4.28 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.858 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 . . . . . 0 C--N 1.316 -0.849 0 CA-C-O 118.531 -0.747 . . . . 0.0 109.719 178.364 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.477 ' O ' ' HD2' ' A' ' 19' ' ' HIS . . . . . . . . 0 N--CA 1.482 1.701 0 N-CA-C 112.393 -0.283 . . . . 0.0 112.393 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t 71.4 21.6 4.52 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.433 0.693 . . . . 0.0 111.414 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.477 ' HD2' ' O ' ' A' ' 17' ' ' GLY . 7.7 p80 -163.63 112.52 1.24 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -104.79 6.36 33.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.721 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 p 47.89 -99.22 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 O-C-N 124.021 0.825 . . . . 0.0 111.972 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.836 HG22 ' H ' ' A' ' 23' ' ' LEU . 2.1 m 60.3 -166.8 0.19 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.705 0.288 . . . . 0.0 110.369 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.836 ' H ' HG22 ' A' ' 22' ' ' THR . 1.0 OUTLIER -147.91 88.23 1.66 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -83.89 63.03 7.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.341 0.591 . . . . 0.0 110.079 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.566 ' HB2' HD22 ' A' ' 23' ' ' LEU . 78.5 ttt180 -72.0 -64.04 1.02 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.062 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.51 HG23 ' HG2' ' A' ' 25' ' ' ARG . 61.9 t -116.92 -56.01 3.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.917 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.574 HG22 ' H ' ' A' ' 28' ' ' TYR . 2.6 p -144.79 -178.66 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.863 -177.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.574 ' H ' HG22 ' A' ' 27' ' ' VAL . 98.7 m-85 -49.07 158.27 0.36 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.323 0.582 . . . . 0.0 112.088 175.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.554 ' HB3' ' HD2' ' A' ' 30' ' ' PRO . 16.1 mmm180 -114.63 172.47 3.58 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -178.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 29' ' ' ARG . 87.7 Cg_exo -47.24 153.41 1.75 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.9 2.4 . . . . 0.0 112.579 172.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.96 -30.87 67.27 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.367 0.603 . . . . 0.0 111.05 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.853 HG22 ' H ' ' A' ' 34' ' ' GLN . 28.8 mm -91.82 146.76 5.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.213 172.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.504 ' OD1' ' HB2' ' A' ' 79' ' ' GLN . 6.2 p-10 -71.26 -1.39 12.54 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.764 175.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.853 ' H ' HG22 ' A' ' 32' ' ' ILE . 3.6 pt20 -154.03 -178.51 7.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.302 -175.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 175.82 45.11 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.806 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -108.88 -60.26 1.77 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.34 0.591 . . . . 0.0 110.983 -177.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -102.77 -168.51 1.53 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.917 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.669 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 4.9 tp -70.56 150.56 45.97 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.044 0.449 . . . . 0.0 110.121 178.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 43.1 p -128.77 -174.29 3.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.589 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.25 -46.48 76.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.381 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.52 -27.43 69.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.155 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.503 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 14.4 m-20 -70.9 -37.0 72.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.441 173.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.851 HG22 HD22 ' A' ' 91' ' ' LEU . 67.3 t -59.63 -36.99 68.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.217 0.532 . . . . 0.0 110.784 176.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.0 t -64.77 -15.05 61.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.113 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 47.0 mtpt -81.82 -8.63 59.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.332 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.735 HG23 HD13 ' A' ' 59' ' ' LEU . 24.8 pt -112.67 178.38 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.713 0.768 . . . . 0.0 112.131 176.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.16 151.05 4.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.484 -177.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.552 HG22 HD11 ' A' ' 104' ' ' ILE . 0.8 OUTLIER -72.76 144.41 12.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.101 -177.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.25 -29.05 6.32 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.197 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.566 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 19.2 ptt? -90.24 174.79 7.41 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.119 177.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.875 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 31.2 p -91.61 -176.66 4.56 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.049 -170.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -61.46 -47.05 87.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.704 170.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -37.7 75.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.271 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.875 ' HG3' ' H ' ' A' ' 51' ' ' THR . 5.3 mm-40 -67.45 -54.38 20.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.19 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.63 HG11 ' CD2' ' A' ' 93' ' ' LEU . 73.5 t -62.11 -44.49 99.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.822 -178.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.642 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.31 -34.75 70.92 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.046 0.451 . . . . 0.0 110.104 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -82.15 -36.56 27.29 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.196 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.51 -43.34 77.01 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.772 0.796 . . . . 0.0 111.023 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.735 HD13 HG23 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -89.4 -54.74 3.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.259 -1.337 . . . . 0.0 111.183 -173.39 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 127.15 118.75 2.2 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.713 HG22 ' HG3' ' A' ' 67' ' ' PRO . 32.8 p -55.27 130.54 69.09 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.082 0.468 . . . . 0.0 111.128 -176.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 18.6 Cg_exo -64.95 172.41 7.26 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.871 3.048 . . . . 0.0 113.843 -169.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.433 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 3.9 mt -49.91 -43.24 49.49 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.877 0.735 . . . . 0.0 111.89 -173.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.0 ptt? -63.16 -3.54 1.86 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.328 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 p 59.54 3.25 0.4 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.618 1.167 . . . . 0.0 113.495 174.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -136.45 90.15 17.86 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.226 0.536 . . . . 0.0 109.866 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.713 ' HG3' HG22 ' A' ' 61' ' ' THR . 72.1 Cg_endo -74.74 -32.0 6.18 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.856 2.371 . . . . 0.0 112.128 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -77.97 7.26 6.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.2 -171.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.35 -19.76 17.57 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.085 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.9 t -124.2 165.53 17.43 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -177.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -117.96 12.81 13.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.292 0.568 . . . . 0.0 110.31 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.9 m -136.69 106.89 6.37 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.933 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.692 ' O ' ' HA ' ' A' ' 92' ' ' THR . 47.7 m0 -103.79 147.21 27.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 -173.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -124.42 124.94 43.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.063 0.459 . . . . 0.0 110.764 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.617 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 80.6 m-85 -130.28 173.42 10.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.722 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.7 t -112.07 158.04 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.956 0.407 . . . . 0.0 110.021 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -96.25 165.36 12.25 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.69 176.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.424 ' HG3' HD12 ' A' ' 32' ' ' ILE . 3.5 tmm_? -65.22 114.05 4.43 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.504 ' HB2' ' OD1' ' A' ' 33' ' ' ASN . 43.0 tt0 67.49 110.68 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 124.227 0.954 . . . . 0.0 112.193 -178.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.528 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 44.3 mt-30 -79.76 135.27 56.1 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 172.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.535 ' HG2' HG23 ' A' ' 87' ' ' THR . 3.5 Cg_exo -79.09 66.19 8.79 Favored 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 124.503 3.469 . . . . 0.0 112.429 -174.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.07 144.49 9.07 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.704 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -89.19 -22.67 22.68 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -126.98 131.0 51.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.641 175.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.33 54.97 4.48 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -171.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 88' ' ' GLN . 29.7 t -71.34 138.05 22.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.339 0.59 . . . . 0.0 111.435 -173.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.535 HG23 ' HG2' ' A' ' 81' ' ' PRO . 8.8 t -139.09 20.54 2.62 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.372 177.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.588 ' HG3' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -54.27 116.99 2.91 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.617 179.64 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.706 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 3.1 pm0 -75.14 104.01 5.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.762 0.792 . . . . 0.0 109.94 175.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.588 HG23 ' HG3' ' A' ' 88' ' ' GLN . 1.2 p -88.87 151.58 22.26 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.664 -172.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.906 HD11 HG22 ' A' ' 104' ' ' ILE . 17.5 tp -90.52 111.71 23.1 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.719 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.692 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 81.0 m -107.14 108.55 20.06 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 177.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.884 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.5 tp -91.81 126.71 36.99 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.615 -173.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 20.0 m -104.33 122.13 44.8 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.996 -177.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.52 ' CE2' HD23 ' A' ' 93' ' ' LEU . 67.2 m-85 -114.37 139.33 49.56 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.962 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.497 HD21 ' HB ' ' A' ' 100' ' ' VAL . 33.4 p30 -76.08 -175.75 3.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.432 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.9 m -52.01 -36.24 49.38 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -177.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.469 ' HB3' HG23 ' A' ' 100' ' ' VAL . 10.4 t -89.19 -0.03 57.13 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.161 -0.337 . . . . 0.0 111.182 -171.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.79 29.33 39.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.451 -0.881 . . . . 0.0 111.179 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.497 ' HB ' HD21 ' A' ' 96' ' ' ASN . 21.8 t -105.88 138.92 28.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.004 -0.598 . . . . 0.0 109.667 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.884 HD21 ' HG ' ' A' ' 93' ' ' LEU . 5.9 mt -60.9 125.5 23.94 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.175 0.512 . . . . 0.0 112.026 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.492 HG21 ' HB3' ' A' ' 96' ' ' ASN . 11.2 p -112.52 -43.35 3.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.93 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.427 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 1.9 m-20 -137.53 154.3 49.86 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.3 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.906 HG22 HD11 ' A' ' 91' ' ' LEU . 3.6 mm -115.41 92.47 2.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 169.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 92' ' ' THR . 15.4 m-20 -89.38 96.98 10.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.971 0.415 . . . . 0.0 111.441 -172.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -107.3 109.11 20.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.486 0.66 . . . . 0.0 110.516 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.711 ' H ' ' HE3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -143.86 169.31 10.58 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.259 -179.014 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.706 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 25.9 Cg_endo -66.44 154.21 75.14 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 121.844 1.696 . . . . 0.0 112.715 -173.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.21 149.66 21.68 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.211 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.6 mt 52.24 -88.44 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 O-C-N 124.625 1.203 . . . . 0.0 112.875 175.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.8 t -154.15 109.7 3.18 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -80.52 -122.42 0.48 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.665 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.2 t30 . . . . . 0 C--N 1.313 -1.003 0 CA-C-O 118.723 -0.656 . . . . 0.0 109.681 176.585 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.826 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.6 p -109.09 -32.0 7.39 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -175.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -117.79 47.61 1.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.303 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.8 ttt 62.39 80.75 0.22 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.346 0.593 . . . . 0.0 110.3 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.1 t -84.05 140.43 31.85 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.697 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.8 p -80.21 59.6 3.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.199 0.523 . . . . 0.0 111.566 -178.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.9 mt -125.94 78.3 1.74 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.799 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -104.98 -46.07 4.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.698 -176.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.478 ' NE ' ' HA ' ' A' ' 25' ' ' ARG . 3.8 mmp_? -84.41 57.59 4.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.87 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.98 148.76 18.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.25 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.95 172.94 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.198 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -74.48 118.43 17.43 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.228 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -110.28 105.04 56.83 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -48.02 128.29 16.33 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.062 2.508 . . . . 0.0 112.416 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -161.78 105.31 1.22 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -175.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.66 HG22 ' H ' ' A' ' 34' ' ' GLN . 37.4 mm -56.89 138.42 17.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.942 -175.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -30.41 49.95 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.57 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.66 ' H ' HG22 ' A' ' 32' ' ' ILE . 6.1 pt20 -102.32 -171.89 2.04 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.118 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.88 -1.93 0.72 Allowed Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.122 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -72.45 -39.83 67.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.205 0.526 . . . . 0.0 109.95 176.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -109.27 -167.59 1.23 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.423 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.718 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 2.5 mm? -77.76 153.22 33.11 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.583 0.706 . . . . 0.0 111.792 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 43' ' ' VAL . 30.6 p -128.64 -174.94 3.38 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.66 174.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -71.35 -35.0 71.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.804 0.812 . . . . 0.0 109.813 176.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -61.54 -43.88 98.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.183 -1.371 . . . . 0.0 110.388 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.426 ' HB2' HD12 ' A' ' 38' ' ' LEU . 35.0 m-20 -72.02 -30.77 65.54 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.073 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.876 HG22 HD22 ' A' ' 91' ' ' LEU . 54.6 t -57.87 -36.68 56.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.134 0.492 . . . . 0.0 110.289 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.2 t -61.85 -18.3 59.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.578 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 46.1 mtpt -74.33 -36.15 63.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.768 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.784 HG23 HD13 ' A' ' 59' ' ' LEU . 39.3 pt -87.64 178.61 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.848 0.832 . . . . 0.0 112.268 -177.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.68 150.9 2.23 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.997 -1.456 . . . . 0.0 109.467 -175.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.479 HG22 HD11 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -70.74 144.09 13.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.206 -177.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.41 -32.74 4.58 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.776 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.512 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 13.1 ptt? -87.35 177.64 7.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.017 0.437 . . . . 0.0 111.053 177.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.835 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 22.2 p -92.57 -174.76 3.76 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.904 -171.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.476 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 26.3 mt-30 -64.64 -43.88 92.28 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.921 173.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.554 ' HG3' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -66.46 -35.1 79.45 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.216 0.531 . . . . 0.0 109.996 -175.417 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.835 ' HG3' ' H ' ' A' ' 51' ' ' THR . 11.4 mm-40 -59.86 -51.12 71.06 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.729 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.658 HG11 ' CD2' ' A' ' 93' ' ' LEU . 70.5 t -68.75 -42.78 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.663 -176.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.536 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.98 -25.67 68.23 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.388 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -81.7 -40.93 22.06 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.555 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.41 -45.16 69.89 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.591 0.71 . . . . 0.0 111.332 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.784 HD13 HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -90.58 -44.09 9.78 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.232 -174.365 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.57 132.24 4.01 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -171.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.536 HG22 ' HB1' ' A' ' 56' ' ' ALA . 16.7 p -59.96 134.32 90.01 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.028 0.442 . . . . 0.0 110.684 -177.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.493 ' HG3' ' OH ' ' A' ' 75' ' ' TYR . 20.4 Cg_exo -64.16 171.97 6.94 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.902 3.068 . . . . 0.0 114.358 -169.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.499 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 7.2 mt -50.03 -47.45 53.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.244 -175.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.473 ' HE3' HG21 ' A' ' 70' ' ' THR . 0.0 OUTLIER -54.98 -12.92 0.93 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.957 179.018 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.4 t 70.75 1.58 3.78 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.292 0.568 . . . . 0.0 111.332 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -144.38 102.23 4.71 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-O 121.592 0.71 . . . . 0.0 109.435 174.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.509 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 43.5 Cg_endo -68.45 -25.8 35.16 Favored 'Trans proline' 0 C--N 1.327 -0.565 0 C-N-CA 123.198 2.599 . . . . 0.0 112.608 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -86.63 12.36 10.78 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.547 -173.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -102.39 -20.25 12.54 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.241 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.473 HG21 ' HE3' ' A' ' 64' ' ' MET . 6.6 t -126.25 172.61 9.94 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -122.03 10.14 10.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.187 0.518 . . . . 0.0 109.867 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.2 m -139.4 112.52 8.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.171 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.534 ' O ' ' HA ' ' A' ' 92' ' ' THR . 44.7 m0 -104.34 144.83 31.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.736 -176.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -121.87 112.88 18.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 110.644 -176.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.612 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 33.2 m-85 -125.4 174.69 8.0 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.54 HG22 ' H ' ' A' ' 77' ' ' PHE . 5.8 p -137.15 168.56 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.858 -174.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.54 ' H ' HG22 ' A' ' 76' ' ' VAL . 2.0 m-30 -95.04 166.19 12.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.049 -176.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.427 ' HG3' HD12 ' A' ' 32' ' ' ILE . 13.2 ttt180 -56.95 133.64 54.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.126 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.427 ' H ' ' NE2' ' A' ' 34' ' ' GLN . 6.2 tp-100 44.83 67.68 0.67 Allowed 'General case' 0 C--O 1.234 0.282 0 O-C-N 124.194 0.933 . . . . 0.0 111.461 176.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.63 ' HB2' ' HG2' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -78.93 141.13 58.57 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.194 -179.187 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 12.0 Cg_exo -73.32 93.85 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.838 2.359 . . . . 0.0 111.301 174.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.26 -12.15 14.23 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.875 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -57.29 -52.81 63.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.823 0.344 . . . . 0.0 110.805 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -155.2 143.32 20.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.236 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 113' ' ' ASN . . . 63.14 60.85 7.0 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.683 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 111' ' ' SER . 43.2 t -53.66 128.15 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.565 0.698 . . . . 0.0 111.086 -177.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.403 ' CG2' ' HG2' ' A' ' 81' ' ' PRO . 11.6 t -140.04 16.05 2.45 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.311 -177.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.63 ' HG2' ' HB2' ' A' ' 80' ' ' GLN . 77.7 mt-30 -35.71 111.95 0.15 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.548 -1.205 . . . . 0.0 113.557 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.731 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 95.5 mt-30 -73.85 104.12 4.62 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 172.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.6 p -97.58 143.9 27.8 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.972 -170.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.876 HD22 HG22 ' A' ' 43' ' ' VAL . 16.8 tp -97.81 104.0 15.99 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.716 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.691 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 24.9 m -99.51 105.18 17.06 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.839 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.7 tp -88.03 123.61 32.9 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.582 -174.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 21.6 m -105.48 123.67 48.27 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.971 -176.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.507 ' CE2' HD23 ' A' ' 93' ' ' LEU . 33.7 m-85 -111.29 151.28 28.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.894 0.854 . . . . 0.0 112.966 -175.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -75.17 -176.01 2.87 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.292 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.7 p -67.02 -41.04 87.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.848 0.356 . . . . 0.0 111.097 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.46 ' HB3' HG23 ' A' ' 100' ' ' VAL . 38.2 t -74.95 -13.82 60.57 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.112 0.482 . . . . 0.0 110.592 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 52' ' ' GLN . . . 95.04 31.01 7.9 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -176.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.46 HG23 ' HB3' ' A' ' 98' ' ' SER . 21.9 t -101.42 140.25 20.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.839 HD21 ' HG ' ' A' ' 93' ' ' LEU . 5.5 mt -60.17 126.18 26.53 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.133 0.492 . . . . 0.0 111.356 177.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 70.9 p -113.39 -45.06 3.16 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.854 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.486 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 3.4 m-20 -136.85 153.66 50.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.501 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.858 HG22 HD11 ' A' ' 91' ' ' LEU . 3.6 mm -120.13 93.52 2.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 172.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.691 ' HB2' ' HB ' ' A' ' 92' ' ' THR . 6.9 m-20 -78.23 96.41 5.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.962 0.41 . . . . 0.0 110.716 -176.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -111.2 104.33 12.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.579 0.704 . . . . 0.0 110.081 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.438 ' N ' ' HD3' ' A' ' 107' ' ' LYS . 0.4 OUTLIER -150.82 166.54 14.87 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.712 -176.069 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.731 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 36.9 Cg_endo -83.47 155.23 14.1 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.639 2.226 . . . . 0.0 111.929 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.63 170.3 16.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.005 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 47.7 mt -49.17 -37.67 23.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.463 -167.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 55.2 m 69.48 37.68 1.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.652 175.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.08 113.42 3.68 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.297 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.402 ' HB2' ' HA2' ' A' ' 85' ' ' GLY . 29.2 t-20 . . . . . 0 C--N 1.314 -0.967 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.944 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 112.126 -0.39 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.2 m -66.28 144.99 56.25 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.847 0.356 . . . . 0.0 110.589 177.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -84.46 55.38 3.36 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.099 0.476 . . . . 0.0 111.581 -173.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 47.9 ttm -176.78 42.67 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 172.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.3 t -79.59 77.19 6.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.833 -176.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 t -79.81 108.6 13.5 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.582 0.706 . . . . 0.0 109.318 175.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 99.1 mt -105.64 142.11 35.95 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.658 -174.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -79.77 49.35 1.04 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.243 178.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 69.55 147.93 0.07 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.248 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.4 m -80.33 122.35 35.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.397 0.618 . . . . 0.0 111.861 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.627 HG22 ' H ' ' A' ' 28' ' ' TYR . 3.0 p -81.62 -171.92 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.627 ' H ' HG22 ' A' ' 27' ' ' VAL . 94.5 m-85 -48.06 126.05 10.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.171 0.51 . . . . 0.0 111.479 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -82.94 155.91 67.52 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.25 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -52.18 152.91 13.82 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.479 2.786 . . . . 0.0 111.807 171.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.8 t70 67.62 103.54 0.05 OUTLIER 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.765 0.793 . . . . 0.0 109.215 -172.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.01 HG22 ' H ' ' A' ' 34' ' ' GLN . 45.2 mm -54.49 139.87 12.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.179 -1.373 . . . . 0.0 113.028 -168.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -68.07 -12.51 60.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.775 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 1.01 ' H ' HG22 ' A' ' 32' ' ' ILE . 23.4 pt20 -134.24 178.3 7.08 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.583 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.44 28.9 0.12 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.853 177.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -77.93 -26.47 48.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.062 0.458 . . . . 0.0 110.625 -175.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.34 -165.72 2.29 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.851 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.528 ' CD2' ' HG ' ' A' ' 59' ' ' LEU . 6.4 tp -70.41 154.97 41.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.172 0.511 . . . . 0.0 111.259 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.4 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 44.8 p -128.62 -178.07 4.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.292 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.509 ' HB2' ' H ' ' A' ' 78' ' ' ARG . . . -66.49 -36.61 83.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.935 0.874 . . . . 0.0 110.209 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.682 ' OD1' HD11 ' A' ' 32' ' ' ILE . 9.2 m120 -61.94 -41.4 97.92 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.382 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.574 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 16.7 m-20 -69.89 -27.01 64.45 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.238 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.862 HG22 HD22 ' A' ' 91' ' ' LEU . 63.0 t -62.75 -37.03 78.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.322 0.582 . . . . 0.0 110.391 174.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -65.63 -16.55 63.84 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.807 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.574 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 45.5 mtpt -73.76 -29.51 62.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.656 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.742 HG23 HD13 ' A' ' 59' ' ' LEU . 40.3 pt -92.7 -178.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 121.795 0.807 . . . . 0.0 111.798 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.41 149.74 5.93 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.424 -177.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.542 HG22 HD11 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -71.48 148.0 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.505 -178.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.86 -30.22 7.58 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.215 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.523 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 19.9 ptt? -84.97 173.03 10.86 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.938 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.852 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 19.1 p -89.72 -174.32 4.26 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.438 -170.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 95' ' ' PHE . 37.1 mt-30 -64.89 -43.15 93.83 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.855 174.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 11.3 pt20 -65.8 -35.75 81.57 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.448 0.642 . . . . 0.0 109.913 -175.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.852 ' HG3' ' H ' ' A' ' 51' ' ' THR . 9.8 mm-40 -58.91 -55.22 37.92 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.297 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.682 HG11 HD22 ' A' ' 93' ' ' LEU . 92.8 t -66.73 -41.05 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.492 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.709 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -58.56 -34.45 71.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.184 0.516 . . . . 0.0 110.103 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -82.47 -38.81 23.39 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.755 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.58 -46.66 65.82 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.546 0.688 . . . . 0.0 111.343 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.742 HD13 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -92.1 -29.67 16.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.751 -173.08 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.55 127.85 6.02 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.709 HG22 ' HB1' ' A' ' 56' ' ' ALA . 34.9 p -59.9 134.09 89.79 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-O 121.237 0.541 . . . . 0.0 110.794 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 21.2 Cg_exo -65.85 162.12 36.33 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.189 2.592 . . . . 0.0 111.699 -174.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.438 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 1.2 mt -49.14 -33.53 12.25 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.57 -168.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.434 ' H ' ' HG2' ' A' ' 64' ' ' MET . 9.7 ptt? -62.55 -6.39 3.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 92.8 p 58.92 8.71 1.02 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.392 1.077 . . . . 0.0 112.503 177.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.434 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 1.9 t70 -141.21 94.77 7.62 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 122.021 0.915 . . . . 0.0 109.749 177.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.604 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 74.3 Cg_endo -75.26 -34.56 3.52 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.294 2.663 . . . . 0.0 113.356 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -79.55 2.94 20.34 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -174.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.08 -23.95 42.89 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.539 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.8 t -124.23 174.89 7.39 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -123.57 4.25 8.96 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.8 m -125.61 109.64 12.88 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.19 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.604 ' CZ2' ' HB2' ' A' ' 67' ' ' PRO . 45.2 m0 -108.18 140.25 41.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.55 -176.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -117.17 112.45 20.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.34 0.591 . . . . 0.0 111.24 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.673 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 88.1 m-85 -113.31 174.92 5.67 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.982 174.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.504 HG23 ' CD ' ' A' ' 88' ' ' GLN . 2.5 p -122.28 150.51 25.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.206 0.526 . . . . 0.0 110.038 -174.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.53 -176.86 6.01 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.427 -175.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.705 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 62.9 ttt180 -50.03 147.72 3.8 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.146 174.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -46.61 95.31 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -175.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.705 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 7.7 mm100 -106.35 162.77 18.64 Favored Pre-proline 0 N--CA 1.448 -0.559 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.508 172.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.13 101.16 0.18 Allowed 'Trans proline' 0 C--N 1.33 -0.417 0 C-N-CA 123.437 2.758 . . . . 0.0 111.941 173.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.07 30.19 4.88 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.823 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -96.19 -49.58 5.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.358 0.599 . . . . 0.0 109.669 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -146.89 136.59 23.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.489 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.5 62.61 6.07 Favored Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -173.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 88' ' ' GLN . 20.9 t -55.8 133.9 19.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.686 0.755 . . . . 0.0 112.352 -171.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.4 t -127.63 11.2 6.72 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.178 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.504 ' CD ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -68.4 132.94 47.91 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.563 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.678 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 27.2 mt-30 -102.8 107.57 18.48 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 173.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.403 HG23 ' HB2' ' A' ' 109' ' ' ALA . 3.4 p -86.45 150.98 23.9 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.898 -172.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.966 HD11 HG22 ' A' ' 104' ' ' ILE . 22.1 tp -89.54 107.51 19.12 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.527 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 73' ' ' TRP . 23.8 m -99.03 101.53 12.94 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.865 ' HG ' HD21 ' A' ' 101' ' ' LEU . 8.0 tp -87.12 122.96 31.65 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.985 -174.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 103' ' ' ASN . 27.6 m -104.14 118.13 35.91 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.077 -176.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.605 ' CE2' HD23 ' A' ' 93' ' ' LEU . 31.4 m-85 -105.63 149.29 26.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.737 0.78 . . . . 0.0 111.862 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -73.92 173.13 10.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.557 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.5 m -57.64 -36.87 72.43 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.794 0.331 . . . . 0.0 110.664 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.462 ' HB3' HG23 ' A' ' 100' ' ' VAL . 18.7 t -80.98 -4.1 53.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 120.927 0.394 . . . . 0.0 110.885 -177.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.36 30.01 26.02 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.402 -179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 98' ' ' SER . 21.4 t -105.99 138.88 29.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.865 HD21 ' HG ' ' A' ' 93' ' ' LEU . 5.9 mt -61.76 124.09 19.78 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.075 0.464 . . . . 0.0 111.747 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.0 p -114.02 -39.72 3.88 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.11 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.5 ' HB2' ' HB ' ' A' ' 94' ' ' THR . 5.1 m-20 -136.76 154.6 50.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.554 0.692 . . . . 0.0 111.54 177.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.966 HG22 HD11 ' A' ' 91' ' ' LEU . 3.0 mm -118.73 92.38 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 168.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 92' ' ' THR . 13.3 m-20 -86.84 95.86 10.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.838 0.351 . . . . 0.0 110.947 -174.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -99.18 101.06 12.27 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.146 0.974 . . . . 0.0 109.634 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.459 ' HE3' ' HB3' ' A' ' 105' ' ' ASP . 71.2 mttt -137.06 154.7 76.14 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.289 -172.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.678 ' HA ' ' HA ' ' A' ' 89' ' ' GLN . 1.0 OUTLIER -60.41 132.67 44.8 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.681 2.254 . . . . 0.0 111.892 -174.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.403 ' HB2' HG23 ' A' ' 90' ' ' THR . . . -67.97 134.83 51.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.438 -172.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 57.9 mt 28.09 -90.15 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 O-C-N 125.553 1.783 . . . . 0.0 114.23 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.9 m -82.68 40.59 0.68 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 122.951 0.501 . . . . 0.0 112.192 -174.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -98.82 -157.6 29.41 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.716 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.5 t30 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.778 -0.629 . . . . 0.0 110.064 179.167 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.645 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.7 t 64.86 23.22 12.62 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.911 0.484 . . . . 0.0 111.46 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.53 80.28 1.29 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.102 0.477 . . . . 0.0 109.859 177.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -151.39 175.65 12.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.926 -177.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 75.6 m 59.59 45.96 12.58 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.612 0.57 . . . . 0.0 110.953 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.91 -40.8 53.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.647 178.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.6 tp 57.82 97.35 0.02 OUTLIER 'General case' 0 C--O 1.237 0.418 0 O-C-N 123.813 0.695 . . . . 0.0 112.582 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -76.0 -176.69 3.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.965 174.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -66.95 -82.51 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t 66.26 -67.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.61 HG22 ' H ' ' A' ' 28' ' ' TYR . 3.1 p -135.86 -160.09 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -171.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.61 ' H ' HG22 ' A' ' 27' ' ' VAL . 95.4 m-85 -46.88 111.02 0.34 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.981 0.419 . . . . 0.0 111.06 176.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -91.61 113.65 59.34 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.665 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.28 129.02 29.62 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.616 2.211 . . . . 0.0 111.075 172.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -69.15 -30.6 68.87 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.779 0.799 . . . . 0.0 110.247 -176.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.885 HG22 ' H ' ' A' ' 34' ' ' GLN . 41.0 mm -83.81 142.21 13.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.941 176.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -77.76 0.79 22.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.786 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.885 ' H ' HG22 ' A' ' 32' ' ' ILE . 9.8 pt20 -145.81 29.7 1.1 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.872 0.844 . . . . 0.0 110.325 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.57 58.4 4.71 Favored Glycine 0 C--N 1.318 -0.432 0 CA-C-N 114.266 -1.333 . . . . 0.0 112.317 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -128.1 -42.91 1.51 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -100.65 -164.94 1.16 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.633 -0.876 . . . . 0.0 108.633 172.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.676 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 3.0 tp -81.36 143.31 32.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.418 0.628 . . . . 0.0 111.568 -175.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.721 ' HB ' ' HB3' ' A' ' 78' ' ' ARG . 43.8 p -128.17 -175.24 3.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.93 177.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.561 ' HB2' ' CG ' ' A' ' 77' ' ' PHE . . . -65.65 -33.29 75.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.058 0.456 . . . . 0.0 110.811 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -59.47 -43.46 93.25 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.739 0.78 . . . . 0.0 109.717 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.409 ' HB2' ' HG ' ' A' ' 38' ' ' LEU . 6.9 m-20 -70.17 -34.29 72.82 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.633 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.793 HG22 HD22 ' A' ' 91' ' ' LEU . 55.9 t -55.59 -36.51 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.046 0.45 . . . . 0.0 111.154 177.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 t -64.27 -11.43 31.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.64 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.446 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 47.8 mtpt -80.53 -26.34 38.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.733 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.81 HG23 HD13 ' A' ' 59' ' ' LEU . 38.4 pt -95.49 -178.5 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.797 0.808 . . . . 0.0 112.305 -178.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.25 152.7 3.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.585 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.457 ' H ' HG23 ' A' ' 48' ' ' VAL . 0.5 OUTLIER -72.73 144.07 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.265 -178.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.19 -32.47 4.72 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.954 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.53 ' HB2' ' CG ' ' A' ' 54' ' ' GLN . 18.4 ptt? -90.07 177.14 6.53 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.551 -0.459 . . . . 0.0 111.488 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.912 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 62.4 p -94.0 -174.97 3.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.467 -170.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.47 ' O ' ' HH2' ' A' ' 73' ' ' TRP . 97.9 mt-30 -64.79 -42.26 95.18 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.581 172.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.423 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 9.2 pt20 -67.01 -37.97 85.15 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.705 -177.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.912 ' HG3' ' H ' ' A' ' 51' ' ' THR . 5.7 mm-40 -58.98 -53.2 61.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.966 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.645 HG11 ' CD2' ' A' ' 93' ' ' LEU . 74.7 t -66.5 -46.39 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.997 -176.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.595 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -64.33 -26.61 68.55 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.636 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -81.48 -37.28 28.18 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.614 177.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.98 -48.87 41.87 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.922 0.868 . . . . 0.0 110.78 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.81 HD13 HG23 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -84.21 -55.37 4.22 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.16 -173.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.72 133.35 3.23 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 -172.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.595 HG22 ' HB1' ' A' ' 56' ' ' ALA . 39.4 p -68.32 130.91 92.04 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-O 121.238 0.542 . . . . 0.0 110.386 -177.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.532 ' HG2' ' HE2' ' A' ' 64' ' ' MET . 6.9 Cg_exo -69.75 160.89 48.01 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.177 2.584 . . . . 0.0 113.062 -170.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.78 -28.33 69.38 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.506 -171.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.532 ' HE2' ' HG2' ' A' ' 62' ' ' PRO . 10.7 ptt? -61.79 -4.28 1.44 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.111 177.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.4 t 73.54 -4.0 2.34 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 170.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -146.86 99.71 4.01 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-O 120.907 0.384 . . . . 0.0 110.954 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.432 ' HB2' ' CZ2' ' A' ' 73' ' ' TRP . 39.6 Cg_endo -70.13 -30.95 19.76 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.074 1.85 . . . . 0.0 111.527 175.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -85.72 12.02 9.8 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.535 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.82 -20.27 13.33 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.884 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.7 t -125.84 174.0 8.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.646 0.26 . . . . 0.0 110.375 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -117.95 -1.09 11.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.266 174.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.8 m -125.26 111.42 15.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.542 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.47 ' HH2' ' O ' ' A' ' 52' ' ' GLN . 42.7 m0 -104.12 141.3 36.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.366 -177.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -118.68 118.97 33.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.113 0.482 . . . . 0.0 110.844 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.599 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 63.9 m-85 -127.87 174.41 9.18 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 176.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.489 HG22 ' H ' ' A' ' 77' ' ' PHE . 2.7 p -129.15 167.54 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.127 -173.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.561 ' CG ' ' HB2' ' A' ' 40' ' ' ALA . 7.2 m-30 -107.13 141.11 38.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.265 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.721 ' HB3' ' HB ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -72.28 130.3 40.46 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.792 -175.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 7.4 tp-100 172.43 -105.19 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.486 -177.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.488 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 22.1 pt20 -83.56 140.1 41.27 Favored Pre-proline 0 C--N 1.303 -1.456 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.915 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 80' ' ' GLN . 4.3 Cg_exo -75.77 99.79 1.31 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.074 2.516 . . . . 0.0 110.425 173.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.39 45.89 3.57 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.921 -170.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -89.3 77.55 7.41 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 172.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.709 ' HG2' ' H ' ' A' ' 85' ' ' GLY . 22.3 tt0 -178.31 -151.36 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -169.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.709 ' H ' ' HG2' ' A' ' 84' ' ' GLU . . . -72.38 80.07 0.64 Allowed Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 167.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.6 t -36.3 123.71 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 O-C-N 124.729 0.899 . . . . 0.0 112.904 -170.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 111' ' ' SER . 8.9 t -139.59 12.81 2.53 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.509 -175.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.457 HE21 ' HB3' ' A' ' 88' ' ' GLN . 0.6 OUTLIER -66.83 -157.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 122.726 1.25 . . . . 0.0 111.782 178.153 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 108' ' ' PRO . 90.7 mt-30 -118.34 143.95 46.23 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.553 -1.658 . . . . 0.0 107.506 167.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.3 p -131.73 143.99 50.65 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -170.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.965 HD11 HG22 ' A' ' 104' ' ' ILE . 16.3 tp -95.71 123.52 39.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.192 174.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.685 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 34.4 m -114.53 101.26 8.95 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.845 ' HG ' HD21 ' A' ' 101' ' ' LEU . 7.2 tp -88.3 126.34 35.13 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.996 -173.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.8 m -112.4 123.22 49.81 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.889 -175.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.537 ' CE2' HD23 ' A' ' 93' ' ' LEU . 80.2 m-85 -113.27 141.25 47.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.884 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.495 ' HB3' HG21 ' A' ' 102' ' ' THR . 32.1 p30 -75.41 -173.63 2.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.903 175.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.4 m -56.29 -35.1 67.11 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -174.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.427 ' HB3' HG23 ' A' ' 100' ' ' VAL . 20.8 t -88.83 9.74 23.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.814 0.34 . . . . 0.0 111.059 -175.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.75 33.85 76.62 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.091 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.48 ' HB ' HD21 ' A' ' 96' ' ' ASN . 7.6 t -106.12 140.06 25.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.845 HD21 ' HG ' ' A' ' 93' ' ' LEU . 6.3 mt -62.17 124.42 20.8 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.43 0.633 . . . . 0.0 112.246 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.495 HG21 ' HB3' ' A' ' 96' ' ' ASN . 18.0 p -111.03 -43.94 3.68 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.612 -1.177 . . . . 0.0 109.965 175.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -136.67 152.75 50.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.745 0.783 . . . . 0.0 111.692 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.965 HG22 HD11 ' A' ' 91' ' ' LEU . 3.6 mm -117.86 93.61 2.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 170.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.685 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 23.4 t70 -87.03 96.47 10.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.948 0.404 . . . . 0.0 110.624 -173.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -105.62 104.31 14.0 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.85 0.834 . . . . 0.0 109.898 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.637 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 22.5 pttm -140.75 177.95 1.76 Allowed Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.773 -176.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.637 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 56.2 Cg_endo -72.51 173.42 13.27 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 121.231 1.287 . . . . 0.0 112.258 -177.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.88 -176.93 3.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.549 0.69 . . . . 0.0 112.237 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.4 mt -58.01 -52.58 64.92 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.139 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 87' ' ' THR . 41.9 t -123.33 164.21 19.26 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.085 -172.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.86 96.65 0.94 Allowed Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.53 173.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.6 m120 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.812 176.046 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.8 m -69.24 -35.71 76.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.979 0.39 . . . . 0.0 110.509 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -157.84 21.12 0.27 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.499 172.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.42 -81.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 175.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.7 p -121.73 -67.31 0.97 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.857 HG22 ' HG2' ' A' ' 24' ' ' GLU . 2.1 m 61.99 91.54 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.466 172.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 23' ' ' LEU . 5.8 mp -83.34 65.16 8.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.014 -175.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.857 ' HG2' HG22 ' A' ' 22' ' ' THR . 19.8 mm-40 -86.69 71.82 10.3 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.102 0.477 . . . . 0.0 110.956 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -97.52 93.27 6.35 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.046 0.451 . . . . 0.0 109.939 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.32 -178.48 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.717 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.528 HG22 ' H ' ' A' ' 28' ' ' TYR . 2.3 p -131.96 178.31 5.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.02 -177.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.528 ' H ' HG22 ' A' ' 27' ' ' VAL . 83.2 m-85 -49.08 130.65 18.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.1 0.476 . . . . 0.0 112.176 176.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -130.84 121.72 19.12 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.62 170.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.38 122.45 11.25 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.699 2.266 . . . . 0.0 112.28 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.4 t70 179.29 97.5 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.27 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.938 HG22 ' H ' ' A' ' 34' ' ' GLN . 31.3 mm -73.56 140.07 18.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.212 0.53 . . . . 0.0 111.055 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -99.29 -8.54 24.8 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.798 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.938 ' H ' HG22 ' A' ' 32' ' ' ILE . 9.2 pt20 -127.22 48.97 2.14 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.626 -165.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.19 52.09 3.99 Favored Glycine 0 C--N 1.313 -0.749 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.316 172.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -121.03 -48.03 2.25 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -107.18 -162.43 0.84 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.743 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.62 ' CD1' ' HG ' ' A' ' 59' ' ' LEU . 4.5 tp -82.76 151.54 26.11 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.114 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.7 p -127.7 -175.78 3.57 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.631 174.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . . . -70.19 -31.53 69.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.053 0.454 . . . . 0.0 110.904 178.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -60.05 -41.19 91.79 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.563 0.696 . . . . 0.0 109.776 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 11.4 m-20 -67.9 -37.11 81.32 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.887 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.857 HG22 HD22 ' A' ' 91' ' ' LEU . 81.2 t -60.04 -40.66 83.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.77 0.319 . . . . 0.0 111.094 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.1 p -64.5 -18.93 65.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.025 0.441 . . . . 0.0 111.028 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 30.1 mtpp -77.54 -28.42 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.987 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.587 HG23 HD13 ' A' ' 59' ' ' LEU . 43.5 pt -89.56 174.08 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-O 121.758 0.79 . . . . 0.0 111.822 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 50' ' ' MET . 0.0 OUTLIER -163.4 143.33 8.71 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.719 -176.252 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.467 HG22 HG12 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -69.61 142.27 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.484 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 120.19 -30.69 5.55 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.86 -175.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.553 ' HE1' ' HA ' ' A' ' 46' ' ' ILE . 21.2 ptt? -87.11 175.12 8.24 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.813 176.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.839 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 23.6 p -92.99 -170.0 2.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.846 -171.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -67.51 -46.33 73.19 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.611 173.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.449 ' HG3' ' N ' ' A' ' 54' ' ' GLN . 11.9 pt20 -61.98 -38.8 89.96 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.832 -176.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.839 ' HG3' ' H ' ' A' ' 51' ' ' THR . 7.1 mm-40 -59.52 -46.37 89.04 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.303 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.692 HG11 ' CD2' ' A' ' 93' ' ' LEU . 58.4 t -73.24 -43.46 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.834 -176.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.6 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -63.11 -24.01 67.7 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.261 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -80.04 -39.47 29.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.773 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.66 -44.06 44.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.008 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.62 ' HG ' ' CD1' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -93.07 -10.03 37.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.917 -172.531 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.66 129.14 1.57 Allowed Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.6 HG22 ' HB1' ' A' ' 56' ' ' ALA . 41.3 p -56.11 131.52 74.56 Favored Pre-proline 0 N--CA 1.439 -0.986 0 CA-C-O 122.028 0.918 . . . . 0.0 111.835 -176.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 67' ' ' PRO . 74.8 Cg_exo -50.6 165.94 0.37 Allowed 'Trans proline' 0 C--N 1.332 -0.333 1 C-N-CA 125.742 4.295 . . . . 0.0 115.431 -176.381 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.478 ' H ' ' HG ' ' A' ' 63' ' ' LEU . 8.1 mt -51.7 -49.28 62.77 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.655 -177.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.471 ' HE3' HG21 ' A' ' 70' ' ' THR . 0.0 OUTLIER -54.1 -13.55 0.85 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.986 179.543 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.0 t 76.11 -17.79 0.51 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.359 0.664 . . . . 0.0 112.066 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -122.21 92.96 48.81 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-O 121.971 0.891 . . . . 0.0 109.819 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.57 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 29.0 Cg_endo -64.49 -30.59 61.76 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.619 2.212 . . . . 0.0 112.493 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -81.35 13.84 2.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.718 -173.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -102.93 -25.15 7.68 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.091 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.471 HG21 ' HE3' ' A' ' 64' ' ' MET . 6.6 t -124.13 169.23 11.91 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -120.52 1.64 10.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.651 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.8 m -118.15 109.08 15.96 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.959 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.416 ' O ' ' HA ' ' A' ' 92' ' ' THR . 46.9 m0 -106.84 134.34 50.12 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.687 -176.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -113.36 125.92 54.79 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.161 0.288 . . . . 0.0 110.661 -177.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.562 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 60.8 m-85 -135.14 174.93 10.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.424 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.426 HG12 ' OE1' ' A' ' 88' ' ' GLN . 0.1 OUTLIER -118.38 162.99 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 120.849 0.357 . . . . 0.0 110.264 -177.106 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.414 ' HB2' ' H ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -98.71 -176.43 3.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.464 -176.516 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.449 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 8.2 ttm180 -65.0 119.39 10.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.727 178.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.708 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . 9.0 tt0 63.36 119.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 O-C-N 124.341 1.026 . . . . 0.0 113.253 177.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 1.109 ' HA ' ' HG2' ' A' ' 88' ' ' GLN . 30.4 mt-30 -75.38 169.61 19.62 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.243 174.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.818 ' HD2' ' HB3' ' A' ' 80' ' ' GLN . 11.0 Cg_exo -34.24 115.92 0.1 OUTLIER 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 123.818 3.012 . . . . 0.0 113.021 -174.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.39 -77.8 0.44 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 114.469 -1.242 . . . . 0.0 113.204 -171.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -135.45 -66.32 0.57 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -117.48 131.02 56.8 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 171.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.84 125.51 1.39 Allowed Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.7 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 88' ' ' GLN . 58.6 t -73.04 126.26 33.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.297 0.57 . . . . 0.0 110.415 177.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.8 t -103.73 0.97 31.21 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.924 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 1.109 ' HG2' ' HA ' ' A' ' 80' ' ' GLN . 13.9 mm-40 -73.46 152.87 40.59 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.916 0.865 . . . . 0.0 112.435 177.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.414 ' H ' ' HB2' ' A' ' 77' ' ' PHE . 36.0 mt-30 -145.2 125.7 14.06 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.712 -1.585 . . . . 0.0 108.636 175.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.93 128.58 36.25 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.234 0.54 . . . . 0.0 110.911 -175.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.052 HD11 HG22 ' A' ' 104' ' ' ILE . 21.3 tp -90.16 115.48 27.43 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.056 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.718 ' HB ' ' HB3' ' A' ' 105' ' ' ASP . 11.8 m -109.2 95.62 5.75 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.766 ' HG ' HD21 ' A' ' 101' ' ' LEU . 8.3 tp -81.39 125.1 29.99 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.38 -171.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 37.2 m -107.45 121.64 45.02 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.178 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.532 ' CE2' HD23 ' A' ' 93' ' ' LEU . 77.3 m-85 -115.28 139.71 49.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.537 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.499 ' HB3' HG21 ' A' ' 102' ' ' THR . 32.0 p30 -74.52 -176.38 2.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.614 175.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.2 t -55.13 -37.21 66.64 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -176.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.452 ' HB3' HG23 ' A' ' 100' ' ' VAL . 19.0 t -82.17 2.29 32.31 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.784 0.326 . . . . 0.0 111.059 -174.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.99 31.16 56.21 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.922 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.472 ' HB ' HD21 ' A' ' 96' ' ' ASN . 6.7 t -107.57 139.78 28.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.766 HD21 ' HG ' ' A' ' 93' ' ' LEU . 7.3 mt -60.87 124.8 21.51 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.237 0.541 . . . . 0.0 112.0 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.499 HG21 ' HB3' ' A' ' 96' ' ' ASN . 10.1 p -113.01 -35.92 5.27 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.049 176.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -148.76 148.46 30.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.441 0.639 . . . . 0.0 111.932 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.052 HG22 HD11 ' A' ' 91' ' ' LEU . 5.6 mm -106.01 93.21 2.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 170.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.718 ' HB3' ' HB ' ' A' ' 92' ' ' THR . 17.6 t70 -81.58 97.3 7.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.141 0.496 . . . . 0.0 110.643 -171.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -105.38 110.78 23.26 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.363 0.601 . . . . 0.0 109.814 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.538 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 13.3 ptmm? -136.3 174.91 3.96 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.823 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 30.1 Cg_endo -79.62 155.8 24.39 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.898 1.732 . . . . 0.0 111.265 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.92 172.36 12.85 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.627 0.727 . . . . 0.0 112.418 -175.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mt -85.57 -55.28 4.07 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.401 -175.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 21.9 t -138.98 -162.68 1.35 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.397 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 133.2 -22.53 3.97 Favored Glycine 0 CA--C 1.498 -1.03 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 . . . . . 0 C--N 1.305 -1.353 0 CA-C-N 113.775 -1.213 . . . . 0.0 109.664 176.941 . . . . . . . . 0 0 . 1 stop_ save_